The table below lists the options of the executed module.
Option | Value |
---|---|
analyze.sites | yes |
differential.report.sites | yes |
region.types | tiling, genes, promoters, cpgislands |
differential.permutations | 0 |
differential.comparison.columns | tissue, blood_lineage, differentiation_level_blood, differentiation_level_skin, cmp_blood_CLP_CMP |
differential.comparison.columns.all.pairwise | blood_lineage, differentiation_level_blood, differentiation_level_skin |
columns.pairing | default |
differential.site.test.method | limma |
differential.variability | no |
differential.variability.method | diffVar |
covariate.adjustment.columns | default |
differential.adjustment.sva | yes |
differential.adjustment.celltype | yes |
differential.enrichment.go | yes |
differential.enrichment.lola | no |
differential.enrichment.lola.dbs | ${LOLACore} |
Differential methylation analysis was conducted on site and region level according to the sample groups specified in the analysis.
The following comparisons were made:
In the following anlyses, p-values on the site level were computed using the limma
method. I.e. hierarchical linear models from the limma package were employed and fitted using an empirical Bayes approach on derived M-values.
Differential methylation on the site level was computed based on a variety of metrics. Of particular interest for the following plots and analyses are the following quantities for each site: a) the difference in mean methylation levels of the two groups being compared, b) the quotient in mean methylation and c) a statistical test (limma or t-test depending on the settings) assessing whether the methylation values in the two groups originate from distinct distributions. Additionally each site was assigned a rank based on each of these three criteria. A combined rank is computed as the maximum (i.e. worst) rank among the three ranks. The smaller the combined rank for a site, the more evidence for differential methylation it exhibits. This section includes scatterplots of the site group means as well as volcano plots of each pairwise comparison colored according to the combined ranks or p-values of a given site.
The following rank cutfoffs have been automatically selected for the analysis of differentially methylated sites:
Rank Cutoff | |
blood vs. skin (based on tissue) | 136763 |
lymphoid vs. multi (based on blood_lineage) | 492830 |
lymphoid vs. myeloid (based on blood_lineage) | 519017 |
multi vs. myeloid (based on blood_lineage) | 528486 |
differentiated vs. progenitor (based on differentiation_level_blood) | 457021 |
differentiated vs. stemCell (based on differentiation_level_blood) | 594371 |
progenitor vs. stemCell (based on differentiation_level_blood) | 540603 |
differentiated vs. progenitor (based on differentiation_level_skin) | 4838 |
differentiated vs. stemCell (based on differentiation_level_skin) | 549082 |
progenitor vs. stemCell (based on differentiation_level_skin) | 507161 |
CLP vs. CMP (based on cmp_blood_CLP_CMP) | 616010 |
comparison | |
differential methylation measure |
Scatterplot for differential methylation (sites). If the selected criterion is not rankGradient
:
The transparency corresponds to point density. If the number of points exceeds 2e+06 then the number of points for density estimation is reduced to that number by random sampling.The1% of the points in the sparsest populated plot regions are drawn explicitly (up to a maximum of 10000 points).Additionally, the colored points represent differentially methylated sites (according to the selected criterion).
If the selected criterion is rankGradient
: median combined ranks accross hexagonal bins are shown
as a gradient according to the color legend.
comparison | |
difference metric | |
significance metric |
Volcano plot for differential methylation quantified by various metrics. Color scale according to combined ranking.
A tabular overview of measures for differential methylation on the site level for the individual comparisons are provided in this section. Below, a brief explanation of the different columns can be found:
The tables for the individual comparisons can be found here:
Differential methylation on the region level was computed based on a variety of metrics. Of particular interest for the following plots and analyses are the following quantities for each region: the mean difference in means across all sites in a region of the two groups being compared and the mean of quotients in mean methylation as well as a combined p-value calculated from all site p-values in the region [1]. Additionally each region was assigned a rank based on each of these three criteria. A combined rank is computed as the maximum (i.e. worst) value among the three ranks. The smaller the combined rank for a region, the more evidence for differential methylation it exhibits. Regions were defined based on the region types specified in the analysis. This section includes scatterplots of the region group means as well as volcano plots of each pairwise comparison colored according to the combined rank of a given region.
The following rank cutfoffs have been automatically selected for the analysis of differentially methylated regions:
tiling | genes | promoters | cpgislands | |
blood vs. skin (based on tissue) | 11848 | 2604 | 3178 | 722 |
lymphoid vs. multi (based on blood_lineage) | 20549 | 924 | 1326 | 576 |
lymphoid vs. myeloid (based on blood_lineage) | 3824 | 269 | 259 | 142 |
multi vs. myeloid (based on blood_lineage) | 24432 | 1929 | 3492 | 1402 |
differentiated vs. progenitor (based on differentiation_level_blood) | 1103 | 165 | 231 | 148 |
differentiated vs. stemCell (based on differentiation_level_blood) | 34831 | 6192 | 5886 | 2720 |
progenitor vs. stemCell (based on differentiation_level_blood) | 32326 | 3577 | 4475 | 1796 |
differentiated vs. progenitor (based on differentiation_level_skin) | 17090 | 1585 | 1850 | 1200 |
differentiated vs. stemCell (based on differentiation_level_skin) | 12389 | 1056 | 1228 | 668 |
progenitor vs. stemCell (based on differentiation_level_skin) | 11766 | 1112 | 1225 | 687 |
CLP vs. CMP (based on cmp_blood_CLP_CMP) | 22567 | 2511 | 2787 | 1771 |
comparison | |
regions | |
differential methylation measure |
Scatterplot for differential methylation (regions). If the selected criterion is not rankGradient
:
The transparency corresponds to point density. The 1% of the points in the sparsest populated plot regions are drawn explicitly.
Additionally, the colored points represent differentially methylated regions (according to the selected criterion).
If the selected criterion is rankGradient
: median combined ranks accross hexagonal bins are shown
as a gradient according to the color legend.
comparison | |
regions | |
difference metric | |
significance metric |
Volcano plot for differential methylation quantified by various metrics. Color scale according to combined ranking.
A tabular overview of measures for differential methylation on the region level for the individual comparisons are provided in this section.
The tables for the individual comparisons can be found here:
tiling | genes | promoters | cpgislands | |
blood vs. skin (based on tissue) | csv | csv | csv | csv |
lymphoid vs. multi (based on blood_lineage) | csv | csv | csv | csv |
lymphoid vs. myeloid (based on blood_lineage) | csv | csv | csv | csv |
multi vs. myeloid (based on blood_lineage) | csv | csv | csv | csv |
differentiated vs. progenitor (based on differentiation_level_blood) | csv | csv | csv | csv |
differentiated vs. stemCell (based on differentiation_level_blood) | csv | csv | csv | csv |
progenitor vs. stemCell (based on differentiation_level_blood) | csv | csv | csv | csv |
differentiated vs. progenitor (based on differentiation_level_skin) | csv | csv | csv | csv |
differentiated vs. stemCell (based on differentiation_level_skin) | csv | csv | csv | csv |
progenitor vs. stemCell (based on differentiation_level_skin) | csv | csv | csv | csv |
CLP vs. CMP (based on cmp_blood_CLP_CMP) | csv | csv | csv | csv |
GO Enrichment Analysis was conducted. The wordclouds and tables below contains significant GO terms as determined by a hypergeometric test.
comparison | |
Hypermethylation/hypomethylation | |
ontology | |
regions | |
differential methylation measure |
Wordclouds for GO enrichment terms.
comparison | |
Hypermethylation/hypomethylation | |
ontology | |
regions | |
differential methylation measure |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0032946 | 6e-04 | 11.6298 | 0.3818 | 4 | 117 | positive regulation of mononuclear cell proliferation |
GO:0051251 | 6e-04 | 8.096 | 0.6885 | 5 | 211 | positive regulation of lymphocyte activation |
GO:0022407 | 9e-04 | 5.8745 | 1.1454 | 6 | 351 | regulation of cell-cell adhesion |
GO:0050867 | 0.0016 | 6.4939 | 0.8517 | 5 | 261 | positive regulation of cell activation |
GO:0002376 | 0.0016 | 2.8717 | 5.9391 | 14 | 1820 | immune system process |
GO:0033599 | 0.0017 | 37.3318 | 0.062 | 2 | 19 | regulation of mammary gland epithelial cell proliferation |
GO:1903039 | 0.0018 | 8.4559 | 0.5189 | 4 | 159 | positive regulation of leukocyte cell-cell adhesion |
GO:0042110 | 0.002 | 5.023 | 1.3314 | 6 | 408 | T cell activation |
GO:0060749 | 0.0021 | 33.3979 | 0.0685 | 2 | 21 | mammary gland alveolus development |
GO:1903708 | 0.0021 | 8.0368 | 0.545 | 4 | 167 | positive regulation of hemopoiesis |
GO:0002694 | 0.0022 | 4.9348 | 1.3543 | 6 | 415 | regulation of leukocyte activation |
GO:0042102 | 0.0023 | 12.5677 | 0.2611 | 3 | 80 | positive regulation of T cell proliferation |
GO:0060216 | 0.0025 | 30.2133 | 0.0751 | 2 | 23 | definitive hemopoiesis |
GO:0006958 | 0.003 | 27.5826 | 0.0816 | 2 | 25 | complement activation, classical pathway |
GO:0030878 | 0.0032 | 26.4317 | 0.0848 | 2 | 26 | thyroid gland development |
GO:0035702 | 0.0033 | Inf | 0.0033 | 1 | 1 | monocyte homeostasis |
GO:0097052 | 0.0033 | Inf | 0.0033 | 1 | 1 | L-kynurenine metabolic process |
GO:1905221 | 0.0033 | Inf | 0.0033 | 1 | 1 | positive regulation of platelet formation |
GO:1990959 | 0.0033 | Inf | 0.0033 | 1 | 1 | eosinophil homeostasis |
GO:1990960 | 0.0033 | Inf | 0.0033 | 1 | 1 | basophil homeostasis |
GO:0050670 | 0.0035 | 6.9947 | 0.6233 | 4 | 191 | regulation of lymphocyte proliferation |
GO:0070663 | 0.0041 | 6.6696 | 0.6527 | 4 | 200 | regulation of leukocyte proliferation |
GO:0002460 | 0.0046 | 6.4368 | 0.6755 | 4 | 207 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
GO:0043588 | 0.0059 | 5.9881 | 0.7244 | 4 | 222 | skin development |
GO:0001817 | 0.0064 | 3.9397 | 1.6806 | 6 | 515 | regulation of cytokine production |
GO:0001869 | 0.0065 | 311.4118 | 0.0065 | 1 | 2 | negative regulation of complement activation, lectin pathway |
GO:0060574 | 0.0065 | 311.4118 | 0.0065 | 1 | 2 | intestinal epithelial cell maturation |
GO:0060764 | 0.0065 | 311.4118 | 0.0065 | 1 | 2 | cell-cell signaling involved in mammary gland development |
GO:0090271 | 0.0065 | 311.4118 | 0.0065 | 1 | 2 | positive regulation of fibroblast growth factor production |
GO:0097535 | 0.0065 | 311.4118 | 0.0065 | 1 | 2 | lymphoid lineage cell migration into thymus |
GO:0097536 | 0.0065 | 311.4118 | 0.0065 | 1 | 2 | thymus epithelium morphogenesis |
GO:1902232 | 0.0065 | 311.4118 | 0.0065 | 1 | 2 | regulation of positive thymic T cell selection |
GO:1903860 | 0.0065 | 311.4118 | 0.0065 | 1 | 2 | negative regulation of dendrite extension |
GO:2000813 | 0.0065 | 311.4118 | 0.0065 | 1 | 2 | negative regulation of barbed-end actin filament capping |
GO:0045580 | 0.0066 | 8.4689 | 0.3818 | 3 | 117 | regulation of T cell differentiation |
GO:0051142 | 0.0098 | 155.6961 | 0.0098 | 1 | 3 | positive regulation of NK T cell proliferation |
GO:0060435 | 0.0098 | 155.6961 | 0.0098 | 1 | 3 | bronchiole development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0071593 | 1e-04 | 278.4912 | 0.0148 | 2 | 4 | lymphocyte aggregation |
GO:0050776 | 1e-04 | 5.2945 | 1.966 | 9 | 531 | regulation of immune response |
GO:0070257 | 6e-04 | 69.5965 | 0.037 | 2 | 10 | positive regulation of mucus secretion |
GO:0032941 | 7e-04 | 19.7255 | 0.1703 | 3 | 46 | secretion by tissue |
GO:0008284 | 7e-04 | 3.8561 | 2.9917 | 10 | 808 | positive regulation of cell proliferation |
GO:0003093 | 7e-04 | 61.8596 | 0.0407 | 2 | 11 | regulation of glomerular filtration |
GO:1903555 | 9e-04 | 10.2364 | 0.4295 | 4 | 116 | regulation of tumor necrosis factor superfamily cytokine production |
GO:0032418 | 0.0014 | 14.8675 | 0.2222 | 3 | 60 | lysosome localization |
GO:0002521 | 0.0015 | 4.5728 | 1.7069 | 7 | 461 | leukocyte differentiation |
GO:0042534 | 0.0016 | 39.7544 | 0.0592 | 2 | 16 | regulation of tumor necrosis factor biosynthetic process |
GO:0032103 | 0.0017 | 6.3548 | 0.8627 | 5 | 233 | positive regulation of response to external stimulus |
GO:0032760 | 0.002 | 13.2355 | 0.2481 | 3 | 67 | positive regulation of tumor necrosis factor production |
GO:0007204 | 0.002 | 6.1099 | 0.896 | 5 | 242 | positive regulation of cytosolic calcium ion concentration |
GO:0002274 | 0.0023 | 7.8356 | 0.5554 | 4 | 150 | myeloid leukocyte activation |
GO:0002703 | 0.0026 | 7.5234 | 0.5776 | 4 | 156 | regulation of leukocyte mediated immunity |
GO:0044273 | 0.0027 | 29.2835 | 0.0778 | 2 | 21 | sulfur compound catabolic process |
GO:1990266 | 0.0028 | 11.5971 | 0.2814 | 3 | 76 | neutrophil migration |
GO:0003071 | 0.003 | 27.8175 | 0.0815 | 2 | 22 | renal system process involved in regulation of systemic arterial blood pressure |
GO:0035929 | 0.003 | 27.8175 | 0.0815 | 2 | 22 | steroid hormone secretion |
GO:0045730 | 0.003 | 27.8175 | 0.0815 | 2 | 22 | respiratory burst |
GO:0051969 | 0.003 | 27.8175 | 0.0815 | 2 | 22 | regulation of transmission of nerve impulse |
GO:0007589 | 0.0032 | 10.9919 | 0.2962 | 3 | 80 | body fluid secretion |
GO:0002684 | 0.0035 | 3.5325 | 2.5288 | 8 | 683 | positive regulation of immune system process |
GO:0045061 | 0.0035 | 25.2855 | 0.0889 | 2 | 24 | thymic T cell selection |
GO:0044057 | 0.0036 | 4.427 | 1.4918 | 6 | 416 | regulation of system process |
GO:0003106 | 0.0037 | Inf | 0.0037 | 1 | 1 | negative regulation of glomerular filtration by angiotensin |
GO:0014895 | 0.0037 | Inf | 0.0037 | 1 | 1 | smooth muscle hypertrophy |
GO:0015993 | 0.0037 | Inf | 0.0037 | 1 | 1 | molecular hydrogen transport |
GO:0036275 | 0.0037 | Inf | 0.0037 | 1 | 1 | response to 5-fluorouracil |
GO:0046005 | 0.0037 | Inf | 0.0037 | 1 | 1 | positive regulation of circadian sleep/wake cycle, REM sleep |
GO:0070453 | 0.0037 | Inf | 0.0037 | 1 | 1 | regulation of heme biosynthetic process |
GO:1901401 | 0.0037 | Inf | 0.0037 | 1 | 1 | regulation of tetrapyrrole metabolic process |
GO:1901805 | 0.0037 | Inf | 0.0037 | 1 | 1 | beta-glucoside catabolic process |
GO:0014821 | 0.0038 | 24.1846 | 0.0926 | 2 | 25 | phasic smooth muscle contraction |
GO:0045187 | 0.0038 | 24.1846 | 0.0926 | 2 | 25 | regulation of circadian sleep/wake cycle, sleep |
GO:0050886 | 0.0038 | 10.3184 | 0.3147 | 3 | 85 | endocrine process |
GO:0051046 | 0.0039 | 3.4681 | 2.5733 | 8 | 695 | regulation of secretion |
GO:0022410 | 0.0045 | 22.247 | 0.1 | 2 | 27 | circadian sleep/wake cycle process |
GO:0043304 | 0.0051 | 20.5965 | 0.1074 | 2 | 29 | regulation of mast cell degranulation |
GO:0046329 | 0.0055 | 19.8596 | 0.1111 | 2 | 30 | negative regulation of JNK cascade |
GO:0031347 | 0.0063 | 3.9256 | 1.6698 | 6 | 451 | regulation of defense response |
GO:0050865 | 0.0065 | 3.8986 | 1.681 | 6 | 454 | regulation of cell activation |
GO:0002707 | 0.0066 | 17.9344 | 0.1222 | 2 | 33 | negative regulation of lymphocyte mediated immunity |
GO:0001555 | 0.0074 | 273.7069 | 0.0074 | 1 | 2 | oocyte growth |
GO:0001581 | 0.0074 | 273.7069 | 0.0074 | 1 | 2 | detection of chemical stimulus involved in sensory perception of sour taste |
GO:0001808 | 0.0074 | 273.7069 | 0.0074 | 1 | 2 | negative regulation of type IV hypersensitivity |
GO:0010841 | 0.0074 | 273.7069 | 0.0074 | 1 | 2 | positive regulation of circadian sleep/wake cycle, wakefulness |
GO:0036228 | 0.0074 | 273.7069 | 0.0074 | 1 | 2 | protein localization to nuclear inner membrane |
GO:0046967 | 0.0074 | 273.7069 | 0.0074 | 1 | 2 | cytosol to ER transport |
GO:0071594 | 0.0074 | 273.7069 | 0.0074 | 1 | 2 | thymocyte aggregation |
GO:0071626 | 0.0074 | 273.7069 | 0.0074 | 1 | 2 | mastication |
GO:0090290 | 0.0074 | 273.7069 | 0.0074 | 1 | 2 | positive regulation of osteoclast proliferation |
GO:0098583 | 0.0074 | 273.7069 | 0.0074 | 1 | 2 | learned vocalization behavior |
GO:0120054 | 0.0074 | 273.7069 | 0.0074 | 1 | 2 | intestinal motility |
GO:0120058 | 0.0074 | 273.7069 | 0.0074 | 1 | 2 | positive regulation of small intestinal transit |
GO:1901750 | 0.0074 | 273.7069 | 0.0074 | 1 | 2 | leukotriene D4 biosynthetic process |
GO:1902173 | 0.0074 | 273.7069 | 0.0074 | 1 | 2 | negative regulation of keratinocyte apoptotic process |
GO:1904346 | 0.0074 | 273.7069 | 0.0074 | 1 | 2 | positive regulation of gastric mucosal blood circulation |
GO:1905747 | 0.0074 | 273.7069 | 0.0074 | 1 | 2 | negative regulation of saliva secretion |
GO:1905748 | 0.0074 | 273.7069 | 0.0074 | 1 | 2 | hard palate morphogenesis |
GO:2000506 | 0.0074 | 273.7069 | 0.0074 | 1 | 2 | negative regulation of energy homeostasis |
GO:2000870 | 0.0074 | 273.7069 | 0.0074 | 1 | 2 | regulation of progesterone secretion |
GO:0030431 | 0.0074 | 16.8453 | 0.1296 | 2 | 35 | sleep |
GO:0070303 | 0.0074 | 16.8453 | 0.1296 | 2 | 35 | negative regulation of stress-activated protein kinase signaling cascade |
GO:0045987 | 0.0078 | 16.3488 | 0.1333 | 2 | 36 | positive regulation of smooth muscle contraction |
GO:0050856 | 0.0078 | 16.3488 | 0.1333 | 2 | 36 | regulation of T cell receptor signaling pathway |
GO:0060135 | 0.0078 | 16.3488 | 0.1333 | 2 | 36 | maternal process involved in female pregnancy |
GO:0032675 | 0.0081 | 7.8214 | 0.411 | 3 | 111 | regulation of interleukin-6 production |
GO:0009268 | 0.0083 | 15.8807 | 0.137 | 2 | 37 | response to pH |
GO:0048534 | 0.0086 | 3.0075 | 2.9435 | 8 | 795 | hematopoietic or lymphoid organ development |
GO:0006997 | 0.0087 | 7.6086 | 0.4221 | 3 | 114 | nucleus organization |
GO:0006810 | 0.0088 | 1.9929 | 14.3548 | 23 | 3877 | transport |
GO:0003012 | 0.0091 | 4.2057 | 1.2848 | 5 | 347 | muscle system process |
GO:0051249 | 0.0091 | 4.2057 | 1.2848 | 5 | 347 | regulation of lymphocyte activation |
GO:0002279 | 0.0091 | 15.0204 | 0.1444 | 2 | 39 | mast cell activation involved in immune response |
GO:0030217 | 0.0095 | 5.1755 | 0.8294 | 4 | 224 | T cell differentiation |
GO:0002448 | 0.0096 | 14.6242 | 0.1481 | 2 | 40 | mast cell mediated immunity |
GO:0033003 | 0.0096 | 14.6242 | 0.1481 | 2 | 40 | regulation of mast cell activation |
GO:0044058 | 0.0096 | 14.6242 | 0.1481 | 2 | 40 | regulation of digestive system process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006597 | 0 | Inf | 0.0049 | 2 | 2 | spermine biosynthetic process |
GO:0008295 | 1e-04 | 286.3604 | 0.0122 | 2 | 5 | spermidine biosynthetic process |
GO:0071468 | 3e-04 | 95.4174 | 0.0269 | 2 | 11 | cellular response to acidic pH |
GO:0006595 | 4e-04 | 78.059 | 0.0318 | 2 | 13 | polyamine metabolic process |
GO:0042401 | 4e-04 | 78.059 | 0.0318 | 2 | 13 | cellular biogenic amine biosynthetic process |
GO:0072755 | 0.0024 | Inf | 0.0024 | 1 | 1 | cellular response to benomyl |
GO:0007338 | 0.0025 | 12.1821 | 0.2717 | 3 | 111 | single fertilization |
GO:0009416 | 0.0028 | 7.5188 | 0.5923 | 4 | 242 | response to light stimulus |
GO:0006110 | 0.0033 | 25.9836 | 0.0857 | 2 | 35 | regulation of glycolytic process |
GO:0009268 | 0.0037 | 24.4958 | 0.0906 | 2 | 37 | response to pH |
GO:0006696 | 0.0049 | 418.2895 | 0.0049 | 1 | 2 | ergosterol biosynthetic process |
GO:0036292 | 0.0049 | 418.2895 | 0.0049 | 1 | 2 | DNA rewinding |
GO:0038156 | 0.0049 | 418.2895 | 0.0049 | 1 | 2 | interleukin-3-mediated signaling pathway |
GO:0045338 | 0.0049 | 418.2895 | 0.0049 | 1 | 2 | farnesyl diphosphate metabolic process |
GO:0060733 | 0.0049 | 418.2895 | 0.0049 | 1 | 2 | regulation of eIF2 alpha phosphorylation by amino acid starvation |
GO:0071264 | 0.0049 | 418.2895 | 0.0049 | 1 | 2 | positive regulation of translational initiation in response to starvation |
GO:0042149 | 0.0054 | 19.9283 | 0.1101 | 2 | 45 | cellular response to glucose starvation |
GO:0051193 | 0.0054 | 19.9283 | 0.1101 | 2 | 45 | regulation of cofactor metabolic process |
GO:0016128 | 0.0073 | 209.1316 | 0.0073 | 1 | 3 | phytosteroid metabolic process |
GO:0044107 | 0.0073 | 209.1316 | 0.0073 | 1 | 3 | cellular alcohol metabolic process |
GO:0021888 | 0.0098 | 139.4123 | 0.0098 | 1 | 4 | hypothalamus gonadotrophin-releasing hormone neuron development |
GO:0033026 | 0.0098 | 139.4123 | 0.0098 | 1 | 4 | negative regulation of mast cell apoptotic process |
GO:0070668 | 0.0098 | 139.4123 | 0.0098 | 1 | 4 | positive regulation of mast cell proliferation |
GO:0071494 | 0.0098 | 139.4123 | 0.0098 | 1 | 4 | cellular response to UV-C |
GO:0090315 | 0.0098 | 139.4123 | 0.0098 | 1 | 4 | negative regulation of protein targeting to membrane |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006597 | 0 | Inf | 0.0056 | 2 | 2 | spermine biosynthetic process |
GO:0008295 | 1e-04 | 246.3101 | 0.0141 | 2 | 5 | spermidine biosynthetic process |
GO:0006595 | 6e-04 | 67.1416 | 0.0367 | 2 | 13 | polyamine metabolic process |
GO:0042401 | 6e-04 | 67.1416 | 0.0367 | 2 | 13 | cellular biogenic amine biosynthetic process |
GO:0002070 | 9e-04 | 52.7442 | 0.0452 | 2 | 16 | epithelial cell maturation |
GO:0018191 | 0.0028 | Inf | 0.0028 | 1 | 1 | peptidyl-serine octanoylation |
GO:0036292 | 0.0056 | 361.1136 | 0.0056 | 1 | 2 | DNA rewinding |
GO:0060574 | 0.0056 | 361.1136 | 0.0056 | 1 | 2 | intestinal epithelial cell maturation |
GO:0060764 | 0.0056 | 361.1136 | 0.0056 | 1 | 2 | cell-cell signaling involved in mammary gland development |
GO:0060435 | 0.0084 | 180.5455 | 0.0085 | 1 | 3 | bronchiole development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0097052 | 0.0028 | Inf | 0.0028 | 1 | 1 | L-kynurenine metabolic process |
GO:1903118 | 0.0028 | Inf | 0.0028 | 1 | 1 | urate homeostasis |
GO:1903217 | 0.0028 | Inf | 0.0028 | 1 | 1 | negative regulation of protein processing involved in protein targeting to mitochondrion |
GO:1904182 | 0.0028 | Inf | 0.0028 | 1 | 1 | regulation of pyruvate dehydrogenase activity |
GO:1905642 | 0.0028 | Inf | 0.0028 | 1 | 1 | negative regulation of DNA methylation |
GO:1905643 | 0.0028 | Inf | 0.0028 | 1 | 1 | positive regulation of DNA methylation |
GO:0002933 | 0.0055 | 369.5349 | 0.0055 | 1 | 2 | lipid hydroxylation |
GO:1901253 | 0.0055 | 369.5349 | 0.0055 | 1 | 2 | negative regulation of intracellular transport of viral material |
GO:0007606 | 0.0076 | 8.058 | 0.4031 | 3 | 146 | sensory perception of chemical stimulus |
GO:0046676 | 0.0078 | 16.4027 | 0.1325 | 2 | 48 | negative regulation of insulin secretion |
GO:0036092 | 0.0083 | 184.7558 | 0.0083 | 1 | 3 | phosphatidylinositol-3-phosphate biosynthetic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0030825 | 8e-04 | 58.1685 | 0.0412 | 2 | 16 | positive regulation of cGMP metabolic process |
GO:0045606 | 0.0013 | 42.8475 | 0.054 | 2 | 21 | positive regulation of epidermal cell differentiation |
GO:0032887 | 0.0026 | Inf | 0.0026 | 1 | 1 | regulation of spindle elongation |
GO:0051257 | 0.0026 | Inf | 0.0026 | 1 | 1 | meiotic spindle midzone assembly |
GO:0055048 | 0.0026 | Inf | 0.0026 | 1 | 1 | anastral spindle assembly |
GO:1902365 | 0.0026 | Inf | 0.0026 | 1 | 1 | positive regulation of protein localization to spindle pole body |
GO:1902846 | 0.0026 | Inf | 0.0026 | 1 | 1 | positive regulation of mitotic spindle elongation |
GO:0043060 | 0.0051 | 397.325 | 0.0051 | 1 | 2 | meiotic metaphase I plate congression |
GO:1903860 | 0.0051 | 397.325 | 0.0051 | 1 | 2 | negative regulation of dendrite extension |
GO:0007060 | 0.0077 | 198.65 | 0.0077 | 1 | 3 | male meiosis chromosome segregation |
GO:0010482 | 0.0077 | 198.65 | 0.0077 | 1 | 3 | regulation of epidermal cell division |
GO:0051310 | 0.0085 | 15.6233 | 0.1389 | 2 | 54 | metaphase plate congression |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042110 | 1e-04 | 5.284 | 1.9203 | 9 | 408 | T cell activation |
GO:0002568 | 2e-04 | 144.8128 | 0.0235 | 2 | 5 | somatic diversification of T cell receptor genes |
GO:0033153 | 2e-04 | 144.8128 | 0.0235 | 2 | 5 | T cell receptor V(D)J recombination |
GO:0043320 | 5e-04 | 86.8767 | 0.0329 | 2 | 7 | natural killer cell degranulation |
GO:0042102 | 5e-04 | 11.7005 | 0.3765 | 4 | 80 | positive regulation of T cell proliferation |
GO:0042100 | 6e-04 | 11.2541 | 0.3906 | 4 | 83 | B cell proliferation |
GO:0001775 | 0.0011 | 3.3409 | 3.7041 | 11 | 787 | cell activation |
GO:0002228 | 0.0012 | 16.0762 | 0.2071 | 3 | 44 | natural killer cell mediated immunity |
GO:0042761 | 0.0014 | 43.4247 | 0.0565 | 2 | 12 | very long-chain fatty acid biosynthetic process |
GO:0030497 | 0.0016 | 39.4745 | 0.0612 | 2 | 13 | fatty acid elongation |
GO:1903428 | 0.0017 | 14.0186 | 0.2353 | 3 | 50 | positive regulation of reactive oxygen species biosynthetic process |
GO:0050670 | 0.0021 | 6.0192 | 0.899 | 5 | 191 | regulation of lymphocyte proliferation |
GO:0045428 | 0.0021 | 12.9158 | 0.2542 | 3 | 54 | regulation of nitric oxide biosynthetic process |
GO:1900153 | 0.0022 | 33.3973 | 0.0706 | 2 | 15 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay |
GO:0032946 | 0.0022 | 7.8509 | 0.5507 | 4 | 117 | positive regulation of mononuclear cell proliferation |
GO:0002562 | 0.0024 | 12.196 | 0.2683 | 3 | 57 | somatic diversification of immune receptors via germline recombination within a single locus |
GO:0070663 | 0.0025 | 5.7381 | 0.9413 | 5 | 200 | regulation of leukocyte proliferation |
GO:0042534 | 0.0025 | 31.0098 | 0.0753 | 2 | 16 | regulation of tumor necrosis factor biosynthetic process |
GO:0001817 | 0.0028 | 3.6158 | 2.4239 | 8 | 515 | regulation of cytokine production |
GO:0002250 | 0.0031 | 4.541 | 1.4308 | 6 | 304 | adaptive immune response |
GO:0065003 | 0.0031 | 2.4788 | 6.9093 | 15 | 1468 | macromolecular complex assembly |
GO:0021542 | 0.0032 | 27.1301 | 0.0847 | 2 | 18 | dentate gyrus development |
GO:0046209 | 0.0034 | 10.7917 | 0.3012 | 3 | 64 | nitric oxide metabolic process |
GO:0010575 | 0.0035 | 25.5326 | 0.0894 | 2 | 19 | positive regulation of vascular endothelial growth factor production |
GO:0030098 | 0.0037 | 4.3762 | 1.4826 | 6 | 315 | lymphocyte differentiation |
GO:1900120 | 0.0039 | 24.1126 | 0.0941 | 2 | 20 | regulation of receptor binding |
GO:0002285 | 0.0046 | 6.3719 | 0.673 | 4 | 143 | lymphocyte activation involved in immune response |
GO:0002875 | 0.0047 | Inf | 0.0047 | 1 | 1 | negative regulation of chronic inflammatory response to antigenic stimulus |
GO:0003106 | 0.0047 | Inf | 0.0047 | 1 | 1 | negative regulation of glomerular filtration by angiotensin |
GO:0006294 | 0.0047 | Inf | 0.0047 | 1 | 1 | nucleotide-excision repair, preincision complex assembly |
GO:0014739 | 0.0047 | Inf | 0.0047 | 1 | 1 | positive regulation of muscle hyperplasia |
GO:0014895 | 0.0047 | Inf | 0.0047 | 1 | 1 | smooth muscle hypertrophy |
GO:0015878 | 0.0047 | Inf | 0.0047 | 1 | 1 | biotin transport |
GO:0015887 | 0.0047 | Inf | 0.0047 | 1 | 1 | pantothenate transmembrane transport |
GO:1901586 | 0.0047 | Inf | 0.0047 | 1 | 1 | negative regulation of acid-sensing ion channel activity |
GO:0006875 | 0.0047 | 3.6503 | 2.0803 | 7 | 442 | cellular metal ion homeostasis |
GO:0002861 | 0.0048 | 21.6986 | 0.1035 | 2 | 22 | regulation of inflammatory response to antigenic stimulus |
GO:0030595 | 0.0053 | 6.1059 | 0.7013 | 4 | 149 | leukocyte chemotaxis |
GO:0002274 | 0.0055 | 6.0637 | 0.706 | 4 | 150 | myeloid leukocyte activation |
GO:0001909 | 0.0055 | 9.0108 | 0.3577 | 3 | 76 | leukocyte mediated cytotoxicity |
GO:0045061 | 0.0056 | 19.7235 | 0.113 | 2 | 24 | thymic T cell selection |
GO:0031348 | 0.0059 | 5.9404 | 0.7201 | 4 | 153 | negative regulation of defense response |
GO:0060713 | 0.0061 | 18.8648 | 0.1177 | 2 | 25 | labyrinthine layer morphogenesis |
GO:0006909 | 0.0061 | 5.861 | 0.7295 | 4 | 155 | phagocytosis |
GO:0002696 | 0.0061 | 4.6098 | 1.1625 | 5 | 247 | positive regulation of leukocyte activation |
GO:0022407 | 0.0062 | 3.9105 | 1.652 | 6 | 351 | regulation of cell-cell adhesion |
GO:0050679 | 0.0063 | 5.8221 | 0.7342 | 4 | 156 | positive regulation of epithelial cell proliferation |
GO:0071353 | 0.0066 | 18.0776 | 0.1224 | 2 | 26 | cellular response to interleukin-4 |
GO:1903039 | 0.0067 | 5.7083 | 0.7484 | 4 | 159 | positive regulation of leukocyte cell-cell adhesion |
GO:0032101 | 0.0067 | 3.1067 | 2.8004 | 8 | 595 | regulation of response to external stimulus |
GO:0002682 | 0.0069 | 2.5816 | 4.7113 | 11 | 1001 | regulation of immune system process |
GO:0007369 | 0.007 | 5.6349 | 0.7578 | 4 | 161 | gastrulation |
GO:2000377 | 0.007 | 5.6349 | 0.7578 | 4 | 161 | regulation of reactive oxygen species metabolic process |
GO:0035987 | 0.0071 | 17.3534 | 0.1271 | 2 | 27 | endodermal cell differentiation |
GO:0061351 | 0.0073 | 5.5633 | 0.7672 | 4 | 163 | neural precursor cell proliferation |
GO:0002443 | 0.0075 | 4.3886 | 1.219 | 5 | 259 | leukocyte mediated immunity |
GO:0006364 | 0.0076 | 5.4935 | 0.7766 | 4 | 165 | rRNA processing |
GO:0048661 | 0.0077 | 7.9202 | 0.4048 | 3 | 86 | positive regulation of smooth muscle cell proliferation |
GO:0007617 | 0.0082 | 16.066 | 0.1365 | 2 | 29 | mating behavior |
GO:0001562 | 0.0087 | 15.4912 | 0.1412 | 2 | 30 | response to protozoan |
GO:0042742 | 0.0091 | 5.1997 | 0.819 | 4 | 174 | defense response to bacterium |
GO:0001808 | 0.0094 | 214.3108 | 0.0094 | 1 | 2 | negative regulation of type IV hypersensitivity |
GO:0003245 | 0.0094 | 214.3108 | 0.0094 | 1 | 2 | cardiac muscle tissue growth involved in heart morphogenesis |
GO:0006393 | 0.0094 | 214.3108 | 0.0094 | 1 | 2 | termination of mitochondrial transcription |
GO:0032796 | 0.0094 | 214.3108 | 0.0094 | 1 | 2 | uropod organization |
GO:0043316 | 0.0094 | 214.3108 | 0.0094 | 1 | 2 | cytotoxic T cell degranulation |
GO:0046967 | 0.0094 | 214.3108 | 0.0094 | 1 | 2 | cytosol to ER transport |
GO:0060302 | 0.0094 | 214.3108 | 0.0094 | 1 | 2 | negative regulation of cytokine activity |
GO:0061153 | 0.0094 | 214.3108 | 0.0094 | 1 | 2 | trachea gland development |
GO:0070682 | 0.0094 | 214.3108 | 0.0094 | 1 | 2 | proteasome regulatory particle assembly |
GO:0071594 | 0.0094 | 214.3108 | 0.0094 | 1 | 2 | thymocyte aggregation |
GO:1990108 | 0.0094 | 214.3108 | 0.0094 | 1 | 2 | protein linear deubiquitination |
GO:0055082 | 0.0098 | 2.9009 | 2.9887 | 8 | 635 | cellular chemical homeostasis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006393 | 0 | Inf | 0.0055 | 2 | 2 | termination of mitochondrial transcription |
GO:0140053 | 0.001 | 16.7784 | 0.1988 | 3 | 72 | mitochondrial gene expression |
GO:0018900 | 0.0028 | Inf | 0.0028 | 1 | 1 | dichloromethane metabolic process |
GO:1900124 | 0.0028 | Inf | 0.0028 | 1 | 1 | negative regulation of nodal receptor complex assembly |
GO:0042462 | 0.0033 | 26.046 | 0.0856 | 2 | 31 | eye photoreceptor cell development |
GO:0042197 | 0.0055 | 369.5349 | 0.0055 | 1 | 2 | halogenated hydrocarbon metabolic process |
GO:0042489 | 0.0055 | 369.5349 | 0.0055 | 1 | 2 | negative regulation of odontogenesis of dentin-containing tooth |
GO:2000156 | 0.0055 | 369.5349 | 0.0055 | 1 | 2 | regulation of retrograde vesicle-mediated transport, Golgi to ER |
GO:0002253 | 0.0069 | 5.7638 | 0.7593 | 4 | 275 | activation of immune response |
GO:0006391 | 0.0083 | 184.7558 | 0.0083 | 1 | 3 | transcription initiation from mitochondrial promoter |
GO:0060060 | 0.0083 | 184.7558 | 0.0083 | 1 | 3 | post-embryonic retina morphogenesis in camera-type eye |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0001855 | 0.0033 | Inf | 0.0033 | 1 | 1 | complement component C4b binding |
GO:0016517 | 0.0033 | Inf | 0.0033 | 1 | 1 | interleukin-12 receptor activity |
GO:0033038 | 0.0033 | Inf | 0.0033 | 1 | 1 | bitter taste receptor activity |
GO:0038164 | 0.0033 | Inf | 0.0033 | 1 | 1 | thrombopoietin receptor activity |
GO:0047312 | 0.0033 | Inf | 0.0033 | 1 | 1 | L-phenylalanine:pyruvate aminotransferase activity |
GO:0047316 | 0.0033 | Inf | 0.0033 | 1 | 1 | glutamine-phenylpyruvate transaminase activity |
GO:0047945 | 0.0033 | Inf | 0.0033 | 1 | 1 | L-glutamine:pyruvate aminotransferase activity |
GO:0017080 | 0.0043 | 22.6043 | 0.0981 | 2 | 30 | sodium channel regulator activity |
GO:0003955 | 0.0065 | 310.7843 | 0.0065 | 1 | 2 | NAD(P)H dehydrogenase (quinone) activity |
GO:0004909 | 0.0065 | 310.7843 | 0.0065 | 1 | 2 | interleukin-1, Type I, activating receptor activity |
GO:0042019 | 0.0065 | 310.7843 | 0.0065 | 1 | 2 | interleukin-23 binding |
GO:0042020 | 0.0065 | 310.7843 | 0.0065 | 1 | 2 | interleukin-23 receptor activity |
GO:0045523 | 0.0065 | 310.7843 | 0.0065 | 1 | 2 | interleukin-27 receptor binding |
GO:0047804 | 0.0065 | 310.7843 | 0.0065 | 1 | 2 | cysteine-S-conjugate beta-lyase activity |
GO:0004888 | 0.008 | 3.3519 | 2.3216 | 7 | 710 | transmembrane signaling receptor activity |
GO:0051870 | 0.0098 | 155.3824 | 0.0098 | 1 | 3 | methotrexate binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005125 | 0.001 | 9.9771 | 0.4437 | 4 | 144 | cytokine activity |
GO:0032500 | 0.0031 | Inf | 0.0031 | 1 | 1 | muramyl dipeptide binding |
GO:0042007 | 0.0031 | Inf | 0.0031 | 1 | 1 | interleukin-18 binding |
GO:0030545 | 0.0042 | 5.1388 | 1.0723 | 5 | 348 | receptor regulator activity |
GO:0005547 | 0.0052 | 20.401 | 0.1078 | 2 | 35 | phosphatidylinositol-3,4,5-trisphosphate binding |
GO:0004014 | 0.0062 | 330.2708 | 0.0062 | 1 | 2 | adenosylmethionine decarboxylase activity |
GO:0008650 | 0.0062 | 330.2708 | 0.0062 | 1 | 2 | rRNA (uridine-2'-O-)-methyltransferase activity |
GO:0019810 | 0.0062 | 330.2708 | 0.0062 | 1 | 2 | putrescine binding |
GO:0048248 | 0.0062 | 330.2708 | 0.0062 | 1 | 2 | CXCR3 chemokine receptor binding |
GO:0050436 | 0.0062 | 330.2708 | 0.0062 | 1 | 2 | microfibril binding |
GO:0008083 | 0.0066 | 8.4799 | 0.3821 | 3 | 124 | growth factor activity |
GO:0008201 | 0.008 | 7.8883 | 0.4098 | 3 | 133 | heparin binding |
GO:0004459 | 0.0092 | 165.125 | 0.0092 | 1 | 3 | L-lactate dehydrogenase activity |
GO:0004566 | 0.0092 | 165.125 | 0.0092 | 1 | 3 | beta-glucuronidase activity |
GO:0005136 | 0.0092 | 165.125 | 0.0092 | 1 | 3 | interleukin-4 receptor binding |
GO:0005160 | 0.01 | 14.3115 | 0.151 | 2 | 49 | transforming growth factor beta receptor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0032500 | 0.0033 | Inf | 0.0033 | 1 | 1 | muramyl dipeptide binding |
GO:0042007 | 0.0033 | Inf | 0.0033 | 1 | 1 | interleukin-18 binding |
GO:0102076 | 0.0033 | Inf | 0.0033 | 1 | 1 | beta,beta-carotene-9',10'-cleaving oxygenase activity |
GO:0030545 | 0.0059 | 4.7094 | 1.1598 | 5 | 348 | receptor regulator activity |
GO:0004020 | 0.0067 | 304.7885 | 0.0067 | 1 | 2 | adenylylsulfate kinase activity |
GO:0004781 | 0.0067 | 304.7885 | 0.0067 | 1 | 2 | sulfate adenylyltransferase (ATP) activity |
GO:0016501 | 0.0067 | 304.7885 | 0.0067 | 1 | 2 | prostacyclin receptor activity |
GO:0048248 | 0.0067 | 304.7885 | 0.0067 | 1 | 2 | CXCR3 chemokine receptor binding |
GO:0050436 | 0.0067 | 304.7885 | 0.0067 | 1 | 2 | microfibril binding |
GO:0030544 | 0.0075 | 16.7599 | 0.13 | 2 | 39 | Hsp70 protein binding |
GO:0005136 | 0.01 | 152.3846 | 0.01 | 1 | 3 | interleukin-4 receptor binding |
GO:0015057 | 0.01 | 152.3846 | 0.01 | 1 | 3 | thrombin-activated receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0003823 | 5e-04 | 21.0253 | 0.1605 | 3 | 44 | antigen binding |
GO:0003912 | 0.0036 | Inf | 0.0036 | 1 | 1 | DNA nucleotidylexotransferase activity |
GO:0009007 | 0.0036 | Inf | 0.0036 | 1 | 1 | site-specific DNA-methyltransferase (adenine-specific) activity |
GO:0030305 | 0.0036 | Inf | 0.0036 | 1 | 1 | heparanase activity |
GO:0031768 | 0.0036 | Inf | 0.0036 | 1 | 1 | ghrelin receptor binding |
GO:0047988 | 0.0036 | Inf | 0.0036 | 1 | 1 | hydroxyacid-oxoacid transhydrogenase activity |
GO:0050313 | 0.0036 | Inf | 0.0036 | 1 | 1 | sulfur dioxygenase activity |
GO:0098770 | 0.0036 | Inf | 0.0036 | 1 | 1 | FBXO family protein binding |
GO:0048018 | 0.0061 | 4.6662 | 1.1634 | 5 | 319 | receptor ligand activity |
GO:0000048 | 0.0073 | 277.9649 | 0.0073 | 1 | 2 | peptidyltransferase activity |
GO:0002951 | 0.0073 | 277.9649 | 0.0073 | 1 | 2 | leukotriene-C(4) hydrolase |
GO:0004348 | 0.0073 | 277.9649 | 0.0073 | 1 | 2 | glucosylceramidase activity |
GO:0015433 | 0.0073 | 277.9649 | 0.0073 | 1 | 2 | peptide antigen-transporting ATPase activity |
GO:0016608 | 0.0073 | 277.9649 | 0.0073 | 1 | 2 | growth hormone-releasing hormone activity |
GO:0033040 | 0.0073 | 277.9649 | 0.0073 | 1 | 2 | sour taste receptor activity |
GO:0042610 | 0.0073 | 277.9649 | 0.0073 | 1 | 2 | CD8 receptor binding |
GO:0046980 | 0.0073 | 277.9649 | 0.0073 | 1 | 2 | tapasin binding |
GO:0043548 | 0.0093 | 14.8562 | 0.1459 | 2 | 40 | phosphatidylinositol 3-kinase binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045296 | 0.0025 | 5.8124 | 0.9493 | 5 | 296 | cadherin binding |
GO:0032500 | 0.0032 | Inf | 0.0032 | 1 | 1 | muramyl dipeptide binding |
GO:0042007 | 0.0032 | Inf | 0.0032 | 1 | 1 | interleukin-18 binding |
GO:0001205 | 0.0053 | 20.1786 | 0.109 | 2 | 34 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding |
GO:0016501 | 0.0064 | 317.02 | 0.0064 | 1 | 2 | prostacyclin receptor activity |
GO:0048248 | 0.0064 | 317.02 | 0.0064 | 1 | 2 | CXCR3 chemokine receptor binding |
GO:0050436 | 0.0064 | 317.02 | 0.0064 | 1 | 2 | microfibril binding |
GO:0004459 | 0.0096 | 158.5 | 0.0096 | 1 | 3 | L-lactate dehydrogenase activity |
GO:0005136 | 0.0096 | 158.5 | 0.0096 | 1 | 3 | interleukin-4 receptor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004014 | 0 | Inf | 0.006 | 2 | 2 | adenosylmethionine decarboxylase activity |
GO:0019810 | 0 | Inf | 0.006 | 2 | 2 | putrescine binding |
GO:0016412 | 0.003 | Inf | 0.003 | 1 | 1 | serine O-acyltransferase activity |
GO:0031854 | 0.003 | Inf | 0.003 | 1 | 1 | orexigenic neuropeptide QRFP receptor binding |
GO:0004909 | 0.006 | 337.3191 | 0.006 | 1 | 2 | interleukin-1, Type I, activating receptor activity |
GO:0004060 | 0.009 | 168.6489 | 0.0091 | 1 | 3 | arylamine N-acetyltransferase activity |
GO:0004082 | 0.009 | 168.6489 | 0.0091 | 1 | 3 | bisphosphoglycerate mutase activity |
GO:0017077 | 0.009 | 168.6489 | 0.0091 | 1 | 3 | oxidative phosphorylation uncoupler activity |
GO:0046538 | 0.009 | 168.6489 | 0.0091 | 1 | 3 | 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity |
GO:0016830 | 0.0092 | 14.9423 | 0.1449 | 2 | 48 | carbon-carbon lyase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0047312 | 0.0028 | Inf | 0.0028 | 1 | 1 | L-phenylalanine:pyruvate aminotransferase activity |
GO:0047316 | 0.0028 | Inf | 0.0028 | 1 | 1 | glutamine-phenylpyruvate transaminase activity |
GO:0047945 | 0.0028 | Inf | 0.0028 | 1 | 1 | L-glutamine:pyruvate aminotransferase activity |
GO:0061690 | 0.0028 | Inf | 0.0028 | 1 | 1 | lipoamidase activity |
GO:1990081 | 0.0028 | Inf | 0.0028 | 1 | 1 | trimethylamine receptor activity |
GO:0008227 | 0.0035 | 25.3873 | 0.0877 | 2 | 31 | G-protein coupled amine receptor activity |
GO:0003955 | 0.0057 | 360.3864 | 0.0057 | 1 | 2 | NAD(P)H dehydrogenase (quinone) activity |
GO:0047708 | 0.0057 | 360.3864 | 0.0057 | 1 | 2 | biotinidase activity |
GO:0047804 | 0.0057 | 360.3864 | 0.0057 | 1 | 2 | cysteine-S-conjugate beta-lyase activity |
GO:0019153 | 0.0085 | 180.1818 | 0.0085 | 1 | 3 | protein-disulfide reductase (glutathione) activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0001962 | 0.0053 | 386.8293 | 0.0053 | 1 | 2 | alpha-1,3-galactosyltransferase activity |
GO:0004081 | 0.0053 | 386.8293 | 0.0053 | 1 | 2 | bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity |
GO:0047276 | 0.0053 | 386.8293 | 0.0053 | 1 | 2 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity |
GO:0032137 | 0.0079 | 193.4024 | 0.0079 | 1 | 3 | guanine/thymine mispair binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0003885 | 0.0026 | Inf | 0.0026 | 1 | 1 | D-arabinono-1,4-lactone oxidase activity |
GO:0050105 | 0.0026 | Inf | 0.0026 | 1 | 1 | L-gulonolactone oxidase activity |
GO:1905574 | 0.0026 | Inf | 0.0026 | 1 | 1 | ganglioside GM2 binding |
GO:1905575 | 0.0026 | Inf | 0.0026 | 1 | 1 | ganglioside GM3 binding |
GO:1905577 | 0.0026 | Inf | 0.0026 | 1 | 1 | ganglioside GP1c binding |
GO:0046873 | 0.0037 | 5.3688 | 1.0441 | 5 | 405 | metal ion transmembrane transporter activity |
GO:0052689 | 0.0037 | 10.5335 | 0.312 | 3 | 121 | carboxylic ester hydrolase activity |
GO:0030116 | 0.0051 | 396.525 | 0.0052 | 1 | 2 | glial cell-derived neurotrophic factor receptor binding |
GO:1905573 | 0.0051 | 396.525 | 0.0052 | 1 | 2 | ganglioside GM1 binding |
GO:0016015 | 0.0077 | 198.25 | 0.0077 | 1 | 3 | morphogen activity |
GO:1905576 | 0.0077 | 198.25 | 0.0077 | 1 | 3 | ganglioside GT1b binding |
GO:0015077 | 0.0088 | 5.3705 | 0.8173 | 4 | 317 | monovalent inorganic cation transmembrane transporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0061135 | 0.0014 | 8.9295 | 0.4897 | 4 | 132 | endopeptidase regulator activity |
GO:0030414 | 0.0015 | 8.8598 | 0.4934 | 4 | 133 | peptidase inhibitor activity |
GO:0005031 | 0.0025 | 30.8499 | 0.0742 | 2 | 20 | tumor necrosis factor-activated receptor activity |
GO:0004867 | 0.0026 | 11.9012 | 0.2745 | 3 | 74 | serine-type endopeptidase inhibitor activity |
GO:0001918 | 0.0037 | Inf | 0.0037 | 1 | 1 | farnesylated protein binding |
GO:0005144 | 0.0037 | Inf | 0.0037 | 1 | 1 | interleukin-13 receptor binding |
GO:0042922 | 0.0037 | Inf | 0.0037 | 1 | 1 | neuromedin U receptor binding |
GO:0047408 | 0.0037 | Inf | 0.0037 | 1 | 1 | alkenylglycerophosphocholine hydrolase activity |
GO:0047409 | 0.0037 | Inf | 0.0037 | 1 | 1 | alkenylglycerophosphoethanolamine hydrolase activity |
GO:0071791 | 0.0037 | Inf | 0.0037 | 1 | 1 | chemokine (C-C motif) ligand 5 binding |
GO:0016501 | 0.0074 | 273.1552 | 0.0074 | 1 | 2 | prostacyclin receptor activity |
GO:0030549 | 0.0074 | 273.1552 | 0.0074 | 1 | 2 | acetylcholine receptor activator activity |
GO:0030545 | 0.0093 | 4.1845 | 1.2911 | 5 | 348 | receptor regulator activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005125 | 0 | 18.2744 | 0.3887 | 6 | 126 | cytokine activity |
GO:0030545 | 0 | 8.4881 | 1.116 | 8 | 348 | receptor regulator activity |
GO:0005126 | 0 | 10.7031 | 0.6471 | 6 | 210 | cytokine receptor binding |
GO:0005164 | 1e-04 | 44.9716 | 0.0802 | 3 | 25 | tumor necrosis factor receptor binding |
GO:0004872 | 9e-04 | 3.7627 | 3.1268 | 10 | 975 | receptor activity |
GO:0008009 | 0.0015 | 40.398 | 0.0577 | 2 | 18 | chemokine activity |
GO:0005031 | 0.0018 | 35.9048 | 0.0641 | 2 | 20 | tumor necrosis factor-activated receptor activity |
GO:0043027 | 0.0029 | 28.0905 | 0.0802 | 2 | 25 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process |
GO:0003912 | 0.0032 | Inf | 0.0032 | 1 | 1 | DNA nucleotidylexotransferase activity |
GO:0005129 | 0.0032 | Inf | 0.0032 | 1 | 1 | granulocyte macrophage colony-stimulating factor receptor binding |
GO:0005147 | 0.0032 | Inf | 0.0032 | 1 | 1 | oncostatin-M receptor binding |
GO:0019782 | 0.0032 | Inf | 0.0032 | 1 | 1 | ISG15 activating enzyme activity |
GO:0042163 | 0.0032 | Inf | 0.0032 | 1 | 1 | interleukin-12 beta subunit binding |
GO:0045513 | 0.0032 | Inf | 0.0032 | 1 | 1 | interleukin-27 binding |
GO:1990175 | 0.0032 | Inf | 0.0032 | 1 | 1 | EH domain binding |
GO:0004839 | 0.0064 | 317.02 | 0.0064 | 1 | 2 | ubiquitin activating enzyme activity |
GO:0019767 | 0.0064 | 317.02 | 0.0064 | 1 | 2 | IgE receptor activity |
GO:0048248 | 0.0064 | 317.02 | 0.0064 | 1 | 2 | CXCR3 chemokine receptor binding |
GO:0005515 | 0.007 | 2.1195 | 24.7897 | 34 | 7730 | protein binding |
GO:0008083 | 0.0073 | 8.1255 | 0.3977 | 3 | 124 | growth factor activity |
GO:0004566 | 0.0096 | 158.5 | 0.0096 | 1 | 3 | beta-glucuronidase activity |
GO:0015057 | 0.0096 | 158.5 | 0.0096 | 1 | 3 | thrombin-activated receptor activity |
GO:0019863 | 0.0096 | 158.5 | 0.0096 | 1 | 3 | IgE binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0001856 | 0.0036 | Inf | 0.0036 | 1 | 1 | complement component C5a binding |
GO:0003912 | 0.0036 | Inf | 0.0036 | 1 | 1 | DNA nucleotidylexotransferase activity |
GO:0004555 | 0.0036 | Inf | 0.0036 | 1 | 1 | alpha,alpha-trehalase activity |
GO:0008720 | 0.0036 | Inf | 0.0036 | 1 | 1 | D-lactate dehydrogenase activity |
GO:0030171 | 0.0036 | Inf | 0.0036 | 1 | 1 | voltage-gated proton channel activity |
GO:0035757 | 0.0036 | Inf | 0.0036 | 1 | 1 | chemokine (C-C motif) ligand 19 binding |
GO:0035758 | 0.0036 | Inf | 0.0036 | 1 | 1 | chemokine (C-C motif) ligand 21 binding |
GO:0038117 | 0.0036 | Inf | 0.0036 | 1 | 1 | C-C motif chemokine 19 receptor activity |
GO:0038121 | 0.0036 | Inf | 0.0036 | 1 | 1 | C-C motif chemokine 21 receptor activity |
GO:0045509 | 0.0036 | Inf | 0.0036 | 1 | 1 | interleukin-27 receptor activity |
GO:0015197 | 0.0049 | 9.4104 | 0.3441 | 3 | 96 | peptide transporter activity |
GO:0004458 | 0.0072 | 282.9464 | 0.0072 | 1 | 2 | D-lactate dehydrogenase (cytochrome) activity |
GO:0004878 | 0.0072 | 282.9464 | 0.0072 | 1 | 2 | complement component C5a receptor activity |
GO:0015433 | 0.0072 | 282.9464 | 0.0072 | 1 | 2 | peptide antigen-transporting ATPase activity |
GO:0046980 | 0.0072 | 282.9464 | 0.0072 | 1 | 2 | tapasin binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004896 | 0.0013 | 15.367 | 0.2157 | 3 | 70 | cytokine receptor activity |
GO:0003912 | 0.0031 | Inf | 0.0031 | 1 | 1 | DNA nucleotidylexotransferase activity |
GO:0008720 | 0.0031 | Inf | 0.0031 | 1 | 1 | D-lactate dehydrogenase activity |
GO:0030171 | 0.0031 | Inf | 0.0031 | 1 | 1 | voltage-gated proton channel activity |
GO:0035757 | 0.0031 | Inf | 0.0031 | 1 | 1 | chemokine (C-C motif) ligand 19 binding |
GO:0035758 | 0.0031 | Inf | 0.0031 | 1 | 1 | chemokine (C-C motif) ligand 21 binding |
GO:0038117 | 0.0031 | Inf | 0.0031 | 1 | 1 | C-C motif chemokine 19 receptor activity |
GO:0038121 | 0.0031 | Inf | 0.0031 | 1 | 1 | C-C motif chemokine 21 receptor activity |
GO:0003692 | 0.0062 | 330.2708 | 0.0062 | 1 | 2 | left-handed Z-DNA binding |
GO:0004458 | 0.0062 | 330.2708 | 0.0062 | 1 | 2 | D-lactate dehydrogenase (cytochrome) activity |
GO:0003726 | 0.0092 | 165.125 | 0.0092 | 1 | 3 | double-stranded RNA adenosine deaminase activity |
GO:0042015 | 0.0092 | 165.125 | 0.0092 | 1 | 3 | interleukin-20 binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004014 | 0 | Inf | 0.005 | 2 | 2 | adenosylmethionine decarboxylase activity |
GO:0019810 | 0 | Inf | 0.005 | 2 | 2 | putrescine binding |
GO:0004603 | 0.0025 | Inf | 0.0025 | 1 | 1 | phenylethanolamine N-methyltransferase activity |
GO:0042007 | 0.0025 | Inf | 0.0025 | 1 | 1 | interleukin-18 binding |
GO:0045155 | 0.005 | 406.7179 | 0.005 | 1 | 2 | electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity |
GO:0016830 | 0.0065 | 18.0973 | 0.1207 | 2 | 48 | carbon-carbon lyase activity |
GO:0004082 | 0.0075 | 203.3462 | 0.0075 | 1 | 3 | bisphosphoglycerate mutase activity |
GO:0046538 | 0.0075 | 203.3462 | 0.0075 | 1 | 3 | 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity |
GO:0000981 | 0.008 | 3.8169 | 1.7783 | 6 | 707 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0003912 | 0.0027 | Inf | 0.0027 | 1 | 1 | DNA nucleotidylexotransferase activity |
GO:0030171 | 0.0027 | Inf | 0.0027 | 1 | 1 | voltage-gated proton channel activity |
GO:0003823 | 0.0063 | 18.3717 | 0.119 | 2 | 44 | antigen binding |
GO:0004566 | 0.0081 | 188.7857 | 0.0081 | 1 | 3 | beta-glucuronidase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0047844 | 0.0025 | Inf | 0.0025 | 1 | 1 | deoxycytidine deaminase activity |
GO:0004082 | 0.0073 | 208.7105 | 0.0074 | 1 | 3 | bisphosphoglycerate mutase activity |
GO:0016015 | 0.0073 | 208.7105 | 0.0074 | 1 | 3 | morphogen activity |
GO:0046538 | 0.0073 | 208.7105 | 0.0074 | 1 | 3 | 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity |
GO:0051870 | 0.0073 | 208.7105 | 0.0074 | 1 | 3 | methotrexate binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0008397 | 0.0028 | Inf | 0.0028 | 1 | 1 | sterol 12-alpha-hydroxylase activity |
GO:0016824 | 0.0028 | Inf | 0.0028 | 1 | 1 | hydrolase activity, acting on acid halide bonds |
GO:0047651 | 0.0028 | Inf | 0.0028 | 1 | 1 | alkylhalidase activity |
GO:0050571 | 0.0028 | Inf | 0.0028 | 1 | 1 | 1,5-anhydro-D-fructose reductase activity |
GO:0005484 | 0.0046 | 21.6471 | 0.1019 | 2 | 36 | SNAP receptor activity |
GO:0016501 | 0.0057 | 360.3864 | 0.0057 | 1 | 2 | prostacyclin receptor activity |
GO:0034235 | 0.0085 | 180.1818 | 0.0085 | 1 | 3 | GPI anchor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0008720 | 0.0028 | Inf | 0.0028 | 1 | 1 | D-lactate dehydrogenase activity |
GO:0031835 | 0.0028 | Inf | 0.0028 | 1 | 1 | substance P receptor binding |
GO:0050459 | 0.0028 | Inf | 0.0028 | 1 | 1 | ethanolamine-phosphate phospho-lyase activity |
GO:0003924 | 0.0045 | 6.5141 | 0.6735 | 4 | 238 | GTPase activity |
GO:0004458 | 0.0057 | 360.3864 | 0.0057 | 1 | 2 | D-lactate dehydrogenase (cytochrome) activity |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:1902952 | 1e-04 | 251.3208 | 0.0164 | 2 | 4 | positive regulation of dendritic spine maintenance |
GO:0021578 | 2e-04 | 125.6415 | 0.0247 | 2 | 6 | hindbrain maturation |
GO:0042048 | 7e-04 | 62.8019 | 0.0411 | 2 | 10 | olfactory behavior |
GO:0031268 | 0.0011 | 50.234 | 0.0493 | 2 | 12 | pseudopodium organization |
GO:0046847 | 0.0012 | 15.9543 | 0.2097 | 3 | 51 | filopodium assembly |
GO:0060749 | 0.0024 | 31.3821 | 0.074 | 2 | 18 | mammary gland alveolus development |
GO:0033599 | 0.0027 | 29.5339 | 0.0781 | 2 | 19 | regulation of mammary gland epithelial cell proliferation |
GO:0002415 | 0.0041 | Inf | 0.0041 | 1 | 1 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor |
GO:0009624 | 0.0041 | Inf | 0.0041 | 1 | 1 | response to nematode |
GO:0018964 | 0.0041 | Inf | 0.0041 | 1 | 1 | propylene metabolic process |
GO:0021686 | 0.0041 | Inf | 0.0041 | 1 | 1 | cerebellar granular layer maturation |
GO:0035499 | 0.0041 | Inf | 0.0041 | 1 | 1 | carnosine biosynthetic process |
GO:0060574 | 0.0041 | Inf | 0.0041 | 1 | 1 | intestinal epithelial cell maturation |
GO:0060857 | 0.0041 | Inf | 0.0041 | 1 | 1 | establishment of glial blood-brain barrier |
GO:0070268 | 0.0041 | Inf | 0.0041 | 1 | 1 | cornification |
GO:1905429 | 0.0041 | Inf | 0.0041 | 1 | 1 | response to glycine |
GO:0010634 | 0.007 | 8.2964 | 0.3906 | 3 | 95 | positive regulation of epithelial cell migration |
GO:0090132 | 0.0078 | 5.5091 | 0.7853 | 4 | 191 | epithelium migration |
GO:0021933 | 0.0082 | 246.6852 | 0.0082 | 1 | 2 | radial glia guided migration of cerebellar granule cell |
GO:0021941 | 0.0082 | 246.6852 | 0.0082 | 1 | 2 | negative regulation of cerebellar granule cell precursor proliferation |
GO:0048014 | 0.0082 | 246.6852 | 0.0082 | 1 | 2 | Tie signaling pathway |
GO:0060435 | 0.0082 | 246.6852 | 0.0082 | 1 | 2 | bronchiole development |
GO:0060764 | 0.0082 | 246.6852 | 0.0082 | 1 | 2 | cell-cell signaling involved in mammary gland development |
GO:1900673 | 0.0082 | 246.6852 | 0.0082 | 1 | 2 | olefin metabolic process |
GO:0098815 | 0.0096 | 14.7481 | 0.148 | 2 | 36 | modulation of excitatory postsynaptic potential |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:2000026 | 0 | 3.8197 | 6.5805 | 19 | 1492 | regulation of multicellular organismal development |
GO:0051093 | 1e-04 | 4.4027 | 3.2726 | 12 | 742 | negative regulation of developmental process |
GO:0048534 | 1e-04 | 4.4735 | 2.911 | 11 | 660 | hematopoietic or lymphoid organ development |
GO:0010719 | 2e-04 | 29.6741 | 0.1191 | 3 | 27 | negative regulation of epithelial to mesenchymal transition |
GO:0002252 | 4e-04 | 5.1186 | 1.7819 | 8 | 404 | immune effector process |
GO:0045346 | 4e-04 | 93.4246 | 0.0309 | 2 | 7 | regulation of MHC class II biosynthetic process |
GO:0008285 | 4e-04 | 4.4748 | 2.3111 | 9 | 524 | negative regulation of cell proliferation |
GO:0048731 | 5e-04 | 2.5006 | 14.9386 | 27 | 3387 | system development |
GO:0097066 | 7e-04 | 66.7218 | 0.0397 | 2 | 9 | response to thyroid hormone |
GO:0045862 | 7e-04 | 6.1952 | 1.0806 | 6 | 245 | positive regulation of proteolysis |
GO:0010033 | 9e-04 | 2.7011 | 8.2918 | 18 | 1880 | response to organic substance |
GO:0033619 | 9e-04 | 17.783 | 0.1897 | 3 | 43 | membrane protein proteolysis |
GO:0045019 | 0.001 | 51.8869 | 0.0485 | 2 | 11 | negative regulation of nitric oxide biosynthetic process |
GO:0045647 | 0.001 | 51.8869 | 0.0485 | 2 | 11 | negative regulation of erythrocyte differentiation |
GO:0048869 | 0.0011 | 2.3874 | 13.9418 | 25 | 3161 | cellular developmental process |
GO:0002521 | 0.0011 | 4.8316 | 1.6231 | 7 | 368 | leukocyte differentiation |
GO:0043901 | 0.0012 | 9.4232 | 0.4675 | 4 | 106 | negative regulation of multi-organism process |
GO:0044130 | 0.0012 | 46.6947 | 0.0529 | 2 | 12 | negative regulation of growth of symbiont in host |
GO:0050776 | 0.0013 | 4.6848 | 1.6716 | 7 | 379 | regulation of immune response |
GO:0030512 | 0.0015 | 14.5069 | 0.2293 | 3 | 52 | negative regulation of transforming growth factor beta receptor signaling pathway |
GO:0044110 | 0.0017 | 38.9064 | 0.0617 | 2 | 14 | growth involved in symbiotic interaction |
GO:0044144 | 0.0017 | 38.9064 | 0.0617 | 2 | 14 | modulation of growth of symbiont involved in interaction with host |
GO:0006952 | 0.0017 | 3.3959 | 3.3741 | 10 | 765 | defense response |
GO:0070887 | 0.0018 | 2.5686 | 8.0713 | 17 | 1830 | cellular response to chemical stimulus |
GO:0007165 | 0.0018 | 2.2642 | 15.2782 | 26 | 3464 | signal transduction |
GO:0009888 | 0.0026 | 2.6762 | 6.1792 | 14 | 1401 | tissue development |
GO:0019835 | 0.0027 | 29.6897 | 0.0781 | 2 | 18 | cytolysis |
GO:0007167 | 0.0028 | 3.3873 | 3.0036 | 9 | 681 | enzyme linked receptor protein signaling pathway |
GO:0009408 | 0.0028 | 11.6426 | 0.2823 | 3 | 64 | response to heat |
GO:0044403 | 0.0029 | 5.6156 | 0.9768 | 5 | 229 | symbiosis, encompassing mutualism through parasitism |
GO:0051240 | 0.0031 | 2.7093 | 5.6058 | 13 | 1271 | positive regulation of multicellular organismal process |
GO:0042832 | 0.0031 | 27.453 | 0.0838 | 2 | 19 | defense response to protozoan |
GO:0051043 | 0.0031 | 27.453 | 0.0838 | 2 | 19 | regulation of membrane protein ectodomain proteolysis |
GO:0009628 | 0.0033 | 3.2993 | 3.0786 | 9 | 698 | response to abiotic stimulus |
GO:0009605 | 0.0035 | 2.6694 | 5.6808 | 13 | 1288 | response to external stimulus |
GO:0016477 | 0.0035 | 2.9011 | 4.3488 | 11 | 986 | cell migration |
GO:0042089 | 0.0036 | 10.5951 | 0.3087 | 3 | 70 | cytokine biosynthetic process |
GO:0043066 | 0.0036 | 3.2446 | 3.1271 | 9 | 709 | negative regulation of apoptotic process |
GO:0045639 | 0.0041 | 10.1388 | 0.322 | 3 | 73 | positive regulation of myeloid cell differentiation |
GO:0000821 | 0.0044 | Inf | 0.0044 | 1 | 1 | regulation of arginine metabolic process |
GO:0001878 | 0.0044 | Inf | 0.0044 | 1 | 1 | response to yeast |
GO:0002149 | 0.0044 | Inf | 0.0044 | 1 | 1 | hypochlorous acid biosynthetic process |
GO:0002426 | 0.0044 | Inf | 0.0044 | 1 | 1 | immunoglobulin production in mucosal tissue |
GO:0002875 | 0.0044 | Inf | 0.0044 | 1 | 1 | negative regulation of chronic inflammatory response to antigenic stimulus |
GO:0006507 | 0.0044 | Inf | 0.0044 | 1 | 1 | GPI anchor release |
GO:0034769 | 0.0044 | Inf | 0.0044 | 1 | 1 | basement membrane disassembly |
GO:0060376 | 0.0044 | Inf | 0.0044 | 1 | 1 | positive regulation of mast cell differentiation |
GO:0071282 | 0.0044 | Inf | 0.0044 | 1 | 1 | cellular response to iron(II) ion |
GO:0071401 | 0.0044 | Inf | 0.0044 | 1 | 1 | cellular response to triglyceride |
GO:0071461 | 0.0044 | Inf | 0.0044 | 1 | 1 | cellular response to redox state |
GO:2001237 | 0.0047 | 9.5878 | 0.3396 | 3 | 77 | negative regulation of extrinsic apoptotic signaling pathway |
GO:0071559 | 0.0049 | 6.2995 | 0.688 | 4 | 156 | response to transforming growth factor beta |
GO:0001775 | 0.005 | 3.3192 | 2.686 | 8 | 609 | cell activation |
GO:2000145 | 0.005 | 3.3192 | 2.686 | 8 | 609 | regulation of cell motility |
GO:0010604 | 0.0052 | 2.2055 | 10.4927 | 19 | 2379 | positive regulation of macromolecule metabolic process |
GO:0009653 | 0.0056 | 2.2625 | 8.9887 | 17 | 2038 | anatomical structure morphogenesis |
GO:0030851 | 0.0058 | 19.4357 | 0.1147 | 2 | 26 | granulocyte differentiation |
GO:0061053 | 0.006 | 8.7546 | 0.3705 | 3 | 84 | somite development |
GO:0071887 | 0.006 | 8.7546 | 0.3705 | 3 | 84 | leukocyte apoptotic process |
GO:1903844 | 0.006 | 8.7546 | 0.3705 | 3 | 84 | regulation of cellular response to transforming growth factor beta stimulus |
GO:0048762 | 0.0061 | 5.9062 | 0.7322 | 4 | 166 | mesenchymal cell differentiation |
GO:0050789 | 0.0062 | 2.0975 | 33.1806 | 43 | 7523 | regulation of biological process |
GO:0045595 | 0.0066 | 2.4507 | 6.1307 | 13 | 1390 | regulation of cell differentiation |
GO:0007212 | 0.0067 | 17.9379 | 0.1235 | 2 | 28 | dopamine receptor signaling pathway |
GO:0045071 | 0.0067 | 17.9379 | 0.1235 | 2 | 28 | negative regulation of viral genome replication |
GO:0048584 | 0.0067 | 2.4448 | 6.1439 | 13 | 1393 | positive regulation of response to stimulus |
GO:0002683 | 0.0068 | 4.5433 | 1.1953 | 5 | 271 | negative regulation of immune system process |
GO:0051674 | 0.0068 | 2.6339 | 4.7502 | 11 | 1077 | localization of cell |
GO:0042592 | 0.0068 | 2.5273 | 5.4426 | 12 | 1234 | homeostatic process |
GO:1901700 | 0.0074 | 2.7248 | 4.1371 | 10 | 938 | response to oxygen-containing compound |
GO:0051241 | 0.0074 | 2.8942 | 3.4984 | 9 | 834 | negative regulation of multicellular organismal process |
GO:0050864 | 0.0075 | 8.054 | 0.4014 | 3 | 91 | regulation of B cell activation |
GO:0051173 | 0.0076 | 2.151 | 10.0692 | 18 | 2322 | positive regulation of nitrogen compound metabolic process |
GO:0040011 | 0.0077 | 2.4847 | 5.5264 | 12 | 1253 | locomotion |
GO:0030225 | 0.0077 | 16.6541 | 0.1323 | 2 | 30 | macrophage differentiation |
GO:0048585 | 0.0078 | 2.5812 | 4.8384 | 11 | 1097 | negative regulation of response to stimulus |
GO:0072593 | 0.0078 | 5.4938 | 0.7851 | 4 | 178 | reactive oxygen species metabolic process |
GO:2000249 | 0.0082 | 16.0786 | 0.1367 | 2 | 31 | regulation of actin cytoskeleton reorganization |
GO:0002696 | 0.0084 | 5.3687 | 0.8027 | 4 | 182 | positive regulation of leukocyte activation |
GO:0060548 | 0.0085 | 2.8203 | 3.5637 | 9 | 808 | negative regulation of cell death |
GO:0002430 | 0.0088 | 229.6034 | 0.0088 | 1 | 2 | complement receptor mediated signaling pathway |
GO:0002554 | 0.0088 | 229.6034 | 0.0088 | 1 | 2 | serotonin secretion by platelet |
GO:0002740 | 0.0088 | 229.6034 | 0.0088 | 1 | 2 | negative regulation of cytokine secretion involved in immune response |
GO:0008588 | 0.0088 | 229.6034 | 0.0088 | 1 | 2 | release of cytoplasmic sequestered NF-kappaB |
GO:0010983 | 0.0088 | 229.6034 | 0.0088 | 1 | 2 | positive regulation of high-density lipoprotein particle clearance |
GO:0045919 | 0.0088 | 229.6034 | 0.0088 | 1 | 2 | positive regulation of cytolysis |
GO:0060302 | 0.0088 | 229.6034 | 0.0088 | 1 | 2 | negative regulation of cytokine activity |
GO:2000611 | 0.0088 | 229.6034 | 0.0088 | 1 | 2 | positive regulation of thyroid hormone generation |
GO:0010470 | 0.0098 | 14.568 | 0.15 | 2 | 34 | regulation of gastrulation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050832 | 0.001 | 51.8869 | 0.0485 | 2 | 11 | defense response to fungus |
GO:0006828 | 0.0012 | 46.6947 | 0.0529 | 2 | 12 | manganese ion transport |
GO:0050820 | 0.0028 | 29.1711 | 0.0794 | 2 | 18 | positive regulation of coagulation |
GO:0043486 | 0.0031 | 27.453 | 0.0838 | 2 | 19 | histone exchange |
GO:0001581 | 0.0044 | Inf | 0.0044 | 1 | 1 | detection of chemical stimulus involved in sensory perception of sour taste |
GO:0001878 | 0.0044 | Inf | 0.0044 | 1 | 1 | response to yeast |
GO:0002124 | 0.0044 | Inf | 0.0044 | 1 | 1 | territorial aggressive behavior |
GO:0002149 | 0.0044 | Inf | 0.0044 | 1 | 1 | hypochlorous acid biosynthetic process |
GO:0033580 | 0.0044 | Inf | 0.0044 | 1 | 1 | protein galactosylation at cell surface |
GO:0035971 | 0.0044 | Inf | 0.0044 | 1 | 1 | peptidyl-histidine dephosphorylation |
GO:0036413 | 0.0044 | Inf | 0.0044 | 1 | 1 | histone H3-R26 citrullination |
GO:0048047 | 0.0044 | Inf | 0.0044 | 1 | 1 | mating behavior, sex discrimination |
GO:1901624 | 0.0044 | Inf | 0.0044 | 1 | 1 | negative regulation of lymphocyte chemotaxis |
GO:1902436 | 0.0044 | Inf | 0.0044 | 1 | 1 | negative regulation of male mating behavior |
GO:1903141 | 0.0044 | Inf | 0.0044 | 1 | 1 | negative regulation of establishment of endothelial barrier |
GO:0007340 | 0.005 | 21.2057 | 0.1059 | 2 | 24 | acrosome reaction |
GO:0021904 | 0.0067 | 17.9379 | 0.1235 | 2 | 28 | dorsal/ventral neural tube patterning |
GO:0006335 | 0.0082 | 16.0786 | 0.1367 | 2 | 31 | DNA replication-dependent nucleosome assembly |
GO:2000249 | 0.0082 | 16.0786 | 0.1367 | 2 | 31 | regulation of actin cytoskeleton reorganization |
GO:0031333 | 0.0085 | 7.7015 | 0.419 | 3 | 95 | negative regulation of protein complex assembly |
GO:0006452 | 0.0088 | 229.6034 | 0.0088 | 1 | 2 | translational frameshifting |
GO:0010848 | 0.0088 | 229.6034 | 0.0088 | 1 | 2 | regulation of chromatin disassembly |
GO:0036228 | 0.0088 | 229.6034 | 0.0088 | 1 | 2 | protein localization to nuclear inner membrane |
GO:0042371 | 0.0088 | 229.6034 | 0.0088 | 1 | 2 | vitamin K biosynthetic process |
GO:0045905 | 0.0088 | 229.6034 | 0.0088 | 1 | 2 | positive regulation of translational termination |
GO:0071626 | 0.0088 | 229.6034 | 0.0088 | 1 | 2 | mastication |
GO:0098583 | 0.0088 | 229.6034 | 0.0088 | 1 | 2 | learned vocalization behavior |
GO:1901750 | 0.0088 | 229.6034 | 0.0088 | 1 | 2 | leukotriene D4 biosynthetic process |
GO:1905747 | 0.0088 | 229.6034 | 0.0088 | 1 | 2 | negative regulation of saliva secretion |
GO:1905748 | 0.0088 | 229.6034 | 0.0088 | 1 | 2 | hard palate morphogenesis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045595 | 7e-04 | 3.0302 | 6.0268 | 15 | 1390 | regulation of cell differentiation |
GO:0007186 | 0.0015 | 4.0851 | 2.2113 | 8 | 510 | G-protein coupled receptor signaling pathway |
GO:0048534 | 0.002 | 3.5742 | 2.8616 | 9 | 660 | hematopoietic or lymphoid organ development |
GO:0048869 | 0.002 | 2.2911 | 13.7055 | 24 | 3161 | cellular developmental process |
GO:0030816 | 0.0022 | 12.6909 | 0.2601 | 3 | 60 | positive regulation of cAMP metabolic process |
GO:0045639 | 0.0036 | 10.6683 | 0.3068 | 3 | 72 | positive regulation of myeloid cell differentiation |
GO:0060216 | 0.0037 | 25 | 0.0911 | 2 | 21 | definitive hemopoiesis |
GO:0000821 | 0.0043 | Inf | 0.0043 | 1 | 1 | regulation of arginine metabolic process |
GO:0034769 | 0.0043 | Inf | 0.0043 | 1 | 1 | basement membrane disassembly |
GO:0035702 | 0.0043 | Inf | 0.0043 | 1 | 1 | monocyte homeostasis |
GO:0060376 | 0.0043 | Inf | 0.0043 | 1 | 1 | positive regulation of mast cell differentiation |
GO:0071461 | 0.0043 | Inf | 0.0043 | 1 | 1 | cellular response to redox state |
GO:0097231 | 0.0043 | Inf | 0.0043 | 1 | 1 | cell motility in response to calcium ion |
GO:1905221 | 0.0043 | Inf | 0.0043 | 1 | 1 | positive regulation of platelet formation |
GO:1990959 | 0.0043 | Inf | 0.0043 | 1 | 1 | eosinophil homeostasis |
GO:1990960 | 0.0043 | Inf | 0.0043 | 1 | 1 | basophil homeostasis |
GO:0050671 | 0.0043 | 9.8974 | 0.3295 | 3 | 76 | positive regulation of lymphocyte proliferation |
GO:0007155 | 0.0044 | 2.9592 | 3.8415 | 10 | 886 | cell adhesion |
GO:1900542 | 0.0053 | 6.1702 | 0.7024 | 4 | 162 | regulation of purine nucleotide metabolic process |
GO:0070665 | 0.0054 | 9.1415 | 0.3555 | 3 | 82 | positive regulation of leukocyte proliferation |
GO:1903706 | 0.0058 | 4.7199 | 1.1533 | 5 | 266 | regulation of hemopoiesis |
GO:0023052 | 0.006 | 2.0391 | 16.5671 | 26 | 3821 | signaling |
GO:0010719 | 0.006 | 18.9914 | 0.1171 | 2 | 27 | negative regulation of epithelial to mesenchymal transition |
GO:0051716 | 0.0063 | 2.0045 | 19.3463 | 29 | 4462 | cellular response to stimulus |
GO:0022604 | 0.0063 | 3.9288 | 1.6736 | 6 | 386 | regulation of cell morphogenesis |
GO:0051094 | 0.0067 | 2.6416 | 4.7477 | 11 | 1095 | positive regulation of developmental process |
GO:0007154 | 0.007 | 2.0071 | 16.7535 | 26 | 3864 | cell communication |
GO:0001960 | 0.0074 | 16.9528 | 0.1301 | 2 | 30 | negative regulation of cytokine-mediated signaling pathway |
GO:0045981 | 0.0085 | 7.6741 | 0.4206 | 3 | 97 | positive regulation of nucleotide metabolic process |
GO:0002554 | 0.0087 | 233.6491 | 0.0087 | 1 | 2 | serotonin secretion by platelet |
GO:0008588 | 0.0087 | 233.6491 | 0.0087 | 1 | 2 | release of cytoplasmic sequestered NF-kappaB |
GO:0009115 | 0.0087 | 233.6491 | 0.0087 | 1 | 2 | xanthine catabolic process |
GO:0035589 | 0.0087 | 233.6491 | 0.0087 | 1 | 2 | G-protein coupled purinergic nucleotide receptor signaling pathway |
GO:0051012 | 0.0087 | 233.6491 | 0.0087 | 1 | 2 | microtubule sliding |
GO:2000611 | 0.0087 | 233.6491 | 0.0087 | 1 | 2 | positive regulation of thyroid hormone generation |
GO:0007167 | 0.0087 | 3.0065 | 2.9527 | 8 | 681 | enzyme linked receptor protein signaling pathway |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050670 | 0 | 22.4456 | 0.5734 | 10 | 130 | regulation of lymphocyte proliferation |
GO:0001775 | 0 | 14.1127 | 1.2819 | 13 | 358 | cell activation |
GO:0070663 | 0 | 21.1972 | 0.6042 | 10 | 137 | regulation of leukocyte proliferation |
GO:0006955 | 0 | 8.0225 | 3.1271 | 18 | 709 | immune response |
GO:0042832 | 0 | 87.9894 | 0.0838 | 5 | 19 | defense response to protozoan |
GO:0002694 | 0 | 14.0599 | 0.795 | 9 | 203 | regulation of leukocyte activation |
GO:0051251 | 0 | 13.5872 | 0.7057 | 8 | 160 | positive regulation of lymphocyte activation |
GO:0048534 | 0 | 6.1028 | 2.911 | 14 | 660 | hematopoietic or lymphoid organ development |
GO:0097530 | 0 | 22.0588 | 0.3264 | 6 | 74 | granulocyte migration |
GO:0046649 | 0 | 10.1964 | 1.0804 | 9 | 280 | lymphocyte activation |
GO:0050867 | 0 | 11.1356 | 0.8512 | 8 | 193 | positive regulation of cell activation |
GO:0022407 | 0 | 9.258 | 1.16 | 9 | 263 | regulation of cell-cell adhesion |
GO:0002274 | 0 | 21.7544 | 0.2713 | 5 | 67 | myeloid leukocyte activation |
GO:0050863 | 0 | 14.7488 | 0.4753 | 6 | 113 | regulation of T cell activation |
GO:1903039 | 0 | 13.7189 | 0.5072 | 6 | 115 | positive regulation of leukocyte cell-cell adhesion |
GO:0007599 | 0 | 12.4509 | 0.5557 | 6 | 126 | hemostasis |
GO:0050817 | 0 | 12.245 | 0.5646 | 6 | 128 | coagulation |
GO:0032946 | 0 | 16.7998 | 0.344 | 5 | 78 | positive regulation of mononuclear cell proliferation |
GO:0045579 | 0 | 64.8068 | 0.0617 | 3 | 14 | positive regulation of B cell differentiation |
GO:0050864 | 0 | 14.2463 | 0.4014 | 5 | 91 | regulation of B cell activation |
GO:0090023 | 1e-04 | 50.9082 | 0.075 | 3 | 17 | positive regulation of neutrophil chemotaxis |
GO:0002351 | 1e-04 | 467.2632 | 0.0132 | 2 | 3 | serotonin production involved in inflammatory response |
GO:0030886 | 1e-04 | 467.2632 | 0.0132 | 2 | 3 | negative regulation of myeloid dendritic cell activation |
GO:0002690 | 1e-04 | 20.1061 | 0.2293 | 4 | 52 | positive regulation of leukocyte chemotaxis |
GO:0042102 | 1e-04 | 20.1061 | 0.2293 | 4 | 52 | positive regulation of T cell proliferation |
GO:0042060 | 1e-04 | 7.3667 | 1.085 | 7 | 246 | wound healing |
GO:0030217 | 1e-04 | 9.0801 | 0.7498 | 6 | 170 | T cell differentiation |
GO:0032943 | 1e-04 | 18.6454 | 0.2462 | 4 | 64 | mononuclear cell proliferation |
GO:0002521 | 1e-04 | 7.2698 | 1.1061 | 7 | 267 | leukocyte differentiation |
GO:0001819 | 1e-04 | 7.213 | 1.107 | 7 | 251 | positive regulation of cytokine production |
GO:0007155 | 1e-04 | 4.8432 | 2.4666 | 10 | 622 | cell adhesion |
GO:0051270 | 2e-04 | 4.3673 | 2.9771 | 11 | 675 | regulation of cellular component movement |
GO:0010647 | 2e-04 | 3.5133 | 5.2618 | 15 | 1193 | positive regulation of cell communication |
GO:0045785 | 2e-04 | 6.8413 | 1.1644 | 7 | 264 | positive regulation of cell adhesion |
GO:0023056 | 2e-04 | 3.4873 | 5.2971 | 15 | 1201 | positive regulation of signaling |
GO:1902622 | 2e-04 | 32.3766 | 0.1103 | 3 | 25 | regulation of neutrophil migration |
GO:0045918 | 2e-04 | 155.731 | 0.0221 | 2 | 5 | negative regulation of cytolysis |
GO:0030851 | 2e-04 | 30.9666 | 0.1147 | 3 | 26 | granulocyte differentiation |
GO:0032715 | 2e-04 | 29.6741 | 0.1191 | 3 | 27 | negative regulation of interleukin-6 production |
GO:0030168 | 3e-04 | 14.6028 | 0.3087 | 4 | 70 | platelet activation |
GO:0050920 | 3e-04 | 9.7726 | 0.5734 | 5 | 130 | regulation of chemotaxis |
GO:0008283 | 3e-04 | 4.1101 | 3.2416 | 11 | 822 | cell proliferation |
GO:0016477 | 3e-04 | 3.5856 | 4.3488 | 13 | 986 | cell migration |
GO:0071622 | 3e-04 | 25.4273 | 0.1367 | 3 | 31 | regulation of granulocyte chemotaxis |
GO:0033004 | 4e-04 | 93.4246 | 0.0309 | 2 | 7 | negative regulation of mast cell activation |
GO:2001185 | 4e-04 | 93.4246 | 0.0309 | 2 | 7 | regulation of CD8-positive, alpha-beta T cell activation |
GO:0006952 | 4e-04 | 3.8186 | 3.3741 | 11 | 765 | defense response |
GO:0009605 | 5e-04 | 3.4116 | 4.6101 | 13 | 1106 | response to external stimulus |
GO:0010744 | 5e-04 | 77.848 | 0.0353 | 2 | 8 | positive regulation of macrophage derived foam cell differentiation |
GO:0051001 | 5e-04 | 77.848 | 0.0353 | 2 | 8 | negative regulation of nitric-oxide synthase activity |
GO:0051707 | 6e-04 | 4.7819 | 1.9009 | 8 | 431 | response to other organism |
GO:0045637 | 6e-04 | 8.074 | 0.688 | 5 | 156 | regulation of myeloid cell differentiation |
GO:0045576 | 6e-04 | 70.2646 | 0.0378 | 2 | 9 | mast cell activation |
GO:0009966 | 6e-04 | 2.7313 | 8.7858 | 19 | 1992 | regulation of signal transduction |
GO:0002429 | 6e-04 | 11.3224 | 0.3925 | 4 | 89 | immune response-activating cell surface receptor signaling pathway |
GO:0065007 | 7e-04 | 2.724 | 34.8522 | 47 | 7902 | biological regulation |
GO:1905153 | 7e-04 | 66.7218 | 0.0397 | 2 | 9 | regulation of membrane invagination |
GO:0051674 | 7e-04 | 3.2548 | 4.7502 | 13 | 1077 | localization of cell |
GO:0002366 | 7e-04 | 7.8632 | 0.7057 | 5 | 160 | leukocyte activation involved in immune response |
GO:1902533 | 7e-04 | 3.8405 | 3.008 | 10 | 682 | positive regulation of intracellular signal transduction |
GO:0001820 | 8e-04 | 58.3772 | 0.0441 | 2 | 10 | serotonin secretion |
GO:0007264 | 9e-04 | 5.077 | 1.5481 | 7 | 351 | small GTPase mediated signal transduction |
GO:0009607 | 9e-04 | 4.4753 | 2.0244 | 8 | 459 | response to biotic stimulus |
GO:0040011 | 9e-04 | 3.033 | 5.5264 | 14 | 1253 | locomotion |
GO:2000147 | 0.001 | 4.9298 | 1.5922 | 7 | 361 | positive regulation of cell motility |
GO:1902107 | 0.001 | 9.9127 | 0.4455 | 4 | 101 | positive regulation of leukocyte differentiation |
GO:0044092 | 0.001 | 3.6457 | 3.158 | 10 | 716 | negative regulation of molecular function |
GO:0032945 | 0.0012 | 15.8012 | 0.2117 | 3 | 48 | negative regulation of mononuclear cell proliferation |
GO:0002376 | 0.0013 | 4.9165 | 1.6922 | 7 | 573 | immune system process |
GO:0045619 | 0.0013 | 9.331 | 0.4719 | 4 | 107 | regulation of lymphocyte differentiation |
GO:0002684 | 0.0014 | 5.4789 | 1.2324 | 6 | 325 | positive regulation of immune system process |
GO:0050688 | 0.0014 | 15.1265 | 0.2205 | 3 | 50 | regulation of defense response to virus |
GO:0050764 | 0.0019 | 13.408 | 0.247 | 3 | 56 | regulation of phagocytosis |
GO:0030889 | 0.0019 | 35.9109 | 0.0662 | 2 | 15 | negative regulation of B cell proliferation |
GO:0043011 | 0.0019 | 35.9109 | 0.0662 | 2 | 15 | myeloid dendritic cell differentiation |
GO:0002699 | 0.0021 | 8.0666 | 0.5425 | 4 | 123 | positive regulation of immune effector process |
GO:0007229 | 0.0024 | 12.2475 | 0.269 | 3 | 61 | integrin-mediated signaling pathway |
GO:0042035 | 0.0024 | 12.2475 | 0.269 | 3 | 61 | regulation of cytokine biosynthetic process |
GO:0030595 | 0.0026 | 11.9044 | 0.2765 | 3 | 67 | leukocyte chemotaxis |
GO:0050868 | 0.0027 | 11.8375 | 0.2779 | 3 | 63 | negative regulation of T cell activation |
GO:0042044 | 0.0031 | 27.453 | 0.0838 | 2 | 19 | fluid transport |
GO:0046631 | 0.0032 | 11.1389 | 0.2945 | 3 | 69 | alpha-beta T cell activation |
GO:0008284 | 0.0033 | 3.2943 | 3.083 | 9 | 699 | positive regulation of cell proliferation |
GO:0006935 | 0.0034 | 5.3928 | 1.0191 | 5 | 250 | chemotaxis |
GO:0010648 | 0.0034 | 2.9076 | 4.34 | 11 | 984 | negative regulation of cell communication |
GO:0090077 | 0.0035 | 25.9259 | 0.0882 | 2 | 20 | foam cell differentiation |
GO:0046849 | 0.0035 | 10.7565 | 0.3043 | 3 | 69 | bone remodeling |
GO:0023057 | 0.0035 | 2.8979 | 4.3532 | 11 | 987 | negative regulation of signaling |
GO:0048584 | 0.0036 | 2.7793 | 5.0477 | 12 | 1211 | positive regulation of response to stimulus |
GO:0042107 | 0.0038 | 10.4386 | 0.3131 | 3 | 71 | cytokine metabolic process |
GO:0046633 | 0.0038 | 24.5596 | 0.0926 | 2 | 21 | alpha-beta T cell proliferation |
GO:0051354 | 0.0038 | 24.5596 | 0.0926 | 2 | 21 | negative regulation of oxidoreductase activity |
GO:0030224 | 0.0042 | 23.3298 | 0.097 | 2 | 22 | monocyte differentiation |
GO:0043368 | 0.0042 | 23.3298 | 0.097 | 2 | 22 | positive T cell selection |
GO:0045648 | 0.0042 | 23.3298 | 0.097 | 2 | 22 | positive regulation of erythrocyte differentiation |
GO:0001300 | 0.0044 | Inf | 0.0044 | 1 | 1 | chronological cell aging |
GO:0002277 | 0.0044 | Inf | 0.0044 | 1 | 1 | myeloid dendritic cell activation involved in immune response |
GO:0002552 | 0.0044 | Inf | 0.0044 | 1 | 1 | serotonin secretion by mast cell |
GO:0034125 | 0.0044 | Inf | 0.0044 | 1 | 1 | negative regulation of MyD88-dependent toll-like receptor signaling pathway |
GO:0034157 | 0.0044 | Inf | 0.0044 | 1 | 1 | positive regulation of toll-like receptor 7 signaling pathway |
GO:0034165 | 0.0044 | Inf | 0.0044 | 1 | 1 | positive regulation of toll-like receptor 9 signaling pathway |
GO:0035644 | 0.0044 | Inf | 0.0044 | 1 | 1 | phosphoanandamide dephosphorylation |
GO:0035702 | 0.0044 | Inf | 0.0044 | 1 | 1 | monocyte homeostasis |
GO:0043378 | 0.0044 | Inf | 0.0044 | 1 | 1 | positive regulation of CD8-positive, alpha-beta T cell differentiation |
GO:0051134 | 0.0044 | Inf | 0.0044 | 1 | 1 | negative regulation of NK T cell activation |
GO:0060101 | 0.0044 | Inf | 0.0044 | 1 | 1 | negative regulation of phagocytosis, engulfment |
GO:0071460 | 0.0044 | Inf | 0.0044 | 1 | 1 | cellular response to cell-matrix adhesion |
GO:0071663 | 0.0044 | Inf | 0.0044 | 1 | 1 | positive regulation of granzyme B production |
GO:0071918 | 0.0044 | Inf | 0.0044 | 1 | 1 | urea transmembrane transport |
GO:1902567 | 0.0044 | Inf | 0.0044 | 1 | 1 | negative regulation of eosinophil activation |
GO:1905221 | 0.0044 | Inf | 0.0044 | 1 | 1 | positive regulation of platelet formation |
GO:1905222 | 0.0044 | Inf | 0.0044 | 1 | 1 | atrioventricular canal morphogenesis |
GO:1990959 | 0.0044 | Inf | 0.0044 | 1 | 1 | eosinophil homeostasis |
GO:1990960 | 0.0044 | Inf | 0.0044 | 1 | 1 | basophil homeostasis |
GO:2000866 | 0.0044 | Inf | 0.0044 | 1 | 1 | positive regulation of estradiol secretion |
GO:0043304 | 0.0046 | 22.2172 | 0.1014 | 2 | 23 | regulation of mast cell degranulation |
GO:0050853 | 0.0048 | 21.5828 | 0.1041 | 2 | 24 | B cell receptor signaling pathway |
GO:0043281 | 0.0048 | 6.3417 | 0.6836 | 4 | 155 | regulation of cysteine-type endopeptidase activity involved in apoptotic process |
GO:0090200 | 0.005 | 21.2057 | 0.1059 | 2 | 24 | positive regulation of release of cytochrome c from mitochondria |
GO:2001258 | 0.005 | 21.2057 | 0.1059 | 2 | 24 | negative regulation of cation channel activity |
GO:0002377 | 0.0051 | 9.3341 | 0.3484 | 3 | 79 | immunoglobulin production |
GO:0007159 | 0.0052 | 9.264 | 0.3517 | 3 | 88 | leukocyte cell-cell adhesion |
GO:0010604 | 0.0052 | 2.2055 | 10.4927 | 19 | 2379 | positive regulation of macromolecule metabolic process |
GO:0015696 | 0.0053 | 9.2122 | 0.3528 | 3 | 80 | ammonium transport |
GO:0046686 | 0.0054 | 20.2822 | 0.1103 | 2 | 25 | response to cadmium ion |
GO:0050856 | 0.0054 | 20.2822 | 0.1103 | 2 | 25 | regulation of T cell receptor signaling pathway |
GO:0002685 | 0.0055 | 19.9276 | 0.1117 | 2 | 28 | regulation of leukocyte migration |
GO:0032496 | 0.0057 | 6.019 | 0.7189 | 4 | 163 | response to lipopolysaccharide |
GO:0002695 | 0.0058 | 8.8725 | 0.3662 | 3 | 89 | negative regulation of leukocyte activation |
GO:0001816 | 0.0062 | 5.9029 | 0.7369 | 4 | 186 | cytokine production |
GO:2001240 | 0.0063 | 18.6568 | 0.1191 | 2 | 27 | negative regulation of extrinsic apoptotic signaling pathway in absence of ligand |
GO:0002687 | 0.0063 | 18.5087 | 0.1197 | 2 | 29 | positive regulation of leukocyte migration |
GO:0002764 | 0.0065 | 5.7975 | 0.7454 | 4 | 169 | immune response-regulating signaling pathway |
GO:0050798 | 0.0067 | 17.9379 | 0.1235 | 2 | 28 | activated T cell proliferation |
GO:0051050 | 0.0069 | 2.9212 | 3.4491 | 9 | 782 | positive regulation of transport |
GO:0030593 | 0.007 | 17.5608 | 0.1257 | 2 | 30 | neutrophil chemotaxis |
GO:0042993 | 0.0072 | 17.2723 | 0.1279 | 2 | 29 | positive regulation of transcription factor import into nucleus |
GO:0071901 | 0.0073 | 8.1472 | 0.3969 | 3 | 90 | negative regulation of protein serine/threonine kinase activity |
GO:0007165 | 0.0074 | 2.7233 | 4.9377 | 11 | 1437 | signal transduction |
GO:0048147 | 0.0077 | 16.6541 | 0.1323 | 2 | 30 | negative regulation of fibroblast proliferation |
GO:0048585 | 0.0078 | 2.5812 | 4.8384 | 11 | 1097 | negative regulation of response to stimulus |
GO:0046903 | 0.008 | 2.8506 | 3.5284 | 9 | 800 | secretion |
GO:0032768 | 0.0082 | 16.0786 | 0.1367 | 2 | 31 | regulation of monooxygenase activity |
GO:0045124 | 0.0082 | 16.0786 | 0.1367 | 2 | 31 | regulation of bone resorption |
GO:0045214 | 0.0082 | 16.0786 | 0.1367 | 2 | 31 | sarcomere organization |
GO:0032103 | 0.0084 | 5.3687 | 0.8027 | 4 | 182 | positive regulation of response to external stimulus |
GO:0097191 | 0.0084 | 5.3687 | 0.8027 | 4 | 182 | extrinsic apoptotic signaling pathway |
GO:0002279 | 0.0087 | 15.5415 | 0.1411 | 2 | 32 | mast cell activation involved in immune response |
GO:0002448 | 0.0087 | 15.5415 | 0.1411 | 2 | 32 | mast cell mediated immunity |
GO:0002443 | 0.0088 | 5.3083 | 0.8115 | 4 | 184 | leukocyte mediated immunity |
GO:0002554 | 0.0088 | 229.6034 | 0.0088 | 1 | 2 | serotonin secretion by platelet |
GO:0006710 | 0.0088 | 229.6034 | 0.0088 | 1 | 2 | androgen catabolic process |
GO:0008588 | 0.0088 | 229.6034 | 0.0088 | 1 | 2 | release of cytoplasmic sequestered NF-kappaB |
GO:0021754 | 0.0088 | 229.6034 | 0.0088 | 1 | 2 | facial nucleus development |
GO:0045659 | 0.0088 | 229.6034 | 0.0088 | 1 | 2 | negative regulation of neutrophil differentiation |
GO:0046874 | 0.0088 | 229.6034 | 0.0088 | 1 | 2 | quinolinate metabolic process |
GO:0050859 | 0.0088 | 229.6034 | 0.0088 | 1 | 2 | negative regulation of B cell receptor signaling pathway |
GO:0060468 | 0.0088 | 229.6034 | 0.0088 | 1 | 2 | prevention of polyspermy |
GO:0070358 | 0.0088 | 229.6034 | 0.0088 | 1 | 2 | actin polymerization-dependent cell motility |
GO:0070483 | 0.0088 | 229.6034 | 0.0088 | 1 | 2 | detection of hypoxia |
GO:0071593 | 0.0088 | 229.6034 | 0.0088 | 1 | 2 | lymphocyte aggregation |
GO:1901509 | 0.0088 | 229.6034 | 0.0088 | 1 | 2 | regulation of endothelial tube morphogenesis |
GO:1902569 | 0.0088 | 229.6034 | 0.0088 | 1 | 2 | negative regulation of activation of Janus kinase activity |
GO:2000360 | 0.0088 | 229.6034 | 0.0088 | 1 | 2 | negative regulation of binding of sperm to zona pellucida |
GO:2000417 | 0.0088 | 229.6034 | 0.0088 | 1 | 2 | negative regulation of eosinophil migration |
GO:2000566 | 0.0088 | 229.6034 | 0.0088 | 1 | 2 | positive regulation of CD8-positive, alpha-beta T cell proliferation |
GO:1903169 | 0.0092 | 7.4566 | 0.4322 | 3 | 98 | regulation of calcium ion transmembrane transport |
GO:0019932 | 0.0093 | 5.2201 | 0.8248 | 4 | 187 | second-messenger-mediated signaling |
GO:1902532 | 0.0093 | 3.6095 | 1.8127 | 6 | 411 | negative regulation of intracellular signal transduction |
GO:0051239 | 0.0094 | 2.1284 | 9.4606 | 17 | 2145 | regulation of multicellular organismal process |
GO:0032270 | 0.0097 | 2.4959 | 4.9883 | 11 | 1131 | positive regulation of cellular protein metabolic process |
GO:0045766 | 0.0097 | 7.3017 | 0.4411 | 3 | 100 | positive regulation of angiogenesis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0002250 | 0 | 8.9624 | 0.9042 | 7 | 216 | adaptive immune response |
GO:0043368 | 1e-04 | 39.6286 | 0.0921 | 3 | 22 | positive T cell selection |
GO:1903039 | 1e-04 | 11.7745 | 0.4814 | 5 | 115 | positive regulation of leukocyte cell-cell adhesion |
GO:0002684 | 2e-04 | 8.4028 | 0.8184 | 6 | 214 | positive regulation of immune system process |
GO:0045321 | 2e-04 | 10.8802 | 0.5241 | 5 | 142 | leukocyte activation |
GO:0051251 | 5e-04 | 8.3276 | 0.6698 | 5 | 160 | positive regulation of lymphocyte activation |
GO:0045087 | 6e-04 | 5.4215 | 1.461 | 7 | 349 | innate immune response |
GO:0072540 | 6e-04 | 70.4444 | 0.0377 | 2 | 9 | T-helper 17 cell lineage commitment |
GO:0045785 | 8e-04 | 6.0758 | 1.1052 | 6 | 264 | positive regulation of cell adhesion |
GO:0050863 | 8e-04 | 7.5393 | 0.7368 | 5 | 176 | regulation of T cell activation |
GO:0043373 | 9e-04 | 54.7819 | 0.046 | 2 | 11 | CD4-positive, alpha-beta T cell lineage commitment |
GO:0045954 | 9e-04 | 54.7819 | 0.046 | 2 | 11 | positive regulation of natural killer cell mediated cytotoxicity |
GO:0046651 | 0.001 | 7.2389 | 0.7661 | 5 | 183 | lymphocyte proliferation |
GO:0050867 | 0.0012 | 6.8487 | 0.808 | 5 | 193 | positive regulation of cell activation |
GO:0070661 | 0.0013 | 6.8119 | 0.8121 | 5 | 194 | leukocyte proliferation |
GO:0032616 | 0.0013 | 44.8148 | 0.0544 | 2 | 13 | interleukin-13 production |
GO:0072538 | 0.0013 | 44.8148 | 0.0544 | 2 | 13 | T-helper 17 type immune response |
GO:0042102 | 0.0013 | 15.3315 | 0.2177 | 3 | 52 | positive regulation of T cell proliferation |
GO:0002694 | 0.0016 | 5.2804 | 1.2643 | 6 | 302 | regulation of leukocyte activation |
GO:0050778 | 0.0016 | 5.2804 | 1.2643 | 6 | 302 | positive regulation of immune response |
GO:0002286 | 0.0024 | 12.3044 | 0.2679 | 3 | 64 | T cell activation involved in immune response |
GO:0002360 | 0.0025 | 30.7986 | 0.0754 | 2 | 18 | T cell lineage commitment |
GO:0002715 | 0.0025 | 30.7986 | 0.0754 | 2 | 18 | regulation of natural killer cell mediated immunity |
GO:0009620 | 0.0028 | 28.9847 | 0.0795 | 2 | 19 | response to fungus |
GO:0046632 | 0.0029 | 11.5437 | 0.2847 | 3 | 68 | alpha-beta T cell differentiation |
GO:0002521 | 0.0041 | 5.1531 | 1.0659 | 5 | 267 | leukocyte differentiation |
GO:0009624 | 0.0042 | Inf | 0.0042 | 1 | 1 | response to nematode |
GO:0032078 | 0.0042 | Inf | 0.0042 | 1 | 1 | negative regulation of endodeoxyribonuclease activity |
GO:0033580 | 0.0042 | Inf | 0.0042 | 1 | 1 | protein galactosylation at cell surface |
GO:0035971 | 0.0042 | Inf | 0.0042 | 1 | 1 | peptidyl-histidine dephosphorylation |
GO:0045368 | 0.0042 | Inf | 0.0042 | 1 | 1 | positive regulation of interleukin-13 biosynthetic process |
GO:0032946 | 0.0042 | 9.997 | 0.3265 | 3 | 78 | positive regulation of mononuclear cell proliferation |
GO:0002366 | 0.0045 | 6.4916 | 0.6698 | 4 | 160 | leukocyte activation involved in immune response |
GO:0042110 | 0.0045 | 22.2718 | 0.1004 | 2 | 28 | T cell activation |
GO:0022407 | 0.0048 | 4.9639 | 1.101 | 5 | 263 | regulation of cell-cell adhesion |
GO:0050850 | 0.0052 | 20.5201 | 0.1088 | 2 | 26 | positive regulation of calcium-mediated signaling |
GO:0002437 | 0.0056 | 19.6978 | 0.113 | 2 | 27 | inflammatory response to antigenic stimulus |
GO:0048534 | 0.0059 | 3.2385 | 2.763 | 8 | 660 | hematopoietic or lymphoid organ development |
GO:0002252 | 0.0066 | 3.8964 | 1.6913 | 6 | 404 | immune effector process |
GO:0030217 | 0.007 | 8.3097 | 0.3904 | 3 | 98 | T cell differentiation |
GO:0031343 | 0.0074 | 16.9757 | 0.1298 | 2 | 31 | positive regulation of cell killing |
GO:0031349 | 0.0076 | 5.5533 | 0.7786 | 4 | 186 | positive regulation of defense response |
GO:0002331 | 0.0084 | 242.1818 | 0.0084 | 1 | 2 | pre-B cell allelic exclusion |
GO:0036228 | 0.0084 | 242.1818 | 0.0084 | 1 | 2 | protein localization to nuclear inner membrane |
GO:0045082 | 0.0084 | 242.1818 | 0.0084 | 1 | 2 | positive regulation of interleukin-10 biosynthetic process |
GO:0046874 | 0.0084 | 242.1818 | 0.0084 | 1 | 2 | quinolinate metabolic process |
GO:0071626 | 0.0084 | 242.1818 | 0.0084 | 1 | 2 | mastication |
GO:0098583 | 0.0084 | 242.1818 | 0.0084 | 1 | 2 | learned vocalization behavior |
GO:1905747 | 0.0084 | 242.1818 | 0.0084 | 1 | 2 | negative regulation of saliva secretion |
GO:1905748 | 0.0084 | 242.1818 | 0.0084 | 1 | 2 | hard palate morphogenesis |
GO:1902107 | 0.0087 | 7.6375 | 0.4228 | 3 | 101 | positive regulation of leukocyte differentiation |
GO:0043207 | 0.009 | 3.6412 | 1.8043 | 6 | 431 | response to external biotic stimulus |
GO:0001910 | 0.0094 | 14.9136 | 0.1465 | 2 | 35 | regulation of leukocyte mediated cytotoxicity |
GO:0009988 | 0.0094 | 14.9136 | 0.1465 | 2 | 35 | cell-cell recognition |
GO:0042093 | 0.0094 | 14.9136 | 0.1465 | 2 | 35 | T-helper cell differentiation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0002250 | 0 | 11.7223 | 0.6136 | 6 | 216 | adaptive immune response |
GO:0002684 | 1e-04 | 6.7354 | 1.4658 | 8 | 516 | positive regulation of immune system process |
GO:0051251 | 1e-04 | 12.8876 | 0.4545 | 5 | 160 | positive regulation of lymphocyte activation |
GO:0008037 | 1e-04 | 18.3446 | 0.2528 | 4 | 89 | cell recognition |
GO:0050863 | 1e-04 | 11.6676 | 0.5 | 5 | 176 | regulation of T cell activation |
GO:0002694 | 2e-04 | 8.262 | 0.8579 | 6 | 302 | regulation of leukocyte activation |
GO:0050867 | 2e-04 | 10.5988 | 0.5483 | 5 | 193 | positive regulation of cell activation |
GO:1903039 | 3e-04 | 14.0201 | 0.3267 | 4 | 115 | positive regulation of leukocyte cell-cell adhesion |
GO:0045087 | 4e-04 | 7.1042 | 0.9914 | 6 | 349 | innate immune response |
GO:0022407 | 8e-04 | 7.6821 | 0.7471 | 5 | 263 | regulation of cell-cell adhesion |
GO:0045321 | 0.0017 | 8.7724 | 0.5213 | 4 | 213 | leukocyte activation |
GO:0046651 | 0.0017 | 8.6494 | 0.5198 | 4 | 183 | lymphocyte proliferation |
GO:0043368 | 0.0018 | 36.9972 | 0.0625 | 2 | 22 | positive T cell selection |
GO:0002429 | 0.002 | 13.209 | 0.2528 | 3 | 89 | immune response-activating cell surface receptor signaling pathway |
GO:0070661 | 0.0022 | 8.1418 | 0.5511 | 4 | 194 | leukocyte proliferation |
GO:0035036 | 0.0024 | 30.8218 | 0.0739 | 2 | 26 | sperm-egg recognition |
GO:0050850 | 0.0024 | 30.8218 | 0.0739 | 2 | 26 | positive regulation of calcium-mediated signaling |
GO:0050853 | 0.0024 | 30.8218 | 0.0739 | 2 | 26 | B cell receptor signaling pathway |
GO:0032078 | 0.0028 | Inf | 0.0028 | 1 | 1 | negative regulation of endodeoxyribonuclease activity |
GO:0033580 | 0.0028 | Inf | 0.0028 | 1 | 1 | protein galactosylation at cell surface |
GO:1902107 | 0.0029 | 11.581 | 0.2869 | 3 | 101 | positive regulation of leukocyte differentiation |
GO:0042110 | 0.0038 | 10.5194 | 0.3175 | 3 | 127 | T cell activation |
GO:0050776 | 0.0041 | 5.2524 | 1.0766 | 5 | 379 | regulation of immune response |
GO:0046381 | 0.0057 | 360.4865 | 0.0057 | 1 | 2 | CMP-N-acetylneuraminate metabolic process |
GO:0071626 | 0.0057 | 360.4865 | 0.0057 | 1 | 2 | mastication |
GO:0098583 | 0.0057 | 360.4865 | 0.0057 | 1 | 2 | learned vocalization behavior |
GO:1905747 | 0.0057 | 360.4865 | 0.0057 | 1 | 2 | negative regulation of saliva secretion |
GO:1905748 | 0.0057 | 360.4865 | 0.0057 | 1 | 2 | hard palate morphogenesis |
GO:2000297 | 0.0057 | 360.4865 | 0.0057 | 1 | 2 | negative regulation of synapse maturation |
GO:0038083 | 0.0057 | 19.4459 | 0.1136 | 2 | 40 | peptidyl-tyrosine autophosphorylation |
GO:0045785 | 0.0065 | 5.9181 | 0.7499 | 4 | 264 | positive regulation of cell adhesion |
GO:0007356 | 0.0085 | 180.2297 | 0.0085 | 1 | 3 | thorax and anterior abdomen determination |
GO:0043366 | 0.0085 | 180.2297 | 0.0085 | 1 | 3 | beta selection |
GO:0042102 | 0.0095 | 14.7656 | 0.1477 | 2 | 52 | positive regulation of T cell proliferation |
GO:0045582 | 0.0095 | 14.7656 | 0.1477 | 2 | 52 | positive regulation of T cell differentiation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006733 | 6e-04 | 8.1757 | 0.6732 | 5 | 114 | oxidoreduction coenzyme metabolic process |
GO:0098787 | 9e-04 | 57.5411 | 0.0472 | 2 | 8 | mRNA cleavage involved in mRNA processing |
GO:2001256 | 9e-04 | 57.5411 | 0.0472 | 2 | 8 | regulation of store-operated calcium entry |
GO:0051186 | 0.001 | 4.8753 | 1.5768 | 7 | 267 | cofactor metabolic process |
GO:0061615 | 0.0012 | 49.3173 | 0.0532 | 2 | 9 | glycolytic process through fructose-6-phosphate |
GO:0046496 | 0.0026 | 7.5728 | 0.5728 | 4 | 97 | nicotinamide nucleotide metabolic process |
GO:0072524 | 0.0032 | 7.1106 | 0.6083 | 4 | 103 | pyridine-containing compound metabolic process |
GO:0045321 | 0.0033 | 3.2504 | 3.0414 | 9 | 515 | leukocyte activation |
GO:0006757 | 0.0038 | 10.4589 | 0.313 | 3 | 53 | ATP generation from ADP |
GO:0019637 | 0.0041 | 2.781 | 4.382 | 11 | 742 | organophosphate metabolic process |
GO:0090501 | 0.0044 | 9.8647 | 0.3307 | 3 | 56 | RNA phosphodiester bond hydrolysis |
GO:0006907 | 0.0044 | 23.0009 | 0.1004 | 2 | 17 | pinocytosis |
GO:0032943 | 0.0047 | 4.9242 | 1.0925 | 5 | 185 | mononuclear cell proliferation |
GO:0042147 | 0.0053 | 9.1697 | 0.3543 | 3 | 60 | retrograde transport, endosome to Golgi |
GO:0000717 | 0.0059 | Inf | 0.0059 | 1 | 1 | nucleotide-excision repair, DNA duplex unwinding |
GO:0002277 | 0.0059 | Inf | 0.0059 | 1 | 1 | myeloid dendritic cell activation involved in immune response |
GO:0031437 | 0.0059 | Inf | 0.0059 | 1 | 1 | regulation of mRNA cleavage |
GO:0035971 | 0.0059 | Inf | 0.0059 | 1 | 1 | peptidyl-histidine dephosphorylation |
GO:0051025 | 0.0059 | Inf | 0.0059 | 1 | 1 | negative regulation of immunoglobulin secretion |
GO:1902292 | 0.0059 | Inf | 0.0059 | 1 | 1 | cell cycle DNA replication initiation |
GO:1902975 | 0.0059 | Inf | 0.0059 | 1 | 1 | mitotic DNA replication initiation |
GO:1904482 | 0.0059 | Inf | 0.0059 | 1 | 1 | cellular response to tetrahydrofolate |
GO:1904721 | 0.0059 | Inf | 0.0059 | 1 | 1 | negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response |
GO:0042036 | 0.0061 | 19.1631 | 0.1181 | 2 | 20 | negative regulation of cytokine biosynthetic process |
GO:0009123 | 0.0063 | 4.5879 | 1.1693 | 5 | 198 | nucleoside monophosphate metabolic process |
GO:0007596 | 0.0064 | 5.808 | 0.7382 | 4 | 125 | blood coagulation |
GO:0009179 | 0.0064 | 8.5658 | 0.378 | 3 | 64 | purine ribonucleoside diphosphate metabolic process |
GO:0050670 | 0.0073 | 5.5754 | 0.7677 | 4 | 130 | regulation of lymphocyte proliferation |
GO:0033260 | 0.0074 | 17.2442 | 0.1299 | 2 | 22 | nuclear DNA replication |
GO:0046854 | 0.0074 | 17.2442 | 0.1299 | 2 | 22 | phosphatidylinositol phosphorylation |
GO:0046939 | 0.0079 | 7.9139 | 0.4075 | 3 | 69 | nucleotide phosphorylation |
GO:0042107 | 0.0085 | 7.68 | 0.4193 | 3 | 71 | cytokine metabolic process |
GO:0070663 | 0.0087 | 5.2792 | 0.8091 | 4 | 137 | regulation of leukocyte proliferation |
GO:0042110 | 0.009 | 3.5979 | 1.7894 | 6 | 303 | T cell activation |
GO:0030890 | 0.0095 | 14.9915 | 0.1476 | 2 | 25 | positive regulation of B cell proliferation |
GO:0006090 | 0.0095 | 7.3538 | 0.437 | 3 | 74 | pyruvate metabolic process |
GO:0002252 | 0.0098 | 3.1594 | 2.3859 | 7 | 404 | immune effector process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007512 | 8e-04 | 59.4241 | 0.0434 | 2 | 10 | adult heart development |
GO:0000032 | 0.0043 | Inf | 0.0043 | 1 | 1 | cell wall mannoprotein biosynthetic process |
GO:0001985 | 0.0043 | Inf | 0.0043 | 1 | 1 | negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure |
GO:0002940 | 0.0043 | Inf | 0.0043 | 1 | 1 | tRNA N2-guanine methylation |
GO:0006056 | 0.0043 | Inf | 0.0043 | 1 | 1 | mannoprotein metabolic process |
GO:0015862 | 0.0043 | Inf | 0.0043 | 1 | 1 | uridine transport |
GO:0036146 | 0.0043 | Inf | 0.0043 | 1 | 1 | cellular response to mycotoxin |
GO:0044038 | 0.0043 | Inf | 0.0043 | 1 | 1 | cell wall macromolecule biosynthetic process |
GO:0061611 | 0.0043 | Inf | 0.0043 | 1 | 1 | mannose to fructose-6-phosphate metabolic process |
GO:0061619 | 0.0043 | Inf | 0.0043 | 1 | 1 | glycolytic process from mannose through fructose-6-phosphate |
GO:0072721 | 0.0043 | Inf | 0.0043 | 1 | 1 | cellular response to dithiothreitol |
GO:0090675 | 0.0043 | Inf | 0.0043 | 1 | 1 | intermicrovillar adhesion |
GO:0070306 | 0.0056 | 19.7842 | 0.1127 | 2 | 26 | lens fiber cell differentiation |
GO:0045907 | 0.0079 | 16.367 | 0.1344 | 2 | 31 | positive regulation of vasoconstriction |
GO:0003404 | 0.0087 | 233.6491 | 0.0087 | 1 | 2 | optic vesicle morphogenesis |
GO:0009946 | 0.0087 | 233.6491 | 0.0087 | 1 | 2 | proximal/distal axis specification |
GO:0014846 | 0.0087 | 233.6491 | 0.0087 | 1 | 2 | esophagus smooth muscle contraction |
GO:0030241 | 0.0087 | 233.6491 | 0.0087 | 1 | 2 | skeletal muscle myosin thick filament assembly |
GO:0046874 | 0.0087 | 233.6491 | 0.0087 | 1 | 2 | quinolinate metabolic process |
GO:0048769 | 0.0087 | 233.6491 | 0.0087 | 1 | 2 | sarcomerogenesis |
GO:0070165 | 0.0087 | 233.6491 | 0.0087 | 1 | 2 | positive regulation of adiponectin secretion |
GO:0097402 | 0.0087 | 233.6491 | 0.0087 | 1 | 2 | neuroblast migration |
GO:2000298 | 0.0087 | 233.6491 | 0.0087 | 1 | 2 | regulation of Rho-dependent protein serine/threonine kinase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0098641 | 0.0028 | 29.1316 | 0.0795 | 2 | 18 | cadherin binding involved in cell-cell adhesion |
GO:0030380 | 0.0044 | Inf | 0.0044 | 1 | 1 | interleukin-17E receptor binding |
GO:0047730 | 0.0044 | Inf | 0.0044 | 1 | 1 | carnosine synthase activity |
GO:0005262 | 0.0063 | 8.6355 | 0.3754 | 3 | 85 | calcium channel activity |
GO:0098631 | 0.0077 | 16.6316 | 0.1325 | 2 | 30 | cell adhesion mediator activity |
GO:0042015 | 0.0088 | 229.2931 | 0.0088 | 1 | 2 | interleukin-20 binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005126 | 1e-04 | 9.4138 | 0.7301 | 6 | 184 | cytokine receptor binding |
GO:0050660 | 0.0014 | 14.9921 | 0.2223 | 3 | 55 | flavin adenine dinucleotide binding |
GO:0005125 | 0.0015 | 8.9403 | 0.4932 | 4 | 122 | cytokine activity |
GO:0031683 | 0.0032 | 26.8947 | 0.0849 | 2 | 21 | G-protein beta/gamma-subunit complex binding |
GO:0004056 | 0.004 | Inf | 0.004 | 1 | 1 | argininosuccinate lyase activity |
GO:0004332 | 0.004 | Inf | 0.004 | 1 | 1 | fructose-bisphosphate aldolase activity |
GO:0004362 | 0.004 | Inf | 0.004 | 1 | 1 | glutathione-disulfide reductase activity |
GO:0004964 | 0.004 | Inf | 0.004 | 1 | 1 | luteinizing hormone receptor activity |
GO:0008720 | 0.004 | Inf | 0.004 | 1 | 1 | D-lactate dehydrogenase activity |
GO:0035472 | 0.004 | Inf | 0.004 | 1 | 1 | choriogonadotropin hormone receptor activity |
GO:0038106 | 0.004 | Inf | 0.004 | 1 | 1 | choriogonadotropin hormone binding |
GO:0050250 | 0.004 | Inf | 0.004 | 1 | 1 | retinal oxidase activity |
GO:0043425 | 0.0057 | 19.6435 | 0.1132 | 2 | 28 | bHLH transcription factor binding |
GO:0004031 | 0.0081 | 251.0189 | 0.0081 | 1 | 2 | aldehyde oxidase activity |
GO:0004458 | 0.0081 | 251.0189 | 0.0081 | 1 | 2 | D-lactate dehydrogenase (cytochrome) activity |
GO:0004854 | 0.0081 | 251.0189 | 0.0081 | 1 | 2 | xanthine dehydrogenase activity |
GO:0004963 | 0.0081 | 251.0189 | 0.0081 | 1 | 2 | follicle-stimulating hormone receptor activity |
GO:0005133 | 0.0081 | 251.0189 | 0.0081 | 1 | 2 | interferon-gamma receptor binding |
GO:0048248 | 0.0081 | 251.0189 | 0.0081 | 1 | 2 | CXCR3 chemokine receptor binding |
GO:0001102 | 0.0083 | 15.9531 | 0.1374 | 2 | 34 | RNA polymerase II activating transcription factor binding |
GO:0048037 | 0.0085 | 5.3785 | 0.8044 | 4 | 199 | cofactor binding |
GO:0070888 | 0.0088 | 15.4685 | 0.1415 | 2 | 35 | E-box binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004871 | 3e-04 | 3.7956 | 3.7352 | 12 | 818 | signal transducer activity |
GO:0005125 | 0.0023 | 7.8382 | 0.5571 | 4 | 122 | cytokine activity |
GO:0004888 | 0.0027 | 3.687 | 2.4247 | 8 | 531 | transmembrane signaling receptor activity |
GO:0005261 | 0.0042 | 5.0955 | 1.0685 | 5 | 234 | cation channel activity |
GO:0004362 | 0.0046 | Inf | 0.0046 | 1 | 1 | glutathione-disulfide reductase activity |
GO:0004621 | 0.0046 | Inf | 0.0046 | 1 | 1 | glycosylphosphatidylinositol phospholipase D activity |
GO:0004900 | 0.0046 | Inf | 0.0046 | 1 | 1 | erythropoietin receptor activity |
GO:0005141 | 0.0046 | Inf | 0.0046 | 1 | 1 | interleukin-10 receptor binding |
GO:0030023 | 0.0046 | Inf | 0.0046 | 1 | 1 | extracellular matrix constituent conferring elasticity |
GO:0004872 | 0.0052 | 3.0549 | 3.2968 | 9 | 722 | receptor activity |
GO:0043425 | 0.0072 | 17.3038 | 0.1279 | 2 | 28 | bHLH transcription factor binding |
GO:0001965 | 0.0082 | 16.0654 | 0.137 | 2 | 30 | G-protein alpha-subunit binding |
GO:0005133 | 0.0091 | 221.6167 | 0.0091 | 1 | 2 | interferon-gamma receptor binding |
GO:0005146 | 0.0091 | 221.6167 | 0.0091 | 1 | 2 | leukemia inhibitory factor receptor binding |
GO:0048248 | 0.0091 | 221.6167 | 0.0091 | 1 | 2 | CXCR3 chemokine receptor binding |
GO:0098640 | 0.0091 | 221.6167 | 0.0091 | 1 | 2 | integrin binding involved in cell-matrix adhesion |
GO:0008201 | 0.0099 | 7.2656 | 0.4429 | 3 | 97 | heparin binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005262 | 5e-04 | 11.8689 | 0.3754 | 4 | 85 | calcium channel activity |
GO:0072509 | 0.0028 | 7.4255 | 0.5874 | 4 | 133 | divalent inorganic cation transmembrane transporter activity |
GO:0033040 | 0.0044 | Inf | 0.0044 | 1 | 1 | sour taste receptor activity |
GO:0047058 | 0.0044 | Inf | 0.0044 | 1 | 1 | vitamin-K-epoxide reductase (warfarin-insensitive) activity |
GO:0047402 | 0.0044 | Inf | 0.0044 | 1 | 1 | protein-glucosylgalactosylhydroxylysine glucosidase activity |
GO:0101006 | 0.0044 | Inf | 0.0044 | 1 | 1 | protein histidine phosphatase activity |
GO:0008378 | 0.0058 | 19.4094 | 0.1148 | 2 | 26 | galactosyltransferase activity |
GO:0000048 | 0.0088 | 229.2931 | 0.0088 | 1 | 2 | peptidyltransferase activity |
GO:0002951 | 0.0088 | 229.2931 | 0.0088 | 1 | 2 | leukotriene-C(4) hydrolase |
GO:0016262 | 0.0088 | 229.2931 | 0.0088 | 1 | 2 | protein N-acetylglucosaminyltransferase activity |
GO:0036505 | 0.0088 | 229.2931 | 0.0088 | 1 | 2 | prosaposin receptor activity |
GO:0044729 | 0.0088 | 229.2931 | 0.0088 | 1 | 2 | hemi-methylated DNA-binding |
GO:0047057 | 0.0088 | 229.2931 | 0.0088 | 1 | 2 | vitamin-K-epoxide reductase (warfarin-sensitive) activity |
GO:0047276 | 0.0088 | 229.2931 | 0.0088 | 1 | 2 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity |
GO:0102490 | 0.0088 | 229.2931 | 0.0088 | 1 | 2 | 8-oxo-dGTP phosphohydrolase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004871 | 2e-04 | 3.875 | 3.6739 | 12 | 818 | signal transducer activity |
GO:0004872 | 0.0013 | 3.5357 | 3.2428 | 10 | 722 | receptor activity |
GO:0001614 | 0.0015 | 41.6552 | 0.0584 | 2 | 13 | purinergic nucleotide receptor activity |
GO:0004888 | 0.0024 | 3.7582 | 2.3849 | 8 | 531 | transmembrane signaling receptor activity |
GO:0031683 | 0.0039 | 24.1016 | 0.0943 | 2 | 21 | G-protein beta/gamma-subunit complex binding |
GO:0038164 | 0.0045 | Inf | 0.0045 | 1 | 1 | thrombopoietin receptor activity |
GO:0047017 | 0.0045 | Inf | 0.0045 | 1 | 1 | prostaglandin-F synthase activity |
GO:0050250 | 0.0045 | Inf | 0.0045 | 1 | 1 | retinal oxidase activity |
GO:0005044 | 0.0047 | 21.803 | 0.1033 | 2 | 23 | scavenger receptor activity |
GO:0005126 | 0.008 | 5.4594 | 0.7904 | 4 | 182 | cytokine receptor binding |
GO:0004031 | 0.009 | 225.3898 | 0.009 | 1 | 2 | aldehyde oxidase activity |
GO:0004854 | 0.009 | 225.3898 | 0.009 | 1 | 2 | xanthine dehydrogenase activity |
GO:0005133 | 0.009 | 225.3898 | 0.009 | 1 | 2 | interferon-gamma receptor binding |
GO:0005146 | 0.009 | 225.3898 | 0.009 | 1 | 2 | leukemia inhibitory factor receptor binding |
GO:0008184 | 0.009 | 225.3898 | 0.009 | 1 | 2 | glycogen phosphorylase activity |
GO:0048248 | 0.009 | 225.3898 | 0.009 | 1 | 2 | CXCR3 chemokine receptor binding |
GO:0051916 | 0.009 | 225.3898 | 0.009 | 1 | 2 | granulocyte colony-stimulating factor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004014 | 0 | Inf | 0.0055 | 2 | 2 | adenosylmethionine decarboxylase activity |
GO:0019810 | 0 | Inf | 0.0055 | 2 | 2 | putrescine binding |
GO:0031683 | 0.0015 | 40.009 | 0.0582 | 2 | 21 | G-protein beta/gamma-subunit complex binding |
GO:0004964 | 0.0028 | Inf | 0.0028 | 1 | 1 | luteinizing hormone receptor activity |
GO:0035472 | 0.0028 | Inf | 0.0028 | 1 | 1 | choriogonadotropin hormone receptor activity |
GO:0038106 | 0.0028 | Inf | 0.0028 | 1 | 1 | choriogonadotropin hormone binding |
GO:0016830 | 0.0044 | 22.3328 | 0.0997 | 2 | 36 | carbon-carbon lyase activity |
GO:0004517 | 0.0055 | 370.0278 | 0.0055 | 1 | 2 | nitric-oxide synthase activity |
GO:0004963 | 0.0055 | 370.0278 | 0.0055 | 1 | 2 | follicle-stimulating hormone receptor activity |
GO:0034617 | 0.0055 | 370.0278 | 0.0055 | 1 | 2 | tetrahydrobiopterin binding |
GO:0004082 | 0.0083 | 185 | 0.0083 | 1 | 3 | bisphosphoglycerate mutase activity |
GO:0031852 | 0.0083 | 185 | 0.0083 | 1 | 3 | mu-type opioid receptor binding |
GO:0046538 | 0.0083 | 185 | 0.0083 | 1 | 3 | 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity |
GO:0051430 | 0.0083 | 185 | 0.0083 | 1 | 3 | corticotropin-releasing hormone receptor 1 binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031433 | 1e-04 | 229.2586 | 0.018 | 2 | 4 | telethonin binding |
GO:0005501 | 0.0029 | 28.6272 | 0.0808 | 2 | 18 | retinoid binding |
GO:0008081 | 0.003 | 11.4219 | 0.2874 | 3 | 64 | phosphoric diester hydrolase activity |
GO:0004621 | 0.0045 | Inf | 0.0045 | 1 | 1 | glycosylphosphatidylinositol phospholipase D activity |
GO:0004900 | 0.0045 | Inf | 0.0045 | 1 | 1 | erythropoietin receptor activity |
GO:0004991 | 0.0045 | Inf | 0.0045 | 1 | 1 | parathyroid hormone receptor activity |
GO:0008700 | 0.0045 | Inf | 0.0045 | 1 | 1 | 4-hydroxy-2-oxoglutarate aldolase activity |
GO:0003700 | 0.0066 | 2.7752 | 4.0602 | 10 | 904 | DNA binding transcription factor activity |
GO:0046943 | 0.0086 | 7.6391 | 0.4222 | 3 | 94 | carboxylic acid transmembrane transporter activity |
GO:0008401 | 0.009 | 225.3898 | 0.009 | 1 | 2 | retinoic acid 4-hydroxylase activity |
GO:0019948 | 0.009 | 225.3898 | 0.009 | 1 | 2 | SUMO activating enzyme activity |
GO:0036004 | 0.009 | 225.3898 | 0.009 | 1 | 2 | GAF domain binding |
GO:0015081 | 0.01 | 7.2385 | 0.4446 | 3 | 99 | sodium ion transmembrane transporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005031 | 1e-04 | 49.2111 | 0.0768 | 3 | 18 | tumor necrosis factor-activated receptor activity |
GO:0004872 | 2e-04 | 4.2347 | 3.0806 | 11 | 722 | receptor activity |
GO:0048406 | 8e-04 | 60.4273 | 0.0427 | 2 | 10 | nerve growth factor binding |
GO:0042165 | 0.0032 | 26.8364 | 0.0853 | 2 | 20 | neurotransmitter binding |
GO:0004362 | 0.0043 | Inf | 0.0043 | 1 | 1 | glutathione-disulfide reductase activity |
GO:0004621 | 0.0043 | Inf | 0.0043 | 1 | 1 | glycosylphosphatidylinositol phospholipase D activity |
GO:0004900 | 0.0043 | Inf | 0.0043 | 1 | 1 | erythropoietin receptor activity |
GO:0005144 | 0.0043 | Inf | 0.0043 | 1 | 1 | interleukin-13 receptor binding |
GO:0004252 | 0.0067 | 8.4387 | 0.384 | 3 | 90 | serine-type endopeptidase activity |
GO:0004888 | 0.0071 | 3.414 | 2.2657 | 7 | 531 | transmembrane signaling receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004872 | 0 | 5.0188 | 3.1887 | 13 | 722 | receptor activity |
GO:0005125 | 0 | 12.8666 | 0.5388 | 6 | 122 | cytokine activity |
GO:0004871 | 0 | 4.3866 | 3.6127 | 13 | 818 | signal transducer activity |
GO:0005164 | 2e-04 | 29.6339 | 0.1192 | 3 | 27 | tumor necrosis factor receptor binding |
GO:0030545 | 2e-04 | 6.3056 | 1.2587 | 7 | 285 | receptor regulator activity |
GO:0004888 | 4e-04 | 4.5051 | 2.3012 | 9 | 530 | transmembrane signaling receptor activity |
GO:0005126 | 0.0012 | 6.8763 | 0.8033 | 5 | 185 | cytokine receptor binding |
GO:0043027 | 0.0022 | 33.2982 | 0.0707 | 2 | 16 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process |
GO:0000334 | 0.0044 | Inf | 0.0044 | 1 | 1 | 3-hydroxyanthranilate 3,4-dioxygenase activity |
GO:0005129 | 0.0044 | Inf | 0.0044 | 1 | 1 | granulocyte macrophage colony-stimulating factor receptor binding |
GO:0015265 | 0.0044 | Inf | 0.0044 | 1 | 1 | urea channel activity |
GO:0030369 | 0.0044 | Inf | 0.0044 | 1 | 1 | ICAM-3 receptor activity |
GO:0030487 | 0.0044 | Inf | 0.0044 | 1 | 1 | inositol-4,5-bisphosphate 5-phosphatase activity |
GO:0038164 | 0.0044 | Inf | 0.0044 | 1 | 1 | thrombopoietin receptor activity |
GO:0070002 | 0.0044 | Inf | 0.0044 | 1 | 1 | glutamic-type peptidase activity |
GO:0019207 | 0.0058 | 6.0107 | 0.7199 | 4 | 163 | kinase regulator activity |
GO:0004949 | 0.0088 | 229.2931 | 0.0088 | 1 | 2 | cannabinoid receptor activity |
GO:0048248 | 0.0088 | 229.2931 | 0.0088 | 1 | 2 | CXCR3 chemokine receptor binding |
GO:0051916 | 0.0088 | 229.2931 | 0.0088 | 1 | 2 | granulocyte colony-stimulating factor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005044 | 0.0041 | 23.425 | 0.0964 | 2 | 23 | scavenger receptor activity |
GO:0000334 | 0.0042 | Inf | 0.0042 | 1 | 1 | 3-hydroxyanthranilate 3,4-dioxygenase activity |
GO:0030369 | 0.0042 | Inf | 0.0042 | 1 | 1 | ICAM-3 receptor activity |
GO:0030380 | 0.0042 | Inf | 0.0042 | 1 | 1 | interleukin-17E receptor binding |
GO:0031854 | 0.0042 | Inf | 0.0042 | 1 | 1 | orexigenic neuropeptide QRFP receptor binding |
GO:0045509 | 0.0042 | Inf | 0.0042 | 1 | 1 | interleukin-27 receptor activity |
GO:0101006 | 0.0042 | Inf | 0.0042 | 1 | 1 | protein histidine phosphatase activity |
GO:0004693 | 0.0045 | 22.3586 | 0.1006 | 2 | 24 | cyclin-dependent protein serine/threonine kinase activity |
GO:0005157 | 0.0084 | 241.8545 | 0.0084 | 1 | 2 | macrophage colony-stimulating factor receptor binding |
GO:0047276 | 0.0084 | 241.8545 | 0.0084 | 1 | 2 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity |
GO:0070891 | 0.0084 | 241.8545 | 0.0084 | 1 | 2 | lipoteichoic acid binding |
GO:0001784 | 0.0084 | 15.8566 | 0.1383 | 2 | 33 | phosphotyrosine residue binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005044 | 0 | 51.1423 | 0.0723 | 3 | 23 | scavenger receptor activity |
GO:0015026 | 9e-04 | 55.4375 | 0.044 | 2 | 14 | coreceptor activity |
GO:0004991 | 0.0031 | Inf | 0.0031 | 1 | 1 | parathyroid hormone receptor activity |
GO:0031854 | 0.0031 | Inf | 0.0031 | 1 | 1 | orexigenic neuropeptide QRFP receptor binding |
GO:0042610 | 0.0031 | Inf | 0.0031 | 1 | 1 | CD8 receptor binding |
GO:0102009 | 0.0031 | Inf | 0.0031 | 1 | 1 | proline dipeptidase activity |
GO:0042169 | 0.0037 | 24.6111 | 0.0912 | 2 | 29 | SH2 domain binding |
GO:0001784 | 0.0048 | 21.429 | 0.1038 | 2 | 33 | phosphotyrosine residue binding |
GO:0004715 | 0.006 | 18.9743 | 0.1163 | 2 | 37 | non-membrane spanning protein tyrosine kinase activity |
GO:0005157 | 0.0063 | 324.7805 | 0.0063 | 1 | 2 | macrophage colony-stimulating factor receptor binding |
GO:0019958 | 0.0063 | 324.7805 | 0.0063 | 1 | 2 | C-X-C chemokine binding |
GO:0047276 | 0.0063 | 324.7805 | 0.0063 | 1 | 2 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity |
GO:0070698 | 0.0063 | 324.7805 | 0.0063 | 1 | 2 | type I activin receptor binding |
GO:0070891 | 0.0063 | 324.7805 | 0.0063 | 1 | 2 | lipoteichoic acid binding |
GO:0001077 | 0.0072 | 5.7113 | 0.7703 | 4 | 245 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
GO:0016494 | 0.0094 | 162.378 | 0.0094 | 1 | 3 | C-X-C chemokine receptor activity |
GO:0038100 | 0.0094 | 162.378 | 0.0094 | 1 | 3 | nodal binding |
GO:0016279 | 0.0099 | 14.425 | 0.1509 | 2 | 48 | protein-lysine N-methyltransferase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0003823 | 1e-04 | 37.9743 | 0.0939 | 3 | 33 | antigen binding |
GO:0016641 | 4e-04 | 82.1728 | 0.0313 | 2 | 11 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor |
GO:0060089 | 0.0011 | 4.4508 | 2.1647 | 8 | 761 | molecular transducer activity |
GO:0005044 | 0.0019 | 35.1852 | 0.0654 | 2 | 23 | scavenger receptor activity |
GO:0004693 | 0.0021 | 33.5833 | 0.0683 | 2 | 24 | cyclin-dependent protein serine/threonine kinase activity |
GO:0030338 | 0.0028 | Inf | 0.0028 | 1 | 1 | CMP-N-acetylneuraminate monooxygenase activity |
GO:0042610 | 0.0028 | Inf | 0.0028 | 1 | 1 | CD8 receptor binding |
GO:0102009 | 0.0028 | Inf | 0.0028 | 1 | 1 | proline dipeptidase activity |
GO:0042169 | 0.003 | 27.3539 | 0.0825 | 2 | 29 | SH2 domain binding |
GO:0001784 | 0.0039 | 23.8172 | 0.0939 | 2 | 33 | phosphotyrosine residue binding |
GO:0004715 | 0.0049 | 21.0889 | 0.1052 | 2 | 37 | non-membrane spanning protein tyrosine kinase activity |
GO:0005507 | 0.0049 | 21.0889 | 0.1052 | 2 | 37 | copper ion binding |
GO:0005157 | 0.0057 | 360 | 0.0057 | 1 | 2 | macrophage colony-stimulating factor receptor binding |
GO:0047276 | 0.0057 | 360 | 0.0057 | 1 | 2 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity |
GO:0070891 | 0.0057 | 360 | 0.0057 | 1 | 2 | lipoteichoic acid binding |
GO:0034987 | 0.0085 | 179.9865 | 0.0085 | 1 | 3 | immunoglobulin receptor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0000182 | 9e-04 | 57.4632 | 0.0473 | 2 | 8 | rDNA binding |
GO:0000979 | 0.0049 | 9.4916 | 0.343 | 3 | 58 | RNA polymerase II core promoter sequence-specific DNA binding |
GO:0004138 | 0.0059 | Inf | 0.0059 | 1 | 1 | deoxyguanosine kinase activity |
GO:0004807 | 0.0059 | Inf | 0.0059 | 1 | 1 | triose-phosphate isomerase activity |
GO:0008431 | 0.0059 | Inf | 0.0059 | 1 | 1 | vitamin E binding |
GO:0033570 | 0.0059 | Inf | 0.0059 | 1 | 1 | transferrin transmembrane transporter activity |
GO:0043325 | 0.0061 | 19.1371 | 0.1183 | 2 | 20 | phosphatidylinositol-3,4-bisphosphate binding |
GO:0016891 | 0.0095 | 14.9712 | 0.1478 | 2 | 25 | endoribonuclease activity, producing 5'-phosphomonoesters |
GO:0140098 | 0.0096 | 3.5441 | 1.8155 | 6 | 307 | catalytic activity, acting on RNA |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0051575 | 1e-04 | 184.8056 | 0.0187 | 2 | 5 | 5'-deoxyribose-5-phosphate lyase activity |
GO:0003680 | 3e-04 | 110.8667 | 0.0262 | 2 | 7 | AT DNA binding |
GO:0003906 | 9e-04 | 55.4125 | 0.0449 | 2 | 12 | DNA-(apurinic or apyrimidinic site) lyase activity |
GO:0042975 | 0.0018 | 36.9278 | 0.0636 | 2 | 17 | peroxisome proliferator activated receptor binding |
GO:0046965 | 0.0025 | 30.7662 | 0.0749 | 2 | 20 | retinoid X receptor binding |
GO:0080025 | 0.0025 | 30.7662 | 0.0749 | 2 | 20 | phosphatidylinositol-3,5-bisphosphate binding |
GO:0004056 | 0.0037 | Inf | 0.0037 | 1 | 1 | argininosuccinate lyase activity |
GO:0015265 | 0.0037 | Inf | 0.0037 | 1 | 1 | urea channel activity |
GO:0047017 | 0.0037 | Inf | 0.0037 | 1 | 1 | prostaglandin-F synthase activity |
GO:0047988 | 0.0037 | Inf | 0.0037 | 1 | 1 | hydroxyacid-oxoacid transhydrogenase activity |
GO:0030507 | 0.0042 | 23.0642 | 0.0973 | 2 | 26 | spectrin binding |
GO:0005547 | 0.0071 | 17.2878 | 0.1273 | 2 | 34 | phosphatidylinositol-3,4,5-trisphosphate binding |
GO:0004022 | 0.0075 | 271.5918 | 0.0075 | 1 | 2 | alcohol dehydrogenase (NAD) activity |
GO:0032029 | 0.0075 | 271.5918 | 0.0075 | 1 | 2 | myosin tail binding |
GO:0036505 | 0.0075 | 271.5918 | 0.0075 | 1 | 2 | prosaposin receptor activity |
GO:0047498 | 0.0075 | 271.5918 | 0.0075 | 1 | 2 | calcium-dependent phospholipase A2 activity |
GO:0030374 | 0.0084 | 15.8024 | 0.1385 | 2 | 37 | ligand-dependent nuclear receptor transcription coactivator activity |
GO:0015459 | 0.0089 | 15.3623 | 0.1422 | 2 | 38 | potassium channel regulator activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005141 | 0.0034 | Inf | 0.0034 | 1 | 1 | interleukin-10 receptor binding |
GO:0022894 | 0.0034 | Inf | 0.0034 | 1 | 1 | Intermediate conductance calcium-activated potassium channel activity |
GO:0045550 | 0.0034 | Inf | 0.0034 | 1 | 1 | geranylgeranyl reductase activity |
GO:0047718 | 0.0034 | Inf | 0.0034 | 1 | 1 | indanol dehydrogenase activity |
GO:1990841 | 0.0037 | 24.7237 | 0.0909 | 2 | 27 | promoter-specific chromatin binding |
GO:0000048 | 0.0067 | 302.5682 | 0.0067 | 1 | 2 | peptidyltransferase activity |
GO:0002951 | 0.0067 | 302.5682 | 0.0067 | 1 | 2 | leukotriene-C(4) hydrolase |
GO:0005548 | 0.0088 | 15.4349 | 0.1415 | 2 | 42 | phospholipid transporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0016247 | 0.0011 | 9.681 | 0.4559 | 4 | 105 | channel regulator activity |
GO:0016701 | 0.0033 | 26.3552 | 0.0868 | 2 | 20 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen |
GO:0000334 | 0.0043 | Inf | 0.0043 | 1 | 1 | 3-hydroxyanthranilate 3,4-dioxygenase activity |
GO:0004476 | 0.0043 | Inf | 0.0043 | 1 | 1 | mannose-6-phosphate isomerase activity |
GO:0005427 | 0.0043 | Inf | 0.0043 | 1 | 1 | proton-dependent oligopeptide secondary active transmembrane transporter activity |
GO:0031073 | 0.0043 | Inf | 0.0043 | 1 | 1 | cholesterol 26-hydroxylase activity |
GO:0042936 | 0.0043 | Inf | 0.0043 | 1 | 1 | dipeptide transporter activity |
GO:0050313 | 0.0043 | Inf | 0.0043 | 1 | 1 | sulfur dioxygenase activity |
GO:0004930 | 0.0044 | 5.0695 | 1.0767 | 5 | 248 | G-protein coupled receptor activity |
GO:0005506 | 0.0083 | 7.7466 | 0.4168 | 3 | 96 | iron ion binding |
GO:0003985 | 0.0087 | 233.3333 | 0.0087 | 1 | 2 | acetyl-CoA C-acetyltransferase activity |
GO:0004937 | 0.0087 | 233.3333 | 0.0087 | 1 | 2 | alpha1-adrenergic receptor activity |
GO:0030343 | 0.0087 | 233.3333 | 0.0087 | 1 | 2 | vitamin D3 25-hydroxylase activity |
GO:0035673 | 0.0087 | 233.3333 | 0.0087 | 1 | 2 | oligopeptide transmembrane transporter activity |
GO:0070080 | 0.0087 | 233.3333 | 0.0087 | 1 | 2 | titin Z domain binding |
GO:0005216 | 0.0093 | 4.1883 | 1.2938 | 5 | 298 | ion channel activity |
GO:0044325 | 0.0098 | 7.2738 | 0.4428 | 3 | 102 | ion channel binding |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050670 | 0 | 5.0495 | 3.5479 | 16 | 191 | regulation of lymphocyte proliferation |
GO:0002694 | 0 | 3.441 | 7.7088 | 24 | 415 | regulation of leukocyte activation |
GO:0070663 | 0 | 4.7997 | 3.7151 | 16 | 200 | regulation of leukocyte proliferation |
GO:0022407 | 0 | 3.5426 | 6.52 | 21 | 351 | regulation of cell-cell adhesion |
GO:0050863 | 0 | 4.0288 | 4.6439 | 17 | 250 | regulation of T cell activation |
GO:0007162 | 0 | 3.7937 | 4.3095 | 15 | 232 | negative regulation of cell adhesion |
GO:0050866 | 1e-04 | 4.2767 | 3.065 | 12 | 165 | negative regulation of cell activation |
GO:0032945 | 1e-04 | 6.6556 | 1.356 | 8 | 73 | negative regulation of mononuclear cell proliferation |
GO:0022610 | 1e-04 | 2.0255 | 20.9717 | 39 | 1129 | biological adhesion |
GO:0051250 | 1e-04 | 4.5991 | 2.3777 | 10 | 128 | negative regulation of lymphocyte activation |
GO:0042130 | 1e-04 | 6.863 | 1.1517 | 7 | 62 | negative regulation of T cell proliferation |
GO:1903038 | 2e-04 | 5.0245 | 1.969 | 9 | 106 | negative regulation of leukocyte cell-cell adhesion |
GO:0010466 | 2e-04 | 3.9588 | 3.0092 | 11 | 162 | negative regulation of peptidase activity |
GO:0030216 | 2e-04 | 5.4024 | 1.6346 | 8 | 88 | keratinocyte differentiation |
GO:0002683 | 2e-04 | 2.7717 | 6.9658 | 18 | 375 | negative regulation of immune system process |
GO:0008544 | 3e-04 | 3.2126 | 4.681 | 14 | 252 | epidermis development |
GO:0050867 | 4e-04 | 3.0937 | 4.8482 | 14 | 261 | positive regulation of cell activation |
GO:0060429 | 0.001 | 1.9017 | 18.594 | 33 | 1001 | epithelium development |
GO:0046813 | 0.001 | 106.381 | 0.0557 | 2 | 3 | receptor-mediated virion attachment to host cell |
GO:0006952 | 0.0012 | 1.8619 | 19.56 | 34 | 1053 | defense response |
GO:0032501 | 0.0012 | 1.4511 | 103.6368 | 129 | 5660 | multicellular organismal process |
GO:0030104 | 0.0013 | 6.8729 | 0.8173 | 5 | 44 | water homeostasis |
GO:0030823 | 0.0015 | 9.3008 | 0.5015 | 4 | 27 | regulation of cGMP metabolic process |
GO:0045619 | 0.0015 | 3.6014 | 2.6749 | 9 | 144 | regulation of lymphocyte differentiation |
GO:0050878 | 0.0017 | 2.6369 | 5.6284 | 14 | 303 | regulation of body fluid levels |
GO:0006955 | 0.0017 | 2.3709 | 7.606 | 17 | 423 | immune response |
GO:0051251 | 0.002 | 2.9795 | 3.9194 | 11 | 211 | positive regulation of lymphocyte activation |
GO:0021615 | 0.002 | 53.1871 | 0.0743 | 2 | 4 | glossopharyngeal nerve morphogenesis |
GO:0002684 | 0.0025 | 2.1713 | 9.2565 | 19 | 512 | positive regulation of immune system process |
GO:0060986 | 0.0027 | 5.7001 | 0.9659 | 5 | 52 | endocrine hormone secretion |
GO:0042060 | 0.0029 | 2.4711 | 5.9813 | 14 | 322 | wound healing |
GO:0001817 | 0.0029 | 2.1398 | 9.3767 | 19 | 508 | regulation of cytokine production |
GO:1903039 | 0.0029 | 3.2381 | 2.9535 | 9 | 159 | positive regulation of leukocyte cell-cell adhesion |
GO:0030879 | 0.003 | 3.533 | 2.4148 | 8 | 130 | mammary gland development |
GO:0033031 | 0.0033 | 35.4558 | 0.0929 | 2 | 5 | positive regulation of neutrophil apoptotic process |
GO:2000668 | 0.0033 | 35.4558 | 0.0929 | 2 | 5 | regulation of dendritic cell apoptotic process |
GO:0046006 | 0.0035 | 7.1274 | 0.6316 | 4 | 34 | regulation of activated T cell proliferation |
GO:1903318 | 0.0035 | 7.1274 | 0.6316 | 4 | 34 | negative regulation of protein maturation |
GO:0044550 | 0.0036 | 11.4274 | 0.3158 | 3 | 17 | secondary metabolite biosynthetic process |
GO:0042102 | 0.0037 | 4.3518 | 1.486 | 6 | 80 | positive regulation of T cell proliferation |
GO:1903708 | 0.0041 | 3.0726 | 3.1021 | 9 | 167 | positive regulation of hemopoiesis |
GO:0001780 | 0.0042 | 10.6648 | 0.3344 | 3 | 18 | neutrophil homeostasis |
GO:0034111 | 0.0042 | 10.6648 | 0.3344 | 3 | 18 | negative regulation of homotypic cell-cell adhesion |
GO:0008284 | 0.0046 | 1.8295 | 15.009 | 26 | 808 | positive regulation of cell proliferation |
GO:0015670 | 0.0049 | 26.5901 | 0.1115 | 2 | 6 | carbon dioxide transport |
GO:0044650 | 0.0049 | 26.5901 | 0.1115 | 2 | 6 | adhesion of symbiont to host cell |
GO:0060558 | 0.0049 | 26.5901 | 0.1115 | 2 | 6 | regulation of calcidiol 1-monooxygenase activity |
GO:0006884 | 0.0049 | 9.9977 | 0.3529 | 3 | 19 | cell volume homeostasis |
GO:0033599 | 0.0049 | 9.9977 | 0.3529 | 3 | 19 | regulation of mammary gland epithelial cell proliferation |
GO:0050776 | 0.005 | 2.0265 | 9.8636 | 19 | 531 | regulation of immune response |
GO:1901615 | 0.0053 | 2.2213 | 7.0958 | 15 | 382 | organic hydroxy compound metabolic process |
GO:0002253 | 0.0055 | 2.4703 | 5.1083 | 12 | 275 | activation of immune response |
GO:0045589 | 0.0057 | 9.409 | 0.3715 | 3 | 20 | regulation of regulatory T cell differentiation |
GO:2000831 | 0.0057 | 9.409 | 0.3715 | 3 | 20 | regulation of steroid hormone secretion |
GO:0032946 | 0.0062 | 3.4194 | 2.1733 | 7 | 117 | positive regulation of mononuclear cell proliferation |
GO:0043567 | 0.0066 | 8.8857 | 0.3901 | 3 | 21 | regulation of insulin-like growth factor receptor signaling pathway |
GO:0060749 | 0.0066 | 8.8857 | 0.3901 | 3 | 21 | mammary gland alveolus development |
GO:0045916 | 0.0068 | 21.2707 | 0.13 | 2 | 7 | negative regulation of complement activation |
GO:0071670 | 0.0068 | 21.2707 | 0.13 | 2 | 7 | smooth muscle cell chemotaxis |
GO:0090270 | 0.0068 | 21.2707 | 0.13 | 2 | 7 | regulation of fibroblast growth factor production |
GO:0006629 | 0.0084 | 1.6575 | 19.7271 | 31 | 1062 | lipid metabolic process |
GO:0060216 | 0.0085 | 7.9961 | 0.4272 | 3 | 23 | definitive hemopoiesis |
GO:0001942 | 0.0085 | 3.6149 | 1.7647 | 6 | 95 | hair follicle development |
GO:0002260 | 0.0086 | 4.2481 | 1.2631 | 5 | 68 | lymphocyte homeostasis |
GO:0070509 | 0.0086 | 4.2481 | 1.2631 | 5 | 68 | calcium ion import |
GO:0042368 | 0.0089 | 17.7245 | 0.1486 | 2 | 8 | vitamin D biosynthetic process |
GO:0048513 | 0.009 | 1.4153 | 52.6429 | 69 | 2834 | animal organ development |
GO:0070613 | 0.0091 | 4.1814 | 1.2817 | 5 | 69 | regulation of protein processing |
GO:0022404 | 0.0094 | 3.535 | 1.8018 | 6 | 97 | molting cycle process |
GO:0032369 | 0.0096 | 7.6148 | 0.4458 | 3 | 24 | negative regulation of lipid transport |
GO:0008283 | 0.0098 | 1.6991 | 16.759 | 27 | 939 | cell proliferation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0016139 | 0 | 83.8706 | 0.1412 | 4 | 6 | glycoside catabolic process |
GO:0050865 | 0 | 2.6339 | 10.684 | 26 | 454 | regulation of cell activation |
GO:0046649 | 2e-04 | 2.2231 | 13.4845 | 28 | 573 | lymphocyte activation |
GO:0071705 | 3e-04 | 1.6548 | 45.5366 | 69 | 1935 | nitrogen compound transport |
GO:0002764 | 4e-04 | 2.9188 | 5.5067 | 15 | 234 | immune response-regulating signaling pathway |
GO:0050776 | 5e-04 | 2.6659 | 6.8098 | 17 | 297 | regulation of immune response |
GO:0002685 | 5e-04 | 3.5592 | 3.3417 | 11 | 142 | regulation of leukocyte migration |
GO:0046967 | 6e-04 | Inf | 0.0471 | 2 | 2 | cytosol to ER transport |
GO:0001562 | 6e-04 | 8.3973 | 0.706 | 5 | 30 | response to protozoan |
GO:0002429 | 7e-04 | 3.7452 | 2.8946 | 10 | 123 | immune response-activating cell surface receptor signaling pathway |
GO:0016192 | 7e-04 | 1.7825 | 25.8158 | 43 | 1097 | vesicle-mediated transport |
GO:0001913 | 7e-04 | 8.0738 | 0.7295 | 5 | 31 | T cell mediated cytotoxicity |
GO:0015833 | 0.001 | 1.6166 | 39.3003 | 59 | 1670 | peptide transport |
GO:0001819 | 0.0011 | 2.4167 | 7.9071 | 18 | 336 | positive regulation of cytokine production |
GO:0051224 | 0.0011 | 2.8897 | 4.8008 | 13 | 204 | negative regulation of protein transport |
GO:0060326 | 0.0011 | 2.8897 | 4.8008 | 13 | 204 | cell chemotaxis |
GO:0048246 | 0.0011 | 7.2372 | 0.8001 | 5 | 34 | macrophage chemotaxis |
GO:0080134 | 0.0011 | 1.7668 | 24.1214 | 40 | 1025 | regulation of response to stress |
GO:0045184 | 0.0012 | 1.596 | 40.4534 | 60 | 1719 | establishment of protein localization |
GO:0002703 | 0.0012 | 3.2127 | 3.6712 | 11 | 156 | regulation of leukocyte mediated immunity |
GO:0032844 | 0.0012 | 2.1773 | 10.7076 | 22 | 455 | regulation of homeostatic process |
GO:0050710 | 0.0012 | 5.6061 | 1.2002 | 6 | 51 | negative regulation of cytokine secretion |
GO:0002684 | 0.0013 | 2.2127 | 10.0607 | 21 | 436 | positive regulation of immune system process |
GO:0032103 | 0.0013 | 2.7166 | 5.4832 | 14 | 233 | positive regulation of response to external stimulus |
GO:0038083 | 0.0013 | 5.4839 | 1.2237 | 6 | 52 | peptidyl-tyrosine autophosphorylation |
GO:0097529 | 0.0016 | 3.3031 | 3.2476 | 10 | 138 | myeloid leukocyte migration |
GO:0035928 | 0.0016 | 83.4263 | 0.0706 | 2 | 3 | rRNA import into mitochondrion |
GO:1903061 | 0.0016 | 83.4263 | 0.0706 | 2 | 3 | positive regulation of protein lipidation |
GO:1903555 | 0.0017 | 3.5513 | 2.7298 | 9 | 116 | regulation of tumor necrosis factor superfamily cytokine production |
GO:1904293 | 0.0019 | 15.6774 | 0.2589 | 3 | 11 | negative regulation of ERAD pathway |
GO:0030970 | 0.0019 | 8.8188 | 0.5413 | 4 | 23 | retrograde protein transport, ER to cytosol |
GO:0045861 | 0.0021 | 2.5735 | 5.7656 | 14 | 245 | negative regulation of proteolysis |
GO:0002252 | 0.0021 | 2.0015 | 12.6608 | 24 | 538 | immune effector process |
GO:0009205 | 0.0022 | 2.6635 | 5.1773 | 13 | 220 | purine ribonucleoside triphosphate metabolic process |
GO:0002253 | 0.0023 | 2.4519 | 6.4716 | 15 | 275 | activation of immune response |
GO:0033003 | 0.0023 | 5.9942 | 0.9413 | 5 | 40 | regulation of mast cell activation |
GO:0050746 | 0.0024 | 13.9346 | 0.2824 | 3 | 12 | regulation of lipoprotein metabolic process |
GO:1901836 | 0.0024 | 13.9346 | 0.2824 | 3 | 12 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter |
GO:0070972 | 0.0026 | 5.8273 | 0.9649 | 5 | 41 | protein localization to endoplasmic reticulum |
GO:1901657 | 0.003 | 3.5485 | 2.4239 | 8 | 103 | glycosyl compound metabolic process |
GO:0032324 | 0.0032 | 41.7105 | 0.0941 | 2 | 4 | molybdopterin cofactor biosynthetic process |
GO:0042270 | 0.0032 | 41.7105 | 0.0941 | 2 | 4 | protection from natural killer cell mediated cytotoxicity |
GO:0071593 | 0.0032 | 41.7105 | 0.0941 | 2 | 4 | lymphocyte aggregation |
GO:1904688 | 0.0032 | 41.7105 | 0.0941 | 2 | 4 | regulation of cytoplasmic translational initiation |
GO:1905037 | 0.0034 | 3.8754 | 1.9532 | 7 | 83 | autophagosome organization |
GO:0002690 | 0.0036 | 4.4225 | 1.4826 | 6 | 63 | positive regulation of leukocyte chemotaxis |
GO:0045779 | 0.0039 | 11.3996 | 0.3295 | 3 | 14 | negative regulation of bone resorption |
GO:0071850 | 0.0039 | 11.3996 | 0.3295 | 3 | 14 | mitotic cell cycle arrest |
GO:0009303 | 0.004 | 6.9793 | 0.6589 | 4 | 28 | rRNA transcription |
GO:0022407 | 0.0041 | 2.1647 | 8.2601 | 17 | 351 | regulation of cell-cell adhesion |
GO:0002275 | 0.0042 | 4.272 | 1.5297 | 6 | 65 | myeloid cell activation involved in immune response |
GO:0043304 | 0.0045 | 6.6997 | 0.6825 | 4 | 29 | regulation of mast cell degranulation |
GO:0033036 | 0.0046 | 1.4385 | 55.2743 | 74 | 2388 | macromolecule localization |
GO:0065009 | 0.0046 | 1.4598 | 49.0665 | 67 | 2085 | regulation of molecular function |
GO:0010867 | 0.0048 | 10.4489 | 0.353 | 3 | 15 | positive regulation of triglyceride biosynthetic process |
GO:0032760 | 0.0049 | 4.1314 | 1.5767 | 6 | 67 | positive regulation of tumor necrosis factor production |
GO:0009141 | 0.0051 | 2.3936 | 5.7185 | 13 | 243 | nucleoside triphosphate metabolic process |
GO:0050900 | 0.0052 | 4.894 | 1.124 | 5 | 49 | leukocyte migration |
GO:0002583 | 0.0053 | 27.8052 | 0.1177 | 2 | 5 | regulation of antigen processing and presentation of peptide antigen |
GO:0003105 | 0.0053 | 27.8052 | 0.1177 | 2 | 5 | negative regulation of glomerular filtration |
GO:0006751 | 0.0053 | 27.8052 | 0.1177 | 2 | 5 | glutathione catabolic process |
GO:0030885 | 0.0053 | 27.8052 | 0.1177 | 2 | 5 | regulation of myeloid dendritic cell activation |
GO:0034242 | 0.0053 | 27.8052 | 0.1177 | 2 | 5 | negative regulation of syncytium formation by plasma membrane fusion |
GO:0042320 | 0.0053 | 27.8052 | 0.1177 | 2 | 5 | regulation of circadian sleep/wake cycle, REM sleep |
GO:0042536 | 0.0053 | 27.8052 | 0.1177 | 2 | 5 | negative regulation of tumor necrosis factor biosynthetic process |
GO:0071169 | 0.0053 | 27.8052 | 0.1177 | 2 | 5 | establishment of protein localization to chromatin |
GO:0000002 | 0.0057 | 6.2027 | 0.7295 | 4 | 31 | mitochondrial genome maintenance |
GO:0002696 | 0.0058 | 2.3521 | 5.8127 | 13 | 247 | positive regulation of leukocyte activation |
GO:0050727 | 0.0058 | 2.3521 | 5.8127 | 13 | 247 | regulation of inflammatory response |
GO:0006403 | 0.006 | 2.7053 | 3.9065 | 10 | 166 | RNA localization |
GO:1903409 | 0.0063 | 3.4226 | 2.1886 | 7 | 93 | reactive oxygen species biosynthetic process |
GO:0051649 | 0.0064 | 1.475 | 41.0182 | 57 | 1743 | establishment of localization in cell |
GO:0050863 | 0.0064 | 2.3218 | 5.8833 | 13 | 250 | regulation of T cell activation |
GO:0046364 | 0.0065 | 3.8762 | 1.6709 | 6 | 71 | monosaccharide biosynthetic process |
GO:0031342 | 0.0069 | 8.9551 | 0.4001 | 3 | 17 | negative regulation of cell killing |
GO:0030217 | 0.0069 | 2.3933 | 5.2714 | 12 | 224 | T cell differentiation |
GO:0045087 | 0.0073 | 1.8799 | 11.696 | 21 | 497 | innate immune response |
GO:0002709 | 0.0074 | 4.4603 | 1.2237 | 5 | 52 | regulation of T cell mediated immunity |
GO:0006004 | 0.0078 | 20.8525 | 0.1412 | 2 | 6 | fucose metabolic process |
GO:0006777 | 0.0078 | 20.8525 | 0.1412 | 2 | 6 | Mo-molybdopterin cofactor biosynthetic process |
GO:0010985 | 0.0078 | 20.8525 | 0.1412 | 2 | 6 | negative regulation of lipoprotein particle clearance |
GO:0043504 | 0.0078 | 20.8525 | 0.1412 | 2 | 6 | mitochondrial DNA repair |
GO:0071864 | 0.0078 | 20.8525 | 0.1412 | 2 | 6 | positive regulation of cell proliferation in bone marrow |
GO:0070663 | 0.0079 | 2.4577 | 4.7066 | 11 | 200 | regulation of leukocyte proliferation |
GO:0051235 | 0.008 | 2.2542 | 6.048 | 13 | 257 | maintenance of location |
GO:0071216 | 0.0081 | 2.748 | 3.4594 | 9 | 147 | cellular response to biotic stimulus |
GO:0051156 | 0.0081 | 8.3575 | 0.4236 | 3 | 18 | glucose 6-phosphate metabolic process |
GO:0060333 | 0.0081 | 8.3575 | 0.4236 | 3 | 18 | interferon-gamma-mediated signaling pathway |
GO:0002237 | 0.0082 | 2.3374 | 5.3891 | 12 | 229 | response to molecule of bacterial origin |
GO:0007159 | 0.0085 | 2.1635 | 6.7775 | 14 | 288 | leukocyte cell-cell adhesion |
GO:0045428 | 0.0086 | 4.2777 | 1.2708 | 5 | 54 | regulation of nitric oxide biosynthetic process |
GO:0050714 | 0.0087 | 2.3157 | 5.4361 | 12 | 231 | positive regulation of protein secretion |
GO:0043030 | 0.0089 | 5.4009 | 0.8237 | 4 | 35 | regulation of macrophage activation |
GO:1902749 | 0.0089 | 3.5981 | 1.7885 | 6 | 76 | regulation of cell cycle G2/M phase transition |
GO:0048870 | 0.009 | 1.5237 | 29.6988 | 43 | 1262 | cell motility |
GO:0042116 | 0.0093 | 7.904 | 0.4433 | 3 | 19 | macrophage activation |
GO:0050765 | 0.0095 | 7.8347 | 0.4471 | 3 | 19 | negative regulation of phagocytosis |
GO:0010972 | 0.0098 | 5.2318 | 0.8472 | 4 | 36 | negative regulation of G2/M transition of mitotic cell cycle |
GO:0050856 | 0.0098 | 5.2318 | 0.8472 | 4 | 36 | regulation of T cell receptor signaling pathway |
GO:0051281 | 0.0098 | 5.2318 | 0.8472 | 4 | 36 | positive regulation of release of sequestered calcium ion into cytosol |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0002823 | 3e-04 | 9.9629 | 0.5987 | 5 | 30 | negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
GO:0043011 | 5e-04 | 13.2501 | 0.3792 | 4 | 19 | myeloid dendritic cell differentiation |
GO:0072359 | 5e-04 | 1.9531 | 18.6789 | 34 | 936 | circulatory system development |
GO:0007275 | 9e-04 | 1.4667 | 87.3876 | 113 | 4379 | multicellular organism development |
GO:0042130 | 0.0014 | 5.3438 | 1.2373 | 6 | 62 | negative regulation of T cell proliferation |
GO:0001944 | 0.0017 | 8.9813 | 0.519 | 4 | 27 | vasculature development |
GO:0001568 | 0.0017 | 2.0733 | 11.7541 | 23 | 589 | blood vessel development |
GO:0006776 | 0.0023 | 49.4146 | 0.0798 | 2 | 4 | vitamin A metabolic process |
GO:0045347 | 0.0023 | 49.4146 | 0.0798 | 2 | 4 | negative regulation of MHC class II biosynthetic process |
GO:2000110 | 0.0023 | 49.4146 | 0.0798 | 2 | 4 | negative regulation of macrophage apoptotic process |
GO:0032722 | 0.0028 | 5.6539 | 0.9778 | 5 | 49 | positive regulation of chemokine production |
GO:0042127 | 0.0031 | 1.6295 | 28.8365 | 44 | 1445 | regulation of cell proliferation |
GO:0032945 | 0.0033 | 4.4633 | 1.4568 | 6 | 73 | negative regulation of mononuclear cell proliferation |
GO:0030335 | 0.0036 | 2.1936 | 8.162 | 17 | 409 | positive regulation of cell migration |
GO:0033993 | 0.0037 | 1.9728 | 11.7541 | 22 | 589 | response to lipid |
GO:0009642 | 0.0038 | 32.9409 | 0.0998 | 2 | 5 | response to light intensity |
GO:0043415 | 0.0038 | 32.9409 | 0.0998 | 2 | 5 | positive regulation of skeletal muscle tissue regeneration |
GO:0002707 | 0.004 | 6.8474 | 0.6586 | 4 | 33 | negative regulation of lymphocyte mediated immunity |
GO:0051250 | 0.0042 | 3.3327 | 2.5544 | 8 | 128 | negative regulation of lymphocyte activation |
GO:0030154 | 0.0045 | 1.4104 | 69.946 | 90 | 3505 | cell differentiation |
GO:0043433 | 0.0048 | 3.2508 | 2.6142 | 8 | 131 | negative regulation of DNA binding transcription factor activity |
GO:0006955 | 0.0051 | 1.7215 | 19.0181 | 31 | 953 | immune response |
GO:0044259 | 0.0053 | 4.0392 | 1.5965 | 6 | 80 | multicellular organismal macromolecule metabolic process |
GO:1903038 | 0.0053 | 3.5281 | 2.1153 | 7 | 106 | negative regulation of leukocyte cell-cell adhesion |
GO:0007498 | 0.0056 | 3.4926 | 2.1353 | 7 | 107 | mesoderm development |
GO:0050715 | 0.0056 | 3.4926 | 2.1353 | 7 | 107 | positive regulation of cytokine secretion |
GO:0060481 | 0.0056 | 24.7041 | 0.1197 | 2 | 6 | lobar bronchus epithelium development |
GO:0061302 | 0.0056 | 24.7041 | 0.1197 | 2 | 6 | smooth muscle cell-matrix adhesion |
GO:0007155 | 0.0057 | 1.6532 | 22.3907 | 35 | 1122 | cell adhesion |
GO:0032502 | 0.0059 | 1.3541 | 101.4966 | 123 | 5086 | developmental process |
GO:0050866 | 0.0059 | 2.8867 | 3.2928 | 9 | 165 | negative regulation of cell activation |
GO:0001525 | 0.0069 | 2.0961 | 8.0024 | 16 | 401 | angiogenesis |
GO:0006925 | 0.007 | 8.7395 | 0.3991 | 3 | 20 | inflammatory cell apoptotic process |
GO:0030574 | 0.007 | 8.7395 | 0.3991 | 3 | 20 | collagen catabolic process |
GO:0051220 | 0.007 | 8.7395 | 0.3991 | 3 | 20 | cytoplasmic sequestering of protein |
GO:0051272 | 0.0071 | 2.0386 | 8.7408 | 17 | 438 | positive regulation of cellular component movement |
GO:0002371 | 0.0078 | 19.762 | 0.1397 | 2 | 7 | dendritic cell cytokine production |
GO:0070345 | 0.0078 | 19.762 | 0.1397 | 2 | 7 | negative regulation of fat cell proliferation |
GO:0002320 | 0.008 | 8.2534 | 0.4191 | 3 | 21 | lymphoid progenitor cell differentiation |
GO:0071624 | 0.008 | 8.2534 | 0.4191 | 3 | 21 | positive regulation of granulocyte chemotaxis |
GO:0016101 | 0.0088 | 5.3641 | 0.8182 | 4 | 41 | diterpenoid metabolic process |
GO:0048662 | 0.0088 | 5.3641 | 0.8182 | 4 | 41 | negative regulation of smooth muscle cell proliferation |
GO:0002385 | 0.0092 | 7.8185 | 0.439 | 3 | 22 | mucosal immune response |
GO:2000145 | 0.0094 | 1.758 | 14.3085 | 24 | 717 | regulation of cell motility |
GO:0006720 | 0.0095 | 4.1419 | 1.2971 | 5 | 65 | isoprenoid metabolic process |
GO:0002889 | 0.0096 | 5.2226 | 0.8382 | 4 | 42 | regulation of immunoglobulin mediated immune response |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006597 | 3e-04 | Inf | 0.0334 | 2 | 2 | spermine biosynthetic process |
GO:0009584 | 7e-04 | 11.3762 | 0.4173 | 4 | 25 | detection of visible light |
GO:0002695 | 8e-04 | 3.9702 | 2.4372 | 9 | 146 | negative regulation of leukocyte activation |
GO:0050482 | 0.0013 | 9.5536 | 0.4841 | 4 | 29 | arachidonic acid secretion |
GO:0015909 | 0.0013 | 6.8029 | 0.8179 | 5 | 49 | long-chain fatty acid transport |
GO:0050868 | 0.0013 | 4.5761 | 1.6526 | 7 | 99 | negative regulation of T cell activation |
GO:0046546 | 0.0017 | 4.3843 | 1.7194 | 7 | 103 | development of primary male sexual characteristics |
GO:0007190 | 0.0022 | 13.7374 | 0.2671 | 3 | 16 | activation of adenylate cyclase activity |
GO:0072520 | 0.0022 | 13.7374 | 0.2671 | 3 | 16 | seminiferous tubule development |
GO:0045063 | 0.0026 | 12.7553 | 0.2838 | 3 | 17 | T-helper 1 cell differentiation |
GO:0008295 | 0.0027 | 39.5606 | 0.0835 | 2 | 5 | spermidine biosynthetic process |
GO:0007601 | 0.0042 | 3.6878 | 2.0198 | 7 | 121 | visual perception |
GO:0015886 | 0.0055 | 23.7333 | 0.1168 | 2 | 7 | heme transport |
GO:0021910 | 0.0055 | 23.7333 | 0.1168 | 2 | 7 | smoothened signaling pathway involved in ventral spinal cord patterning |
GO:0070345 | 0.0055 | 23.7333 | 0.1168 | 2 | 7 | negative regulation of fat cell proliferation |
GO:0071715 | 0.0071 | 5.6805 | 0.7679 | 4 | 46 | icosanoid transport |
GO:0002839 | 0.0073 | 19.7765 | 0.1335 | 2 | 8 | positive regulation of immune response to tumor cell |
GO:0050672 | 0.0075 | 4.3951 | 1.2186 | 5 | 73 | negative regulation of lymphocyte proliferation |
GO:0070664 | 0.0088 | 4.2086 | 1.2687 | 5 | 76 | negative regulation of leukocyte proliferation |
GO:1904354 | 0.0092 | 16.9502 | 0.1502 | 2 | 9 | negative regulation of telomere capping |
GO:0009179 | 0.0098 | 4.0928 | 1.302 | 5 | 78 | purine ribonucleoside diphosphate metabolic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0072520 | 1e-04 | 20.8074 | 0.256 | 4 | 16 | seminiferous tubule development |
GO:0006597 | 3e-04 | Inf | 0.032 | 2 | 2 | spermine biosynthetic process |
GO:0006885 | 7e-04 | 5.1181 | 1.4882 | 7 | 93 | regulation of pH |
GO:0042401 | 0.001 | 18.6548 | 0.208 | 3 | 13 | cellular biogenic amine biosynthetic process |
GO:0050482 | 0.0011 | 9.9793 | 0.4641 | 4 | 29 | arachidonic acid secretion |
GO:0046546 | 0.0013 | 4.582 | 1.6483 | 7 | 103 | development of primary male sexual characteristics |
GO:0006952 | 0.0024 | 1.8678 | 16.5998 | 29 | 1045 | defense response |
GO:0008295 | 0.0025 | 41.3096 | 0.08 | 2 | 5 | spermidine biosynthetic process |
GO:0050832 | 0.0032 | 11.6548 | 0.304 | 3 | 19 | defense response to fungus |
GO:0032277 | 0.0037 | 30.9802 | 0.096 | 2 | 6 | negative regulation of gonadotropin secretion |
GO:0002448 | 0.0037 | 6.9252 | 0.6401 | 4 | 40 | mast cell mediated immunity |
GO:0030819 | 0.0038 | 5.2067 | 1.0402 | 5 | 65 | positive regulation of cAMP biosynthetic process |
GO:0052652 | 0.0049 | 3.57 | 2.0803 | 7 | 130 | cyclic purine nucleotide metabolic process |
GO:0033005 | 0.005 | 9.8127 | 0.3521 | 3 | 22 | positive regulation of mast cell activation |
GO:0006955 | 0.0055 | 1.8069 | 15.2504 | 26 | 953 | immune response |
GO:0071715 | 0.0062 | 5.9336 | 0.7361 | 4 | 46 | icosanoid transport |
GO:0002679 | 0.0067 | 20.6509 | 0.128 | 2 | 8 | respiratory burst involved in defense response |
GO:0042742 | 0.007 | 3.027 | 2.7844 | 8 | 174 | defense response to bacterium |
GO:0051453 | 0.0074 | 4.3969 | 1.2162 | 5 | 76 | regulation of intracellular pH |
GO:0015909 | 0.0077 | 5.537 | 0.7841 | 4 | 49 | long-chain fatty acid transport |
GO:0090308 | 0.0085 | 17.6996 | 0.144 | 2 | 9 | regulation of methylation-dependent chromatin silencing |
GO:0002443 | 0.009 | 2.5295 | 4.1447 | 10 | 259 | leukocyte mediated immunity |
GO:0002695 | 0.0092 | 3.1558 | 2.3364 | 7 | 146 | negative regulation of leukocyte activation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031424 | 2e-04 | 17.4918 | 0.2897 | 4 | 19 | keratinization |
GO:0045606 | 3e-04 | 15.4319 | 0.3202 | 4 | 21 | positive regulation of epidermal cell differentiation |
GO:0010839 | 5e-04 | 24.5063 | 0.1677 | 3 | 11 | negative regulation of keratinocyte proliferation |
GO:0048490 | 0.002 | 13.9982 | 0.2592 | 3 | 17 | anterograde synaptic vesicle transport |
GO:0099514 | 0.002 | 13.9982 | 0.2592 | 3 | 17 | synaptic vesicle cytoskeletal transport |
GO:0043588 | 0.0022 | 3.1339 | 3.3854 | 10 | 222 | skin development |
GO:0016056 | 0.0022 | 43.3997 | 0.0762 | 2 | 5 | rhodopsin mediated signaling pathway |
GO:1903215 | 0.0022 | 43.3997 | 0.0762 | 2 | 5 | negative regulation of protein targeting to mitochondrion |
GO:0000237 | 0.0033 | 32.5477 | 0.0915 | 2 | 6 | leptotene |
GO:0006627 | 0.0033 | 32.5477 | 0.0915 | 2 | 6 | protein processing involved in protein targeting to mitochondrion |
GO:0045109 | 0.0038 | 10.8847 | 0.3202 | 3 | 21 | intermediate filament organization |
GO:0045682 | 0.0045 | 4.9739 | 1.0827 | 5 | 71 | regulation of epidermis development |
GO:0060216 | 0.005 | 9.795 | 0.3507 | 3 | 23 | definitive hemopoiesis |
GO:0052696 | 0.0061 | 21.6957 | 0.122 | 2 | 8 | flavonoid glucuronidation |
GO:0052697 | 0.0061 | 21.6957 | 0.122 | 2 | 8 | xenobiotic glucuronidation |
GO:0048869 | 0.009 | 1.4225 | 55.752 | 72 | 3656 | cellular developmental process |
GO:0003149 | 0.0096 | 16.2697 | 0.1525 | 2 | 10 | membranous septum morphogenesis |
GO:0015937 | 0.0096 | 16.2697 | 0.1525 | 2 | 10 | coenzyme A biosynthetic process |
GO:0019585 | 0.0096 | 16.2697 | 0.1525 | 2 | 10 | glucuronate metabolic process |
GO:0030953 | 0.0096 | 16.2697 | 0.1525 | 2 | 10 | astral microtubule organization |
GO:0045199 | 0.0096 | 16.2697 | 0.1525 | 2 | 10 | maintenance of epithelial cell apical/basal polarity |
GO:0051324 | 0.0096 | 16.2697 | 0.1525 | 2 | 10 | prophase |
GO:0009247 | 0.0098 | 5.1328 | 0.8387 | 4 | 55 | glycolipid biosynthetic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0003130 | 8e-04 | 120.5538 | 0.0493 | 2 | 3 | BMP signaling pathway involved in heart induction |
GO:0003133 | 8e-04 | 120.5538 | 0.0493 | 2 | 3 | endodermal-mesodermal cell signaling |
GO:0048490 | 0.0025 | 12.9556 | 0.2795 | 3 | 17 | anterograde synaptic vesicle transport |
GO:0099514 | 0.0025 | 12.9556 | 0.2795 | 3 | 17 | synaptic vesicle cytoskeletal transport |
GO:0016056 | 0.0026 | 40.1795 | 0.0822 | 2 | 5 | rhodopsin mediated signaling pathway |
GO:0044341 | 0.0026 | 40.1795 | 0.0822 | 2 | 5 | sodium-dependent phosphate transport |
GO:0048245 | 0.0026 | 40.1795 | 0.0822 | 2 | 5 | eosinophil chemotaxis |
GO:0009583 | 0.0034 | 7.1313 | 0.6248 | 4 | 38 | detection of light stimulus |
GO:0032462 | 0.0041 | 10.6673 | 0.3288 | 3 | 20 | regulation of protein homooligomerization |
GO:0046325 | 0.0041 | 10.6673 | 0.3288 | 3 | 20 | negative regulation of glucose import |
GO:0045606 | 0.0047 | 10.074 | 0.3453 | 3 | 21 | positive regulation of epidermal cell differentiation |
GO:0003129 | 0.0054 | 24.1046 | 0.1151 | 2 | 7 | heart induction |
GO:0030718 | 0.0054 | 24.1046 | 0.1151 | 2 | 7 | germ-line stem cell population maintenance |
GO:0042538 | 0.0054 | 24.1046 | 0.1151 | 2 | 7 | hyperosmotic salinity response |
GO:1905906 | 0.0054 | 24.1046 | 0.1151 | 2 | 7 | regulation of amyloid fibril formation |
GO:0060326 | 0.0067 | 2.8236 | 3.3541 | 9 | 204 | cell chemotaxis |
GO:0098868 | 0.0069 | 8.6332 | 0.3946 | 3 | 24 | bone growth |
GO:0071472 | 0.0071 | 20.0859 | 0.1315 | 2 | 8 | cellular response to salt stress |
GO:0050829 | 0.0079 | 5.507 | 0.7892 | 4 | 48 | defense response to Gram-negative bacterium |
GO:0050900 | 0.0079 | 2.5846 | 4.0611 | 10 | 247 | leukocyte migration |
GO:0002021 | 0.0086 | 7.8815 | 0.4275 | 3 | 26 | response to dietary excess |
GO:0018298 | 0.009 | 17.2154 | 0.148 | 2 | 9 | protein-chromophore linkage |
GO:1902004 | 0.009 | 17.2154 | 0.148 | 2 | 9 | positive regulation of amyloid-beta formation |
GO:0030850 | 0.0097 | 5.1545 | 0.8385 | 4 | 51 | prostate gland development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045653 | 0 | 166.368 | 0.3393 | 13 | 17 | negative regulation of megakaryocyte differentiation |
GO:0006336 | 0 | 47.5033 | 0.5388 | 13 | 27 | DNA replication-independent nucleosome assembly |
GO:0006335 | 0 | 36.9375 | 0.6186 | 13 | 31 | DNA replication-dependent nucleosome assembly |
GO:0051290 | 0 | 20.1284 | 0.918 | 13 | 46 | protein heterotetramerization |
GO:0034728 | 0 | 8.1867 | 2.4746 | 17 | 124 | nucleosome organization |
GO:0031497 | 0 | 8.4768 | 2.255 | 16 | 113 | chromatin assembly |
GO:0048534 | 0 | 3.0039 | 15.8651 | 42 | 795 | hematopoietic or lymphoid organ development |
GO:0065004 | 0 | 6.199 | 3.1531 | 17 | 158 | protein-DNA complex assembly |
GO:0045637 | 0 | 5.5509 | 3.6919 | 18 | 185 | regulation of myeloid cell differentiation |
GO:1903707 | 0 | 6.6733 | 2.5943 | 15 | 130 | negative regulation of hemopoiesis |
GO:0071103 | 0 | 5.2569 | 3.652 | 17 | 183 | DNA conformation change |
GO:0002250 | 0 | 4.0417 | 6.0666 | 22 | 304 | adaptive immune response |
GO:0002768 | 0 | 6.101 | 2.6142 | 14 | 131 | immune response-regulating cell surface receptor signaling pathway |
GO:0043368 | 0 | 14.6237 | 0.6186 | 7 | 31 | positive T cell selection |
GO:0002682 | 0 | 2.8409 | 11.6671 | 30 | 626 | regulation of immune system process |
GO:0002757 | 0 | 4.2045 | 4.4702 | 17 | 224 | immune response-activating signal transduction |
GO:0050865 | 0 | 3.0208 | 9.0601 | 25 | 454 | regulation of cell activation |
GO:1903037 | 0 | 3.749 | 5.2684 | 18 | 264 | regulation of leukocyte cell-cell adhesion |
GO:0022409 | 0 | 4.3184 | 3.8316 | 15 | 192 | positive regulation of cell-cell adhesion |
GO:0002696 | 0 | 3.7784 | 4.9291 | 17 | 247 | positive regulation of leukocyte activation |
GO:0050854 | 0 | 8.9905 | 0.918 | 7 | 46 | regulation of antigen receptor-mediated signaling pathway |
GO:0046632 | 0 | 15.9273 | 0.4102 | 5 | 21 | alpha-beta T cell differentiation |
GO:0002521 | 1e-04 | 2.7019 | 9.1997 | 23 | 461 | leukocyte differentiation |
GO:0002568 | 1e-04 | 74.3571 | 0.0998 | 3 | 5 | somatic diversification of T cell receptor genes |
GO:0033153 | 1e-04 | 74.3571 | 0.0998 | 3 | 5 | T cell receptor V(D)J recombination |
GO:0050778 | 1e-04 | 2.7178 | 8.3217 | 21 | 417 | positive regulation of immune response |
GO:0043029 | 2e-04 | 8.5615 | 0.8182 | 6 | 41 | T cell homeostasis |
GO:0051259 | 2e-04 | 2.4378 | 10.5767 | 24 | 530 | protein oligomerization |
GO:0001775 | 2e-04 | 2.8988 | 6.3025 | 17 | 333 | cell activation |
GO:0050860 | 3e-04 | 15.2905 | 0.3393 | 4 | 17 | negative regulation of T cell receptor signaling pathway |
GO:0046649 | 4e-04 | 3.2756 | 4.2625 | 13 | 226 | lymphocyte activation |
GO:0061153 | 4e-04 | Inf | 0.0399 | 2 | 2 | trachea gland development |
GO:1902340 | 4e-04 | Inf | 0.0399 | 2 | 2 | negative regulation of chromosome condensation |
GO:0035710 | 4e-04 | 5.647 | 1.377 | 7 | 69 | CD4-positive, alpha-beta T cell activation |
GO:0050670 | 5e-04 | 3.3822 | 3.8116 | 12 | 191 | regulation of lymphocyte proliferation |
GO:0030217 | 5e-04 | 8.6498 | 0.6713 | 5 | 35 | T cell differentiation |
GO:0032946 | 6e-04 | 4.1826 | 2.3349 | 9 | 117 | positive regulation of mononuclear cell proliferation |
GO:0001787 | 6e-04 | 24.7794 | 0.1796 | 3 | 9 | natural killer cell proliferation |
GO:0051239 | 7e-04 | 1.5806 | 50.888 | 73 | 2550 | regulation of multicellular organismal process |
GO:0070663 | 7e-04 | 3.2184 | 3.9912 | 12 | 200 | regulation of leukocyte proliferation |
GO:0032729 | 8e-04 | 6.1099 | 1.0976 | 6 | 55 | positive regulation of interferon-gamma production |
GO:0072540 | 9e-04 | 21.2381 | 0.1996 | 3 | 10 | T-helper 17 cell lineage commitment |
GO:0002683 | 9e-04 | 2.9505 | 4.6969 | 13 | 245 | negative regulation of immune system process |
GO:0033077 | 9e-04 | 4.9283 | 1.5566 | 7 | 78 | T cell differentiation in thymus |
GO:0002562 | 9e-04 | 5.8695 | 1.1375 | 6 | 57 | somatic diversification of immune receptors via germline recombination within a single locus |
GO:0002360 | 0.001 | 10.4579 | 0.459 | 4 | 23 | T cell lineage commitment |
GO:0042102 | 0.0011 | 4.7927 | 1.5965 | 7 | 80 | positive regulation of T cell proliferation |
GO:0031509 | 0.0012 | 98.8354 | 0.0599 | 2 | 3 | telomeric heterochromatin assembly |
GO:0001819 | 0.0014 | 2.6923 | 5.5209 | 14 | 281 | positive regulation of cytokine production |
GO:1905521 | 0.0014 | 9.4607 | 0.4989 | 4 | 25 | regulation of macrophage migration |
GO:0043207 | 0.0014 | 2.108 | 11.5745 | 23 | 580 | response to external biotic stimulus |
GO:0050864 | 0.0015 | 3.9645 | 2.1752 | 8 | 109 | regulation of B cell activation |
GO:0031349 | 0.0016 | 2.7542 | 5.009 | 13 | 251 | positive regulation of defense response |
GO:0010759 | 0.0019 | 14.8638 | 0.2594 | 3 | 13 | positive regulation of macrophage chemotaxis |
GO:0043373 | 0.0019 | 14.8638 | 0.2594 | 3 | 13 | CD4-positive, alpha-beta T cell lineage commitment |
GO:0045060 | 0.0019 | 14.8638 | 0.2594 | 3 | 13 | negative thymic T cell selection |
GO:0042093 | 0.0019 | 6.2208 | 0.898 | 5 | 45 | T-helper cell differentiation |
GO:0032655 | 0.0022 | 6.0687 | 0.918 | 5 | 46 | regulation of interleukin-12 production |
GO:0050870 | 0.0023 | 4.834 | 1.3535 | 6 | 69 | positive regulation of T cell activation |
GO:0031508 | 0.0023 | 49.4146 | 0.0798 | 2 | 4 | pericentric heterochromatin assembly |
GO:0002293 | 0.0024 | 5.9239 | 0.9379 | 5 | 47 | alpha-beta T cell differentiation involved in immune response |
GO:0050862 | 0.0024 | 13.5117 | 0.2794 | 3 | 14 | positive regulation of T cell receptor signaling pathway |
GO:0080134 | 0.0025 | 1.7669 | 20.455 | 34 | 1025 | regulation of response to stress |
GO:0006954 | 0.0026 | 2.1165 | 9.978 | 20 | 500 | inflammatory response |
GO:0001776 | 0.0027 | 4.0178 | 1.8759 | 7 | 94 | leukocyte homeostasis |
GO:0036037 | 0.003 | 12.3849 | 0.2993 | 3 | 15 | CD8-positive, alpha-beta T cell activation |
GO:0048002 | 0.0031 | 5.5279 | 0.9978 | 5 | 50 | antigen processing and presentation of peptide antigen |
GO:0002376 | 0.0031 | 1.921 | 13.8427 | 25 | 797 | immune system process |
GO:0032713 | 0.0038 | 32.9409 | 0.0998 | 2 | 5 | negative regulation of interleukin-4 production |
GO:0035549 | 0.0038 | 32.9409 | 0.0998 | 2 | 5 | positive regulation of interferon-beta secretion |
GO:1903753 | 0.0038 | 32.9409 | 0.0998 | 2 | 5 | negative regulation of p38MAPK cascade |
GO:0046634 | 0.0038 | 4.3333 | 1.4967 | 6 | 75 | regulation of alpha-beta T cell activation |
GO:0071621 | 0.0044 | 4.2107 | 1.5366 | 6 | 77 | granulocyte chemotaxis |
GO:0046638 | 0.0045 | 6.6187 | 0.6785 | 4 | 34 | positive regulation of alpha-beta T cell differentiation |
GO:0045471 | 0.0047 | 4.9735 | 1.0976 | 5 | 55 | response to ethanol |
GO:0072538 | 0.0051 | 9.906 | 0.3592 | 3 | 18 | T-helper 17 type immune response |
GO:0002286 | 0.0053 | 4.0392 | 1.5965 | 6 | 80 | T cell activation involved in immune response |
GO:0045087 | 0.0053 | 2.0126 | 9.9182 | 19 | 497 | innate immune response |
GO:0002700 | 0.0053 | 3.5281 | 2.1153 | 7 | 106 | regulation of production of molecular mediator of immune response |
GO:0034154 | 0.0056 | 24.7041 | 0.1197 | 2 | 6 | toll-like receptor 7 signaling pathway |
GO:0072610 | 0.0056 | 24.7041 | 0.1197 | 2 | 6 | interleukin-12 secretion |
GO:0051607 | 0.0059 | 2.8867 | 3.2928 | 9 | 165 | defense response to virus |
GO:0002443 | 0.006 | 2.4403 | 5.1686 | 12 | 259 | leukocyte mediated immunity |
GO:0032703 | 0.006 | 9.2863 | 0.3792 | 3 | 19 | negative regulation of interleukin-2 production |
GO:0045621 | 0.0063 | 3.8811 | 1.6564 | 6 | 83 | positive regulation of lymphocyte differentiation |
GO:0045596 | 0.0064 | 1.8486 | 13.0712 | 23 | 655 | negative regulation of cell differentiation |
GO:0097529 | 0.0065 | 3.0743 | 2.7539 | 8 | 138 | myeloid leukocyte migration |
GO:0050851 | 0.0068 | 4.5291 | 1.194 | 5 | 61 | antigen receptor-mediated signaling pathway |
GO:0002438 | 0.007 | 8.7395 | 0.3991 | 3 | 20 | acute inflammatory response to antigenic stimulus |
GO:0010039 | 0.007 | 8.7395 | 0.3991 | 3 | 20 | response to iron ion |
GO:0090023 | 0.007 | 8.7395 | 0.3991 | 3 | 20 | positive regulation of neutrophil chemotaxis |
GO:0002366 | 0.0072 | 2.6222 | 4.0112 | 10 | 201 | leukocyte activation involved in immune response |
GO:0032103 | 0.0073 | 2.4847 | 4.6498 | 11 | 233 | positive regulation of response to external stimulus |
GO:0030155 | 0.0073 | 1.8802 | 11.7142 | 21 | 587 | regulation of cell adhesion |
GO:0051249 | 0.0073 | 3.3104 | 2.2424 | 7 | 117 | regulation of lymphocyte activation |
GO:0042088 | 0.0074 | 5.6713 | 0.7783 | 4 | 39 | T-helper 1 type immune response |
GO:2000510 | 0.0078 | 19.762 | 0.1397 | 2 | 7 | positive regulation of dendritic cell chemotaxis |
GO:0002706 | 0.0079 | 3.2626 | 2.275 | 7 | 114 | regulation of lymphocyte mediated immunity |
GO:0032680 | 0.0079 | 3.2626 | 2.275 | 7 | 114 | regulation of tumor necrosis factor production |
GO:0051224 | 0.008 | 2.5812 | 4.071 | 10 | 204 | negative regulation of protein transport |
GO:0048305 | 0.008 | 8.2534 | 0.4191 | 3 | 21 | immunoglobulin secretion |
GO:0009617 | 0.009 | 2.0862 | 7.5234 | 15 | 377 | response to bacterium |
GO:0045580 | 0.009 | 3.173 | 2.3349 | 7 | 117 | regulation of T cell differentiation |
GO:0071706 | 0.0094 | 3.1442 | 2.3548 | 7 | 118 | tumor necrosis factor superfamily cytokine production |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006597 | 3e-04 | Inf | 0.0324 | 2 | 2 | spermine biosynthetic process |
GO:0022412 | 3e-04 | 3.07 | 5.2458 | 15 | 324 | cellular process involved in reproduction in multicellular organism |
GO:0048295 | 0.0015 | 61.2305 | 0.0648 | 2 | 4 | positive regulation of isotype switching to IgE isotypes |
GO:0048477 | 0.0015 | 5.2334 | 1.2467 | 6 | 77 | oogenesis |
GO:0007190 | 0.002 | 14.1756 | 0.2591 | 3 | 16 | activation of adenylate cyclase activity |
GO:0072520 | 0.002 | 14.1756 | 0.2591 | 3 | 16 | seminiferous tubule development |
GO:0034587 | 0.0024 | 13.1622 | 0.2752 | 3 | 17 | piRNA metabolic process |
GO:0008295 | 0.0025 | 40.8177 | 0.081 | 2 | 5 | spermidine biosynthetic process |
GO:0072513 | 0.0025 | 40.8177 | 0.081 | 2 | 5 | positive regulation of secondary heart field cardioblast proliferation |
GO:0032277 | 0.0038 | 30.6113 | 0.0971 | 2 | 6 | negative regulation of gonadotropin secretion |
GO:2000582 | 0.0038 | 30.6113 | 0.0971 | 2 | 6 | positive regulation of ATP-dependent microtubule motor activity, plus-end-directed |
GO:0006706 | 0.0039 | 10.8374 | 0.3238 | 3 | 20 | steroid catabolic process |
GO:0007141 | 0.0039 | 10.8374 | 0.3238 | 3 | 20 | male meiosis I |
GO:0030903 | 0.0039 | 10.8374 | 0.3238 | 3 | 20 | notochord development |
GO:0071695 | 0.0042 | 3.3124 | 2.5581 | 8 | 158 | anatomical structure maturation |
GO:0043949 | 0.0051 | 9.6954 | 0.3562 | 3 | 22 | regulation of cAMP-mediated signaling |
GO:0050857 | 0.0051 | 9.6954 | 0.3562 | 3 | 22 | positive regulation of antigen receptor-mediated signaling pathway |
GO:0090502 | 0.0051 | 9.6954 | 0.3562 | 3 | 22 | RNA phosphodiester bond hydrolysis, endonucleolytic |
GO:0007341 | 0.0052 | 24.4875 | 0.1133 | 2 | 7 | penetration of zona pellucida |
GO:0046546 | 0.0066 | 3.8243 | 1.6676 | 6 | 103 | development of primary male sexual characteristics |
GO:0000470 | 0.0066 | 8.7709 | 0.3886 | 3 | 24 | maturation of LSU-rRNA |
GO:0007144 | 0.0069 | 20.4049 | 0.1295 | 2 | 8 | female meiosis I |
GO:0009584 | 0.0074 | 8.3717 | 0.4048 | 3 | 25 | detection of visible light |
GO:0019953 | 0.008 | 1.9 | 11.0745 | 20 | 684 | sexual reproduction |
GO:0071600 | 0.0087 | 17.4888 | 0.1457 | 2 | 9 | otic vesicle morphogenesis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 55.3703 | 0.7898 | 18 | 31 | DNA replication-dependent nucleosome assembly |
GO:0045653 | 0 | 128.3874 | 0.4331 | 13 | 17 | negative regulation of megakaryocyte differentiation |
GO:0051290 | 0 | 23.3579 | 1.172 | 17 | 46 | protein heterotetramerization |
GO:0006336 | 0 | 42.6264 | 0.6879 | 14 | 27 | DNA replication-independent nucleosome assembly |
GO:0034728 | 0 | 8.1691 | 3.1593 | 21 | 124 | nucleosome organization |
GO:0031497 | 0 | 8.5999 | 2.8791 | 20 | 113 | chromatin assembly |
GO:0065004 | 0 | 6.8477 | 4.0256 | 23 | 158 | protein-DNA complex assembly |
GO:0006342 | 0 | 10.059 | 1.8854 | 15 | 74 | chromatin silencing |
GO:0048534 | 0 | 2.8549 | 20.2554 | 51 | 795 | hematopoietic or lymphoid organ development |
GO:0071103 | 0 | 5.1741 | 4.6626 | 21 | 183 | DNA conformation change |
GO:0045637 | 0 | 4.8246 | 4.7135 | 20 | 185 | regulation of myeloid cell differentiation |
GO:1903707 | 0 | 5.5475 | 3.3122 | 16 | 130 | negative regulation of hemopoiesis |
GO:0002323 | 0 | 16.0083 | 0.6115 | 7 | 24 | natural killer cell activation involved in immune response |
GO:0033141 | 0 | 23.2785 | 0.4077 | 6 | 16 | positive regulation of peptidyl-serine phosphorylation of STAT protein |
GO:0042100 | 0 | 5.9784 | 2.1147 | 11 | 83 | B cell proliferation |
GO:0040029 | 0 | 3.8675 | 4.5607 | 16 | 179 | regulation of gene expression, epigenetic |
GO:0043330 | 1e-04 | 7.9954 | 1.0446 | 7 | 41 | response to exogenous dsRNA |
GO:0051276 | 1e-04 | 2.0897 | 19.0887 | 37 | 781 | chromosome organization |
GO:0030183 | 1e-04 | 4.4304 | 2.7517 | 11 | 108 | B cell differentiation |
GO:0002521 | 1e-04 | 2.3741 | 11.7456 | 26 | 461 | leukocyte differentiation |
GO:0046483 | 2e-04 | 1.4571 | 119.0611 | 152 | 4673 | heterocycle metabolic process |
GO:0033135 | 3e-04 | 4.2746 | 2.5772 | 10 | 102 | regulation of peptidyl-serine phosphorylation |
GO:0065003 | 3e-04 | 1.7039 | 37.4024 | 59 | 1468 | macromolecular complex assembly |
GO:0045596 | 3e-04 | 2.0472 | 16.6884 | 32 | 655 | negative regulation of cell differentiation |
GO:0006725 | 5e-04 | 1.4213 | 120.2076 | 151 | 4718 | cellular aromatic compound metabolic process |
GO:0002708 | 6e-04 | 4.6387 | 1.9109 | 8 | 75 | positive regulation of lymphocyte mediated immunity |
GO:0002874 | 6e-04 | Inf | 0.051 | 2 | 2 | regulation of chronic inflammatory response to antigenic stimulus |
GO:0002366 | 7e-04 | 2.9301 | 5.1212 | 14 | 201 | leukocyte activation involved in immune response |
GO:0070271 | 7e-04 | 1.72 | 29.8353 | 48 | 1171 | protein complex biogenesis |
GO:1901360 | 9e-04 | 1.3982 | 124.2587 | 154 | 4877 | organic cyclic compound metabolic process |
GO:0021542 | 0.001 | 11.027 | 0.4586 | 4 | 18 | dentate gyrus development |
GO:0002824 | 0.001 | 4.3152 | 2.0383 | 8 | 80 | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
GO:0051259 | 0.0011 | 2.0397 | 13.5036 | 26 | 530 | protein oligomerization |
GO:0016043 | 0.0012 | 1.3795 | 129.0232 | 158 | 5064 | cellular component organization |
GO:0006991 | 0.0012 | 19.2593 | 0.2293 | 3 | 9 | response to sterol depletion |
GO:0032933 | 0.0012 | 19.2593 | 0.2293 | 3 | 9 | SREBP signaling pathway |
GO:0048193 | 0.0013 | 2.7235 | 5.4779 | 14 | 215 | Golgi vesicle transport |
GO:0090304 | 0.0013 | 2.2191 | 10.1166 | 21 | 425 | nucleic acid metabolic process |
GO:0019985 | 0.0017 | 16.5069 | 0.2548 | 3 | 10 | translesion synthesis |
GO:0009892 | 0.0017 | 1.4763 | 59.212 | 81 | 2324 | negative regulation of metabolic process |
GO:0010629 | 0.0018 | 1.5889 | 36.9184 | 55 | 1449 | negative regulation of gene expression |
GO:0002682 | 0.0018 | 1.7047 | 25.504 | 41 | 1001 | regulation of immune system process |
GO:0052572 | 0.0019 | 76.8713 | 0.0764 | 2 | 3 | response to host immune response |
GO:0032943 | 0.0022 | 2.4648 | 6.4461 | 15 | 253 | mononuclear cell proliferation |
GO:0002703 | 0.0022 | 2.9546 | 3.9746 | 11 | 156 | regulation of leukocyte mediated immunity |
GO:0071822 | 0.0024 | 1.596 | 33.2749 | 50 | 1306 | protein complex subunit organization |
GO:0034641 | 0.0026 | 1.6206 | 32.0263 | 48 | 1352 | cellular nitrogen compound metabolic process |
GO:0033260 | 0.0029 | 7.7159 | 0.6115 | 4 | 24 | nuclear DNA replication |
GO:0045672 | 0.0029 | 7.7159 | 0.6115 | 4 | 24 | positive regulation of osteoclast differentiation |
GO:0071281 | 0.003 | 12.8371 | 0.3057 | 3 | 12 | cellular response to iron ion |
GO:0046649 | 0.0033 | 1.874 | 14.5992 | 26 | 573 | lymphocyte activation |
GO:0033137 | 0.0034 | 7.348 | 0.637 | 4 | 25 | negative regulation of peptidyl-serine phosphorylation |
GO:0010564 | 0.0035 | 2.4203 | 6.1105 | 14 | 244 | regulation of cell cycle process |
GO:0006281 | 0.0037 | 2.0435 | 10.2933 | 20 | 404 | DNA repair |
GO:0002740 | 0.0038 | 38.4332 | 0.1019 | 2 | 4 | negative regulation of cytokine secretion involved in immune response |
GO:0016557 | 0.0038 | 38.4332 | 0.1019 | 2 | 4 | peroxisome membrane biogenesis |
GO:0035359 | 0.0038 | 38.4332 | 0.1019 | 2 | 4 | negative regulation of peroxisome proliferator activated receptor signaling pathway |
GO:0071593 | 0.0038 | 38.4332 | 0.1019 | 2 | 4 | lymphocyte aggregation |
GO:0090191 | 0.0038 | 38.4332 | 0.1019 | 2 | 4 | negative regulation of branching involved in ureteric bud morphogenesis |
GO:0007614 | 0.0039 | 11.5526 | 0.3312 | 3 | 13 | short-term memory |
GO:0042254 | 0.0039 | 2.3862 | 6.1913 | 14 | 243 | ribosome biogenesis |
GO:0031327 | 0.004 | 1.5584 | 33.2749 | 49 | 1306 | negative regulation of cellular biosynthetic process |
GO:0043457 | 0.004 | 7.0136 | 0.6624 | 4 | 26 | regulation of cellular respiration |
GO:0002286 | 0.0043 | 3.7145 | 2.0383 | 7 | 80 | T cell activation involved in immune response |
GO:0018209 | 0.0048 | 2.1866 | 7.6945 | 16 | 302 | peptidyl-serine modification |
GO:0030730 | 0.0048 | 10.5017 | 0.3567 | 3 | 14 | sequestering of triglyceride |
GO:0002250 | 0.005 | 2.633 | 4.4203 | 11 | 176 | adaptive immune response |
GO:0010467 | 0.005 | 1.3997 | 69.042 | 89 | 2850 | gene expression |
GO:0071705 | 0.0054 | 1.4454 | 49.3009 | 67 | 1935 | nitrogen compound transport |
GO:1901136 | 0.0054 | 3.1978 | 2.6752 | 8 | 105 | carbohydrate derivative catabolic process |
GO:0002819 | 0.0055 | 2.9357 | 3.2612 | 9 | 128 | regulation of adaptive immune response |
GO:1900153 | 0.0059 | 9.6259 | 0.3822 | 3 | 15 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay |
GO:0050715 | 0.006 | 3.1328 | 2.7262 | 8 | 107 | positive regulation of cytokine secretion |
GO:2000779 | 0.0061 | 4.7102 | 1.172 | 5 | 46 | regulation of double-strand break repair |
GO:0033554 | 0.0061 | 1.4953 | 37.4534 | 53 | 1470 | cellular response to stress |
GO:0002904 | 0.0062 | 25.6205 | 0.1274 | 2 | 5 | positive regulation of B cell apoptotic process |
GO:0042663 | 0.0062 | 25.6205 | 0.1274 | 2 | 5 | regulation of endodermal cell fate specification |
GO:0052173 | 0.0062 | 25.6205 | 0.1274 | 2 | 5 | response to defenses of other organism involved in symbiotic interaction |
GO:0075136 | 0.0062 | 25.6205 | 0.1274 | 2 | 5 | response to host |
GO:1900157 | 0.0062 | 25.6205 | 0.1274 | 2 | 5 | regulation of bone mineralization involved in bone maturation |
GO:0001775 | 0.0063 | 1.6743 | 20.0516 | 32 | 787 | cell activation |
GO:0002252 | 0.0064 | 2.0146 | 9.3664 | 18 | 373 | immune effector process |
GO:0045806 | 0.0067 | 4.5977 | 1.1975 | 5 | 47 | negative regulation of endocytosis |
GO:2000134 | 0.0067 | 4.5977 | 1.1975 | 5 | 47 | negative regulation of G1/S transition of mitotic cell cycle |
GO:0001562 | 0.0067 | 5.933 | 0.7644 | 4 | 30 | response to protozoan |
GO:0044271 | 0.0068 | 1.3292 | 96.2323 | 118 | 3777 | cellular nitrogen compound biosynthetic process |
GO:0010558 | 0.0071 | 1.5244 | 31.7717 | 46 | 1247 | negative regulation of macromolecule biosynthetic process |
GO:0001711 | 0.0072 | 8.8849 | 0.4077 | 3 | 16 | endodermal cell fate commitment |
GO:0060456 | 0.0072 | 8.8849 | 0.4077 | 3 | 16 | positive regulation of digestive system process |
GO:0046425 | 0.0074 | 2.7937 | 3.4141 | 9 | 134 | regulation of JAK-STAT cascade |
GO:0001913 | 0.0076 | 5.7129 | 0.7898 | 4 | 31 | T cell mediated cytotoxicity |
GO:0002891 | 0.0076 | 5.7129 | 0.7898 | 4 | 31 | positive regulation of immunoglobulin mediated immune response |
GO:0006826 | 0.0076 | 5.7129 | 0.7898 | 4 | 31 | iron ion transport |
GO:0060255 | 0.0076 | 1.3014 | 122.0675 | 145 | 4791 | regulation of macromolecule metabolic process |
GO:0002377 | 0.0076 | 3.3049 | 2.2676 | 7 | 89 | immunoglobulin production |
GO:0031623 | 0.0076 | 3.3049 | 2.2676 | 7 | 89 | receptor internalization |
GO:0051983 | 0.0076 | 3.3049 | 2.2676 | 7 | 89 | regulation of chromosome segregation |
GO:0034645 | 0.008 | 1.319 | 97.6591 | 119 | 3833 | cellular macromolecule biosynthetic process |
GO:0071702 | 0.0082 | 1.3897 | 57.3776 | 75 | 2252 | organic substance transport |
GO:0045454 | 0.0087 | 4.2904 | 1.2739 | 5 | 50 | cell redox homeostasis |
GO:0071840 | 0.0087 | 2.7212 | 3.5132 | 9 | 154 | cellular component organization or biogenesis |
GO:0032680 | 0.0087 | 2.9246 | 2.9045 | 8 | 114 | regulation of tumor necrosis factor production |
GO:1901214 | 0.0089 | 2.0342 | 8.2296 | 16 | 323 | regulation of neuron death |
GO:0016070 | 0.009 | 1.3191 | 92.3851 | 113 | 3626 | RNA metabolic process |
GO:0033625 | 0.0091 | 19.2141 | 0.1529 | 2 | 6 | positive regulation of integrin activation |
GO:0045046 | 0.0091 | 19.2141 | 0.1529 | 2 | 6 | protein import into peroxisome membrane |
GO:1901987 | 0.0093 | 2.2101 | 6.1658 | 13 | 242 | regulation of cell cycle phase transition |
GO:0006261 | 0.0097 | 2.8701 | 2.9555 | 8 | 116 | DNA-dependent DNA replication |
GO:0002699 | 0.0098 | 2.5047 | 4.204 | 10 | 165 | positive regulation of immune effector process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0002251 | 7e-04 | 11.8395 | 0.407 | 4 | 23 | organ or tissue specific immune response |
GO:0007186 | 7e-04 | 2.2 | 11.6623 | 24 | 659 | G-protein coupled receptor signaling pathway |
GO:0035964 | 9e-04 | 111.8 | 0.0531 | 2 | 3 | COPI-coated vesicle budding |
GO:0010107 | 0.0011 | 10.223 | 0.4601 | 4 | 26 | potassium ion import |
GO:0071804 | 0.0018 | 3.5015 | 2.743 | 9 | 155 | cellular potassium ion transport |
GO:0031296 | 0.0018 | 55.8964 | 0.0708 | 2 | 4 | B cell costimulation |
GO:1900108 | 0.0018 | 55.8964 | 0.0708 | 2 | 4 | negative regulation of nodal signaling pathway |
GO:0002227 | 0.0021 | 14.0152 | 0.2655 | 3 | 15 | innate immune response in mucosa |
GO:0060326 | 0.0035 | 2.9296 | 3.6102 | 10 | 204 | cell chemotaxis |
GO:0043031 | 0.0045 | 27.9446 | 0.1062 | 2 | 6 | negative regulation of macrophage activation |
GO:0043567 | 0.0058 | 9.3399 | 0.3716 | 3 | 21 | regulation of insulin-like growth factor receptor signaling pathway |
GO:0050830 | 0.0058 | 4.691 | 1.1503 | 5 | 65 | defense response to Gram-positive bacterium |
GO:0030718 | 0.0062 | 22.3543 | 0.1239 | 2 | 7 | germ-line stem cell population maintenance |
GO:0006954 | 0.0079 | 2.0148 | 8.8484 | 17 | 500 | inflammatory response |
GO:0002741 | 0.0081 | 18.6274 | 0.1416 | 2 | 8 | positive regulation of cytokine secretion involved in immune response |
GO:0019896 | 0.0081 | 18.6274 | 0.1416 | 2 | 8 | axonal transport of mitochondrion |
GO:0051607 | 0.0092 | 2.8818 | 2.92 | 8 | 165 | defense response to virus |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045653 | 0 | 175.1414 | 0.3233 | 13 | 17 | negative regulation of megakaryocyte differentiation |
GO:0006336 | 0 | 67.7951 | 0.5134 | 15 | 27 | DNA replication-independent nucleosome assembly |
GO:0006335 | 0 | 50.8333 | 0.5895 | 15 | 31 | DNA replication-dependent nucleosome assembly |
GO:0051290 | 0 | 21.1899 | 0.8747 | 13 | 46 | protein heterotetramerization |
GO:0031497 | 0 | 8.9285 | 2.1487 | 16 | 113 | chromatin assembly |
GO:0034728 | 0 | 8.0134 | 2.3578 | 16 | 124 | nucleosome organization |
GO:0065004 | 0 | 6.0814 | 3.0043 | 16 | 158 | protein-DNA complex assembly |
GO:0071103 | 0 | 5.538 | 3.4797 | 17 | 183 | DNA conformation change |
GO:1903707 | 0 | 6.4797 | 2.4719 | 14 | 130 | negative regulation of hemopoiesis |
GO:0045637 | 0 | 4.38 | 3.5177 | 14 | 185 | regulation of myeloid cell differentiation |
GO:0002682 | 2e-04 | 2.0493 | 19.0338 | 36 | 1001 | regulation of immune system process |
GO:0006393 | 4e-04 | Inf | 0.038 | 2 | 2 | termination of mitochondrial transcription |
GO:0051259 | 5e-04 | 2.3309 | 10.0778 | 22 | 530 | protein oligomerization |
GO:0002003 | 0.0011 | 103.8605 | 0.057 | 2 | 3 | angiotensin maturation |
GO:0051541 | 0.0021 | 51.9269 | 0.0761 | 2 | 4 | elastin metabolic process |
GO:2000298 | 0.0021 | 51.9269 | 0.0761 | 2 | 4 | regulation of Rho-dependent protein serine/threonine kinase activity |
GO:2000427 | 0.0035 | 34.6157 | 0.0951 | 2 | 5 | positive regulation of apoptotic cell clearance |
GO:0014744 | 0.0051 | 25.9601 | 0.1141 | 2 | 6 | positive regulation of muscle adaptation |
GO:0035931 | 0.0051 | 25.9601 | 0.1141 | 2 | 6 | mineralocorticoid secretion |
GO:0048743 | 0.0051 | 25.9601 | 0.1141 | 2 | 6 | positive regulation of skeletal muscle fiber development |
GO:2000858 | 0.0051 | 25.9601 | 0.1141 | 2 | 6 | regulation of aldosterone secretion |
GO:0006144 | 0.0061 | 9.1853 | 0.3803 | 3 | 20 | purine nucleobase metabolic process |
GO:0060177 | 0.0071 | 20.7668 | 0.1331 | 2 | 7 | regulation of angiotensin metabolic process |
GO:0015748 | 0.0084 | 4.2829 | 1.255 | 5 | 66 | organophosphate ester transport |
GO:0019896 | 0.0094 | 17.3045 | 0.1521 | 2 | 8 | axonal transport of mitochondrion |
GO:2001140 | 0.0094 | 17.3045 | 0.1521 | 2 | 8 | positive regulation of phospholipid transport |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007218 | 0 | 10.0322 | 1.1979 | 10 | 63 | neuropeptide signaling pathway |
GO:0097529 | 3e-04 | 4.134 | 2.624 | 10 | 138 | myeloid leukocyte migration |
GO:0042418 | 4e-04 | Inf | 0.038 | 2 | 2 | epinephrine biosynthetic process |
GO:0042730 | 4e-04 | 13.9282 | 0.3613 | 4 | 19 | fibrinolysis |
GO:0032101 | 4e-04 | 2.2689 | 11.3138 | 24 | 595 | regulation of response to external stimulus |
GO:0071621 | 6e-04 | 5.2574 | 1.4641 | 7 | 77 | granulocyte chemotaxis |
GO:2000410 | 0.0011 | 103.8605 | 0.057 | 2 | 3 | regulation of thymocyte migration |
GO:1905521 | 0.0012 | 9.9449 | 0.4754 | 4 | 25 | regulation of macrophage migration |
GO:0007187 | 0.0014 | 3.6504 | 2.643 | 9 | 139 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO:1900047 | 0.0016 | 6.5403 | 0.8557 | 5 | 45 | negative regulation of hemostasis |
GO:0010759 | 0.0017 | 15.622 | 0.2472 | 3 | 13 | positive regulation of macrophage chemotaxis |
GO:0050819 | 0.0019 | 6.228 | 0.8937 | 5 | 47 | negative regulation of coagulation |
GO:0010748 | 0.0021 | 51.9269 | 0.0761 | 2 | 4 | negative regulation of plasma membrane long-chain fatty acid transport |
GO:2000525 | 0.0021 | 51.9269 | 0.0761 | 2 | 4 | positive regulation of T cell costimulation |
GO:0071674 | 0.0023 | 5.9442 | 0.9317 | 5 | 49 | mononuclear cell migration |
GO:0019935 | 0.0024 | 4.13 | 1.8254 | 7 | 96 | cyclic-nucleotide-mediated signaling |
GO:0044057 | 0.0029 | 2.1909 | 8.6707 | 18 | 456 | regulation of system process |
GO:0008217 | 0.0034 | 3.1596 | 3.0233 | 9 | 159 | regulation of blood pressure |
GO:0002513 | 0.0035 | 34.6157 | 0.0951 | 2 | 5 | tolerance induction to self antigen |
GO:0010986 | 0.0035 | 34.6157 | 0.0951 | 2 | 5 | positive regulation of lipoprotein particle clearance |
GO:0032482 | 0.0035 | 34.6157 | 0.0951 | 2 | 5 | Rab protein signal transduction |
GO:0043410 | 0.0036 | 2.1958 | 8.1573 | 17 | 429 | positive regulation of MAPK cascade |
GO:0007189 | 0.0045 | 5.0271 | 1.0838 | 5 | 57 | adenylate cyclase-activating G-protein coupled receptor signaling pathway |
GO:0050921 | 0.0046 | 3.6365 | 2.0536 | 7 | 108 | positive regulation of chemotaxis |
GO:0046887 | 0.0047 | 3.2591 | 2.605 | 8 | 137 | positive regulation of hormone secretion |
GO:0010634 | 0.0048 | 3.6006 | 2.0726 | 7 | 109 | positive regulation of epithelial cell migration |
GO:0072676 | 0.0048 | 4.9319 | 1.1029 | 5 | 58 | lymphocyte migration |
GO:0003418 | 0.0051 | 25.9601 | 0.1141 | 2 | 6 | growth plate cartilage chondrocyte differentiation |
GO:0003433 | 0.0051 | 25.9601 | 0.1141 | 2 | 6 | chondrocyte development involved in endochondral bone morphogenesis |
GO:0042760 | 0.0051 | 25.9601 | 0.1141 | 2 | 6 | very long-chain fatty acid catabolic process |
GO:0032098 | 0.0053 | 9.76 | 0.3613 | 3 | 19 | regulation of appetite |
GO:0061045 | 0.0064 | 4.5847 | 1.1789 | 5 | 62 | negative regulation of wound healing |
GO:0032891 | 0.007 | 8.6744 | 0.3993 | 3 | 21 | negative regulation of organic acid transport |
GO:0071467 | 0.007 | 8.6744 | 0.3993 | 3 | 21 | cellular response to pH |
GO:0002604 | 0.0071 | 20.7668 | 0.1331 | 2 | 7 | regulation of dendritic cell antigen processing and presentation |
GO:0098700 | 0.0071 | 20.7668 | 0.1331 | 2 | 7 | neurotransmitter loading into synaptic vesicle |
GO:0001952 | 0.0074 | 3.7393 | 1.7113 | 6 | 90 | regulation of cell-matrix adhesion |
GO:0003015 | 0.0079 | 2.7515 | 3.4417 | 9 | 181 | heart process |
GO:0008016 | 0.008 | 2.9582 | 2.8522 | 8 | 150 | regulation of heart contraction |
GO:0003416 | 0.008 | 8.2174 | 0.4183 | 3 | 22 | endochondral bone growth |
GO:0031639 | 0.008 | 8.2174 | 0.4183 | 3 | 22 | plasminogen activation |
GO:0050729 | 0.0082 | 3.6519 | 1.7494 | 6 | 92 | positive regulation of inflammatory response |
GO:0009713 | 0.0091 | 7.806 | 0.4373 | 3 | 23 | catechol-containing compound biosynthetic process |
GO:0007600 | 0.0093 | 1.9354 | 9.7356 | 18 | 512 | sensory perception |
GO:0010459 | 0.0094 | 17.3045 | 0.1521 | 2 | 8 | negative regulation of heart rate |
GO:0046877 | 0.0094 | 17.3045 | 0.1521 | 2 | 8 | regulation of saliva secretion |
GO:1901387 | 0.0094 | 17.3045 | 0.1521 | 2 | 8 | positive regulation of voltage-gated calcium channel activity |
GO:1902001 | 0.0094 | 17.3045 | 0.1521 | 2 | 8 | fatty acid transmembrane transport |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0061134 | 2e-04 | 3.9104 | 3.0441 | 11 | 163 | peptidase regulator activity |
GO:0098772 | 0.001 | 1.7679 | 25.6231 | 42 | 1372 | molecular function regulator |
GO:0004872 | 0.0014 | 1.8777 | 18.2088 | 32 | 975 | receptor activity |
GO:0004896 | 0.0019 | 5.0071 | 1.3073 | 6 | 70 | cytokine receptor activity |
GO:0043236 | 0.0022 | 8.1806 | 0.5603 | 4 | 30 | laminin binding |
GO:0072341 | 0.0024 | 4.782 | 1.3633 | 6 | 73 | modified amino acid binding |
GO:0004866 | 0.0025 | 3.6333 | 2.3531 | 8 | 126 | endopeptidase inhibitor activity |
GO:0005179 | 0.0034 | 4.4485 | 1.4567 | 6 | 78 | hormone activity |
GO:0001848 | 0.0036 | 11.3644 | 0.3175 | 3 | 17 | complement binding |
GO:0005518 | 0.0045 | 5.0249 | 1.0832 | 5 | 58 | collagen binding |
GO:0050431 | 0.005 | 9.9426 | 0.3548 | 3 | 19 | transforming growth factor beta binding |
GO:0048018 | 0.0051 | 2.614 | 4.4317 | 11 | 241 | receptor ligand activity |
GO:0015294 | 0.0068 | 3.81 | 1.6808 | 6 | 90 | solute:cation symporter activity |
GO:0004190 | 0.0076 | 8.3711 | 0.4109 | 3 | 22 | aspartic-type endopeptidase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004014 | 3e-04 | Inf | 0.0345 | 2 | 2 | adenosylmethionine decarboxylase activity |
GO:0019810 | 3e-04 | Inf | 0.0345 | 2 | 2 | putrescine binding |
GO:0005160 | 0.0015 | 6.5837 | 0.8442 | 5 | 49 | transforming growth factor beta receptor binding |
GO:0001158 | 0.0018 | 4.3328 | 1.7402 | 7 | 101 | enhancer sequence-specific DNA binding |
GO:0001205 | 0.0027 | 7.7032 | 0.5858 | 4 | 34 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding |
GO:1990430 | 0.0029 | 38.299 | 0.0861 | 2 | 5 | extracellular matrix protein binding |
GO:0030247 | 0.0034 | 11.5232 | 0.3101 | 3 | 18 | polysaccharide binding |
GO:0042975 | 0.0034 | 11.5232 | 0.3101 | 3 | 18 | peroxisome proliferator activated receptor binding |
GO:0005125 | 0.0035 | 3.4261 | 2.481 | 8 | 144 | cytokine activity |
GO:0047617 | 0.004 | 10.8024 | 0.3274 | 3 | 19 | acyl-CoA hydrolase activity |
GO:0043546 | 0.0042 | 28.7224 | 0.1034 | 2 | 6 | molybdopterin cofactor binding |
GO:0051575 | 0.0042 | 28.7224 | 0.1034 | 2 | 6 | 5'-deoxyribose-5-phosphate lyase activity |
GO:0102991 | 0.0042 | 28.7224 | 0.1034 | 2 | 6 | myristoyl-CoA hydrolase activity |
GO:0046965 | 0.0061 | 9.095 | 0.379 | 3 | 22 | retinoid X receptor binding |
GO:0030545 | 0.0075 | 2.2739 | 5.9958 | 13 | 348 | receptor regulator activity |
GO:0003680 | 0.0077 | 19.1458 | 0.1378 | 2 | 8 | AT DNA binding |
GO:0004030 | 0.0077 | 19.1458 | 0.1378 | 2 | 8 | aldehyde dehydrogenase [NAD(P)+] activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0019767 | 4e-04 | Inf | 0.04 | 2 | 2 | IgE receptor activity |
GO:0004872 | 0.0011 | 1.8631 | 19.4963 | 34 | 975 | receptor activity |
GO:0019863 | 0.0012 | 98.6329 | 0.06 | 2 | 3 | IgE binding |
GO:0005126 | 0.0012 | 3.0167 | 4.2392 | 12 | 212 | cytokine receptor binding |
GO:0001077 | 0.0039 | 2.4736 | 5.539 | 13 | 277 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
GO:0004029 | 0.0044 | 10.5925 | 0.3399 | 3 | 17 | aldehyde dehydrogenase (NAD) activity |
GO:0004888 | 0.0045 | 1.856 | 14.1973 | 25 | 710 | transmembrane signaling receptor activity |
GO:0048018 | 0.0051 | 2.3072 | 6.3788 | 14 | 319 | receptor ligand activity |
GO:0008009 | 0.0052 | 9.8857 | 0.3599 | 3 | 18 | chemokine activity |
GO:0050431 | 0.0061 | 9.2673 | 0.3799 | 3 | 19 | transforming growth factor beta binding |
GO:0019864 | 0.0078 | 19.7215 | 0.14 | 2 | 7 | IgG binding |
GO:0034987 | 0.0078 | 19.7215 | 0.14 | 2 | 7 | immunoglobulin receptor binding |
GO:0045118 | 0.0078 | 19.7215 | 0.14 | 2 | 7 | azole transporter activity |
GO:0045236 | 0.0078 | 19.7215 | 0.14 | 2 | 7 | CXCR chemokine receptor binding |
GO:0005539 | 0.0084 | 2.722 | 3.4793 | 9 | 174 | glycosaminoglycan binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004560 | 6e-04 | Inf | 0.0473 | 2 | 2 | alpha-L-fucosidase activity |
GO:0015433 | 6e-04 | Inf | 0.0473 | 2 | 2 | peptide antigen-transporting ATPase activity |
GO:0046980 | 6e-04 | Inf | 0.0473 | 2 | 2 | tapasin binding |
GO:0023029 | 0.0016 | 83.0267 | 0.0709 | 2 | 3 | MHC class Ib protein binding |
GO:0036374 | 0.0016 | 83.0267 | 0.0709 | 2 | 3 | glutathione hydrolase activity |
GO:0046978 | 0.0016 | 83.0267 | 0.0709 | 2 | 3 | TAP1 binding |
GO:0046979 | 0.0016 | 83.0267 | 0.0709 | 2 | 3 | TAP2 binding |
GO:0050750 | 0.0019 | 8.7765 | 0.5438 | 4 | 23 | low-density lipoprotein particle receptor binding |
GO:0005125 | 0.0022 | 3.1386 | 3.4046 | 10 | 144 | cytokine activity |
GO:0005102 | 0.0024 | 1.6137 | 31.6584 | 48 | 1339 | receptor binding |
GO:0070122 | 0.0032 | 41.5107 | 0.0946 | 2 | 4 | isopeptidase activity |
GO:0043130 | 0.0034 | 4.48 | 1.4659 | 6 | 62 | ubiquitin binding |
GO:0017127 | 0.0048 | 10.3988 | 0.3547 | 3 | 15 | cholesterol transporter activity |
GO:1990381 | 0.0048 | 10.3988 | 0.3547 | 3 | 15 | ubiquitin-specific protease binding |
GO:0004715 | 0.0049 | 4.9689 | 1.1112 | 5 | 47 | non-membrane spanning protein tyrosine kinase activity |
GO:0015485 | 0.0052 | 6.4107 | 0.7093 | 4 | 30 | cholesterol binding |
GO:0071987 | 0.0053 | 27.672 | 0.1182 | 2 | 5 | WD40-repeat domain binding |
GO:0008137 | 0.0082 | 8.3174 | 0.4256 | 3 | 18 | NADH dehydrogenase (ubiquinone) activity |
GO:0030545 | 0.0089 | 2.0341 | 8.2279 | 16 | 348 | receptor regulator activity |
GO:1904680 | 0.0096 | 7.7971 | 0.4492 | 3 | 19 | peptide transmembrane transporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004014 | 3e-04 | Inf | 0.0341 | 2 | 2 | adenosylmethionine decarboxylase activity |
GO:0019810 | 3e-04 | Inf | 0.0341 | 2 | 2 | putrescine binding |
GO:0004857 | 0.0026 | 2.6017 | 5.2827 | 13 | 310 | enzyme inhibitor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004014 | 3e-04 | Inf | 0.0332 | 2 | 2 | adenosylmethionine decarboxylase activity |
GO:0019810 | 3e-04 | Inf | 0.0332 | 2 | 2 | putrescine binding |
GO:0102991 | 0.0039 | 29.8378 | 0.0996 | 2 | 6 | myristoyl-CoA hydrolase activity |
GO:0098772 | 0.004 | 1.6904 | 22.7761 | 36 | 1372 | molecular function regulator |
GO:0019955 | 0.0041 | 4.2555 | 1.5107 | 6 | 91 | cytokine binding |
GO:0001653 | 0.0061 | 3.8875 | 1.6435 | 6 | 99 | peptide receptor activity |
GO:0061135 | 0.0065 | 3.3805 | 2.1913 | 7 | 132 | endopeptidase regulator activity |
GO:0030414 | 0.0068 | 3.3534 | 2.2079 | 7 | 133 | peptidase inhibitor activity |
GO:0016176 | 0.0072 | 19.8893 | 0.1328 | 2 | 8 | superoxide-generating NADPH oxidase activator activity |
GO:0004867 | 0.0077 | 4.3562 | 1.2284 | 5 | 74 | serine-type endopeptidase inhibitor activity |
GO:0005179 | 0.0096 | 4.1165 | 1.2949 | 5 | 78 | hormone activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0001972 | 1e-04 | 26.3064 | 0.2191 | 4 | 13 | retinoic acid binding |
GO:0019840 | 2e-04 | 10.99 | 0.5393 | 5 | 32 | isoprenoid binding |
GO:0004871 | 7e-04 | 1.9655 | 17.5431 | 32 | 1041 | signal transducer activity |
GO:0004872 | 0.001 | 1.9595 | 16.4309 | 30 | 975 | receptor activity |
GO:0004745 | 0.0027 | 12.6315 | 0.2865 | 3 | 17 | retinol dehydrogenase activity |
GO:0004888 | 0.0037 | 1.9792 | 11.7638 | 22 | 703 | transmembrane signaling receptor activity |
GO:0005166 | 0.0041 | 29.3816 | 0.1011 | 2 | 6 | neurotrophin p75 receptor binding |
GO:0016861 | 0.0056 | 23.5038 | 0.118 | 2 | 7 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses |
GO:0019763 | 0.0056 | 23.5038 | 0.118 | 2 | 7 | immunoglobulin receptor activity |
GO:0019864 | 0.0056 | 23.5038 | 0.118 | 2 | 7 | IgG binding |
GO:0101020 | 0.0074 | 19.5852 | 0.1348 | 2 | 8 | estrogen 16-alpha-hydroxylase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0022850 | 7e-04 | 132.7458 | 0.0449 | 2 | 3 | serotonin-gated cation-selective channel activity |
GO:0043015 | 0.0067 | 8.682 | 0.3891 | 3 | 26 | gamma-tubulin binding |
GO:0016814 | 0.0082 | 7.9864 | 0.419 | 3 | 28 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines |
GO:0033293 | 0.0098 | 5.1325 | 0.8381 | 4 | 56 | monocarboxylic acid binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0022850 | 8e-04 | 119.374 | 0.0498 | 2 | 3 | serotonin-gated cation-selective channel activity |
GO:0008324 | 0.0014 | 2.2403 | 9.4956 | 20 | 572 | cation transmembrane transporter activity |
GO:1901677 | 0.0018 | 14.9684 | 0.249 | 3 | 15 | phosphate transmembrane transporter activity |
GO:0022891 | 0.0024 | 1.9609 | 13.5627 | 25 | 817 | substrate-specific transmembrane transporter activity |
GO:0015077 | 0.0025 | 2.6126 | 5.2624 | 13 | 317 | monovalent inorganic cation transmembrane transporter activity |
GO:0008020 | 0.0039 | 29.8378 | 0.0996 | 2 | 6 | G-protein coupled photoreceptor activity |
GO:0017171 | 0.0071 | 3.0232 | 2.7889 | 8 | 168 | serine hydrolase activity |
GO:0042056 | 0.0071 | 8.5484 | 0.3984 | 3 | 24 | chemoattractant activity |
GO:0005436 | 0.0072 | 19.8893 | 0.1328 | 2 | 8 | sodium:phosphate symporter activity |
GO:0046873 | 0.0079 | 2.1839 | 6.7233 | 14 | 405 | metal ion transmembrane transporter activity |
GO:0004252 | 0.0079 | 3.2494 | 2.2743 | 7 | 137 | serine-type endopeptidase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004872 | 0 | 2.212 | 19.3124 | 39 | 975 | receptor activity |
GO:0004888 | 1e-04 | 2.2588 | 13.8424 | 29 | 703 | transmembrane signaling receptor activity |
GO:0004871 | 8e-04 | 1.8723 | 20.6197 | 36 | 1041 | signal transducer activity |
GO:0030545 | 0.0016 | 2.459 | 6.893 | 16 | 348 | receptor regulator activity |
GO:0005125 | 0.0023 | 3.3667 | 2.8523 | 9 | 144 | cytokine activity |
GO:0030414 | 0.005 | 3.2236 | 2.6344 | 8 | 133 | peptidase inhibitor activity |
GO:0034711 | 0.0056 | 24.8946 | 0.1188 | 2 | 6 | inhibin binding |
GO:0005031 | 0.0068 | 8.8071 | 0.3962 | 3 | 20 | tumor necrosis factor-activated receptor activity |
GO:0019763 | 0.0077 | 19.9144 | 0.1387 | 2 | 7 | immunoglobulin receptor activity |
GO:0043548 | 0.0079 | 5.5563 | 0.7923 | 4 | 40 | phosphatidylinositol 3-kinase binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004872 | 1e-04 | 2.0912 | 19.7416 | 38 | 975 | receptor activity |
GO:0003700 | 3e-04 | 1.9577 | 20.3692 | 37 | 1006 | DNA binding transcription factor activity |
GO:0005031 | 6e-04 | 12.2366 | 0.405 | 4 | 20 | tumor necrosis factor-activated receptor activity |
GO:0005125 | 7e-04 | 3.6947 | 2.9157 | 10 | 144 | cytokine activity |
GO:0030545 | 0.002 | 2.4016 | 7.0462 | 16 | 348 | receptor regulator activity |
GO:0004715 | 0.0025 | 5.8356 | 0.9516 | 5 | 47 | non-membrane spanning protein tyrosine kinase activity |
GO:0004888 | 0.0027 | 1.913 | 14.3759 | 26 | 710 | transmembrane signaling receptor activity |
GO:0005126 | 0.004 | 2.7064 | 4.2925 | 11 | 212 | cytokine receptor binding |
GO:0042975 | 0.0054 | 9.7592 | 0.3645 | 3 | 18 | peroxisome proliferator activated receptor binding |
GO:0051575 | 0.0058 | 24.3391 | 0.1215 | 2 | 6 | 5'-deoxyribose-5-phosphate lyase activity |
GO:0042609 | 0.008 | 19.47 | 0.1417 | 2 | 7 | CD4 receptor binding |
GO:0046965 | 0.0095 | 7.7027 | 0.4455 | 3 | 22 | retinoid X receptor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0015485 | 5e-04 | 8.9224 | 0.6659 | 5 | 30 | cholesterol binding |
GO:0015433 | 5e-04 | Inf | 0.0444 | 2 | 2 | peptide antigen-transporting ATPase activity |
GO:0046980 | 5e-04 | Inf | 0.0444 | 2 | 2 | tapasin binding |
GO:0023029 | 0.0015 | 88.5983 | 0.0666 | 2 | 3 | MHC class Ib protein binding |
GO:0046978 | 0.0015 | 88.5983 | 0.0666 | 2 | 3 | TAP1 binding |
GO:0046979 | 0.0015 | 88.5983 | 0.0666 | 2 | 3 | TAP2 binding |
GO:0016796 | 0.0018 | 6.369 | 0.8879 | 5 | 40 | exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters |
GO:0004529 | 0.0049 | 10.2442 | 0.3552 | 3 | 16 | exodeoxyribonuclease activity |
GO:0043531 | 0.0059 | 6.1342 | 0.7325 | 4 | 33 | ADP binding |
GO:0003950 | 0.0069 | 8.8771 | 0.3995 | 3 | 18 | NAD+ ADP-ribosyltransferase activity |
GO:0030620 | 0.0069 | 22.1453 | 0.1332 | 2 | 6 | U2 snRNA binding |
GO:0034511 | 0.0069 | 22.1453 | 0.1332 | 2 | 6 | U3 snoRNA binding |
GO:0004540 | 0.0092 | 3.5677 | 1.798 | 6 | 81 | ribonuclease activity |
GO:0140097 | 0.0095 | 2.6681 | 3.5515 | 9 | 160 | catalytic activity, acting on DNA |
GO:0008297 | 0.0096 | 17.7151 | 0.1554 | 2 | 7 | single-stranded DNA exodeoxyribonuclease activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 6.0138 | 3.4376 | 18 | 173 | histone binding |
GO:0016493 | 0 | 39.9538 | 0.1788 | 4 | 9 | C-C chemokine receptor activity |
GO:0004896 | 1e-04 | 6.504 | 1.3909 | 8 | 70 | cytokine receptor activity |
GO:0019957 | 1e-04 | 49.7891 | 0.1192 | 3 | 6 | C-C chemokine binding |
GO:0001637 | 2e-04 | 18.1538 | 0.2981 | 4 | 15 | G-protein coupled chemoattractant receptor activity |
GO:0005031 | 6e-04 | 12.4768 | 0.3974 | 4 | 20 | tumor necrosis factor-activated receptor activity |
GO:0015440 | 0.0012 | 99.2739 | 0.0596 | 2 | 3 | peptide-transporting ATPase activity |
GO:0019904 | 0.0014 | 1.9869 | 14.4458 | 27 | 727 | protein domain specific binding |
GO:0003823 | 0.0017 | 6.4094 | 0.8743 | 5 | 44 | antigen binding |
GO:0019955 | 0.0022 | 4.181 | 1.8082 | 7 | 91 | cytokine binding |
GO:0015272 | 0.0023 | 49.6338 | 0.0795 | 2 | 4 | ATP-activated inward rectifier potassium channel activity |
GO:0004872 | 0.0037 | 1.7498 | 19.3737 | 32 | 975 | receptor activity |
GO:0005044 | 0.0087 | 5.3881 | 0.8147 | 4 | 41 | scavenger receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004014 | 3e-04 | Inf | 0.0323 | 2 | 2 | adenosylmethionine decarboxylase activity |
GO:0019810 | 3e-04 | Inf | 0.0323 | 2 | 2 | putrescine binding |
GO:0005501 | 0.0012 | 9.8789 | 0.4687 | 4 | 29 | retinoid binding |
GO:0061575 | 0.0025 | 40.8967 | 0.0808 | 2 | 5 | cyclin-dependent protein serine/threonine kinase activator activity |
GO:0005166 | 0.0037 | 30.6706 | 0.097 | 2 | 6 | neurotrophin p75 receptor binding |
GO:0048019 | 0.0068 | 20.4444 | 0.1293 | 2 | 8 | receptor antagonist activity |
GO:0003735 | 0.0077 | 3.2659 | 2.2625 | 7 | 140 | structural constituent of ribosome |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0003823 | 0 | 9.7788 | 0.8522 | 7 | 44 | antigen binding |
GO:0015433 | 4e-04 | Inf | 0.0387 | 2 | 2 | peptide antigen-transporting ATPase activity |
GO:0030369 | 4e-04 | Inf | 0.0387 | 2 | 2 | ICAM-3 receptor activity |
GO:0046980 | 4e-04 | Inf | 0.0387 | 2 | 2 | tapasin binding |
GO:0019955 | 4e-04 | 4.9838 | 1.7624 | 8 | 91 | cytokine binding |
GO:0016801 | 6e-04 | 25.5557 | 0.1743 | 3 | 9 | hydrolase activity, acting on ether bonds |
GO:0023029 | 0.0011 | 101.9216 | 0.0581 | 2 | 3 | MHC class Ib protein binding |
GO:0046978 | 0.0011 | 101.9216 | 0.0581 | 2 | 3 | TAP1 binding |
GO:0046979 | 0.0011 | 101.9216 | 0.0581 | 2 | 3 | TAP2 binding |
GO:0004950 | 0.0028 | 12.773 | 0.2905 | 3 | 15 | chemokine receptor activity |
GO:0099600 | 0.0029 | 1.8993 | 14.4868 | 26 | 748 | transmembrane receptor activity |
GO:0038023 | 0.0036 | 1.8449 | 15.4746 | 27 | 799 | signaling receptor activity |
GO:0004301 | 0.0036 | 33.9695 | 0.0968 | 2 | 5 | epoxide hydrolase activity |
GO:0004896 | 0.004 | 5.1777 | 1.0558 | 5 | 55 | cytokine receptor activity |
GO:0004872 | 0.0044 | 3.3029 | 2.5739 | 8 | 139 | receptor activity |
GO:0019957 | 0.0053 | 25.4755 | 0.1162 | 2 | 6 | C-C chemokine binding |
GO:0097677 | 0.0097 | 16.9815 | 0.1549 | 2 | 8 | STAT family protein binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 4.6286 | 4.384 | 18 | 173 | histone binding |
GO:0003723 | 1e-04 | 1.802 | 36.922 | 61 | 1457 | RNA binding |
GO:0019904 | 2e-04 | 2.0352 | 18.423 | 35 | 727 | protein domain specific binding |
GO:1990381 | 4e-04 | 14.1162 | 0.3801 | 4 | 15 | ubiquitin-specific protease binding |
GO:0015433 | 6e-04 | Inf | 0.0507 | 2 | 2 | peptide antigen-transporting ATPase activity |
GO:0046980 | 6e-04 | Inf | 0.0507 | 2 | 2 | tapasin binding |
GO:1904680 | 0.0012 | 10.3492 | 0.4815 | 4 | 19 | peptide transmembrane transporter activity |
GO:0023029 | 0.0019 | 77.3017 | 0.076 | 2 | 3 | MHC class Ib protein binding |
GO:0046978 | 0.0019 | 77.3017 | 0.076 | 2 | 3 | TAP1 binding |
GO:0046979 | 0.0019 | 77.3017 | 0.076 | 2 | 3 | TAP2 binding |
GO:0050750 | 0.0025 | 8.1683 | 0.5828 | 4 | 23 | low-density lipoprotein particle receptor binding |
GO:0043130 | 0.0047 | 4.168 | 1.5712 | 6 | 62 | ubiquitin binding |
GO:0004950 | 0.0059 | 9.68 | 0.3801 | 3 | 15 | chemokine receptor activity |
GO:0015485 | 0.0066 | 5.9665 | 0.7602 | 4 | 30 | cholesterol binding |
GO:0016894 | 0.0071 | 8.9348 | 0.4055 | 3 | 16 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters |
GO:0016787 | 0.0075 | 1.4023 | 55.3704 | 73 | 2185 | hydrolase activity |
GO:0140097 | 0.0077 | 2.6039 | 4.0546 | 10 | 160 | catalytic activity, acting on DNA |
GO:0140098 | 0.0082 | 2.0529 | 8.1598 | 16 | 322 | catalytic activity, acting on RNA |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 6.1606 | 4.4058 | 23 | 173 | histone binding |
GO:0005132 | 0 | 38.8271 | 0.3056 | 6 | 12 | type I interferon receptor binding |
GO:0003723 | 0 | 1.8274 | 37.1053 | 62 | 1457 | RNA binding |
GO:0003677 | 6e-04 | 1.5978 | 46.7063 | 69 | 1834 | DNA binding |
GO:0004722 | 6e-04 | 5.434 | 1.4516 | 7 | 57 | protein serine/threonine phosphatase activity |
GO:0046964 | 6e-04 | Inf | 0.0509 | 2 | 2 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity |
GO:0005125 | 0.0012 | 3.2254 | 3.6672 | 11 | 144 | cytokine activity |
GO:0030545 | 0.0016 | 2.2695 | 8.8625 | 19 | 348 | receptor regulator activity |
GO:0003896 | 0.0019 | 76.9082 | 0.0764 | 2 | 3 | DNA primase activity |
GO:0043022 | 0.0027 | 4.7411 | 1.4007 | 6 | 55 | ribosome binding |
GO:0003743 | 0.0055 | 4.8306 | 1.146 | 5 | 45 | translation initiation factor activity |
GO:1990381 | 0.0059 | 9.6306 | 0.382 | 3 | 15 | ubiquitin-specific protease binding |
GO:0030292 | 0.0061 | 25.6328 | 0.1273 | 2 | 5 | protein tyrosine kinase inhibitor activity |
GO:0035473 | 0.0061 | 25.6328 | 0.1273 | 2 | 5 | lipase binding |
GO:0032550 | 0.0066 | 2.1052 | 7.9711 | 16 | 313 | purine ribonucleoside binding |
GO:0015035 | 0.0072 | 8.8892 | 0.4075 | 3 | 16 | protein disulfide oxidoreductase activity |
GO:0097159 | 0.0087 | 1.3043 | 113.1836 | 135 | 4532 | organic cyclic compound binding |
GO:0034511 | 0.0091 | 19.2233 | 0.1528 | 2 | 6 | U3 snoRNA binding |
GO:1901363 | 0.0095 | 1.301 | 111.5603 | 133 | 4467 | heterocyclic compound binding |
GO:0001882 | 0.0099 | 2.0085 | 8.3277 | 16 | 327 | nucleoside binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004872 | 1e-04 | 2.1388 | 17.2892 | 34 | 975 | receptor activity |
GO:0004888 | 0.0012 | 2.1078 | 12.1373 | 24 | 691 | transmembrane signaling receptor activity |
GO:0016502 | 0.0017 | 15.259 | 0.2483 | 3 | 14 | nucleotide receptor activity |
GO:0042134 | 0.003 | 37.1857 | 0.0887 | 2 | 5 | rRNA primary transcript binding |
GO:0004871 | 0.0032 | 1.7867 | 18.4595 | 31 | 1041 | signal transducer activity |
GO:0005242 | 0.0043 | 10.4872 | 0.3369 | 3 | 19 | inward rectifier potassium channel activity |
GO:0035586 | 0.0043 | 10.4872 | 0.3369 | 3 | 19 | purinergic receptor activity |
GO:0045028 | 0.0045 | 27.8875 | 0.1064 | 2 | 6 | G-protein coupled purinergic nucleotide receptor activity |
GO:0051575 | 0.0045 | 27.8875 | 0.1064 | 2 | 6 | 5'-deoxyribose-5-phosphate lyase activity |
GO:0102991 | 0.0045 | 27.8875 | 0.1064 | 2 | 6 | myristoyl-CoA hydrolase activity |
GO:0005267 | 0.0058 | 3.4625 | 2.1456 | 7 | 121 | potassium channel activity |
GO:0052689 | 0.0058 | 3.4625 | 2.1456 | 7 | 121 | carboxylic ester hydrolase activity |
GO:0071837 | 0.0075 | 8.3876 | 0.4078 | 3 | 23 | HMG box domain binding |
GO:0003680 | 0.0082 | 18.5893 | 0.1419 | 2 | 8 | AT DNA binding |
GO:0030545 | 0.0094 | 2.2052 | 6.1709 | 13 | 348 | receptor regulator activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 5.0018 | 3.3506 | 15 | 173 | histone binding |
GO:0005484 | 6e-04 | 8.2849 | 0.6972 | 5 | 36 | SNAP receptor activity |
GO:0030280 | 0.0022 | 50.9575 | 0.0775 | 2 | 4 | structural constituent of epidermis |
GO:0033130 | 0.0022 | 13.935 | 0.2711 | 3 | 14 | acetylcholine receptor binding |
GO:0070011 | 0.0042 | 2.0614 | 9.7031 | 19 | 501 | peptidase activity, acting on L-amino acid peptides |
GO:0016247 | 0.0064 | 3.3982 | 2.1885 | 7 | 113 | channel regulator activity |
GO:0004190 | 0.0084 | 8.0635 | 0.4261 | 3 | 22 | aspartic-type endopeptidase activity |
GO:0008242 | 0.0097 | 16.9815 | 0.1549 | 2 | 8 | omega peptidase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004602 | 0.0015 | 16.1948 | 0.2387 | 3 | 13 | glutathione peroxidase activity |
GO:0005178 | 0.0027 | 4.0115 | 1.8729 | 7 | 102 | integrin binding |
GO:0016765 | 0.0028 | 5.6486 | 0.9731 | 5 | 53 | transferase activity, transferring alkyl or aryl (other than methyl) groups |
GO:0016936 | 0.0032 | 35.8805 | 0.0918 | 2 | 5 | galactoside binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031014 | 0.0021 | 52.3523 | 0.0755 | 2 | 4 | troponin T binding |
GO:0004888 | 0.0043 | 1.8909 | 13.3937 | 24 | 710 | transmembrane signaling receptor activity |
GO:0016247 | 0.0056 | 3.4928 | 2.1317 | 7 | 113 | channel regulator activity |
GO:0016597 | 0.0062 | 4.6227 | 1.1696 | 5 | 62 | amino acid binding |
GO:0016714 | 0.007 | 20.9369 | 0.1321 | 2 | 7 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen |
GO:0005184 | 0.0078 | 8.285 | 0.415 | 3 | 22 | neuropeptide hormone activity |
GO:0071813 | 0.0078 | 8.285 | 0.415 | 3 | 22 | lipoprotein particle binding |
GO:0008528 | 0.0092 | 3.5574 | 1.7921 | 6 | 95 | G-protein coupled peptide receptor activity |
GO:0097677 | 0.0092 | 17.4463 | 0.1509 | 2 | 8 | STAT family protein binding |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0070165 | 5e-04 | Inf | 0.0426 | 2 | 2 | positive regulation of adiponectin secretion |
GO:1902340 | 5e-04 | Inf | 0.0426 | 2 | 2 | negative regulation of chromosome condensation |
GO:0010466 | 8e-04 | 3.9572 | 2.4714 | 9 | 116 | negative regulation of peptidase activity |
GO:0010634 | 9e-04 | 4.3172 | 2.024 | 8 | 95 | positive regulation of epithelial cell migration |
GO:0001523 | 0.0011 | 10.3393 | 0.4687 | 4 | 22 | retinoid metabolic process |
GO:0031509 | 0.0013 | 92.5159 | 0.0639 | 2 | 3 | telomeric heterochromatin assembly |
GO:0006721 | 0.0024 | 8.0885 | 0.5752 | 4 | 27 | terpenoid metabolic process |
GO:0031508 | 0.0026 | 46.2544 | 0.0852 | 2 | 4 | pericentric heterochromatin assembly |
GO:0043415 | 0.0026 | 46.2544 | 0.0852 | 2 | 4 | positive regulation of skeletal muscle tissue regeneration |
GO:1902952 | 0.0026 | 46.2544 | 0.0852 | 2 | 4 | positive regulation of dendritic spine maintenance |
GO:0042104 | 0.0029 | 12.6509 | 0.2983 | 3 | 14 | positive regulation of activated T cell proliferation |
GO:0019433 | 0.0036 | 11.5957 | 0.3196 | 3 | 15 | triglyceride catabolic process |
GO:0045916 | 0.0043 | 30.8339 | 0.1065 | 2 | 5 | negative regulation of complement activation |
GO:2001286 | 0.0043 | 30.8339 | 0.1065 | 2 | 5 | regulation of caveolin-mediated endocytosis |
GO:0009888 | 0.0055 | 1.5788 | 29.8486 | 44 | 1401 | tissue development |
GO:0046503 | 0.0057 | 6.1979 | 0.7244 | 4 | 34 | glycerolipid catabolic process |
GO:0003015 | 0.0057 | 2.9116 | 3.281 | 9 | 154 | heart process |
GO:0071467 | 0.0062 | 9.2745 | 0.3835 | 3 | 18 | cellular response to pH |
GO:0071804 | 0.0064 | 3.096 | 2.7484 | 8 | 129 | cellular potassium ion transport |
GO:0021578 | 0.0064 | 23.1237 | 0.1278 | 2 | 6 | hindbrain maturation |
GO:0006952 | 0.0069 | 1.7518 | 16.2985 | 27 | 765 | defense response |
GO:1901379 | 0.0072 | 4.478 | 1.2144 | 5 | 57 | regulation of potassium ion transmembrane transport |
GO:0033599 | 0.0072 | 8.6941 | 0.4048 | 3 | 19 | regulation of mammary gland epithelial cell proliferation |
GO:0090132 | 0.0079 | 2.5939 | 4.0693 | 10 | 191 | epithelium migration |
GO:0090208 | 0.0083 | 8.1821 | 0.4261 | 3 | 20 | positive regulation of triglyceride metabolic process |
GO:0010927 | 0.0085 | 3.635 | 1.7683 | 6 | 83 | cellular component assembly involved in morphogenesis |
GO:2000257 | 0.0089 | 18.4975 | 0.1491 | 2 | 7 | regulation of protein activation cascade |
GO:0046461 | 0.0096 | 7.727 | 0.4474 | 3 | 21 | neutral lipid catabolic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0008295 | 1e-04 | 73.906 | 0.1005 | 3 | 5 | spermidine biosynthetic process |
GO:0043950 | 3e-04 | 36.9474 | 0.1408 | 3 | 7 | positive regulation of cAMP-mediated signaling |
GO:0022603 | 3e-04 | 2.1192 | 15.3433 | 30 | 763 | regulation of anatomical structure morphogenesis |
GO:0006597 | 4e-04 | Inf | 0.0402 | 2 | 2 | spermine biosynthetic process |
GO:0010949 | 4e-04 | Inf | 0.0402 | 2 | 2 | negative regulation of intestinal phytosterol absorption |
GO:0042700 | 4e-04 | Inf | 0.0402 | 2 | 2 | luteinizing hormone signaling pathway |
GO:0045796 | 4e-04 | Inf | 0.0402 | 2 | 2 | negative regulation of intestinal cholesterol absorption |
GO:1904479 | 4e-04 | Inf | 0.0402 | 2 | 2 | negative regulation of intestinal absorption |
GO:0042401 | 9e-04 | 21.1079 | 0.2011 | 3 | 10 | cellular biogenic amine biosynthetic process |
GO:0045647 | 0.0012 | 18.468 | 0.2212 | 3 | 11 | negative regulation of erythrocyte differentiation |
GO:0046544 | 0.0012 | 98.1798 | 0.0603 | 2 | 3 | development of secondary male sexual characteristics |
GO:0016525 | 0.0013 | 5.515 | 1.2065 | 6 | 60 | negative regulation of angiogenesis |
GO:0060429 | 0.0021 | 1.8481 | 17.9776 | 31 | 894 | epithelium development |
GO:0044106 | 0.0022 | 6.0361 | 0.925 | 5 | 46 | cellular amine metabolic process |
GO:0002636 | 0.0024 | 49.0861 | 0.0804 | 2 | 4 | positive regulation of germinal center formation |
GO:1901343 | 0.0024 | 4.8004 | 1.3674 | 6 | 68 | negative regulation of vasculature development |
GO:2000026 | 0.0035 | 1.6189 | 30.0028 | 45 | 1492 | regulation of multicellular organismal development |
GO:1904729 | 0.0039 | 32.7216 | 0.1005 | 2 | 5 | regulation of intestinal lipid absorption |
GO:0003341 | 0.0045 | 5.0475 | 1.0859 | 5 | 54 | cilium movement |
GO:0048856 | 0.0048 | 1.4063 | 82.7692 | 103 | 4116 | anatomical structure development |
GO:0006956 | 0.0052 | 9.8444 | 0.362 | 3 | 18 | complement activation |
GO:0007188 | 0.0055 | 3.5108 | 2.1316 | 7 | 106 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
GO:0006595 | 0.0057 | 24.717 | 0.1198 | 2 | 6 | polyamine metabolic process |
GO:0009445 | 0.0057 | 24.5393 | 0.1207 | 2 | 6 | putrescine metabolic process |
GO:0007588 | 0.0063 | 5.9806 | 0.744 | 4 | 37 | excretion |
GO:0051093 | 0.0076 | 1.8247 | 13.319 | 23 | 674 | negative regulation of developmental process |
GO:0048646 | 0.0079 | 1.7165 | 17.2738 | 28 | 859 | anatomical structure formation involved in morphogenesis |
GO:0044241 | 0.0079 | 19.63 | 0.1408 | 2 | 7 | lipid digestion |
GO:0032501 | 0.0079 | 1.3629 | 97.4891 | 117 | 4848 | multicellular organismal process |
GO:0030879 | 0.0082 | 3.2463 | 2.2924 | 7 | 114 | mammary gland development |
GO:0070286 | 0.0082 | 8.2018 | 0.4223 | 3 | 21 | axonemal dynein complex assembly |
GO:0042551 | 0.0083 | 5.4809 | 0.8044 | 4 | 40 | neuron maturation |
GO:0002684 | 0.0083 | 1.9284 | 10.3763 | 19 | 516 | positive regulation of immune system process |
GO:0030947 | 0.0093 | 7.7695 | 0.4424 | 3 | 22 | regulation of vascular endothelial growth factor receptor signaling pathway |
GO:0060285 | 0.0093 | 7.7695 | 0.4424 | 3 | 22 | cilium-dependent cell motility |
GO:0090189 | 0.0093 | 7.7695 | 0.4424 | 3 | 22 | regulation of branching involved in ureteric bud morphogenesis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0022603 | 1e-04 | 2.1655 | 18.1381 | 36 | 763 | regulation of anatomical structure morphogenesis |
GO:2000026 | 1e-04 | 1.8084 | 35.468 | 58 | 1492 | regulation of multicellular organismal development |
GO:0042127 | 6e-04 | 1.7473 | 29.8103 | 48 | 1254 | regulation of cell proliferation |
GO:0001775 | 7e-04 | 2.0736 | 14.4772 | 28 | 609 | cell activation |
GO:0035082 | 7e-04 | 6.2591 | 1.0935 | 6 | 46 | axoneme assembly |
GO:0019221 | 8e-04 | 2.8876 | 5.2061 | 14 | 219 | cytokine-mediated signaling pathway |
GO:0120031 | 0.0011 | 2.2953 | 9.2949 | 20 | 391 | plasma membrane bounded cell projection assembly |
GO:0007186 | 0.0012 | 2.1119 | 12.1238 | 24 | 510 | G-protein coupled receptor signaling pathway |
GO:0003229 | 0.0013 | 5.5615 | 1.2124 | 6 | 51 | ventricular cardiac muscle tissue development |
GO:0046544 | 0.0017 | 82.6456 | 0.0713 | 2 | 3 | development of secondary male sexual characteristics |
GO:0055017 | 0.0017 | 4.431 | 1.7354 | 7 | 73 | cardiac muscle tissue growth |
GO:0030502 | 0.0019 | 15.5369 | 0.2615 | 3 | 11 | negative regulation of bone mineralization |
GO:0035023 | 0.002 | 3.8038 | 2.2821 | 8 | 96 | regulation of Rho protein signal transduction |
GO:0009888 | 0.0022 | 1.6168 | 33.3048 | 50 | 1401 | tissue development |
GO:0048646 | 0.0024 | 1.7753 | 20.4203 | 34 | 859 | anatomical structure formation involved in morphogenesis |
GO:0072359 | 0.0024 | 1.7886 | 19.6596 | 33 | 827 | circulatory system development |
GO:0006954 | 0.0025 | 2.2311 | 8.558 | 18 | 360 | inflammatory response |
GO:0031532 | 0.0027 | 4.0599 | 1.878 | 7 | 79 | actin cytoskeleton reorganization |
GO:0030336 | 0.0027 | 2.8705 | 4.0888 | 11 | 172 | negative regulation of cell migration |
GO:2000145 | 0.0029 | 1.9054 | 14.4772 | 26 | 609 | regulation of cell motility |
GO:0050896 | 0.0029 | 1.3791 | 125.5645 | 150 | 5282 | response to stimulus |
GO:0016525 | 0.0029 | 4.6314 | 1.4263 | 6 | 60 | negative regulation of angiogenesis |
GO:0051674 | 0.0031 | 1.6681 | 25.6026 | 40 | 1077 | localization of cell |
GO:0000255 | 0.0033 | 41.3196 | 0.0951 | 2 | 4 | allantoin metabolic process |
GO:0002679 | 0.0033 | 41.3196 | 0.0951 | 2 | 4 | respiratory burst involved in defense response |
GO:0034374 | 0.0033 | 41.3196 | 0.0951 | 2 | 4 | low-density lipoprotein particle remodeling |
GO:0040011 | 0.0033 | 1.6171 | 29.7865 | 45 | 1253 | locomotion |
GO:0023052 | 0.0037 | 1.3901 | 90.8334 | 113 | 3821 | signaling |
GO:0050673 | 0.0042 | 2.2229 | 7.6071 | 16 | 320 | epithelial cell proliferation |
GO:0051093 | 0.0047 | 1.8083 | 15.8004 | 27 | 674 | negative regulation of developmental process |
GO:0002274 | 0.0047 | 3.2782 | 2.6149 | 8 | 110 | myeloid leukocyte activation |
GO:0006600 | 0.0054 | 27.5443 | 0.1189 | 2 | 5 | creatine metabolic process |
GO:0019530 | 0.0054 | 27.5443 | 0.1189 | 2 | 5 | taurine metabolic process |
GO:0034384 | 0.0054 | 27.5443 | 0.1189 | 2 | 5 | high-density lipoprotein particle clearance |
GO:1901343 | 0.0055 | 4.0313 | 1.6165 | 6 | 68 | negative regulation of vasculature development |
GO:0007154 | 0.0055 | 1.3678 | 91.8556 | 113 | 3864 | cell communication |
GO:0097435 | 0.0055 | 1.9366 | 11.4344 | 21 | 481 | supramolecular fiber organization |
GO:0002685 | 0.0058 | 3.1535 | 2.71 | 8 | 114 | regulation of leukocyte migration |
GO:0002684 | 0.006 | 1.8905 | 12.2664 | 22 | 516 | positive regulation of immune system process |
GO:0003008 | 0.0063 | 1.584 | 27.5044 | 41 | 1157 | system process |
GO:0010033 | 0.0064 | 1.4667 | 44.6916 | 61 | 1880 | response to organic substance |
GO:0002886 | 0.0067 | 5.9286 | 0.7607 | 4 | 32 | regulation of myeloid leukocyte mediated immunity |
GO:0007010 | 0.007 | 1.6299 | 22.7262 | 35 | 956 | cytoskeleton organization |
GO:0051271 | 0.0075 | 2.4798 | 4.6831 | 11 | 197 | negative regulation of cellular component movement |
GO:0048514 | 0.0079 | 1.9361 | 10.3171 | 19 | 434 | blood vessel morphogenesis |
GO:0002576 | 0.0079 | 20.6566 | 0.1426 | 2 | 6 | platelet degranulation |
GO:0033860 | 0.0079 | 20.6566 | 0.1426 | 2 | 6 | regulation of NAD(P)H oxidase activity |
GO:1904491 | 0.0079 | 20.6566 | 0.1426 | 2 | 6 | protein localization to ciliary transition zone |
GO:1900544 | 0.0083 | 3.2434 | 2.3059 | 7 | 97 | positive regulation of purine nucleotide metabolic process |
GO:0071467 | 0.0083 | 8.2819 | 0.4279 | 3 | 18 | cellular response to pH |
GO:0003341 | 0.009 | 4.2414 | 1.2837 | 5 | 54 | cilium movement |
GO:2000351 | 0.0092 | 5.3536 | 0.832 | 4 | 35 | regulation of endothelial cell apoptotic process |
GO:0050776 | 0.0093 | 1.981 | 9.0096 | 17 | 379 | regulation of immune response |
GO:0030154 | 0.0095 | 1.3628 | 71.8632 | 90 | 3023 | cell differentiation |
GO:0001516 | 0.0097 | 7.7637 | 0.4517 | 3 | 19 | prostaglandin biosynthetic process |
GO:0051043 | 0.0097 | 7.7637 | 0.4517 | 3 | 19 | regulation of membrane protein ectodomain proteolysis |
GO:2000738 | 0.0097 | 7.7637 | 0.4517 | 3 | 19 | positive regulation of stem cell differentiation |
GO:0007166 | 0.0099 | 1.4909 | 34.2861 | 48 | 1484 | cell surface receptor signaling pathway |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0002366 | 0 | 5.1596 | 4.7484 | 21 | 160 | leukocyte activation involved in immune response |
GO:0046649 | 0 | 2.7015 | 13.0582 | 32 | 440 | lymphocyte activation |
GO:0033141 | 0 | 18.0921 | 0.5045 | 6 | 17 | positive regulation of peptidyl-serine phosphorylation of STAT protein |
GO:0002252 | 0 | 2.8171 | 10.5287 | 27 | 359 | immune effector process |
GO:0002323 | 0 | 16.5831 | 0.5342 | 6 | 18 | natural killer cell activation involved in immune response |
GO:0032943 | 0 | 3.6439 | 5.4904 | 18 | 185 | mononuclear cell proliferation |
GO:0002286 | 0 | 6.5842 | 1.8016 | 10 | 61 | T cell activation involved in immune response |
GO:0042100 | 0 | 5.8584 | 1.9884 | 10 | 67 | B cell proliferation |
GO:0002682 | 1e-04 | 2.3064 | 14.0913 | 30 | 486 | regulation of immune system process |
GO:0032418 | 1e-04 | 6.3352 | 1.4839 | 8 | 50 | lysosome localization |
GO:0046425 | 1e-04 | 4.0554 | 3.2942 | 12 | 111 | regulation of JAK-STAT cascade |
GO:0043330 | 1e-04 | 7.2625 | 1.1574 | 7 | 39 | response to exogenous dsRNA |
GO:0097696 | 2e-04 | 3.7149 | 3.5613 | 12 | 120 | STAT cascade |
GO:0002279 | 3e-04 | 7.6455 | 0.9497 | 6 | 32 | mast cell activation involved in immune response |
GO:0002448 | 3e-04 | 7.6455 | 0.9497 | 6 | 32 | mast cell mediated immunity |
GO:0043304 | 5e-04 | 9.1851 | 0.6826 | 5 | 23 | regulation of mast cell degranulation |
GO:0030183 | 5e-04 | 3.8742 | 2.8491 | 10 | 96 | B cell differentiation |
GO:0002532 | 0.0011 | 5.8429 | 1.1871 | 6 | 40 | production of molecular mediator involved in inflammatory response |
GO:0001775 | 0.0012 | 2.4022 | 8.0053 | 18 | 277 | cell activation |
GO:0031349 | 0.0013 | 2.722 | 5.5201 | 14 | 186 | positive regulation of defense response |
GO:0051716 | 0.0014 | 1.3766 | 132.4224 | 161 | 4462 | cellular response to stimulus |
GO:0050670 | 0.0017 | 3.0799 | 3.8581 | 11 | 130 | regulation of lymphocyte proliferation |
GO:0050778 | 0.0017 | 2.2552 | 8.9627 | 19 | 302 | positive regulation of immune response |
GO:0033003 | 0.0017 | 6.6097 | 0.8903 | 5 | 30 | regulation of mast cell activation |
GO:0002224 | 0.0017 | 4.4623 | 1.751 | 7 | 59 | toll-like receptor signaling pathway |
GO:0006691 | 0.0019 | 16.4645 | 0.2671 | 3 | 9 | leukotriene metabolic process |
GO:0043299 | 0.002 | 5.0919 | 1.3355 | 6 | 45 | leukocyte degranulation |
GO:0006402 | 0.002 | 2.8381 | 4.5407 | 12 | 153 | mRNA catabolic process |
GO:0050865 | 0.0022 | 2.154 | 9.853 | 20 | 332 | regulation of cell activation |
GO:0002637 | 0.0023 | 4.9642 | 1.3652 | 6 | 46 | regulation of immunoglobulin production |
GO:0070663 | 0.0026 | 2.9072 | 4.0659 | 11 | 137 | regulation of leukocyte proliferation |
GO:0000965 | 0.0026 | 65.7165 | 0.089 | 2 | 3 | mitochondrial RNA 3'-end processing |
GO:0002291 | 0.0026 | 65.7165 | 0.089 | 2 | 3 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
GO:0034124 | 0.0026 | 65.7165 | 0.089 | 2 | 3 | regulation of MyD88-dependent toll-like receptor signaling pathway |
GO:0045658 | 0.0026 | 65.7165 | 0.089 | 2 | 3 | regulation of neutrophil differentiation |
GO:0002683 | 0.003 | 2.2414 | 8.0427 | 17 | 271 | negative regulation of immune system process |
GO:0042116 | 0.0031 | 5.6963 | 1.009 | 5 | 34 | macrophage activation |
GO:0006950 | 0.0033 | 1.417 | 68.7041 | 90 | 2315 | response to stress |
GO:0002757 | 0.0038 | 2.6131 | 4.8968 | 12 | 165 | immune response-activating signal transduction |
GO:0043487 | 0.0039 | 3.8013 | 2.0181 | 7 | 68 | regulation of RNA stability |
GO:0007166 | 0.0041 | 1.4607 | 50.5413 | 69 | 1703 | cell surface receptor signaling pathway |
GO:0007154 | 0.0042 | 1.3386 | 114.675 | 139 | 3864 | cell communication |
GO:0032846 | 0.0042 | 2.4629 | 5.6091 | 13 | 189 | positive regulation of homeostatic process |
GO:0002438 | 0.0047 | 10.9738 | 0.3561 | 3 | 12 | acute inflammatory response to antigenic stimulus |
GO:1900017 | 0.0047 | 10.9738 | 0.3561 | 3 | 12 | positive regulation of cytokine production involved in inflammatory response |
GO:0001561 | 0.0051 | 32.8557 | 0.1187 | 2 | 4 | fatty acid alpha-oxidation |
GO:0070375 | 0.0051 | 32.8557 | 0.1187 | 2 | 4 | ERK5 cascade |
GO:0071415 | 0.0051 | 32.8557 | 0.1187 | 2 | 4 | cellular response to purine-containing compound |
GO:0023052 | 0.0051 | 1.3296 | 113.3989 | 137 | 3821 | signaling |
GO:0002250 | 0.0052 | 2.3123 | 6.4104 | 14 | 216 | adaptive immune response |
GO:0009966 | 0.0054 | 1.4137 | 59.1182 | 78 | 1992 | regulation of signal transduction |
GO:0001816 | 0.0058 | 1.8666 | 12.9692 | 23 | 437 | cytokine production |
GO:0050871 | 0.0079 | 3.7428 | 1.751 | 6 | 59 | positive regulation of B cell activation |
GO:0002703 | 0.008 | 2.7646 | 3.4723 | 9 | 117 | regulation of leukocyte mediated immunity |
GO:0033135 | 0.008 | 2.7646 | 3.4723 | 9 | 117 | regulation of peptidyl-serine phosphorylation |
GO:0002696 | 0.0081 | 2.3487 | 5.4014 | 12 | 182 | positive regulation of leukocyte activation |
GO:0034655 | 0.0083 | 2.1113 | 7.4788 | 15 | 252 | nucleobase-containing compound catabolic process |
GO:0048522 | 0.0084 | 1.3049 | 113.9628 | 136 | 3840 | positive regulation of cellular process |
GO:0007204 | 0.0089 | 2.321 | 5.4607 | 12 | 184 | positive regulation of cytosolic calcium ion concentration |
GO:0044265 | 0.0097 | 1.5972 | 22.3474 | 34 | 753 | cellular macromolecule catabolic process |
GO:0002520 | 0.0097 | 1.621 | 20.7151 | 32 | 698 | immune system development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0097530 | 1e-04 | 5.8226 | 1.7591 | 9 | 74 | granulocyte migration |
GO:0007155 | 1e-04 | 2.0771 | 21.0621 | 40 | 886 | cell adhesion |
GO:0002685 | 4e-04 | 4.0444 | 2.71 | 10 | 114 | regulation of leukocyte migration |
GO:0051674 | 5e-04 | 1.8184 | 25.6026 | 43 | 1077 | localization of cell |
GO:0035082 | 7e-04 | 6.2591 | 1.0935 | 6 | 46 | axoneme assembly |
GO:0071622 | 8e-04 | 8.0075 | 0.7369 | 5 | 31 | regulation of granulocyte chemotaxis |
GO:0050482 | 9e-04 | 11.0777 | 0.4517 | 4 | 19 | arachidonic acid secretion |
GO:0007166 | 0.001 | 1.6159 | 40.484 | 60 | 1703 | cell surface receptor signaling pathway |
GO:0008360 | 0.0012 | 3.7745 | 2.5912 | 9 | 109 | regulation of cell shape |
GO:0016477 | 0.0012 | 1.7878 | 23.4393 | 39 | 986 | cell migration |
GO:0002442 | 0.0017 | 82.6456 | 0.0713 | 2 | 3 | serotonin secretion involved in inflammatory response |
GO:0006145 | 0.0017 | 82.6456 | 0.0713 | 2 | 3 | purine nucleobase catabolic process |
GO:0046544 | 0.0017 | 82.6456 | 0.0713 | 2 | 3 | development of secondary male sexual characteristics |
GO:1902566 | 0.0017 | 82.6456 | 0.0713 | 2 | 3 | regulation of eosinophil activation |
GO:0040011 | 0.0019 | 1.6606 | 29.7865 | 46 | 1253 | locomotion |
GO:0035023 | 0.002 | 3.8038 | 2.2821 | 8 | 96 | regulation of Rho protein signal transduction |
GO:0030595 | 0.0021 | 3.4287 | 2.8289 | 9 | 119 | leukocyte chemotaxis |
GO:0070098 | 0.0023 | 8.3051 | 0.5705 | 4 | 24 | chemokine-mediated signaling pathway |
GO:0046135 | 0.0033 | 41.3196 | 0.0951 | 2 | 4 | pyrimidine nucleoside catabolic process |
GO:0060287 | 0.0033 | 41.3196 | 0.0951 | 2 | 4 | epithelial cilium movement involved in determination of left/right asymmetry |
GO:0030593 | 0.005 | 4.9509 | 1.1173 | 5 | 47 | neutrophil chemotaxis |
GO:0046683 | 0.0051 | 4.0977 | 1.5927 | 6 | 67 | response to organophosphorus |
GO:0060485 | 0.0052 | 2.496 | 5.0872 | 12 | 214 | mesenchyme development |
GO:0007186 | 0.0052 | 1.9146 | 12.1238 | 22 | 510 | G-protein coupled receptor signaling pathway |
GO:0019530 | 0.0054 | 27.5443 | 0.1189 | 2 | 5 | taurine metabolic process |
GO:0018149 | 0.0059 | 9.5575 | 0.3804 | 3 | 16 | peptide cross-linking |
GO:0071715 | 0.0059 | 6.1486 | 0.7369 | 4 | 31 | icosanoid transport |
GO:0030168 | 0.0063 | 3.9047 | 1.6641 | 6 | 70 | platelet activation |
GO:0006140 | 0.0066 | 2.6681 | 3.9699 | 10 | 167 | regulation of nucleotide metabolic process |
GO:0050921 | 0.0066 | 3.3953 | 2.2108 | 7 | 93 | positive regulation of chemotaxis |
GO:0030801 | 0.0068 | 3.8444 | 1.6878 | 6 | 71 | positive regulation of cyclic nucleotide metabolic process |
GO:0007160 | 0.0068 | 2.8307 | 3.3756 | 9 | 142 | cell-matrix adhesion |
GO:0060393 | 0.0071 | 4.519 | 1.2124 | 5 | 51 | regulation of pathway-restricted SMAD protein phosphorylation |
GO:0006928 | 0.0079 | 1.5168 | 32.972 | 47 | 1387 | movement of cell or subcellular component |
GO:0002576 | 0.0079 | 20.6566 | 0.1426 | 2 | 6 | platelet degranulation |
GO:0035989 | 0.0079 | 20.6566 | 0.1426 | 2 | 6 | tendon development |
GO:1904491 | 0.0079 | 20.6566 | 0.1426 | 2 | 6 | protein localization to ciliary transition zone |
GO:0048869 | 0.0081 | 1.3672 | 75.1438 | 94 | 3161 | cellular developmental process |
GO:1900544 | 0.0083 | 3.2434 | 2.3059 | 7 | 97 | positive regulation of purine nucleotide metabolic process |
GO:0022603 | 0.0085 | 1.685 | 18.1381 | 29 | 763 | regulation of anatomical structure morphogenesis |
GO:0010717 | 0.0088 | 3.6204 | 1.7829 | 6 | 75 | regulation of epithelial to mesenchymal transition |
GO:0014074 | 0.0088 | 3.6204 | 1.7829 | 6 | 75 | response to purine-containing compound |
GO:0003341 | 0.009 | 4.2414 | 1.2837 | 5 | 54 | cilium movement |
GO:0002699 | 0.0091 | 2.9047 | 2.924 | 8 | 123 | positive regulation of immune effector process |
GO:0045596 | 0.0091 | 1.7902 | 13.5026 | 23 | 568 | negative regulation of cell differentiation |
GO:0051384 | 0.0097 | 4.1562 | 1.3075 | 5 | 55 | response to glucocorticoid |
GO:0001516 | 0.0097 | 7.7637 | 0.4517 | 3 | 19 | prostaglandin biosynthetic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0008295 | 0 | 86.4737 | 0.0863 | 3 | 5 | spermidine biosynthetic process |
GO:0009886 | 1e-04 | 25.721 | 0.2245 | 4 | 13 | post-embryonic animal morphogenesis |
GO:0007276 | 2e-04 | 2.6928 | 8.0644 | 20 | 467 | gamete generation |
GO:0006597 | 3e-04 | Inf | 0.0345 | 2 | 2 | spermine biosynthetic process |
GO:0042700 | 3e-04 | Inf | 0.0345 | 2 | 2 | luteinizing hormone signaling pathway |
GO:0060435 | 3e-04 | Inf | 0.0345 | 2 | 2 | bronchiole development |
GO:1904970 | 3e-04 | Inf | 0.0345 | 2 | 2 | brush border assembly |
GO:0001539 | 5e-04 | 12.8517 | 0.3799 | 4 | 22 | cilium or flagellum-dependent cell motility |
GO:0042401 | 6e-04 | 24.6974 | 0.1727 | 3 | 10 | cellular biogenic amine biosynthetic process |
GO:0000003 | 7e-04 | 2.0127 | 16.7677 | 31 | 971 | reproduction |
GO:0030317 | 8e-04 | 6.0175 | 1.1052 | 6 | 64 | flagellated sperm motility |
GO:0006182 | 0.001 | 10.5118 | 0.449 | 4 | 26 | cGMP biosynthetic process |
GO:0006595 | 0.001 | 19.2061 | 0.2072 | 3 | 12 | polyamine metabolic process |
GO:0006958 | 0.001 | 19.2061 | 0.2072 | 3 | 12 | complement activation, classical pathway |
GO:0007283 | 0.001 | 2.6886 | 5.9749 | 15 | 346 | spermatogenesis |
GO:0022412 | 0.0013 | 2.8438 | 4.887 | 13 | 283 | cellular process involved in reproduction in multicellular organism |
GO:0072521 | 0.0014 | 2.5001 | 6.8383 | 16 | 396 | purine-containing compound metabolic process |
GO:0007498 | 0.0017 | 4.3861 | 1.7268 | 7 | 100 | mesoderm development |
GO:0001545 | 0.0017 | 57.3974 | 0.0691 | 2 | 4 | primary ovarian follicle growth |
GO:0090315 | 0.0017 | 57.3974 | 0.0691 | 2 | 4 | negative regulation of protein targeting to membrane |
GO:0009790 | 0.0018 | 1.9168 | 16.3187 | 29 | 945 | embryo development |
GO:0044703 | 0.0018 | 2.1159 | 11.1381 | 22 | 645 | multi-organism reproductive process |
GO:0046660 | 0.0018 | 4.3391 | 1.7441 | 7 | 101 | female sex differentiation |
GO:0060294 | 0.0024 | 13.2925 | 0.2763 | 3 | 16 | cilium movement involved in cell motility |
GO:0006753 | 0.0028 | 2.2673 | 7.978 | 17 | 462 | nucleoside phosphate metabolic process |
GO:0032532 | 0.0029 | 38.262 | 0.0863 | 2 | 5 | regulation of microvillus length |
GO:2000821 | 0.0029 | 38.262 | 0.0863 | 2 | 5 | regulation of grooming behavior |
GO:2001286 | 0.0029 | 38.262 | 0.0863 | 2 | 5 | regulation of caveolin-mediated endocytosis |
GO:0001707 | 0.003 | 5.571 | 0.9843 | 5 | 57 | mesoderm formation |
GO:0009582 | 0.0031 | 4.5261 | 1.4333 | 6 | 83 | detection of abiotic stimulus |
GO:0060429 | 0.0032 | 1.8745 | 15.438 | 27 | 894 | epithelium development |
GO:0051924 | 0.0033 | 3.1894 | 3.0047 | 9 | 174 | regulation of calcium ion transport |
GO:0009581 | 0.0033 | 4.4677 | 1.4505 | 6 | 84 | detection of external stimulus |
GO:0009150 | 0.0038 | 2.401 | 6.1821 | 14 | 358 | purine ribonucleotide metabolic process |
GO:0008585 | 0.0039 | 4.3012 | 1.5024 | 6 | 87 | female gonad development |
GO:0008635 | 0.0043 | 28.6943 | 0.1036 | 2 | 6 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c |
GO:0014816 | 0.0043 | 28.6943 | 0.1036 | 2 | 6 | skeletal muscle satellite cell differentiation |
GO:0031282 | 0.0043 | 28.6943 | 0.1036 | 2 | 6 | regulation of guanylate cyclase activity |
GO:0007369 | 0.0043 | 3.3088 | 2.573 | 8 | 149 | gastrulation |
GO:0007286 | 0.0046 | 3.6367 | 2.0549 | 7 | 119 | spermatid development |
GO:0030804 | 0.0046 | 4.9924 | 1.0879 | 5 | 63 | positive regulation of cyclic nucleotide biosynthetic process |
GO:0019835 | 0.0047 | 10.1618 | 0.3454 | 3 | 20 | cytolysis |
GO:0030903 | 0.0047 | 10.1618 | 0.3454 | 3 | 20 | notochord development |
GO:0042551 | 0.0049 | 6.417 | 0.6907 | 4 | 40 | neuron maturation |
GO:0006732 | 0.0051 | 2.7739 | 3.8163 | 10 | 221 | coenzyme metabolic process |
GO:0019693 | 0.0053 | 2.3046 | 6.4239 | 14 | 372 | ribose phosphate metabolic process |
GO:0030823 | 0.0054 | 9.5965 | 0.3626 | 3 | 21 | regulation of cGMP metabolic process |
GO:0060065 | 0.0054 | 9.5965 | 0.3626 | 3 | 21 | uterus development |
GO:0001894 | 0.0057 | 3.1506 | 2.6939 | 8 | 156 | tissue homeostasis |
GO:0016584 | 0.0059 | 22.9537 | 0.1209 | 2 | 7 | nucleosome positioning |
GO:0043950 | 0.0059 | 22.9537 | 0.1209 | 2 | 7 | positive regulation of cAMP-mediated signaling |
GO:0072497 | 0.0059 | 22.9537 | 0.1209 | 2 | 7 | mesenchymal stem cell differentiation |
GO:0032845 | 0.0062 | 3.1082 | 2.7284 | 8 | 158 | negative regulation of homeostatic process |
GO:0048729 | 0.0065 | 2.0235 | 9.4113 | 18 | 545 | tissue morphogenesis |
GO:0045981 | 0.0067 | 3.8256 | 1.675 | 6 | 97 | positive regulation of nucleotide metabolic process |
GO:1900373 | 0.0067 | 4.5223 | 1.1915 | 5 | 69 | positive regulation of purine nucleotide biosynthetic process |
GO:0021700 | 0.0069 | 2.6463 | 3.989 | 10 | 231 | developmental maturation |
GO:0048562 | 0.0071 | 2.4977 | 4.6452 | 11 | 269 | embryonic organ morphogenesis |
GO:0030808 | 0.0073 | 3.7428 | 1.7096 | 6 | 99 | regulation of nucleotide biosynthetic process |
GO:0051346 | 0.0075 | 2.6103 | 4.0408 | 10 | 234 | negative regulation of hydrolase activity |
GO:0032352 | 0.0078 | 19.1266 | 0.1381 | 2 | 8 | positive regulation of hormone metabolic process |
GO:0060314 | 0.0078 | 19.1266 | 0.1381 | 2 | 8 | regulation of ryanodine-sensitive calcium-release channel activity |
GO:2000035 | 0.0078 | 19.1266 | 0.1381 | 2 | 8 | regulation of stem cell division |
GO:0072376 | 0.0079 | 8.2237 | 0.4144 | 3 | 24 | protein activation cascade |
GO:0045137 | 0.0082 | 2.949 | 2.8666 | 8 | 166 | development of primary sexual characteristics |
GO:0061458 | 0.0084 | 2.2461 | 6.0958 | 13 | 353 | reproductive system development |
GO:0009187 | 0.0086 | 3.2035 | 2.314 | 7 | 134 | cyclic nucleotide metabolic process |
GO:0021575 | 0.0086 | 5.3695 | 0.8116 | 4 | 47 | hindbrain morphogenesis |
GO:0002262 | 0.009 | 3.1782 | 2.3312 | 7 | 135 | myeloid cell homeostasis |
GO:0006968 | 0.0099 | 16.393 | 0.1554 | 2 | 9 | cellular defense response |
GO:0032463 | 0.0099 | 16.393 | 0.1554 | 2 | 9 | negative regulation of protein homooligomerization |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0030317 | 1e-04 | 7.7374 | 1.0286 | 7 | 64 | flagellated sperm motility |
GO:0006597 | 3e-04 | Inf | 0.0321 | 2 | 2 | spermine biosynthetic process |
GO:0042700 | 3e-04 | Inf | 0.0321 | 2 | 2 | luteinizing hormone signaling pathway |
GO:1904970 | 3e-04 | Inf | 0.0321 | 2 | 2 | brush border assembly |
GO:0009259 | 3e-04 | 2.9605 | 5.8503 | 16 | 364 | ribonucleotide metabolic process |
GO:0046031 | 4e-04 | 7.1007 | 0.9483 | 6 | 59 | ADP metabolic process |
GO:0006140 | 4e-04 | 4.0407 | 2.6841 | 10 | 167 | regulation of nucleotide metabolic process |
GO:0001539 | 4e-04 | 13.8431 | 0.3536 | 4 | 22 | cilium or flagellum-dependent cell motility |
GO:0032504 | 5e-04 | 2.4314 | 9.3541 | 21 | 582 | multicellular organism reproduction |
GO:0072376 | 5e-04 | 12.4569 | 0.3857 | 4 | 24 | protein activation cascade |
GO:0007276 | 5e-04 | 2.5871 | 7.5058 | 18 | 467 | gamete generation |
GO:0009135 | 6e-04 | 6.4861 | 1.0286 | 6 | 64 | purine nucleoside diphosphate metabolic process |
GO:0044703 | 7e-04 | 2.2942 | 10.3667 | 22 | 645 | multi-organism reproductive process |
GO:0002578 | 8e-04 | 123.5775 | 0.0482 | 2 | 3 | negative regulation of antigen processing and presentation |
GO:1990918 | 8e-04 | 123.5775 | 0.0482 | 2 | 3 | double-strand break repair involved in meiotic recombination |
GO:0009185 | 8e-04 | 6.0658 | 1.0929 | 6 | 68 | ribonucleoside diphosphate metabolic process |
GO:0006958 | 8e-04 | 20.6808 | 0.1929 | 3 | 12 | complement activation, classical pathway |
GO:0030810 | 8e-04 | 5.969 | 1.109 | 6 | 69 | positive regulation of nucleotide biosynthetic process |
GO:1900544 | 9e-04 | 4.888 | 1.559 | 7 | 97 | positive regulation of purine nucleotide metabolic process |
GO:0030801 | 0.001 | 5.7845 | 1.1411 | 6 | 71 | positive regulation of cyclic nucleotide metabolic process |
GO:0007283 | 0.0014 | 2.6917 | 5.561 | 14 | 346 | spermatogenesis |
GO:0045137 | 0.0015 | 3.619 | 2.668 | 9 | 166 | development of primary sexual characteristics |
GO:0042698 | 0.0015 | 5.2932 | 1.2376 | 6 | 77 | ovulation cycle |
GO:0001545 | 0.0015 | 61.784 | 0.0643 | 2 | 4 | primary ovarian follicle growth |
GO:0030819 | 0.0017 | 6.3717 | 0.8679 | 5 | 54 | positive regulation of cAMP biosynthetic process |
GO:0048469 | 0.0018 | 3.8444 | 2.2341 | 8 | 139 | cell maturation |
GO:0009152 | 0.0019 | 3.4626 | 2.7805 | 9 | 173 | purine ribonucleotide biosynthetic process |
GO:0060294 | 0.002 | 14.3131 | 0.2572 | 3 | 16 | cilium movement involved in cell motility |
GO:0071695 | 0.002 | 3.786 | 2.2662 | 8 | 141 | anatomical structure maturation |
GO:0016052 | 0.0022 | 4.8785 | 1.334 | 6 | 83 | carbohydrate catabolic process |
GO:0046390 | 0.0023 | 3.3589 | 2.8609 | 9 | 178 | ribose phosphate biosynthetic process |
GO:0008295 | 0.0025 | 41.1862 | 0.0804 | 2 | 5 | spermidine biosynthetic process |
GO:0032532 | 0.0025 | 41.1862 | 0.0804 | 2 | 5 | regulation of microvillus length |
GO:2001286 | 0.0025 | 41.1862 | 0.0804 | 2 | 5 | regulation of caveolin-mediated endocytosis |
GO:0055086 | 0.0025 | 2.2932 | 7.9076 | 17 | 492 | nucleobase-containing small molecule metabolic process |
GO:1901293 | 0.0027 | 3.0529 | 3.4877 | 10 | 217 | nucleoside phosphate biosynthetic process |
GO:0008585 | 0.0028 | 4.6362 | 1.3983 | 6 | 87 | female gonad development |
GO:0072522 | 0.003 | 3.2236 | 2.9734 | 9 | 185 | purine-containing compound biosynthetic process |
GO:0030802 | 0.0033 | 4.4696 | 1.4465 | 6 | 90 | regulation of cyclic nucleotide biosynthetic process |
GO:0014816 | 0.0037 | 30.8873 | 0.0964 | 2 | 6 | skeletal muscle satellite cell differentiation |
GO:0060065 | 0.0044 | 10.3333 | 0.3375 | 3 | 21 | uterus development |
GO:0006165 | 0.0044 | 5.0307 | 1.0768 | 5 | 67 | nucleoside diphosphate phosphorylation |
GO:0002763 | 0.0045 | 6.5473 | 0.675 | 4 | 42 | positive regulation of myeloid leukocyte differentiation |
GO:0043950 | 0.0051 | 24.708 | 0.1125 | 2 | 7 | positive regulation of cAMP-mediated signaling |
GO:1900371 | 0.0052 | 4.0343 | 1.5912 | 6 | 99 | regulation of purine nucleotide biosynthetic process |
GO:0052652 | 0.0055 | 3.991 | 1.6072 | 6 | 100 | cyclic purine nucleotide metabolic process |
GO:0048477 | 0.0056 | 4.7244 | 1.1411 | 5 | 71 | oogenesis |
GO:0046660 | 0.0057 | 3.9487 | 1.6233 | 6 | 101 | female sex differentiation |
GO:1901385 | 0.0065 | 8.8551 | 0.3857 | 3 | 24 | regulation of voltage-gated calcium channel activity |
GO:0006090 | 0.0067 | 4.5179 | 1.1894 | 5 | 74 | pyruvate metabolic process |
GO:0007342 | 0.0068 | 20.5884 | 0.1286 | 2 | 8 | fusion of sperm to egg plasma membrane involved in single fertilization |
GO:0010755 | 0.0068 | 20.5884 | 0.1286 | 2 | 8 | regulation of plasminogen activation |
GO:0030948 | 0.0068 | 20.5884 | 0.1286 | 2 | 8 | negative regulation of vascular endothelial growth factor receptor signaling pathway |
GO:0032352 | 0.0068 | 20.5884 | 0.1286 | 2 | 8 | positive regulation of hormone metabolic process |
GO:0051924 | 0.0071 | 3.0257 | 2.7966 | 8 | 174 | regulation of calcium ion transport |
GO:0046058 | 0.0076 | 3.7124 | 1.7197 | 6 | 107 | cAMP metabolic process |
GO:0046427 | 0.0078 | 5.5259 | 0.7875 | 4 | 49 | positive regulation of JAK-STAT cascade |
GO:0006968 | 0.0086 | 17.6459 | 0.1447 | 2 | 9 | cellular defense response |
GO:0032463 | 0.0086 | 17.6459 | 0.1447 | 2 | 9 | negative regulation of protein homooligomerization |
GO:0006732 | 0.0095 | 2.6688 | 3.552 | 9 | 221 | coenzyme metabolic process |
GO:0006110 | 0.01 | 7.436 | 0.45 | 3 | 28 | regulation of glycolytic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0016115 | 0.0022 | 50.8333 | 0.0777 | 2 | 4 | terpenoid catabolic process |
GO:0043415 | 0.0022 | 50.8333 | 0.0777 | 2 | 4 | positive regulation of skeletal muscle tissue regeneration |
GO:0007205 | 0.0034 | 11.7665 | 0.311 | 3 | 16 | protein kinase C-activating G-protein coupled receptor signaling pathway |
GO:0051461 | 0.0036 | 33.8863 | 0.0972 | 2 | 5 | positive regulation of corticotropin secretion |
GO:0071169 | 0.0036 | 33.8863 | 0.0972 | 2 | 5 | establishment of protein localization to chromatin |
GO:0071321 | 0.0054 | 25.4128 | 0.1166 | 2 | 6 | cellular response to cGMP |
GO:0060290 | 0.0074 | 20.3287 | 0.1361 | 2 | 7 | transdifferentiation |
GO:0060426 | 0.0074 | 20.3287 | 0.1361 | 2 | 7 | lung vasculature development |
GO:0001829 | 0.0096 | 7.6442 | 0.447 | 3 | 23 | trophectodermal cell differentiation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:1902340 | 3e-04 | Inf | 0.0347 | 2 | 2 | negative regulation of chromosome condensation |
GO:0031509 | 9e-04 | 114.2957 | 0.052 | 2 | 3 | telomeric heterochromatin assembly |
GO:0019637 | 0.0011 | 2.0934 | 12.8687 | 25 | 742 | organophosphate metabolic process |
GO:0045453 | 0.0014 | 6.7114 | 0.8325 | 5 | 48 | bone resorption |
GO:0048771 | 0.0017 | 3.9094 | 2.2026 | 8 | 127 | tissue remodeling |
GO:0031508 | 0.0018 | 57.1435 | 0.0694 | 2 | 4 | pericentric heterochromatin assembly |
GO:0034112 | 0.0018 | 57.1435 | 0.0694 | 2 | 4 | positive regulation of homotypic cell-cell adhesion |
GO:0002176 | 0.0029 | 38.0928 | 0.0867 | 2 | 5 | male germ cell proliferation |
GO:0060023 | 0.0029 | 38.0928 | 0.0867 | 2 | 5 | soft palate development |
GO:0002062 | 0.0032 | 4.5057 | 1.4395 | 6 | 83 | chondrocyte differentiation |
GO:0048705 | 0.0037 | 2.9155 | 3.6421 | 10 | 210 | skeletal system morphogenesis |
GO:0007600 | 0.0041 | 2.2971 | 6.9199 | 15 | 399 | sensory perception |
GO:0032224 | 0.0043 | 28.5674 | 0.1041 | 2 | 6 | positive regulation of synaptic transmission, cholinergic |
GO:0061037 | 0.0054 | 9.5539 | 0.3642 | 3 | 21 | negative regulation of cartilage development |
GO:0015672 | 0.0057 | 2.3639 | 5.81 | 13 | 335 | monovalent inorganic cation transport |
GO:0006811 | 0.0058 | 1.7341 | 18.5052 | 30 | 1067 | ion transport |
GO:0007155 | 0.0059 | 1.8029 | 15.3661 | 26 | 886 | cell adhesion |
GO:0048752 | 0.0059 | 22.8522 | 0.1214 | 2 | 7 | semicircular canal morphogenesis |
GO:0007186 | 0.0077 | 2.0292 | 8.845 | 17 | 510 | G-protein coupled receptor signaling pathway |
GO:2000392 | 0.0078 | 19.042 | 0.1387 | 2 | 8 | regulation of lamellipodium morphogenesis |
GO:0006959 | 0.0087 | 4.2359 | 1.2661 | 5 | 73 | humoral immune response |
GO:0061448 | 0.009 | 2.6943 | 3.5207 | 9 | 203 | connective tissue development |
GO:0098660 | 0.0093 | 2.0841 | 7.579 | 15 | 437 | inorganic ion transmembrane transport |
GO:0048286 | 0.0094 | 5.2237 | 0.8325 | 4 | 48 | lung alveolus development |
GO:0003008 | 0.0099 | 1.6462 | 20.0661 | 31 | 1157 | system process |
GO:0015937 | 0.0099 | 16.3205 | 0.1561 | 2 | 9 | coenzyme A biosynthetic process |
GO:0071600 | 0.0099 | 16.3205 | 0.1561 | 2 | 9 | otic vesicle morphogenesis |
GO:0019432 | 0.01 | 7.4741 | 0.4509 | 3 | 26 | triglyceride biosynthetic process |
GO:0048011 | 0.01 | 7.4741 | 0.4509 | 3 | 26 | neurotrophin TRK receptor signaling pathway |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031424 | 1e-04 | 25.3797 | 0.2274 | 4 | 13 | keratinization |
GO:1902340 | 3e-04 | Inf | 0.035 | 2 | 2 | negative regulation of chromosome condensation |
GO:0031509 | 9e-04 | 113.2931 | 0.0525 | 2 | 3 | telomeric heterochromatin assembly |
GO:0044703 | 9e-04 | 2.1943 | 11.2828 | 23 | 645 | multi-organism reproductive process |
GO:0006182 | 0.001 | 10.3723 | 0.4548 | 4 | 26 | cGMP biosynthetic process |
GO:0006692 | 0.001 | 10.3723 | 0.4548 | 4 | 26 | prostanoid metabolic process |
GO:0006936 | 0.0011 | 3.2416 | 3.6385 | 11 | 208 | muscle contraction |
GO:0048705 | 0.0012 | 3.2085 | 3.6735 | 11 | 210 | skeletal system morphogenesis |
GO:0001894 | 0.0017 | 3.5363 | 2.7289 | 9 | 156 | tissue homeostasis |
GO:0031508 | 0.0018 | 56.6422 | 0.07 | 2 | 4 | pericentric heterochromatin assembly |
GO:0034112 | 0.0018 | 56.6422 | 0.07 | 2 | 4 | positive regulation of homotypic cell-cell adhesion |
GO:0035995 | 0.0018 | 56.6422 | 0.07 | 2 | 4 | detection of muscle stretch |
GO:0031281 | 0.0025 | 7.8645 | 0.5773 | 4 | 33 | positive regulation of cyclase activity |
GO:0051349 | 0.0025 | 7.8645 | 0.5773 | 4 | 33 | positive regulation of lyase activity |
GO:0002176 | 0.0029 | 37.7586 | 0.0875 | 2 | 5 | male germ cell proliferation |
GO:0060023 | 0.0029 | 37.7586 | 0.0875 | 2 | 5 | soft palate development |
GO:1904180 | 0.0029 | 37.7586 | 0.0875 | 2 | 5 | negative regulation of membrane depolarization |
GO:2001286 | 0.0029 | 37.7586 | 0.0875 | 2 | 5 | regulation of caveolin-mediated endocytosis |
GO:0003009 | 0.003 | 12.179 | 0.2974 | 3 | 17 | skeletal muscle contraction |
GO:0032504 | 0.0031 | 2.0922 | 10.1808 | 20 | 582 | multicellular organism reproduction |
GO:0022600 | 0.0034 | 5.3926 | 1.0146 | 5 | 58 | digestive system process |
GO:0042127 | 0.0037 | 1.7204 | 21.9359 | 35 | 1254 | regulation of cell proliferation |
GO:0001516 | 0.0042 | 10.655 | 0.3324 | 3 | 19 | prostaglandin biosynthetic process |
GO:0031282 | 0.0044 | 28.3168 | 0.105 | 2 | 6 | regulation of guanylate cyclase activity |
GO:0032224 | 0.0044 | 28.3168 | 0.105 | 2 | 6 | positive regulation of synaptic transmission, cholinergic |
GO:0045410 | 0.0044 | 28.3168 | 0.105 | 2 | 6 | positive regulation of interleukin-6 biosynthetic process |
GO:0060558 | 0.0044 | 28.3168 | 0.105 | 2 | 6 | regulation of calcidiol 1-monooxygenase activity |
GO:0086103 | 0.0044 | 28.3168 | 0.105 | 2 | 6 | G-protein coupled receptor signaling pathway involved in heart process |
GO:0030804 | 0.0048 | 4.9258 | 1.102 | 5 | 63 | positive regulation of cyclic nucleotide biosynthetic process |
GO:0002026 | 0.0056 | 9.4697 | 0.3673 | 3 | 21 | regulation of the force of heart contraction |
GO:0051354 | 0.0056 | 9.4697 | 0.3673 | 3 | 21 | negative regulation of oxidoreductase activity |
GO:0006054 | 0.006 | 22.6517 | 0.1224 | 2 | 7 | N-acetylneuraminate metabolic process |
GO:0048515 | 0.0061 | 3.4332 | 2.1691 | 7 | 124 | spermatid differentiation |
GO:0003013 | 0.0061 | 2.3422 | 5.8601 | 13 | 335 | circulatory system process |
GO:0045981 | 0.0071 | 3.7744 | 1.6968 | 6 | 97 | positive regulation of nucleotide metabolic process |
GO:0031644 | 0.0071 | 4.462 | 1.207 | 5 | 69 | regulation of neurological system process |
GO:1900373 | 0.0071 | 4.462 | 1.207 | 5 | 69 | positive regulation of purine nucleotide biosynthetic process |
GO:0060348 | 0.008 | 2.9661 | 2.8513 | 8 | 163 | bone development |
GO:0042368 | 0.008 | 18.875 | 0.1399 | 2 | 8 | vitamin D biosynthetic process |
GO:2000392 | 0.008 | 18.875 | 0.1399 | 2 | 8 | regulation of lamellipodium morphogenesis |
GO:0048477 | 0.008 | 4.3261 | 1.242 | 5 | 71 | oogenesis |
GO:0007276 | 0.0081 | 2.0655 | 8.1691 | 16 | 467 | gamete generation |
GO:1902305 | 0.0084 | 5.4248 | 0.8047 | 4 | 46 | regulation of sodium ion transmembrane transport |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:2000822 | 1e-04 | 61.1812 | 0.1207 | 3 | 5 | regulation of behavioral fear response |
GO:0050808 | 2e-04 | 3.146 | 5.1672 | 15 | 214 | synapse organization |
GO:0007606 | 2e-04 | 4.3124 | 2.5595 | 10 | 106 | sensory perception of chemical stimulus |
GO:0030001 | 3e-04 | 2.1446 | 14.56 | 29 | 603 | metal ion transport |
GO:0072511 | 4e-04 | 2.5779 | 7.9199 | 19 | 328 | divalent inorganic cation transport |
GO:0022610 | 4e-04 | 1.9072 | 21.514 | 38 | 891 | biological adhesion |
GO:0043950 | 5e-04 | 30.5859 | 0.169 | 3 | 7 | positive regulation of cAMP-mediated signaling |
GO:0045776 | 5e-04 | 6.6589 | 1.0383 | 6 | 43 | negative regulation of blood pressure |
GO:0006816 | 6e-04 | 2.6404 | 6.9057 | 17 | 286 | calcium ion transport |
GO:0055085 | 6e-04 | 1.9438 | 18.8097 | 34 | 779 | transmembrane transport |
GO:0006955 | 0.001 | 1.9379 | 17.1195 | 31 | 709 | immune response |
GO:0019835 | 0.0012 | 10.2179 | 0.4829 | 4 | 20 | cytolysis |
GO:2000026 | 0.0015 | 1.6216 | 36.0257 | 54 | 1492 | regulation of multicellular organismal development |
GO:0030801 | 0.0016 | 4.4961 | 1.7144 | 7 | 71 | positive regulation of cyclic nucleotide metabolic process |
GO:0098609 | 0.0017 | 2.0849 | 11.7349 | 23 | 486 | cell-cell adhesion |
GO:0002684 | 0.0017 | 2.0494 | 12.4593 | 24 | 516 | positive regulation of immune system process |
GO:0046544 | 0.0017 | 81.3271 | 0.0724 | 2 | 3 | development of secondary male sexual characteristics |
GO:0014821 | 0.0017 | 9.0812 | 0.5312 | 4 | 22 | phasic smooth muscle contraction |
GO:0043270 | 0.0019 | 2.7089 | 5.1189 | 13 | 212 | positive regulation of ion transport |
GO:0070098 | 0.0024 | 8.1718 | 0.5795 | 4 | 24 | chemokine-mediated signaling pathway |
GO:1901385 | 0.0024 | 8.1718 | 0.5795 | 4 | 24 | regulation of voltage-gated calcium channel activity |
GO:1903169 | 0.0025 | 3.6583 | 2.3663 | 8 | 98 | regulation of calcium ion transmembrane transport |
GO:0060134 | 0.0026 | 13.5885 | 0.2898 | 3 | 12 | prepulse inhibition |
GO:0001659 | 0.0028 | 7.7821 | 0.6036 | 4 | 25 | temperature homeostasis |
GO:0006954 | 0.0029 | 2.1936 | 8.6925 | 18 | 360 | inflammatory response |
GO:0098655 | 0.0029 | 2.0563 | 10.8174 | 21 | 448 | cation transmembrane transport |
GO:0048731 | 0.003 | 1.4134 | 81.7822 | 104 | 3387 | system development |
GO:1904659 | 0.0034 | 40.6604 | 0.0966 | 2 | 4 | glucose transmembrane transport |
GO:0010719 | 0.0038 | 7.1043 | 0.6519 | 4 | 27 | negative regulation of epithelial to mesenchymal transition |
GO:0090280 | 0.0042 | 11.1162 | 0.338 | 3 | 14 | positive regulation of calcium ion import |
GO:0040011 | 0.0044 | 1.5873 | 30.2548 | 45 | 1253 | locomotion |
GO:0006936 | 0.0047 | 2.5313 | 5.0224 | 12 | 208 | muscle contraction |
GO:0019433 | 0.0051 | 10.1891 | 0.3622 | 3 | 15 | triglyceride catabolic process |
GO:0032501 | 0.0055 | 1.351 | 113.837 | 136 | 4779 | multicellular organismal process |
GO:0033602 | 0.0055 | 27.1049 | 0.1207 | 2 | 5 | negative regulation of dopamine secretion |
GO:0034242 | 0.0055 | 27.1049 | 0.1207 | 2 | 5 | negative regulation of syncytium formation by plasma membrane fusion |
GO:0034384 | 0.0055 | 27.1049 | 0.1207 | 2 | 5 | high-density lipoprotein particle clearance |
GO:0045964 | 0.0055 | 27.1049 | 0.1207 | 2 | 5 | positive regulation of dopamine metabolic process |
GO:0071872 | 0.0055 | 27.1049 | 0.1207 | 2 | 5 | cellular response to epinephrine stimulus |
GO:0072513 | 0.0055 | 27.1049 | 0.1207 | 2 | 5 | positive regulation of secondary heart field cardioblast proliferation |
GO:1901897 | 0.0055 | 27.1049 | 0.1207 | 2 | 5 | regulation of relaxation of cardiac muscle |
GO:0098659 | 0.0056 | 6.2831 | 0.7244 | 4 | 30 | inorganic cation import across plasma membrane |
GO:1900271 | 0.0056 | 6.2831 | 0.7244 | 4 | 30 | regulation of long-term synaptic potentiation |
GO:0015844 | 0.0059 | 3.9662 | 1.6419 | 6 | 68 | monoamine transport |
GO:0090101 | 0.0061 | 3.4618 | 2.1731 | 7 | 90 | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:0001504 | 0.0062 | 9.4046 | 0.3863 | 3 | 16 | neurotransmitter uptake |
GO:0048148 | 0.0062 | 9.4046 | 0.3863 | 3 | 16 | behavioral response to cocaine |
GO:0032496 | 0.0062 | 2.6939 | 3.9358 | 10 | 163 | response to lipopolysaccharide |
GO:0033555 | 0.0063 | 3.903 | 1.6661 | 6 | 69 | multicellular organismal response to stress |
GO:0008015 | 0.0067 | 2.1077 | 7.9923 | 16 | 331 | blood circulation |
GO:0042493 | 0.0068 | 2.6588 | 3.9841 | 10 | 165 | response to drug |
GO:0050867 | 0.0073 | 2.4935 | 4.6602 | 11 | 193 | positive regulation of cell activation |
GO:0010039 | 0.0074 | 8.7321 | 0.4105 | 3 | 17 | response to iron ion |
GO:0050877 | 0.0076 | 1.7165 | 17.1919 | 28 | 712 | nervous system process |
GO:0001819 | 0.0081 | 2.2582 | 6.0606 | 13 | 251 | positive regulation of cytokine production |
GO:0042135 | 0.0082 | 20.3271 | 0.1449 | 2 | 6 | neurotransmitter catabolic process |
GO:0060586 | 0.0082 | 20.3271 | 0.1449 | 2 | 6 | multicellular organismal iron ion homeostasis |
GO:0071467 | 0.0087 | 8.1494 | 0.4346 | 3 | 18 | cellular response to pH |
GO:0009952 | 0.0087 | 2.4259 | 4.7809 | 11 | 198 | anterior/posterior pattern specification |
GO:0002042 | 0.0087 | 5.4437 | 0.821 | 4 | 34 | cell migration involved in sprouting angiogenesis |
GO:0003156 | 0.0087 | 5.4437 | 0.821 | 4 | 34 | regulation of animal organ formation |
GO:0010033 | 0.0089 | 1.438 | 45.3943 | 61 | 1880 | response to organic substance |
GO:1900544 | 0.009 | 3.1909 | 2.3422 | 7 | 97 | positive regulation of purine nucleotide metabolic process |
GO:1903845 | 0.0096 | 4.1731 | 1.3039 | 5 | 54 | negative regulation of cellular response to transforming growth factor beta stimulus |
GO:0015872 | 0.0097 | 5.2677 | 0.8451 | 4 | 35 | dopamine transport |
GO:0002793 | 0.0097 | 2.387 | 4.8533 | 11 | 201 | positive regulation of peptide secretion |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0001775 | 0 | 5.3508 | 5.9373 | 27 | 286 | cell activation |
GO:0046649 | 0 | 5.2239 | 6.0589 | 27 | 280 | lymphocyte activation |
GO:0006955 | 0 | 8.5219 | 2.1209 | 15 | 105 | immune response |
GO:0032943 | 0 | 10.9205 | 1.376 | 12 | 64 | mononuclear cell proliferation |
GO:0002694 | 0 | 4.1689 | 6.5306 | 24 | 296 | regulation of leukocyte activation |
GO:0042832 | 0 | 26.2862 | 0.4218 | 7 | 19 | defense response to protozoan |
GO:0050670 | 0 | 5.9968 | 2.8863 | 15 | 130 | regulation of lymphocyte proliferation |
GO:0070663 | 0 | 5.6496 | 3.0417 | 15 | 137 | regulation of leukocyte proliferation |
GO:0033141 | 0 | 24.4967 | 0.3774 | 6 | 17 | positive regulation of peptidyl-serine phosphorylation of STAT protein |
GO:0009607 | 0 | 3.0548 | 10.1908 | 28 | 459 | response to biotic stimulus |
GO:0002323 | 0 | 22.4536 | 0.3996 | 6 | 18 | natural killer cell activation involved in immune response |
GO:0042100 | 0 | 9.5655 | 1.1441 | 9 | 52 | B cell proliferation |
GO:0002521 | 0 | 3.2548 | 8.1704 | 24 | 368 | leukocyte differentiation |
GO:0006952 | 0 | 5.6795 | 2.394 | 12 | 120 | defense response |
GO:0006954 | 0 | 3.1741 | 7.9928 | 23 | 360 | inflammatory response |
GO:0002252 | 0 | 3.5597 | 5.8945 | 19 | 273 | immune effector process |
GO:0030886 | 0 | Inf | 0.0666 | 3 | 3 | negative regulation of myeloid dendritic cell activation |
GO:0051707 | 0 | 4.428 | 3.5189 | 14 | 163 | response to other organism |
GO:0022407 | 0 | 3.3799 | 5.8392 | 18 | 263 | regulation of cell-cell adhesion |
GO:0045087 | 0 | 3.6289 | 4.8421 | 16 | 222 | innate immune response |
GO:0019221 | 0 | 3.6119 | 4.8623 | 16 | 219 | cytokine-mediated signaling pathway |
GO:0006959 | 0 | 6.3555 | 1.6208 | 9 | 73 | humoral immune response |
GO:0009605 | 0 | 2.2168 | 17.8807 | 36 | 831 | response to external stimulus |
GO:0002684 | 1e-04 | 2.6535 | 9.4224 | 23 | 435 | positive regulation of immune system process |
GO:0030183 | 1e-04 | 5.6219 | 1.8041 | 9 | 82 | B cell differentiation |
GO:0002286 | 1e-04 | 6.438 | 1.4209 | 8 | 64 | T cell activation involved in immune response |
GO:0050863 | 1e-04 | 3.8177 | 3.7289 | 13 | 169 | regulation of T cell activation |
GO:0007599 | 1e-04 | 4.3361 | 2.7975 | 11 | 126 | hemostasis |
GO:0050776 | 1e-04 | 2.7038 | 8.4147 | 21 | 379 | regulation of immune response |
GO:0050817 | 1e-04 | 4.2613 | 2.8419 | 11 | 128 | coagulation |
GO:0030168 | 2e-04 | 5.8123 | 1.5542 | 8 | 70 | platelet activation |
GO:0002366 | 2e-04 | 4.558 | 2.4235 | 10 | 111 | leukocyte activation involved in immune response |
GO:0048534 | 2e-04 | 2.2204 | 14.6535 | 30 | 660 | hematopoietic or lymphoid organ development |
GO:0051607 | 2e-04 | 4.1538 | 2.9085 | 11 | 131 | defense response to virus |
GO:0046425 | 2e-04 | 4.4775 | 2.4645 | 10 | 111 | regulation of JAK-STAT cascade |
GO:0043330 | 2e-04 | 8.1518 | 0.8659 | 6 | 39 | response to exogenous dsRNA |
GO:0050866 | 2e-04 | 4.3474 | 2.5311 | 10 | 114 | negative regulation of cell activation |
GO:0097530 | 2e-04 | 5.4583 | 1.643 | 8 | 74 | granulocyte migration |
GO:1903039 | 2e-04 | 4.3056 | 2.5533 | 10 | 115 | positive regulation of leukocyte cell-cell adhesion |
GO:0008283 | 3e-04 | 1.7605 | 33.7475 | 54 | 1520 | cell proliferation |
GO:0006935 | 3e-04 | 2.5511 | 8.4369 | 20 | 380 | chemotaxis |
GO:0097696 | 3e-04 | 4.1083 | 2.6643 | 10 | 120 | STAT cascade |
GO:0050867 | 4e-04 | 3.2805 | 4.285 | 13 | 193 | positive regulation of cell activation |
GO:0007165 | 4e-04 | 1.5353 | 76.9087 | 103 | 3464 | signal transduction |
GO:0051674 | 5e-04 | 1.8619 | 23.9119 | 41 | 1077 | localization of cell |
GO:0001819 | 5e-04 | 2.8949 | 5.5728 | 15 | 251 | positive regulation of cytokine production |
GO:0016477 | 6e-04 | 1.8776 | 21.8915 | 38 | 986 | cell migration |
GO:0030595 | 6e-04 | 5.3106 | 1.4682 | 7 | 67 | leukocyte chemotaxis |
GO:0002275 | 7e-04 | 6.2513 | 1.0879 | 6 | 49 | myeloid cell activation involved in immune response |
GO:0046631 | 9e-04 | 4.3879 | 1.9982 | 8 | 90 | alpha-beta T cell activation |
GO:0051251 | 9e-04 | 3.3379 | 3.5524 | 11 | 160 | positive regulation of lymphocyte activation |
GO:0042102 | 0.001 | 5.8422 | 1.1545 | 6 | 52 | positive regulation of T cell proliferation |
GO:0031347 | 0.001 | 2.5093 | 7.2379 | 17 | 326 | regulation of defense response |
GO:0045576 | 0.0011 | 7.2547 | 0.7943 | 5 | 36 | mast cell activation |
GO:0002250 | 0.0011 | 2.9036 | 4.7957 | 13 | 216 | adaptive immune response |
GO:0051270 | 0.0011 | 2.0002 | 14.9865 | 28 | 675 | regulation of cellular component movement |
GO:0042060 | 0.0012 | 2.7396 | 5.4618 | 14 | 246 | wound healing |
GO:0002442 | 0.0015 | 88.6712 | 0.0666 | 2 | 3 | serotonin secretion involved in inflammatory response |
GO:0034154 | 0.0015 | 88.6712 | 0.0666 | 2 | 3 | toll-like receptor 7 signaling pathway |
GO:0050912 | 0.0016 | 16.6735 | 0.2442 | 3 | 11 | detection of chemical stimulus involved in sensory perception of taste |
GO:0032946 | 0.0017 | 4.4227 | 1.7318 | 7 | 78 | positive regulation of mononuclear cell proliferation |
GO:0040012 | 0.0021 | 1.9311 | 14.8977 | 27 | 671 | regulation of locomotion |
GO:0050856 | 0.0021 | 8.4895 | 0.5551 | 4 | 25 | regulation of T cell receptor signaling pathway |
GO:0034097 | 0.0021 | 2.0775 | 11.2566 | 22 | 507 | response to cytokine |
GO:0007155 | 0.0022 | 1.9777 | 13.4712 | 25 | 622 | cell adhesion |
GO:0007229 | 0.0023 | 4.8828 | 1.3543 | 6 | 61 | integrin-mediated signaling pathway |
GO:0050853 | 0.0024 | 8.103 | 0.5773 | 4 | 26 | B cell receptor signaling pathway |
GO:0030574 | 0.0026 | 13.3367 | 0.2886 | 3 | 13 | collagen catabolic process |
GO:0009617 | 0.0027 | 2.498 | 5.9502 | 14 | 268 | response to bacterium |
GO:0065007 | 0.0027 | 1.4174 | 175.4425 | 199 | 7902 | biological regulation |
GO:0032715 | 0.0028 | 7.7501 | 0.5995 | 4 | 27 | negative regulation of interleukin-6 production |
GO:0071415 | 0.0029 | 44.3322 | 0.0888 | 2 | 4 | cellular response to purine-containing compound |
GO:2001187 | 0.0029 | 44.3322 | 0.0888 | 2 | 4 | positive regulation of CD8-positive, alpha-beta T cell activation |
GO:0045579 | 0.0033 | 12.1234 | 0.3108 | 3 | 14 | positive regulation of B cell differentiation |
GO:0032496 | 0.0035 | 2.9439 | 3.619 | 10 | 163 | response to lipopolysaccharide |
GO:0002687 | 0.0035 | 7.2267 | 0.6355 | 4 | 29 | positive regulation of leukocyte migration |
GO:0030593 | 0.004 | 6.9178 | 0.6602 | 4 | 30 | neutrophil chemotaxis |
GO:0030889 | 0.004 | 11.1122 | 0.333 | 3 | 15 | negative regulation of B cell proliferation |
GO:0032945 | 0.0041 | 5.1915 | 1.0657 | 5 | 48 | negative regulation of mononuclear cell proliferation |
GO:0042089 | 0.0045 | 4.1933 | 1.5542 | 6 | 70 | cytokine biosynthetic process |
GO:0043300 | 0.0047 | 6.5999 | 0.6883 | 4 | 31 | regulation of leukocyte degranulation |
GO:0030217 | 0.0047 | 2.8136 | 3.7744 | 10 | 170 | T cell differentiation |
GO:0034162 | 0.0047 | 29.5525 | 0.111 | 2 | 5 | toll-like receptor 9 signaling pathway |
GO:0034242 | 0.0047 | 29.5525 | 0.111 | 2 | 5 | negative regulation of syncytium formation by plasma membrane fusion |
GO:0045588 | 0.0047 | 29.5525 | 0.111 | 2 | 5 | positive regulation of gamma-delta T cell differentiation |
GO:0045918 | 0.0047 | 29.5525 | 0.111 | 2 | 5 | negative regulation of cytolysis |
GO:0051133 | 0.0047 | 29.5525 | 0.111 | 2 | 5 | regulation of NK T cell activation |
GO:0001525 | 0.005 | 2.1796 | 7.7486 | 16 | 349 | angiogenesis |
GO:0002886 | 0.0052 | 6.3637 | 0.7105 | 4 | 32 | regulation of myeloid leukocyte mediated immunity |
GO:0043303 | 0.0052 | 6.3637 | 0.7105 | 4 | 32 | mast cell degranulation |
GO:0045987 | 0.0052 | 6.3637 | 0.7105 | 4 | 32 | positive regulation of smooth muscle contraction |
GO:0015850 | 0.0053 | 2.9523 | 3.2415 | 9 | 146 | organic hydroxy compound transport |
GO:0002685 | 0.0054 | 6.3035 | 0.7148 | 4 | 33 | regulation of leukocyte migration |
GO:0045639 | 0.0056 | 4.0046 | 1.6208 | 6 | 73 | positive regulation of myeloid cell differentiation |
GO:0002690 | 0.0058 | 4.7483 | 1.1545 | 5 | 52 | positive regulation of leukocyte chemotaxis |
GO:0090023 | 0.0058 | 9.5233 | 0.3774 | 3 | 17 | positive regulation of neutrophil chemotaxis |
GO:0045785 | 0.0062 | 2.3396 | 5.8614 | 13 | 264 | positive regulation of cell adhesion |
GO:0032101 | 0.0066 | 1.9727 | 10.1464 | 19 | 457 | regulation of response to external stimulus |
GO:0001773 | 0.0067 | 8.9794 | 0.3957 | 3 | 18 | myeloid dendritic cell activation |
GO:2000147 | 0.0069 | 2.1018 | 8.015 | 16 | 361 | positive regulation of cell motility |
GO:0001955 | 0.0069 | 22.1627 | 0.1332 | 2 | 6 | blood vessel maturation |
GO:0019886 | 0.0069 | 22.1627 | 0.1332 | 2 | 6 | antigen processing and presentation of exogenous peptide antigen via MHC class II |
GO:1902563 | 0.0069 | 22.1627 | 0.1332 | 2 | 6 | regulation of neutrophil activation |
GO:0001662 | 0.0073 | 5.7466 | 0.7771 | 4 | 35 | behavioral fear response |
GO:0009988 | 0.0073 | 5.7466 | 0.7771 | 4 | 35 | cell-cell recognition |
GO:0051930 | 0.0073 | 5.7466 | 0.7771 | 4 | 35 | regulation of sensory perception of pain |
GO:0045089 | 0.0074 | 3.015 | 2.8197 | 8 | 127 | positive regulation of innate immune response |
GO:0002683 | 0.0076 | 2.2749 | 6.0168 | 13 | 271 | negative regulation of immune system process |
GO:1902531 | 0.0092 | 1.5537 | 27.331 | 40 | 1231 | regulation of intracellular signal transduction |
GO:0001776 | 0.0092 | 3.5753 | 1.7984 | 6 | 81 | leukocyte homeostasis |
GO:0002862 | 0.0096 | 17.7288 | 0.1554 | 2 | 7 | negative regulation of inflammatory response to antigenic stimulus |
GO:0033004 | 0.0096 | 17.7288 | 0.1554 | 2 | 7 | negative regulation of mast cell activation |
GO:0045346 | 0.0096 | 17.7288 | 0.1554 | 2 | 7 | regulation of MHC class II biosynthetic process |
GO:0046643 | 0.0096 | 17.7288 | 0.1554 | 2 | 7 | regulation of gamma-delta T cell activation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006342 | 0 | 8.2138 | 1.9634 | 13 | 67 | chromatin silencing |
GO:0002250 | 0 | 4.1313 | 6.3297 | 23 | 216 | adaptive immune response |
GO:0002366 | 0 | 4.6401 | 4.6886 | 19 | 160 | leukocyte activation involved in immune response |
GO:0002286 | 0 | 7.854 | 1.8755 | 12 | 64 | T cell activation involved in immune response |
GO:0032943 | 0 | 8.0367 | 1.5246 | 10 | 53 | mononuclear cell proliferation |
GO:0033141 | 0 | 18.3335 | 0.4982 | 6 | 17 | positive regulation of peptidyl-serine phosphorylation of STAT protein |
GO:0002323 | 0 | 16.8044 | 0.5275 | 6 | 18 | natural killer cell activation involved in immune response |
GO:0002252 | 0 | 4.2044 | 3.7289 | 14 | 131 | immune effector process |
GO:0002521 | 0 | 2.6261 | 10.7839 | 26 | 368 | leukocyte differentiation |
GO:0043330 | 1e-04 | 7.3597 | 1.1429 | 7 | 39 | response to exogenous dsRNA |
GO:0042100 | 1e-04 | 5.2374 | 1.9634 | 9 | 67 | B cell proliferation |
GO:0045087 | 1e-04 | 2.526 | 9.837 | 23 | 338 | innate immune response |
GO:0051249 | 2e-04 | 2.7399 | 7.5018 | 19 | 256 | regulation of lymphocyte activation |
GO:0006959 | 3e-04 | 4.7442 | 2.1392 | 9 | 73 | humoral immune response |
GO:0040029 | 4e-04 | 3.3127 | 4.2795 | 13 | 147 | regulation of gene expression, epigenetic |
GO:0043368 | 4e-04 | 9.8556 | 0.6447 | 5 | 22 | positive T cell selection |
GO:0002562 | 8e-04 | 5.2283 | 1.5238 | 7 | 52 | somatic diversification of immune receptors via germline recombination within a single locus |
GO:0008340 | 0.001 | 11.1452 | 0.4689 | 4 | 16 | determination of adult lifespan |
GO:0002443 | 0.0011 | 2.7919 | 5.3919 | 14 | 184 | leukocyte mediated immunity |
GO:0098542 | 0.0012 | 2.4703 | 7.3553 | 17 | 251 | defense response to other organism |
GO:0032944 | 0.0017 | 3.0694 | 3.8681 | 11 | 132 | regulation of mononuclear cell proliferation |
GO:0072540 | 0.0018 | 16.6825 | 0.2637 | 3 | 9 | T-helper 17 cell lineage commitment |
GO:0050865 | 0.0019 | 2.1838 | 9.7289 | 20 | 332 | regulation of cell activation |
GO:0030183 | 0.002 | 3.4837 | 2.8132 | 9 | 96 | B cell differentiation |
GO:0042113 | 0.0022 | 5.0033 | 1.3522 | 6 | 47 | B cell activation |
GO:0002520 | 0.0025 | 1.7623 | 20.4542 | 34 | 698 | immune system development |
GO:0002696 | 0.0028 | 2.6012 | 5.3333 | 13 | 182 | positive regulation of leukocyte activation |
GO:0009988 | 0.0033 | 5.5792 | 1.0256 | 5 | 35 | cell-cell recognition |
GO:0002227 | 0.0035 | 12.51 | 0.3223 | 3 | 11 | innate immune response in mucosa |
GO:0043373 | 0.0035 | 12.51 | 0.3223 | 3 | 11 | CD4-positive, alpha-beta T cell lineage commitment |
GO:0046632 | 0.0037 | 3.8522 | 1.9927 | 7 | 68 | alpha-beta T cell differentiation |
GO:0042110 | 0.0037 | 3.147 | 3.0787 | 9 | 110 | T cell activation |
GO:0019724 | 0.004 | 3.7897 | 2.022 | 7 | 69 | B cell mediated immunity |
GO:0043207 | 0.0042 | 1.9214 | 12.63 | 23 | 431 | response to external biotic stimulus |
GO:0007339 | 0.0048 | 6.683 | 0.7033 | 4 | 24 | binding of sperm to zona pellucida |
GO:0006334 | 0.0055 | 3.1997 | 2.696 | 8 | 92 | nucleosome assembly |
GO:0042129 | 0.0055 | 3.1997 | 2.696 | 8 | 92 | regulation of T cell proliferation |
GO:0032616 | 0.0057 | 10.0064 | 0.381 | 3 | 13 | interleukin-13 production |
GO:0072538 | 0.0057 | 10.0064 | 0.381 | 3 | 13 | T-helper 17 type immune response |
GO:0045321 | 0.0061 | 2.2646 | 6.5313 | 14 | 235 | leukocyte activation |
GO:0050830 | 0.0066 | 4.6472 | 1.2015 | 5 | 41 | defense response to Gram-positive bacterium |
GO:0050671 | 0.0068 | 3.4034 | 2.2271 | 7 | 76 | positive regulation of lymphocyte proliferation |
GO:0006950 | 0.0069 | 1.3772 | 67.8388 | 87 | 2315 | response to stress |
GO:0031341 | 0.0073 | 4.5213 | 1.2308 | 5 | 42 | regulation of cell killing |
GO:0002568 | 0.0081 | 22.1915 | 0.1465 | 2 | 5 | somatic diversification of T cell receptor genes |
GO:0030854 | 0.0081 | 22.1915 | 0.1465 | 2 | 5 | positive regulation of granulocyte differentiation |
GO:0033153 | 0.0081 | 22.1915 | 0.1465 | 2 | 5 | T cell receptor V(D)J recombination |
GO:2000646 | 0.0081 | 22.1915 | 0.1465 | 2 | 5 | positive regulation of receptor catabolic process |
GO:2001034 | 0.0081 | 22.1915 | 0.1465 | 2 | 5 | positive regulation of double-strand break repair via nonhomologous end joining |
GO:0050776 | 0.0083 | 1.8909 | 11.1062 | 20 | 379 | regulation of immune response |
GO:0006955 | 0.0083 | 2.9635 | 2.8854 | 8 | 105 | immune response |
GO:0030217 | 0.0084 | 2.9593 | 2.8932 | 8 | 100 | T cell differentiation |
GO:0019731 | 0.0087 | 8.3374 | 0.4396 | 3 | 15 | antibacterial humoral response |
GO:0045815 | 0.0087 | 8.3374 | 0.4396 | 3 | 15 | positive regulation of gene expression, epigenetic |
GO:0002697 | 0.009 | 2.2266 | 6.1538 | 13 | 210 | regulation of immune effector process |
GO:0006325 | 0.0092 | 1.7413 | 15.0632 | 25 | 529 | chromatin organization |
GO:1903037 | 0.0099 | 2.2851 | 5.5385 | 12 | 189 | regulation of leukocyte cell-cell adhesion |
GO:0006323 | 0.0099 | 2.5105 | 4.2198 | 10 | 144 | DNA packaging |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045653 | 0 | 145.9596 | 0.3863 | 13 | 17 | negative regulation of megakaryocyte differentiation |
GO:0006336 | 0 | 44.8797 | 0.5909 | 13 | 26 | DNA replication-independent nucleosome assembly |
GO:0006335 | 0 | 32.4007 | 0.7045 | 13 | 31 | DNA replication-dependent nucleosome assembly |
GO:0051290 | 0 | 20.0938 | 0.9545 | 13 | 42 | protein heterotetramerization |
GO:0006323 | 0 | 7.354 | 3.2725 | 20 | 144 | DNA packaging |
GO:0006333 | 0 | 7.8564 | 2.9316 | 19 | 129 | chromatin assembly or disassembly |
GO:0071824 | 0 | 5.9511 | 4.1361 | 21 | 182 | protein-DNA complex subunit organization |
GO:1903707 | 0 | 6.7379 | 2.4316 | 14 | 107 | negative regulation of hemopoiesis |
GO:0002682 | 0 | 3.0521 | 12.1722 | 33 | 547 | regulation of immune system process |
GO:0045637 | 0 | 5.1321 | 3.5452 | 16 | 156 | regulation of myeloid cell differentiation |
GO:0006342 | 0 | 7.767 | 1.5226 | 10 | 67 | chromatin silencing |
GO:0048534 | 0 | 2.5038 | 14.9989 | 34 | 660 | hematopoietic or lymphoid organ development |
GO:0043368 | 0 | 16.4308 | 0.5 | 6 | 22 | positive T cell selection |
GO:0002250 | 0 | 3.832 | 4.9087 | 17 | 216 | adaptive immune response |
GO:0098542 | 0 | 3.4683 | 5.7041 | 18 | 251 | defense response to other organism |
GO:0050830 | 0 | 9.0387 | 0.9317 | 7 | 41 | defense response to Gram-positive bacterium |
GO:0043207 | 0 | 2.6675 | 9.7947 | 24 | 431 | response to external biotic stimulus |
GO:0051276 | 1e-04 | 2.1083 | 20.2712 | 39 | 892 | chromosome organization |
GO:0043373 | 1e-04 | 24.8876 | 0.25 | 4 | 11 | CD4-positive, alpha-beta T cell lineage commitment |
GO:0045321 | 1e-04 | 2.4068 | 11.7037 | 26 | 515 | leukocyte activation |
GO:0042093 | 1e-04 | 9.0562 | 0.7954 | 6 | 35 | T-helper cell differentiation |
GO:0002293 | 2e-04 | 8.4707 | 0.8408 | 6 | 37 | alpha-beta T cell differentiation involved in immune response |
GO:0051259 | 4e-04 | 2.3556 | 10.4992 | 23 | 462 | protein oligomerization |
GO:0002360 | 6e-04 | 12.4371 | 0.4091 | 4 | 18 | T cell lineage commitment |
GO:0032634 | 9e-04 | 21.706 | 0.2045 | 3 | 9 | interleukin-5 production |
GO:0072540 | 9e-04 | 21.706 | 0.2045 | 3 | 9 | T-helper 17 cell lineage commitment |
GO:0042110 | 0.001 | 2.8022 | 5.3498 | 14 | 239 | T cell activation |
GO:0035710 | 0.001 | 5.8291 | 1.159 | 6 | 51 | CD4-positive, alpha-beta T cell activation |
GO:0006334 | 0.0011 | 5.7018 | 1.178 | 6 | 54 | nucleosome assembly |
GO:0030098 | 0.0016 | 2.6604 | 5.6132 | 14 | 247 | lymphocyte differentiation |
GO:0045087 | 0.0016 | 2.9055 | 4.4163 | 12 | 198 | innate immune response |
GO:0032656 | 0.0022 | 14.4673 | 0.2727 | 3 | 12 | regulation of interleukin-13 production |
GO:0072538 | 0.0028 | 13.0196 | 0.2954 | 3 | 13 | T-helper 17 type immune response |
GO:0031584 | 0.003 | 43.2815 | 0.0909 | 2 | 4 | activation of phospholipase D activity |
GO:0002286 | 0.0033 | 4.5181 | 1.4544 | 6 | 64 | T cell activation involved in immune response |
GO:0032673 | 0.0035 | 11.8351 | 0.3182 | 3 | 14 | regulation of interleukin-4 production |
GO:0050778 | 0.0039 | 2.3123 | 6.8631 | 15 | 302 | positive regulation of immune response |
GO:0040029 | 0.0039 | 2.8914 | 3.6815 | 10 | 162 | regulation of gene expression, epigenetic |
GO:0002757 | 0.0045 | 2.8348 | 3.7497 | 10 | 165 | immune response-activating signal transduction |
GO:0007189 | 0.0045 | 5.0673 | 1.0908 | 5 | 48 | adenylate cyclase-activating G-protein coupled receptor signaling pathway |
GO:0002568 | 0.0049 | 28.8521 | 0.1136 | 2 | 5 | somatic diversification of T cell receptor genes |
GO:0030854 | 0.0049 | 28.8521 | 0.1136 | 2 | 5 | positive regulation of granulocyte differentiation |
GO:0033153 | 0.0049 | 28.8521 | 0.1136 | 2 | 5 | T cell receptor V(D)J recombination |
GO:0051799 | 0.0049 | 28.8521 | 0.1136 | 2 | 5 | negative regulation of hair follicle development |
GO:0002218 | 0.0055 | 3.518 | 2.1362 | 7 | 94 | activation of innate immune response |
GO:0051249 | 0.0058 | 2.3587 | 5.8177 | 13 | 256 | regulation of lymphocyte activation |
GO:0002562 | 0.0064 | 4.6346 | 1.1817 | 5 | 52 | somatic diversification of immune receptors via germline recombination within a single locus |
GO:0032602 | 0.0064 | 4.6346 | 1.1817 | 5 | 52 | chemokine production |
GO:0045088 | 0.0076 | 2.7782 | 3.4316 | 9 | 151 | regulation of innate immune response |
GO:1902107 | 0.0081 | 3.2543 | 2.2953 | 7 | 101 | positive regulation of leukocyte differentiation |
GO:0009617 | 0.0084 | 2.2456 | 6.0905 | 13 | 268 | response to bacterium |
GO:0002697 | 0.0086 | 2.4288 | 4.7724 | 11 | 210 | regulation of immune effector process |
GO:0002376 | 0.0087 | 1.9217 | 10.4324 | 19 | 510 | immune system process |
GO:0032479 | 0.0094 | 4.1874 | 1.2954 | 5 | 57 | regulation of type I interferon production |
GO:0002443 | 0.0094 | 2.5215 | 4.1815 | 10 | 184 | leukocyte mediated immunity |
GO:0043029 | 0.0096 | 5.2687 | 0.8408 | 4 | 37 | T cell homeostasis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042401 | 0 | 38.2475 | 0.1742 | 4 | 10 | cellular biogenic amine biosynthetic process |
GO:0006595 | 0 | 28.6812 | 0.209 | 4 | 12 | polyamine metabolic process |
GO:0008295 | 1e-04 | 85.7087 | 0.0871 | 3 | 5 | spermidine biosynthetic process |
GO:0044106 | 1e-04 | 8.659 | 0.8012 | 6 | 46 | cellular amine metabolic process |
GO:0006597 | 3e-04 | Inf | 0.0348 | 2 | 2 | spermine biosynthetic process |
GO:0042700 | 3e-04 | Inf | 0.0348 | 2 | 2 | luteinizing hormone signaling pathway |
GO:0001539 | 5e-04 | 12.7375 | 0.3832 | 4 | 22 | cilium or flagellum-dependent cell motility |
GO:0046544 | 9e-04 | 113.7922 | 0.0523 | 2 | 3 | development of secondary male sexual characteristics |
GO:1990918 | 9e-04 | 113.7922 | 0.0523 | 2 | 3 | double-strand break repair involved in meiotic recombination |
GO:0007283 | 0.0011 | 2.6635 | 6.0266 | 15 | 346 | spermatogenesis |
GO:0007286 | 0.0011 | 4.1747 | 2.0727 | 8 | 119 | spermatid development |
GO:0022412 | 0.0014 | 2.8175 | 4.9293 | 13 | 283 | cellular process involved in reproduction in multicellular organism |
GO:0006344 | 0.0018 | 56.8918 | 0.0697 | 2 | 4 | maintenance of chromatin silencing |
GO:0016998 | 0.0018 | 56.8918 | 0.0697 | 2 | 4 | cell wall macromolecule catabolic process |
GO:0060486 | 0.0018 | 56.8918 | 0.0697 | 2 | 4 | Clara cell differentiation |
GO:0060294 | 0.0025 | 13.1749 | 0.2787 | 3 | 16 | cilium movement involved in cell motility |
GO:0003006 | 0.0027 | 2.1641 | 9.3534 | 19 | 537 | developmental process involved in reproduction |
GO:0009446 | 0.0029 | 37.925 | 0.0871 | 2 | 5 | putrescine biosynthetic process |
GO:0019530 | 0.0029 | 37.925 | 0.0871 | 2 | 5 | taurine metabolic process |
GO:0060510 | 0.0029 | 37.925 | 0.0871 | 2 | 5 | Type II pneumocyte differentiation |
GO:0071554 | 0.0029 | 37.925 | 0.0871 | 2 | 5 | cell wall organization or biogenesis |
GO:0070193 | 0.003 | 12.2329 | 0.2961 | 3 | 17 | synaptonemal complex organization |
GO:0006575 | 0.0034 | 3.8463 | 1.9508 | 7 | 112 | cellular modified amino acid metabolic process |
GO:0061053 | 0.0034 | 4.4277 | 1.4631 | 6 | 84 | somite development |
GO:0048732 | 0.0037 | 2.4074 | 6.166 | 14 | 354 | gland development |
GO:0000237 | 0.0043 | 28.4416 | 0.1045 | 2 | 6 | leptotene |
GO:0030317 | 0.0051 | 4.8636 | 1.1147 | 5 | 64 | flagellated sperm motility |
GO:0043009 | 0.0055 | 1.9804 | 10.712 | 20 | 615 | chordate embryonic development |
GO:0070286 | 0.0055 | 9.5116 | 0.3658 | 3 | 21 | axonemal dynein complex assembly |
GO:0060429 | 0.006 | 1.8471 | 13.8321 | 24 | 810 | epithelium development |
GO:0000183 | 0.006 | 22.7515 | 0.1219 | 2 | 7 | chromatin silencing at rDNA |
GO:0043950 | 0.006 | 22.7515 | 0.1219 | 2 | 7 | positive regulation of cAMP-mediated signaling |
GO:0051324 | 0.006 | 22.7515 | 0.1219 | 2 | 7 | prophase |
GO:0048598 | 0.0072 | 2.0004 | 9.5102 | 18 | 546 | embryonic morphogenesis |
GO:0007276 | 0.0078 | 2.0751 | 8.1342 | 16 | 467 | gamete generation |
GO:0032352 | 0.0079 | 18.9582 | 0.1393 | 2 | 8 | positive regulation of hormone metabolic process |
GO:0098762 | 0.0079 | 18.9582 | 0.1393 | 2 | 8 | meiotic cell cycle phase |
GO:0033032 | 0.0081 | 8.1509 | 0.418 | 3 | 24 | regulation of myeloid cell apoptotic process |
GO:0022602 | 0.0083 | 4.2802 | 1.2541 | 5 | 72 | ovulation cycle process |
GO:0060271 | 0.0084 | 2.5632 | 4.1106 | 10 | 236 | cilium assembly |
GO:0021575 | 0.0089 | 5.3218 | 0.8186 | 4 | 47 | hindbrain morphogenesis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006342 | 0 | 8.2242 | 1.4425 | 10 | 67 | chromatin silencing |
GO:0002694 | 0 | 3.1962 | 6.5019 | 19 | 302 | regulation of leukocyte activation |
GO:0045321 | 0 | 3.7604 | 4.3822 | 15 | 213 | leukocyte activation |
GO:0002250 | 1e-04 | 3.523 | 4.6504 | 15 | 216 | adaptive immune response |
GO:0050863 | 1e-04 | 3.7488 | 3.7892 | 13 | 176 | regulation of T cell activation |
GO:0002684 | 2e-04 | 3.3926 | 4.4846 | 14 | 214 | positive regulation of immune system process |
GO:0051251 | 2e-04 | 3.8017 | 3.4447 | 12 | 160 | positive regulation of lymphocyte activation |
GO:1903039 | 2e-04 | 4.4481 | 2.4759 | 10 | 115 | positive regulation of leukocyte cell-cell adhesion |
GO:0048251 | 2e-04 | 45.9158 | 0.1292 | 3 | 6 | elastic fiber assembly |
GO:0046632 | 6e-04 | 5.3203 | 1.464 | 7 | 68 | alpha-beta T cell differentiation |
GO:0040029 | 8e-04 | 3.4025 | 3.4878 | 11 | 162 | regulation of gene expression, epigenetic |
GO:0060326 | 9e-04 | 3.3137 | 3.5739 | 11 | 166 | cell chemotaxis |
GO:0050867 | 0.001 | 3.1006 | 4.1552 | 12 | 193 | positive regulation of cell activation |
GO:0042110 | 0.0011 | 3.816 | 2.5538 | 9 | 123 | T cell activation |
GO:0043368 | 0.0011 | 10.2277 | 0.4736 | 4 | 22 | positive T cell selection |
GO:0007155 | 0.0014 | 2.0504 | 13.0443 | 25 | 622 | cell adhesion |
GO:0046629 | 0.0014 | 17.2118 | 0.2368 | 3 | 11 | gamma-delta T cell activation |
GO:0050830 | 0.0018 | 6.4061 | 0.8827 | 5 | 41 | defense response to Gram-positive bacterium |
GO:1900017 | 0.0019 | 15.2982 | 0.2584 | 3 | 12 | positive regulation of cytokine production involved in inflammatory response |
GO:0050670 | 0.002 | 3.4572 | 2.7988 | 9 | 130 | regulation of lymphocyte proliferation |
GO:0032616 | 0.0024 | 13.7674 | 0.2799 | 3 | 13 | interleukin-13 production |
GO:0002437 | 0.0025 | 8.0012 | 0.5813 | 4 | 27 | inflammatory response to antigenic stimulus |
GO:0043207 | 0.0025 | 2.1733 | 9.2792 | 19 | 431 | response to external biotic stimulus |
GO:0070663 | 0.0028 | 3.2664 | 2.9495 | 9 | 137 | regulation of leukocyte proliferation |
GO:0006955 | 0.0029 | 3.9716 | 1.9029 | 7 | 96 | immune response |
GO:0002757 | 0.0031 | 3.0016 | 3.5524 | 10 | 165 | immune response-activating signal transduction |
GO:0019748 | 0.0033 | 7.36 | 0.6244 | 4 | 29 | secondary metabolic process |
GO:0002285 | 0.0034 | 3.4665 | 2.4759 | 8 | 115 | lymphocyte activation involved in immune response |
GO:0002768 | 0.0037 | 3.8111 | 1.9807 | 7 | 92 | immune response-regulating cell surface receptor signaling pathway |
GO:0002313 | 0.0037 | 11.4711 | 0.3229 | 3 | 15 | mature B cell differentiation involved in immune response |
GO:0002568 | 0.0044 | 30.5035 | 0.1076 | 2 | 5 | somatic diversification of T cell receptor genes |
GO:0033153 | 0.0044 | 30.5035 | 0.1076 | 2 | 5 | T cell receptor V(D)J recombination |
GO:0022407 | 0.0046 | 2.4277 | 5.6623 | 13 | 263 | regulation of cell-cell adhesion |
GO:0045785 | 0.0048 | 2.4179 | 5.6838 | 13 | 264 | positive regulation of cell adhesion |
GO:0042102 | 0.0051 | 4.9026 | 1.1195 | 5 | 52 | positive regulation of T cell proliferation |
GO:0045582 | 0.0051 | 4.9026 | 1.1195 | 5 | 52 | positive regulation of T cell differentiation |
GO:0006954 | 0.0052 | 2.2354 | 7.084 | 15 | 333 | inflammatory response |
GO:0042113 | 0.0059 | 2.7174 | 3.8968 | 10 | 181 | B cell activation |
GO:0050778 | 0.0059 | 2.2711 | 6.5019 | 14 | 302 | positive regulation of immune response |
GO:0050851 | 0.0062 | 3.9011 | 1.6578 | 6 | 77 | antigen receptor-mediated signaling pathway |
GO:0002360 | 0.0063 | 9.1747 | 0.3875 | 3 | 18 | T cell lineage commitment |
GO:0000237 | 0.0065 | 22.8759 | 0.1292 | 2 | 6 | leptotene |
GO:0019886 | 0.0065 | 22.8759 | 0.1292 | 2 | 6 | antigen processing and presentation of exogenous peptide antigen via MHC class II |
GO:0036066 | 0.0065 | 22.8759 | 0.1292 | 2 | 6 | protein O-linked fucosylation |
GO:0032946 | 0.0066 | 3.8466 | 1.6793 | 6 | 78 | positive regulation of mononuclear cell proliferation |
GO:0031349 | 0.0071 | 2.6392 | 4.0045 | 10 | 186 | positive regulation of defense response |
GO:0009620 | 0.0074 | 8.6007 | 0.4091 | 3 | 19 | response to fungus |
GO:0042832 | 0.0074 | 8.6007 | 0.4091 | 3 | 19 | defense response to protozoan |
GO:0002260 | 0.0075 | 4.4295 | 1.2272 | 5 | 57 | lymphocyte homeostasis |
GO:0045619 | 0.0083 | 3.2357 | 2.3037 | 7 | 107 | regulation of lymphocyte differentiation |
GO:0019835 | 0.0086 | 8.0941 | 0.4306 | 3 | 20 | cytolysis |
GO:0045087 | 0.0087 | 2.0983 | 7.5138 | 15 | 349 | innate immune response |
GO:0002263 | 0.0088 | 2.7095 | 3.5093 | 9 | 163 | cell activation involved in immune response |
GO:0032074 | 0.009 | 18.2993 | 0.1507 | 2 | 7 | negative regulation of nuclease activity |
GO:0033029 | 0.009 | 18.2993 | 0.1507 | 2 | 7 | regulation of neutrophil apoptotic process |
GO:0045586 | 0.009 | 18.2993 | 0.1507 | 2 | 7 | regulation of gamma-delta T cell differentiation |
GO:0051324 | 0.009 | 18.2993 | 0.1507 | 2 | 7 | prophase |
GO:0030098 | 0.0099 | 2.8543 | 2.9646 | 8 | 140 | lymphocyte differentiation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045653 | 0 | 97.7267 | 0.563 | 13 | 17 | negative regulation of megakaryocyte differentiation |
GO:0006335 | 0 | 24.7961 | 1.0266 | 14 | 31 | DNA replication-dependent nucleosome assembly |
GO:0006336 | 0 | 30.0488 | 0.861 | 13 | 26 | DNA replication-independent nucleosome assembly |
GO:0051290 | 0 | 13.4535 | 1.3909 | 13 | 42 | protein heterotetramerization |
GO:0034728 | 0 | 5.4356 | 3.9078 | 18 | 118 | nucleosome organization |
GO:0031497 | 0 | 5.632 | 3.5766 | 17 | 108 | chromatin assembly |
GO:0071103 | 0 | 4.1297 | 5.7954 | 21 | 175 | DNA conformation change |
GO:1903707 | 0 | 5.2883 | 3.5435 | 16 | 107 | negative regulation of hemopoiesis |
GO:0065004 | 0 | 4.2484 | 5.0999 | 19 | 154 | protein-DNA complex assembly |
GO:0002323 | 0 | 18.8618 | 0.5961 | 7 | 18 | natural killer cell activation involved in immune response |
GO:0045637 | 0 | 4.1858 | 5.1662 | 19 | 156 | regulation of myeloid cell differentiation |
GO:0002366 | 0 | 4.0658 | 5.2986 | 19 | 160 | leukocyte activation involved in immune response |
GO:0033141 | 0 | 16.1302 | 0.563 | 6 | 17 | positive regulation of peptidyl-serine phosphorylation of STAT protein |
GO:0002252 | 0 | 2.5338 | 13.3791 | 31 | 404 | immune effector process |
GO:0002682 | 0 | 2.0434 | 25.0692 | 47 | 757 | regulation of immune system process |
GO:0051259 | 0 | 2.3462 | 15.2998 | 33 | 462 | protein oligomerization |
GO:0048534 | 0 | 2.0873 | 21.8569 | 42 | 660 | hematopoietic or lymphoid organ development |
GO:0002286 | 0 | 5.5085 | 2.1195 | 10 | 64 | T cell activation involved in immune response |
GO:0002250 | 1e-04 | 2.8973 | 7.1532 | 19 | 216 | adaptive immune response |
GO:0032943 | 1e-04 | 3.0324 | 6.1266 | 17 | 185 | mononuclear cell proliferation |
GO:0046649 | 1e-04 | 2.2189 | 14.5713 | 30 | 440 | lymphocyte activation |
GO:0043330 | 3e-04 | 6.4732 | 1.2915 | 7 | 39 | response to exogenous dsRNA |
GO:0071285 | 3e-04 | 16.8266 | 0.3643 | 4 | 11 | cellular response to lithium ion |
GO:2001034 | 3e-04 | 44.0864 | 0.1656 | 3 | 5 | positive regulation of double-strand break repair via nonhomologous end joining |
GO:0042100 | 3e-04 | 4.6037 | 2.2188 | 9 | 67 | B cell proliferation |
GO:0045830 | 4e-04 | 9.8318 | 0.6623 | 5 | 20 | positive regulation of isotype switching |
GO:0006996 | 6e-04 | 1.4407 | 94.2828 | 123 | 2847 | organelle organization |
GO:0090502 | 6e-04 | 8.6738 | 0.7286 | 5 | 22 | RNA phosphodiester bond hydrolysis, endonucleolytic |
GO:0060179 | 7e-04 | 29.3886 | 0.1987 | 3 | 6 | male mating behavior |
GO:0032438 | 9e-04 | 11.7759 | 0.4636 | 4 | 14 | melanosome organization |
GO:0002714 | 0.001 | 7.7596 | 0.7948 | 5 | 24 | positive regulation of B cell mediated immunity |
GO:0006427 | 0.0011 | Inf | 0.0662 | 2 | 2 | histidyl-tRNA aminoacylation |
GO:0000726 | 0.0012 | 5.7148 | 1.2253 | 6 | 37 | non-recombinational repair |
GO:0030183 | 0.0013 | 3.4502 | 3.1792 | 10 | 96 | B cell differentiation |
GO:0002204 | 0.0014 | 5.5358 | 1.2584 | 6 | 38 | somatic recombination of immunoglobulin genes involved in immune response |
GO:0090305 | 0.0016 | 3.3332 | 3.2785 | 10 | 99 | nucleic acid phosphodiester bond hydrolysis |
GO:0006907 | 0.002 | 9.0562 | 0.563 | 4 | 17 | pinocytosis |
GO:0002312 | 0.0024 | 4.2218 | 1.8545 | 7 | 56 | B cell activation involved in immune response |
GO:0002381 | 0.0024 | 4.9191 | 1.3909 | 6 | 42 | immunoglobulin production involved in immunoglobulin mediated immune response |
GO:0032570 | 0.0026 | 14.6909 | 0.298 | 3 | 9 | response to progesterone |
GO:0045087 | 0.003 | 2.0147 | 11.5577 | 22 | 349 | innate immune response |
GO:0032259 | 0.0031 | 2.1844 | 8.7428 | 18 | 264 | methylation |
GO:0050864 | 0.0031 | 3.2502 | 3.0136 | 9 | 91 | regulation of B cell activation |
GO:1901666 | 0.0032 | 58.6531 | 0.0993 | 2 | 3 | positive regulation of NAD+ ADP-ribosyltransferase activity |
GO:1903679 | 0.0032 | 58.6531 | 0.0993 | 2 | 3 | positive regulation of cap-independent translational initiation |
GO:0044550 | 0.0036 | 12.5912 | 0.3312 | 3 | 10 | secondary metabolite biosynthetic process |
GO:0001775 | 0.0038 | 1.7269 | 20.168 | 33 | 609 | cell activation |
GO:0002701 | 0.0038 | 7.3565 | 0.6623 | 4 | 20 | negative regulation of production of molecular mediator of immune response |
GO:0006379 | 0.0038 | 7.3565 | 0.6623 | 4 | 20 | mRNA cleavage |
GO:0032801 | 0.0038 | 7.3565 | 0.6623 | 4 | 20 | receptor catabolic process |
GO:0002637 | 0.0039 | 4.4259 | 1.5234 | 6 | 46 | regulation of immunoglobulin production |
GO:0071822 | 0.0041 | 1.519 | 38.3821 | 55 | 1159 | protein complex subunit organization |
GO:0070271 | 0.0045 | 1.54 | 34.3419 | 50 | 1037 | protein complex biogenesis |
GO:0001510 | 0.0048 | 4.2144 | 1.5896 | 6 | 48 | RNA methylation |
GO:0016445 | 0.0048 | 4.2144 | 1.5896 | 6 | 48 | somatic diversification of immunoglobulins |
GO:0002889 | 0.0049 | 5.0799 | 1.126 | 5 | 34 | regulation of immunoglobulin mediated immune response |
GO:0006289 | 0.0053 | 4.1161 | 1.6227 | 6 | 49 | nucleotide-excision repair |
GO:0006396 | 0.0054 | 1.6423 | 23.0822 | 36 | 697 | RNA processing |
GO:0051054 | 0.0055 | 2.2993 | 6.4577 | 14 | 195 | positive regulation of DNA metabolic process |
GO:0050688 | 0.0059 | 4.0223 | 1.6558 | 6 | 50 | regulation of defense response to virus |
GO:0007619 | 0.0063 | 29.3243 | 0.1325 | 2 | 4 | courtship behavior |
GO:0048023 | 0.0063 | 29.3243 | 0.1325 | 2 | 4 | positive regulation of melanin biosynthetic process |
GO:0052200 | 0.0063 | 29.3243 | 0.1325 | 2 | 4 | response to host defenses |
GO:0070375 | 0.0063 | 29.3243 | 0.1325 | 2 | 4 | ERK5 cascade |
GO:1902746 | 0.0063 | 29.3243 | 0.1325 | 2 | 4 | regulation of lens fiber cell differentiation |
GO:1904688 | 0.0063 | 29.3243 | 0.1325 | 2 | 4 | regulation of cytoplasmic translational initiation |
GO:0033059 | 0.0063 | 4.7514 | 1.1922 | 5 | 36 | cellular pigmentation |
GO:0006582 | 0.0063 | 9.7917 | 0.3974 | 3 | 12 | melanin metabolic process |
GO:0035563 | 0.0063 | 9.7917 | 0.3974 | 3 | 12 | positive regulation of chromatin binding |
GO:0000470 | 0.0064 | 6.1935 | 0.7617 | 4 | 23 | maturation of LSU-rRNA |
GO:0007259 | 0.0065 | 2.6924 | 3.974 | 10 | 120 | JAK-STAT cascade |
GO:0002562 | 0.0072 | 3.8468 | 1.7221 | 6 | 52 | somatic diversification of immune receptors via germline recombination within a single locus |
GO:0065003 | 0.0073 | 1.4476 | 43.8132 | 60 | 1323 | macromolecular complex assembly |
GO:0000479 | 0.0081 | 8.8118 | 0.4305 | 3 | 13 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) |
GO:0006517 | 0.0081 | 8.8118 | 0.4305 | 3 | 13 | protein deglycosylation |
GO:0040015 | 0.0081 | 8.8118 | 0.4305 | 3 | 13 | negative regulation of multicellular organism growth |
GO:1901987 | 0.0084 | 2.1133 | 7.4843 | 15 | 226 | regulation of cell cycle phase transition |
GO:0044260 | 0.0088 | 1.2641 | 198.0038 | 223 | 5979 | cellular macromolecule metabolic process |
GO:0000724 | 0.0092 | 2.9182 | 2.9474 | 8 | 89 | double-strand break repair via homologous recombination |
GO:0006367 | 0.0094 | 3.6104 | 1.8214 | 6 | 55 | transcription initiation from RNA polymerase II promoter |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006342 | 0 | 7.1085 | 2.2489 | 13 | 67 | chromatin silencing |
GO:0002323 | 0 | 18.5971 | 0.6042 | 7 | 18 | natural killer cell activation involved in immune response |
GO:0002366 | 0 | 3.7605 | 5.3704 | 18 | 160 | leukocyte activation involved in immune response |
GO:0002286 | 0 | 6.1008 | 2.1482 | 11 | 64 | T cell activation involved in immune response |
GO:0090304 | 0 | 1.5568 | 124.325 | 166 | 3704 | nucleic acid metabolic process |
GO:0033141 | 0 | 15.9044 | 0.5706 | 6 | 17 | positive regulation of peptidyl-serine phosphorylation of STAT protein |
GO:1901360 | 0 | 1.5171 | 146.0081 | 188 | 4350 | organic cyclic compound metabolic process |
GO:0046483 | 0 | 1.5088 | 141.1411 | 182 | 4205 | heterocycle metabolic process |
GO:0006725 | 0 | 1.5048 | 142.2824 | 183 | 4239 | cellular aromatic compound metabolic process |
GO:0030183 | 1e-04 | 4.1988 | 3.2222 | 12 | 96 | B cell differentiation |
GO:0044260 | 1e-04 | 1.4252 | 200.6856 | 239 | 5979 | cellular macromolecule metabolic process |
GO:0006396 | 2e-04 | 1.9336 | 23.3949 | 42 | 697 | RNA processing |
GO:0034641 | 2e-04 | 1.4167 | 155.3392 | 191 | 4628 | cellular nitrogen compound metabolic process |
GO:0043330 | 3e-04 | 6.3824 | 1.309 | 7 | 39 | response to exogenous dsRNA |
GO:0040029 | 4e-04 | 3.005 | 5.4375 | 15 | 162 | regulation of gene expression, epigenetic |
GO:0042100 | 4e-04 | 4.5388 | 2.2489 | 9 | 67 | B cell proliferation |
GO:0006959 | 7e-04 | 4.1114 | 2.4503 | 9 | 73 | humoral immune response |
GO:0006427 | 0.0011 | Inf | 0.0671 | 2 | 2 | histidyl-tRNA aminoacylation |
GO:0051276 | 0.0014 | 1.6718 | 29.94 | 47 | 892 | chromosome organization |
GO:0008104 | 0.0014 | 1.457 | 68.3049 | 92 | 2035 | protein localization |
GO:0015031 | 0.0014 | 1.5306 | 48.3337 | 69 | 1440 | protein transport |
GO:0032943 | 0.0014 | 2.5938 | 6.2095 | 15 | 185 | mononuclear cell proliferation |
GO:0034498 | 0.0019 | 17.3852 | 0.2685 | 3 | 8 | early endosome to Golgi transport |
GO:0042886 | 0.0019 | 1.5052 | 49.777 | 70 | 1483 | amide transport |
GO:0045780 | 0.0021 | 8.93 | 0.5706 | 4 | 17 | positive regulation of bone resorption |
GO:0006367 | 0.0023 | 4.2496 | 1.8461 | 7 | 55 | transcription initiation from RNA polymerase II promoter |
GO:0002250 | 0.0026 | 2.3516 | 7.2501 | 16 | 216 | adaptive immune response |
GO:0000724 | 0.0029 | 3.285 | 2.9873 | 9 | 89 | double-strand break repair via homologous recombination |
GO:0051253 | 0.003 | 1.5764 | 33.6322 | 50 | 1002 | negative regulation of RNA metabolic process |
GO:0034660 | 0.0031 | 1.9437 | 13.0568 | 24 | 389 | ncRNA metabolic process |
GO:1903507 | 0.0031 | 1.5948 | 31.2155 | 47 | 930 | negative regulation of nucleic acid-templated transcription |
GO:0090481 | 0.0033 | 57.8389 | 0.1007 | 2 | 3 | pyrimidine nucleotide-sugar transmembrane transport |
GO:0002697 | 0.0049 | 2.2568 | 7.0487 | 15 | 210 | regulation of immune effector process |
GO:0055089 | 0.0051 | 10.8632 | 0.3692 | 3 | 11 | fatty acid homeostasis |
GO:0001510 | 0.0051 | 4.1554 | 1.6111 | 6 | 48 | RNA methylation |
GO:0048278 | 0.0051 | 4.1554 | 1.6111 | 6 | 48 | vesicle docking |
GO:0006281 | 0.0052 | 1.8849 | 12.8554 | 23 | 383 | DNA repair |
GO:0045648 | 0.0057 | 6.4469 | 0.7384 | 4 | 22 | positive regulation of erythrocyte differentiation |
GO:0033135 | 0.006 | 2.7294 | 3.9271 | 10 | 117 | regulation of peptidyl-serine phosphorylation |
GO:0048023 | 0.0064 | 28.9172 | 0.1343 | 2 | 4 | positive regulation of melanin biosynthetic process |
GO:1902746 | 0.0064 | 28.9172 | 0.1343 | 2 | 4 | regulation of lens fiber cell differentiation |
GO:0000470 | 0.0067 | 6.1072 | 0.772 | 4 | 23 | maturation of LSU-rRNA |
GO:0048194 | 0.0067 | 6.1072 | 0.772 | 4 | 23 | Golgi vesicle budding |
GO:0034105 | 0.0078 | 5.8013 | 0.8056 | 4 | 24 | positive regulation of tissue remodeling |
GO:0032259 | 0.0079 | 2.0203 | 8.8612 | 17 | 264 | methylation |
GO:0060055 | 0.0084 | 8.6892 | 0.4363 | 3 | 13 | angiogenesis involved in wound healing |
GO:2000726 | 0.0084 | 8.6892 | 0.4363 | 3 | 13 | negative regulation of cardiac muscle cell differentiation |
GO:0071824 | 0.0085 | 2.2511 | 6.1088 | 13 | 182 | protein-DNA complex subunit organization |
GO:0071702 | 0.0085 | 1.3657 | 64.5792 | 83 | 1924 | organic substance transport |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0033141 | 0 | 23.9908 | 0.3851 | 6 | 17 | positive regulation of peptidyl-serine phosphorylation of STAT protein |
GO:0002323 | 0 | 21.9899 | 0.4077 | 6 | 18 | natural killer cell activation involved in immune response |
GO:0006342 | 0 | 7.7941 | 1.5176 | 10 | 67 | chromatin silencing |
GO:0006959 | 0 | 6.2229 | 1.6535 | 9 | 73 | humoral immune response |
GO:0042100 | 1e-04 | 5.9822 | 1.5176 | 8 | 67 | B cell proliferation |
GO:0043330 | 2e-04 | 7.9835 | 0.8834 | 6 | 39 | response to exogenous dsRNA |
GO:0042700 | 5e-04 | Inf | 0.0453 | 2 | 2 | luteinizing hormone signaling pathway |
GO:1904970 | 5e-04 | Inf | 0.0453 | 2 | 2 | brush border assembly |
GO:0002286 | 6e-04 | 5.4006 | 1.4497 | 7 | 64 | T cell activation involved in immune response |
GO:0040029 | 0.0012 | 3.224 | 3.6694 | 11 | 162 | regulation of gene expression, epigenetic |
GO:0030183 | 0.0015 | 4.0018 | 2.1745 | 8 | 96 | B cell differentiation |
GO:0010756 | 0.0015 | 86.8638 | 0.068 | 2 | 3 | positive regulation of plasminogen activation |
GO:0035964 | 0.0015 | 86.8638 | 0.068 | 2 | 3 | COPI-coated vesicle budding |
GO:0002250 | 0.0038 | 2.6016 | 4.8926 | 12 | 216 | adaptive immune response |
GO:0002263 | 0.004 | 2.8823 | 3.6921 | 10 | 163 | cell activation involved in immune response |
GO:0019221 | 0.0043 | 2.5633 | 4.9605 | 12 | 219 | cytokine-mediated signaling pathway |
GO:0034764 | 0.0044 | 3.3177 | 2.5822 | 8 | 114 | positive regulation of transmembrane transport |
GO:0032532 | 0.0049 | 28.9502 | 0.1133 | 2 | 5 | regulation of microvillus length |
GO:0031295 | 0.0052 | 10.0469 | 0.3624 | 3 | 16 | T cell costimulation |
GO:1904064 | 0.0061 | 3.4503 | 2.1745 | 7 | 96 | positive regulation of cation transmembrane transport |
GO:1903169 | 0.0068 | 3.374 | 2.2198 | 7 | 98 | regulation of calcium ion transmembrane transport |
GO:0031113 | 0.0078 | 5.6287 | 0.7928 | 4 | 35 | regulation of microtubule polymerization |
GO:0006936 | 0.0079 | 2.4624 | 4.7114 | 11 | 208 | muscle contraction |
GO:0070972 | 0.0086 | 5.4523 | 0.8154 | 4 | 36 | protein localization to endoplasmic reticulum |
GO:0032943 | 0.0096 | 2.5157 | 4.1904 | 10 | 185 | mononuclear cell proliferation |
GO:0019896 | 0.01 | 17.3674 | 0.1586 | 2 | 7 | axonal transport of mitochondrion |
GO:0042364 | 0.01 | 17.3674 | 0.1586 | 2 | 7 | water-soluble vitamin biosynthetic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007155 | 0 | 2.3651 | 17.4193 | 37 | 886 | cell adhesion |
GO:0030240 | 1e-04 | 50.4269 | 0.118 | 3 | 6 | skeletal muscle thin filament assembly |
GO:0001580 | 6e-04 | 25.2077 | 0.1769 | 3 | 9 | detection of chemical stimulus involved in sensory perception of bitter taste |
GO:0055002 | 8e-04 | 4.0052 | 2.4379 | 9 | 124 | striated muscle cell development |
GO:0045019 | 0.0011 | 18.9029 | 0.2163 | 3 | 11 | negative regulation of nitric oxide biosynthetic process |
GO:0036414 | 0.0011 | 100.4828 | 0.059 | 2 | 3 | histone citrullination |
GO:0061209 | 0.0011 | 100.4828 | 0.059 | 2 | 3 | cell proliferation involved in mesonephros development |
GO:0030879 | 0.0018 | 3.8499 | 2.2413 | 8 | 114 | mammary gland development |
GO:0060979 | 0.0019 | 15.12 | 0.2556 | 3 | 13 | vasculogenesis involved in coronary vascular morphogenesis |
GO:0009952 | 0.0019 | 3.0175 | 3.8928 | 11 | 198 | anterior/posterior pattern specification |
GO:0003097 | 0.0023 | 50.2375 | 0.0786 | 2 | 4 | renal water transport |
GO:0051480 | 0.0028 | 2.8621 | 4.0894 | 11 | 208 | regulation of cytosolic calcium ion concentration |
GO:1901861 | 0.0033 | 3.485 | 2.4576 | 8 | 125 | regulation of muscle tissue development |
GO:0048513 | 0.0034 | 1.511 | 48.0899 | 66 | 2446 | animal organ development |
GO:0006884 | 0.0035 | 11.6281 | 0.3146 | 3 | 16 | cell volume homeostasis |
GO:0045542 | 0.0037 | 33.4891 | 0.0983 | 2 | 5 | positive regulation of cholesterol biosynthetic process |
GO:0060681 | 0.0037 | 33.4891 | 0.0983 | 2 | 5 | branch elongation involved in ureteric bud branching |
GO:0071688 | 0.0037 | 33.4891 | 0.0983 | 2 | 5 | striated muscle myosin thick filament assembly |
GO:0072179 | 0.0037 | 33.4891 | 0.0983 | 2 | 5 | nephric duct formation |
GO:0048634 | 0.0038 | 3.3971 | 2.5166 | 8 | 128 | regulation of muscle organ development |
GO:2000756 | 0.0041 | 5.1673 | 1.0617 | 5 | 54 | regulation of peptidyl-lysine acetylation |
GO:0030513 | 0.0043 | 6.7356 | 0.6685 | 4 | 34 | positive regulation of BMP signaling pathway |
GO:0048015 | 0.0044 | 3.6694 | 2.0447 | 7 | 104 | phosphatidylinositol-mediated signaling |
GO:0007267 | 0.0045 | 1.7176 | 20.5257 | 33 | 1044 | cell-cell signaling |
GO:0045165 | 0.0047 | 2.6565 | 4.3843 | 11 | 223 | cell fate commitment |
GO:0042127 | 0.0047 | 1.6525 | 24.6544 | 38 | 1254 | regulation of cell proliferation |
GO:0050710 | 0.0047 | 6.5179 | 0.6881 | 4 | 35 | negative regulation of cytokine secretion |
GO:2000351 | 0.0047 | 6.5179 | 0.6881 | 4 | 35 | regulation of endothelial cell apoptotic process |
GO:0061138 | 0.0049 | 2.7929 | 3.7945 | 10 | 193 | morphogenesis of a branching epithelium |
GO:0043901 | 0.0049 | 3.5947 | 2.084 | 7 | 106 | negative regulation of multi-organism process |
GO:0031058 | 0.0052 | 4.0588 | 1.5925 | 6 | 81 | positive regulation of histone modification |
GO:0001755 | 0.0052 | 6.3137 | 0.7078 | 4 | 36 | neural crest cell migration |
GO:0007275 | 0.0053 | 1.4141 | 74.6317 | 94 | 3796 | multicellular organism development |
GO:0055080 | 0.0054 | 2.0581 | 9.2405 | 18 | 470 | cation homeostasis |
GO:0003180 | 0.0055 | 25.1149 | 0.118 | 2 | 6 | aortic valve morphogenesis |
GO:0007182 | 0.0055 | 25.1149 | 0.118 | 2 | 6 | common-partner SMAD protein phosphorylation |
GO:0019695 | 0.0055 | 25.1149 | 0.118 | 2 | 6 | choline metabolic process |
GO:0061218 | 0.0055 | 25.1149 | 0.118 | 2 | 6 | negative regulation of mesonephros development |
GO:0061312 | 0.0055 | 25.1149 | 0.118 | 2 | 6 | BMP signaling pathway involved in heart development |
GO:0072205 | 0.0055 | 25.1149 | 0.118 | 2 | 6 | metanephric collecting duct development |
GO:1901723 | 0.0055 | 25.1149 | 0.118 | 2 | 6 | negative regulation of cell proliferation involved in kidney development |
GO:1904706 | 0.0055 | 25.1149 | 0.118 | 2 | 6 | negative regulation of vascular smooth muscle cell proliferation |
GO:0048514 | 0.0055 | 2.1042 | 8.5327 | 17 | 434 | blood vessel morphogenesis |
GO:0060675 | 0.0055 | 4.7759 | 1.1403 | 5 | 58 | ureteric bud morphogenesis |
GO:0033599 | 0.0058 | 9.4457 | 0.3736 | 3 | 19 | regulation of mammary gland epithelial cell proliferation |
GO:0048646 | 0.0058 | 1.7611 | 16.8885 | 28 | 859 | anatomical structure formation involved in morphogenesis |
GO:0071773 | 0.0064 | 3.0854 | 2.7525 | 8 | 140 | cellular response to BMP stimulus |
GO:0033002 | 0.0065 | 2.8507 | 3.3423 | 9 | 170 | muscle cell proliferation |
GO:0098771 | 0.0072 | 1.9985 | 9.4961 | 18 | 483 | inorganic ion homeostasis |
GO:0044057 | 0.0074 | 2.1428 | 7.3727 | 15 | 375 | regulation of system process |
GO:0045765 | 0.0075 | 2.7807 | 3.4209 | 9 | 174 | regulation of angiogenesis |
GO:0033029 | 0.0076 | 20.0904 | 0.1376 | 2 | 7 | regulation of neutrophil apoptotic process |
GO:0048743 | 0.0076 | 20.0904 | 0.1376 | 2 | 7 | positive regulation of skeletal muscle fiber development |
GO:0060363 | 0.0076 | 20.0904 | 0.1376 | 2 | 7 | cranial suture morphogenesis |
GO:0003197 | 0.0077 | 5.6105 | 0.7864 | 4 | 40 | endocardial cushion development |
GO:0098661 | 0.0077 | 5.6105 | 0.7864 | 4 | 40 | inorganic anion transmembrane transport |
GO:0001759 | 0.0077 | 8.3949 | 0.4129 | 3 | 21 | organ induction |
GO:0014031 | 0.0079 | 4.3625 | 1.2386 | 5 | 63 | mesenchymal cell development |
GO:0003008 | 0.0081 | 1.772 | 14.9517 | 25 | 784 | system process |
GO:0090287 | 0.0082 | 2.5784 | 4.0894 | 10 | 208 | regulation of cellular response to growth factor stimulus |
GO:0048483 | 0.0084 | 5.4584 | 0.8061 | 4 | 41 | autonomic nervous system development |
GO:0045844 | 0.0084 | 4.2882 | 1.2583 | 5 | 64 | positive regulation of striated muscle tissue development |
GO:0048864 | 0.0084 | 4.2882 | 1.2583 | 5 | 64 | stem cell development |
GO:0002697 | 0.0087 | 2.5522 | 4.1287 | 10 | 210 | regulation of immune effector process |
GO:0048705 | 0.0087 | 2.5522 | 4.1287 | 10 | 210 | skeletal system morphogenesis |
GO:0023019 | 0.0088 | 7.9524 | 0.4325 | 3 | 22 | signal transduction involved in regulation of gene expression |
GO:0014033 | 0.0089 | 4.2164 | 1.2779 | 5 | 65 | neural crest cell differentiation |
GO:0070848 | 0.0092 | 1.9859 | 9.0046 | 17 | 458 | response to growth factor |
GO:0002831 | 0.0095 | 3.5367 | 1.8088 | 6 | 92 | regulation of response to biotic stimulus |
GO:0072078 | 0.0095 | 4.147 | 1.2976 | 5 | 66 | nephron tubule morphogenesis |
GO:0031032 | 0.0096 | 2.8659 | 2.9491 | 8 | 150 | actomyosin structure organization |
GO:0001944 | 0.0098 | 1.8935 | 10.5577 | 19 | 537 | vasculature development |
GO:0046622 | 0.0099 | 5.1777 | 0.8454 | 4 | 43 | positive regulation of organ growth |
GO:0002407 | 0.01 | 16.7407 | 0.1573 | 2 | 8 | dendritic cell chemotaxis |
GO:0007042 | 0.01 | 16.7407 | 0.1573 | 2 | 8 | lysosomal lumen acidification |
GO:0031033 | 0.01 | 16.7407 | 0.1573 | 2 | 8 | myosin filament organization |
GO:0048739 | 0.01 | 16.7407 | 0.1573 | 2 | 8 | cardiac muscle fiber development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006342 | 0 | 7.1948 | 1.4525 | 9 | 67 | chromatin silencing |
GO:0007267 | 1e-04 | 2.0426 | 22.6329 | 42 | 1044 | cell-cell signaling |
GO:0001958 | 2e-04 | 11.4623 | 0.542 | 5 | 25 | endochondral ossification |
GO:2001012 | 2e-04 | 45.5889 | 0.1301 | 3 | 6 | mesenchymal cell differentiation involved in renal system development |
GO:0040029 | 2e-04 | 3.7229 | 3.512 | 12 | 162 | regulation of gene expression, epigenetic |
GO:0043269 | 5e-04 | 2.3176 | 10.6661 | 23 | 492 | regulation of ion transport |
GO:0006565 | 5e-04 | Inf | 0.0434 | 2 | 2 | L-serine catabolic process |
GO:0009946 | 5e-04 | Inf | 0.0434 | 2 | 2 | proximal/distal axis specification |
GO:0048389 | 5e-04 | Inf | 0.0434 | 2 | 2 | intermediate mesoderm development |
GO:0061227 | 5e-04 | Inf | 0.0434 | 2 | 2 | pattern specification involved in mesonephros development |
GO:0072098 | 5e-04 | Inf | 0.0434 | 2 | 2 | anterior/posterior pattern specification involved in kidney development |
GO:0086098 | 5e-04 | Inf | 0.0434 | 2 | 2 | angiotensin-activated signaling pathway involved in heart process |
GO:0007218 | 5e-04 | 6.7224 | 1.0189 | 6 | 47 | neuropeptide signaling pathway |
GO:0098660 | 6e-04 | 2.3779 | 9.4737 | 21 | 437 | inorganic ion transmembrane transport |
GO:0002504 | 8e-04 | 22.7892 | 0.1951 | 3 | 9 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II |
GO:0051899 | 8e-04 | 5.1135 | 1.5175 | 7 | 70 | membrane depolarization |
GO:0007268 | 0.0011 | 2.2492 | 9.9723 | 21 | 460 | chemical synaptic transmission |
GO:0099537 | 0.0011 | 2.2439 | 9.994 | 21 | 461 | trans-synaptic signaling |
GO:0002028 | 0.0012 | 4.7357 | 1.6259 | 7 | 75 | regulation of sodium ion transport |
GO:0035993 | 0.0014 | 90.875 | 0.065 | 2 | 3 | deltoid tuberosity development |
GO:0061792 | 0.0014 | 90.875 | 0.065 | 2 | 3 | secretory granule maturation |
GO:0072190 | 0.0014 | 90.875 | 0.065 | 2 | 3 | ureter urothelium development |
GO:0030001 | 0.0015 | 2.0417 | 13.0724 | 25 | 603 | metal ion transport |
GO:0003148 | 0.0016 | 9.1378 | 0.5203 | 4 | 24 | outflow tract septum morphogenesis |
GO:0034762 | 0.0019 | 2.4228 | 7.024 | 16 | 324 | regulation of transmembrane transport |
GO:0006936 | 0.002 | 2.839 | 4.5092 | 12 | 208 | muscle contraction |
GO:0003008 | 0.0022 | 1.8592 | 17.2694 | 30 | 822 | system process |
GO:0042415 | 0.0025 | 13.6693 | 0.2818 | 3 | 13 | norepinephrine metabolic process |
GO:0072074 | 0.0025 | 13.6693 | 0.2818 | 3 | 13 | kidney mesenchyme development |
GO:1904062 | 0.0025 | 2.7534 | 4.6393 | 12 | 214 | regulation of cation transmembrane transport |
GO:0044236 | 0.0026 | 4.0728 | 1.8644 | 7 | 86 | multicellular organism metabolic process |
GO:0003013 | 0.0027 | 2.3372 | 7.2625 | 16 | 335 | circulatory system process |
GO:0050801 | 0.0027 | 2.0369 | 11.4682 | 22 | 529 | ion homeostasis |
GO:0086103 | 0.0027 | 45.7517 | 0.0861 | 2 | 4 | G-protein coupled receptor signaling pathway involved in heart process |
GO:0035990 | 0.0027 | 45.434 | 0.0867 | 2 | 4 | tendon cell differentiation |
GO:0060279 | 0.0027 | 45.434 | 0.0867 | 2 | 4 | positive regulation of ovulation |
GO:0060686 | 0.0027 | 45.434 | 0.0867 | 2 | 4 | negative regulation of prostatic bud formation |
GO:0070779 | 0.0027 | 45.434 | 0.0867 | 2 | 4 | D-aspartate import |
GO:0072162 | 0.0027 | 45.434 | 0.0867 | 2 | 4 | metanephric mesenchymal cell differentiation |
GO:2001259 | 0.0028 | 5.7224 | 0.9756 | 5 | 45 | positive regulation of cation channel activity |
GO:0008344 | 0.0028 | 4.0216 | 1.8861 | 7 | 87 | adult locomotory behavior |
GO:0010954 | 0.0031 | 12.4257 | 0.3035 | 3 | 14 | positive regulation of protein processing |
GO:0097094 | 0.0031 | 12.4257 | 0.3035 | 3 | 14 | craniofacial suture morphogenesis |
GO:0007155 | 0.0031 | 1.7767 | 19.2076 | 32 | 886 | cell adhesion |
GO:0032963 | 0.0032 | 4.5114 | 1.4525 | 6 | 67 | collagen metabolic process |
GO:0031639 | 0.0038 | 11.3894 | 0.3252 | 3 | 15 | plasminogen activation |
GO:0051956 | 0.0038 | 11.3894 | 0.3252 | 3 | 15 | negative regulation of amino acid transport |
GO:1904385 | 0.0038 | 11.3894 | 0.3252 | 3 | 15 | cellular response to angiotensin |
GO:0030501 | 0.0043 | 6.7651 | 0.672 | 4 | 31 | positive regulation of bone mineralization |
GO:0035725 | 0.0043 | 4.2325 | 1.5392 | 6 | 71 | sodium ion transmembrane transport |
GO:0048706 | 0.0044 | 3.3163 | 2.5798 | 8 | 119 | embryonic skeletal system development |
GO:0044036 | 0.0045 | 30.287 | 0.1084 | 2 | 5 | cell wall macromolecule metabolic process |
GO:0072104 | 0.0045 | 30.287 | 0.1084 | 2 | 5 | glomerular capillary formation |
GO:0072239 | 0.0045 | 30.287 | 0.1084 | 2 | 5 | metanephric glomerulus vasculature development |
GO:0072111 | 0.0046 | 10.5125 | 0.3469 | 3 | 16 | cell proliferation involved in kidney development |
GO:1903861 | 0.0046 | 10.5125 | 0.3469 | 3 | 16 | positive regulation of dendrite extension |
GO:0051952 | 0.0053 | 4.0448 | 1.6042 | 6 | 74 | regulation of amine transport |
GO:0048002 | 0.0054 | 6.2976 | 0.7154 | 4 | 33 | antigen processing and presentation of peptide antigen |
GO:0032412 | 0.0058 | 3.1542 | 2.7018 | 8 | 126 | regulation of ion transmembrane transporter activity |
GO:0032890 | 0.0061 | 4.6681 | 1.1707 | 5 | 54 | regulation of organic acid transport |
GO:0032411 | 0.0065 | 3.873 | 1.6693 | 6 | 77 | positive regulation of transporter activity |
GO:0003085 | 0.0065 | 9.1094 | 0.3902 | 3 | 18 | negative regulation of systemic arterial blood pressure |
GO:0060004 | 0.0065 | 9.1094 | 0.3902 | 3 | 18 | reflex |
GO:0061437 | 0.0065 | 9.1094 | 0.3902 | 3 | 18 | renal system vasculature development |
GO:0061844 | 0.0065 | 9.1094 | 0.3902 | 3 | 18 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0015672 | 0.0065 | 2.1762 | 7.2625 | 15 | 335 | monovalent inorganic cation transport |
GO:0003057 | 0.0066 | 22.7135 | 0.1301 | 2 | 6 | regulation of the force of heart contraction by chemical signal |
GO:0003180 | 0.0066 | 22.7135 | 0.1301 | 2 | 6 | aortic valve morphogenesis |
GO:0010459 | 0.0066 | 22.7135 | 0.1301 | 2 | 6 | negative regulation of heart rate |
GO:0019886 | 0.0066 | 22.7135 | 0.1301 | 2 | 6 | antigen processing and presentation of exogenous peptide antigen via MHC class II |
GO:0030916 | 0.0066 | 22.7135 | 0.1301 | 2 | 6 | otic vesicle formation |
GO:0035989 | 0.0066 | 22.7135 | 0.1301 | 2 | 6 | tendon development |
GO:0042940 | 0.0066 | 22.7135 | 0.1301 | 2 | 6 | D-amino acid transport |
GO:0061439 | 0.0066 | 22.7135 | 0.1301 | 2 | 6 | kidney vasculature morphogenesis |
GO:0090080 | 0.0066 | 22.7135 | 0.1301 | 2 | 6 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway |
GO:0014048 | 0.0076 | 8.5394 | 0.4119 | 3 | 19 | regulation of glutamate secretion |
GO:0055065 | 0.0078 | 2.022 | 8.845 | 17 | 408 | metal ion homeostasis |
GO:0034767 | 0.0082 | 3.245 | 2.298 | 7 | 106 | positive regulation of ion transmembrane transport |
GO:0001508 | 0.0086 | 3.2123 | 2.3197 | 7 | 107 | action potential |
GO:0072507 | 0.0087 | 2.1621 | 6.8072 | 14 | 314 | divalent inorganic cation homeostasis |
GO:0003272 | 0.0087 | 8.0365 | 0.4336 | 3 | 20 | endocardial cushion formation |
GO:1901018 | 0.0087 | 8.0365 | 0.4336 | 3 | 20 | positive regulation of potassium ion transmembrane transporter activity |
GO:0009712 | 0.0089 | 5.3694 | 0.8238 | 4 | 38 | catechol-containing compound metabolic process |
GO:0021798 | 0.0092 | 18.1694 | 0.1518 | 2 | 7 | forebrain dorsal/ventral pattern formation |
GO:0060235 | 0.0092 | 18.1694 | 0.1518 | 2 | 7 | lens induction in camera-type eye |
GO:0072201 | 0.0092 | 18.1694 | 0.1518 | 2 | 7 | negative regulation of mesenchymal cell proliferation |
GO:0098712 | 0.0092 | 18.1694 | 0.1518 | 2 | 7 | L-glutamate import across plasma membrane |
GO:0008406 | 0.0092 | 2.6898 | 3.5337 | 9 | 163 | gonad development |
GO:0006171 | 0.0092 | 3.5696 | 1.7994 | 6 | 83 | cAMP biosynthetic process |
GO:0030799 | 0.0095 | 3.1489 | 2.363 | 7 | 109 | regulation of cyclic nucleotide metabolic process |
GO:0030816 | 0.0096 | 4.1569 | 1.3007 | 5 | 60 | positive regulation of cAMP metabolic process |
GO:0010524 | 0.0098 | 5.2156 | 0.8455 | 4 | 39 | positive regulation of calcium ion transport into cytosol |
GO:2000649 | 0.0098 | 5.2156 | 0.8455 | 4 | 39 | regulation of sodium ion transmembrane transporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004867 | 6e-04 | 8.5355 | 0.6899 | 5 | 32 | serine-type endopeptidase inhibitor activity |
GO:0004745 | 8e-04 | 22.9211 | 0.194 | 3 | 9 | retinol dehydrogenase activity |
GO:0015459 | 0.0013 | 6.9804 | 0.8192 | 5 | 38 | potassium channel regulator activity |
GO:0031433 | 0.0027 | 45.6958 | 0.0862 | 2 | 4 | telethonin binding |
GO:0016298 | 0.0045 | 4.1925 | 1.5522 | 6 | 72 | lipase activity |
GO:0050431 | 0.0054 | 9.8173 | 0.3665 | 3 | 17 | transforming growth factor beta binding |
GO:0005267 | 0.0058 | 3.4763 | 2.1558 | 7 | 100 | potassium channel activity |
GO:0030414 | 0.0059 | 3.9517 | 1.6384 | 6 | 76 | peptidase inhibitor activity |
GO:0098641 | 0.0064 | 9.1621 | 0.3881 | 3 | 18 | cadherin binding involved in cell-cell adhesion |
GO:0005509 | 0.0064 | 2.067 | 8.6665 | 17 | 402 | calcium ion binding |
GO:0022838 | 0.0065 | 2.244 | 6.5753 | 14 | 305 | substrate-specific channel activity |
GO:0061135 | 0.0067 | 3.8413 | 1.6816 | 6 | 78 | endopeptidase regulator activity |
GO:0016247 | 0.0076 | 3.2977 | 2.2636 | 7 | 105 | channel regulator activity |
GO:0000979 | 0.0081 | 4.3396 | 1.2504 | 5 | 58 | RNA polymerase II core promoter sequence-specific DNA binding |
GO:0005089 | 0.0081 | 4.3396 | 1.2504 | 5 | 58 | Rho guanyl-nucleotide exchange factor activity |
GO:0016814 | 0.0099 | 7.6333 | 0.4527 | 3 | 21 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines |
GO:0022803 | 0.01 | 2.1243 | 6.9203 | 14 | 321 | passive transmembrane transporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004014 | 4e-04 | Inf | 0.04 | 2 | 2 | adenosylmethionine decarboxylase activity |
GO:0019810 | 4e-04 | Inf | 0.04 | 2 | 2 | putrescine binding |
GO:0046965 | 6e-04 | 12.4297 | 0.3997 | 4 | 20 | retinoid X receptor binding |
GO:0017127 | 0.0012 | 18.5852 | 0.2199 | 3 | 11 | cholesterol transporter activity |
GO:0016829 | 0.0012 | 3.7395 | 2.5982 | 9 | 130 | lyase activity |
GO:0043546 | 0.0023 | 49.3962 | 0.0799 | 2 | 4 | molybdopterin cofactor binding |
GO:0005125 | 0.0031 | 3.5164 | 2.4384 | 8 | 122 | cytokine activity |
GO:0051575 | 0.0038 | 32.9283 | 0.0999 | 2 | 5 | 5'-deoxyribose-5-phosphate lyase activity |
GO:0005126 | 0.0042 | 2.8555 | 3.7175 | 10 | 186 | cytokine receptor binding |
GO:0042975 | 0.0044 | 10.6153 | 0.3398 | 3 | 17 | peroxisome proliferator activated receptor binding |
GO:0003680 | 0.0078 | 19.754 | 0.1399 | 2 | 7 | AT DNA binding |
GO:0031683 | 0.008 | 8.2538 | 0.4197 | 3 | 21 | G-protein beta/gamma-subunit complex binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004872 | 0 | 2.7973 | 17.0245 | 42 | 722 | receptor activity |
GO:0004871 | 0 | 2.5739 | 19.2881 | 44 | 818 | signal transducer activity |
GO:0004888 | 0 | 2.7417 | 11.2347 | 28 | 484 | transmembrane signaling receptor activity |
GO:0005126 | 0 | 3.764 | 4.3858 | 15 | 186 | cytokine receptor binding |
GO:0051916 | 6e-04 | Inf | 0.0472 | 2 | 2 | granulocyte colony-stimulating factor binding |
GO:0005125 | 6e-04 | 3.7857 | 2.8767 | 10 | 122 | cytokine activity |
GO:0004896 | 8e-04 | 6.1582 | 1.1082 | 6 | 47 | cytokine receptor activity |
GO:0001614 | 0.0031 | 12.5327 | 0.3065 | 3 | 13 | purinergic nucleotide receptor activity |
GO:0043546 | 0.0032 | 41.6677 | 0.0943 | 2 | 4 | molybdopterin cofactor binding |
GO:0022803 | 0.004 | 2.235 | 7.5691 | 16 | 321 | passive transmembrane transporter activity |
GO:0022838 | 0.0059 | 2.199 | 7.1918 | 15 | 305 | substrate-specific channel activity |
GO:0030545 | 0.0078 | 2.1922 | 6.7202 | 14 | 285 | receptor regulator activity |
GO:0008239 | 0.0078 | 20.8307 | 0.1415 | 2 | 6 | dipeptidyl-peptidase activity |
GO:0005031 | 0.0081 | 8.3519 | 0.4244 | 3 | 18 | tumor necrosis factor-activated receptor activity |
GO:0015108 | 0.0094 | 4.1916 | 1.2969 | 5 | 55 | chloride transmembrane transporter activity |
GO:0005261 | 0.0097 | 2.2874 | 5.5176 | 12 | 234 | cation channel activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005132 | 0 | 28.7787 | 0.3815 | 6 | 13 | type I interferon receptor binding |
GO:0030545 | 8e-04 | 2.4322 | 8.3629 | 19 | 285 | receptor regulator activity |
GO:0008187 | 0.0029 | 7.8532 | 0.6162 | 4 | 21 | poly-pyrimidine tract binding |
GO:0008409 | 0.0058 | 9.9925 | 0.3815 | 3 | 13 | 5'-3' exonuclease activity |
GO:0001602 | 0.0081 | 22.1607 | 0.1467 | 2 | 5 | pancreatic polypeptide receptor activity |
GO:0045545 | 0.0081 | 22.1607 | 0.1467 | 2 | 5 | syndecan binding |
GO:0005125 | 0.0098 | 2.673 | 3.5799 | 9 | 122 | cytokine activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0060089 | 0 | 2.4768 | 18.001 | 40 | 761 | molecular transducer activity |
GO:0099600 | 0 | 2.676 | 13.2228 | 32 | 559 | transmembrane receptor activity |
GO:0038023 | 0 | 2.5753 | 14.1454 | 33 | 598 | signaling receptor activity |
GO:0005126 | 0 | 4.0386 | 4.3997 | 16 | 186 | cytokine receptor binding |
GO:0022836 | 1e-04 | 3.291 | 5.2986 | 16 | 224 | gated channel activity |
GO:0022838 | 1e-04 | 2.8535 | 7.2146 | 19 | 305 | substrate-specific channel activity |
GO:0022803 | 2e-04 | 2.6989 | 7.5931 | 19 | 321 | passive transmembrane transporter activity |
GO:0099094 | 5e-04 | 5.6595 | 1.3956 | 7 | 59 | ligand-gated cation channel activity |
GO:0022835 | 0.001 | 7.473 | 0.7806 | 5 | 33 | transmitter-gated channel activity |
GO:0004977 | 0.0016 | 83.0701 | 0.071 | 2 | 3 | melanocortin receptor activity |
GO:0042562 | 0.0022 | 4.9306 | 1.3483 | 6 | 57 | hormone binding |
GO:0001614 | 0.0031 | 12.4917 | 0.3075 | 3 | 13 | purinergic nucleotide receptor activity |
GO:0043546 | 0.0032 | 41.5318 | 0.0946 | 2 | 4 | molybdopterin cofactor binding |
GO:0005125 | 0.0033 | 3.4969 | 2.4633 | 8 | 105 | cytokine activity |
GO:0046914 | 0.0035 | 1.8299 | 16.227 | 28 | 686 | transition metal ion binding |
GO:0004497 | 0.0044 | 5.0984 | 1.0881 | 5 | 46 | monooxygenase activity |
GO:0004896 | 0.0049 | 4.9766 | 1.1118 | 5 | 47 | cytokine receptor activity |
GO:0044323 | 0.0053 | 27.6858 | 0.1183 | 2 | 5 | retinoic acid-responsive element binding |
GO:0015276 | 0.0055 | 6.297 | 0.7202 | 4 | 31 | ligand-gated ion channel activity |
GO:0005234 | 0.0058 | 9.6068 | 0.3785 | 3 | 16 | extracellularly glutamate-gated ion channel activity |
GO:0004970 | 0.007 | 8.9199 | 0.4021 | 3 | 17 | ionotropic glutamate receptor activity |
GO:0008009 | 0.007 | 8.9199 | 0.4021 | 3 | 17 | chemokine activity |
GO:0005509 | 0.0073 | 1.9912 | 9.5091 | 18 | 402 | calcium ion binding |
GO:0003700 | 0.0085 | 1.6296 | 21.3836 | 33 | 904 | DNA binding transcription factor activity |
GO:0005231 | 0.0094 | 7.8714 | 0.4457 | 3 | 19 | excitatory extracellular ligand-gated ion channel activity |
GO:0050660 | 0.0095 | 4.1778 | 1.301 | 5 | 55 | flavin adenine dinucleotide binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004014 | 3e-04 | Inf | 0.0347 | 2 | 2 | adenosylmethionine decarboxylase activity |
GO:0019810 | 3e-04 | Inf | 0.0347 | 2 | 2 | putrescine binding |
GO:0019828 | 9e-04 | 114.1391 | 0.0521 | 2 | 3 | aspartic-type endopeptidase inhibitor activity |
GO:0005149 | 0.006 | 22.8209 | 0.1216 | 2 | 7 | interleukin-1 receptor binding |
GO:0005261 | 0.0078 | 2.5947 | 4.0638 | 10 | 234 | cation channel activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004014 | 3e-04 | Inf | 0.0326 | 2 | 2 | adenosylmethionine decarboxylase activity |
GO:0019810 | 3e-04 | Inf | 0.0326 | 2 | 2 | putrescine binding |
GO:0051575 | 0.0026 | 40.5494 | 0.0816 | 2 | 5 | 5'-deoxyribose-5-phosphate lyase activity |
GO:0005125 | 0.0038 | 3.7578 | 1.9909 | 7 | 122 | cytokine activity |
GO:0046965 | 0.004 | 10.7721 | 0.3264 | 3 | 20 | retinoid X receptor binding |
GO:0003680 | 0.0053 | 24.3259 | 0.1142 | 2 | 7 | AT DNA binding |
GO:0015179 | 0.0061 | 5.9722 | 0.7343 | 4 | 45 | L-amino acid transmembrane transporter activity |
GO:0030169 | 0.007 | 20.2701 | 0.1305 | 2 | 8 | low-density lipoprotein particle binding |
GO:0030545 | 0.0072 | 2.4955 | 4.6508 | 11 | 285 | receptor regulator activity |
GO:0005310 | 0.0084 | 7.9583 | 0.4243 | 3 | 26 | dicarboxylic acid transmembrane transporter activity |
GO:0001848 | 0.0088 | 17.373 | 0.1469 | 2 | 9 | complement binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0043621 | 4e-04 | 7.1522 | 0.9544 | 6 | 50 | protein self-association |
GO:0005509 | 0.0019 | 2.3597 | 7.6735 | 17 | 402 | calcium ion binding |
GO:0016833 | 0.0021 | 51.7866 | 0.0764 | 2 | 4 | oxo-acid-lyase activity |
GO:0031433 | 0.0021 | 51.7866 | 0.0764 | 2 | 4 | telethonin binding |
GO:0015081 | 0.0028 | 3.9921 | 1.8897 | 7 | 99 | sodium ion transmembrane transporter activity |
GO:0015291 | 0.0038 | 3.1175 | 3.0732 | 9 | 161 | secondary active transmembrane transporter activity |
GO:0003700 | 0.0041 | 1.7934 | 17.2558 | 29 | 904 | DNA binding transcription factor activity |
GO:0005501 | 0.0045 | 10.3881 | 0.3436 | 3 | 18 | retinoid binding |
GO:0033265 | 0.0052 | 25.8893 | 0.1145 | 2 | 6 | choline binding |
GO:0015298 | 0.0062 | 9.1646 | 0.3818 | 3 | 20 | solute:cation antiporter activity |
GO:0099516 | 0.0063 | 5.9506 | 0.7444 | 4 | 39 | ion antiporter activity |
GO:0005451 | 0.0072 | 20.7099 | 0.1336 | 2 | 7 | monovalent cation:proton antiporter activity |
GO:0031995 | 0.0072 | 20.7099 | 0.1336 | 2 | 7 | insulin-like growth factor II binding |
GO:0008081 | 0.0074 | 4.422 | 1.2216 | 5 | 64 | phosphoric diester hydrolase activity |
GO:0033293 | 0.0075 | 5.6281 | 0.7826 | 4 | 41 | monocarboxylic acid binding |
GO:0071855 | 0.0081 | 8.1986 | 0.4199 | 3 | 22 | neuropeptide receptor binding |
GO:0000980 | 0.009 | 4.2071 | 1.2789 | 5 | 67 | RNA polymerase II distal enhancer sequence-specific DNA binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0015075 | 1e-04 | 2.5938 | 10.1392 | 24 | 602 | ion transmembrane transporter activity |
GO:0015464 | 0.0012 | 17.7351 | 0.219 | 3 | 13 | acetylcholine receptor activity |
GO:0022892 | 0.0016 | 2.0352 | 13.2214 | 25 | 785 | substrate-specific transporter activity |
GO:0005332 | 0.0017 | 58.8879 | 0.0674 | 2 | 4 | gamma-aminobutyric acid:sodium symporter activity |
GO:0031433 | 0.0017 | 58.8879 | 0.0674 | 2 | 4 | telethonin binding |
GO:0022838 | 0.002 | 2.6969 | 5.137 | 13 | 305 | substrate-specific channel activity |
GO:0005261 | 0.0021 | 2.976 | 3.9412 | 11 | 234 | cation channel activity |
GO:0022803 | 0.0031 | 2.5536 | 5.4065 | 13 | 321 | passive transmembrane transporter activity |
GO:0005501 | 0.0032 | 11.8189 | 0.3032 | 3 | 18 | retinoid binding |
GO:0015077 | 0.0039 | 2.7268 | 4.278 | 11 | 254 | monovalent inorganic cation transmembrane transporter activity |
GO:0042165 | 0.0043 | 10.4269 | 0.3369 | 3 | 20 | neurotransmitter binding |
GO:0022836 | 0.0047 | 2.8081 | 3.7727 | 10 | 224 | gated channel activity |
GO:0033293 | 0.0049 | 6.4068 | 0.6905 | 4 | 41 | monocarboxylic acid binding |
GO:0005230 | 0.0079 | 5.5103 | 0.7916 | 4 | 47 | extracellular ligand-gated ion channel activity |
GO:0046873 | 0.0085 | 2.3306 | 5.4233 | 12 | 322 | metal ion transmembrane transporter activity |
GO:0004143 | 0.0094 | 16.8187 | 0.1516 | 2 | 9 | diacylglycerol kinase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004623 | 0.0013 | 16.9578 | 0.2287 | 3 | 13 | phospholipase A2 activity |
GO:0017080 | 0.0014 | 9.4517 | 0.4926 | 4 | 28 | sodium channel regulator activity |
GO:0005179 | 0.0032 | 5.4649 | 1.0027 | 5 | 57 | hormone activity |
GO:0071253 | 0.0044 | 28.1545 | 0.1055 | 2 | 6 | connexin binding |
GO:0030545 | 0.0046 | 2.5331 | 5.0135 | 12 | 285 | receptor regulator activity |
GO:0038036 | 0.008 | 18.7668 | 0.1407 | 2 | 8 | sphingosine-1-phosphate receptor activity |
GO:0016298 | 0.0087 | 4.2365 | 1.2666 | 5 | 72 | lipase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0048248 | 6e-04 | Inf | 0.0478 | 2 | 2 | CXCR3 chemokine receptor binding |
GO:0005031 | 7e-04 | 11.815 | 0.4298 | 4 | 18 | tumor necrosis factor-activated receptor activity |
GO:0042165 | 0.0011 | 10.3365 | 0.4776 | 4 | 20 | neurotransmitter binding |
GO:0022890 | 0.0012 | 2.2778 | 9.3606 | 20 | 392 | inorganic cation transmembrane transporter activity |
GO:0015075 | 0.0013 | 2.0045 | 14.3752 | 27 | 602 | ion transmembrane transporter activity |
GO:0030594 | 0.0013 | 5.5357 | 1.2178 | 6 | 51 | neurotransmitter receptor activity |
GO:0060089 | 0.0013 | 1.8829 | 18.1719 | 32 | 761 | molecular transducer activity |
GO:0015276 | 0.0014 | 4.0649 | 2.1491 | 8 | 90 | ligand-gated ion channel activity |
GO:0048018 | 0.0014 | 2.5876 | 6.1847 | 15 | 259 | receptor ligand activity |
GO:0005261 | 0.0015 | 2.6748 | 5.5877 | 14 | 234 | cation channel activity |
GO:0005412 | 0.0017 | 82.265 | 0.0716 | 2 | 3 | glucose:sodium symporter activity |
GO:0046870 | 0.0017 | 82.265 | 0.0716 | 2 | 3 | cadmium ion binding |
GO:0005126 | 0.0017 | 2.8903 | 4.4415 | 12 | 186 | cytokine receptor binding |
GO:0022803 | 0.0019 | 2.3583 | 7.6652 | 17 | 321 | passive transmembrane transporter activity |
GO:0099600 | 0.002 | 1.9915 | 13.3484 | 25 | 559 | transmembrane receptor activity |
GO:0022838 | 0.0028 | 2.3298 | 7.2831 | 16 | 305 | substrate-specific channel activity |
GO:0022892 | 0.0041 | 1.7539 | 18.745 | 31 | 785 | substrate-specific transporter activity |
GO:0015294 | 0.0052 | 4.0787 | 1.5999 | 6 | 67 | solute:cation symporter activity |
GO:0048495 | 0.0054 | 27.4175 | 0.1194 | 2 | 5 | Roundabout binding |
GO:0008009 | 0.0072 | 8.8332 | 0.4059 | 3 | 17 | chemokine activity |
GO:0022824 | 0.0076 | 5.6972 | 0.788 | 4 | 33 | transmitter-gated ion channel activity |
GO:0022836 | 0.0076 | 2.3652 | 5.3489 | 12 | 224 | gated channel activity |
GO:0016709 | 0.0084 | 8.2437 | 0.4298 | 3 | 18 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen |
GO:0005231 | 0.0093 | 5.3288 | 0.8358 | 4 | 35 | excitatory extracellular ligand-gated ion channel activity |
GO:0015081 | 0.0095 | 3.1576 | 2.364 | 7 | 99 | sodium ion transmembrane transporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005132 | 0 | 38.7257 | 0.2871 | 6 | 13 | type I interferon receptor binding |
GO:0005125 | 0 | 5.9768 | 2.6941 | 14 | 122 | cytokine activity |
GO:0030545 | 0 | 3.716 | 6.2935 | 21 | 285 | receptor regulator activity |
GO:0060089 | 1e-04 | 2.2106 | 16.8048 | 34 | 761 | molecular transducer activity |
GO:0038023 | 1e-04 | 2.2987 | 13.2053 | 28 | 598 | signaling receptor activity |
GO:0005164 | 3e-04 | 10.221 | 0.5962 | 5 | 27 | tumor necrosis factor receptor binding |
GO:0099600 | 3e-04 | 2.2724 | 12.3441 | 26 | 559 | transmembrane receptor activity |
GO:0004896 | 6e-04 | 6.5945 | 1.0379 | 6 | 47 | cytokine receptor activity |
GO:0005070 | 0.0012 | 9.9626 | 0.4858 | 4 | 22 | SH3/SH2 adaptor activity |
GO:0016502 | 0.0026 | 13.4116 | 0.2871 | 3 | 13 | nucleotide receptor activity |
GO:0046934 | 0.0028 | 44.5802 | 0.0883 | 2 | 4 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity |
GO:0005126 | 0.0045 | 2.8353 | 3.7462 | 10 | 173 | cytokine receptor binding |
GO:0045028 | 0.0047 | 29.7179 | 0.1104 | 2 | 5 | G-protein coupled purinergic nucleotide receptor activity |
GO:0051575 | 0.0047 | 29.7179 | 0.1104 | 2 | 5 | 5'-deoxyribose-5-phosphate lyase activity |
GO:0003700 | 0.0055 | 1.7012 | 19.9626 | 32 | 904 | DNA binding transcription factor activity |
GO:0035586 | 0.0058 | 9.5768 | 0.3754 | 3 | 17 | purinergic receptor activity |
GO:0042975 | 0.0058 | 9.5768 | 0.3754 | 3 | 17 | peroxisome proliferator activated receptor binding |
GO:0008239 | 0.0069 | 22.2867 | 0.1325 | 2 | 6 | dipeptidyl-peptidase activity |
GO:0034511 | 0.0069 | 22.2867 | 0.1325 | 2 | 6 | U3 snoRNA binding |
GO:0035005 | 0.0069 | 22.2867 | 0.1325 | 2 | 6 | 1-phosphatidylinositol-4-phosphate 3-kinase activity |
GO:0046965 | 0.0092 | 7.885 | 0.4416 | 3 | 20 | retinoid X receptor binding |
GO:0003680 | 0.0095 | 17.828 | 0.1546 | 2 | 7 | AT DNA binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005132 | 0 | 29.0108 | 0.3785 | 6 | 13 | type I interferon receptor binding |
GO:0097677 | 0 | 33.6779 | 0.233 | 4 | 8 | STAT family protein binding |
GO:0004704 | 1e-04 | 100.7953 | 0.1165 | 3 | 4 | NF-kappaB-inducing kinase activity |
GO:0005125 | 2e-04 | 3.7212 | 3.5525 | 12 | 122 | cytokine activity |
GO:0016422 | 0.0025 | 67.0233 | 0.0874 | 2 | 3 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity |
GO:0003684 | 0.0035 | 4.4996 | 1.4851 | 6 | 51 | damaged DNA binding |
GO:0030545 | 0.0042 | 2.1659 | 8.2989 | 17 | 285 | receptor regulator activity |
GO:1990381 | 0.007 | 9.1561 | 0.4077 | 3 | 14 | ubiquitin-specific protease binding |
GO:0004563 | 0.008 | 22.3376 | 0.1456 | 2 | 5 | beta-N-acetylhexosaminidase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 5.5463 | 3.7424 | 18 | 165 | histone binding |
GO:0015026 | 0.0035 | 11.8591 | 0.3175 | 3 | 14 | coreceptor activity |
GO:0003677 | 0.0052 | 1.5181 | 38.2407 | 54 | 1686 | DNA binding |
GO:0003823 | 0.0063 | 6.0095 | 0.7485 | 4 | 33 | antigen binding |
GO:0008373 | 0.0073 | 8.694 | 0.4083 | 3 | 18 | sialyltransferase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004014 | 3e-04 | Inf | 0.0347 | 2 | 2 | adenosylmethionine decarboxylase activity |
GO:0019810 | 3e-04 | Inf | 0.0347 | 2 | 2 | putrescine binding |
GO:0019840 | 5e-04 | 12.7768 | 0.3821 | 4 | 22 | isoprenoid binding |
GO:0001972 | 6e-04 | 24.554 | 0.1737 | 3 | 10 | retinoic acid binding |
GO:0051959 | 8e-04 | 10.949 | 0.4342 | 4 | 25 | dynein light intermediate chain binding |
GO:0019828 | 9e-04 | 114.1391 | 0.0521 | 2 | 3 | aspartic-type endopeptidase inhibitor activity |
GO:0003796 | 0.0018 | 57.0652 | 0.0695 | 2 | 4 | lysozyme activity |
GO:1990939 | 0.0034 | 7.1793 | 0.6252 | 4 | 36 | ATP-dependent microtubule motor activity |
GO:0016810 | 0.0043 | 4.2235 | 1.5283 | 6 | 88 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds |
GO:0045503 | 0.0055 | 9.5408 | 0.3647 | 3 | 21 | dynein light chain binding |
GO:0019841 | 0.006 | 22.8209 | 0.1216 | 2 | 7 | retinol binding |
GO:0045505 | 0.0071 | 8.5854 | 0.3994 | 3 | 23 | dynein intermediate chain binding |
GO:0004000 | 0.01 | 16.2981 | 0.1563 | 2 | 9 | adenosine deaminase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0035005 | 2e-04 | 47.2058 | 0.1258 | 3 | 6 | 1-phosphatidylinositol-4-phosphate 3-kinase activity |
GO:0019958 | 4e-04 | Inf | 0.0419 | 2 | 2 | C-X-C chemokine binding |
GO:0016303 | 7e-04 | 23.5975 | 0.1886 | 3 | 9 | 1-phosphatidylinositol-3-kinase activity |
GO:0005044 | 0.0012 | 9.9619 | 0.4821 | 4 | 23 | scavenger receptor activity |
GO:0016494 | 0.0013 | 94.0863 | 0.0629 | 2 | 3 | C-X-C chemokine receptor activity |
GO:0033829 | 0.0013 | 94.0863 | 0.0629 | 2 | 3 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity |
GO:0016641 | 0.0013 | 17.6954 | 0.2306 | 3 | 11 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor |
GO:0046934 | 0.0026 | 47.0396 | 0.0838 | 2 | 4 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity |
GO:0004872 | 0.005 | 1.8212 | 15.1329 | 26 | 722 | receptor activity |
GO:0001727 | 0.0062 | 23.5162 | 0.1258 | 2 | 6 | lipid kinase activity |
GO:0005184 | 0.008 | 8.3215 | 0.4192 | 3 | 20 | neuropeptide hormone activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 5.294 | 5.3728 | 24 | 165 | histone binding |
GO:0005132 | 0 | 25.8082 | 0.4233 | 6 | 13 | type I interferon receptor binding |
GO:0003684 | 0 | 7.3934 | 1.6607 | 10 | 51 | damaged DNA binding |
GO:0003723 | 0 | 1.8124 | 44.5127 | 73 | 1367 | RNA binding |
GO:0035005 | 6e-04 | 29.9097 | 0.1954 | 3 | 6 | 1-phosphatidylinositol-4-phosphate 3-kinase activity |
GO:0004821 | 0.0011 | Inf | 0.0651 | 2 | 2 | histidine-tRNA ligase activity |
GO:0016231 | 0.0011 | Inf | 0.0651 | 2 | 2 | beta-N-acetylglucosaminidase activity |
GO:0097677 | 0.0017 | 17.9431 | 0.2605 | 3 | 8 | STAT family protein binding |
GO:0016303 | 0.0025 | 14.9514 | 0.2931 | 3 | 9 | 1-phosphatidylinositol-3-kinase activity |
GO:0016422 | 0.0031 | 59.6905 | 0.0977 | 2 | 3 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity |
GO:0097159 | 0.0037 | 1.3181 | 141.4507 | 168 | 4344 | organic cyclic compound binding |
GO:0061733 | 0.0049 | 4.1896 | 1.5956 | 6 | 49 | peptide-lysine-N-acetyltransferase activity |
GO:1901363 | 0.0053 | 1.3026 | 139.7575 | 165 | 4292 | heterocyclic compound binding |
GO:0004768 | 0.0061 | 29.843 | 0.1302 | 2 | 4 | stearoyl-CoA 9-desaturase activity |
GO:0034714 | 0.0061 | 29.843 | 0.1302 | 2 | 4 | type III transforming growth factor beta receptor binding |
GO:0046934 | 0.0061 | 29.843 | 0.1302 | 2 | 4 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity |
GO:0051425 | 0.0061 | 29.843 | 0.1302 | 2 | 4 | PTB domain binding |
GO:0001104 | 0.0064 | 3.1259 | 2.7678 | 8 | 85 | RNA polymerase II transcription cofactor activity |
GO:0008173 | 0.0073 | 3.8319 | 1.7258 | 6 | 53 | RNA methyltransferase activity |
GO:0140036 | 0.0099 | 19.8938 | 0.1628 | 2 | 5 | ubiquitin-dependent protein binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005132 | 0 | 25.0826 | 0.435 | 6 | 13 | type I interferon receptor binding |
GO:0097159 | 3e-04 | 1.4163 | 145.3528 | 180 | 4344 | organic cyclic compound binding |
GO:0044877 | 4e-04 | 1.7562 | 30.583 | 50 | 914 | macromolecular complex binding |
GO:1901363 | 4e-04 | 1.4014 | 143.6128 | 177 | 4292 | heterocyclic compound binding |
GO:0004821 | 0.0011 | Inf | 0.0669 | 2 | 2 | histidine-tRNA ligase activity |
GO:0015091 | 0.0011 | Inf | 0.0669 | 2 | 2 | ferric iron transmembrane transporter activity |
GO:0003723 | 0.0014 | 1.546 | 45.7406 | 66 | 1367 | RNA binding |
GO:0008173 | 0.0018 | 4.4497 | 1.7734 | 7 | 53 | RNA methyltransferase activity |
GO:0097677 | 0.0018 | 17.4419 | 0.2677 | 3 | 8 | STAT family protein binding |
GO:0003677 | 0.0025 | 1.4619 | 56.4146 | 77 | 1686 | DNA binding |
GO:0140101 | 0.0033 | 2.9921 | 3.6137 | 10 | 108 | catalytic activity, acting on a tRNA |
GO:0043325 | 0.0039 | 7.2777 | 0.6692 | 4 | 20 | phosphatidylinositol-3,4-bisphosphate binding |
GO:0016423 | 0.005 | 10.8986 | 0.3681 | 3 | 11 | tRNA (guanine) methyltransferase activity |
GO:0004768 | 0.0064 | 29.0112 | 0.1338 | 2 | 4 | stearoyl-CoA 9-desaturase activity |
GO:0035243 | 0.0064 | 29.0112 | 0.1338 | 2 | 4 | protein-arginine omega-N symmetric methyltransferase activity |
GO:0035650 | 0.0064 | 29.0112 | 0.1338 | 2 | 4 | AP-1 adaptor complex binding |
GO:0051425 | 0.0064 | 29.0112 | 0.1338 | 2 | 4 | PTB domain binding |
GO:0016741 | 0.0072 | 2.3 | 5.9894 | 13 | 179 | transferase activity, transferring one-carbon groups |
GO:0046966 | 0.0077 | 5.8203 | 0.8031 | 4 | 24 | thyroid hormone receptor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005132 | 0 | 37.7896 | 0.2939 | 6 | 13 | type I interferon receptor binding |
GO:0030545 | 0 | 3.2284 | 6.4428 | 19 | 285 | receptor regulator activity |
GO:0005125 | 1e-04 | 4.4087 | 2.758 | 11 | 122 | cytokine activity |
GO:0051916 | 5e-04 | Inf | 0.0452 | 2 | 2 | granulocyte colony-stimulating factor binding |
GO:0030507 | 0.0026 | 7.953 | 0.5878 | 4 | 26 | spectrin binding |
GO:0015038 | 0.003 | 43.5167 | 0.0904 | 2 | 4 | glutathione disulfide oxidoreductase activity |
GO:0031694 | 0.003 | 43.5167 | 0.0904 | 2 | 4 | alpha-2A adrenergic receptor binding |
GO:0016209 | 0.0037 | 5.3445 | 1.0399 | 5 | 46 | antioxidant activity |
GO:0051575 | 0.0049 | 29.0089 | 0.113 | 2 | 5 | 5'-deoxyribose-5-phosphate lyase activity |
GO:0015459 | 0.0049 | 6.519 | 0.6965 | 4 | 31 | potassium channel regulator activity |
GO:0038024 | 0.0077 | 5.6402 | 0.7912 | 4 | 35 | cargo receptor activity |
GO:0003680 | 0.0099 | 17.4027 | 0.1582 | 2 | 7 | AT DNA binding |
GO:0019870 | 0.0099 | 17.4027 | 0.1582 | 2 | 7 | potassium channel inhibitor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005164 | 4e-04 | 9.4843 | 0.6407 | 5 | 27 | tumor necrosis factor receptor binding |
GO:0030545 | 5e-04 | 2.701 | 6.7629 | 17 | 285 | receptor regulator activity |
GO:0019958 | 6e-04 | Inf | 0.0475 | 2 | 2 | C-X-C chemokine binding |
GO:0016494 | 0.0017 | 82.8 | 0.0712 | 2 | 3 | C-X-C chemokine receptor activity |
GO:0031493 | 0.0017 | 82.8 | 0.0712 | 2 | 3 | nucleosomal histone binding |
GO:0030507 | 0.0031 | 7.5632 | 0.617 | 4 | 26 | spectrin binding |
GO:0015278 | 0.0049 | 10.3742 | 0.3559 | 3 | 15 | calcium-release channel activity |
GO:0005126 | 0.0049 | 2.6431 | 4.4137 | 11 | 186 | cytokine receptor binding |
GO:0019784 | 0.0054 | 27.5958 | 0.1186 | 2 | 5 | NEDD8-specific protease activity |
GO:0070011 | 0.0054 | 2.0561 | 9.2307 | 18 | 389 | peptidase activity, acting on L-amino acid peptides |
GO:0004252 | 0.0055 | 3.5256 | 2.1356 | 7 | 90 | serine-type endopeptidase activity |
GO:0016679 | 0.0079 | 20.6952 | 0.1424 | 2 | 6 | oxidoreductase activity, acting on diphenols and related substances as donors |
GO:0030550 | 0.0079 | 20.6952 | 0.1424 | 2 | 6 | acetylcholine receptor inhibitor activity |
GO:0005125 | 0.0086 | 2.936 | 2.895 | 8 | 122 | cytokine activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0033265 | 1e-04 | 51.3647 | 0.1159 | 3 | 6 | choline binding |
GO:0051371 | 2e-04 | 38.5206 | 0.1352 | 3 | 7 | muscle alpha-actinin binding |
GO:0005509 | 3e-04 | 2.6398 | 7.7638 | 19 | 402 | calcium ion binding |
GO:0003990 | 4e-04 | Inf | 0.0386 | 2 | 2 | acetylcholinesterase activity |
GO:0019958 | 4e-04 | Inf | 0.0386 | 2 | 2 | C-X-C chemokine binding |
GO:0030545 | 4e-04 | 2.9335 | 5.5042 | 15 | 285 | receptor regulator activity |
GO:0003993 | 8e-04 | 22.0067 | 0.1931 | 3 | 10 | acid phosphatase activity |
GO:0004668 | 0.0011 | 102.3438 | 0.0579 | 2 | 3 | protein-arginine deiminase activity |
GO:0016494 | 0.0011 | 102.3438 | 0.0579 | 2 | 3 | C-X-C chemokine receptor activity |
GO:0019828 | 0.0011 | 102.3438 | 0.0579 | 2 | 3 | aspartic-type endopeptidase inhibitor activity |
GO:0003700 | 0.0013 | 1.9128 | 17.4588 | 31 | 904 | DNA binding transcription factor activity |
GO:0008201 | 0.0027 | 4.0317 | 1.8733 | 7 | 97 | heparin binding |
GO:0008083 | 0.0038 | 3.778 | 1.9892 | 7 | 103 | growth factor activity |
GO:0070851 | 0.0038 | 3.778 | 1.9892 | 7 | 103 | growth factor receptor binding |
GO:0030550 | 0.0053 | 25.5801 | 0.1159 | 2 | 6 | acetylcholine receptor inhibitor activity |
GO:0097493 | 0.0053 | 25.5801 | 0.1159 | 2 | 6 | structural molecule activity conferring elasticity |
GO:0017171 | 0.0072 | 3.3241 | 2.2403 | 7 | 116 | serine hydrolase activity |
GO:0008307 | 0.0073 | 8.551 | 0.4056 | 3 | 21 | structural constituent of muscle |
GO:0005125 | 0.0094 | 3.1492 | 2.3562 | 7 | 122 | cytokine activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0001653 | 0 | 5.9912 | 1.7031 | 9 | 79 | peptide receptor activity |
GO:0005509 | 1e-04 | 2.7622 | 8.6665 | 22 | 402 | calcium ion binding |
GO:0008188 | 3e-04 | 10.023 | 0.6036 | 5 | 28 | neuropeptide receptor activity |
GO:0004930 | 3e-04 | 3.0274 | 5.3465 | 15 | 248 | G-protein coupled receptor activity |
GO:0016247 | 4e-04 | 4.3599 | 2.2636 | 9 | 105 | channel regulator activity |
GO:0070080 | 5e-04 | Inf | 0.0431 | 2 | 2 | titin Z domain binding |
GO:0004977 | 0.0014 | 91.3986 | 0.0647 | 2 | 3 | melanocortin receptor activity |
GO:0070905 | 0.0014 | 91.3986 | 0.0647 | 2 | 3 | serine binding |
GO:0044325 | 0.0016 | 3.9444 | 2.199 | 8 | 102 | ion channel binding |
GO:0042923 | 0.0019 | 15.2772 | 0.2587 | 3 | 12 | neuropeptide binding |
GO:0005216 | 0.0021 | 2.4828 | 6.4244 | 15 | 298 | ion channel activity |
GO:0099600 | 0.0023 | 2.0297 | 12.0512 | 23 | 559 | transmembrane receptor activity |
GO:0051373 | 0.0027 | 45.6958 | 0.0862 | 2 | 4 | FATZ binding |
GO:0099104 | 0.0027 | 45.6958 | 0.0862 | 2 | 4 | potassium channel activator activity |
GO:0022836 | 0.0034 | 2.6372 | 4.8291 | 12 | 224 | gated channel activity |
GO:0070006 | 0.0037 | 11.4553 | 0.3234 | 3 | 15 | metalloaminopeptidase activity |
GO:0022803 | 0.0042 | 2.2921 | 6.9203 | 15 | 321 | passive transmembrane transporter activity |
GO:0031432 | 0.0044 | 30.4615 | 0.1078 | 2 | 5 | titin binding |
GO:0001786 | 0.0059 | 6.1225 | 0.733 | 4 | 34 | phosphatidylserine binding |
GO:0042056 | 0.0064 | 9.1621 | 0.3881 | 3 | 18 | chemoattractant activity |
GO:0016702 | 0.0086 | 8.083 | 0.4312 | 3 | 20 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen |
GO:0051371 | 0.0091 | 18.2741 | 0.1509 | 2 | 7 | muscle alpha-actinin binding |
GO:0005104 | 0.0099 | 7.6333 | 0.4527 | 3 | 21 | fibroblast growth factor receptor binding |
GO:0008307 | 0.0099 | 7.6333 | 0.4527 | 3 | 21 | structural constituent of muscle |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007162 | 0 | 2.943 | 9.3761 | 25 | 232 | negative regulation of cell adhesion |
GO:0050866 | 0 | 3.3479 | 6.6683 | 20 | 165 | negative regulation of cell activation |
GO:0022610 | 0 | 1.7518 | 45.6276 | 74 | 1129 | biological adhesion |
GO:0032945 | 0 | 4.7406 | 2.9502 | 12 | 73 | negative regulation of mononuclear cell proliferation |
GO:0051250 | 1e-04 | 3.4529 | 5.173 | 16 | 128 | negative regulation of lymphocyte activation |
GO:0050863 | 1e-04 | 2.5804 | 10.1035 | 24 | 250 | regulation of T cell activation |
GO:1903038 | 1e-04 | 3.6713 | 4.2839 | 14 | 106 | negative regulation of leukocyte cell-cell adhesion |
GO:0022407 | 1e-04 | 2.2786 | 14.1854 | 30 | 351 | regulation of cell-cell adhesion |
GO:0050670 | 1e-04 | 2.834 | 7.7191 | 20 | 191 | regulation of lymphocyte proliferation |
GO:0002694 | 2e-04 | 2.1079 | 16.7719 | 33 | 415 | regulation of leukocyte activation |
GO:0070663 | 2e-04 | 2.6907 | 8.0828 | 20 | 200 | regulation of leukocyte proliferation |
GO:0030216 | 2e-04 | 3.8012 | 3.5564 | 12 | 88 | keratinocyte differentiation |
GO:0042060 | 3e-04 | 2.2245 | 13.0134 | 27 | 322 | wound healing |
GO:0009888 | 4e-04 | 1.5174 | 64.1373 | 91 | 1587 | tissue development |
GO:0022404 | 5e-04 | 3.3967 | 3.9202 | 12 | 97 | molting cycle process |
GO:0098773 | 5e-04 | 3.3967 | 3.9202 | 12 | 97 | skin epidermis development |
GO:1903317 | 5e-04 | 3.938 | 2.8694 | 10 | 71 | regulation of protein maturation |
GO:0030879 | 8e-04 | 2.9071 | 5.2538 | 14 | 130 | mammary gland development |
GO:0050891 | 8e-04 | 5.24 | 1.5762 | 7 | 39 | multicellular organismal water homeostasis |
GO:0048562 | 0.0012 | 2.1059 | 12.1243 | 24 | 300 | embryonic organ morphogenesis |
GO:0008285 | 0.0016 | 1.7229 | 24.491 | 40 | 606 | negative regulation of cell proliferation |
GO:0021568 | 0.0016 | Inf | 0.0808 | 2 | 2 | rhombomere 2 development |
GO:1903352 | 0.0016 | Inf | 0.0808 | 2 | 2 | L-ornithine transmembrane transport |
GO:0042633 | 0.0018 | 2.9137 | 4.486 | 12 | 111 | hair cycle |
GO:0019748 | 0.0018 | 4.5304 | 1.7782 | 7 | 44 | secondary metabolic process |
GO:0001977 | 0.0019 | 9.5506 | 0.5658 | 4 | 14 | renal system process involved in regulation of blood volume |
GO:0006721 | 0.0023 | 4.2975 | 1.8591 | 7 | 46 | terpenoid metabolic process |
GO:0002684 | 0.0027 | 1.6379 | 27.6029 | 43 | 683 | positive regulation of immune system process |
GO:0002683 | 0.0028 | 1.879 | 15.1553 | 27 | 375 | negative regulation of immune system process |
GO:0030855 | 0.003 | 1.7348 | 20.6112 | 34 | 510 | epithelial cell differentiation |
GO:0030823 | 0.0041 | 5.4307 | 1.0912 | 5 | 27 | regulation of cGMP metabolic process |
GO:0097205 | 0.0041 | 7.3452 | 0.687 | 4 | 17 | renal filtration |
GO:0030850 | 0.0042 | 3.8079 | 2.0611 | 7 | 51 | prostate gland development |
GO:0042130 | 0.0046 | 3.739 | 2.0931 | 7 | 52 | negative regulation of T cell proliferation |
GO:0043901 | 0.0047 | 2.4406 | 5.6984 | 13 | 141 | negative regulation of multi-organism process |
GO:0010749 | 0.0048 | 47.6324 | 0.1212 | 2 | 3 | regulation of nitric oxide mediated signal transduction |
GO:0016129 | 0.0048 | 47.6324 | 0.1212 | 2 | 3 | phytosteroid biosynthetic process |
GO:0032929 | 0.0048 | 47.6324 | 0.1212 | 2 | 3 | negative regulation of superoxide anion generation |
GO:0046813 | 0.0048 | 47.6324 | 0.1212 | 2 | 3 | receptor-mediated virion attachment to host cell |
GO:1903400 | 0.0048 | 47.6324 | 0.1212 | 2 | 3 | L-arginine transmembrane transport |
GO:1903401 | 0.0048 | 47.6324 | 0.1212 | 2 | 3 | L-lysine transmembrane transport |
GO:2000255 | 0.0048 | 47.6324 | 0.1212 | 2 | 3 | negative regulation of male germ cell proliferation |
GO:0034111 | 0.0051 | 6.8201 | 0.7275 | 4 | 18 | negative regulation of homotypic cell-cell adhesion |
GO:0048705 | 0.0053 | 2.0649 | 9.2144 | 18 | 228 | skeletal system morphogenesis |
GO:0031069 | 0.0056 | 4.9775 | 1.172 | 5 | 29 | hair follicle morphogenesis |
GO:0006066 | 0.0058 | 2.0452 | 9.2953 | 18 | 230 | alcohol metabolic process |
GO:0010466 | 0.0061 | 2.2737 | 6.5471 | 14 | 162 | negative regulation of peptidase activity |
GO:0045591 | 0.0064 | 10.2189 | 0.4041 | 3 | 10 | positive regulation of regulatory T cell differentiation |
GO:0046642 | 0.0064 | 10.2189 | 0.4041 | 3 | 10 | negative regulation of alpha-beta T cell proliferation |
GO:0060576 | 0.0064 | 10.2189 | 0.4041 | 3 | 10 | intestinal epithelial cell development |
GO:0030903 | 0.0076 | 5.9668 | 0.8083 | 4 | 20 | notochord development |
GO:0050803 | 0.0077 | 2.3805 | 5.3751 | 12 | 133 | regulation of synapse structure or activity |
GO:0007156 | 0.0078 | 2.8004 | 3.4756 | 9 | 86 | homophilic cell adhesion via plasma membrane adhesion molecules |
GO:0006629 | 0.0079 | 1.4367 | 42.9199 | 59 | 1062 | lipid metabolic process |
GO:0002526 | 0.0084 | 2.7643 | 3.516 | 9 | 87 | acute inflammatory response |
GO:0019755 | 0.0085 | 8.9409 | 0.4446 | 3 | 11 | one-carbon compound transport |
GO:0071295 | 0.0085 | 8.9409 | 0.4446 | 3 | 11 | cellular response to vitamin |
GO:0010954 | 0.0091 | 5.6154 | 0.8487 | 4 | 21 | positive regulation of protein processing |
GO:0043567 | 0.0091 | 5.6154 | 0.8487 | 4 | 21 | regulation of insulin-like growth factor receptor signaling pathway |
GO:0002159 | 0.0093 | 23.8146 | 0.1617 | 2 | 4 | desmosome assembly |
GO:0003104 | 0.0093 | 23.8146 | 0.1617 | 2 | 4 | positive regulation of glomerular filtration |
GO:0014028 | 0.0093 | 23.8146 | 0.1617 | 2 | 4 | notochord formation |
GO:0021615 | 0.0093 | 23.8146 | 0.1617 | 2 | 4 | glossopharyngeal nerve morphogenesis |
GO:0033159 | 0.0093 | 23.8146 | 0.1617 | 2 | 4 | negative regulation of protein import into nucleus, translocation |
GO:0060221 | 0.0093 | 23.8146 | 0.1617 | 2 | 4 | retinal rod cell differentiation |
GO:0070295 | 0.0093 | 23.8146 | 0.1617 | 2 | 4 | renal water absorption |
GO:0070327 | 0.0093 | 23.8146 | 0.1617 | 2 | 4 | thyroid hormone transport |
GO:0006952 | 0.0099 | 1.4221 | 42.5561 | 58 | 1053 | defense response |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0002820 | 2e-04 | 6.784 | 1.2715 | 7 | 33 | negative regulation of adaptive immune response |
GO:0006955 | 6e-04 | 1.6475 | 36.7206 | 57 | 953 | immune response |
GO:0030903 | 8e-04 | 8.3777 | 0.7706 | 5 | 20 | notochord development |
GO:0002826 | 0.001 | 25.0704 | 0.2312 | 3 | 6 | negative regulation of T-helper 1 type immune response |
GO:0007200 | 0.0011 | 3.5561 | 3.1211 | 10 | 81 | phospholipase C-activating G-protein coupled receptor signaling pathway |
GO:0043954 | 0.0013 | 4.7637 | 1.6954 | 7 | 44 | cellular component maintenance |
GO:0007188 | 0.0014 | 2.8353 | 4.9706 | 13 | 129 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
GO:0006597 | 0.0015 | Inf | 0.0771 | 2 | 2 | spermine biosynthetic process |
GO:0010949 | 0.0015 | Inf | 0.0771 | 2 | 2 | negative regulation of intestinal phytosterol absorption |
GO:0038156 | 0.0015 | Inf | 0.0771 | 2 | 2 | interleukin-3-mediated signaling pathway |
GO:0045796 | 0.0015 | Inf | 0.0771 | 2 | 2 | negative regulation of intestinal cholesterol absorption |
GO:0030816 | 0.0016 | 3.6612 | 2.7357 | 9 | 71 | positive regulation of cAMP metabolic process |
GO:0030509 | 0.0019 | 2.6247 | 5.7412 | 14 | 149 | BMP signaling pathway |
GO:1904892 | 0.002 | 2.7172 | 5.1632 | 13 | 134 | regulation of STAT cascade |
GO:0007389 | 0.0021 | 1.8732 | 16.3374 | 29 | 424 | pattern specification process |
GO:0021983 | 0.0023 | 5.0299 | 1.3871 | 6 | 36 | pituitary gland development |
GO:0090022 | 0.0023 | 6.2812 | 0.9633 | 5 | 25 | regulation of neutrophil chemotaxis |
GO:0048646 | 0.0025 | 1.5526 | 37.3016 | 55 | 971 | anatomical structure formation involved in morphogenesis |
GO:0032722 | 0.0026 | 4.1952 | 1.888 | 7 | 49 | positive regulation of chemokine production |
GO:0045217 | 0.0027 | 15.0887 | 0.3073 | 3 | 8 | cell-cell junction maintenance |
GO:0043306 | 0.0027 | 8.3656 | 0.6165 | 4 | 16 | positive regulation of mast cell degranulation |
GO:0007588 | 0.0029 | 4.0974 | 1.9266 | 7 | 50 | excretion |
GO:0090092 | 0.0029 | 2.2557 | 8.0146 | 17 | 208 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:0009607 | 0.0029 | 1.6827 | 23.7354 | 38 | 616 | response to biotic stimulus |
GO:0042742 | 0.003 | 2.3879 | 6.7045 | 15 | 174 | defense response to bacterium |
GO:0009952 | 0.0032 | 2.232 | 8.0916 | 17 | 210 | anterior/posterior pattern specification |
GO:0046426 | 0.0032 | 4.004 | 1.9651 | 7 | 51 | negative regulation of JAK-STAT cascade |
GO:0051707 | 0.0033 | 1.6951 | 22.3098 | 36 | 579 | response to other organism |
GO:0007275 | 0.0035 | 1.291 | 149.1635 | 178 | 3955 | multicellular organism development |
GO:0003333 | 0.0035 | 4.5718 | 1.5027 | 6 | 39 | amino acid transmembrane transport |
GO:0071772 | 0.0036 | 2.4252 | 6.165 | 14 | 160 | response to BMP |
GO:1900542 | 0.0037 | 2.2633 | 7.5136 | 16 | 195 | regulation of purine nucleotide metabolic process |
GO:0032689 | 0.0039 | 5.4608 | 1.0789 | 5 | 28 | negative regulation of interferon-gamma production |
GO:0090209 | 0.004 | 12.5327 | 0.3468 | 3 | 9 | negative regulation of triglyceride metabolic process |
GO:0045218 | 0.0043 | 50.0654 | 0.1156 | 2 | 3 | zonula adherens maintenance |
GO:1904479 | 0.0043 | 50.0654 | 0.1156 | 2 | 3 | negative regulation of intestinal absorption |
GO:0051883 | 0.0043 | 7.1696 | 0.6936 | 4 | 18 | killing of cells in other organism involved in symbiotic interaction |
GO:0000768 | 0.0045 | 3.7477 | 2.0807 | 7 | 54 | syncytium formation by plasma membrane fusion |
GO:0050482 | 0.0046 | 5.233 | 1.1174 | 5 | 29 | arachidonic acid secretion |
GO:0030154 | 0.0049 | 1.2842 | 135.053 | 162 | 3505 | cell differentiation |
GO:0007596 | 0.005 | 2.3286 | 6.3962 | 14 | 166 | blood coagulation |
GO:0015711 | 0.0053 | 1.8783 | 12.8695 | 23 | 334 | organic anion transport |
GO:0045639 | 0.0054 | 2.984 | 3.2752 | 9 | 85 | positive regulation of myeloid cell differentiation |
GO:0045981 | 0.0055 | 2.6184 | 4.5082 | 11 | 117 | positive regulation of nucleotide metabolic process |
GO:0030512 | 0.0055 | 3.5943 | 2.1578 | 7 | 56 | negative regulation of transforming growth factor beta receptor signaling pathway |
GO:0043950 | 0.0056 | 10.7416 | 0.3853 | 3 | 10 | positive regulation of cAMP-mediated signaling |
GO:0002684 | 0.0056 | 1.5908 | 26.317 | 40 | 683 | positive regulation of immune system process |
GO:0015849 | 0.0058 | 2.0448 | 9.2861 | 18 | 241 | organic acid transport |
GO:0002886 | 0.0058 | 4.0765 | 1.6569 | 6 | 43 | regulation of myeloid leukocyte mediated immunity |
GO:0050707 | 0.006 | 2.3626 | 5.8568 | 13 | 152 | regulation of cytokine secretion |
GO:0002526 | 0.0062 | 2.9071 | 3.3522 | 9 | 87 | acute inflammatory response |
GO:0015908 | 0.0063 | 3.1471 | 2.7743 | 8 | 72 | fatty acid transport |
GO:0019221 | 0.0064 | 1.9798 | 10.1021 | 19 | 263 | cytokine-mediated signaling pathway |
GO:0008285 | 0.0068 | 1.6118 | 23.3501 | 36 | 606 | negative regulation of cell proliferation |
GO:0048513 | 0.007 | 1.2919 | 109.1984 | 133 | 2834 | animal organ development |
GO:0050878 | 0.007 | 1.8886 | 11.6751 | 21 | 303 | regulation of body fluid levels |
GO:0090288 | 0.007 | 2.5226 | 4.6623 | 11 | 121 | negative regulation of cellular response to growth factor stimulus |
GO:0046903 | 0.0075 | 1.4703 | 37.6838 | 53 | 978 | secretion |
GO:0051051 | 0.0075 | 1.6941 | 17.9006 | 29 | 466 | negative regulation of transport |
GO:0071624 | 0.0077 | 5.9032 | 0.8092 | 4 | 21 | positive regulation of granulocyte chemotaxis |
GO:0032496 | 0.0078 | 2.0754 | 8.1302 | 16 | 211 | response to lipopolysaccharide |
GO:0010862 | 0.0081 | 3.77 | 1.7725 | 6 | 46 | positive regulation of pathway-restricted SMAD protein phosphorylation |
GO:0071715 | 0.0081 | 3.77 | 1.7725 | 6 | 46 | icosanoid transport |
GO:0014028 | 0.0084 | 25.031 | 0.1541 | 2 | 4 | notochord formation |
GO:0034165 | 0.0084 | 25.031 | 0.1541 | 2 | 4 | positive regulation of toll-like receptor 9 signaling pathway |
GO:0048295 | 0.0084 | 25.031 | 0.1541 | 2 | 4 | positive regulation of isotype switching to IgE isotypes |
GO:2000110 | 0.0084 | 25.031 | 0.1541 | 2 | 4 | negative regulation of macrophage apoptotic process |
GO:0007166 | 0.0088 | 1.3521 | 65.2414 | 84 | 1724 | cell surface receptor signaling pathway |
GO:0032103 | 0.0089 | 1.9913 | 8.9778 | 17 | 233 | positive regulation of response to external stimulus |
GO:0050819 | 0.009 | 3.6778 | 1.811 | 6 | 47 | negative regulation of coagulation |
GO:0033005 | 0.0092 | 5.5749 | 0.8477 | 4 | 22 | positive regulation of mast cell activation |
GO:0003128 | 0.0097 | 8.3535 | 0.4624 | 3 | 12 | heart field specification |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0051234 | 0 | 1.4604 | 198.2112 | 256 | 3988 | establishment of localization |
GO:0002274 | 0 | 3.3516 | 7.4553 | 22 | 150 | myeloid leukocyte activation |
GO:0042886 | 0 | 1.5809 | 83.7974 | 122 | 1686 | amide transport |
GO:0071702 | 0 | 1.5166 | 98.1945 | 137 | 2018 | organic substance transport |
GO:0016139 | 1e-04 | 38.4289 | 0.2982 | 4 | 6 | glycoside catabolic process |
GO:0002429 | 1e-04 | 3.1117 | 6.1133 | 17 | 123 | immune response-activating cell surface receptor signaling pathway |
GO:0050865 | 2e-04 | 1.9471 | 22.5647 | 41 | 454 | regulation of cell activation |
GO:0008104 | 2e-04 | 1.4189 | 113.8671 | 150 | 2291 | protein localization |
GO:0002703 | 3e-04 | 2.6923 | 7.7535 | 19 | 156 | regulation of leukocyte mediated immunity |
GO:0071216 | 4e-04 | 2.7067 | 7.3062 | 18 | 147 | cellular response to biotic stimulus |
GO:0032800 | 4e-04 | 7.6987 | 1.0437 | 6 | 21 | receptor biosynthetic process |
GO:0006984 | 4e-04 | 6.129 | 1.4414 | 7 | 29 | ER-nucleus signaling pathway |
GO:0032324 | 5e-04 | 57.5741 | 0.1988 | 3 | 4 | molybdopterin cofactor biosynthetic process |
GO:0002682 | 6e-04 | 1.5552 | 49.7516 | 73 | 1001 | regulation of immune system process |
GO:0002764 | 6e-04 | 2.2222 | 11.6302 | 24 | 234 | immune response-regulating signaling pathway |
GO:0033003 | 7e-04 | 4.8186 | 1.9881 | 8 | 40 | regulation of mast cell activation |
GO:0046907 | 9e-04 | 1.8676 | 19.9345 | 35 | 417 | intracellular transport |
GO:1901135 | 9e-04 | 1.5468 | 47.1671 | 69 | 949 | carbohydrate derivative metabolic process |
GO:0038083 | 9e-04 | 4.0364 | 2.5845 | 9 | 52 | peptidyl-tyrosine autophosphorylation |
GO:0071222 | 0.0011 | 2.7128 | 6.0636 | 15 | 122 | cellular response to lipopolysaccharide |
GO:0006403 | 0.0011 | 2.5053 | 7.3761 | 17 | 149 | RNA localization |
GO:0044419 | 0.0012 | 1.9815 | 15.0597 | 28 | 303 | interspecies interaction between organisms |
GO:0001819 | 0.0014 | 1.9089 | 16.6998 | 30 | 336 | positive regulation of cytokine production |
GO:0032459 | 0.0014 | 4.8137 | 1.7396 | 7 | 35 | regulation of protein oligomerization |
GO:0070266 | 0.0014 | 5.7721 | 1.2922 | 6 | 26 | necroptotic process |
GO:0061024 | 0.0015 | 1.6773 | 28.3301 | 45 | 570 | membrane organization |
GO:0051338 | 0.0015 | 1.5765 | 38.1214 | 57 | 767 | regulation of transferase activity |
GO:0006955 | 0.0016 | 1.5132 | 47.3659 | 68 | 953 | immune response |
GO:0015031 | 0.0019 | 1.6356 | 30.3275 | 47 | 629 | protein transport |
GO:0010256 | 0.0021 | 1.9038 | 15.6064 | 28 | 314 | endomembrane system organization |
GO:0016310 | 0.0021 | 1.3581 | 94.2348 | 121 | 1896 | phosphorylation |
GO:0043299 | 0.0021 | 3.5407 | 2.8827 | 9 | 58 | leukocyte degranulation |
GO:0044090 | 0.0022 | 9.6034 | 0.5964 | 4 | 12 | positive regulation of vacuole organization |
GO:0050746 | 0.0022 | 9.6034 | 0.5964 | 4 | 12 | regulation of lipoprotein metabolic process |
GO:0002349 | 0.0022 | 19.1888 | 0.2982 | 3 | 6 | histamine production involved in inflammatory response |
GO:0002553 | 0.0022 | 19.1888 | 0.2982 | 3 | 6 | histamine secretion by mast cell |
GO:0051235 | 0.0023 | 1.9997 | 12.7734 | 24 | 257 | maintenance of location |
GO:0015931 | 0.0024 | 2.3173 | 7.9026 | 17 | 159 | nucleobase-containing compound transport |
GO:0002237 | 0.0024 | 2.0616 | 11.3817 | 22 | 229 | response to molecule of bacterial origin |
GO:0002874 | 0.0025 | Inf | 0.0994 | 2 | 2 | regulation of chronic inflammatory response to antigenic stimulus |
GO:0046967 | 0.0025 | Inf | 0.0994 | 2 | 2 | cytosol to ER transport |
GO:1901740 | 0.0025 | Inf | 0.0994 | 2 | 2 | negative regulation of myoblast fusion |
GO:1905602 | 0.0025 | Inf | 0.0994 | 2 | 2 | positive regulation of receptor-mediated endocytosis involved in cholesterol transport |
GO:0016032 | 0.0025 | 2.0515 | 11.4314 | 22 | 230 | viral process |
GO:0009615 | 0.0026 | 2.1296 | 10.0398 | 20 | 202 | response to virus |
GO:0043304 | 0.0026 | 5.0183 | 1.4414 | 6 | 29 | regulation of mast cell degranulation |
GO:0090150 | 0.0027 | 2.2848 | 8.002 | 17 | 161 | establishment of protein localization to membrane |
GO:0002279 | 0.0028 | 4.2109 | 1.9384 | 7 | 39 | mast cell activation involved in immune response |
GO:0050864 | 0.0029 | 2.6157 | 5.4175 | 13 | 109 | regulation of B cell activation |
GO:0060627 | 0.0029 | 1.7111 | 22.1671 | 36 | 446 | regulation of vesicle-mediated transport |
GO:0046649 | 0.003 | 2.2632 | 8.0656 | 17 | 165 | lymphocyte activation |
GO:0002739 | 0.003 | 8.5358 | 0.6461 | 4 | 13 | regulation of cytokine secretion involved in immune response |
GO:1904874 | 0.003 | 8.5358 | 0.6461 | 4 | 13 | positive regulation of telomerase RNA localization to Cajal body |
GO:0032846 | 0.0032 | 2.0454 | 10.9344 | 21 | 220 | positive regulation of homeostatic process |
GO:0002448 | 0.0032 | 4.083 | 1.9881 | 7 | 40 | mast cell mediated immunity |
GO:0042594 | 0.0032 | 2.3094 | 7.4553 | 16 | 150 | response to starvation |
GO:0006897 | 0.0033 | 1.711 | 21.542 | 35 | 436 | endocytosis |
GO:0050710 | 0.0034 | 3.5833 | 2.5348 | 8 | 51 | negative regulation of cytokine secretion |
GO:0006054 | 0.0037 | 14.3907 | 0.3479 | 3 | 7 | N-acetylneuraminate metabolic process |
GO:0051189 | 0.0037 | 14.3907 | 0.3479 | 3 | 7 | prosthetic group metabolic process |
GO:0060368 | 0.0037 | 14.3907 | 0.3479 | 3 | 7 | regulation of Fc receptor mediated stimulatory signaling pathway |
GO:0006749 | 0.0037 | 3.9626 | 2.0378 | 7 | 41 | glutathione metabolic process |
GO:0001913 | 0.0037 | 4.6162 | 1.5408 | 6 | 31 | T cell mediated cytotoxicity |
GO:0097191 | 0.0039 | 2.0498 | 10.3877 | 20 | 209 | extrinsic apoptotic signaling pathway |
GO:1901264 | 0.0039 | 3.5016 | 2.5845 | 8 | 52 | carbohydrate derivative transport |
GO:0006734 | 0.0039 | 5.6529 | 1.0934 | 5 | 22 | NADH metabolic process |
GO:0034104 | 0.0039 | 5.6529 | 1.0934 | 5 | 22 | negative regulation of tissue remodeling |
GO:0045779 | 0.0041 | 7.6817 | 0.6958 | 4 | 14 | negative regulation of bone resorption |
GO:0048311 | 0.0041 | 7.6817 | 0.6958 | 4 | 14 | mitochondrion distribution |
GO:0071850 | 0.0041 | 7.6817 | 0.6958 | 4 | 14 | mitotic cell cycle arrest |
GO:0042110 | 0.0042 | 1.7122 | 20.2784 | 33 | 408 | T cell activation |
GO:0032269 | 0.0042 | 1.4813 | 42.4454 | 60 | 854 | negative regulation of cellular protein metabolic process |
GO:0070727 | 0.0042 | 1.3615 | 75.5966 | 98 | 1521 | cellular macromolecule localization |
GO:0005975 | 0.0045 | 1.6492 | 23.5587 | 37 | 474 | carbohydrate metabolic process |
GO:0002819 | 0.0046 | 2.3723 | 6.3618 | 14 | 128 | regulation of adaptive immune response |
GO:0002687 | 0.0046 | 2.5732 | 5.0696 | 12 | 102 | positive regulation of leukocyte migration |
GO:0043409 | 0.0047 | 2.2826 | 7.0577 | 15 | 142 | negative regulation of MAPK cascade |
GO:0033674 | 0.0048 | 1.6791 | 21.2724 | 34 | 428 | positive regulation of kinase activity |
GO:0006886 | 0.0049 | 1.459 | 44.4832 | 62 | 895 | intracellular protein transport |
GO:0007033 | 0.005 | 2.3419 | 6.4335 | 14 | 130 | vacuole organization |
GO:0010876 | 0.0051 | 1.815 | 15.1094 | 26 | 304 | lipid localization |
GO:0000422 | 0.0051 | 2.8349 | 3.8767 | 10 | 78 | autophagy of mitochondrion |
GO:0015748 | 0.0052 | 3.0421 | 3.2803 | 9 | 66 | organophosphate ester transport |
GO:0010867 | 0.0053 | 6.9829 | 0.7455 | 4 | 15 | positive regulation of triglyceride biosynthetic process |
GO:0002253 | 0.0054 | 1.8541 | 13.668 | 24 | 275 | activation of immune response |
GO:0006893 | 0.0056 | 3.6406 | 2.1869 | 7 | 44 | Golgi to plasma membrane transport |
GO:0000045 | 0.0056 | 2.7937 | 3.9265 | 10 | 79 | autophagosome assembly |
GO:0050727 | 0.006 | 1.8943 | 12.2764 | 22 | 247 | regulation of inflammatory response |
GO:0051246 | 0.006 | 1.2904 | 110.1112 | 135 | 2225 | regulation of protein metabolic process |
GO:0002711 | 0.006 | 4.1208 | 1.6899 | 6 | 34 | positive regulation of T cell mediated immunity |
GO:0048246 | 0.006 | 4.1208 | 1.6899 | 6 | 34 | macrophage chemotaxis |
GO:0060341 | 0.0061 | 1.4566 | 42.346 | 59 | 852 | regulation of cellular localization |
GO:2000378 | 0.0062 | 3.209 | 2.7833 | 8 | 56 | negative regulation of reactive oxygen species metabolic process |
GO:0051279 | 0.0063 | 2.9386 | 3.3797 | 9 | 68 | regulation of release of sequestered calcium ion into cytosol |
GO:0001775 | 0.0064 | 1.7579 | 16.1542 | 27 | 333 | cell activation |
GO:0050658 | 0.0064 | 2.2719 | 6.6104 | 14 | 133 | RNA transport |
GO:0051224 | 0.0064 | 1.9874 | 10.1392 | 19 | 204 | negative regulation of protein transport |
GO:0042790 | 0.0068 | 6.4006 | 0.7952 | 4 | 16 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter |
GO:2000010 | 0.0068 | 6.4006 | 0.7952 | 4 | 16 | positive regulation of protein localization to cell surface |
GO:0006413 | 0.0069 | 2.5556 | 4.672 | 11 | 94 | translational initiation |
GO:2001244 | 0.0069 | 3.1433 | 2.833 | 8 | 57 | positive regulation of intrinsic apoptotic signaling pathway |
GO:0009605 | 0.007 | 1.3259 | 80.5668 | 102 | 1621 | response to external stimulus |
GO:0000960 | 0.0072 | 38.3342 | 0.1491 | 2 | 3 | regulation of mitochondrial RNA catabolic process |
GO:0032382 | 0.0072 | 38.3342 | 0.1491 | 2 | 3 | positive regulation of intracellular sterol transport |
GO:0035928 | 0.0072 | 38.3342 | 0.1491 | 2 | 3 | rRNA import into mitochondrion |
GO:0060448 | 0.0072 | 38.3342 | 0.1491 | 2 | 3 | dichotomous subdivision of terminal units involved in lung branching |
GO:1900126 | 0.0072 | 38.3342 | 0.1491 | 2 | 3 | negative regulation of hyaluronan biosynthetic process |
GO:1902564 | 0.0072 | 38.3342 | 0.1491 | 2 | 3 | negative regulation of neutrophil activation |
GO:1903061 | 0.0072 | 38.3342 | 0.1491 | 2 | 3 | positive regulation of protein lipidation |
GO:0033619 | 0.0072 | 3.4535 | 2.2863 | 7 | 46 | membrane protein proteolysis |
GO:0050854 | 0.0072 | 3.4535 | 2.2863 | 7 | 46 | regulation of antigen receptor-mediated signaling pathway |
GO:1902105 | 0.0072 | 1.8912 | 11.7297 | 21 | 236 | regulation of leukocyte differentiation |
GO:0009057 | 0.0072 | 1.4136 | 48.7576 | 66 | 981 | macromolecule catabolic process |
GO:0030183 | 0.0073 | 2.4114 | 5.3678 | 12 | 108 | B cell differentiation |
GO:0051283 | 0.0074 | 2.525 | 4.7217 | 11 | 95 | negative regulation of sequestering of calcium ion |
GO:0065009 | 0.0078 | 1.286 | 103.6285 | 127 | 2085 | regulation of molecular function |
GO:0032943 | 0.0078 | 1.8444 | 12.5746 | 22 | 253 | mononuclear cell proliferation |
GO:0016197 | 0.0079 | 1.9066 | 11.0835 | 20 | 223 | endosomal transport |
GO:0045806 | 0.0081 | 3.3669 | 2.336 | 7 | 47 | negative regulation of endocytosis |
GO:0002699 | 0.0081 | 2.0749 | 8.2008 | 16 | 165 | positive regulation of immune effector process |
GO:0043085 | 0.0081 | 1.4161 | 46.4216 | 63 | 934 | positive regulation of catalytic activity |
GO:0006995 | 0.0082 | 9.5925 | 0.4473 | 3 | 9 | cellular response to nitrogen starvation |
GO:2000628 | 0.0082 | 9.5925 | 0.4473 | 3 | 9 | regulation of miRNA metabolic process |
GO:0045859 | 0.0082 | 1.5178 | 30.2685 | 44 | 609 | regulation of protein kinase activity |
GO:0070588 | 0.0083 | 1.8648 | 11.8788 | 21 | 239 | calcium ion transmembrane transport |
GO:0046364 | 0.0083 | 2.7959 | 3.5288 | 9 | 71 | monosaccharide biosynthetic process |
GO:0001894 | 0.0086 | 1.9664 | 9.6919 | 18 | 195 | tissue homeostasis |
GO:0006401 | 0.0086 | 1.9664 | 9.6919 | 18 | 195 | RNA catabolic process |
GO:0016192 | 0.0086 | 1.6479 | 19.7026 | 31 | 407 | vesicle-mediated transport |
GO:0030889 | 0.0086 | 5.9078 | 0.8449 | 4 | 17 | negative regulation of B cell proliferation |
GO:0050860 | 0.0086 | 5.9078 | 0.8449 | 4 | 17 | negative regulation of T cell receptor signaling pathway |
GO:0090670 | 0.0086 | 5.9078 | 0.8449 | 4 | 17 | RNA localization to Cajal body |
GO:0090672 | 0.0086 | 5.9078 | 0.8449 | 4 | 17 | telomerase RNA localization |
GO:1904355 | 0.0086 | 5.9078 | 0.8449 | 4 | 17 | positive regulation of telomere capping |
GO:0016236 | 0.0086 | 2.0609 | 8.2505 | 16 | 166 | macroautophagy |
GO:0002688 | 0.0086 | 2.604 | 4.175 | 10 | 84 | regulation of leukocyte chemotaxis |
GO:0097529 | 0.0088 | 2.1796 | 6.8589 | 14 | 138 | myeloid leukocyte migration |
GO:0032675 | 0.0091 | 2.3378 | 5.5169 | 12 | 111 | regulation of interleukin-6 production |
GO:0032418 | 0.0093 | 2.9613 | 2.9821 | 8 | 60 | lysosome localization |
GO:0043525 | 0.0099 | 2.7082 | 3.6282 | 9 | 73 | positive regulation of neuron apoptotic process |
GO:0009144 | 0.01 | 1.8602 | 11.332 | 20 | 228 | purine nucleoside triphosphate metabolic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0002275 | 0 | 5.7252 | 2.7615 | 13 | 65 | myeloid cell activation involved in immune response |
GO:0072359 | 0 | 1.8511 | 39.766 | 68 | 936 | circulatory system development |
GO:0002263 | 0 | 2.9295 | 8.667 | 23 | 204 | cell activation involved in immune response |
GO:0007154 | 0 | 1.6368 | 62.4712 | 93 | 1625 | cell communication |
GO:0002820 | 1e-04 | 7.2863 | 1.402 | 8 | 33 | negative regulation of adaptive immune response |
GO:0048583 | 1e-04 | 1.4452 | 125.2036 | 165 | 2947 | regulation of response to stimulus |
GO:0023052 | 1e-04 | 1.6276 | 59.8831 | 89 | 1559 | signaling |
GO:0090310 | 1e-04 | Inf | 0.1275 | 3 | 3 | negative regulation of methylation-dependent chromatin silencing |
GO:0045055 | 1e-04 | 2.948 | 7.095 | 19 | 167 | regulated exocytosis |
GO:0051716 | 1e-04 | 1.3665 | 212.7832 | 258 | 5067 | cellular response to stimulus |
GO:0048514 | 1e-04 | 2.0246 | 21.2001 | 40 | 499 | blood vessel morphogenesis |
GO:0002694 | 1e-04 | 2.1345 | 17.6313 | 35 | 415 | regulation of leukocyte activation |
GO:0043011 | 1e-04 | 10.4861 | 0.8072 | 6 | 19 | myeloid dendritic cell differentiation |
GO:0051250 | 1e-04 | 3.2734 | 5.4381 | 16 | 128 | negative regulation of lymphocyte activation |
GO:0019220 | 1e-04 | 1.57 | 64.3649 | 94 | 1515 | regulation of phosphate metabolic process |
GO:0010862 | 1e-04 | 5.5425 | 1.9543 | 9 | 46 | positive regulation of pathway-restricted SMAD protein phosphorylation |
GO:1903555 | 1e-04 | 3.4004 | 4.9283 | 15 | 116 | regulation of tumor necrosis factor superfamily cytokine production |
GO:0032689 | 1e-04 | 7.5806 | 1.1896 | 7 | 28 | negative regulation of interferon-gamma production |
GO:0032502 | 2e-04 | 1.42 | 131.2676 | 168 | 3291 | developmental process |
GO:0007267 | 2e-04 | 1.6169 | 50.9396 | 77 | 1199 | cell-cell signaling |
GO:0033006 | 2e-04 | 7.2355 | 1.2321 | 7 | 29 | regulation of mast cell activation involved in immune response |
GO:0009719 | 2e-04 | 1.6423 | 46.1813 | 71 | 1087 | response to endogenous stimulus |
GO:0050866 | 2e-04 | 2.8078 | 7.01 | 18 | 165 | negative regulation of cell activation |
GO:0048646 | 2e-04 | 1.7095 | 36.1606 | 58 | 863 | anatomical structure formation involved in morphogenesis |
GO:0010562 | 3e-04 | 1.6552 | 41.8478 | 65 | 985 | positive regulation of phosphorus metabolic process |
GO:0043300 | 3e-04 | 5.5171 | 1.7419 | 8 | 41 | regulation of leukocyte degranulation |
GO:0002351 | 3e-04 | 67.9095 | 0.1699 | 3 | 4 | serotonin production involved in inflammatory response |
GO:0043303 | 3e-04 | 8.0584 | 0.9724 | 6 | 23 | mast cell degranulation |
GO:0001944 | 3e-04 | 2.0874 | 15.8862 | 31 | 379 | vasculature development |
GO:0090209 | 3e-04 | 18.1314 | 0.3824 | 4 | 9 | negative regulation of triglyceride metabolic process |
GO:0051046 | 4e-04 | 1.7649 | 29.5271 | 49 | 695 | regulation of secretion |
GO:0002886 | 4e-04 | 5.2011 | 1.8269 | 8 | 43 | regulation of myeloid leukocyte mediated immunity |
GO:0044255 | 4e-04 | 1.7029 | 33.6907 | 54 | 793 | cellular lipid metabolic process |
GO:0051050 | 4e-04 | 1.6392 | 40.1909 | 62 | 946 | positive regulation of transport |
GO:0048332 | 4e-04 | 4.0699 | 2.804 | 10 | 66 | mesoderm morphogenesis |
GO:1903038 | 5e-04 | 3.1925 | 4.5034 | 13 | 106 | negative regulation of leukocyte cell-cell adhesion |
GO:0007200 | 6e-04 | 3.5836 | 3.4413 | 11 | 81 | phospholipase C-activating G-protein coupled receptor signaling pathway |
GO:0032879 | 6e-04 | 1.4002 | 101.1995 | 132 | 2382 | regulation of localization |
GO:0032720 | 6e-04 | 4.7896 | 1.9543 | 8 | 46 | negative regulation of tumor necrosis factor production |
GO:0032733 | 6e-04 | 6.8128 | 1.1046 | 6 | 26 | positive regulation of interleukin-10 production |
GO:0007167 | 7e-04 | 2.1918 | 11.7114 | 24 | 281 | enzyme linked receptor protein signaling pathway |
GO:0033993 | 7e-04 | 1.7788 | 25.0237 | 42 | 589 | response to lipid |
GO:0050707 | 8e-04 | 2.6915 | 6.4577 | 16 | 152 | regulation of cytokine secretion |
GO:0048534 | 8e-04 | 1.6616 | 33.7757 | 53 | 795 | hematopoietic or lymphoid organ development |
GO:0009967 | 8e-04 | 1.5313 | 51.9593 | 75 | 1223 | positive regulation of signal transduction |
GO:0030154 | 8e-04 | 1.3623 | 124.7094 | 157 | 3020 | cell differentiation |
GO:0070528 | 8e-04 | 6.488 | 1.1471 | 6 | 27 | protein kinase C signaling |
GO:0007599 | 8e-04 | 2.577 | 7.1375 | 17 | 168 | hemostasis |
GO:0050817 | 9e-04 | 2.5598 | 7.18 | 17 | 169 | coagulation |
GO:0070374 | 9e-04 | 2.5429 | 7.2225 | 17 | 170 | positive regulation of ERK1 and ERK2 cascade |
GO:0032703 | 0.001 | 8.1016 | 0.8072 | 5 | 19 | negative regulation of interleukin-2 production |
GO:0032945 | 0.001 | 3.616 | 3.1014 | 10 | 73 | negative regulation of mononuclear cell proliferation |
GO:0023051 | 0.001 | 1.3844 | 99.0212 | 128 | 2367 | regulation of signaling |
GO:0010646 | 0.0011 | 1.3848 | 98.1846 | 127 | 2347 | regulation of cell communication |
GO:0060326 | 0.0011 | 2.3526 | 8.667 | 19 | 204 | cell chemotaxis |
GO:0007188 | 0.0012 | 2.7805 | 5.4806 | 14 | 129 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
GO:1901700 | 0.0012 | 1.5294 | 47.7108 | 69 | 1123 | response to oxygen-containing compound |
GO:0060149 | 0.0012 | 11.3299 | 0.5098 | 4 | 12 | negative regulation of posttranscriptional gene silencing |
GO:0060967 | 0.0012 | 11.3299 | 0.5098 | 4 | 12 | negative regulation of gene silencing by RNA |
GO:0002793 | 0.0013 | 2.1754 | 10.7912 | 22 | 254 | positive regulation of peptide secretion |
GO:0008285 | 0.0013 | 1.7232 | 25.746 | 42 | 606 | negative regulation of cell proliferation |
GO:0002521 | 0.0013 | 1.8366 | 19.5856 | 34 | 461 | leukocyte differentiation |
GO:0035556 | 0.0013 | 1.3921 | 88.789 | 116 | 2105 | intracellular signal transduction |
GO:0060969 | 0.0014 | 22.7567 | 0.2536 | 3 | 6 | negative regulation of gene silencing |
GO:1904238 | 0.0014 | 22.6335 | 0.2549 | 3 | 6 | pericyte cell differentiation |
GO:0051240 | 0.0014 | 1.4528 | 63.4302 | 87 | 1493 | positive regulation of multicellular organismal process |
GO:0002683 | 0.0014 | 1.9288 | 15.9319 | 29 | 375 | negative regulation of immune system process |
GO:0007498 | 0.0015 | 4.7316 | 1.7233 | 7 | 41 | mesoderm development |
GO:0002704 | 0.0015 | 4.6781 | 1.7419 | 7 | 41 | negative regulation of leukocyte mediated immunity |
GO:0045944 | 0.0016 | 1.529 | 44.8643 | 65 | 1056 | positive regulation of transcription from RNA polymerase II promoter |
GO:0007229 | 0.0017 | 3.3491 | 3.3138 | 10 | 78 | integrin-mediated signaling pathway |
GO:0051051 | 0.0017 | 1.8018 | 19.9255 | 34 | 469 | negative regulation of transport |
GO:0090130 | 0.0018 | 2.2026 | 9.6866 | 20 | 228 | tissue migration |
GO:0032765 | 0.0018 | Inf | 0.085 | 2 | 2 | positive regulation of mast cell cytokine production |
GO:1900168 | 0.0018 | Inf | 0.085 | 2 | 2 | positive regulation of glial cell-derived neurotrophic factor secretion |
GO:1900673 | 0.0018 | Inf | 0.085 | 2 | 2 | olefin metabolic process |
GO:0002237 | 0.0019 | 2.1919 | 9.7291 | 20 | 229 | response to molecule of bacterial origin |
GO:0030168 | 0.002 | 5.2771 | 1.3501 | 6 | 32 | platelet activation |
GO:0033005 | 0.002 | 6.6706 | 0.9347 | 5 | 22 | positive regulation of mast cell activation |
GO:0048333 | 0.002 | 6.6706 | 0.9347 | 5 | 22 | mesodermal cell differentiation |
GO:0051094 | 0.002 | 1.4749 | 52.9364 | 74 | 1246 | positive regulation of developmental process |
GO:0071222 | 0.002 | 2.721 | 5.1832 | 13 | 122 | cellular response to lipopolysaccharide |
GO:0042327 | 0.0022 | 1.5609 | 37.0895 | 55 | 873 | positive regulation of phosphorylation |
GO:0022407 | 0.0022 | 1.9146 | 14.9123 | 27 | 351 | regulation of cell-cell adhesion |
GO:0065008 | 0.0022 | 1.3173 | 127.5403 | 157 | 3002 | regulation of biological quality |
GO:0002710 | 0.0023 | 9.0627 | 0.5948 | 4 | 14 | negative regulation of T cell mediated immunity |
GO:0012501 | 0.0024 | 1.4032 | 71.5874 | 95 | 1685 | programmed cell death |
GO:0060216 | 0.0024 | 6.2996 | 0.9772 | 5 | 23 | definitive hemopoiesis |
GO:0045137 | 0.0025 | 2.2997 | 7.9022 | 17 | 186 | development of primary sexual characteristics |
GO:0001704 | 0.0025 | 2.9483 | 4.0786 | 11 | 96 | formation of primary germ layer |
GO:0015696 | 0.0025 | 2.9483 | 4.0786 | 11 | 96 | ammonium transport |
GO:0042060 | 0.0028 | 1.9315 | 13.6802 | 25 | 322 | wound healing |
GO:0046883 | 0.0028 | 2.0643 | 10.7912 | 21 | 254 | regulation of hormone secretion |
GO:0002675 | 0.003 | 5.9677 | 1.0196 | 5 | 24 | positive regulation of acute inflammatory response |
GO:0018904 | 0.003 | 8.2383 | 0.6373 | 4 | 15 | ether metabolic process |
GO:0031323 | 0.003 | 1.2598 | 207.9221 | 241 | 4894 | regulation of cellular metabolic process |
GO:1903532 | 0.003 | 1.843 | 16.0169 | 28 | 377 | positive regulation of secretion by cell |
GO:0002285 | 0.0031 | 2.4765 | 6.0754 | 14 | 143 | lymphocyte activation involved in immune response |
GO:0043408 | 0.0031 | 1.6432 | 26.2133 | 41 | 617 | regulation of MAPK cascade |
GO:0045576 | 0.0032 | 4.7257 | 1.478 | 6 | 35 | mast cell activation |
GO:0022603 | 0.0033 | 1.5341 | 36.962 | 54 | 870 | regulation of anatomical structure morphogenesis |
GO:0010631 | 0.0033 | 2.1203 | 9.5167 | 19 | 224 | epithelial cell migration |
GO:0032870 | 0.0034 | 1.7689 | 18.4385 | 31 | 434 | cellular response to hormone stimulus |
GO:0090092 | 0.0034 | 2.1662 | 8.8369 | 18 | 208 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:0072593 | 0.0035 | 2.1099 | 9.5591 | 19 | 225 | reactive oxygen species metabolic process |
GO:1903799 | 0.0036 | 13.5783 | 0.3399 | 3 | 8 | negative regulation of production of miRNAs involved in gene silencing by miRNA |
GO:0060395 | 0.0037 | 3.4968 | 2.5491 | 8 | 60 | SMAD protein signal transduction |
GO:0021983 | 0.0038 | 4.5389 | 1.5295 | 6 | 36 | pituitary gland development |
GO:0050867 | 0.0039 | 2.0032 | 11.0886 | 21 | 261 | positive regulation of cell activation |
GO:0043306 | 0.0039 | 7.5513 | 0.6798 | 4 | 16 | positive regulation of mast cell degranulation |
GO:0071216 | 0.004 | 2.4014 | 6.2453 | 14 | 147 | cellular response to biotic stimulus |
GO:0008584 | 0.004 | 2.7528 | 4.3335 | 11 | 102 | male gonad development |
GO:0043534 | 0.004 | 3.1492 | 3.1439 | 9 | 74 | blood vessel endothelial cell migration |
GO:1903706 | 0.0041 | 1.8673 | 14.1051 | 25 | 332 | regulation of hemopoiesis |
GO:0071622 | 0.0043 | 4.3922 | 1.5719 | 6 | 37 | regulation of granulocyte chemotaxis |
GO:0045598 | 0.0044 | 2.5794 | 5.0132 | 12 | 118 | regulation of fat cell differentiation |
GO:0023014 | 0.0044 | 1.5799 | 29.1873 | 44 | 687 | signal transduction by protein phosphorylation |
GO:0032722 | 0.0044 | 3.7851 | 2.0818 | 7 | 49 | positive regulation of chemokine production |
GO:0050727 | 0.0044 | 2.0157 | 10.4938 | 20 | 247 | regulation of inflammatory response |
GO:0007389 | 0.0045 | 1.7493 | 18.0137 | 30 | 424 | pattern specification process |
GO:0042130 | 0.0045 | 3.3669 | 2.6341 | 8 | 62 | negative regulation of T cell proliferation |
GO:0098609 | 0.0046 | 1.969 | 11.2616 | 21 | 270 | cell-cell adhesion |
GO:0050673 | 0.0047 | 1.8236 | 14.9972 | 26 | 353 | epithelial cell proliferation |
GO:0010604 | 0.0048 | 1.301 | 113.3078 | 139 | 2667 | positive regulation of macromolecule metabolic process |
GO:0007166 | 0.0049 | 1.4675 | 43.6738 | 61 | 1087 | cell surface receptor signaling pathway |
GO:0008284 | 0.0049 | 1.5255 | 34.328 | 50 | 808 | positive regulation of cell proliferation |
GO:0045064 | 0.0049 | 6.9699 | 0.7222 | 4 | 17 | T-helper 2 cell differentiation |
GO:0002376 | 0.0049 | 1.3978 | 60.1774 | 80 | 1445 | immune system process |
GO:0006954 | 0.005 | 1.9941 | 10.5954 | 20 | 253 | inflammatory response |
GO:0030335 | 0.005 | 1.7522 | 17.3764 | 29 | 409 | positive regulation of cell migration |
GO:0098542 | 0.005 | 1.8123 | 15.0822 | 26 | 355 | defense response to other organism |
GO:0032102 | 0.0051 | 1.989 | 10.6213 | 20 | 250 | negative regulation of response to external stimulus |
GO:0032103 | 0.0051 | 2.0299 | 9.899 | 19 | 233 | positive regulation of response to external stimulus |
GO:0060548 | 0.0051 | 1.4914 | 38.619 | 55 | 909 | negative regulation of cell death |
GO:0002367 | 0.0052 | 3.0096 | 3.2714 | 9 | 77 | cytokine production involved in immune response |
GO:0002554 | 0.0053 | 45.2059 | 0.1275 | 2 | 3 | serotonin secretion by platelet |
GO:0002877 | 0.0053 | 45.2059 | 0.1275 | 2 | 3 | regulation of acute inflammatory response to non-antigenic stimulus |
GO:0007060 | 0.0053 | 45.2059 | 0.1275 | 2 | 3 | male meiosis chromosome segregation |
GO:0019676 | 0.0053 | 45.2059 | 0.1275 | 2 | 3 | ammonia assimilation cycle |
GO:0036301 | 0.0053 | 45.2059 | 0.1275 | 2 | 3 | macrophage colony-stimulating factor production |
GO:0038095 | 0.0053 | 45.2059 | 0.1275 | 2 | 3 | Fc-epsilon receptor signaling pathway |
GO:0060375 | 0.0053 | 45.2059 | 0.1275 | 2 | 3 | regulation of mast cell differentiation |
GO:0070164 | 0.0053 | 45.2059 | 0.1275 | 2 | 3 | negative regulation of adiponectin secretion |
GO:0071655 | 0.0053 | 45.2059 | 0.1275 | 2 | 3 | regulation of granulocyte colony-stimulating factor production |
GO:0097195 | 0.0053 | 45.2059 | 0.1275 | 2 | 3 | pilomotor reflex |
GO:1900158 | 0.0053 | 45.2059 | 0.1275 | 2 | 3 | negative regulation of bone mineralization involved in bone maturation |
GO:1900625 | 0.0053 | 45.2059 | 0.1275 | 2 | 3 | positive regulation of monocyte aggregation |
GO:0060215 | 0.0053 | 11.3145 | 0.3824 | 3 | 9 | primitive hemopoiesis |
GO:0072677 | 0.0053 | 11.3145 | 0.3824 | 3 | 9 | eosinophil migration |
GO:0009968 | 0.0053 | 1.4586 | 43.8021 | 61 | 1031 | negative regulation of signal transduction |
GO:0042981 | 0.0054 | 1.3991 | 57.7372 | 77 | 1359 | regulation of apoptotic process |
GO:0048731 | 0.0055 | 1.2926 | 120.5088 | 146 | 2968 | system development |
GO:0018212 | 0.0056 | 1.9003 | 12.1932 | 22 | 287 | peptidyl-tyrosine modification |
GO:0048598 | 0.0057 | 1.5985 | 25.5335 | 39 | 601 | embryonic morphogenesis |
GO:0007169 | 0.0059 | 1.6528 | 21.5399 | 34 | 507 | transmembrane receptor protein tyrosine kinase signaling pathway |
GO:0042127 | 0.006 | 2.1448 | 7.913 | 16 | 193 | regulation of cell proliferation |
GO:1901342 | 0.0061 | 1.9921 | 10.069 | 19 | 237 | regulation of vasculature development |
GO:0045766 | 0.0061 | 2.4624 | 5.2257 | 12 | 123 | positive regulation of angiogenesis |
GO:0001780 | 0.0061 | 6.4717 | 0.7647 | 4 | 18 | neutrophil homeostasis |
GO:0030220 | 0.0061 | 6.4717 | 0.7647 | 4 | 18 | platelet formation |
GO:0031935 | 0.0061 | 6.4717 | 0.7647 | 4 | 18 | regulation of chromatin silencing |
GO:0035855 | 0.0061 | 6.4717 | 0.7647 | 4 | 18 | megakaryocyte development |
GO:0002292 | 0.0061 | 3.532 | 2.2092 | 7 | 52 | T cell differentiation involved in immune response |
GO:0038083 | 0.0061 | 3.532 | 2.2092 | 7 | 52 | peptidyl-tyrosine autophosphorylation |
GO:0051173 | 0.0065 | 1.2902 | 110.6312 | 135 | 2604 | positive regulation of nitrogen compound metabolic process |
GO:0031399 | 0.0072 | 1.3649 | 63.7276 | 83 | 1500 | regulation of protein modification process |
GO:0030728 | 0.0072 | 9.7358 | 0.4233 | 3 | 10 | ovulation |
GO:0032760 | 0.0073 | 3.0805 | 2.8465 | 8 | 67 | positive regulation of tumor necrosis factor production |
GO:0043950 | 0.0073 | 9.6975 | 0.4249 | 3 | 10 | positive regulation of cAMP-mediated signaling |
GO:0060124 | 0.0073 | 9.6975 | 0.4249 | 3 | 10 | positive regulation of growth hormone secretion |
GO:0060452 | 0.0073 | 9.6975 | 0.4249 | 3 | 10 | positive regulation of cardiac muscle contraction |
GO:0070486 | 0.0073 | 9.6975 | 0.4249 | 3 | 10 | leukocyte aggregation |
GO:1901030 | 0.0073 | 9.6975 | 0.4249 | 3 | 10 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway |
GO:0051241 | 0.0073 | 1.4333 | 44.4859 | 61 | 1050 | negative regulation of multicellular organismal process |
GO:0032504 | 0.0073 | 1.5366 | 29.2297 | 43 | 688 | multicellular organism reproduction |
GO:0048870 | 0.0075 | 1.6121 | 22.7096 | 35 | 546 | cell motility |
GO:0007275 | 0.0075 | 1.7166 | 17.1681 | 28 | 446 | multicellular organism development |
GO:0007204 | 0.0076 | 1.9468 | 10.2814 | 19 | 242 | positive regulation of cytosolic calcium ion concentration |
GO:0007155 | 0.0076 | 1.8757 | 11.769 | 21 | 289 | cell adhesion |
GO:0035249 | 0.0079 | 2.8026 | 3.4838 | 9 | 82 | synaptic transmission, glutamatergic |
GO:0001562 | 0.008 | 4.5336 | 1.2746 | 5 | 30 | response to protozoan |
GO:0002712 | 0.0082 | 3.7809 | 1.7844 | 6 | 42 | regulation of B cell mediated immunity |
GO:0032715 | 0.0082 | 3.7809 | 1.7844 | 6 | 42 | negative regulation of interleukin-6 production |
GO:0009952 | 0.0083 | 2.0106 | 8.9219 | 17 | 210 | anterior/posterior pattern specification |
GO:0070527 | 0.0084 | 3.3106 | 2.3367 | 7 | 55 | platelet aggregation |
GO:0048259 | 0.0085 | 2.7645 | 3.5263 | 9 | 83 | regulation of receptor-mediated endocytosis |
GO:0007215 | 0.0087 | 2.9791 | 2.9315 | 8 | 69 | glutamate receptor signaling pathway |
GO:2001057 | 0.0087 | 2.9791 | 2.9315 | 8 | 69 | reactive nitrogen species metabolic process |
GO:0046058 | 0.0088 | 2.3352 | 5.4806 | 12 | 129 | cAMP metabolic process |
GO:0032642 | 0.0089 | 5.7057 | 0.8435 | 4 | 20 | regulation of chemokine production |
GO:0060627 | 0.009 | 1.6543 | 18.9484 | 30 | 446 | regulation of vesicle-mediated transport |
GO:0051704 | 0.0091 | 1.3479 | 65.2146 | 84 | 1535 | multi-organism process |
GO:0006925 | 0.0091 | 5.662 | 0.8497 | 4 | 20 | inflammatory cell apoptotic process |
GO:0019433 | 0.0091 | 5.662 | 0.8497 | 4 | 20 | triglyceride catabolic process |
GO:0030903 | 0.0091 | 5.662 | 0.8497 | 4 | 20 | notochord development |
GO:1900542 | 0.0091 | 2.0391 | 8.2846 | 16 | 195 | regulation of purine nucleotide metabolic process |
GO:0045646 | 0.0092 | 3.6785 | 1.8269 | 6 | 43 | regulation of erythrocyte differentiation |
GO:2000145 | 0.0092 | 1.5064 | 30.4618 | 44 | 717 | regulation of cell motility |
GO:0032652 | 0.0092 | 3.2429 | 2.3792 | 7 | 56 | regulation of interleukin-1 production |
GO:0002891 | 0.0093 | 4.359 | 1.317 | 5 | 31 | positive regulation of immunoglobulin mediated immune response |
GO:0043267 | 0.0093 | 4.359 | 1.317 | 5 | 31 | negative regulation of potassium ion transport |
GO:0097530 | 0.0097 | 2.7025 | 3.5973 | 9 | 85 | granulocyte migration |
GO:0019935 | 0.0097 | 2.7021 | 3.5977 | 9 | 85 | cyclic-nucleotide-mediated signaling |
GO:0001542 | 0.0098 | 8.4848 | 0.4673 | 3 | 11 | ovulation from ovarian follicle |
GO:0002862 | 0.0098 | 8.4848 | 0.4673 | 3 | 11 | negative regulation of inflammatory response to antigenic stimulus |
GO:0019934 | 0.0098 | 8.4848 | 0.4673 | 3 | 11 | cGMP-mediated signaling |
GO:0045217 | 0.0098 | 8.4848 | 0.4673 | 3 | 11 | cell-cell junction maintenance |
GO:0045346 | 0.0098 | 8.4848 | 0.4673 | 3 | 11 | regulation of MHC class II biosynthetic process |
GO:0097011 | 0.0098 | 8.4848 | 0.4673 | 3 | 11 | cellular response to granulocyte macrophage colony-stimulating factor stimulus |
GO:0045639 | 0.0099 | 2.6914 | 3.6112 | 9 | 85 | positive regulation of myeloid cell differentiation |
GO:0043433 | 0.0099 | 2.2957 | 5.5655 | 12 | 131 | negative regulation of DNA binding transcription factor activity |
GO:0031589 | 0.0099 | 1.8252 | 12.0658 | 21 | 284 | cell-substrate adhesion |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0030220 | 5e-04 | 9.3482 | 0.7162 | 5 | 18 | platelet formation |
GO:0006597 | 0.0016 | Inf | 0.0796 | 2 | 2 | spermine biosynthetic process |
GO:0014728 | 0.0016 | Inf | 0.0796 | 2 | 2 | regulation of the force of skeletal muscle contraction |
GO:0042727 | 0.0016 | Inf | 0.0796 | 2 | 2 | flavin-containing compound biosynthetic process |
GO:0030168 | 0.0023 | 3.1685 | 3.4614 | 10 | 87 | platelet activation |
GO:0072520 | 0.0031 | 8.0894 | 0.6366 | 4 | 16 | seminiferous tubule development |
GO:0010970 | 0.0042 | 2.5931 | 4.9733 | 12 | 125 | transport along microtubule |
GO:1904354 | 0.0044 | 12.1197 | 0.3581 | 3 | 9 | negative regulation of telomere capping |
GO:0051835 | 0.0046 | 48.4177 | 0.1194 | 2 | 3 | positive regulation of synapse structural plasticity |
GO:0070164 | 0.0046 | 48.4177 | 0.1194 | 2 | 3 | negative regulation of adiponectin secretion |
GO:0001780 | 0.0049 | 6.9329 | 0.7162 | 4 | 18 | neutrophil homeostasis |
GO:0060969 | 0.0049 | 6.9329 | 0.7162 | 4 | 18 | negative regulation of gene silencing |
GO:0043950 | 0.0061 | 10.3876 | 0.3979 | 3 | 10 | positive regulation of cAMP-mediated signaling |
GO:0060965 | 0.0061 | 10.3876 | 0.3979 | 3 | 10 | negative regulation of gene silencing by miRNA |
GO:0043488 | 0.0065 | 3.1411 | 2.7851 | 8 | 70 | regulation of mRNA stability |
GO:1903708 | 0.0069 | 2.2356 | 6.6444 | 14 | 167 | positive regulation of hemopoiesis |
GO:0090501 | 0.0079 | 3.3383 | 2.3076 | 7 | 58 | RNA phosphodiester bond hydrolysis |
GO:0071468 | 0.0081 | 9.0885 | 0.4377 | 3 | 11 | cellular response to acidic pH |
GO:0014724 | 0.009 | 24.2073 | 0.1591 | 2 | 4 | regulation of twitch skeletal muscle contraction |
GO:0031860 | 0.009 | 24.2073 | 0.1591 | 2 | 4 | telomeric 3' overhang formation |
GO:0035720 | 0.009 | 24.2073 | 0.1591 | 2 | 4 | intraciliary anterograde transport |
GO:1902746 | 0.009 | 24.2073 | 0.1591 | 2 | 4 | regulation of lens fiber cell differentiation |
GO:0021846 | 0.0092 | 4.336 | 1.313 | 5 | 33 | cell proliferation in forebrain |
GO:0010862 | 0.0094 | 3.6451 | 1.8302 | 6 | 46 | positive regulation of pathway-restricted SMAD protein phosphorylation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0030819 | 6e-04 | 4.252 | 2.3944 | 9 | 65 | positive regulation of cAMP biosynthetic process |
GO:0006597 | 0.0014 | Inf | 0.0737 | 2 | 2 | spermine biosynthetic process |
GO:0014728 | 0.0014 | Inf | 0.0737 | 2 | 2 | regulation of the force of skeletal muscle contraction |
GO:2000669 | 0.0014 | Inf | 0.0737 | 2 | 2 | negative regulation of dendritic cell apoptotic process |
GO:0002684 | 0.0014 | 1.7962 | 21.1733 | 36 | 581 | positive regulation of immune system process |
GO:0009584 | 0.0019 | 6.5842 | 0.9209 | 5 | 25 | detection of visible light |
GO:0007190 | 0.0023 | 8.7684 | 0.5894 | 4 | 16 | activation of adenylate cyclase activity |
GO:0072520 | 0.0023 | 8.7684 | 0.5894 | 4 | 16 | seminiferous tubule development |
GO:0097499 | 0.0024 | 15.7634 | 0.2947 | 3 | 8 | protein localization to non-motile cilium |
GO:2000508 | 0.0024 | 15.7634 | 0.2947 | 3 | 8 | regulation of dendritic cell chemotaxis |
GO:0051250 | 0.0027 | 2.7404 | 4.7152 | 12 | 128 | negative regulation of lymphocyte activation |
GO:0002763 | 0.0028 | 4.1043 | 1.9155 | 7 | 52 | positive regulation of myeloid leukocyte differentiation |
GO:0045063 | 0.003 | 8.0934 | 0.6262 | 4 | 17 | T-helper 1 cell differentiation |
GO:0052652 | 0.0031 | 2.6936 | 4.7888 | 12 | 130 | cyclic purine nucleotide metabolic process |
GO:0006954 | 0.0034 | 1.7688 | 18.4186 | 31 | 500 | inflammatory response |
GO:0050482 | 0.0038 | 5.4854 | 1.0683 | 5 | 29 | arachidonic acid secretion |
GO:0030099 | 0.0039 | 1.9336 | 12.5246 | 23 | 340 | myeloid cell differentiation |
GO:0046813 | 0.004 | 52.4684 | 0.1105 | 2 | 3 | receptor-mediated virion attachment to host cell |
GO:0060435 | 0.004 | 52.4684 | 0.1105 | 2 | 3 | bronchiole development |
GO:0030801 | 0.0043 | 3.0881 | 3.168 | 9 | 86 | positive regulation of cyclic nucleotide metabolic process |
GO:0030810 | 0.0043 | 3.0881 | 3.168 | 9 | 86 | positive regulation of nucleotide biosynthetic process |
GO:0002687 | 0.0043 | 2.8739 | 3.7574 | 10 | 102 | positive regulation of leukocyte migration |
GO:0043950 | 0.0049 | 11.2581 | 0.3684 | 3 | 10 | positive regulation of cAMP-mediated signaling |
GO:0072584 | 0.0049 | 11.2581 | 0.3684 | 3 | 10 | caveolin-mediated endocytosis |
GO:0045087 | 0.0057 | 1.7163 | 18.3081 | 30 | 497 | innate immune response |
GO:1900371 | 0.0057 | 2.5979 | 4.531 | 11 | 123 | regulation of purine nucleotide biosynthetic process |
GO:1903706 | 0.0059 | 1.8889 | 12.2299 | 22 | 332 | regulation of hemopoiesis |
GO:0003009 | 0.0067 | 4.7005 | 1.2156 | 5 | 33 | skeletal muscle contraction |
GO:0003219 | 0.0077 | 26.2325 | 0.1473 | 2 | 4 | cardiac right ventricle formation |
GO:0014724 | 0.0077 | 26.2325 | 0.1473 | 2 | 4 | regulation of twitch skeletal muscle contraction |
GO:0021615 | 0.0077 | 26.2325 | 0.1473 | 2 | 4 | glossopharyngeal nerve morphogenesis |
GO:0045730 | 0.0079 | 5.8433 | 0.8104 | 4 | 22 | respiratory burst |
GO:0050866 | 0.0081 | 2.2642 | 6.0781 | 13 | 165 | negative regulation of cell activation |
GO:0030802 | 0.0083 | 2.5905 | 4.1258 | 10 | 112 | regulation of cyclic nucleotide biosynthetic process |
GO:0043649 | 0.0085 | 8.7551 | 0.442 | 3 | 12 | dicarboxylic acid catabolic process |
GO:1900029 | 0.0085 | 8.7551 | 0.442 | 3 | 12 | positive regulation of ruffle assembly |
GO:0043030 | 0.0087 | 4.3866 | 1.2893 | 5 | 35 | regulation of macrophage activation |
GO:0050850 | 0.0087 | 4.3866 | 1.2893 | 5 | 35 | positive regulation of calcium-mediated signaling |
GO:1902107 | 0.0087 | 2.9586 | 2.9214 | 8 | 80 | positive regulation of leukocyte differentiation |
GO:0015909 | 0.0089 | 3.6757 | 1.805 | 6 | 49 | long-chain fatty acid transport |
GO:0002250 | 0.0091 | 1.871 | 11.1985 | 20 | 304 | adaptive immune response |
GO:0045066 | 0.0092 | 5.5354 | 0.8473 | 4 | 23 | regulatory T cell differentiation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0052696 | 0 | 178.5058 | 0.3052 | 7 | 8 | flavonoid glucuronidation |
GO:0052697 | 0 | 178.5058 | 0.3052 | 7 | 8 | xenobiotic glucuronidation |
GO:0019585 | 0 | 59.4942 | 0.3816 | 7 | 10 | glucuronate metabolic process |
GO:0071466 | 0 | 6.7582 | 1.6407 | 9 | 43 | cellular response to xenobiotic stimulus |
GO:0032787 | 0 | 2.1804 | 17.7802 | 36 | 466 | monocarboxylic acid metabolic process |
GO:0032733 | 1e-04 | 9.5681 | 0.8369 | 6 | 22 | positive regulation of interleukin-10 production |
GO:0051971 | 4e-04 | 16.9106 | 0.3816 | 4 | 10 | positive regulation of transmission of nerve impulse |
GO:0035898 | 5e-04 | 37.9959 | 0.1908 | 3 | 5 | parathyroid hormone secretion |
GO:0003334 | 8e-04 | 12.6813 | 0.4579 | 4 | 12 | keratinocyte development |
GO:0042098 | 0.001 | 2.6115 | 6.6008 | 16 | 173 | T cell proliferation |
GO:0006690 | 0.0013 | 3.4468 | 3.205 | 10 | 84 | icosanoid metabolic process |
GO:0006696 | 0.0015 | Inf | 0.0763 | 2 | 2 | ergosterol biosynthetic process |
GO:0045368 | 0.0015 | Inf | 0.0763 | 2 | 2 | positive regulation of interleukin-13 biosynthetic process |
GO:0046226 | 0.0015 | Inf | 0.0763 | 2 | 2 | coumarin catabolic process |
GO:0045087 | 0.0015 | 1.8384 | 18.963 | 33 | 497 | innate immune response |
GO:0032196 | 0.0015 | 10.1437 | 0.5342 | 4 | 14 | transposition |
GO:1902107 | 0.0016 | 2.7922 | 5.0365 | 13 | 132 | positive regulation of leukocyte differentiation |
GO:0050870 | 0.0017 | 2.6523 | 5.6851 | 14 | 149 | positive regulation of T cell activation |
GO:0032943 | 0.0017 | 2.2034 | 9.6532 | 20 | 253 | mononuclear cell proliferation |
GO:0043436 | 0.0019 | 1.6249 | 31.1345 | 48 | 816 | oxoacid metabolic process |
GO:0046649 | 0.0024 | 1.7334 | 21.8628 | 36 | 573 | lymphocyte activation |
GO:0060142 | 0.0032 | 5.7685 | 1.0302 | 5 | 27 | regulation of syncytium formation by plasma membrane fusion |
GO:0032689 | 0.0038 | 5.5173 | 1.0683 | 5 | 28 | negative regulation of interferon-gamma production |
GO:0046640 | 0.0038 | 5.5173 | 1.0683 | 5 | 28 | regulation of alpha-beta T cell proliferation |
GO:0050966 | 0.0042 | 7.2436 | 0.6868 | 4 | 18 | detection of mechanical stimulus involved in sensory perception of pain |
GO:0001805 | 0.0042 | 50.5809 | 0.1145 | 2 | 3 | positive regulation of type III hypersensitivity |
GO:0009436 | 0.0042 | 50.5809 | 0.1145 | 2 | 3 | glyoxylate catabolic process |
GO:0009698 | 0.0042 | 50.5809 | 0.1145 | 2 | 3 | phenylpropanoid metabolic process |
GO:0016128 | 0.0042 | 50.5809 | 0.1145 | 2 | 3 | phytosteroid metabolic process |
GO:0021773 | 0.0042 | 50.5809 | 0.1145 | 2 | 3 | striatal medium spiny neuron differentiation |
GO:0034241 | 0.0042 | 50.5809 | 0.1145 | 2 | 3 | positive regulation of macrophage fusion |
GO:0044107 | 0.0042 | 50.5809 | 0.1145 | 2 | 3 | cellular alcohol metabolic process |
GO:0051835 | 0.0042 | 50.5809 | 0.1145 | 2 | 3 | positive regulation of synapse structural plasticity |
GO:0061792 | 0.0042 | 50.5809 | 0.1145 | 2 | 3 | secretory granule maturation |
GO:0071672 | 0.0042 | 50.5809 | 0.1145 | 2 | 3 | negative regulation of smooth muscle cell chemotaxis |
GO:1901536 | 0.0042 | 50.5809 | 0.1145 | 2 | 3 | negative regulation of DNA demethylation |
GO:0070663 | 0.0043 | 2.2243 | 7.631 | 16 | 200 | regulation of leukocyte proliferation |
GO:0001775 | 0.0044 | 1.5711 | 30.028 | 45 | 787 | cell activation |
GO:0006487 | 0.0047 | 3.7075 | 2.0985 | 7 | 55 | protein N-linked glycosylation |
GO:0045639 | 0.005 | 3.0151 | 3.2432 | 9 | 85 | positive regulation of myeloid cell differentiation |
GO:0010951 | 0.0052 | 2.7998 | 3.8537 | 10 | 101 | negative regulation of endopeptidase activity |
GO:0043388 | 0.0052 | 3.6316 | 2.1367 | 7 | 56 | positive regulation of DNA binding |
GO:0002524 | 0.0054 | 10.8524 | 0.3816 | 3 | 10 | hypersensitivity |
GO:0034116 | 0.0054 | 10.8524 | 0.3816 | 3 | 10 | positive regulation of heterotypic cell-cell adhesion |
GO:0046631 | 0.0054 | 2.6209 | 4.5023 | 11 | 118 | alpha-beta T cell activation |
GO:1903037 | 0.0062 | 1.9858 | 10.0729 | 19 | 264 | regulation of leukocyte cell-cell adhesion |
GO:0050670 | 0.0066 | 2.1775 | 7.2876 | 15 | 191 | regulation of lymphocyte proliferation |
GO:0002696 | 0.0067 | 2.0114 | 9.4243 | 18 | 247 | positive regulation of leukocyte activation |
GO:0002863 | 0.0073 | 9.4952 | 0.4197 | 3 | 11 | positive regulation of inflammatory response to antigenic stimulus |
GO:0006721 | 0.0077 | 3.8091 | 1.7551 | 6 | 46 | terpenoid metabolic process |
GO:0010466 | 0.0079 | 3.33 | 2.3038 | 7 | 61 | negative regulation of peptidase activity |
GO:0001798 | 0.0083 | 25.2888 | 0.1526 | 2 | 4 | positive regulation of type IIa hypersensitivity |
GO:0002322 | 0.0083 | 25.2888 | 0.1526 | 2 | 4 | B cell proliferation involved in immune response |
GO:0002892 | 0.0083 | 25.2888 | 0.1526 | 2 | 4 | regulation of type II hypersensitivity |
GO:0014028 | 0.0083 | 25.2888 | 0.1526 | 2 | 4 | notochord formation |
GO:0021615 | 0.0083 | 25.2888 | 0.1526 | 2 | 4 | glossopharyngeal nerve morphogenesis |
GO:0035666 | 0.0083 | 25.2888 | 0.1526 | 2 | 4 | TRIF-dependent toll-like receptor signaling pathway |
GO:0060535 | 0.0083 | 25.2888 | 0.1526 | 2 | 4 | trachea cartilage morphogenesis |
GO:2001181 | 0.0083 | 25.2888 | 0.1526 | 2 | 4 | positive regulation of interleukin-10 secretion |
GO:0032673 | 0.0089 | 5.6325 | 0.8394 | 4 | 22 | regulation of interleukin-4 production |
GO:0051602 | 0.0089 | 5.6325 | 0.8394 | 4 | 22 | response to electrical stimulus |
GO:0060100 | 0.0094 | 8.4397 | 0.4579 | 3 | 12 | positive regulation of phagocytosis, engulfment |
GO:0007218 | 0.0099 | 3.1762 | 2.4038 | 7 | 63 | neuropeptide signaling pathway |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0052696 | 0 | 182.2852 | 0.2992 | 7 | 8 | flavonoid glucuronidation |
GO:0052697 | 0 | 182.2852 | 0.2992 | 7 | 8 | xenobiotic glucuronidation |
GO:0019585 | 0 | 60.7538 | 0.374 | 7 | 10 | glucuronate metabolic process |
GO:0071466 | 0 | 6.9017 | 1.6083 | 9 | 43 | cellular response to xenobiotic stimulus |
GO:0030850 | 6e-04 | 4.8397 | 1.9075 | 8 | 51 | prostate gland development |
GO:0022404 | 0.001 | 3.335 | 3.628 | 11 | 97 | molting cycle process |
GO:0098773 | 0.001 | 3.335 | 3.628 | 11 | 97 | skin epidermis development |
GO:0046226 | 0.0014 | Inf | 0.0748 | 2 | 2 | coumarin catabolic process |
GO:0097752 | 0.0014 | Inf | 0.0748 | 2 | 2 | regulation of DNA stability |
GO:2000079 | 0.0014 | Inf | 0.0748 | 2 | 2 | regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation |
GO:2000543 | 0.0025 | 15.515 | 0.2992 | 3 | 8 | positive regulation of gastrulation |
GO:0042633 | 0.0029 | 2.8655 | 4.1516 | 11 | 111 | hair cycle |
GO:0060572 | 0.0031 | 7.9657 | 0.6358 | 4 | 17 | morphogenesis of an epithelial bud |
GO:0001696 | 0.0039 | 7.3962 | 0.6732 | 4 | 18 | gastric acid secretion |
GO:0035510 | 0.0039 | 7.3962 | 0.6732 | 4 | 18 | DNA dealkylation |
GO:0031069 | 0.0041 | 5.3987 | 1.0847 | 5 | 29 | hair follicle morphogenesis |
GO:0007060 | 0.0041 | 51.6431 | 0.1122 | 2 | 3 | male meiosis chromosome segregation |
GO:0009698 | 0.0041 | 51.6431 | 0.1122 | 2 | 3 | phenylpropanoid metabolic process |
GO:0009972 | 0.0041 | 51.6431 | 0.1122 | 2 | 3 | cytidine deamination |
GO:0035993 | 0.0041 | 51.6431 | 0.1122 | 2 | 3 | deltoid tuberosity development |
GO:0042706 | 0.0041 | 51.6431 | 0.1122 | 2 | 3 | eye photoreceptor cell fate commitment |
GO:0044725 | 0.0041 | 51.6431 | 0.1122 | 2 | 3 | chromatin reprogramming in the zygote |
GO:0046087 | 0.0041 | 51.6431 | 0.1122 | 2 | 3 | cytidine metabolic process |
GO:0048696 | 0.0041 | 51.6431 | 0.1122 | 2 | 3 | regulation of collateral sprouting in absence of injury |
GO:0070164 | 0.0041 | 51.6431 | 0.1122 | 2 | 3 | negative regulation of adiponectin secretion |
GO:0000466 | 0.0048 | 6.9027 | 0.7106 | 4 | 19 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) |
GO:0031424 | 0.0048 | 6.9027 | 0.7106 | 4 | 19 | keratinization |
GO:0045926 | 0.0052 | 2.1152 | 8.4902 | 17 | 227 | negative regulation of growth |
GO:0098609 | 0.0062 | 1.6213 | 23.2266 | 36 | 621 | cell-cell adhesion |
GO:0060740 | 0.0063 | 4.7979 | 1.1969 | 5 | 32 | prostate gland epithelium morphogenesis |
GO:0001542 | 0.0069 | 9.695 | 0.4114 | 3 | 11 | ovulation from ovarian follicle |
GO:0010839 | 0.0069 | 9.695 | 0.4114 | 3 | 11 | negative regulation of keratinocyte proliferation |
GO:0016446 | 0.0069 | 9.695 | 0.4114 | 3 | 11 | somatic hypermutation of immunoglobulin genes |
GO:0032891 | 0.007 | 6.0898 | 0.7854 | 4 | 21 | negative regulation of organic acid transport |
GO:0045606 | 0.007 | 6.0898 | 0.7854 | 4 | 21 | positive regulation of epidermal cell differentiation |
GO:0043627 | 0.0078 | 3.7945 | 1.7579 | 6 | 47 | response to estrogen |
GO:0035990 | 0.008 | 25.8199 | 0.1496 | 2 | 4 | tendon cell differentiation |
GO:0045950 | 0.008 | 25.8199 | 0.1496 | 2 | 4 | negative regulation of mitotic recombination |
GO:0046133 | 0.008 | 25.8199 | 0.1496 | 2 | 4 | pyrimidine ribonucleoside catabolic process |
GO:0060686 | 0.008 | 25.8199 | 0.1496 | 2 | 4 | negative regulation of prostatic bud formation |
GO:0090245 | 0.008 | 25.8199 | 0.1496 | 2 | 4 | axis elongation involved in somitogenesis |
GO:1901535 | 0.008 | 25.8199 | 0.1496 | 2 | 4 | regulation of DNA demethylation |
GO:1905562 | 0.008 | 25.8199 | 0.1496 | 2 | 4 | regulation of vascular endothelial cell proliferation |
GO:0070233 | 0.0083 | 5.7511 | 0.8228 | 4 | 22 | negative regulation of T cell apoptotic process |
GO:2000107 | 0.0086 | 3.7039 | 1.7953 | 6 | 48 | negative regulation of leukocyte apoptotic process |
GO:0051798 | 0.0089 | 8.6172 | 0.4488 | 3 | 12 | positive regulation of hair follicle development |
GO:0060601 | 0.0089 | 8.6172 | 0.4488 | 3 | 12 | lateral sprouting from an epithelium |
GO:0072529 | 0.0089 | 8.6172 | 0.4488 | 3 | 12 | pyrimidine-containing compound catabolic process |
GO:0006112 | 0.0093 | 2.9257 | 2.9548 | 8 | 79 | energy reserve metabolic process |
GO:0060216 | 0.0097 | 5.4481 | 0.8602 | 4 | 23 | definitive hemopoiesis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0030510 | 5e-04 | 3.6122 | 3.3807 | 11 | 91 | regulation of BMP signaling pathway |
GO:0007602 | 7e-04 | 8.7041 | 0.743 | 5 | 20 | phototransduction |
GO:0038156 | 0.0014 | Inf | 0.0743 | 2 | 2 | interleukin-3-mediated signaling pathway |
GO:0043605 | 0.0014 | Inf | 0.0743 | 2 | 2 | cellular amide catabolic process |
GO:0071733 | 0.0014 | Inf | 0.0743 | 2 | 2 | transcriptional activation by promoter-enhancer looping |
GO:0090579 | 0.0014 | Inf | 0.0743 | 2 | 2 | dsDNA loop formation |
GO:1900176 | 0.0014 | Inf | 0.0743 | 2 | 2 | negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry |
GO:1990845 | 0.0019 | 9.4818 | 0.5573 | 4 | 15 | adaptive thermogenesis |
GO:0003382 | 0.0026 | 4.899 | 1.4117 | 6 | 38 | epithelial cell morphogenesis |
GO:0018298 | 0.0036 | 13.0195 | 0.3344 | 3 | 9 | protein-chromophore linkage |
GO:1902004 | 0.0036 | 13.0195 | 0.3344 | 3 | 9 | positive regulation of amyloid-beta formation |
GO:1903792 | 0.0039 | 5.4369 | 1.0774 | 5 | 29 | negative regulation of anion transport |
GO:0003130 | 0.004 | 52.0068 | 0.1115 | 2 | 3 | BMP signaling pathway involved in heart induction |
GO:0003133 | 0.004 | 52.0068 | 0.1115 | 2 | 3 | endodermal-mesodermal cell signaling |
GO:0046068 | 0.0041 | 3.8129 | 2.0433 | 7 | 55 | cGMP metabolic process |
GO:0030282 | 0.0046 | 3.0606 | 3.195 | 9 | 86 | bone mineralization |
GO:0035150 | 0.0052 | 2.4035 | 5.7584 | 13 | 155 | regulation of tube size |
GO:0046325 | 0.0057 | 6.5166 | 0.743 | 4 | 20 | negative regulation of glucose import |
GO:0003018 | 0.0058 | 2.284 | 6.5014 | 14 | 175 | vascular process in circulatory system |
GO:0007498 | 0.0065 | 2.7006 | 3.9751 | 10 | 107 | mesoderm development |
GO:0071773 | 0.0068 | 2.321 | 5.9441 | 13 | 160 | cellular response to BMP stimulus |
GO:0032891 | 0.0068 | 6.1329 | 0.7802 | 4 | 21 | negative regulation of organic acid transport |
GO:0097746 | 0.0075 | 2.3842 | 5.3497 | 12 | 144 | regulation of blood vessel diameter |
GO:0035582 | 0.0079 | 26.0017 | 0.1486 | 2 | 4 | sequestering of BMP in extracellular matrix |
GO:0042938 | 0.0079 | 26.0017 | 0.1486 | 2 | 4 | dipeptide transport |
GO:0048690 | 0.0079 | 26.0017 | 0.1486 | 2 | 4 | regulation of axon extension involved in regeneration |
GO:0060221 | 0.0079 | 26.0017 | 0.1486 | 2 | 4 | retinal rod cell differentiation |
GO:1900108 | 0.0079 | 26.0017 | 0.1486 | 2 | 4 | negative regulation of nodal signaling pathway |
GO:1900145 | 0.0079 | 26.0017 | 0.1486 | 2 | 4 | regulation of nodal signaling pathway involved in determination of left/right asymmetry |
GO:1905562 | 0.0079 | 26.0017 | 0.1486 | 2 | 4 | regulation of vascular endothelial cell proliferation |
GO:0009067 | 0.0081 | 5.7918 | 0.8173 | 4 | 22 | aspartate family amino acid biosynthetic process |
GO:0050829 | 0.0084 | 3.7301 | 1.7832 | 6 | 48 | defense response to Gram-negative bacterium |
GO:0003128 | 0.0087 | 8.678 | 0.4458 | 3 | 12 | heart field specification |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045653 | 0 | 63.3311 | 0.8428 | 13 | 17 | negative regulation of megakaryocyte differentiation |
GO:0006335 | 0 | 18.3012 | 1.5369 | 15 | 31 | DNA replication-dependent nucleosome assembly |
GO:0006336 | 0 | 21 | 1.3386 | 14 | 27 | DNA replication-independent nucleosome assembly |
GO:0006323 | 0 | 4.4877 | 7.486 | 28 | 151 | DNA packaging |
GO:0006333 | 0 | 4.4667 | 6.6928 | 25 | 135 | chromatin assembly or disassembly |
GO:0071824 | 0 | 3.5917 | 9.3204 | 29 | 188 | protein-DNA complex subunit organization |
GO:0051290 | 0 | 7.6618 | 2.2805 | 13 | 46 | protein heterotetramerization |
GO:0002764 | 0 | 3.0063 | 11.6009 | 31 | 234 | immune response-regulating signaling pathway |
GO:0002429 | 0 | 3.7932 | 6.0979 | 20 | 123 | immune response-activating cell surface receptor signaling pathway |
GO:0042110 | 0 | 2.3278 | 19.7652 | 42 | 400 | T cell activation |
GO:0002520 | 0 | 1.8772 | 41.6442 | 72 | 840 | immune system development |
GO:0019884 | 0 | 9.1037 | 1.2394 | 8 | 25 | antigen processing and presentation of exogenous antigen |
GO:0051276 | 0 | 1.7359 | 47.7917 | 77 | 964 | chromosome organization |
GO:0045321 | 0 | 2.5169 | 12.6314 | 29 | 260 | leukocyte activation |
GO:0034622 | 0 | 1.7607 | 41.4955 | 68 | 837 | cellular macromolecular complex assembly |
GO:0002253 | 0 | 2.4006 | 13.6335 | 30 | 275 | activation of immune response |
GO:0045637 | 0 | 2.7734 | 9.1716 | 23 | 185 | regulation of myeloid cell differentiation |
GO:0006342 | 1e-04 | 4.1372 | 3.6687 | 13 | 74 | chromatin silencing |
GO:0050854 | 1e-04 | 5.3807 | 2.2805 | 10 | 46 | regulation of antigen receptor-mediated signaling pathway |
GO:0050860 | 1e-04 | 10.5292 | 0.8428 | 6 | 17 | negative regulation of T cell receptor signaling pathway |
GO:0000209 | 2e-04 | 2.6501 | 8.2793 | 20 | 167 | protein polyubiquitination |
GO:1903707 | 2e-04 | 2.9256 | 6.4449 | 17 | 130 | negative regulation of hemopoiesis |
GO:0002703 | 3e-04 | 2.6996 | 7.7339 | 19 | 156 | regulation of leukocyte mediated immunity |
GO:0046651 | 3e-04 | 2.2567 | 12.4437 | 26 | 251 | lymphocyte proliferation |
GO:0006334 | 4e-04 | 4.1925 | 2.779 | 10 | 57 | nucleosome assembly |
GO:0050852 | 5e-04 | 4.0606 | 2.8566 | 10 | 58 | T cell receptor signaling pathway |
GO:0002684 | 5e-04 | 1.8009 | 25.3909 | 43 | 518 | positive regulation of immune system process |
GO:0051607 | 5e-04 | 2.5317 | 8.1801 | 19 | 165 | defense response to virus |
GO:0051603 | 5e-04 | 1.7599 | 27.7628 | 46 | 560 | proteolysis involved in cellular protein catabolic process |
GO:0043368 | 7e-04 | 5.6326 | 1.5369 | 7 | 31 | positive T cell selection |
GO:0070661 | 7e-04 | 2.1225 | 13.1377 | 26 | 265 | leukocyte proliferation |
GO:0009607 | 7e-04 | 1.7002 | 30.5391 | 49 | 616 | response to biotic stimulus |
GO:0002694 | 8e-04 | 1.8602 | 20.5742 | 36 | 415 | regulation of leukocyte activation |
GO:0016043 | 0.0011 | 1.2673 | 251.0549 | 291 | 5064 | cellular component organization |
GO:0002708 | 0.0011 | 3.3274 | 3.7182 | 11 | 75 | positive regulation of lymphocyte mediated immunity |
GO:0002568 | 0.0011 | 28.8621 | 0.2479 | 3 | 5 | somatic diversification of T cell receptor genes |
GO:0033153 | 0.0011 | 28.8621 | 0.2479 | 3 | 5 | T cell receptor V(D)J recombination |
GO:0032729 | 0.0014 | 3.7825 | 2.7267 | 9 | 55 | positive regulation of interferon-gamma production |
GO:0021542 | 0.0015 | 7.414 | 0.8924 | 5 | 18 | dentate gyrus development |
GO:0016446 | 0.0015 | 11.0055 | 0.5453 | 4 | 11 | somatic hypermutation of immunoglobulin genes |
GO:0006950 | 0.0016 | 1.3146 | 137.179 | 169 | 2776 | response to stress |
GO:0002562 | 0.0018 | 3.6244 | 2.8259 | 9 | 57 | somatic diversification of immune receptors via germline recombination within a single locus |
GO:0045576 | 0.0018 | 3.6244 | 2.8259 | 9 | 57 | mast cell activation |
GO:0051707 | 0.0019 | 1.6527 | 28.7047 | 45 | 579 | response to other organism |
GO:0002824 | 0.0019 | 3.0853 | 3.9661 | 11 | 80 | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
GO:0046719 | 0.0022 | 19.2402 | 0.2975 | 3 | 6 | regulation by virus of viral protein levels in host cell |
GO:0030163 | 0.0023 | 1.7683 | 20.3106 | 34 | 415 | protein catabolic process |
GO:0031347 | 0.0024 | 2.313 | 7.9105 | 17 | 162 | regulation of defense response |
GO:0044265 | 0.0025 | 1.5277 | 40.6031 | 59 | 819 | cellular macromolecule catabolic process |
GO:0001808 | 0.0025 | Inf | 0.0992 | 2 | 2 | negative regulation of type IV hypersensitivity |
GO:0002669 | 0.0025 | Inf | 0.0992 | 2 | 2 | positive regulation of T cell anergy |
GO:0003422 | 0.0025 | Inf | 0.0992 | 2 | 2 | growth plate cartilage morphogenesis |
GO:0032796 | 0.0025 | Inf | 0.0992 | 2 | 2 | uropod organization |
GO:0046967 | 0.0025 | Inf | 0.0992 | 2 | 2 | cytosol to ER transport |
GO:0061153 | 0.0025 | Inf | 0.0992 | 2 | 2 | trachea gland development |
GO:0002438 | 0.0025 | 6.4246 | 0.9915 | 5 | 20 | acute inflammatory response to antigenic stimulus |
GO:0036503 | 0.0026 | 2.9561 | 4.1148 | 11 | 83 | ERAD pathway |
GO:0032633 | 0.0026 | 5.0317 | 1.4377 | 6 | 29 | interleukin-4 production |
GO:0022407 | 0.0027 | 1.8229 | 17.4013 | 30 | 351 | regulation of cell-cell adhesion |
GO:0019886 | 0.003 | 8.5587 | 0.6445 | 4 | 13 | antigen processing and presentation of exogenous peptide antigen via MHC class II |
GO:0001819 | 0.0031 | 1.9173 | 13.82 | 25 | 281 | positive regulation of cytokine production |
GO:0030097 | 0.0033 | 1.5909 | 30.3722 | 46 | 621 | hemopoiesis |
GO:0002699 | 0.0034 | 2.2285 | 8.1801 | 17 | 165 | positive regulation of immune effector process |
GO:0006689 | 0.0037 | 14.4292 | 0.347 | 3 | 7 | ganglioside catabolic process |
GO:0009313 | 0.0037 | 14.4292 | 0.347 | 3 | 7 | oligosaccharide catabolic process |
GO:0043320 | 0.0037 | 14.4292 | 0.347 | 3 | 7 | natural killer cell degranulation |
GO:0048523 | 0.0038 | 1.2478 | 195.5293 | 228 | 3944 | negative regulation of cellular process |
GO:0048311 | 0.004 | 7.7023 | 0.6941 | 4 | 14 | mitochondrion distribution |
GO:0030098 | 0.0041 | 1.8255 | 15.6166 | 27 | 315 | lymphocyte differentiation |
GO:0046632 | 0.0041 | 2.9392 | 3.7556 | 10 | 76 | alpha-beta T cell differentiation |
GO:0043161 | 0.0043 | 1.8402 | 14.9225 | 26 | 301 | proteasome-mediated ubiquitin-dependent protein catabolic process |
GO:0006310 | 0.0044 | 2.0229 | 10.5102 | 20 | 212 | DNA recombination |
GO:0002819 | 0.0045 | 2.3788 | 6.3458 | 14 | 128 | regulation of adaptive immune response |
GO:0050830 | 0.0046 | 3.105 | 3.2225 | 9 | 65 | defense response to Gram-positive bacterium |
GO:0042129 | 0.0046 | 2.2887 | 7.0398 | 15 | 142 | regulation of T cell proliferation |
GO:0033198 | 0.0047 | 5.3528 | 1.1403 | 5 | 23 | response to ATP |
GO:0031663 | 0.0048 | 3.7521 | 2.1318 | 7 | 43 | lipopolysaccharide-mediated signaling pathway |
GO:0007249 | 0.0051 | 2.0374 | 9.9153 | 19 | 200 | I-kappaB kinase/NF-kappaB signaling |
GO:0050867 | 0.0055 | 1.8782 | 12.9394 | 23 | 261 | positive regulation of cell activation |
GO:0002228 | 0.0055 | 3.6504 | 2.1814 | 7 | 44 | natural killer cell mediated immunity |
GO:0051489 | 0.0055 | 3.6504 | 2.1814 | 7 | 44 | regulation of filopodium assembly |
GO:1903039 | 0.0056 | 2.1687 | 7.8826 | 16 | 159 | positive regulation of leukocyte cell-cell adhesion |
GO:0001768 | 0.0056 | 11.5426 | 0.3966 | 3 | 8 | establishment of T cell polarity |
GO:0045061 | 0.0057 | 5.0707 | 1.1898 | 5 | 24 | thymic T cell selection |
GO:0050727 | 0.0058 | 1.8995 | 12.2454 | 22 | 247 | regulation of inflammatory response |
GO:0050900 | 0.0058 | 1.8995 | 12.2454 | 22 | 247 | leukocyte migration |
GO:0042787 | 0.0059 | 2.2975 | 6.5441 | 14 | 132 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process |
GO:0002250 | 0.006 | 2.095 | 8.6402 | 17 | 176 | adaptive immune response |
GO:0032663 | 0.0063 | 3.5541 | 2.2309 | 7 | 45 | regulation of interleukin-2 production |
GO:0070271 | 0.0064 | 1.387 | 58.054 | 77 | 1171 | protein complex biogenesis |
GO:0010390 | 0.0069 | 4.8169 | 1.2394 | 5 | 25 | histone monoubiquitination |
GO:0015825 | 0.0071 | 38.4365 | 0.1487 | 2 | 3 | L-serine transport |
GO:0045404 | 0.0071 | 38.4365 | 0.1487 | 2 | 3 | positive regulation of interleukin-4 biosynthetic process |
GO:0050717 | 0.0071 | 38.4365 | 0.1487 | 2 | 3 | positive regulation of interleukin-1 alpha secretion |
GO:2000405 | 0.0071 | 38.4365 | 0.1487 | 2 | 3 | negative regulation of T cell migration |
GO:0032944 | 0.0075 | 1.9945 | 9.5682 | 18 | 193 | regulation of mononuclear cell proliferation |
GO:0001912 | 0.0079 | 3.8559 | 1.7848 | 6 | 36 | positive regulation of leukocyte mediated cytotoxicity |
GO:0001865 | 0.0081 | 9.6182 | 0.4462 | 3 | 9 | NK T cell differentiation |
GO:0002883 | 0.0081 | 9.6182 | 0.4462 | 3 | 9 | regulation of hypersensitivity |
GO:0006991 | 0.0081 | 9.6182 | 0.4462 | 3 | 9 | response to sterol depletion |
GO:0032933 | 0.0081 | 9.6182 | 0.4462 | 3 | 9 | SREBP signaling pathway |
GO:0035458 | 0.0082 | 4.5872 | 1.289 | 5 | 26 | cellular response to interferon-beta |
GO:0045089 | 0.0084 | 2.0665 | 8.2297 | 16 | 166 | positive regulation of innate immune response |
GO:0051251 | 0.0088 | 1.9192 | 10.4606 | 19 | 211 | positive regulation of lymphocyte activation |
GO:0032675 | 0.0089 | 2.3442 | 5.503 | 12 | 111 | regulation of interleukin-6 production |
GO:0051259 | 0.009 | 1.5499 | 26.2755 | 39 | 530 | protein oligomerization |
GO:0031348 | 0.0091 | 2.1048 | 7.5852 | 15 | 153 | negative regulation of defense response |
GO:0002683 | 0.0091 | 1.8461 | 11.9826 | 21 | 245 | negative regulation of immune system process |
GO:0061014 | 0.0091 | 3.7312 | 1.8343 | 6 | 37 | positive regulation of mRNA catabolic process |
GO:0042176 | 0.0093 | 1.7413 | 15.0712 | 25 | 304 | regulation of protein catabolic process |
GO:0048661 | 0.01 | 2.542 | 4.2636 | 10 | 86 | positive regulation of smooth muscle cell proliferation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0052696 | 0 | 169.6862 | 0.3203 | 7 | 8 | flavonoid glucuronidation |
GO:0052697 | 0 | 169.6862 | 0.3203 | 7 | 8 | xenobiotic glucuronidation |
GO:0019585 | 0 | 56.5547 | 0.4004 | 7 | 10 | glucuronate metabolic process |
GO:0071466 | 3e-04 | 5.5372 | 1.7216 | 8 | 43 | cellular response to xenobiotic stimulus |
GO:0051653 | 7e-04 | 5.463 | 1.5214 | 7 | 38 | spindle localization |
GO:0048477 | 0.001 | 3.6196 | 3.0829 | 10 | 77 | oogenesis |
GO:0006597 | 0.0016 | Inf | 0.0801 | 2 | 2 | spermine biosynthetic process |
GO:0043000 | 0.0016 | Inf | 0.0801 | 2 | 2 | Golgi to plasma membrane CFTR protein transport |
GO:0045338 | 0.0016 | Inf | 0.0801 | 2 | 2 | farnesyl diphosphate metabolic process |
GO:1902340 | 0.0016 | Inf | 0.0801 | 2 | 2 | negative regulation of chromosome condensation |
GO:0050862 | 0.0018 | 9.6448 | 0.5605 | 4 | 14 | positive regulation of T cell receptor signaling pathway |
GO:0098789 | 0.002 | 18.0626 | 0.2803 | 3 | 7 | pre-mRNA cleavage required for polyadenylation |
GO:0070828 | 0.0024 | 8.7674 | 0.6006 | 4 | 15 | heterochromatin organization |
GO:0046631 | 0.0027 | 2.7472 | 4.7244 | 12 | 118 | alpha-beta T cell activation |
GO:0030878 | 0.0033 | 5.7459 | 1.041 | 5 | 26 | thyroid gland development |
GO:0060914 | 0.0033 | 5.7459 | 1.041 | 5 | 26 | heart formation |
GO:0051294 | 0.0039 | 5.4843 | 1.081 | 5 | 27 | establishment of spindle orientation |
GO:0034587 | 0.004 | 7.4176 | 0.6806 | 4 | 17 | piRNA metabolic process |
GO:0071600 | 0.0045 | 12.0402 | 0.3603 | 3 | 9 | otic vesicle morphogenesis |
GO:0031509 | 0.0047 | 48.1006 | 0.1201 | 2 | 3 | telomeric heterochromatin assembly |
GO:0060435 | 0.0047 | 48.1006 | 0.1201 | 2 | 3 | bronchiole development |
GO:0033875 | 0.005 | 6.8873 | 0.7207 | 4 | 18 | ribonucleoside bisphosphate metabolic process |
GO:0034032 | 0.005 | 6.8873 | 0.7207 | 4 | 18 | purine nucleoside bisphosphate metabolic process |
GO:0022412 | 0.0058 | 1.8632 | 12.9722 | 23 | 324 | cellular process involved in reproduction in multicellular organism |
GO:0090501 | 0.0082 | 3.3163 | 2.3222 | 7 | 58 | RNA phosphodiester bond hydrolysis |
GO:0021615 | 0.0091 | 24.0487 | 0.1602 | 2 | 4 | glossopharyngeal nerve morphogenesis |
GO:0031508 | 0.0091 | 24.0487 | 0.1602 | 2 | 4 | pericentric heterochromatin assembly |
GO:0048295 | 0.0091 | 24.0487 | 0.1602 | 2 | 4 | positive regulation of isotype switching to IgE isotypes |
GO:0070350 | 0.0091 | 24.0487 | 0.1602 | 2 | 4 | regulation of white fat cell proliferation |
GO:1901976 | 0.0095 | 4.3074 | 1.3212 | 5 | 33 | regulation of cell cycle checkpoint |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0002684 | 0 | 2.5 | 30.6032 | 68 | 683 | positive regulation of immune system process |
GO:0002694 | 0 | 2.6999 | 18.5949 | 45 | 415 | regulation of leukocyte activation |
GO:0031347 | 0 | 2.5192 | 20.208 | 46 | 451 | regulation of defense response |
GO:0050863 | 0 | 3.1092 | 11.2018 | 31 | 250 | regulation of T cell activation |
GO:0070663 | 0 | 3.268 | 8.9614 | 26 | 200 | regulation of leukocyte proliferation |
GO:0050670 | 0 | 3.2907 | 8.5581 | 25 | 191 | regulation of lymphocyte proliferation |
GO:0002764 | 0 | 2.8506 | 10.4848 | 27 | 234 | immune response-regulating signaling pathway |
GO:0032101 | 0 | 2.0754 | 26.6602 | 51 | 595 | regulation of response to external stimulus |
GO:0043029 | 0 | 6.9602 | 1.8371 | 10 | 41 | T cell homeostasis |
GO:0006950 | 0 | 1.4819 | 124.7876 | 168 | 2785 | response to stress |
GO:0002253 | 0 | 2.5771 | 12.3219 | 29 | 275 | activation of immune response |
GO:0045321 | 0 | 3.3496 | 6.353 | 19 | 149 | leukocyte activation |
GO:0022407 | 0 | 2.9196 | 8.7134 | 23 | 197 | regulation of cell-cell adhesion |
GO:0050728 | 0 | 3.8112 | 4.7944 | 16 | 107 | negative regulation of inflammatory response |
GO:0002429 | 0 | 3.59 | 5.3628 | 17 | 120 | immune response-activating cell surface receptor signaling pathway |
GO:0051251 | 0 | 2.7964 | 9.4543 | 24 | 211 | positive regulation of lymphocyte activation |
GO:1903039 | 0 | 3.1269 | 7.1243 | 20 | 159 | positive regulation of leukocyte cell-cell adhesion |
GO:0048584 | 0 | 1.5651 | 74.5589 | 108 | 1664 | positive regulation of response to stimulus |
GO:0050867 | 0 | 2.5171 | 11.6946 | 27 | 261 | positive regulation of cell activation |
GO:0042102 | 1e-04 | 4.1945 | 3.5846 | 13 | 80 | positive regulation of T cell proliferation |
GO:0032946 | 1e-04 | 3.4316 | 5.2424 | 16 | 117 | positive regulation of mononuclear cell proliferation |
GO:0052547 | 1e-04 | 2.3443 | 13.3973 | 29 | 299 | regulation of peptidase activity |
GO:0030098 | 1e-04 | 2.2986 | 14.1142 | 30 | 315 | lymphocyte differentiation |
GO:0009617 | 1e-04 | 2.1688 | 16.8922 | 34 | 377 | response to bacterium |
GO:0002685 | 1e-04 | 3.8862 | 3.8183 | 13 | 86 | regulation of leukocyte migration |
GO:0032943 | 1e-04 | 3.1468 | 6.0013 | 17 | 136 | mononuclear cell proliferation |
GO:0043207 | 1e-04 | 1.894 | 25.9881 | 46 | 580 | response to external biotic stimulus |
GO:0010522 | 1e-04 | 3.7451 | 3.943 | 13 | 88 | regulation of calcium ion transport into cytosol |
GO:0032729 | 1e-04 | 4.7904 | 2.4644 | 10 | 55 | positive regulation of interferon-gamma production |
GO:0001818 | 2e-04 | 2.5698 | 9.3199 | 22 | 208 | negative regulation of cytokine production |
GO:0007159 | 2e-04 | 3.1261 | 5.6748 | 16 | 129 | leukocyte cell-cell adhesion |
GO:0032844 | 2e-04 | 1.9956 | 20.3872 | 38 | 455 | regulation of homeostatic process |
GO:2000116 | 2e-04 | 2.6205 | 8.7374 | 21 | 195 | regulation of cysteine-type endopeptidase activity |
GO:0045058 | 2e-04 | 5.1007 | 2.1059 | 9 | 47 | T cell selection |
GO:0006955 | 2e-04 | 3.0227 | 5.8321 | 16 | 138 | immune response |
GO:0001776 | 3e-04 | 3.4663 | 4.2119 | 13 | 94 | leukocyte homeostasis |
GO:0051283 | 3e-04 | 3.4238 | 4.2567 | 13 | 95 | negative regulation of sequestering of calcium ion |
GO:0010040 | 3e-04 | 64.2194 | 0.1792 | 3 | 4 | response to iron(II) ion |
GO:2000196 | 3e-04 | 64.2194 | 0.1792 | 3 | 4 | positive regulation of female gonad development |
GO:0022610 | 4e-04 | 1.5776 | 50.5871 | 75 | 1129 | biological adhesion |
GO:0002520 | 4e-04 | 1.6654 | 37.6379 | 59 | 840 | immune system development |
GO:0030595 | 4e-04 | 3.5318 | 3.8199 | 12 | 86 | leukocyte chemotaxis |
GO:0001817 | 4e-04 | 2.2402 | 11.986 | 25 | 273 | regulation of cytokine production |
GO:0002693 | 5e-04 | 9.7513 | 0.7169 | 5 | 16 | positive regulation of cellular extravasation |
GO:0002697 | 5e-04 | 2.1661 | 12.8596 | 26 | 287 | regulation of immune effector process |
GO:1903169 | 6e-04 | 2.8949 | 5.6905 | 15 | 127 | regulation of calcium ion transmembrane transport |
GO:0010951 | 6e-04 | 3.1891 | 4.5255 | 13 | 101 | negative regulation of endopeptidase activity |
GO:0006909 | 6e-04 | 2.6658 | 6.9451 | 17 | 155 | phagocytosis |
GO:0030097 | 7e-04 | 1.6683 | 33.6501 | 53 | 751 | hemopoiesis |
GO:0060401 | 8e-04 | 2.6818 | 6.497 | 16 | 145 | cytosolic calcium ion transport |
GO:0050729 | 8e-04 | 3.2353 | 4.1222 | 12 | 92 | positive regulation of inflammatory response |
GO:0002568 | 8e-04 | 32.1076 | 0.224 | 3 | 5 | somatic diversification of T cell receptor genes |
GO:0033153 | 8e-04 | 32.1076 | 0.224 | 3 | 5 | T cell receptor V(D)J recombination |
GO:0002683 | 9e-04 | 2.0019 | 15.4227 | 29 | 346 | negative regulation of immune system process |
GO:0050854 | 9e-04 | 4.5275 | 2.0611 | 8 | 46 | regulation of antigen receptor-mediated signaling pathway |
GO:0043367 | 9e-04 | 4.0354 | 2.554 | 9 | 57 | CD4-positive, alpha-beta T cell differentiation |
GO:1905939 | 0.0012 | 7.6602 | 0.8513 | 5 | 19 | regulation of gonad development |
GO:0045785 | 0.0013 | 1.9698 | 15.1 | 28 | 337 | positive regulation of cell adhesion |
GO:0032496 | 0.0013 | 2.2678 | 9.4543 | 20 | 211 | response to lipopolysaccharide |
GO:1905517 | 0.0013 | 4.8515 | 1.7027 | 7 | 38 | macrophage migration |
GO:0008283 | 0.0014 | 1.4099 | 78.2331 | 104 | 1746 | cell proliferation |
GO:0002821 | 0.0014 | 3.2028 | 3.8086 | 11 | 85 | positive regulation of adaptive immune response |
GO:0042110 | 0.0015 | 3.1817 | 3.8185 | 11 | 89 | T cell activation |
GO:0097553 | 0.0015 | 2.8327 | 5.0184 | 13 | 112 | calcium ion transmembrane import into cytosol |
GO:0045861 | 0.0016 | 2.1382 | 10.9777 | 22 | 245 | negative regulation of proteolysis |
GO:0090023 | 0.0016 | 7.149 | 0.8961 | 5 | 20 | positive regulation of neutrophil chemotaxis |
GO:0050703 | 0.0016 | 21.4037 | 0.2688 | 3 | 6 | interleukin-1 alpha secretion |
GO:2000354 | 0.0016 | 21.4037 | 0.2688 | 3 | 6 | regulation of ovarian follicle development |
GO:0051248 | 0.0016 | 1.553 | 40.7296 | 60 | 909 | negative regulation of protein metabolic process |
GO:0002366 | 0.0018 | 2.259 | 9.0062 | 19 | 201 | leukocyte activation involved in immune response |
GO:0002250 | 0.0018 | 2.1996 | 9.7134 | 20 | 219 | adaptive immune response |
GO:0002690 | 0.0019 | 3.5856 | 2.8228 | 9 | 63 | positive regulation of leukocyte chemotaxis |
GO:0042098 | 0.0019 | 4.5109 | 1.8031 | 7 | 41 | T cell proliferation |
GO:0032796 | 0.002 | Inf | 0.0896 | 2 | 2 | uropod organization |
GO:0046967 | 0.002 | Inf | 0.0896 | 2 | 2 | cytosol to ER transport |
GO:0061153 | 0.002 | Inf | 0.0896 | 2 | 2 | trachea gland development |
GO:2000388 | 0.002 | Inf | 0.0896 | 2 | 2 | positive regulation of antral ovarian follicle growth |
GO:2000870 | 0.002 | Inf | 0.0896 | 2 | 2 | regulation of progesterone secretion |
GO:0036159 | 0.0021 | 9.5224 | 0.5825 | 4 | 13 | inner dynein arm assembly |
GO:0007166 | 0.0022 | 1.3674 | 89.1212 | 115 | 1989 | cell surface receptor signaling pathway |
GO:0002822 | 0.0022 | 2.6956 | 5.2424 | 13 | 117 | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
GO:0044242 | 0.0022 | 2.4 | 7.1691 | 16 | 160 | cellular lipid catabolic process |
GO:0070838 | 0.0024 | 1.8167 | 18.0124 | 31 | 402 | divalent metal ion transport |
GO:0032673 | 0.0025 | 6.3071 | 0.9858 | 5 | 22 | regulation of interleukin-4 production |
GO:0051272 | 0.0025 | 1.7727 | 19.6255 | 33 | 438 | positive regulation of cellular component movement |
GO:0048771 | 0.0025 | 2.3668 | 7.2587 | 16 | 162 | tissue remodeling |
GO:0051928 | 0.0026 | 2.7806 | 4.7047 | 12 | 105 | positive regulation of calcium ion transport |
GO:0098662 | 0.0026 | 1.7232 | 22.0003 | 36 | 491 | inorganic cation transmembrane transport |
GO:1902622 | 0.0026 | 4.9527 | 1.4338 | 6 | 32 | regulation of neutrophil migration |
GO:0009313 | 0.0027 | 16.0517 | 0.3136 | 3 | 7 | oligosaccharide catabolic process |
GO:0002827 | 0.0028 | 8.5696 | 0.6273 | 4 | 14 | positive regulation of T-helper 1 type immune response |
GO:0002286 | 0.003 | 3.0745 | 3.5846 | 10 | 80 | T cell activation involved in immune response |
GO:0050715 | 0.003 | 2.7217 | 4.7944 | 12 | 107 | positive regulation of cytokine secretion |
GO:0002230 | 0.0031 | 5.9564 | 1.0306 | 5 | 23 | positive regulation of defense response to virus by host |
GO:0010758 | 0.0031 | 5.9564 | 1.0306 | 5 | 23 | regulation of macrophage chemotaxis |
GO:0030335 | 0.0031 | 1.7823 | 18.3261 | 31 | 409 | positive regulation of cell migration |
GO:0002443 | 0.0031 | 2.01 | 11.605 | 22 | 259 | leukocyte mediated immunity |
GO:0097530 | 0.0032 | 2.8538 | 4.2119 | 11 | 94 | granulocyte migration |
GO:0051346 | 0.0032 | 1.9407 | 13.0837 | 24 | 292 | negative regulation of hydrolase activity |
GO:0032879 | 0.0035 | 1.3204 | 106.7303 | 133 | 2382 | regulation of localization |
GO:0045087 | 0.0035 | 1.748 | 19.2614 | 32 | 433 | innate immune response |
GO:0006935 | 0.0036 | 1.7288 | 20.0735 | 33 | 448 | chemotaxis |
GO:0042093 | 0.0036 | 3.956 | 2.0163 | 7 | 45 | T-helper cell differentiation |
GO:0002363 | 0.0037 | 7.79 | 0.6721 | 4 | 15 | alpha-beta T cell lineage commitment |
GO:0008360 | 0.004 | 2.5017 | 5.6009 | 13 | 125 | regulation of cell shape |
GO:0050852 | 0.004 | 3.4548 | 2.587 | 8 | 58 | T cell receptor signaling pathway |
GO:0072676 | 0.0041 | 3.4382 | 2.5988 | 8 | 58 | lymphocyte migration |
GO:0050850 | 0.0042 | 4.4395 | 1.5682 | 6 | 35 | positive regulation of calcium-mediated signaling |
GO:0001768 | 0.0042 | 12.8405 | 0.3585 | 3 | 8 | establishment of T cell polarity |
GO:0030854 | 0.0042 | 12.8405 | 0.3585 | 3 | 8 | positive regulation of granulocyte differentiation |
GO:0046632 | 0.0043 | 5.4188 | 1.1087 | 5 | 25 | alpha-beta T cell differentiation |
GO:0019884 | 0.0045 | 5.36 | 1.1202 | 5 | 25 | antigen processing and presentation of exogenous antigen |
GO:0002293 | 0.0046 | 3.7577 | 2.1059 | 7 | 47 | alpha-beta T cell differentiation involved in immune response |
GO:0009988 | 0.0046 | 3.7577 | 2.1059 | 7 | 47 | cell-cell recognition |
GO:0034765 | 0.0047 | 1.7627 | 17.2955 | 29 | 386 | regulation of ion transmembrane transport |
GO:0023052 | 0.0049 | 1.2423 | 201.766 | 233 | 4503 | signaling |
GO:0051281 | 0.0049 | 4.2912 | 1.6131 | 6 | 36 | positive regulation of release of sequestered calcium ion into cytosol |
GO:0002376 | 0.005 | 2.4201 | 5.7463 | 13 | 144 | immune system process |
GO:0032680 | 0.005 | 2.5338 | 5.108 | 12 | 114 | regulation of tumor necrosis factor production |
GO:0043154 | 0.0052 | 3.0233 | 3.2709 | 9 | 73 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process |
GO:0098542 | 0.0053 | 1.7845 | 15.9065 | 27 | 355 | defense response to other organism |
GO:0032743 | 0.0053 | 5.1044 | 1.165 | 5 | 26 | positive regulation of interleukin-2 production |
GO:0035458 | 0.0053 | 5.1044 | 1.165 | 5 | 26 | cellular response to interferon-beta |
GO:0050853 | 0.0056 | 4.1525 | 1.6579 | 6 | 37 | B cell receptor signaling pathway |
GO:0071622 | 0.0056 | 4.1525 | 1.6579 | 6 | 37 | regulation of granulocyte chemotaxis |
GO:2000145 | 0.0058 | 1.5303 | 32.1266 | 47 | 717 | regulation of cell motility |
GO:0001807 | 0.0058 | 42.7528 | 0.1344 | 2 | 3 | regulation of type IV hypersensitivity |
GO:0002430 | 0.0058 | 42.7528 | 0.1344 | 2 | 3 | complement receptor mediated signaling pathway |
GO:0035723 | 0.0058 | 42.7528 | 0.1344 | 2 | 3 | interleukin-15-mediated signaling pathway |
GO:0045085 | 0.0058 | 42.7528 | 0.1344 | 2 | 3 | negative regulation of interleukin-2 biosynthetic process |
GO:0071926 | 0.0058 | 42.7528 | 0.1344 | 2 | 3 | endocannabinoid signaling pathway |
GO:0097176 | 0.0058 | 42.7528 | 0.1344 | 2 | 3 | epoxide metabolic process |
GO:1904580 | 0.0058 | 42.7528 | 0.1344 | 2 | 3 | regulation of intracellular mRNA localization |
GO:2000048 | 0.0058 | 42.7528 | 0.1344 | 2 | 3 | negative regulation of cell-cell adhesion mediated by cadherin |
GO:2000405 | 0.0058 | 42.7528 | 0.1344 | 2 | 3 | negative regulation of T cell migration |
GO:1904950 | 0.0059 | 2.046 | 9.3199 | 18 | 208 | negative regulation of establishment of protein localization |
GO:0071674 | 0.0059 | 3.5783 | 2.1955 | 7 | 49 | mononuclear cell migration |
GO:0050776 | 0.0059 | 1.8634 | 12.9953 | 23 | 297 | regulation of immune response |
GO:0043369 | 0.006 | 6.5907 | 0.7617 | 4 | 17 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment |
GO:0050860 | 0.006 | 6.5907 | 0.7617 | 4 | 17 | negative regulation of T cell receptor signaling pathway |
GO:1900165 | 0.0061 | 10.6997 | 0.4033 | 3 | 9 | negative regulation of interleukin-6 secretion |
GO:0042130 | 0.0062 | 3.1827 | 2.778 | 8 | 62 | negative regulation of T cell proliferation |
GO:1902107 | 0.0063 | 2.3535 | 5.9145 | 13 | 132 | positive regulation of leukocyte differentiation |
GO:0071887 | 0.0064 | 2.5731 | 4.6151 | 11 | 103 | leukocyte apoptotic process |
GO:0032653 | 0.0064 | 4.0225 | 1.7027 | 6 | 38 | regulation of interleukin-10 production |
GO:0033209 | 0.0066 | 3.4948 | 2.2404 | 7 | 50 | tumor necrosis factor-mediated signaling pathway |
GO:0032635 | 0.0066 | 2.4375 | 5.2872 | 12 | 118 | interleukin-6 production |
GO:0071706 | 0.0066 | 2.4375 | 5.2872 | 12 | 118 | tumor necrosis factor superfamily cytokine production |
GO:1904064 | 0.0066 | 2.4375 | 5.2872 | 12 | 118 | positive regulation of cation transmembrane transport |
GO:0044092 | 0.0067 | 1.4785 | 37.4587 | 53 | 836 | negative regulation of molecular function |
GO:0002040 | 0.0067 | 2.8874 | 3.4053 | 9 | 76 | sprouting angiogenesis |
GO:0070887 | 0.0069 | 1.3041 | 96.0215 | 119 | 2143 | cellular response to chemical stimulus |
GO:0120034 | 0.0069 | 2.6884 | 4.0326 | 10 | 90 | positive regulation of plasma membrane bounded cell projection assembly |
GO:0051674 | 0.007 | 1.3877 | 56.5465 | 75 | 1262 | localization of cell |
GO:0050790 | 0.007 | 1.3524 | 68.958 | 89 | 1539 | regulation of catalytic activity |
GO:0050704 | 0.0074 | 4.66 | 1.2546 | 5 | 28 | regulation of interleukin-1 secretion |
GO:0002274 | 0.0075 | 2.2184 | 6.7211 | 14 | 150 | myeloid leukocyte activation |
GO:0034341 | 0.0075 | 3.0686 | 2.8676 | 8 | 64 | response to interferon-gamma |
GO:0022408 | 0.0078 | 2.2082 | 6.7482 | 14 | 151 | negative regulation of cell-cell adhesion |
GO:0010033 | 0.0078 | 1.294 | 99.158 | 122 | 2213 | response to organic substance |
GO:0040017 | 0.008 | 1.6415 | 20.3872 | 32 | 455 | positive regulation of locomotion |
GO:0050709 | 0.0081 | 2.37 | 5.4217 | 12 | 121 | negative regulation of protein secretion |
GO:1901264 | 0.0081 | 3.3391 | 2.33 | 7 | 52 | carbohydrate derivative transport |
GO:0002524 | 0.0085 | 9.1706 | 0.4481 | 3 | 10 | hypersensitivity |
GO:0070257 | 0.0085 | 9.1706 | 0.4481 | 3 | 10 | positive regulation of mucus secretion |
GO:0072540 | 0.0085 | 9.1706 | 0.4481 | 3 | 10 | T-helper 17 cell lineage commitment |
GO:0002686 | 0.0086 | 4.4655 | 1.2994 | 5 | 29 | negative regulation of leukocyte migration |
GO:0032663 | 0.0089 | 5.7437 | 0.8468 | 4 | 19 | regulation of interleukin-2 production |
GO:0032268 | 0.009 | 1.2952 | 93.1986 | 115 | 2080 | regulation of cellular protein metabolic process |
GO:0031341 | 0.009 | 2.9624 | 2.9573 | 8 | 66 | regulation of cell killing |
GO:0032612 | 0.009 | 2.9624 | 2.9573 | 8 | 66 | interleukin-1 production |
GO:0006954 | 0.0092 | 1.7862 | 13.503 | 23 | 309 | inflammatory response |
GO:0010035 | 0.0094 | 1.7159 | 15.8617 | 26 | 354 | response to inorganic substance |
GO:0034764 | 0.0096 | 2.2217 | 6.2282 | 13 | 139 | positive regulation of transmembrane transport |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0035404 | 4e-04 | 10.0778 | 0.6796 | 5 | 17 | histone-serine phosphorylation |
GO:0050830 | 0.0011 | 3.9006 | 2.5984 | 9 | 65 | defense response to Gram-positive bacterium |
GO:0002874 | 0.0016 | Inf | 0.0799 | 2 | 2 | regulation of chronic inflammatory response to antigenic stimulus |
GO:0010466 | 0.0022 | 2.4856 | 6.4759 | 15 | 162 | negative regulation of peptidase activity |
GO:0098542 | 0.0023 | 1.9361 | 14.1911 | 26 | 355 | defense response to other organism |
GO:0006955 | 0.0024 | 1.5474 | 38.0961 | 56 | 953 | immune response |
GO:0032757 | 0.0028 | 4.8393 | 1.4391 | 6 | 36 | positive regulation of interleukin-8 production |
GO:0045937 | 0.0031 | 1.5218 | 39.3753 | 57 | 985 | positive regulation of phosphate metabolic process |
GO:0007271 | 0.0032 | 4.6829 | 1.4791 | 6 | 37 | synaptic transmission, cholinergic |
GO:0032733 | 0.0033 | 5.7553 | 1.0393 | 5 | 26 | positive regulation of interleukin-10 production |
GO:0050766 | 0.0044 | 3.7662 | 2.0787 | 7 | 52 | positive regulation of phagocytosis |
GO:0016998 | 0.0045 | 12.0599 | 0.3598 | 3 | 9 | cell wall macromolecule catabolic process |
GO:0002003 | 0.0047 | 48.1795 | 0.1199 | 2 | 3 | angiotensin maturation |
GO:0031448 | 0.0047 | 48.1795 | 0.1199 | 2 | 3 | positive regulation of fast-twitch skeletal muscle fiber contraction |
GO:0032675 | 0.0048 | 2.6706 | 4.4372 | 11 | 111 | regulation of interleukin-6 production |
GO:0045428 | 0.0055 | 3.6054 | 2.1586 | 7 | 54 | regulation of nitric oxide biosynthetic process |
GO:0043207 | 0.0061 | 1.6246 | 23.1854 | 36 | 580 | response to external biotic stimulus |
GO:0001946 | 0.0061 | 6.4383 | 0.7595 | 4 | 19 | lymphangiogenesis |
GO:0006954 | 0.0061 | 1.6761 | 19.9874 | 32 | 500 | inflammatory response |
GO:0071902 | 0.0061 | 1.9511 | 10.7932 | 20 | 270 | positive regulation of protein serine/threonine kinase activity |
GO:0071554 | 0.0062 | 10.3364 | 0.3997 | 3 | 10 | cell wall organization or biogenesis |
GO:1901568 | 0.0062 | 2.7255 | 3.9575 | 10 | 99 | fatty acid derivative metabolic process |
GO:0050907 | 0.0062 | 4.8332 | 1.1992 | 5 | 30 | detection of chemical stimulus involved in sensory perception |
GO:0032652 | 0.0067 | 3.4578 | 2.2386 | 7 | 56 | regulation of interleukin-1 production |
GO:0051043 | 0.0074 | 6.0355 | 0.7995 | 4 | 20 | regulation of membrane protein ectodomain proteolysis |
GO:0045123 | 0.0077 | 3.8185 | 1.7589 | 6 | 44 | cellular extravasation |
GO:0043588 | 0.008 | 2.0187 | 8.8744 | 17 | 222 | skin development |
GO:0051092 | 0.0081 | 2.6076 | 4.1174 | 10 | 103 | positive regulation of NF-kappaB transcription factor activity |
GO:0060346 | 0.0082 | 9.0438 | 0.4397 | 3 | 11 | bone trabecula formation |
GO:0042149 | 0.0086 | 3.7203 | 1.7989 | 6 | 45 | cellular response to glucose starvation |
GO:0007155 | 0.0086 | 1.4211 | 44.8518 | 61 | 1122 | cell adhesion |
GO:0050716 | 0.0088 | 5.6801 | 0.8395 | 4 | 21 | positive regulation of interleukin-1 secretion |
GO:0072606 | 0.0088 | 5.6801 | 0.8395 | 4 | 21 | interleukin-8 secretion |
GO:0000733 | 0.0091 | 24.0882 | 0.1599 | 2 | 4 | DNA strand renaturation |
GO:0002678 | 0.0091 | 24.0882 | 0.1599 | 2 | 4 | positive regulation of chronic inflammatory response |
GO:0002740 | 0.0091 | 24.0882 | 0.1599 | 2 | 4 | negative regulation of cytokine secretion involved in immune response |
GO:0010040 | 0.0091 | 24.0882 | 0.1599 | 2 | 4 | response to iron(II) ion |
GO:0010288 | 0.0091 | 24.0882 | 0.1599 | 2 | 4 | response to lead ion |
GO:0014724 | 0.0091 | 24.0882 | 0.1599 | 2 | 4 | regulation of twitch skeletal muscle contraction |
GO:0051541 | 0.0091 | 24.0882 | 0.1599 | 2 | 4 | elastin metabolic process |
GO:0051593 | 0.0091 | 24.0882 | 0.1599 | 2 | 4 | response to folic acid |
GO:0061589 | 0.0091 | 24.0882 | 0.1599 | 2 | 4 | calcium activated phosphatidylserine scrambling |
GO:2000110 | 0.0091 | 24.0882 | 0.1599 | 2 | 4 | negative regulation of macrophage apoptotic process |
GO:0003009 | 0.0094 | 4.3145 | 1.3192 | 5 | 33 | skeletal muscle contraction |
GO:0009617 | 0.0094 | 1.7345 | 15.0705 | 25 | 377 | response to bacterium |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0030545 | 0 | 2.4 | 14.0049 | 31 | 348 | receptor regulator activity |
GO:0005179 | 1e-04 | 4.3998 | 3.139 | 12 | 78 | hormone activity |
GO:0005509 | 3e-04 | 1.9275 | 21.0074 | 38 | 522 | calcium ion binding |
GO:0050431 | 8e-04 | 8.5765 | 0.7646 | 5 | 19 | transforming growth factor beta binding |
GO:0016209 | 0.0012 | 4.2807 | 2.1329 | 8 | 53 | antioxidant activity |
GO:0005289 | 0.0016 | Inf | 0.0805 | 2 | 2 | high-affinity arginine transmembrane transporter activity |
GO:0005292 | 0.0016 | Inf | 0.0805 | 2 | 2 | high-affinity lysine transmembrane transporter activity |
GO:0016262 | 0.0016 | Inf | 0.0805 | 2 | 2 | protein N-acetylglucosaminyltransferase activity |
GO:0004872 | 0.0018 | 1.5591 | 39.2379 | 58 | 975 | receptor activity |
GO:0005102 | 0.002 | 1.5247 | 43.616 | 63 | 1104 | receptor binding |
GO:0030414 | 0.0027 | 2.6164 | 5.3524 | 13 | 133 | peptidase inhibitor activity |
GO:0008047 | 0.0045 | 1.8079 | 15.6952 | 27 | 390 | enzyme activator activity |
GO:0042043 | 0.0045 | 11.9757 | 0.3622 | 3 | 9 | neurexin family protein binding |
GO:0004667 | 0.0047 | 47.8433 | 0.1207 | 2 | 3 | prostaglandin-D synthase activity |
GO:0017077 | 0.0047 | 47.8433 | 0.1207 | 2 | 3 | oxidative phosphorylation uncoupler activity |
GO:0035373 | 0.0047 | 47.8433 | 0.1207 | 2 | 3 | chondroitin sulfate proteoglycan binding |
GO:0042015 | 0.0047 | 47.8433 | 0.1207 | 2 | 3 | interleukin-20 binding |
GO:0051870 | 0.0047 | 47.8433 | 0.1207 | 2 | 3 | methotrexate binding |
GO:0070548 | 0.0047 | 47.8433 | 0.1207 | 2 | 3 | L-glutamine aminotransferase activity |
GO:0001664 | 0.0051 | 2.0744 | 9.1756 | 18 | 228 | G-protein coupled receptor binding |
GO:0001968 | 0.0055 | 4.9997 | 1.1671 | 5 | 29 | fibronectin binding |
GO:0043236 | 0.0064 | 4.7994 | 1.2073 | 5 | 30 | laminin binding |
GO:0004896 | 0.0069 | 3.1035 | 2.8171 | 8 | 70 | cytokine receptor activity |
GO:0061135 | 0.007 | 2.4113 | 5.3122 | 12 | 132 | endopeptidase regulator activity |
GO:0005523 | 0.0084 | 8.9806 | 0.4427 | 3 | 11 | tropomyosin binding |
GO:0072341 | 0.0089 | 2.9597 | 2.9378 | 8 | 73 | modified amino acid binding |
GO:0050694 | 0.0092 | 23.9201 | 0.161 | 2 | 4 | galactose 3-O-sulfotransferase activity |
GO:0004867 | 0.0096 | 2.9147 | 2.9781 | 8 | 74 | serine-type endopeptidase inhibitor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0030545 | 2e-04 | 2.2471 | 13.3703 | 28 | 348 | receptor regulator activity |
GO:0005212 | 5e-04 | 9.6973 | 0.6916 | 5 | 18 | structural constituent of eye lens |
GO:0050431 | 6e-04 | 9.004 | 0.73 | 5 | 19 | transforming growth factor beta binding |
GO:0005125 | 0.0013 | 2.7351 | 5.5325 | 14 | 144 | cytokine activity |
GO:0004014 | 0.0015 | Inf | 0.0768 | 2 | 2 | adenosylmethionine decarboxylase activity |
GO:0016501 | 0.0015 | Inf | 0.0768 | 2 | 2 | prostacyclin receptor activity |
GO:0019810 | 0.0015 | Inf | 0.0768 | 2 | 2 | putrescine binding |
GO:0019955 | 0.0016 | 3.6408 | 2.7469 | 9 | 72 | cytokine binding |
GO:0001158 | 0.0017 | 3.0967 | 3.8805 | 11 | 101 | enhancer sequence-specific DNA binding |
GO:0045236 | 0.0018 | 18.8586 | 0.2689 | 3 | 7 | CXCR chemokine receptor binding |
GO:0003700 | 0.002 | 1.555 | 38.6509 | 57 | 1006 | DNA binding transcription factor activity |
GO:0005160 | 0.0025 | 4.2081 | 1.8826 | 7 | 49 | transforming growth factor beta receptor binding |
GO:0003680 | 0.0027 | 15.0859 | 0.3074 | 3 | 8 | AT DNA binding |
GO:0005102 | 0.0033 | 1.4542 | 51.4449 | 71 | 1339 | receptor binding |
GO:0008184 | 0.0043 | 50.2167 | 0.1153 | 2 | 3 | glycogen phosphorylase activity |
GO:0019828 | 0.0043 | 50.2167 | 0.1153 | 2 | 3 | aspartic-type endopeptidase inhibitor activity |
GO:0001077 | 0.0053 | 1.9798 | 10.6425 | 20 | 277 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
GO:0047617 | 0.0053 | 6.7115 | 0.73 | 4 | 19 | acyl-CoA hydrolase activity |
GO:0003906 | 0.0074 | 9.4268 | 0.4226 | 3 | 11 | DNA-(apurinic or apyrimidinic site) lyase activity |
GO:0005149 | 0.0074 | 9.4268 | 0.4226 | 3 | 11 | interleukin-1 receptor binding |
GO:0038100 | 0.0084 | 25.1067 | 0.1537 | 2 | 4 | nodal binding |
GO:0046965 | 0.0091 | 5.5918 | 0.8452 | 4 | 22 | retinoid X receptor binding |
GO:0001205 | 0.0091 | 4.3425 | 1.3063 | 5 | 34 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding |
GO:0004806 | 0.0096 | 8.3788 | 0.461 | 3 | 12 | triglyceride lipase activity |
GO:0004954 | 0.0096 | 8.3788 | 0.461 | 3 | 12 | prostanoid receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004872 | 0 | 2.023 | 41.9355 | 77 | 975 | receptor activity |
GO:0004871 | 0 | 1.8171 | 44.7742 | 75 | 1041 | signal transducer activity |
GO:0005178 | 0 | 4.2147 | 4.3871 | 16 | 102 | integrin binding |
GO:0019863 | 1e-04 | Inf | 0.129 | 3 | 3 | IgE binding |
GO:0030545 | 2e-04 | 2.1495 | 14.9677 | 30 | 348 | receptor regulator activity |
GO:1901682 | 7e-04 | 6.7252 | 1.1183 | 6 | 26 | sulfur compound transmembrane transporter activity |
GO:0019531 | 9e-04 | 12.7832 | 0.4731 | 4 | 11 | oxalate transmembrane transporter activity |
GO:0004867 | 0.0012 | 3.5133 | 3.1828 | 10 | 74 | serine-type endopeptidase inhibitor activity |
GO:0008271 | 0.0013 | 11.1846 | 0.5161 | 4 | 12 | secondary active sulfate transmembrane transporter activity |
GO:0019199 | 0.0013 | 3.459 | 3.2258 | 10 | 75 | transmembrane receptor protein kinase activity |
GO:0004713 | 0.0014 | 2.7206 | 5.5914 | 14 | 130 | protein tyrosine kinase activity |
GO:0016155 | 0.0018 | Inf | 0.086 | 2 | 2 | formyltetrahydrofolate dehydrogenase activity |
GO:0016501 | 0.0018 | Inf | 0.086 | 2 | 2 | prostacyclin receptor activity |
GO:0019767 | 0.0018 | Inf | 0.086 | 2 | 2 | IgE receptor activity |
GO:0034988 | 0.0018 | Inf | 0.086 | 2 | 2 | Fc-gamma receptor I complex binding |
GO:0005126 | 0.002 | 2.2244 | 9.1183 | 19 | 212 | cytokine receptor binding |
GO:0019864 | 0.0024 | 16.7566 | 0.3011 | 3 | 7 | IgG binding |
GO:0008083 | 0.0026 | 2.637 | 5.3333 | 13 | 124 | growth factor activity |
GO:0005539 | 0.0035 | 2.2832 | 7.4839 | 16 | 174 | glycosaminoglycan binding |
GO:0015103 | 0.0036 | 2.6465 | 4.9032 | 12 | 114 | inorganic anion transmembrane transporter activity |
GO:0005125 | 0.0037 | 2.4253 | 6.1935 | 14 | 144 | cytokine activity |
GO:0030414 | 0.0048 | 2.4377 | 5.7204 | 13 | 133 | peptidase inhibitor activity |
GO:0004029 | 0.0052 | 6.8805 | 0.7312 | 4 | 17 | aldehyde dehydrogenase (NAD) activity |
GO:0005254 | 0.0054 | 3.2628 | 2.7097 | 8 | 63 | chloride channel activity |
GO:0050431 | 0.0078 | 5.9624 | 0.8172 | 4 | 19 | transforming growth factor beta binding |
GO:0004930 | 0.0089 | 1.7663 | 14.2366 | 24 | 331 | G-protein coupled receptor activity |
GO:0004888 | 0.0096 | 1.803 | 12.792 | 22 | 305 | transmembrane signaling receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0002020 | 5e-04 | 2.813 | 6.2689 | 16 | 127 | protease binding |
GO:0050750 | 7e-04 | 6.8418 | 1.1353 | 6 | 23 | low-density lipoprotein particle receptor binding |
GO:0071987 | 0.0011 | 28.9949 | 0.2468 | 3 | 5 | WD40-repeat domain binding |
GO:0004560 | 0.0024 | Inf | 0.0987 | 2 | 2 | alpha-L-fucosidase activity |
GO:0015433 | 0.0024 | Inf | 0.0987 | 2 | 2 | peptide antigen-transporting ATPase activity |
GO:0046980 | 0.0024 | Inf | 0.0987 | 2 | 2 | tapasin binding |
GO:0005319 | 0.0027 | 2.7784 | 4.7387 | 12 | 96 | lipid transporter activity |
GO:0043130 | 0.0032 | 3.2967 | 3.0604 | 9 | 62 | ubiquitin binding |
GO:0008526 | 0.0036 | 14.4955 | 0.3455 | 3 | 7 | phosphatidylinositol transporter activity |
GO:0000340 | 0.0056 | 11.5957 | 0.3949 | 3 | 8 | RNA 7-methylguanosine cap binding |
GO:0003743 | 0.0061 | 3.5706 | 2.2213 | 7 | 45 | translation initiation factor activity |
GO:0004367 | 0.0071 | 38.613 | 0.1481 | 2 | 3 | glycerol-3-phosphate dehydrogenase [NAD+] activity |
GO:0019776 | 0.0071 | 38.613 | 0.1481 | 2 | 3 | Atg8 ligase activity |
GO:0023029 | 0.0071 | 38.613 | 0.1481 | 2 | 3 | MHC class Ib protein binding |
GO:0031849 | 0.0071 | 38.613 | 0.1481 | 2 | 3 | olfactory receptor binding |
GO:0036374 | 0.0071 | 38.613 | 0.1481 | 2 | 3 | glutathione hydrolase activity |
GO:0046978 | 0.0071 | 38.613 | 0.1481 | 2 | 3 | TAP1 binding |
GO:0046979 | 0.0071 | 38.613 | 0.1481 | 2 | 3 | TAP2 binding |
GO:0032813 | 0.0078 | 3.8737 | 1.777 | 6 | 36 | tumor necrosis factor receptor superfamily binding |
GO:0004715 | 0.0078 | 3.3916 | 2.32 | 7 | 47 | non-membrane spanning protein tyrosine kinase activity |
GO:0031625 | 0.008 | 1.7882 | 14.1175 | 24 | 286 | ubiquitin protein ligase binding |
GO:1904264 | 0.008 | 9.6624 | 0.4443 | 3 | 9 | ubiquitin protein ligase activity involved in ERAD pathway |
GO:0019899 | 0.0096 | 1.2902 | 93.3465 | 115 | 1915 | enzyme binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004857 | 8e-04 | 2.14 | 12.4561 | 25 | 310 | enzyme inhibitor activity |
GO:0004014 | 0.0016 | Inf | 0.0804 | 2 | 2 | adenosylmethionine decarboxylase activity |
GO:0019810 | 0.0016 | Inf | 0.0804 | 2 | 2 | putrescine binding |
GO:0005160 | 0.0032 | 4.0142 | 1.9689 | 7 | 49 | transforming growth factor beta receptor binding |
GO:0000014 | 0.0045 | 11.9953 | 0.3616 | 3 | 9 | single-stranded DNA endodeoxyribonuclease activity |
GO:0004521 | 0.0098 | 3.6076 | 1.8483 | 6 | 46 | endoribonuclease activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0030414 | 5e-04 | 3.0811 | 4.9677 | 14 | 133 | peptidase inhibitor activity |
GO:0004014 | 0.0014 | Inf | 0.0747 | 2 | 2 | adenosylmethionine decarboxylase activity |
GO:0019810 | 0.0014 | Inf | 0.0747 | 2 | 2 | putrescine binding |
GO:0004867 | 0.0017 | 3.608 | 2.764 | 9 | 74 | serine-type endopeptidase inhibitor activity |
GO:0019955 | 0.0021 | 3.2192 | 3.399 | 10 | 91 | cytokine binding |
GO:0098772 | 0.003 | 1.4617 | 51.2462 | 71 | 1372 | molecular function regulator |
GO:0061135 | 0.0039 | 2.6098 | 4.9304 | 12 | 132 | endopeptidase regulator activity |
GO:0003906 | 0.0068 | 9.7088 | 0.4109 | 3 | 11 | DNA-(apurinic or apyrimidinic site) lyase activity |
GO:0004715 | 0.0077 | 3.7999 | 1.7555 | 6 | 47 | non-membrane spanning protein tyrosine kinase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0015020 | 0 | 11.8647 | 0.8411 | 7 | 22 | glucuronosyltransferase activity |
GO:0061135 | 2e-04 | 3.2814 | 5.0466 | 15 | 132 | endopeptidase regulator activity |
GO:0030414 | 2e-04 | 3.2534 | 5.0848 | 15 | 133 | peptidase inhibitor activity |
GO:0004675 | 3e-04 | 10.5604 | 0.6499 | 5 | 17 | transmembrane receptor protein serine/threonine kinase activity |
GO:0015026 | 5e-04 | 9.7474 | 0.6882 | 5 | 18 | coreceptor activity |
GO:0004565 | 0.001 | 25.276 | 0.2294 | 3 | 6 | beta-galactosidase activity |
GO:0016757 | 0.0011 | 2.2989 | 9.2903 | 20 | 243 | transferase activity, transferring glycosyl groups |
GO:0001972 | 0.0011 | 11.248 | 0.497 | 4 | 13 | retinoic acid binding |
GO:0008395 | 0.0017 | 4.5562 | 1.7587 | 7 | 46 | steroid hydroxylase activity |
GO:0050543 | 0.0017 | 18.9558 | 0.2676 | 3 | 7 | icosatetraenoic acid binding |
GO:0004888 | 0.002 | 1.6691 | 27.1446 | 43 | 710 | transmembrane signaling receptor activity |
GO:0004867 | 0.002 | 3.5205 | 2.8292 | 9 | 74 | serine-type endopeptidase inhibitor activity |
GO:0004872 | 0.0024 | 1.554 | 37.276 | 55 | 975 | receptor activity |
GO:0004871 | 0.0039 | 1.5045 | 39.7993 | 57 | 1041 | signal transducer activity |
GO:0008508 | 0.0043 | 50.4752 | 0.1147 | 2 | 3 | bile acid:sodium symporter activity |
GO:0070548 | 0.0043 | 50.4752 | 0.1147 | 2 | 3 | L-glutamine aminotransferase activity |
GO:0019840 | 0.0069 | 4.6889 | 1.2234 | 5 | 32 | isoprenoid binding |
GO:0048185 | 0.0073 | 9.4754 | 0.4205 | 3 | 11 | activin binding |
GO:0003996 | 0.0083 | 25.236 | 0.1529 | 2 | 4 | acyl-CoA ligase activity |
GO:0005134 | 0.0083 | 25.236 | 0.1529 | 2 | 4 | interleukin-2 receptor binding |
GO:0016286 | 0.0083 | 25.236 | 0.1529 | 2 | 4 | small conductance calcium-activated potassium channel activity |
GO:0034481 | 0.0083 | 25.236 | 0.1529 | 2 | 4 | chondroitin sulfotransferase activity |
GO:0035594 | 0.0083 | 25.236 | 0.1529 | 2 | 4 | ganglioside binding |
GO:0005504 | 0.0089 | 4.365 | 1.2999 | 5 | 34 | fatty acid binding |
GO:0031406 | 0.0098 | 2.135 | 6.92 | 14 | 181 | carboxylic acid binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0015020 | 0 | 12.2236 | 0.8176 | 7 | 22 | glucuronosyltransferase activity |
GO:0030545 | 6e-04 | 2.1423 | 12.9327 | 26 | 348 | receptor regulator activity |
GO:0005179 | 6e-04 | 3.8585 | 2.8987 | 10 | 78 | hormone activity |
GO:0030116 | 0.0014 | Inf | 0.0743 | 2 | 2 | glial cell-derived neurotrophic factor receptor binding |
GO:0005520 | 0.0029 | 5.93 | 1.0034 | 5 | 27 | insulin-like growth factor binding |
GO:0022850 | 0.004 | 51.9898 | 0.1115 | 2 | 3 | serotonin-gated cation-selective channel activity |
GO:0004896 | 0.0043 | 3.3752 | 2.6014 | 8 | 70 | cytokine receptor activity |
GO:1904680 | 0.0047 | 6.9492 | 0.7061 | 4 | 19 | peptide transmembrane transporter activity |
GO:0015296 | 0.0061 | 4.0166 | 1.6723 | 6 | 45 | anion:cation symporter activity |
GO:0031406 | 0.0077 | 2.2004 | 6.7265 | 14 | 181 | carboxylic acid binding |
GO:0032052 | 0.0079 | 25.9932 | 0.1487 | 2 | 4 | bile acid binding |
GO:0005504 | 0.0079 | 4.4966 | 1.2635 | 5 | 34 | fatty acid binding |
GO:0005313 | 0.0087 | 8.6752 | 0.446 | 3 | 12 | L-glutamate transmembrane transporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004252 | 6e-04 | 2.9909 | 5.0999 | 14 | 137 | serine-type endopeptidase activity |
GO:0005179 | 6e-04 | 3.8516 | 2.9036 | 10 | 78 | hormone activity |
GO:0030545 | 6e-04 | 2.1383 | 12.9545 | 26 | 348 | receptor regulator activity |
GO:0051575 | 9e-04 | 25.9898 | 0.2234 | 3 | 6 | 5'-deoxyribose-5-phosphate lyase activity |
GO:0017171 | 0.0015 | 2.5755 | 6.2539 | 15 | 168 | serine hydrolase activity |
GO:0009881 | 0.0025 | 15.5919 | 0.2978 | 3 | 8 | photoreceptor activity |
GO:0016015 | 0.004 | 51.8983 | 0.1117 | 2 | 3 | morphogen activity |
GO:0017077 | 0.004 | 51.8983 | 0.1117 | 2 | 3 | oxidative phosphorylation uncoupler activity |
GO:0022850 | 0.004 | 51.8983 | 0.1117 | 2 | 3 | serotonin-gated cation-selective channel activity |
GO:0004896 | 0.0044 | 3.3692 | 2.6058 | 8 | 70 | cytokine receptor activity |
GO:0019955 | 0.0067 | 2.867 | 3.3875 | 9 | 91 | cytokine binding |
GO:0070011 | 0.0073 | 1.6819 | 18.6501 | 30 | 501 | peptidase activity, acting on L-amino acid peptides |
GO:0005089 | 0.0095 | 3.2022 | 2.3824 | 7 | 64 | Rho guanyl-nucleotide exchange factor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005125 | 1e-04 | 3.0916 | 6.0758 | 17 | 144 | cytokine activity |
GO:0004888 | 1e-04 | 1.819 | 29.9572 | 51 | 710 | transmembrane signaling receptor activity |
GO:0004872 | 2e-04 | 1.6881 | 41.1385 | 65 | 975 | receptor activity |
GO:0017046 | 0.0015 | 4.7123 | 1.7299 | 7 | 41 | peptide hormone binding |
GO:0048248 | 0.0018 | Inf | 0.0844 | 2 | 2 | CXCR3 chemokine receptor binding |
GO:0004871 | 0.0024 | 1.5102 | 43.9232 | 63 | 1041 | signal transducer activity |
GO:0042393 | 0.0027 | 2.3455 | 7.2994 | 16 | 173 | histone binding |
GO:0043548 | 0.0062 | 4.0331 | 1.6877 | 6 | 40 | phosphatidylinositol 3-kinase binding |
GO:0030545 | 0.0069 | 1.7863 | 14.6833 | 25 | 348 | receptor regulator activity |
GO:0008227 | 0.009 | 4.3907 | 1.308 | 5 | 31 | G-protein coupled amine receptor activity |
GO:0043560 | 0.0096 | 8.5464 | 0.4641 | 3 | 11 | insulin receptor substrate binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004872 | 2e-04 | 1.6951 | 39.054 | 62 | 975 | receptor activity |
GO:0004715 | 5e-04 | 4.9658 | 1.8826 | 8 | 47 | non-membrane spanning protein tyrosine kinase activity |
GO:0046965 | 0.0015 | 7.0965 | 0.8812 | 5 | 22 | retinoid X receptor binding |
GO:0034987 | 0.002 | 18.0544 | 0.2804 | 3 | 7 | immunoglobulin receptor binding |
GO:0023026 | 0.0024 | 8.7635 | 0.6008 | 4 | 15 | MHC class II protein complex binding |
GO:0038036 | 0.0031 | 14.4426 | 0.3204 | 3 | 8 | sphingosine-1-phosphate receptor activity |
GO:0004129 | 0.0032 | 8.0326 | 0.6409 | 4 | 16 | cytochrome-c oxidase activity |
GO:0016675 | 0.004 | 7.4143 | 0.6809 | 4 | 17 | oxidoreductase activity, acting on a heme group of donors |
GO:0004888 | 0.0046 | 1.5845 | 28.4393 | 43 | 710 | transmembrane signaling receptor activity |
GO:0003700 | 0.005 | 1.4826 | 40.2957 | 57 | 1006 | DNA binding transcription factor activity |
GO:0005031 | 0.0074 | 6.0229 | 0.8011 | 4 | 20 | tumor necrosis factor-activated receptor activity |
GO:0046625 | 0.0074 | 6.0229 | 0.8011 | 4 | 20 | sphingolipid binding |
GO:0033549 | 0.0083 | 9.0248 | 0.4406 | 3 | 11 | MAP kinase phosphatase activity |
GO:0032052 | 0.0091 | 24.0378 | 0.1602 | 2 | 4 | bile acid binding |
GO:0004725 | 0.0099 | 2.6867 | 3.605 | 9 | 90 | protein tyrosine phosphatase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 3.164 | 8.5505 | 24 | 173 | histone binding |
GO:0003723 | 1e-04 | 1.5329 | 72.0117 | 103 | 1457 | RNA binding |
GO:0019899 | 1e-04 | 1.4502 | 100.9251 | 136 | 2042 | enzyme binding |
GO:0003677 | 2e-04 | 1.4725 | 87.4207 | 120 | 1781 | DNA binding |
GO:0015485 | 5e-04 | 5.8971 | 1.4827 | 7 | 30 | cholesterol binding |
GO:0003887 | 5e-04 | 7.2601 | 1.0873 | 6 | 22 | DNA-directed DNA polymerase activity |
GO:0097159 | 8e-04 | 1.281 | 240.1543 | 281 | 4859 | organic cyclic compound binding |
GO:0015197 | 9e-04 | 3.0462 | 4.7448 | 13 | 96 | peptide transporter activity |
GO:1901363 | 0.0015 | 1.2621 | 236.9417 | 275 | 4794 | heterocyclic compound binding |
GO:0061630 | 0.002 | 2.1339 | 10.5274 | 21 | 213 | ubiquitin protein ligase activity |
GO:0019957 | 0.0021 | 19.3027 | 0.2965 | 3 | 6 | C-C chemokine binding |
GO:0051575 | 0.0021 | 19.3027 | 0.2965 | 3 | 6 | 5'-deoxyribose-5-phosphate lyase activity |
GO:0015433 | 0.0024 | Inf | 0.0988 | 2 | 2 | peptide antigen-transporting ATPase activity |
GO:0046980 | 0.0024 | Inf | 0.0988 | 2 | 2 | tapasin binding |
GO:0055077 | 0.0024 | Inf | 0.0988 | 2 | 2 | gap junction hemi-channel activity |
GO:0019787 | 0.0028 | 1.744 | 20.5606 | 34 | 416 | ubiquitin-like protein transferase activity |
GO:0051021 | 0.0036 | 14.4761 | 0.346 | 3 | 7 | GDP-dissociation inhibitor binding |
GO:0140097 | 0.0039 | 2.2638 | 7.5852 | 16 | 154 | catalytic activity, acting on DNA |
GO:0003684 | 0.0042 | 3.444 | 2.6195 | 8 | 53 | damaged DNA binding |
GO:0008139 | 0.0047 | 5.3703 | 1.1368 | 5 | 23 | nuclear localization sequence binding |
GO:0043531 | 0.005 | 4.2991 | 1.631 | 6 | 33 | ADP binding |
GO:1990381 | 0.0052 | 7.0244 | 0.7414 | 4 | 15 | ubiquitin-specific protease binding |
GO:0003680 | 0.0056 | 11.5801 | 0.3954 | 3 | 8 | AT DNA binding |
GO:0004579 | 0.0056 | 11.5801 | 0.3954 | 3 | 8 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity |
GO:0097677 | 0.0056 | 11.5801 | 0.3954 | 3 | 8 | STAT family protein binding |
GO:0023029 | 0.0071 | 38.5612 | 0.1483 | 2 | 3 | MHC class Ib protein binding |
GO:0031849 | 0.0071 | 38.5612 | 0.1483 | 2 | 3 | olfactory receptor binding |
GO:0046978 | 0.0071 | 38.5612 | 0.1483 | 2 | 3 | TAP1 binding |
GO:0046979 | 0.0071 | 38.5612 | 0.1483 | 2 | 3 | TAP2 binding |
GO:0071535 | 0.0071 | 38.5612 | 0.1483 | 2 | 3 | RING-like zinc finger domain binding |
GO:0008138 | 0.0078 | 3.8685 | 1.7793 | 6 | 36 | protein tyrosine/serine/threonine phosphatase activity |
GO:0043024 | 0.0081 | 9.6494 | 0.4448 | 3 | 9 | ribosomal small subunit binding |
GO:0097602 | 0.0084 | 5.9429 | 0.8402 | 4 | 17 | cullin family protein binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 3.6094 | 7.2233 | 23 | 173 | histone binding |
GO:0016493 | 3e-04 | 18.4655 | 0.3758 | 4 | 9 | C-C chemokine receptor activity |
GO:0005031 | 0.0011 | 7.7006 | 0.8351 | 5 | 20 | tumor necrosis factor-activated receptor activity |
GO:0019957 | 0.0013 | 23.0499 | 0.2505 | 3 | 6 | C-C chemokine binding |
GO:0097157 | 0.0022 | 17.2863 | 0.2923 | 3 | 7 | pre-mRNA intronic binding |
GO:0001637 | 0.0028 | 8.3901 | 0.6263 | 4 | 15 | G-protein coupled chemoattractant receptor activity |
GO:0008565 | 0.0033 | 3.0108 | 3.6325 | 10 | 87 | protein transporter activity |
GO:0019955 | 0.0046 | 2.8614 | 3.7995 | 10 | 91 | cytokine binding |
GO:0043024 | 0.005 | 11.5227 | 0.3758 | 3 | 9 | ribosomal small subunit binding |
GO:0015440 | 0.0051 | 46.0363 | 0.1253 | 2 | 3 | peptide-transporting ATPase activity |
GO:0017077 | 0.0051 | 46.0363 | 0.1253 | 2 | 3 | oxidative phosphorylation uncoupler activity |
GO:0003950 | 0.0058 | 6.5909 | 0.7516 | 4 | 18 | NAD+ ADP-ribosyltransferase activity |
GO:0005243 | 0.007 | 9.8759 | 0.4175 | 3 | 10 | gap junction channel activity |
GO:0017017 | 0.007 | 9.8759 | 0.4175 | 3 | 10 | MAP kinase tyrosine/serine/threonine phosphatase activity |
GO:0015485 | 0.0075 | 4.6173 | 1.2526 | 5 | 30 | cholesterol binding |
GO:0004896 | 0.0085 | 2.9852 | 2.9227 | 8 | 70 | cytokine receptor activity |
GO:0008301 | 0.0093 | 8.6409 | 0.4593 | 3 | 11 | DNA binding, bending |
GO:0003823 | 0.0095 | 3.6477 | 1.8371 | 6 | 44 | antigen binding |
GO:0015272 | 0.0099 | 23.0166 | 0.167 | 2 | 4 | ATP-activated inward rectifier potassium channel activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0015020 | 0 | 13.879 | 0.8798 | 8 | 22 | glucuronosyltransferase activity |
GO:0001972 | 1e-04 | 15.1139 | 0.5199 | 5 | 13 | retinoic acid binding |
GO:0019840 | 2e-04 | 6.785 | 1.2798 | 7 | 32 | isoprenoid binding |
GO:0004014 | 0.0016 | Inf | 0.08 | 2 | 2 | adenosylmethionine decarboxylase activity |
GO:0019810 | 0.0016 | Inf | 0.08 | 2 | 2 | putrescine binding |
GO:0004857 | 0.0034 | 1.9584 | 12.3977 | 23 | 310 | enzyme inhibitor activity |
GO:0000179 | 0.0047 | 48.1577 | 0.12 | 2 | 3 | rRNA (adenine-N6,N6-)-dimethyltransferase activity |
GO:0019828 | 0.0047 | 48.1577 | 0.12 | 2 | 3 | aspartic-type endopeptidase inhibitor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0015485 | 0 | 7.9176 | 1.3299 | 8 | 30 | cholesterol binding |
GO:0003823 | 1e-04 | 5.6021 | 1.9506 | 9 | 44 | antigen binding |
GO:0004896 | 2e-04 | 4.067 | 3.1032 | 11 | 70 | cytokine receptor activity |
GO:0001637 | 3e-04 | 10.8486 | 0.665 | 5 | 15 | G-protein coupled chemoattractant receptor activity |
GO:0004872 | 6e-04 | 1.5946 | 43.223 | 65 | 975 | receptor activity |
GO:0005243 | 6e-04 | 14.4479 | 0.4433 | 4 | 10 | gap junction channel activity |
GO:0019955 | 7e-04 | 3.3139 | 4.0341 | 12 | 91 | cytokine binding |
GO:0019957 | 0.0016 | 21.6453 | 0.266 | 3 | 6 | C-C chemokine binding |
GO:0005496 | 0.0017 | 3.3499 | 3.3248 | 10 | 75 | steroid binding |
GO:0005102 | 0.0019 | 1.4643 | 56.2281 | 78 | 1278 | receptor binding |
GO:0015433 | 0.002 | Inf | 0.0887 | 2 | 2 | peptide antigen-transporting ATPase activity |
GO:0030369 | 0.002 | Inf | 0.0887 | 2 | 2 | ICAM-3 receptor activity |
GO:0046980 | 0.002 | Inf | 0.0887 | 2 | 2 | tapasin binding |
GO:0016803 | 0.0027 | 16.2329 | 0.3103 | 3 | 7 | ether hydrolase activity |
GO:0004866 | 0.0039 | 2.5079 | 5.5857 | 13 | 126 | endopeptidase inhibitor activity |
GO:0042802 | 0.0043 | 1.3756 | 70.3537 | 92 | 1587 | identical protein binding |
GO:0030971 | 0.0053 | 3.2798 | 2.7042 | 8 | 61 | receptor tyrosine kinase binding |
GO:0016647 | 0.0057 | 43.2347 | 0.133 | 2 | 3 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor |
GO:0023029 | 0.0057 | 43.2347 | 0.133 | 2 | 3 | MHC class Ib protein binding |
GO:0046978 | 0.0057 | 43.2347 | 0.133 | 2 | 3 | TAP1 binding |
GO:0046979 | 0.0057 | 43.2347 | 0.133 | 2 | 3 | TAP2 binding |
GO:1905576 | 0.0057 | 43.2347 | 0.133 | 2 | 3 | ganglioside GT1b binding |
GO:0016493 | 0.006 | 10.8205 | 0.399 | 3 | 9 | C-C chemokine receptor activity |
GO:0004553 | 0.0087 | 2.5889 | 4.1671 | 10 | 94 | hydrolase activity, hydrolyzing O-glycosyl compounds |
GO:0071949 | 0.0087 | 5.7757 | 0.8423 | 4 | 19 | FAD binding |
GO:0005044 | 0.0089 | 3.7187 | 1.8176 | 6 | 41 | scavenger receptor activity |
GO:0005507 | 0.01 | 3.6152 | 1.8619 | 6 | 42 | copper ion binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 3.9621 | 8.9312 | 30 | 173 | histone binding |
GO:0005132 | 0 | 18.4982 | 0.6195 | 6 | 12 | type I interferon receptor binding |
GO:1990381 | 1e-04 | 12.3297 | 0.7744 | 6 | 15 | ubiquitin-specific protease binding |
GO:0019904 | 1e-04 | 1.7709 | 37.5317 | 62 | 727 | protein domain specific binding |
GO:0097159 | 1e-04 | 1.3291 | 250.8482 | 300 | 4859 | organic cyclic compound binding |
GO:1901363 | 1e-04 | 1.3267 | 247.4925 | 296 | 4794 | heterocyclic compound binding |
GO:0003723 | 2e-04 | 1.5461 | 60.7001 | 88 | 1204 | RNA binding |
GO:0003677 | 3e-04 | 1.4339 | 94.6811 | 127 | 1834 | DNA binding |
GO:0004579 | 4e-04 | 18.4553 | 0.413 | 4 | 8 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity |
GO:0016818 | 7e-04 | 1.6199 | 39.2354 | 60 | 760 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides |
GO:0003729 | 0.0017 | 2.2166 | 9.7056 | 20 | 188 | mRNA binding |
GO:0043022 | 0.0019 | 3.6229 | 2.8394 | 9 | 55 | ribosome binding |
GO:0017111 | 0.0022 | 1.5615 | 37.0671 | 55 | 718 | nucleoside-triphosphatase activity |
GO:1904680 | 0.0023 | 6.5949 | 0.9809 | 5 | 19 | peptide transmembrane transporter activity |
GO:0015230 | 0.0027 | Inf | 0.1033 | 2 | 2 | FAD transmembrane transporter activity |
GO:0015433 | 0.0027 | Inf | 0.1033 | 2 | 2 | peptide antigen-transporting ATPase activity |
GO:0046964 | 0.0027 | Inf | 0.1033 | 2 | 2 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity |
GO:0046980 | 0.0027 | Inf | 0.1033 | 2 | 2 | tapasin binding |
GO:0031492 | 0.003 | 4.1752 | 1.9618 | 7 | 38 | nucleosomal DNA binding |
GO:0016787 | 0.0032 | 1.3704 | 78.4394 | 102 | 1547 | hydrolase activity |
GO:0000774 | 0.0041 | 13.8246 | 0.3614 | 3 | 7 | adenyl-nucleotide exchange factor activity |
GO:0097200 | 0.0041 | 13.8246 | 0.3614 | 3 | 7 | cysteine-type endopeptidase activity involved in execution phase of apoptosis |
GO:1990247 | 0.0041 | 13.8246 | 0.3614 | 3 | 7 | N6-methyladenosine-containing RNA binding |
GO:0015932 | 0.0045 | 4.434 | 1.6004 | 6 | 31 | nucleobase-containing compound transmembrane transporter activity |
GO:0003725 | 0.0059 | 2.974 | 3.3557 | 9 | 65 | double-stranded RNA binding |
GO:0003896 | 0.0077 | 36.8278 | 0.1549 | 2 | 3 | DNA primase activity |
GO:0023029 | 0.0077 | 36.8278 | 0.1549 | 2 | 3 | MHC class Ib protein binding |
GO:0046978 | 0.0077 | 36.8278 | 0.1549 | 2 | 3 | TAP1 binding |
GO:0046979 | 0.0077 | 36.8278 | 0.1549 | 2 | 3 | TAP2 binding |
GO:0015605 | 0.0078 | 6.1485 | 0.826 | 4 | 16 | organophosphate ester transmembrane transporter activity |
GO:0004722 | 0.0085 | 3.0189 | 2.9427 | 8 | 57 | protein serine/threonine phosphatase activity |
GO:0016788 | 0.0089 | 1.4889 | 32.9371 | 47 | 638 | hydrolase activity, acting on ester bonds |
GO:0140098 | 0.0091 | 1.7045 | 16.6234 | 27 | 322 | catalytic activity, acting on RNA |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 4.0102 | 8.8333 | 30 | 173 | histone binding |
GO:0003723 | 0 | 1.7362 | 72.0985 | 114 | 1425 | RNA binding |
GO:0005132 | 0 | 18.7159 | 0.6127 | 6 | 12 | type I interferon receptor binding |
GO:0042605 | 2e-04 | 7.2816 | 1.2765 | 7 | 25 | peptide antigen binding |
GO:0043022 | 4e-04 | 4.169 | 2.8083 | 10 | 55 | ribosome binding |
GO:0003735 | 8e-04 | 2.6022 | 7.1483 | 17 | 140 | structural constituent of ribosome |
GO:0030515 | 0.0013 | 5.9052 | 1.2765 | 6 | 25 | snoRNA binding |
GO:0046964 | 0.0026 | Inf | 0.1021 | 2 | 2 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity |
GO:1901363 | 0.0028 | 1.2404 | 244.7795 | 281 | 4794 | heterocyclic compound binding |
GO:0061630 | 0.003 | 2.0601 | 10.8757 | 21 | 213 | ubiquitin protein ligase activity |
GO:0097159 | 0.0031 | 1.2364 | 248.0983 | 284 | 4859 | organic cyclic compound binding |
GO:0047485 | 0.0032 | 2.4801 | 6.1271 | 14 | 120 | protein N-terminus binding |
GO:0008097 | 0.0033 | 8.2959 | 0.6638 | 4 | 13 | 5S rRNA binding |
GO:0001883 | 0.0034 | 1.8292 | 16.1859 | 28 | 317 | purine nucleoside binding |
GO:0032549 | 0.0036 | 1.8228 | 16.2369 | 28 | 318 | ribonucleoside binding |
GO:0051021 | 0.004 | 13.9867 | 0.3574 | 3 | 7 | GDP-dissociation inhibitor binding |
GO:1990247 | 0.004 | 13.9867 | 0.3574 | 3 | 7 | N6-methyladenosine-containing RNA binding |
GO:0003887 | 0.0044 | 5.4938 | 1.1233 | 5 | 22 | DNA-directed DNA polymerase activity |
GO:0005525 | 0.0049 | 1.7997 | 15.8285 | 27 | 310 | GTP binding |
GO:0003924 | 0.0053 | 1.9178 | 12.1522 | 22 | 238 | GTPase activity |
GO:0019001 | 0.0057 | 1.7549 | 16.7986 | 28 | 329 | guanyl nucleotide binding |
GO:1990381 | 0.0059 | 6.7867 | 0.7659 | 4 | 15 | ubiquitin-specific protease binding |
GO:0004579 | 0.0061 | 11.1886 | 0.4085 | 3 | 8 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity |
GO:0003743 | 0.0073 | 3.4446 | 2.2977 | 7 | 45 | translation initiation factor activity |
GO:0004129 | 0.0075 | 6.2207 | 0.817 | 4 | 16 | cytochrome-c oxidase activity |
GO:0015035 | 0.0075 | 6.2207 | 0.817 | 4 | 16 | protein disulfide oxidoreductase activity |
GO:0000386 | 0.0075 | 37.2593 | 0.1532 | 2 | 3 | second spliceosomal transesterification activity |
GO:0003896 | 0.0075 | 37.2593 | 0.1532 | 2 | 3 | DNA primase activity |
GO:0031708 | 0.0075 | 37.2593 | 0.1532 | 2 | 3 | endothelin B receptor binding |
GO:0042799 | 0.0075 | 37.2593 | 0.1532 | 2 | 3 | histone methyltransferase activity (H4-K20 specific) |
GO:0004722 | 0.008 | 3.0545 | 2.9104 | 8 | 57 | protein serine/threonine phosphatase activity |
GO:0030742 | 0.0092 | 4.4462 | 1.3275 | 5 | 26 | GTP-dependent protein binding |
GO:0016675 | 0.0094 | 5.7418 | 0.868 | 4 | 17 | oxidoreductase activity, acting on a heme group of donors |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004252 | 1e-04 | 3.3023 | 5.367 | 16 | 137 | serine-type endopeptidase activity |
GO:0017171 | 1e-04 | 3.001 | 6.5814 | 18 | 168 | serine hydrolase activity |
GO:0060089 | 4e-04 | 1.6394 | 40.2327 | 62 | 1027 | molecular transducer activity |
GO:0099600 | 5e-04 | 1.7387 | 29.3029 | 48 | 748 | transmembrane receptor activity |
GO:0048018 | 7e-04 | 2.1605 | 12.3419 | 25 | 316 | receptor ligand activity |
GO:0071855 | 0.003 | 5.8788 | 1.0185 | 5 | 26 | neuropeptide receptor binding |
GO:0004616 | 0.0045 | 49.2077 | 0.1175 | 2 | 3 | phosphogluconate dehydrogenase (decarboxylating) activity |
GO:0004967 | 0.0045 | 49.2077 | 0.1175 | 2 | 3 | glucagon receptor activity |
GO:0015265 | 0.0045 | 49.2077 | 0.1175 | 2 | 3 | urea channel activity |
GO:0016015 | 0.0045 | 49.2077 | 0.1175 | 2 | 3 | morphogen activity |
GO:0008233 | 0.0047 | 1.6954 | 20.4102 | 33 | 521 | peptidase activity |
GO:0005242 | 0.0057 | 6.5762 | 0.7443 | 4 | 19 | inward rectifier potassium channel activity |
GO:0035586 | 0.0057 | 6.5762 | 0.7443 | 4 | 19 | purinergic receptor activity |
GO:0008200 | 0.0057 | 4.9369 | 1.1752 | 5 | 30 | ion channel inhibitor activity |
GO:0005031 | 0.0068 | 6.1648 | 0.7835 | 4 | 20 | tumor necrosis factor-activated receptor activity |
GO:0003906 | 0.0078 | 9.2371 | 0.4309 | 3 | 11 | DNA-(apurinic or apyrimidinic site) lyase activity |
GO:0005372 | 0.0078 | 9.2371 | 0.4309 | 3 | 11 | water transmembrane transporter activity |
GO:0004181 | 0.0082 | 5.8018 | 0.8227 | 4 | 21 | metallocarboxypeptidase activity |
GO:0051393 | 0.0087 | 4.4071 | 1.2928 | 5 | 33 | alpha-actinin binding |
GO:0030280 | 0.0087 | 24.6023 | 0.1567 | 2 | 4 | structural constituent of epidermis |
GO:0005184 | 0.0097 | 5.4791 | 0.8618 | 4 | 22 | neuropeptide hormone activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031800 | 1e-04 | Inf | 0.126 | 3 | 3 | type 3 metabotropic glutamate receptor binding |
GO:0042393 | 1e-04 | 2.8669 | 7.2668 | 19 | 173 | histone binding |
GO:0008179 | 3e-04 | 11.4819 | 0.6301 | 5 | 15 | adenylate cyclase binding |
GO:0004954 | 0.0012 | 11.4661 | 0.5041 | 4 | 12 | prostanoid receptor activity |
GO:0004957 | 0.0013 | 22.9053 | 0.252 | 3 | 6 | prostaglandin E receptor activity |
GO:0008242 | 0.0035 | 13.7414 | 0.336 | 3 | 8 | omega peptidase activity |
GO:0030235 | 0.0035 | 13.7414 | 0.336 | 3 | 8 | nitric-oxide synthase regulator activity |
GO:0005484 | 0.0036 | 4.5937 | 1.5122 | 6 | 36 | SNAP receptor activity |
GO:0005548 | 0.0046 | 3.7415 | 2.1002 | 7 | 50 | phospholipid transporter activity |
GO:0015222 | 0.0051 | 45.7477 | 0.126 | 2 | 3 | serotonin transmembrane transporter activity |
GO:0016508 | 0.0051 | 45.7477 | 0.126 | 2 | 3 | long-chain-enoyl-CoA hydratase activity |
GO:0031826 | 0.0051 | 45.7477 | 0.126 | 2 | 3 | type 2A serotonin receptor binding |
GO:0004704 | 0.01 | 22.8724 | 0.168 | 2 | 4 | NF-kappaB-inducing kinase activity |
GO:0030280 | 0.01 | 22.8724 | 0.168 | 2 | 4 | structural constituent of epidermis |
GO:0034648 | 0.01 | 22.8724 | 0.168 | 2 | 4 | histone demethylase activity (H3-dimethyl-K4 specific) |
GO:0045134 | 0.01 | 22.8724 | 0.168 | 2 | 4 | uridine-diphosphatase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004556 | 0 | Inf | 0.1615 | 4 | 4 | alpha-amylase activity |
GO:0004872 | 0 | 1.8091 | 39.3605 | 66 | 975 | receptor activity |
GO:0004867 | 2e-04 | 4.2054 | 2.9874 | 11 | 74 | serine-type endopeptidase inhibitor activity |
GO:0030414 | 3e-04 | 3.0701 | 5.3692 | 15 | 133 | peptidase inhibitor activity |
GO:0035174 | 3e-04 | 10.882 | 0.6459 | 5 | 16 | histone serine kinase activity |
GO:0004679 | 4e-04 | 9.9745 | 0.6863 | 5 | 17 | AMP-activated protein kinase activity |
GO:0004871 | 5e-04 | 1.6189 | 42.0249 | 64 | 1041 | signal transducer activity |
GO:0030247 | 6e-04 | 9.2066 | 0.7267 | 5 | 18 | polysaccharide binding |
GO:0005044 | 0.0011 | 4.937 | 1.6552 | 7 | 41 | scavenger receptor activity |
GO:0033130 | 0.0019 | 9.5618 | 0.5652 | 4 | 14 | acetylcholine receptor binding |
GO:0036310 | 0.002 | 17.9073 | 0.2826 | 3 | 7 | annealing helicase activity |
GO:0005125 | 0.0021 | 2.5947 | 5.8132 | 14 | 144 | cytokine activity |
GO:0061135 | 0.0026 | 2.6298 | 5.3288 | 13 | 132 | endopeptidase regulator activity |
GO:0004888 | 0.0031 | 1.6552 | 25.3952 | 40 | 635 | transmembrane signaling receptor activity |
GO:0019199 | 0.0031 | 3.2734 | 3.0277 | 9 | 75 | transmembrane receptor protein kinase activity |
GO:0016408 | 0.0041 | 7.3537 | 0.6863 | 4 | 17 | C-acyltransferase activity |
GO:0003796 | 0.0046 | 11.9366 | 0.3633 | 3 | 9 | lysozyme activity |
GO:0070012 | 0.0048 | 47.6875 | 0.1211 | 2 | 3 | oligopeptidase activity |
GO:0008528 | 0.0049 | 2.825 | 3.8351 | 10 | 95 | G-protein coupled peptide receptor activity |
GO:0030548 | 0.0064 | 10.2307 | 0.4037 | 3 | 10 | acetylcholine receptor regulator activity |
GO:0005178 | 0.0081 | 2.6089 | 4.1177 | 10 | 102 | integrin binding |
GO:0004955 | 0.0085 | 8.9513 | 0.4441 | 3 | 11 | prostaglandin receptor activity |
GO:0004181 | 0.0091 | 5.622 | 0.8478 | 4 | 21 | metallocarboxypeptidase activity |
GO:0003996 | 0.0092 | 23.8422 | 0.1615 | 2 | 4 | acyl-CoA ligase activity |
GO:0004687 | 0.0092 | 23.8422 | 0.1615 | 2 | 4 | myosin light chain kinase activity |
GO:0035594 | 0.0092 | 23.8422 | 0.1615 | 2 | 4 | ganglioside binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004930 | 0 | 2.5383 | 13.7787 | 32 | 331 | G-protein coupled receptor activity |
GO:0099600 | 1e-04 | 1.8617 | 31.1373 | 54 | 748 | transmembrane receptor activity |
GO:0038023 | 3e-04 | 1.7282 | 33.2603 | 54 | 799 | signaling receptor activity |
GO:0060089 | 5e-04 | 1.6161 | 42.7513 | 65 | 1027 | molecular transducer activity |
GO:0051378 | 5e-04 | 15.4357 | 0.4163 | 4 | 10 | serotonin binding |
GO:0005509 | 6e-04 | 1.8567 | 21.7295 | 38 | 522 | calcium ion binding |
GO:0004993 | 8e-04 | 13.2297 | 0.4579 | 4 | 11 | G-protein coupled serotonin receptor activity |
GO:0004909 | 0.0017 | Inf | 0.0833 | 2 | 2 | interleukin-1, Type I, activating receptor activity |
GO:0005219 | 0.005 | 46.1818 | 0.1249 | 2 | 3 | ryanodine-sensitive calcium-release channel activity |
GO:0102490 | 0.005 | 46.1818 | 0.1249 | 2 | 3 | 8-oxo-dGTP phosphohydrolase activity |
GO:0005216 | 0.0068 | 1.7651 | 15.4438 | 26 | 371 | ion channel activity |
GO:0000062 | 0.0085 | 5.7846 | 0.8325 | 4 | 20 | fatty-acyl-CoA binding |
GO:0016833 | 0.0098 | 23.0894 | 0.1665 | 2 | 4 | oxo-acid-lyase activity |
GO:0016934 | 0.0098 | 23.0894 | 0.1665 | 2 | 4 | extracellularly glycine-gated chloride channel activity |
GO:0031014 | 0.0098 | 23.0894 | 0.1665 | 2 | 4 | troponin T binding |
GO:0032052 | 0.0098 | 23.0894 | 0.1665 | 2 | 4 | bile acid binding |
GO:0048763 | 0.0098 | 23.0894 | 0.1665 | 2 | 4 | calcium-induced calcium release activity |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006721 | 8e-04 | 6.5134 | 1.1444 | 6 | 27 | terpenoid metabolic process |
GO:0061436 | 0.0012 | 11.3694 | 0.5086 | 4 | 12 | establishment of skin barrier |
GO:0006104 | 0.0014 | 22.7074 | 0.2543 | 3 | 6 | succinyl-CoA metabolic process |
GO:0031424 | 0.0017 | 10.1054 | 0.551 | 4 | 13 | keratinization |
GO:0006649 | 0.0018 | Inf | 0.0848 | 2 | 2 | phospholipid transfer to membrane |
GO:0042418 | 0.0018 | Inf | 0.0848 | 2 | 2 | epinephrine biosynthetic process |
GO:0070165 | 0.0018 | Inf | 0.0848 | 2 | 2 | positive regulation of adiponectin secretion |
GO:1902340 | 0.0018 | Inf | 0.0848 | 2 | 2 | negative regulation of chromosome condensation |
GO:0001523 | 0.0019 | 6.6951 | 0.9325 | 5 | 22 | retinoid metabolic process |
GO:0009888 | 0.0022 | 1.4508 | 59.383 | 81 | 1401 | tissue development |
GO:0030388 | 0.0023 | 17.0293 | 0.2967 | 3 | 7 | fructose 1,6-bisphosphate metabolic process |
GO:0051897 | 0.0027 | 3.371 | 2.967 | 9 | 70 | positive regulation of protein kinase B signaling |
GO:0007601 | 0.0028 | 3.0899 | 3.5604 | 10 | 84 | visual perception |
GO:0051928 | 0.0028 | 3.0899 | 3.5604 | 10 | 84 | positive regulation of calcium ion transport |
GO:0030239 | 0.0034 | 3.9906 | 1.9922 | 7 | 47 | myofibril assembly |
GO:0021546 | 0.0036 | 13.6223 | 0.3391 | 3 | 8 | rhombomere development |
GO:0010466 | 0.0037 | 2.6416 | 4.9168 | 12 | 116 | negative regulation of peptidase activity |
GO:0050891 | 0.0042 | 5.4181 | 1.102 | 5 | 26 | multicellular organismal water homeostasis |
GO:0016042 | 0.0048 | 2.1446 | 8.4349 | 17 | 199 | lipid catabolic process |
GO:0031509 | 0.0052 | 45.3416 | 0.1272 | 2 | 3 | telomeric heterochromatin assembly |
GO:0036414 | 0.0052 | 45.3416 | 0.1272 | 2 | 3 | histone citrullination |
GO:0048861 | 0.0052 | 45.3416 | 0.1272 | 2 | 3 | leukemia inhibitory factor signaling pathway |
GO:0048548 | 0.0053 | 11.3511 | 0.3815 | 3 | 9 | regulation of pinocytosis |
GO:0006956 | 0.0061 | 6.4938 | 0.763 | 4 | 18 | complement activation |
GO:0055001 | 0.0061 | 2.3622 | 5.8917 | 13 | 139 | muscle cell development |
GO:0010634 | 0.0069 | 2.6877 | 4.0267 | 10 | 95 | positive regulation of epithelial cell migration |
GO:0038166 | 0.0073 | 9.7287 | 0.4239 | 3 | 10 | angiotensin-activated signaling pathway |
GO:0033599 | 0.0074 | 6.0604 | 0.8053 | 4 | 19 | regulation of mammary gland epithelial cell proliferation |
GO:0048266 | 0.0074 | 6.0604 | 0.8053 | 4 | 19 | behavioral response to pain |
GO:0003008 | 0.0077 | 1.4151 | 49.0408 | 66 | 1157 | system process |
GO:0060986 | 0.0081 | 3.795 | 1.7802 | 6 | 42 | endocrine hormone secretion |
GO:0009913 | 0.0081 | 2.3661 | 5.4254 | 12 | 128 | epidermal cell differentiation |
GO:0015908 | 0.0082 | 3.3234 | 2.3312 | 7 | 55 | fatty acid transport |
GO:0006820 | 0.0085 | 1.7553 | 14.9623 | 25 | 353 | anion transport |
GO:0071715 | 0.0092 | 4.3745 | 1.314 | 5 | 31 | icosanoid transport |
GO:0032310 | 0.0097 | 8.512 | 0.4662 | 3 | 11 | prostaglandin secretion |
GO:0032691 | 0.0097 | 8.512 | 0.4662 | 3 | 11 | negative regulation of interleukin-1 beta production |
GO:0043649 | 0.0097 | 8.512 | 0.4662 | 3 | 11 | dicarboxylic acid catabolic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:2000026 | 0 | 1.6411 | 64.0209 | 96 | 1492 | regulation of multicellular organismal development |
GO:0030431 | 2e-04 | 7.1723 | 1.2444 | 7 | 29 | sleep |
GO:0030168 | 2e-04 | 4.2202 | 3.0037 | 11 | 70 | platelet activation |
GO:0022603 | 2e-04 | 1.7714 | 32.7399 | 54 | 763 | regulation of anatomical structure morphogenesis |
GO:0007631 | 3e-04 | 3.387 | 4.2909 | 13 | 100 | feeding behavior |
GO:0007268 | 4e-04 | 1.9536 | 19.7384 | 36 | 460 | chemical synaptic transmission |
GO:0044057 | 4e-04 | 2.0677 | 16.0911 | 31 | 375 | regulation of system process |
GO:0099537 | 4e-04 | 1.9489 | 19.7813 | 36 | 461 | trans-synaptic signaling |
GO:0006811 | 4e-04 | 1.6907 | 36.1094 | 57 | 855 | ion transport |
GO:0035082 | 7e-04 | 4.748 | 1.9738 | 8 | 46 | axoneme assembly |
GO:0044106 | 7e-04 | 4.748 | 1.9738 | 8 | 46 | cellular amine metabolic process |
GO:0008295 | 7e-04 | 33.6278 | 0.2145 | 3 | 5 | spermidine biosynthetic process |
GO:0007588 | 9e-04 | 5.2564 | 1.5877 | 7 | 37 | excretion |
GO:0030502 | 9e-04 | 12.8281 | 0.472 | 4 | 11 | negative regulation of bone mineralization |
GO:0050482 | 0.001 | 8.0272 | 0.8153 | 5 | 19 | arachidonic acid secretion |
GO:0048870 | 0.0012 | 1.543 | 46.2135 | 67 | 1077 | cell motility |
GO:0006595 | 0.0013 | 11.2237 | 0.5149 | 4 | 12 | polyamine metabolic process |
GO:0072358 | 0.0013 | 1.7643 | 23.4715 | 39 | 547 | cardiovascular system development |
GO:0032501 | 0.0014 | 1.3396 | 151.1744 | 182 | 3772 | multicellular organismal process |
GO:0045187 | 0.0016 | 7.0227 | 0.9011 | 5 | 21 | regulation of circadian sleep/wake cycle, sleep |
GO:0048706 | 0.0018 | 2.7757 | 5.1062 | 13 | 119 | embryonic skeletal system development |
GO:0006597 | 0.0018 | Inf | 0.0858 | 2 | 2 | spermine biosynthetic process |
GO:0010949 | 0.0018 | Inf | 0.0858 | 2 | 2 | negative regulation of intestinal phytosterol absorption |
GO:0042700 | 0.0018 | Inf | 0.0858 | 2 | 2 | luteinizing hormone signaling pathway |
GO:0045796 | 0.0018 | Inf | 0.0858 | 2 | 2 | negative regulation of intestinal cholesterol absorption |
GO:1902340 | 0.0018 | Inf | 0.0858 | 2 | 2 | negative regulation of chromosome condensation |
GO:1904479 | 0.0018 | Inf | 0.0858 | 2 | 2 | negative regulation of intestinal absorption |
GO:0045471 | 0.0019 | 4.5037 | 1.8022 | 7 | 42 | response to ethanol |
GO:0046717 | 0.002 | 3.2722 | 3.3898 | 10 | 79 | acid secretion |
GO:0060285 | 0.002 | 6.6091 | 0.944 | 5 | 22 | cilium-dependent cell motility |
GO:0008291 | 0.0024 | 16.8113 | 0.3004 | 3 | 7 | acetylcholine metabolic process |
GO:0043950 | 0.0024 | 16.8113 | 0.3004 | 3 | 7 | positive regulation of cAMP-mediated signaling |
GO:0008360 | 0.0024 | 2.7969 | 4.6771 | 12 | 109 | regulation of cell shape |
GO:0022410 | 0.0025 | 6.2415 | 0.9869 | 5 | 23 | circadian sleep/wake cycle process |
GO:0006813 | 0.0028 | 2.3398 | 7.3375 | 16 | 171 | potassium ion transport |
GO:0007599 | 0.0029 | 2.6023 | 5.4066 | 13 | 126 | hemostasis |
GO:0048646 | 0.0029 | 1.5478 | 36.8592 | 54 | 859 | anatomical structure formation involved in morphogenesis |
GO:0008306 | 0.0032 | 3.2735 | 3.0466 | 9 | 71 | associative learning |
GO:0051241 | 0.0033 | 1.565 | 33.7244 | 50 | 793 | negative regulation of multicellular organismal process |
GO:0050817 | 0.0034 | 2.5567 | 5.4924 | 13 | 128 | coagulation |
GO:0015849 | 0.0034 | 2.2282 | 8.1528 | 17 | 190 | organic acid transport |
GO:0001662 | 0.0034 | 4.653 | 1.5018 | 6 | 35 | behavioral fear response |
GO:0007155 | 0.0035 | 1.5267 | 38.0178 | 55 | 886 | cell adhesion |
GO:0007218 | 0.0036 | 3.9392 | 2.0167 | 7 | 47 | neuropeptide signaling pathway |
GO:0001763 | 0.0037 | 2.1491 | 8.9252 | 18 | 208 | morphogenesis of a branching structure |
GO:0030948 | 0.0037 | 13.448 | 0.3433 | 3 | 8 | negative regulation of vascular endothelial growth factor receptor signaling pathway |
GO:0098711 | 0.0037 | 13.448 | 0.3433 | 3 | 8 | iron ion import across plasma membrane |
GO:0048514 | 0.0038 | 1.7566 | 18.6227 | 31 | 434 | blood vessel morphogenesis |
GO:0016525 | 0.0039 | 3.4659 | 2.5746 | 8 | 60 | negative regulation of angiogenesis |
GO:0015909 | 0.0039 | 4.4975 | 1.5447 | 6 | 36 | long-chain fatty acid transport |
GO:0007283 | 0.004 | 1.8508 | 14.8467 | 26 | 346 | spermatogenesis |
GO:0001504 | 0.004 | 7.4801 | 0.6866 | 4 | 16 | neurotransmitter uptake |
GO:0045940 | 0.004 | 7.4801 | 0.6866 | 4 | 16 | positive regulation of steroid metabolic process |
GO:0031646 | 0.0044 | 5.3486 | 1.1156 | 5 | 26 | positive regulation of neurological system process |
GO:0048856 | 0.0045 | 1.3216 | 112.2182 | 137 | 2715 | anatomical structure development |
GO:0043270 | 0.0045 | 2.1041 | 9.0968 | 18 | 212 | positive regulation of ion transport |
GO:0009712 | 0.0052 | 4.2158 | 1.6306 | 6 | 38 | catechol-containing compound metabolic process |
GO:0001964 | 0.0053 | 5.105 | 1.1586 | 5 | 27 | startle response |
GO:0021558 | 0.0054 | 44.7622 | 0.1287 | 2 | 3 | trochlear nerve development |
GO:0031509 | 0.0054 | 44.7622 | 0.1287 | 2 | 3 | telomeric heterochromatin assembly |
GO:0046544 | 0.0054 | 44.7622 | 0.1287 | 2 | 3 | development of secondary male sexual characteristics |
GO:0097350 | 0.0054 | 44.7622 | 0.1287 | 2 | 3 | neutrophil clearance |
GO:2001015 | 0.0054 | 44.7622 | 0.1287 | 2 | 3 | negative regulation of skeletal muscle cell differentiation |
GO:0048732 | 0.0054 | 1.8045 | 15.19 | 26 | 354 | gland development |
GO:0019226 | 0.0058 | 3.2173 | 2.7462 | 8 | 64 | transmission of nerve impulse |
GO:0098655 | 0.006 | 1.6957 | 19.2234 | 31 | 448 | cation transmembrane transport |
GO:0009888 | 0.0066 | 1.386 | 60.1162 | 79 | 1401 | tissue development |
GO:0045596 | 0.0066 | 1.6077 | 24.1648 | 37 | 565 | negative regulation of cell differentiation |
GO:0048469 | 0.0068 | 2.3315 | 5.9644 | 13 | 139 | cell maturation |
GO:0055085 | 0.0072 | 1.507 | 33.4265 | 48 | 779 | transmembrane transport |
GO:0007169 | 0.0072 | 1.6882 | 18.6656 | 30 | 435 | transmembrane receptor protein tyrosine kinase signaling pathway |
GO:0042417 | 0.0072 | 4.6789 | 1.2444 | 5 | 29 | dopamine metabolic process |
GO:0042401 | 0.0075 | 9.6042 | 0.4291 | 3 | 10 | cellular biogenic amine biosynthetic process |
GO:0050795 | 0.0077 | 3.053 | 2.8749 | 8 | 67 | regulation of behavior |
GO:0015711 | 0.0078 | 1.9059 | 11.0706 | 20 | 258 | organic anion transport |
GO:0007167 | 0.0079 | 1.9404 | 10.3403 | 19 | 246 | enzyme linked receptor protein signaling pathway |
GO:0034765 | 0.0079 | 1.8139 | 13.3448 | 23 | 311 | regulation of ion transmembrane transport |
GO:0003341 | 0.0079 | 3.3507 | 2.3171 | 7 | 54 | cilium movement |
GO:0007267 | 0.0081 | 1.4298 | 44.7975 | 61 | 1044 | cell-cell signaling |
GO:0051480 | 0.0083 | 2.0153 | 8.9252 | 17 | 208 | regulation of cytosolic calcium ion concentration |
GO:1901343 | 0.0084 | 3.0019 | 2.9178 | 8 | 68 | negative regulation of vasculature development |
GO:0051384 | 0.0088 | 3.2806 | 2.36 | 7 | 55 | response to glucocorticoid |
GO:0097755 | 0.0088 | 3.2806 | 2.36 | 7 | 55 | positive regulation of blood vessel diameter |
GO:0071805 | 0.0089 | 2.3353 | 5.4924 | 12 | 128 | potassium ion transmembrane transport |
GO:0040012 | 0.0089 | 1.528 | 28.7923 | 42 | 671 | regulation of locomotion |
GO:0042127 | 0.009 | 1.3865 | 53.8085 | 71 | 1254 | regulation of cell proliferation |
GO:0007187 | 0.0092 | 2.4329 | 4.8488 | 11 | 113 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO:0002021 | 0.0094 | 5.6083 | 0.8582 | 4 | 20 | response to dietary excess |
GO:0030903 | 0.0094 | 5.6083 | 0.8582 | 4 | 20 | notochord development |
GO:0048754 | 0.0095 | 2.1524 | 6.9084 | 14 | 161 | branching morphogenesis of an epithelial tube |
GO:0003333 | 0.0096 | 4.3183 | 1.3302 | 5 | 31 | amino acid transmembrane transport |
GO:0071715 | 0.0096 | 4.3183 | 1.3302 | 5 | 31 | icosanoid transport |
GO:0061053 | 0.0097 | 2.7033 | 3.6044 | 9 | 84 | somite development |
GO:0035296 | 0.0098 | 2.4091 | 4.8917 | 11 | 114 | regulation of tube diameter |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0019221 | 2e-04 | 2.4557 | 10.6741 | 24 | 219 | cytokine-mediated signaling pathway |
GO:0007186 | 3e-04 | 1.8533 | 24.8576 | 43 | 510 | G-protein coupled receptor signaling pathway |
GO:0001578 | 7e-04 | 3.5627 | 3.5093 | 11 | 72 | microtubule bundle formation |
GO:0060336 | 0.0011 | 29.406 | 0.2437 | 3 | 5 | negative regulation of interferon-gamma-mediated signaling pathway |
GO:0003341 | 0.0011 | 3.944 | 2.632 | 9 | 54 | cilium movement |
GO:0030502 | 0.0014 | 11.2152 | 0.5361 | 4 | 11 | negative regulation of bone mineralization |
GO:0009888 | 0.0017 | 1.4328 | 68.2853 | 92 | 1401 | tissue development |
GO:0034097 | 0.0018 | 1.7156 | 24.7114 | 40 | 507 | response to cytokine |
GO:0016525 | 0.0023 | 3.4784 | 2.9244 | 9 | 60 | negative regulation of angiogenesis |
GO:0009804 | 0.0024 | Inf | 0.0975 | 2 | 2 | coumarin metabolic process |
GO:0015864 | 0.0024 | Inf | 0.0975 | 2 | 2 | pyrimidine nucleoside transport |
GO:1902340 | 0.0024 | Inf | 0.0975 | 2 | 2 | negative regulation of chromosome condensation |
GO:0061053 | 0.0025 | 2.9742 | 4.0942 | 11 | 84 | somite development |
GO:2000026 | 0.0025 | 1.4012 | 72.7206 | 96 | 1492 | regulation of multicellular organismal development |
GO:1900544 | 0.0026 | 2.7882 | 4.7278 | 12 | 97 | positive regulation of purine nucleotide metabolic process |
GO:0044458 | 0.0029 | 6.1384 | 1.0235 | 5 | 21 | motile cilium assembly |
GO:0070286 | 0.0029 | 6.1384 | 1.0235 | 5 | 21 | axonemal dynein complex assembly |
GO:0048646 | 0.0029 | 1.5128 | 41.868 | 60 | 859 | anatomical structure formation involved in morphogenesis |
GO:0006527 | 0.0035 | 14.7007 | 0.3412 | 3 | 7 | arginine catabolic process |
GO:0042268 | 0.0035 | 14.7007 | 0.3412 | 3 | 7 | regulation of cytolysis |
GO:0043950 | 0.0035 | 14.7007 | 0.3412 | 3 | 7 | positive regulation of cAMP-mediated signaling |
GO:0051873 | 0.0035 | 14.7007 | 0.3412 | 3 | 7 | killing by host of symbiont cells |
GO:2001046 | 0.0035 | 14.7007 | 0.3412 | 3 | 7 | positive regulation of integrin-mediated signaling pathway |
GO:0030317 | 0.0037 | 3.2244 | 3.1194 | 9 | 64 | flagellated sperm motility |
GO:0007155 | 0.0037 | 1.4888 | 43.184 | 61 | 886 | cell adhesion |
GO:0055074 | 0.0038 | 1.8893 | 14.0372 | 25 | 288 | calcium ion homeostasis |
GO:0007600 | 0.0039 | 1.738 | 19.4474 | 32 | 399 | sensory perception |
GO:0045987 | 0.004 | 4.5364 | 1.5597 | 6 | 32 | positive regulation of smooth muscle contraction |
GO:0048514 | 0.0043 | 1.6952 | 21.1533 | 34 | 434 | blood vessel morphogenesis |
GO:0006812 | 0.0049 | 1.5034 | 37.7738 | 54 | 775 | cation transport |
GO:0042127 | 0.0049 | 1.397 | 61.1204 | 81 | 1254 | regulation of cell proliferation |
GO:0042221 | 0.0051 | 1.2932 | 121.1198 | 147 | 2485 | response to chemical |
GO:0060740 | 0.0053 | 5.168 | 1.1698 | 5 | 24 | prostate gland epithelium morphogenesis |
GO:0006590 | 0.0054 | 11.7596 | 0.3899 | 3 | 8 | thyroid hormone generation |
GO:0010739 | 0.0054 | 11.7596 | 0.3899 | 3 | 8 | positive regulation of protein kinase A signaling |
GO:0060525 | 0.0054 | 11.7596 | 0.3899 | 3 | 8 | prostate glandular acinus development |
GO:0044259 | 0.0055 | 3.0048 | 3.3143 | 9 | 68 | multicellular organismal macromolecule metabolic process |
GO:1901343 | 0.0055 | 3.0048 | 3.3143 | 9 | 68 | negative regulation of vasculature development |
GO:0022603 | 0.0056 | 1.4973 | 37.1889 | 53 | 763 | regulation of anatomical structure morphogenesis |
GO:0051591 | 0.0057 | 3.6234 | 2.1933 | 7 | 45 | response to cAMP |
GO:0001775 | 0.0057 | 1.5575 | 29.6829 | 44 | 609 | cell activation |
GO:0006952 | 0.0059 | 1.4929 | 37.2864 | 53 | 765 | defense response |
GO:0003008 | 0.0062 | 1.3987 | 56.3926 | 75 | 1157 | system process |
GO:0051480 | 0.0063 | 1.9909 | 10.138 | 19 | 208 | regulation of cytosolic calcium ion concentration |
GO:0008360 | 0.0067 | 2.441 | 5.3127 | 12 | 109 | regulation of cell shape |
GO:0050778 | 0.0069 | 1.7918 | 14.7196 | 25 | 302 | positive regulation of immune response |
GO:0006145 | 0.0069 | 39.1508 | 0.1462 | 2 | 3 | purine nucleobase catabolic process |
GO:0031509 | 0.0069 | 39.1508 | 0.1462 | 2 | 3 | telomeric heterochromatin assembly |
GO:0046544 | 0.0069 | 39.1508 | 0.1462 | 2 | 3 | development of secondary male sexual characteristics |
GO:0070949 | 0.0069 | 39.1508 | 0.1462 | 2 | 3 | regulation of neutrophil mediated killing of symbiont cell |
GO:1903849 | 0.0069 | 39.1508 | 0.1462 | 2 | 3 | positive regulation of aorta morphogenesis |
GO:2000736 | 0.0073 | 3.4417 | 2.2908 | 7 | 47 | regulation of stem cell differentiation |
GO:0002682 | 0.0075 | 1.4776 | 36.8965 | 52 | 757 | regulation of immune system process |
GO:0051818 | 0.0078 | 9.7989 | 0.4387 | 3 | 9 | disruption of cells of other organism involved in symbiotic interaction |
GO:0002888 | 0.008 | 6.0361 | 0.8286 | 4 | 17 | positive regulation of myeloid leukocyte mediated immunity |
GO:0048732 | 0.0081 | 1.7066 | 17.2541 | 28 | 354 | gland development |
GO:0010712 | 0.0084 | 3.8033 | 1.8034 | 6 | 37 | regulation of collagen metabolic process |
GO:0043436 | 0.0086 | 1.5087 | 31.2426 | 45 | 641 | oxoacid metabolic process |
GO:0010719 | 0.009 | 4.4622 | 1.316 | 5 | 27 | negative regulation of epithelial to mesenchymal transition |
GO:0032526 | 0.0092 | 2.9701 | 2.9732 | 8 | 61 | response to retinoic acid |
GO:0030336 | 0.0099 | 2.0269 | 8.3833 | 16 | 172 | negative regulation of cell migration |
GO:0006956 | 0.0099 | 5.6045 | 0.8773 | 4 | 18 | complement activation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0002286 | 1e-04 | 3.9976 | 3.8801 | 13 | 64 | T cell activation involved in immune response |
GO:0002366 | 3e-04 | 2.8603 | 6.6877 | 17 | 111 | leukocyte activation involved in immune response |
GO:0033141 | 3e-04 | 8.5071 | 1.0306 | 6 | 17 | positive regulation of peptidyl-serine phosphorylation of STAT protein |
GO:0034121 | 4e-04 | 4.6893 | 2.3644 | 9 | 39 | regulation of toll-like receptor signaling pathway |
GO:0002323 | 5e-04 | 7.7975 | 1.0913 | 6 | 18 | natural killer cell activation involved in immune response |
GO:0002252 | 6e-04 | 2.2592 | 11.5955 | 24 | 194 | immune effector process |
GO:0030183 | 6e-04 | 2.9046 | 5.8201 | 15 | 96 | B cell differentiation |
GO:0032418 | 7e-04 | 3.9095 | 3.0313 | 10 | 50 | lysosome localization |
GO:0002221 | 0.0012 | 2.9505 | 4.9714 | 13 | 82 | pattern recognition receptor signaling pathway |
GO:0046649 | 0.0013 | 1.7162 | 26.6756 | 43 | 440 | lymphocyte activation |
GO:0002218 | 0.0015 | 2.7416 | 5.6989 | 14 | 94 | activation of innate immune response |
GO:0001775 | 0.0019 | 1.5774 | 36.9215 | 55 | 609 | cell activation |
GO:0006260 | 0.0019 | 2.0074 | 13.3984 | 25 | 221 | DNA replication |
GO:0031349 | 0.002 | 2.1086 | 11.2765 | 22 | 186 | positive regulation of defense response |
GO:0043330 | 0.002 | 4.0284 | 2.3644 | 8 | 39 | response to exogenous dsRNA |
GO:0002697 | 0.0021 | 2.0298 | 12.7316 | 24 | 210 | regulation of immune effector process |
GO:0042100 | 0.0022 | 3.0717 | 4.062 | 11 | 67 | B cell proliferation |
GO:0002757 | 0.0024 | 2.1659 | 10.0034 | 20 | 165 | immune response-activating signal transduction |
GO:0032944 | 0.0026 | 2.3181 | 8.0027 | 17 | 132 | regulation of mononuclear cell proliferation |
GO:0032092 | 0.0032 | 2.6082 | 5.517 | 13 | 91 | positive regulation of protein binding |
GO:0006427 | 0.0037 | Inf | 0.1213 | 2 | 2 | histidyl-tRNA aminoacylation |
GO:0036228 | 0.0037 | Inf | 0.1213 | 2 | 2 | protein localization to nuclear inner membrane |
GO:1903660 | 0.0037 | Inf | 0.1213 | 2 | 2 | negative regulation of complement-dependent cytotoxicity |
GO:2000659 | 0.0037 | Inf | 0.1213 | 2 | 2 | regulation of interleukin-1-mediated signaling pathway |
GO:0070665 | 0.0037 | 2.6811 | 4.9714 | 12 | 82 | positive regulation of leukocyte proliferation |
GO:0035556 | 0.0039 | 1.3089 | 111.5527 | 138 | 1840 | intracellular signal transduction |
GO:0051138 | 0.0039 | 15.5483 | 0.3638 | 3 | 6 | positive regulation of NK T cell differentiation |
GO:0032943 | 0.0039 | 3.2329 | 3.1772 | 9 | 53 | mononuclear cell proliferation |
GO:0006950 | 0.0041 | 1.2782 | 140.3502 | 169 | 2315 | response to stress |
GO:1900017 | 0.0045 | 7.7807 | 0.7275 | 4 | 12 | positive regulation of cytokine production involved in inflammatory response |
GO:0030036 | 0.0045 | 1.5745 | 30.1313 | 45 | 497 | actin cytoskeleton organization |
GO:0050778 | 0.0053 | 1.7362 | 18.3092 | 30 | 302 | positive regulation of immune response |
GO:0006974 | 0.0055 | 1.5054 | 36.3152 | 52 | 599 | cellular response to DNA damage stimulus |
GO:0043030 | 0.0058 | 5.1907 | 1.2125 | 5 | 20 | regulation of macrophage activation |
GO:0050671 | 0.0059 | 2.6444 | 4.6076 | 11 | 76 | positive regulation of lymphocyte proliferation |
GO:0051971 | 0.0065 | 11.6603 | 0.4244 | 3 | 7 | positive regulation of transmission of nerve impulse |
GO:0046634 | 0.0069 | 2.9266 | 3.4557 | 9 | 57 | regulation of alpha-beta T cell activation |
GO:0032438 | 0.0082 | 6.2235 | 0.8488 | 4 | 14 | melanosome organization |
GO:1904262 | 0.0082 | 6.2235 | 0.8488 | 4 | 14 | negative regulation of TORC1 signaling |
GO:0006909 | 0.0083 | 2.2121 | 6.8508 | 14 | 113 | phagocytosis |
GO:0002275 | 0.0087 | 3.0435 | 2.9707 | 8 | 49 | myeloid cell activation involved in immune response |
GO:0048583 | 0.0091 | 1.2393 | 151.6874 | 178 | 2502 | regulation of response to stimulus |
GO:0042129 | 0.0094 | 2.3441 | 5.5776 | 12 | 92 | regulation of T cell proliferation |
GO:0002532 | 0.0095 | 3.3066 | 2.4251 | 7 | 40 | production of molecular mediator involved in inflammatory response |
GO:0001816 | 0.0099 | 1.5445 | 26.4938 | 39 | 437 | cytokine production |
GO:0033262 | 0.0099 | 9.3275 | 0.485 | 3 | 8 | regulation of nuclear cell cycle DNA replication |
GO:0051683 | 0.0099 | 9.3275 | 0.485 | 3 | 8 | establishment of Golgi localization |
GO:2000644 | 0.0099 | 9.3275 | 0.485 | 3 | 8 | regulation of receptor catabolic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:2000145 | 0 | 2.2814 | 29.8195 | 61 | 609 | regulation of cell motility |
GO:0007154 | 0 | 1.6043 | 124.9565 | 174 | 2671 | cell communication |
GO:0023052 | 0 | 1.6021 | 118.0493 | 165 | 2541 | signaling |
GO:0072358 | 0 | 2.1793 | 26.7837 | 53 | 547 | cardiovascular system development |
GO:0001568 | 0 | 2.1784 | 25.2168 | 50 | 515 | blood vessel development |
GO:0042330 | 0 | 2.3544 | 18.7045 | 40 | 382 | taxis |
GO:0060326 | 0 | 3.2013 | 8.1281 | 23 | 166 | cell chemotaxis |
GO:0007186 | 0 | 2.1987 | 21.91 | 44 | 451 | G-protein coupled receptor signaling pathway |
GO:0001578 | 0 | 4.7688 | 3.5255 | 14 | 72 | microtubule bundle formation |
GO:0051271 | 0 | 2.8954 | 9.646 | 25 | 197 | negative regulation of cellular component movement |
GO:0040013 | 0 | 2.8167 | 10.2826 | 26 | 210 | negative regulation of locomotion |
GO:0048870 | 0 | 2.1523 | 21.8174 | 43 | 469 | cell motility |
GO:0007368 | 0 | 3.8129 | 4.8475 | 16 | 99 | determination of left/right symmetry |
GO:0007167 | 0 | 1.8868 | 33.3449 | 58 | 681 | enzyme linked receptor protein signaling pathway |
GO:0045766 | 0 | 3.7672 | 4.8965 | 16 | 100 | positive regulation of angiogenesis |
GO:0120036 | 0 | 1.6579 | 57.6314 | 88 | 1177 | plasma membrane bounded cell projection organization |
GO:0009799 | 0 | 3.5541 | 5.1413 | 16 | 105 | specification of symmetry |
GO:0060485 | 0 | 2.6314 | 10.4784 | 25 | 214 | mesenchyme development |
GO:0048729 | 1e-04 | 1.9451 | 26.6857 | 48 | 545 | tissue morphogenesis |
GO:2000026 | 1e-04 | 1.6101 | 61.2855 | 91 | 1283 | regulation of multicellular organismal development |
GO:0003209 | 1e-04 | 7.1378 | 1.4689 | 8 | 30 | cardiac atrium morphogenesis |
GO:0042127 | 1e-04 | 1.6036 | 61.4017 | 91 | 1254 | regulation of cell proliferation |
GO:1901342 | 1e-04 | 2.6711 | 9.4991 | 23 | 194 | regulation of vasculature development |
GO:0050795 | 1e-04 | 4.2981 | 3.2806 | 12 | 67 | regulation of behavior |
GO:0042551 | 1e-04 | 5.7035 | 1.9586 | 9 | 40 | neuron maturation |
GO:0051174 | 1e-04 | 1.5641 | 64.8781 | 94 | 1325 | regulation of phosphorus metabolic process |
GO:0030336 | 1e-04 | 2.7631 | 7.9982 | 20 | 164 | negative regulation of cell migration |
GO:0050767 | 2e-04 | 1.7589 | 34.8139 | 57 | 711 | regulation of neurogenesis |
GO:0036159 | 2e-04 | 13.9725 | 0.5876 | 5 | 12 | inner dynein arm assembly |
GO:0060688 | 2e-04 | 4.6807 | 2.5462 | 10 | 52 | regulation of morphogenesis of a branching structure |
GO:0007155 | 2e-04 | 2.0384 | 19.0521 | 36 | 400 | cell adhesion |
GO:0010975 | 2e-04 | 1.9531 | 22.0341 | 40 | 450 | regulation of neuron projection development |
GO:0050482 | 2e-04 | 9.038 | 0.9303 | 6 | 19 | arachidonic acid secretion |
GO:0010647 | 2e-04 | 1.5631 | 58.4148 | 85 | 1193 | positive regulation of cell communication |
GO:0003341 | 3e-04 | 4.4672 | 2.6441 | 10 | 54 | cilium movement |
GO:0045981 | 3e-04 | 3.3259 | 4.7496 | 14 | 97 | positive regulation of nucleotide metabolic process |
GO:0030799 | 3e-04 | 3.1486 | 5.3371 | 15 | 109 | regulation of cyclic nucleotide metabolic process |
GO:0007156 | 3e-04 | 4.007 | 3.1827 | 11 | 65 | homophilic cell adhesion via plasma membrane adhesion molecules |
GO:0031344 | 3e-04 | 1.7978 | 28.5954 | 48 | 584 | regulation of cell projection organization |
GO:0051241 | 3e-04 | 1.6506 | 42.1586 | 65 | 861 | negative regulation of multicellular organismal process |
GO:0023056 | 3e-04 | 1.5508 | 58.8065 | 85 | 1201 | positive regulation of signaling |
GO:0007399 | 3e-04 | 1.5345 | 62.4076 | 89 | 1306 | nervous system development |
GO:0003211 | 3e-04 | 19.5361 | 0.3917 | 4 | 8 | cardiac ventricle formation |
GO:0021830 | 3e-04 | 19.5361 | 0.3917 | 4 | 8 | interneuron migration from the subpallium to the cortex |
GO:0045187 | 4e-04 | 7.8317 | 1.0283 | 6 | 21 | regulation of circadian sleep/wake cycle, sleep |
GO:0030431 | 4e-04 | 6.236 | 1.42 | 7 | 29 | sleep |
GO:0051094 | 4e-04 | 1.7646 | 29.1012 | 48 | 609 | positive regulation of developmental process |
GO:0002685 | 4e-04 | 2.9884 | 5.582 | 15 | 114 | regulation of leukocyte migration |
GO:0046113 | 5e-04 | 58.5322 | 0.1959 | 3 | 4 | nucleobase catabolic process |
GO:0010720 | 5e-04 | 1.8422 | 23.7968 | 41 | 486 | positive regulation of cell development |
GO:0098609 | 5e-04 | 1.8422 | 23.7968 | 41 | 486 | cell-cell adhesion |
GO:0071772 | 5e-04 | 2.7293 | 6.855 | 17 | 140 | response to BMP |
GO:0061138 | 5e-04 | 2.4168 | 9.4502 | 21 | 193 | morphogenesis of a branching epithelium |
GO:0010033 | 5e-04 | 1.4275 | 92.0535 | 122 | 1880 | response to organic substance |
GO:0032501 | 6e-04 | 1.3526 | 168.414 | 204 | 3687 | multicellular organismal process |
GO:0070286 | 6e-04 | 15.7399 | 0.4377 | 4 | 9 | axonemal dynein complex assembly |
GO:0021826 | 6e-04 | 15.6276 | 0.4407 | 4 | 9 | substrate-independent telencephalic tangential migration |
GO:0001938 | 6e-04 | 3.9293 | 2.9379 | 10 | 60 | positive regulation of endothelial cell proliferation |
GO:0030509 | 6e-04 | 2.7692 | 6.3654 | 16 | 130 | BMP signaling pathway |
GO:0022410 | 7e-04 | 6.9093 | 1.1262 | 6 | 23 | circadian sleep/wake cycle process |
GO:0003012 | 7e-04 | 2.102 | 13.808 | 27 | 282 | muscle system process |
GO:0045666 | 7e-04 | 1.9655 | 17.4314 | 32 | 356 | positive regulation of neuron differentiation |
GO:2001026 | 8e-04 | 8.8888 | 0.7834 | 5 | 16 | regulation of endothelial cell chemotaxis |
GO:0023061 | 8e-04 | 1.9409 | 17.6273 | 32 | 360 | signal release |
GO:0060740 | 8e-04 | 6.5249 | 1.1752 | 6 | 24 | prostate gland epithelium morphogenesis |
GO:0045595 | 9e-04 | 1.6141 | 38.9534 | 59 | 822 | regulation of cell differentiation |
GO:0060562 | 9e-04 | 1.9808 | 16.2073 | 30 | 331 | epithelial tube morphogenesis |
GO:0071621 | 9e-04 | 3.706 | 3.0848 | 10 | 63 | granulocyte chemotaxis |
GO:0007266 | 9e-04 | 2.6518 | 6.6102 | 16 | 135 | Rho protein signal transduction |
GO:0010632 | 9e-04 | 2.561 | 7.2468 | 17 | 148 | regulation of epithelial cell migration |
GO:1900542 | 0.001 | 2.4682 | 7.9323 | 18 | 162 | regulation of purine nucleotide metabolic process |
GO:0006925 | 0.001 | 8.1474 | 0.8324 | 5 | 17 | inflammatory cell apoptotic process |
GO:1903365 | 0.0011 | 29.2638 | 0.2448 | 3 | 5 | regulation of fear response |
GO:0003156 | 0.0011 | 5.0792 | 1.6648 | 7 | 34 | regulation of animal organ formation |
GO:0019221 | 0.0011 | 2.2097 | 10.7233 | 22 | 219 | cytokine-mediated signaling pathway |
GO:0006939 | 0.0012 | 3.1053 | 4.3089 | 12 | 88 | smooth muscle contraction |
GO:0007622 | 0.0012 | 4.3572 | 2.1544 | 8 | 44 | rhythmic behavior |
GO:0070374 | 0.0013 | 2.5648 | 6.8061 | 16 | 139 | positive regulation of ERK1 and ERK2 cascade |
GO:0023014 | 0.0013 | 1.6812 | 29.036 | 46 | 593 | signal transduction by protein phosphorylation |
GO:0006182 | 0.0013 | 5.8715 | 1.2731 | 6 | 26 | cGMP biosynthetic process |
GO:0022603 | 0.0014 | 1.9418 | 15.9364 | 29 | 335 | regulation of anatomical structure morphogenesis |
GO:1903530 | 0.0014 | 1.7177 | 25.9513 | 42 | 530 | regulation of secretion by cell |
GO:0009914 | 0.0014 | 2.0464 | 13.0736 | 25 | 267 | hormone transport |
GO:0035556 | 0.0015 | 1.5056 | 51.6211 | 73 | 1090 | intracellular signal transduction |
GO:0015909 | 0.0016 | 4.7281 | 1.7627 | 7 | 36 | long-chain fatty acid transport |
GO:0007160 | 0.0016 | 2.5031 | 6.953 | 16 | 142 | cell-matrix adhesion |
GO:0048562 | 0.0016 | 2.0293 | 13.1715 | 25 | 269 | embryonic organ morphogenesis |
GO:0048584 | 0.0016 | 1.4345 | 68.2077 | 92 | 1393 | positive regulation of response to stimulus |
GO:0001964 | 0.0016 | 5.5915 | 1.322 | 6 | 27 | startle response |
GO:0051962 | 0.0017 | 1.7386 | 23.7968 | 39 | 486 | positive regulation of nervous system development |
GO:0001516 | 0.0018 | 6.9824 | 0.9303 | 5 | 19 | prostaglandin biosynthetic process |
GO:0050921 | 0.0019 | 2.9125 | 4.5537 | 12 | 93 | positive regulation of chemotaxis |
GO:0055008 | 0.0019 | 3.6032 | 2.8399 | 9 | 58 | cardiac muscle tissue morphogenesis |
GO:0050906 | 0.0021 | 3.2718 | 3.4275 | 10 | 70 | detection of stimulus involved in sensory perception |
GO:0045937 | 0.0021 | 1.5762 | 36.2493 | 54 | 751 | positive regulation of phosphate metabolic process |
GO:0060586 | 0.0021 | 19.5077 | 0.2938 | 3 | 6 | multicellular organismal iron ion homeostasis |
GO:0060638 | 0.0021 | 19.5077 | 0.2938 | 3 | 6 | mesenchymal-epithelial cell signaling |
GO:0001947 | 0.0021 | 3.9202 | 2.3503 | 8 | 48 | heart looping |
GO:0097696 | 0.0022 | 2.5995 | 5.8758 | 14 | 120 | STAT cascade |
GO:0010862 | 0.0022 | 4.4224 | 1.8607 | 7 | 38 | positive regulation of pathway-restricted SMAD protein phosphorylation |
GO:0030850 | 0.0022 | 4.4224 | 1.8607 | 7 | 38 | prostate gland development |
GO:0048871 | 0.0022 | 2.0801 | 11.3128 | 22 | 232 | multicellular organismal homeostasis |
GO:0003002 | 0.0022 | 1.8943 | 15.7176 | 28 | 321 | regionalization |
GO:0032879 | 0.0022 | 1.3541 | 99.3493 | 126 | 2029 | regulation of localization |
GO:0090022 | 0.0023 | 6.5164 | 0.9793 | 5 | 20 | regulation of neutrophil chemotaxis |
GO:0003165 | 0.0024 | Inf | 0.0979 | 2 | 2 | Purkinje myocyte development |
GO:0009115 | 0.0024 | Inf | 0.0979 | 2 | 2 | xanthine catabolic process |
GO:0021524 | 0.0024 | Inf | 0.0979 | 2 | 2 | visceral motor neuron differentiation |
GO:0021842 | 0.0024 | Inf | 0.0979 | 2 | 2 | chemorepulsion involved in interneuron migration from the subpallium to the cortex |
GO:0060577 | 0.0024 | Inf | 0.0979 | 2 | 2 | pulmonary vein morphogenesis |
GO:0097325 | 0.0024 | Inf | 0.0979 | 2 | 2 | melanocyte proliferation |
GO:1902725 | 0.0024 | Inf | 0.0979 | 2 | 2 | negative regulation of satellite cell differentiation |
GO:2000987 | 0.0024 | Inf | 0.0979 | 2 | 2 | positive regulation of behavioral fear response |
GO:0071363 | 0.0024 | 1.7377 | 21.9362 | 36 | 448 | cellular response to growth factor stimulus |
GO:0030816 | 0.0024 | 3.4614 | 2.9379 | 9 | 60 | positive regulation of cAMP metabolic process |
GO:0048666 | 0.0024 | 1.5171 | 43.2055 | 62 | 892 | neuron development |
GO:0030036 | 0.0025 | 1.6953 | 24.3354 | 39 | 497 | actin cytoskeleton organization |
GO:0009968 | 0.0025 | 1.5475 | 38.2416 | 56 | 789 | negative regulation of signal transduction |
GO:0022604 | 0.0025 | 1.7946 | 18.9004 | 32 | 386 | regulation of cell morphogenesis |
GO:0046888 | 0.0025 | 3.1658 | 3.5255 | 10 | 72 | negative regulation of hormone secretion |
GO:0046903 | 0.0026 | 1.5708 | 34.971 | 52 | 721 | secretion |
GO:0090132 | 0.0026 | 2.1798 | 9.3522 | 19 | 191 | epithelium migration |
GO:0001525 | 0.0028 | 2.0777 | 10.7976 | 21 | 225 | angiogenesis |
GO:0001764 | 0.0028 | 2.431 | 6.6814 | 15 | 137 | neuron migration |
GO:0007190 | 0.0029 | 8.6793 | 0.6365 | 4 | 13 | activation of adenylate cyclase activity |
GO:0060973 | 0.0029 | 8.6793 | 0.6365 | 4 | 13 | cell migration involved in heart development |
GO:0097154 | 0.0029 | 8.6793 | 0.6365 | 4 | 13 | GABAergic neuron differentiation |
GO:0010573 | 0.0029 | 6.1087 | 1.0283 | 5 | 21 | vascular endothelial growth factor production |
GO:0045117 | 0.0029 | 6.1087 | 1.0283 | 5 | 21 | azole transport |
GO:1903429 | 0.0029 | 6.1087 | 1.0283 | 5 | 21 | regulation of cell maturation |
GO:0051896 | 0.003 | 2.6084 | 5.4351 | 13 | 111 | regulation of protein kinase B signaling |
GO:0006954 | 0.0032 | 1.8025 | 17.6273 | 30 | 360 | inflammatory response |
GO:0030808 | 0.0032 | 2.7104 | 4.8475 | 12 | 99 | regulation of nucleotide biosynthetic process |
GO:0001667 | 0.0033 | 2.0077 | 11.6753 | 22 | 240 | ameboidal-type cell migration |
GO:0050896 | 0.0033 | 1.2822 | 182.7025 | 213 | 3889 | response to stimulus |
GO:0030804 | 0.0034 | 3.2683 | 3.0848 | 9 | 63 | positive regulation of cyclic nucleotide biosynthetic process |
GO:0021983 | 0.0035 | 4.6953 | 1.5179 | 6 | 31 | pituitary gland development |
GO:0071715 | 0.0035 | 4.6953 | 1.5179 | 6 | 31 | icosanoid transport |
GO:0030335 | 0.0035 | 1.807 | 16.9907 | 29 | 347 | positive regulation of cell migration |
GO:0002741 | 0.0035 | 14.6296 | 0.3428 | 3 | 7 | positive regulation of cytokine secretion involved in immune response |
GO:0016338 | 0.0035 | 14.6296 | 0.3428 | 3 | 7 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules |
GO:0021894 | 0.0035 | 14.6296 | 0.3428 | 3 | 7 | cerebral cortex GABAergic interneuron development |
GO:0021902 | 0.0035 | 14.6296 | 0.3428 | 3 | 7 | commitment of neuronal cell to specific neuron type in forebrain |
GO:0051823 | 0.0035 | 14.6296 | 0.3428 | 3 | 7 | regulation of synapse structural plasticity |
GO:2001046 | 0.0035 | 14.6296 | 0.3428 | 3 | 7 | positive regulation of integrin-mediated signaling pathway |
GO:0060285 | 0.0036 | 5.7489 | 1.0772 | 5 | 22 | cilium-dependent cell motility |
GO:0009653 | 0.0037 | 1.4888 | 44.0654 | 62 | 961 | anatomical structure morphogenesis |
GO:0007268 | 0.0037 | 1.6869 | 22.5237 | 36 | 460 | chemical synaptic transmission |
GO:0065008 | 0.0038 | 1.3032 | 123.8316 | 151 | 2529 | regulation of biological quality |
GO:0099537 | 0.0038 | 1.6828 | 22.5727 | 36 | 461 | trans-synaptic signaling |
GO:0003161 | 0.0038 | 7.8108 | 0.6855 | 4 | 14 | cardiac conduction system development |
GO:0051216 | 0.0039 | 2.2667 | 7.5895 | 16 | 155 | cartilage development |
GO:0030031 | 0.004 | 1.734 | 19.4879 | 32 | 398 | cell projection assembly |
GO:0014033 | 0.0042 | 3.1511 | 3.1827 | 9 | 65 | neural crest cell differentiation |
GO:2001236 | 0.0043 | 2.3943 | 6.3164 | 14 | 129 | regulation of extrinsic apoptotic signaling pathway |
GO:0090101 | 0.0044 | 2.7336 | 4.4068 | 11 | 90 | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:1902533 | 0.0044 | 1.5442 | 33.3939 | 49 | 682 | positive regulation of intracellular signal transduction |
GO:0043408 | 0.0044 | 1.6202 | 26.0002 | 40 | 531 | regulation of MAPK cascade |
GO:0002793 | 0.0046 | 2.0584 | 9.8419 | 19 | 201 | positive regulation of peptide secretion |
GO:0042325 | 0.0047 | 1.4183 | 55.7218 | 75 | 1138 | regulation of phosphorylation |
GO:0010941 | 0.0049 | 1.387 | 64.6333 | 85 | 1320 | regulation of cell death |
GO:0071495 | 0.005 | 1.4857 | 40.3469 | 57 | 824 | cellular response to endogenous stimulus |
GO:0030817 | 0.005 | 2.8431 | 3.8682 | 10 | 79 | regulation of cAMP biosynthetic process |
GO:0046717 | 0.005 | 2.8431 | 3.8682 | 10 | 79 | acid secretion |
GO:0051272 | 0.0051 | 1.7375 | 18.2148 | 30 | 372 | positive regulation of cellular component movement |
GO:0001756 | 0.0052 | 3.042 | 3.2806 | 9 | 67 | somitogenesis |
GO:0035050 | 0.0052 | 3.042 | 3.2806 | 9 | 67 | embryonic heart tube development |
GO:0033032 | 0.0054 | 5.1429 | 1.1752 | 5 | 24 | regulation of myeloid cell apoptotic process |
GO:0032352 | 0.0054 | 11.7028 | 0.3917 | 3 | 8 | positive regulation of hormone metabolic process |
GO:2001223 | 0.0054 | 11.7028 | 0.3917 | 3 | 8 | negative regulation of neuron migration |
GO:0015696 | 0.0055 | 2.8022 | 3.9172 | 10 | 80 | ammonium transport |
GO:0010721 | 0.0055 | 1.8521 | 13.7101 | 24 | 280 | negative regulation of cell development |
GO:0044057 | 0.0057 | 1.722 | 18.3617 | 30 | 375 | regulation of system process |
GO:0003231 | 0.0058 | 2.3873 | 5.8758 | 13 | 120 | cardiac ventricle development |
GO:0032101 | 0.0059 | 1.6454 | 22.3768 | 35 | 457 | regulation of response to external stimulus |
GO:0001819 | 0.006 | 1.8961 | 12.2901 | 22 | 251 | positive regulation of cytokine production |
GO:0014902 | 0.006 | 2.7625 | 3.9661 | 10 | 81 | myotube differentiation |
GO:0019935 | 0.006 | 2.7625 | 3.9661 | 10 | 81 | cyclic-nucleotide-mediated signaling |
GO:0021510 | 0.006 | 2.7625 | 3.9661 | 10 | 81 | spinal cord development |
GO:0070887 | 0.0062 | 1.3406 | 79.604 | 101 | 1664 | cellular response to chemical stimulus |
GO:1900373 | 0.0063 | 2.9401 | 3.3786 | 9 | 69 | positive regulation of purine nucleotide biosynthetic process |
GO:0045596 | 0.0064 | 1.8275 | 13.8755 | 24 | 288 | negative regulation of cell differentiation |
GO:0001504 | 0.0065 | 6.5079 | 0.7834 | 4 | 16 | neurotransmitter uptake |
GO:0018149 | 0.0065 | 6.5079 | 0.7834 | 4 | 16 | peptide cross-linking |
GO:0051953 | 0.0065 | 4.8854 | 1.2241 | 5 | 25 | negative regulation of amine transport |
GO:0050679 | 0.0066 | 2.7179 | 4.02 | 10 | 83 | positive regulation of epithelial cell proliferation |
GO:0030168 | 0.0069 | 2.8917 | 3.4275 | 9 | 70 | platelet activation |
GO:0006811 | 0.0069 | 1.4072 | 52.2453 | 70 | 1067 | ion transport |
GO:0002442 | 0.0069 | 38.9617 | 0.1469 | 2 | 3 | serotonin secretion involved in inflammatory response |
GO:0003350 | 0.0069 | 38.9617 | 0.1469 | 2 | 3 | pulmonary myocardium development |
GO:0007171 | 0.0069 | 38.9617 | 0.1469 | 2 | 3 | activation of transmembrane receptor protein tyrosine kinase activity |
GO:0035993 | 0.0069 | 38.9617 | 0.1469 | 2 | 3 | deltoid tuberosity development |
GO:0046544 | 0.0069 | 38.9617 | 0.1469 | 2 | 3 | development of secondary male sexual characteristics |
GO:1902566 | 0.0069 | 38.9617 | 0.1469 | 2 | 3 | regulation of eosinophil activation |
GO:2000110 | 0.0069 | 38.9617 | 0.1469 | 2 | 3 | negative regulation of macrophage apoptotic process |
GO:0009582 | 0.0071 | 2.6864 | 4.0641 | 10 | 83 | detection of abiotic stimulus |
GO:0022612 | 0.0072 | 2.3217 | 6.0227 | 13 | 123 | gland morphogenesis |
GO:0001755 | 0.0075 | 3.9112 | 1.7627 | 6 | 36 | neural crest cell migration |
GO:0002209 | 0.0075 | 3.9112 | 1.7627 | 6 | 36 | behavioral defense response |
GO:0021953 | 0.0076 | 2.0404 | 8.8626 | 17 | 181 | central nervous system neuron differentiation |
GO:0007200 | 0.0077 | 3.072 | 2.8889 | 8 | 59 | phospholipase C-activating G-protein coupled receptor signaling pathway |
GO:0006692 | 0.0077 | 4.6524 | 1.2731 | 5 | 26 | prostanoid metabolic process |
GO:0031646 | 0.0077 | 4.6524 | 1.2731 | 5 | 26 | positive regulation of neurological system process |
GO:0060343 | 0.0077 | 4.6524 | 1.2731 | 5 | 26 | trabecula formation |
GO:0009581 | 0.0078 | 2.6499 | 4.113 | 10 | 84 | detection of external stimulus |
GO:0030277 | 0.0079 | 9.7515 | 0.4407 | 3 | 9 | maintenance of gastrointestinal epithelium |
GO:0034755 | 0.0079 | 9.7515 | 0.4407 | 3 | 9 | iron ion transmembrane transport |
GO:0035641 | 0.0079 | 9.7515 | 0.4407 | 3 | 9 | locomotory exploration behavior |
GO:0051967 | 0.0079 | 9.7515 | 0.4407 | 3 | 9 | negative regulation of synaptic transmission, glutamatergic |
GO:1902950 | 0.0079 | 9.7515 | 0.4407 | 3 | 9 | regulation of dendritic spine maintenance |
GO:0061053 | 0.0079 | 6.0633 | 0.8251 | 4 | 17 | somite development |
GO:0046425 | 0.0081 | 2.3796 | 5.4351 | 12 | 111 | regulation of JAK-STAT cascade |
GO:0001780 | 0.0081 | 6.0069 | 0.8324 | 4 | 17 | neutrophil homeostasis |
GO:1905276 | 0.0081 | 6.0069 | 0.8324 | 4 | 17 | regulation of epithelial tube formation |
GO:0007423 | 0.0085 | 1.6116 | 22.132 | 34 | 452 | sensory organ development |
GO:0010595 | 0.0085 | 3.0127 | 2.9379 | 8 | 60 | positive regulation of endothelial cell migration |
GO:0010712 | 0.0086 | 3.7848 | 1.8117 | 6 | 37 | regulation of collagen metabolic process |
GO:0048010 | 0.0086 | 3.7848 | 1.8117 | 6 | 37 | vascular endothelial growth factor receptor signaling pathway |
GO:0030073 | 0.0088 | 2.057 | 8.275 | 16 | 169 | insulin secretion |
GO:0045165 | 0.0088 | 2.0049 | 9.001 | 17 | 185 | cell fate commitment |
GO:0009792 | 0.0089 | 1.513 | 30.456 | 44 | 622 | embryo development ending in birth or egg hatching |
GO:0001934 | 0.0089 | 1.4922 | 32.9854 | 47 | 679 | positive regulation of protein phosphorylation |
GO:0060078 | 0.009 | 2.7555 | 3.5744 | 9 | 73 | regulation of postsynaptic membrane potential |
GO:0030198 | 0.0091 | 2.1064 | 7.5895 | 15 | 155 | extracellular matrix organization |
GO:2001240 | 0.0091 | 4.4406 | 1.322 | 5 | 27 | negative regulation of extrinsic apoptotic signaling pathway in absence of ligand |
GO:0044236 | 0.0091 | 2.5798 | 4.211 | 10 | 86 | multicellular organism metabolic process |
GO:0048468 | 0.0092 | 1.5524 | 26.3673 | 39 | 570 | cell development |
GO:0006029 | 0.0094 | 3.2613 | 2.3993 | 7 | 49 | proteoglycan metabolic process |
GO:0021885 | 0.0094 | 2.9556 | 2.9868 | 8 | 61 | forebrain cell migration |
GO:0007623 | 0.0096 | 2.0913 | 7.6385 | 15 | 156 | circadian rhythm |
GO:0007631 | 0.0096 | 2.4245 | 4.8965 | 11 | 100 | feeding behavior |
GO:0035637 | 0.0096 | 2.4245 | 4.8965 | 11 | 100 | multicellular organismal signaling |
GO:0001569 | 0.0097 | 3.6662 | 1.8607 | 6 | 38 | branching involved in blood vessel morphogenesis |
GO:0001709 | 0.0097 | 3.6662 | 1.8607 | 6 | 38 | cell fate determination |
GO:0006813 | 0.0098 | 2.0301 | 8.373 | 16 | 171 | potassium ion transport |
GO:0048644 | 0.0099 | 2.7129 | 3.6234 | 9 | 74 | muscle organ morphogenesis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0032026 | 1e-04 | 33.6896 | 0.2684 | 4 | 7 | response to magnesium ion |
GO:0008295 | 5e-04 | 37.8294 | 0.1917 | 3 | 5 | spermidine biosynthetic process |
GO:0030317 | 7e-04 | 4.1588 | 2.4544 | 9 | 64 | flagellated sperm motility |
GO:0048240 | 8e-04 | 8.4311 | 0.767 | 5 | 20 | sperm capacitation |
GO:0006732 | 9e-04 | 2.4109 | 8.4752 | 19 | 221 | coenzyme metabolic process |
GO:0003341 | 0.001 | 4.4143 | 2.0709 | 8 | 54 | cilium movement |
GO:0048598 | 0.0011 | 1.8282 | 20.9388 | 36 | 546 | embryonic morphogenesis |
GO:0009886 | 0.0012 | 11.2246 | 0.4985 | 4 | 13 | post-embryonic animal morphogenesis |
GO:0006597 | 0.0015 | Inf | 0.0767 | 2 | 2 | spermine biosynthetic process |
GO:0016031 | 0.0015 | Inf | 0.0767 | 2 | 2 | tRNA import into mitochondrion |
GO:0016332 | 0.0015 | Inf | 0.0767 | 2 | 2 | establishment or maintenance of polarity of embryonic epithelium |
GO:0042700 | 0.0015 | Inf | 0.0767 | 2 | 2 | luteinizing hormone signaling pathway |
GO:0060435 | 0.0015 | Inf | 0.0767 | 2 | 2 | bronchiole development |
GO:0070096 | 0.0015 | Inf | 0.0767 | 2 | 2 | mitochondrial outer membrane translocase complex assembly |
GO:1904970 | 0.0015 | Inf | 0.0767 | 2 | 2 | brush border assembly |
GO:2001046 | 0.0017 | 18.9118 | 0.2684 | 3 | 7 | positive regulation of integrin-mediated signaling pathway |
GO:0009888 | 0.0026 | 1.4655 | 53.7275 | 74 | 1401 | tissue development |
GO:0048515 | 0.0029 | 2.7271 | 4.7553 | 12 | 124 | spermatid differentiation |
GO:0009612 | 0.0038 | 2.769 | 4.2951 | 11 | 112 | response to mechanical stimulus |
GO:0006110 | 0.0038 | 5.4951 | 1.0738 | 5 | 28 | regulation of glycolytic process |
GO:0030728 | 0.0043 | 7.213 | 0.6903 | 4 | 18 | ovulation |
GO:0033026 | 0.0043 | 50.3444 | 0.115 | 2 | 3 | negative regulation of mast cell apoptotic process |
GO:0042732 | 0.0043 | 50.3444 | 0.115 | 2 | 3 | D-xylose metabolic process |
GO:0046544 | 0.0043 | 50.3444 | 0.115 | 2 | 3 | development of secondary male sexual characteristics |
GO:2000328 | 0.0043 | 50.3444 | 0.115 | 2 | 3 | regulation of T-helper 17 cell lineage commitment |
GO:0061180 | 0.0043 | 3.3806 | 2.6078 | 8 | 68 | mammary gland epithelium development |
GO:0016052 | 0.0044 | 3.0864 | 3.183 | 9 | 83 | carbohydrate catabolic process |
GO:0046660 | 0.0053 | 2.7905 | 3.8733 | 10 | 101 | female sex differentiation |
GO:0032536 | 0.0055 | 10.8042 | 0.3835 | 3 | 10 | regulation of cell projection size |
GO:0042401 | 0.0055 | 10.8042 | 0.3835 | 3 | 10 | cellular biogenic amine biosynthetic process |
GO:0051606 | 0.0057 | 2.4811 | 5.1772 | 12 | 135 | detection of stimulus |
GO:0008585 | 0.006 | 2.9272 | 3.3364 | 9 | 87 | female gonad development |
GO:0071622 | 0.0061 | 4.8599 | 1.1888 | 5 | 31 | regulation of granulocyte chemotaxis |
GO:0071559 | 0.007 | 2.3129 | 5.9825 | 13 | 156 | response to transforming growth factor beta |
GO:0046031 | 0.0071 | 3.4085 | 2.2626 | 7 | 59 | ADP metabolic process |
GO:0006090 | 0.0072 | 3.0718 | 2.8379 | 8 | 74 | pyruvate metabolic process |
GO:0002295 | 0.0073 | 9.4529 | 0.4218 | 3 | 11 | T-helper cell lineage commitment |
GO:0035584 | 0.0073 | 9.4529 | 0.4218 | 3 | 11 | calcium-mediated signaling using intracellular calcium source |
GO:0048541 | 0.0073 | 9.4529 | 0.4218 | 3 | 11 | Peyer's patch development |
GO:0072539 | 0.0073 | 9.4529 | 0.4218 | 3 | 11 | T-helper 17 cell differentiation |
GO:0030823 | 0.0076 | 5.9387 | 0.8053 | 4 | 21 | regulation of cGMP metabolic process |
GO:0007281 | 0.0077 | 2.0807 | 8.1301 | 16 | 212 | germ cell development |
GO:0071363 | 0.0077 | 1.7105 | 17.1805 | 28 | 448 | cellular response to growth factor stimulus |
GO:0001545 | 0.0084 | 25.1703 | 0.1534 | 2 | 4 | primary ovarian follicle growth |
GO:0033023 | 0.0084 | 25.1703 | 0.1534 | 2 | 4 | mast cell homeostasis |
GO:0050847 | 0.0084 | 25.1703 | 0.1534 | 2 | 4 | progesterone receptor signaling pathway |
GO:0060482 | 0.0084 | 25.1703 | 0.1534 | 2 | 4 | lobar bronchus development |
GO:0060535 | 0.0084 | 25.1703 | 0.1534 | 2 | 4 | trachea cartilage morphogenesis |
GO:0070668 | 0.0084 | 25.1703 | 0.1534 | 2 | 4 | positive regulation of mast cell proliferation |
GO:0090315 | 0.0084 | 25.1703 | 0.1534 | 2 | 4 | negative regulation of protein targeting to membrane |
GO:2000741 | 0.0084 | 25.1703 | 0.1534 | 2 | 4 | positive regulation of mesenchymal stem cell differentiation |
GO:2001257 | 0.0085 | 2.5898 | 4.1417 | 10 | 108 | regulation of cation channel activity |
GO:0060285 | 0.009 | 5.6084 | 0.8437 | 4 | 22 | cilium-dependent cell motility |
GO:0042698 | 0.0092 | 2.9376 | 2.9529 | 8 | 77 | ovulation cycle |
GO:0002070 | 0.0095 | 8.402 | 0.4602 | 3 | 12 | epithelial cell maturation |
GO:0006595 | 0.0095 | 8.402 | 0.4602 | 3 | 12 | polyamine metabolic process |
GO:0006958 | 0.0095 | 8.402 | 0.4602 | 3 | 12 | complement activation, classical pathway |
GO:0048732 | 0.0097 | 1.7773 | 13.5757 | 23 | 354 | gland development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0030317 | 0 | 5.7731 | 2.263 | 11 | 64 | flagellated sperm motility |
GO:0033141 | 0 | 15.059 | 0.6011 | 6 | 17 | positive regulation of peptidyl-serine phosphorylation of STAT protein |
GO:0002323 | 0 | 13.803 | 0.6365 | 6 | 18 | natural killer cell activation involved in immune response |
GO:0006959 | 0 | 4.9316 | 2.5812 | 11 | 73 | humoral immune response |
GO:0001539 | 1e-04 | 10.349 | 0.7779 | 6 | 22 | cilium or flagellum-dependent cell motility |
GO:0046425 | 1e-04 | 3.6929 | 3.9249 | 13 | 111 | regulation of JAK-STAT cascade |
GO:0097696 | 3e-04 | 3.3799 | 4.2431 | 13 | 120 | STAT cascade |
GO:0008295 | 4e-04 | 41.1766 | 0.1768 | 3 | 5 | spermidine biosynthetic process |
GO:0014816 | 8e-04 | 27.4489 | 0.2122 | 3 | 6 | skeletal muscle satellite cell differentiation |
GO:0007276 | 0.0012 | 1.932 | 16.5127 | 30 | 467 | gamete generation |
GO:0001971 | 0.0012 | Inf | 0.0707 | 2 | 2 | negative regulation of activation of membrane attack complex |
GO:0006597 | 0.0012 | Inf | 0.0707 | 2 | 2 | spermine biosynthetic process |
GO:0010749 | 0.0012 | Inf | 0.0707 | 2 | 2 | regulation of nitric oxide mediated signal transduction |
GO:0015817 | 0.0012 | Inf | 0.0707 | 2 | 2 | histidine transport |
GO:0016031 | 0.0012 | Inf | 0.0707 | 2 | 2 | tRNA import into mitochondrion |
GO:0042700 | 0.0012 | Inf | 0.0707 | 2 | 2 | luteinizing hormone signaling pathway |
GO:0070096 | 0.0012 | Inf | 0.0707 | 2 | 2 | mitochondrial outer membrane translocase complex assembly |
GO:1904970 | 0.0012 | Inf | 0.0707 | 2 | 2 | brush border assembly |
GO:0007283 | 0.0013 | 2.0886 | 12.2343 | 24 | 346 | spermatogenesis |
GO:0072376 | 0.0013 | 7.2453 | 0.8486 | 5 | 24 | protein activation cascade |
GO:0006000 | 0.0014 | 20.5851 | 0.2475 | 3 | 7 | fructose metabolic process |
GO:0060294 | 0.002 | 9.1628 | 0.5657 | 4 | 16 | cilium movement involved in cell motility |
GO:0043330 | 0.0023 | 5.0111 | 1.379 | 6 | 39 | response to exogenous dsRNA |
GO:0016052 | 0.0026 | 3.3629 | 2.9348 | 9 | 83 | carbohydrate catabolic process |
GO:0022412 | 0.0026 | 2.1221 | 10.0067 | 20 | 283 | cellular process involved in reproduction in multicellular organism |
GO:0030728 | 0.0032 | 7.8526 | 0.6365 | 4 | 18 | ovulation |
GO:0071467 | 0.0032 | 7.8526 | 0.6365 | 4 | 18 | cellular response to pH |
GO:0008585 | 0.0036 | 3.1895 | 3.0763 | 9 | 87 | female gonad development |
GO:0002578 | 0.0037 | 54.7898 | 0.1061 | 2 | 3 | negative regulation of antigen processing and presentation |
GO:0033026 | 0.0037 | 54.7898 | 0.1061 | 2 | 3 | negative regulation of mast cell apoptotic process |
GO:0046544 | 0.0037 | 54.7898 | 0.1061 | 2 | 3 | development of secondary male sexual characteristics |
GO:1990918 | 0.0037 | 54.7898 | 0.1061 | 2 | 3 | double-strand break repair involved in meiotic recombination |
GO:0042401 | 0.0044 | 11.7602 | 0.3536 | 3 | 10 | cellular biogenic amine biosynthetic process |
GO:1903818 | 0.0044 | 11.7602 | 0.3536 | 3 | 10 | positive regulation of voltage-gated potassium channel activity |
GO:0044703 | 0.0045 | 1.6632 | 22.8067 | 36 | 645 | multi-organism reproductive process |
GO:0046031 | 0.0046 | 3.7126 | 2.0862 | 7 | 59 | ADP metabolic process |
GO:0042698 | 0.0057 | 3.2002 | 2.7227 | 8 | 77 | ovulation cycle |
GO:0030823 | 0.0057 | 6.4653 | 0.7425 | 4 | 21 | regulation of cGMP metabolic process |
GO:0006140 | 0.0064 | 2.3398 | 5.905 | 13 | 167 | regulation of nucleotide metabolic process |
GO:0030804 | 0.0066 | 3.4464 | 2.2276 | 7 | 63 | positive regulation of cyclic nucleotide biosynthetic process |
GO:0001545 | 0.0071 | 27.3928 | 0.1414 | 2 | 4 | primary ovarian follicle growth |
GO:0010989 | 0.0071 | 27.3928 | 0.1414 | 2 | 4 | negative regulation of low-density lipoprotein particle clearance |
GO:0031284 | 0.0071 | 27.3928 | 0.1414 | 2 | 4 | positive regulation of guanylate cyclase activity |
GO:0033023 | 0.0071 | 27.3928 | 0.1414 | 2 | 4 | mast cell homeostasis |
GO:0070668 | 0.0071 | 27.3928 | 0.1414 | 2 | 4 | positive regulation of mast cell proliferation |
GO:0090315 | 0.0071 | 27.3928 | 0.1414 | 2 | 4 | negative regulation of protein targeting to membrane |
GO:0002286 | 0.0072 | 3.3856 | 2.263 | 7 | 64 | T cell activation involved in immune response |
GO:0009135 | 0.0072 | 3.3856 | 2.263 | 7 | 64 | purine nucleoside diphosphate metabolic process |
GO:1900544 | 0.0073 | 2.8248 | 3.4298 | 9 | 97 | positive regulation of purine nucleotide metabolic process |
GO:0072521 | 0.0073 | 1.8007 | 14.0022 | 24 | 396 | purine-containing compound metabolic process |
GO:0006595 | 0.0076 | 9.1454 | 0.4243 | 3 | 12 | polyamine metabolic process |
GO:0006958 | 0.0076 | 9.1454 | 0.4243 | 3 | 12 | complement activation, classical pathway |
GO:0009187 | 0.008 | 2.4741 | 4.7381 | 11 | 134 | cyclic nucleotide metabolic process |
GO:0030154 | 0.0087 | 1.2971 | 106.8909 | 129 | 3023 | cell differentiation |
GO:0042100 | 0.0092 | 3.2156 | 2.3691 | 7 | 67 | B cell proliferation |
GO:0001894 | 0.0094 | 2.3066 | 5.516 | 12 | 156 | tissue homeostasis |
GO:0046660 | 0.0094 | 2.7012 | 3.5713 | 9 | 101 | female sex differentiation |
GO:0007286 | 0.0095 | 2.5353 | 4.2077 | 10 | 119 | spermatid development |
GO:0045141 | 0.0096 | 8.2302 | 0.4597 | 3 | 13 | meiotic telomere clustering |
GO:0009185 | 0.01 | 3.1626 | 2.4044 | 7 | 68 | ribonucleoside diphosphate metabolic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007186 | 0 | 2.3214 | 21.8457 | 46 | 510 | G-protein coupled receptor signaling pathway |
GO:0006144 | 2e-04 | 12.5147 | 0.5997 | 5 | 14 | purine nucleobase metabolic process |
GO:0090280 | 2e-04 | 12.5147 | 0.5997 | 5 | 14 | positive regulation of calcium ion import |
GO:0043415 | 3e-04 | 67.3842 | 0.1713 | 3 | 4 | positive regulation of skeletal muscle tissue regeneration |
GO:0007606 | 6e-04 | 3.1729 | 4.5405 | 13 | 106 | sensory perception of chemical stimulus |
GO:0071670 | 7e-04 | 33.6895 | 0.2142 | 3 | 5 | smooth muscle cell chemotaxis |
GO:0072103 | 7e-04 | 33.6895 | 0.2142 | 3 | 5 | glomerulus vasculature morphogenesis |
GO:0061440 | 8e-04 | 8.6613 | 0.771 | 5 | 18 | kidney vasculature development |
GO:1902259 | 9e-04 | 12.8516 | 0.4712 | 4 | 11 | regulation of delayed rectifier potassium channel activity |
GO:2000377 | 0.0013 | 2.7634 | 5.5257 | 14 | 129 | regulation of reactive oxygen species metabolic process |
GO:0061438 | 0.0014 | 22.4579 | 0.257 | 3 | 6 | renal system vasculature morphogenesis |
GO:0002037 | 0.0018 | Inf | 0.0857 | 2 | 2 | negative regulation of L-glutamate transport |
GO:0009115 | 0.0018 | Inf | 0.0857 | 2 | 2 | xanthine catabolic process |
GO:0060435 | 0.0018 | Inf | 0.0857 | 2 | 2 | bronchiole development |
GO:0072275 | 0.0018 | Inf | 0.0857 | 2 | 2 | metanephric glomerulus morphogenesis |
GO:0072277 | 0.0018 | Inf | 0.0857 | 2 | 2 | metanephric glomerular capillary formation |
GO:0003008 | 0.0029 | 1.4742 | 49.5598 | 69 | 1157 | system process |
GO:0010739 | 0.0037 | 13.4726 | 0.3427 | 3 | 8 | positive regulation of protein kinase A signaling |
GO:0002209 | 0.0039 | 4.5058 | 1.542 | 6 | 36 | behavioral defense response |
GO:0014707 | 0.0053 | 44.8441 | 0.1285 | 2 | 3 | branchiomeric skeletal muscle development |
GO:1902527 | 0.0053 | 44.8441 | 0.1285 | 2 | 3 | positive regulation of protein monoubiquitination |
GO:0060749 | 0.0063 | 6.4223 | 0.771 | 4 | 18 | mammary gland alveolus development |
GO:0046717 | 0.0065 | 2.9029 | 3.3839 | 9 | 79 | acid secretion |
GO:0007600 | 0.0065 | 1.8771 | 12.3638 | 22 | 293 | sensory perception |
GO:0007169 | 0.007 | 1.6914 | 18.6331 | 30 | 435 | transmembrane receptor protein tyrosine kinase signaling pathway |
GO:0060259 | 0.0072 | 4.6875 | 1.2422 | 5 | 29 | regulation of feeding behavior |
GO:0033599 | 0.0077 | 5.9937 | 0.8139 | 4 | 19 | regulation of mammary gland epithelial cell proliferation |
GO:0031644 | 0.0091 | 2.9579 | 2.9556 | 8 | 69 | regulation of neurological system process |
GO:0033555 | 0.0091 | 2.9579 | 2.9556 | 8 | 69 | multicellular organismal response to stress |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0098662 | 4e-04 | 2.0826 | 15.4381 | 30 | 401 | inorganic cation transmembrane transport |
GO:0007155 | 5e-04 | 1.6937 | 34.11 | 54 | 886 | cell adhesion |
GO:2000821 | 5e-04 | 37.6758 | 0.1925 | 3 | 5 | regulation of grooming behavior |
GO:1902259 | 6e-04 | 14.3752 | 0.4235 | 4 | 11 | regulation of delayed rectifier potassium channel activity |
GO:0006811 | 7e-04 | 1.6147 | 41.0783 | 62 | 1067 | ion transport |
GO:0015672 | 0.0012 | 2.0658 | 12.8971 | 25 | 335 | monovalent inorganic cation transport |
GO:0006649 | 0.0015 | Inf | 0.077 | 2 | 2 | phospholipid transfer to membrane |
GO:1902340 | 0.0015 | Inf | 0.077 | 2 | 2 | negative regulation of chromosome condensation |
GO:0007169 | 0.0015 | 1.9026 | 16.747 | 30 | 435 | transmembrane receptor protein tyrosine kinase signaling pathway |
GO:0043266 | 0.0019 | 3.5568 | 2.8104 | 9 | 73 | regulation of potassium ion transport |
GO:0003008 | 0.0019 | 1.528 | 44.5432 | 64 | 1157 | system process |
GO:0034765 | 0.0021 | 2.041 | 11.9732 | 23 | 311 | regulation of ion transmembrane transport |
GO:0055085 | 0.0025 | 1.623 | 29.9907 | 46 | 779 | transmembrane transport |
GO:0007205 | 0.0027 | 8.3823 | 0.616 | 4 | 16 | protein kinase C-activating G-protein coupled receptor signaling pathway |
GO:0006692 | 0.0028 | 5.9949 | 1.001 | 5 | 26 | prostanoid metabolic process |
GO:0007600 | 0.0033 | 1.8576 | 15.3611 | 27 | 399 | sensory perception |
GO:0098916 | 0.0034 | 1.7883 | 17.7095 | 30 | 460 | anterograde trans-synaptic signaling |
GO:0016339 | 0.0035 | 7.7369 | 0.6545 | 4 | 17 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
GO:0072012 | 0.0035 | 7.7369 | 0.6545 | 4 | 17 | glomerulus vasculature development |
GO:0099536 | 0.0035 | 1.7841 | 17.748 | 30 | 461 | synaptic signaling |
GO:0007320 | 0.004 | 12.5547 | 0.3465 | 3 | 9 | insemination |
GO:0061437 | 0.0043 | 7.1837 | 0.693 | 4 | 18 | renal system vasculature development |
GO:0031509 | 0.0043 | 50.1404 | 0.1155 | 2 | 3 | telomeric heterochromatin assembly |
GO:1901069 | 0.0043 | 50.1404 | 0.1155 | 2 | 3 | guanosine-containing compound catabolic process |
GO:0051899 | 0.0053 | 3.2576 | 2.6949 | 8 | 70 | membrane depolarization |
GO:0001516 | 0.0053 | 6.7042 | 0.7315 | 4 | 19 | prostaglandin biosynthetic process |
GO:0097011 | 0.0056 | 10.7603 | 0.385 | 3 | 10 | cellular response to granulocyte macrophage colony-stimulating factor stimulus |
GO:0030001 | 0.006 | 1.6297 | 23.2148 | 36 | 603 | metal ion transport |
GO:0038179 | 0.0062 | 4.8401 | 1.1935 | 5 | 31 | neurotrophin signaling pathway |
GO:0003015 | 0.0065 | 2.3364 | 5.9288 | 13 | 154 | heart process |
GO:0050806 | 0.0066 | 2.4309 | 5.2744 | 12 | 137 | positive regulation of synaptic transmission |
GO:0006959 | 0.0068 | 3.1065 | 2.8104 | 8 | 73 | humoral immune response |
GO:0007625 | 0.0073 | 9.4686 | 0.4212 | 3 | 11 | grooming behavior |
GO:0030199 | 0.0081 | 4.4937 | 1.2705 | 5 | 33 | collagen fibril organization |
GO:0060325 | 0.0081 | 4.4937 | 1.2705 | 5 | 33 | face morphogenesis |
GO:1901570 | 0.0081 | 4.4937 | 1.2705 | 5 | 33 | fatty acid derivative biosynthetic process |
GO:0000255 | 0.0084 | 25.0682 | 0.154 | 2 | 4 | allantoin metabolic process |
GO:0031508 | 0.0084 | 25.0682 | 0.154 | 2 | 4 | pericentric heterochromatin assembly |
GO:0034112 | 0.0084 | 25.0682 | 0.154 | 2 | 4 | positive regulation of homotypic cell-cell adhesion |
GO:0035995 | 0.0084 | 25.0682 | 0.154 | 2 | 4 | detection of muscle stretch |
GO:0050703 | 0.0084 | 25.0682 | 0.154 | 2 | 4 | interleukin-1 alpha secretion |
GO:0051902 | 0.0084 | 25.0682 | 0.154 | 2 | 4 | negative regulation of mitochondrial depolarization |
GO:0001101 | 0.0085 | 2.1771 | 6.8143 | 14 | 177 | response to acid chemical |
GO:0031214 | 0.0089 | 2.7385 | 3.5419 | 9 | 92 | biomineral tissue development |
GO:0007218 | 0.0089 | 3.6861 | 1.8094 | 6 | 47 | neuropeptide signaling pathway |
GO:0019228 | 0.0092 | 4.3384 | 1.309 | 5 | 34 | neuronal action potential |
GO:0014049 | 0.0096 | 8.3678 | 0.462 | 3 | 12 | positive regulation of glutamate secretion |
GO:0060134 | 0.0096 | 8.3678 | 0.462 | 3 | 12 | prepulse inhibition |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006936 | 2e-04 | 2.6844 | 8.1166 | 20 | 208 | muscle contraction |
GO:0035995 | 2e-04 | 74.3006 | 0.1561 | 3 | 4 | detection of muscle stretch |
GO:0060012 | 2e-04 | 74.3006 | 0.1561 | 3 | 4 | synaptic transmission, glycinergic |
GO:0007271 | 3e-04 | 8.2926 | 0.9365 | 6 | 24 | synaptic transmission, cholinergic |
GO:1901379 | 3e-04 | 4.6809 | 2.2243 | 9 | 57 | regulation of potassium ion transmembrane transport |
GO:0071804 | 5e-04 | 3.0531 | 5.0339 | 14 | 129 | cellular potassium ion transport |
GO:1902259 | 6e-04 | 14.1732 | 0.4292 | 4 | 11 | regulation of delayed rectifier potassium channel activity |
GO:0006636 | 6e-04 | 6.7828 | 1.0926 | 6 | 28 | unsaturated fatty acid biosynthetic process |
GO:0015672 | 7e-04 | 2.1283 | 13.0724 | 26 | 335 | monovalent inorganic cation transport |
GO:0034220 | 8e-04 | 1.833 | 22.0866 | 38 | 566 | ion transmembrane transport |
GO:0098662 | 0.0011 | 1.9739 | 15.6479 | 29 | 401 | inorganic cation transmembrane transport |
GO:0086103 | 0.0011 | 24.763 | 0.2341 | 3 | 6 | G-protein coupled receptor signaling pathway involved in heart process |
GO:0031424 | 0.0012 | 11.0219 | 0.5073 | 4 | 13 | keratinization |
GO:0009612 | 0.0014 | 3.0012 | 4.3705 | 12 | 112 | response to mechanical stimulus |
GO:0048705 | 0.0015 | 2.3555 | 8.1947 | 18 | 210 | skeletal system morphogenesis |
GO:0050968 | 0.0015 | Inf | 0.078 | 2 | 2 | detection of chemical stimulus involved in sensory perception of pain |
GO:0070560 | 0.0015 | Inf | 0.078 | 2 | 2 | protein secretion by platelet |
GO:1901731 | 0.0015 | Inf | 0.078 | 2 | 2 | positive regulation of platelet aggregation |
GO:1902340 | 0.0015 | Inf | 0.078 | 2 | 2 | negative regulation of chromosome condensation |
GO:1990845 | 0.0017 | 9.9189 | 0.5463 | 4 | 14 | adaptive thermogenesis |
GO:0034762 | 0.002 | 2.0169 | 12.6432 | 24 | 324 | regulation of transmembrane transport |
GO:0006182 | 0.003 | 5.9105 | 1.0146 | 5 | 26 | cGMP biosynthetic process |
GO:0006692 | 0.003 | 5.9105 | 1.0146 | 5 | 26 | prostanoid metabolic process |
GO:0003013 | 0.0031 | 1.9438 | 13.0724 | 24 | 335 | circulatory system process |
GO:0044057 | 0.0033 | 1.8784 | 14.6333 | 26 | 375 | regulation of system process |
GO:0001867 | 0.0044 | 49.4385 | 0.1171 | 2 | 3 | complement activation, lectin pathway |
GO:0031509 | 0.0044 | 49.4385 | 0.1171 | 2 | 3 | telomeric heterochromatin assembly |
GO:0010959 | 0.0045 | 1.9762 | 11.2384 | 21 | 288 | regulation of metal ion transport |
GO:0032409 | 0.0046 | 2.2754 | 7.024 | 15 | 180 | regulation of transporter activity |
GO:0032412 | 0.0052 | 2.3186 | 6.4387 | 14 | 165 | regulation of ion transmembrane transporter activity |
GO:0001516 | 0.0056 | 6.61 | 0.7414 | 4 | 19 | prostaglandin biosynthetic process |
GO:1903818 | 0.0058 | 10.6094 | 0.3902 | 3 | 10 | positive regulation of voltage-gated potassium channel activity |
GO:0071709 | 0.0067 | 6.1964 | 0.7804 | 4 | 20 | membrane assembly |
GO:0009593 | 0.0077 | 3.8211 | 1.756 | 6 | 45 | detection of chemical stimulus |
GO:0002026 | 0.0081 | 5.8315 | 0.8195 | 4 | 21 | regulation of the force of heart contraction |
GO:0031281 | 0.0085 | 4.4304 | 1.2877 | 5 | 33 | positive regulation of cyclase activity |
GO:0051349 | 0.0085 | 4.4304 | 1.2877 | 5 | 33 | positive regulation of lyase activity |
GO:0030816 | 0.0085 | 3.2832 | 2.3413 | 7 | 60 | positive regulation of cAMP metabolic process |
GO:0031508 | 0.0087 | 24.7173 | 0.1561 | 2 | 4 | pericentric heterochromatin assembly |
GO:0051902 | 0.0087 | 24.7173 | 0.1561 | 2 | 4 | negative regulation of mitochondrial depolarization |
GO:0007218 | 0.0095 | 3.6341 | 1.834 | 6 | 47 | neuropeptide signaling pathway |
GO:0022409 | 0.0096 | 2.3032 | 5.5412 | 12 | 142 | positive regulation of cell-cell adhesion |
GO:0019228 | 0.0097 | 4.2773 | 1.3268 | 5 | 34 | neuronal action potential |
GO:0051895 | 0.01 | 8.2505 | 0.4683 | 3 | 12 | negative regulation of focal adhesion assembly |
GO:0071625 | 0.01 | 8.2505 | 0.4683 | 3 | 12 | vocalization behavior |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050877 | 0 | 1.8329 | 34.8096 | 59 | 712 | nervous system process |
GO:0055074 | 1e-04 | 2.3228 | 14.0803 | 30 | 288 | calcium ion homeostasis |
GO:1901385 | 1e-04 | 8.0864 | 1.1734 | 7 | 24 | regulation of voltage-gated calcium channel activity |
GO:0002578 | 1e-04 | Inf | 0.1467 | 3 | 3 | negative regulation of antigen processing and presentation |
GO:0030825 | 2e-04 | 13.9952 | 0.5867 | 5 | 12 | positive regulation of cGMP metabolic process |
GO:0006954 | 2e-04 | 2.0854 | 17.6004 | 34 | 360 | inflammatory response |
GO:0007204 | 3e-04 | 2.5563 | 8.9957 | 21 | 184 | positive regulation of cytosolic calcium ion concentration |
GO:0072503 | 3e-04 | 2.1564 | 14.5203 | 29 | 297 | cellular divalent inorganic cation homeostasis |
GO:0006342 | 4e-04 | 3.8696 | 3.2756 | 11 | 67 | chromatin silencing |
GO:0022610 | 4e-04 | 1.6188 | 43.5609 | 66 | 891 | biological adhesion |
GO:0007223 | 4e-04 | 58.6267 | 0.1956 | 3 | 4 | Wnt signaling pathway, calcium modulating pathway |
GO:1901842 | 4e-04 | 58.6267 | 0.1956 | 3 | 4 | negative regulation of high voltage-gated calcium channel activity |
GO:1901020 | 5e-04 | 9.7943 | 0.7333 | 5 | 15 | negative regulation of calcium ion transmembrane transporter activity |
GO:0016525 | 6e-04 | 3.9357 | 2.9334 | 10 | 60 | negative regulation of angiogenesis |
GO:0007606 | 6e-04 | 3.0033 | 5.1823 | 14 | 106 | sensory perception of chemical stimulus |
GO:0007186 | 7e-04 | 1.8552 | 21.8761 | 38 | 451 | G-protein coupled receptor signaling pathway |
GO:0045987 | 7e-04 | 5.4953 | 1.5645 | 7 | 32 | positive regulation of smooth muscle contraction |
GO:0051480 | 8e-04 | 6.6677 | 1.1515 | 6 | 24 | regulation of cytosolic calcium ion concentration |
GO:0002690 | 8e-04 | 4.1147 | 2.5423 | 9 | 52 | positive regulation of leukocyte chemotaxis |
GO:0030799 | 8e-04 | 2.9078 | 5.329 | 14 | 109 | regulation of cyclic nucleotide metabolic process |
GO:0046543 | 9e-04 | 13.0431 | 0.4889 | 4 | 10 | development of secondary female sexual characteristics |
GO:1902043 | 0.001 | 8.1606 | 0.8311 | 5 | 17 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors |
GO:2000822 | 0.0011 | 29.3111 | 0.2444 | 3 | 5 | regulation of behavioral fear response |
GO:0007156 | 0.0011 | 3.5765 | 3.1778 | 10 | 65 | homophilic cell adhesion via plasma membrane adhesion molecules |
GO:0050867 | 0.0012 | 2.2884 | 9.4357 | 20 | 193 | positive regulation of cell activation |
GO:0002685 | 0.0013 | 2.7613 | 5.5734 | 14 | 114 | regulation of leukocyte migration |
GO:0043032 | 0.0014 | 11.1789 | 0.5378 | 4 | 11 | positive regulation of macrophage activation |
GO:0043117 | 0.0014 | 11.1789 | 0.5378 | 4 | 11 | positive regulation of vascular permeability |
GO:0001756 | 0.0014 | 3.4505 | 3.2756 | 10 | 67 | somitogenesis |
GO:0002684 | 0.0015 | 1.7246 | 25.2272 | 41 | 516 | positive regulation of immune system process |
GO:1901343 | 0.0016 | 3.3907 | 3.3245 | 10 | 68 | negative regulation of vasculature development |
GO:0007588 | 0.0018 | 4.5776 | 1.8089 | 7 | 37 | excretion |
GO:0006875 | 0.0019 | 1.8694 | 17.0626 | 30 | 349 | cellular metal ion homeostasis |
GO:0060029 | 0.0021 | 19.5392 | 0.2933 | 3 | 6 | convergent extension involved in organogenesis |
GO:0042596 | 0.0022 | 4.4296 | 1.8578 | 7 | 38 | fear response |
GO:0001971 | 0.0024 | Inf | 0.0978 | 2 | 2 | negative regulation of activation of membrane attack complex |
GO:0002583 | 0.0024 | Inf | 0.0978 | 2 | 2 | regulation of antigen processing and presentation of peptide antigen |
GO:0002590 | 0.0024 | Inf | 0.0978 | 2 | 2 | negative regulation of antigen processing and presentation of peptide antigen via MHC class I |
GO:0010749 | 0.0024 | Inf | 0.0978 | 2 | 2 | regulation of nitric oxide mediated signal transduction |
GO:0010949 | 0.0024 | Inf | 0.0978 | 2 | 2 | negative regulation of intestinal phytosterol absorption |
GO:0045796 | 0.0024 | Inf | 0.0978 | 2 | 2 | negative regulation of intestinal cholesterol absorption |
GO:1904479 | 0.0024 | Inf | 0.0978 | 2 | 2 | negative regulation of intestinal absorption |
GO:0050808 | 0.0024 | 2.1471 | 9.9832 | 20 | 205 | synapse organization |
GO:0048568 | 0.0025 | 1.7791 | 19.6537 | 33 | 402 | embryonic organ development |
GO:1900544 | 0.0026 | 2.9455 | 4.1276 | 11 | 85 | positive regulation of purine nucleotide metabolic process |
GO:0034765 | 0.0028 | 1.8861 | 15.2048 | 27 | 311 | regulation of ion transmembrane transport |
GO:0055080 | 0.0029 | 1.7021 | 22.9782 | 37 | 470 | cation homeostasis |
GO:1903169 | 0.0029 | 2.7466 | 4.7912 | 12 | 98 | regulation of calcium ion transmembrane transport |
GO:0050880 | 0.0029 | 2.5083 | 6.0623 | 14 | 124 | regulation of blood vessel size |
GO:0044057 | 0.003 | 1.7906 | 18.3337 | 31 | 375 | regulation of system process |
GO:0090288 | 0.0031 | 2.7265 | 4.8208 | 12 | 99 | negative regulation of cellular response to growth factor stimulus |
GO:0071621 | 0.0034 | 3.2736 | 3.0801 | 9 | 63 | granulocyte chemotaxis |
GO:0042268 | 0.0035 | 14.6532 | 0.3422 | 3 | 7 | regulation of cytolysis |
GO:0043950 | 0.0035 | 14.6532 | 0.3422 | 3 | 7 | positive regulation of cAMP-mediated signaling |
GO:0006955 | 0.0035 | 1.5508 | 34.6629 | 51 | 709 | immune response |
GO:0006816 | 0.0036 | 1.8977 | 13.9825 | 25 | 286 | calcium ion transport |
GO:0051240 | 0.0036 | 1.4114 | 62.139 | 83 | 1271 | positive regulation of multicellular organismal process |
GO:0014821 | 0.0036 | 5.7582 | 1.0756 | 5 | 22 | phasic smooth muscle contraction |
GO:0055085 | 0.0037 | 1.5217 | 38.0852 | 55 | 779 | transmembrane transport |
GO:0097756 | 0.0038 | 2.9778 | 3.7156 | 10 | 76 | negative regulation of blood vessel diameter |
GO:2000026 | 0.0039 | 1.3778 | 72.9437 | 95 | 1492 | regulation of multicellular organismal development |
GO:0060291 | 0.0042 | 3.1562 | 3.1778 | 9 | 65 | long-term synaptic potentiation |
GO:0042221 | 0.0043 | 1.2999 | 121.4914 | 148 | 2485 | response to chemical |
GO:0090101 | 0.0043 | 2.738 | 4.4001 | 11 | 90 | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:0019229 | 0.0044 | 3.4128 | 2.6401 | 8 | 54 | regulation of vasoconstriction |
GO:0045776 | 0.0045 | 3.8129 | 2.1023 | 7 | 43 | negative regulation of blood pressure |
GO:0006811 | 0.0045 | 1.4339 | 52.1655 | 71 | 1067 | ion transport |
GO:0098771 | 0.0045 | 1.6507 | 23.6138 | 37 | 483 | inorganic ion homeostasis |
GO:0019932 | 0.0047 | 2.1024 | 9.1424 | 18 | 187 | second-messenger-mediated signaling |
GO:0046717 | 0.005 | 2.8477 | 3.8623 | 10 | 79 | acid secretion |
GO:0098609 | 0.005 | 1.6393 | 23.7605 | 37 | 486 | cell-cell adhesion |
GO:0060359 | 0.0051 | 3.0469 | 3.2756 | 9 | 67 | response to ammonium ion |
GO:0040011 | 0.0052 | 1.3932 | 61.259 | 81 | 1253 | locomotion |
GO:0070098 | 0.0054 | 5.1512 | 1.1734 | 5 | 24 | chemokine-mediated signaling pathway |
GO:2001258 | 0.0054 | 5.1512 | 1.1734 | 5 | 24 | negative regulation of cation channel activity |
GO:0001991 | 0.0054 | 11.7217 | 0.3911 | 3 | 8 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin |
GO:0019755 | 0.0054 | 11.7217 | 0.3911 | 3 | 8 | one-carbon compound transport |
GO:0030948 | 0.0054 | 11.7217 | 0.3911 | 3 | 8 | negative regulation of vascular endothelial growth factor receptor signaling pathway |
GO:0003156 | 0.0056 | 4.1981 | 1.6623 | 6 | 34 | regulation of animal organ formation |
GO:0019228 | 0.0056 | 4.1981 | 1.6623 | 6 | 34 | neuronal action potential |
GO:0072511 | 0.0057 | 1.7771 | 16.0359 | 27 | 328 | divalent inorganic cation transport |
GO:0050982 | 0.0058 | 3.6116 | 2.2 | 7 | 45 | detection of mechanical stimulus |
GO:0007268 | 0.0063 | 1.6361 | 22.4893 | 35 | 460 | chemical synaptic transmission |
GO:0009887 | 0.0064 | 1.4659 | 40.8231 | 57 | 835 | animal organ morphogenesis |
GO:0001558 | 0.0064 | 1.7813 | 15.4003 | 26 | 315 | regulation of cell growth |
GO:0035929 | 0.0064 | 6.5185 | 0.7822 | 4 | 16 | steroid hormone secretion |
GO:0045940 | 0.0064 | 6.5185 | 0.7822 | 4 | 16 | positive regulation of steroid metabolic process |
GO:0048148 | 0.0064 | 6.5185 | 0.7822 | 4 | 16 | behavioral response to cocaine |
GO:0001659 | 0.0065 | 4.8933 | 1.2222 | 5 | 25 | temperature homeostasis |
GO:0001990 | 0.0065 | 4.8933 | 1.2222 | 5 | 25 | regulation of systemic arterial blood pressure by hormone |
GO:0072678 | 0.0065 | 4.8933 | 1.2222 | 5 | 25 | T cell migration |
GO:0090103 | 0.0065 | 4.8933 | 1.2222 | 5 | 25 | cochlea morphogenesis |
GO:0099537 | 0.0065 | 1.6322 | 22.5382 | 35 | 461 | trans-synaptic signaling |
GO:0006936 | 0.0066 | 1.9843 | 10.1691 | 19 | 208 | muscle contraction |
GO:0008284 | 0.0068 | 1.5043 | 34.174 | 49 | 699 | positive regulation of cell proliferation |
GO:0006145 | 0.0069 | 39.0245 | 0.1467 | 2 | 3 | purine nucleobase catabolic process |
GO:0032430 | 0.0069 | 39.0245 | 0.1467 | 2 | 3 | positive regulation of phospholipase A2 activity |
GO:0046104 | 0.0069 | 39.0245 | 0.1467 | 2 | 3 | thymidine metabolic process |
GO:0046544 | 0.0069 | 39.0245 | 0.1467 | 2 | 3 | development of secondary male sexual characteristics |
GO:0090081 | 0.0069 | 39.0245 | 0.1467 | 2 | 3 | regulation of heart induction by regulation of canonical Wnt signaling pathway |
GO:0097278 | 0.0069 | 39.0245 | 0.1467 | 2 | 3 | complement-dependent cytotoxicity |
GO:1903849 | 0.0069 | 39.0245 | 0.1467 | 2 | 3 | positive regulation of aorta morphogenesis |
GO:0048731 | 0.0072 | 1.249 | 165.59 | 193 | 3387 | system development |
GO:0006873 | 0.0073 | 1.6576 | 20.2893 | 32 | 415 | cellular ion homeostasis |
GO:0060326 | 0.0073 | 2.1021 | 8.1157 | 16 | 166 | cell chemotaxis |
GO:0002209 | 0.0074 | 3.9176 | 1.76 | 6 | 36 | behavioral defense response |
GO:0015909 | 0.0074 | 3.9176 | 1.76 | 6 | 36 | long-chain fatty acid transport |
GO:0003013 | 0.0075 | 1.7358 | 16.3781 | 27 | 335 | circulatory system process |
GO:0010959 | 0.0076 | 1.7978 | 14.0803 | 24 | 288 | regulation of metal ion transport |
GO:0007200 | 0.0076 | 3.077 | 2.8845 | 8 | 59 | phospholipase C-activating G-protein coupled receptor signaling pathway |
GO:0003306 | 0.0078 | 9.7673 | 0.44 | 3 | 9 | Wnt signaling pathway involved in heart development |
GO:0017144 | 0.0078 | 9.7673 | 0.44 | 3 | 9 | drug metabolic process |
GO:0060340 | 0.0078 | 9.7673 | 0.44 | 3 | 9 | positive regulation of type I interferon-mediated signaling pathway |
GO:0090009 | 0.0078 | 9.7673 | 0.44 | 3 | 9 | primitive streak formation |
GO:1900221 | 0.0078 | 9.7673 | 0.44 | 3 | 9 | regulation of amyloid-beta clearance |
GO:1905809 | 0.0078 | 9.7673 | 0.44 | 3 | 9 | negative regulation of synapse organization |
GO:0098662 | 0.0079 | 1.6613 | 19.6048 | 31 | 401 | inorganic cation transmembrane transport |
GO:0032103 | 0.0079 | 2.0312 | 8.898 | 17 | 182 | positive regulation of response to external stimulus |
GO:0090023 | 0.0081 | 6.0166 | 0.8311 | 4 | 17 | positive regulation of neutrophil chemotaxis |
GO:0046888 | 0.0082 | 2.804 | 3.5201 | 9 | 72 | negative regulation of hormone secretion |
GO:0007267 | 0.0087 | 1.3967 | 51.041 | 68 | 1044 | cell-cell signaling |
GO:0001964 | 0.0091 | 4.4478 | 1.32 | 5 | 27 | startle response |
GO:0048265 | 0.0091 | 4.4478 | 1.32 | 5 | 27 | response to pain |
GO:0006813 | 0.0096 | 2.0335 | 8.3602 | 16 | 171 | potassium ion transport |
GO:0030850 | 0.0097 | 3.6722 | 1.8578 | 6 | 38 | prostate gland development |
GO:0035296 | 0.0098 | 2.3128 | 5.5734 | 12 | 114 | regulation of tube diameter |
GO:0042127 | 0.0099 | 1.5433 | 26.4849 | 39 | 555 | regulation of cell proliferation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0070661 | 0 | 5.9877 | 6.321 | 30 | 144 | leukocyte proliferation |
GO:0002323 | 0 | 34.4985 | 0.7979 | 11 | 18 | natural killer cell activation involved in immune response |
GO:0009607 | 0 | 3.0622 | 20.3474 | 54 | 459 | response to biotic stimulus |
GO:0045087 | 0 | 4.3985 | 8.6679 | 32 | 198 | innate immune response |
GO:0002366 | 0 | 4.75 | 7.0928 | 28 | 160 | leukocyte activation involved in immune response |
GO:0033141 | 0 | 31.3085 | 0.7536 | 10 | 17 | positive regulation of peptidyl-serine phosphorylation of STAT protein |
GO:0006959 | 0 | 7.245 | 3.2361 | 18 | 73 | humoral immune response |
GO:0042100 | 0 | 7.5166 | 2.9701 | 17 | 67 | B cell proliferation |
GO:0002286 | 0 | 7.3576 | 2.8371 | 16 | 64 | T cell activation involved in immune response |
GO:0006955 | 0 | 5.8287 | 3.9995 | 19 | 98 | immune response |
GO:0002250 | 0 | 3.6091 | 9.5752 | 30 | 216 | adaptive immune response |
GO:0030183 | 0 | 5.4625 | 4.2557 | 19 | 96 | B cell differentiation |
GO:0042832 | 0 | 19.686 | 0.8423 | 9 | 19 | defense response to protozoan |
GO:0006952 | 0 | 4.5932 | 5.6468 | 22 | 139 | defense response |
GO:0002252 | 0 | 3.9884 | 6.3815 | 22 | 149 | immune effector process |
GO:0046425 | 0 | 4.5665 | 4.9206 | 19 | 111 | regulation of JAK-STAT cascade |
GO:0002521 | 0 | 2.665 | 16.3134 | 39 | 368 | leukocyte differentiation |
GO:0043330 | 0 | 8.6105 | 1.7289 | 11 | 39 | response to exogenous dsRNA |
GO:0042742 | 0 | 4.5686 | 4.6546 | 18 | 105 | defense response to bacterium |
GO:0060326 | 0 | 3.567 | 7.3588 | 23 | 166 | cell chemotaxis |
GO:0097696 | 0 | 4.1566 | 5.3196 | 19 | 120 | STAT cascade |
GO:0034097 | 0 | 2.3062 | 22.4752 | 47 | 507 | response to cytokine |
GO:0050867 | 0 | 3.3052 | 8.5557 | 25 | 193 | positive regulation of cell activation |
GO:0002274 | 0 | 4.3186 | 4.8763 | 18 | 110 | myeloid leukocyte activation |
GO:0046651 | 0 | 4.9414 | 3.6123 | 15 | 84 | lymphocyte proliferation |
GO:1903039 | 0 | 4.0944 | 5.0979 | 18 | 115 | positive regulation of leukocyte cell-cell adhesion |
GO:0032946 | 0 | 4.8057 | 3.4577 | 14 | 78 | positive regulation of mononuclear cell proliferation |
GO:0050865 | 0 | 3.6039 | 5.9885 | 19 | 139 | regulation of cell activation |
GO:0051251 | 0 | 3.3399 | 7.0928 | 21 | 160 | positive regulation of lymphocyte activation |
GO:0048534 | 0 | 2.0133 | 29.2577 | 54 | 660 | hematopoietic or lymphoid organ development |
GO:0019221 | 0 | 3.0882 | 8.3264 | 23 | 189 | cytokine-mediated signaling pathway |
GO:0051607 | 0 | 3.5102 | 5.8072 | 18 | 131 | defense response to virus |
GO:0051707 | 0 | 3.2194 | 6.9507 | 20 | 163 | response to other organism |
GO:0042330 | 0 | 2.2481 | 16.934 | 35 | 382 | taxis |
GO:0022407 | 0 | 3.161 | 6.7118 | 19 | 153 | regulation of cell-cell adhesion |
GO:0045785 | 0 | 2.5255 | 11.7031 | 27 | 264 | positive regulation of cell adhesion |
GO:0032729 | 0 | 6.3399 | 1.7732 | 9 | 40 | positive regulation of interferon-gamma production |
GO:0030168 | 1e-04 | 4.5318 | 3.1031 | 12 | 70 | platelet activation |
GO:0033135 | 1e-04 | 3.4821 | 5.1866 | 16 | 117 | regulation of peptidyl-serine phosphorylation |
GO:0050778 | 1e-04 | 2.3564 | 13.3876 | 29 | 302 | positive regulation of immune response |
GO:0030886 | 1e-04 | Inf | 0.133 | 3 | 3 | negative regulation of myeloid dendritic cell activation |
GO:1903578 | 1e-04 | 5.0824 | 2.3495 | 10 | 53 | regulation of ATP metabolic process |
GO:0032944 | 1e-04 | 5.0631 | 2.351 | 10 | 54 | regulation of mononuclear cell proliferation |
GO:0009605 | 1e-04 | 1.7726 | 35.3041 | 58 | 826 | response to external stimulus |
GO:0007599 | 1e-04 | 3.195 | 5.5856 | 16 | 126 | hemostasis |
GO:0050817 | 2e-04 | 3.1374 | 5.6742 | 16 | 128 | coagulation |
GO:0002532 | 3e-04 | 5.4496 | 1.7732 | 8 | 40 | production of molecular mediator involved in inflammatory response |
GO:0002679 | 3e-04 | 64.9983 | 0.1773 | 3 | 4 | respiratory burst involved in defense response |
GO:0002699 | 3e-04 | 3.0459 | 5.4526 | 15 | 123 | positive regulation of immune effector process |
GO:0097529 | 4e-04 | 3.1957 | 4.8763 | 14 | 110 | myeloid leukocyte migration |
GO:0045937 | 4e-04 | 1.6797 | 37.5917 | 59 | 848 | positive regulation of phosphate metabolic process |
GO:0001580 | 4e-04 | 17.3569 | 0.399 | 4 | 9 | detection of chemical stimulus involved in sensory perception of bitter taste |
GO:0032270 | 4e-04 | 1.5819 | 50.137 | 74 | 1131 | positive regulation of cellular protein metabolic process |
GO:0045321 | 5e-04 | 2.373 | 10.0153 | 22 | 239 | leukocyte activation |
GO:0050776 | 5e-04 | 7.1067 | 1.0731 | 6 | 25 | regulation of immune response |
GO:0050920 | 6e-04 | 2.859 | 5.7629 | 15 | 130 | regulation of chemotaxis |
GO:0051674 | 7e-04 | 1.5653 | 47.7432 | 70 | 1077 | localization of cell |
GO:0006954 | 7e-04 | 2.2399 | 11.0435 | 23 | 254 | inflammatory response |
GO:0001817 | 7e-04 | 2.0549 | 14.5855 | 28 | 332 | regulation of cytokine production |
GO:0002682 | 7e-04 | 2.5232 | 7.7294 | 18 | 185 | regulation of immune system process |
GO:0002474 | 8e-04 | 6.5233 | 1.1526 | 6 | 26 | antigen processing and presentation of peptide antigen via MHC class I |
GO:0050853 | 8e-04 | 6.5233 | 1.1526 | 6 | 26 | B cell receptor signaling pathway |
GO:0051270 | 8e-04 | 1.7077 | 29.9226 | 48 | 675 | regulation of cellular component movement |
GO:0050900 | 9e-04 | 4.4752 | 2.075 | 8 | 48 | leukocyte migration |
GO:0001934 | 0.001 | 1.6728 | 31.7845 | 50 | 717 | positive regulation of protein phosphorylation |
GO:0042107 | 0.0011 | 3.5776 | 3.1474 | 10 | 71 | cytokine metabolic process |
GO:0050672 | 0.0011 | 4.3569 | 2.1278 | 8 | 48 | negative regulation of lymphocyte proliferation |
GO:0032103 | 0.0012 | 2.4089 | 8.068 | 18 | 182 | positive regulation of response to external stimulus |
GO:0002684 | 0.0013 | 4.245 | 2.1645 | 8 | 51 | positive regulation of immune system process |
GO:0042102 | 0.0014 | 4.7896 | 1.7189 | 7 | 39 | positive regulation of T cell proliferation |
GO:0042060 | 0.0014 | 2.1604 | 10.9051 | 22 | 246 | wound healing |
GO:0010715 | 0.0014 | 10.8455 | 0.532 | 4 | 12 | regulation of extracellular matrix disassembly |
GO:0070664 | 0.0015 | 4.1488 | 2.2165 | 8 | 50 | negative regulation of leukocyte proliferation |
GO:2000147 | 0.0015 | 1.9285 | 16.0031 | 29 | 361 | positive regulation of cell motility |
GO:0031349 | 0.0016 | 2.3508 | 8.2453 | 18 | 186 | positive regulation of defense response |
GO:0001955 | 0.0016 | 21.6627 | 0.266 | 3 | 6 | blood vessel maturation |
GO:0019886 | 0.0016 | 21.6627 | 0.266 | 3 | 6 | antigen processing and presentation of exogenous peptide antigen via MHC class II |
GO:0033860 | 0.0016 | 21.6627 | 0.266 | 3 | 6 | regulation of NAD(P)H oxidase activity |
GO:0014074 | 0.0017 | 3.3564 | 3.3247 | 10 | 75 | response to purine-containing compound |
GO:0050868 | 0.0017 | 3.633 | 2.7928 | 9 | 63 | negative regulation of T cell activation |
GO:0071621 | 0.0017 | 3.633 | 2.7928 | 9 | 63 | granulocyte chemotaxis |
GO:0033003 | 0.0018 | 5.4344 | 1.3299 | 6 | 30 | regulation of mast cell activation |
GO:0001525 | 0.0018 | 1.9241 | 15.4711 | 28 | 349 | angiogenesis |
GO:0002429 | 0.0019 | 3.0788 | 3.9454 | 11 | 89 | immune response-activating cell surface receptor signaling pathway |
GO:0009617 | 0.0019 | 2.4436 | 7.0619 | 16 | 163 | response to bacterium |
GO:0045582 | 0.0019 | 3.9596 | 2.3052 | 8 | 52 | positive regulation of T cell differentiation |
GO:0030334 | 0.0019 | 1.6972 | 25.5783 | 41 | 577 | regulation of cell migration |
GO:0006597 | 0.002 | Inf | 0.0887 | 2 | 2 | spermine biosynthetic process |
GO:0060266 | 0.002 | Inf | 0.0887 | 2 | 2 | negative regulation of respiratory burst involved in inflammatory response |
GO:0071593 | 0.002 | Inf | 0.0887 | 2 | 2 | lymphocyte aggregation |
GO:1901731 | 0.002 | Inf | 0.0887 | 2 | 2 | positive regulation of platelet aggregation |
GO:0042221 | 0.002 | 1.3487 | 110.1596 | 138 | 2485 | response to chemical |
GO:0045589 | 0.002 | 9.6397 | 0.5763 | 4 | 13 | regulation of regulatory T cell differentiation |
GO:0046641 | 0.002 | 9.6397 | 0.5763 | 4 | 13 | positive regulation of alpha-beta T cell proliferation |
GO:0050864 | 0.0022 | 3.0014 | 4.034 | 11 | 91 | regulation of B cell activation |
GO:0032496 | 0.0024 | 2.3838 | 7.2258 | 16 | 163 | response to lipopolysaccharide |
GO:0042110 | 0.0024 | 2.462 | 6.5661 | 15 | 154 | T cell activation |
GO:1903708 | 0.0025 | 2.5518 | 5.9402 | 14 | 134 | positive regulation of hemopoiesis |
GO:0002279 | 0.0025 | 5.0156 | 1.4186 | 6 | 32 | mast cell activation involved in immune response |
GO:0002448 | 0.0025 | 5.0156 | 1.4186 | 6 | 32 | mast cell mediated immunity |
GO:0045064 | 0.0027 | 8.675 | 0.6206 | 4 | 14 | T-helper 2 cell differentiation |
GO:0045619 | 0.0027 | 2.7587 | 4.7433 | 12 | 107 | regulation of lymphocyte differentiation |
GO:0002526 | 0.0027 | 3.706 | 2.4381 | 8 | 55 | acute inflammatory response |
GO:0046631 | 0.0028 | 4.8774 | 1.4493 | 6 | 33 | alpha-beta T cell activation |
GO:0042127 | 0.0029 | 1.4483 | 55.5896 | 76 | 1254 | regulation of cell proliferation |
GO:0043304 | 0.0029 | 6.0308 | 1.0196 | 5 | 23 | regulation of mast cell degranulation |
GO:2000106 | 0.003 | 3.3238 | 3.0144 | 9 | 68 | regulation of leukocyte apoptotic process |
GO:0042325 | 0.003 | 1.4683 | 50.4473 | 70 | 1138 | regulation of phosphorylation |
GO:0001776 | 0.003 | 3.0713 | 3.5907 | 10 | 81 | leukocyte homeostasis |
GO:0007165 | 0.0031 | 1.3009 | 144.1937 | 173 | 3295 | signal transduction |
GO:0002695 | 0.0033 | 2.8383 | 4.2351 | 11 | 96 | negative regulation of leukocyte activation |
GO:0043299 | 0.0034 | 4.0067 | 1.9948 | 7 | 45 | leukocyte degranulation |
GO:0046634 | 0.0035 | 3.5542 | 2.5268 | 8 | 57 | regulation of alpha-beta T cell activation |
GO:0050907 | 0.0035 | 5.7129 | 1.0639 | 5 | 24 | detection of chemical stimulus involved in sensory perception |
GO:0065007 | 0.0037 | 1.2673 | 350.2942 | 382 | 7902 | biological regulation |
GO:0043467 | 0.0039 | 2.9461 | 3.7237 | 10 | 84 | regulation of generation of precursor metabolites and energy |
GO:0051249 | 0.004 | 4.4861 | 1.5487 | 6 | 36 | regulation of lymphocyte activation |
GO:0050710 | 0.004 | 4.4957 | 1.5515 | 6 | 35 | negative regulation of cytokine secretion |
GO:0051196 | 0.004 | 4.4957 | 1.5515 | 6 | 35 | regulation of coenzyme metabolic process |
GO:0032000 | 0.0041 | 12.9956 | 0.3546 | 3 | 8 | positive regulation of fatty acid beta-oxidation |
GO:0046007 | 0.0041 | 12.9956 | 0.3546 | 3 | 8 | negative regulation of activated T cell proliferation |
GO:0050856 | 0.0043 | 5.4269 | 1.1082 | 5 | 25 | regulation of T cell receptor signaling pathway |
GO:0072678 | 0.0043 | 5.4269 | 1.1082 | 5 | 25 | T cell migration |
GO:1902622 | 0.0043 | 5.4269 | 1.1082 | 5 | 25 | regulation of neutrophil migration |
GO:0007155 | 0.0045 | 1.6084 | 26.8476 | 41 | 622 | cell adhesion |
GO:0019884 | 0.0045 | 7.2281 | 0.7093 | 4 | 16 | antigen processing and presentation of exogenous antigen |
GO:0031295 | 0.0045 | 7.2281 | 0.7093 | 4 | 16 | T cell costimulation |
GO:0031640 | 0.0045 | 7.2281 | 0.7093 | 4 | 16 | killing of cells of other organism |
GO:0043470 | 0.0046 | 4.3455 | 1.5959 | 6 | 36 | regulation of carbohydrate catabolic process |
GO:0009167 | 0.0047 | 2.1514 | 8.4227 | 17 | 190 | purine ribonucleoside monophosphate metabolic process |
GO:0050909 | 0.0051 | 5.168 | 1.1526 | 5 | 26 | sensory perception of taste |
GO:2000401 | 0.0051 | 5.168 | 1.1526 | 5 | 26 | regulation of lymphocyte migration |
GO:0007229 | 0.0053 | 3.2849 | 2.7041 | 8 | 61 | integrin-mediated signaling pathway |
GO:0042035 | 0.0053 | 3.2849 | 2.7041 | 8 | 61 | regulation of cytokine biosynthetic process |
GO:0002703 | 0.0057 | 2.494 | 5.1866 | 12 | 117 | regulation of leukocyte mediated immunity |
GO:0002442 | 0.0057 | 43.2589 | 0.133 | 2 | 3 | serotonin secretion involved in inflammatory response |
GO:0002476 | 0.0057 | 43.2589 | 0.133 | 2 | 3 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib |
GO:0034154 | 0.0057 | 43.2589 | 0.133 | 2 | 3 | toll-like receptor 7 signaling pathway |
GO:0071313 | 0.0057 | 43.2589 | 0.133 | 2 | 3 | cellular response to caffeine |
GO:0090023 | 0.0057 | 6.6715 | 0.7536 | 4 | 17 | positive regulation of neutrophil chemotaxis |
GO:0050777 | 0.0058 | 2.9696 | 3.3247 | 9 | 75 | negative regulation of immune response |
GO:0001781 | 0.006 | 10.8288 | 0.399 | 3 | 9 | neutrophil apoptotic process |
GO:0002504 | 0.006 | 10.8288 | 0.399 | 3 | 9 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II |
GO:0002689 | 0.006 | 10.8288 | 0.399 | 3 | 9 | negative regulation of leukocyte chemotaxis |
GO:0045820 | 0.006 | 10.8288 | 0.399 | 3 | 9 | negative regulation of glycolytic process |
GO:0060263 | 0.006 | 10.8288 | 0.399 | 3 | 9 | regulation of respiratory burst |
GO:1903862 | 0.006 | 10.8288 | 0.399 | 3 | 9 | positive regulation of oxidative phosphorylation |
GO:0002437 | 0.006 | 4.9327 | 1.1969 | 5 | 27 | inflammatory response to antigenic stimulus |
GO:0032418 | 0.0062 | 3.5394 | 2.2165 | 7 | 50 | lysosome localization |
GO:0048661 | 0.0063 | 2.9251 | 3.3691 | 9 | 76 | positive regulation of smooth muscle cell proliferation |
GO:0009205 | 0.0064 | 2.0783 | 8.6886 | 17 | 196 | purine ribonucleoside triphosphate metabolic process |
GO:0032411 | 0.0068 | 2.8818 | 3.4134 | 9 | 77 | positive regulation of transporter activity |
GO:0009123 | 0.007 | 2.055 | 8.7773 | 17 | 198 | nucleoside monophosphate metabolic process |
GO:0006911 | 0.0071 | 4.7179 | 1.2412 | 5 | 28 | phagocytosis, engulfment |
GO:0009954 | 0.0071 | 4.7179 | 1.2412 | 5 | 28 | proximal/distal pattern formation |
GO:0061844 | 0.0071 | 6.1945 | 0.7979 | 4 | 18 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0045088 | 0.0072 | 2.2321 | 6.6938 | 14 | 151 | regulation of innate immune response |
GO:0034767 | 0.0073 | 2.5245 | 4.699 | 11 | 106 | positive regulation of ion transmembrane transport |
GO:0042129 | 0.0073 | 3.8937 | 1.7471 | 6 | 40 | regulation of T cell proliferation |
GO:0006140 | 0.0074 | 2.1567 | 7.4031 | 15 | 167 | regulation of nucleotide metabolic process |
GO:0002690 | 0.0077 | 3.3816 | 2.3052 | 7 | 52 | positive regulation of leukocyte chemotaxis |
GO:0032755 | 0.0077 | 3.3816 | 2.3052 | 7 | 52 | positive regulation of interleukin-6 production |
GO:0051174 | 0.0078 | 1.3794 | 58.737 | 77 | 1325 | regulation of phosphorus metabolic process |
GO:0007204 | 0.0078 | 2.0824 | 8.1567 | 16 | 184 | positive regulation of cytosolic calcium ion concentration |
GO:0038083 | 0.0079 | 3.833 | 1.7732 | 6 | 40 | peptidyl-tyrosine autophosphorylation |
GO:0002687 | 0.008 | 4.5593 | 1.2753 | 5 | 29 | positive regulation of leukocyte migration |
GO:0002764 | 0.0082 | 2.1284 | 7.4917 | 15 | 169 | immune response-regulating signaling pathway |
GO:0051195 | 0.0082 | 9.2811 | 0.4433 | 3 | 10 | negative regulation of cofactor metabolic process |
GO:0006757 | 0.0085 | 3.3078 | 2.3495 | 7 | 53 | ATP generation from ADP |
GO:0006816 | 0.0086 | 1.8272 | 12.6783 | 22 | 286 | calcium ion transport |
GO:0060142 | 0.0087 | 5.7811 | 0.8423 | 4 | 19 | regulation of syncytium formation by plasma membrane fusion |
GO:0046683 | 0.0093 | 2.9494 | 2.9701 | 8 | 67 | response to organophosphorus |
GO:0006940 | 0.0094 | 3.2372 | 2.3938 | 7 | 54 | regulation of smooth muscle contraction |
GO:0019229 | 0.0094 | 3.2372 | 2.3938 | 7 | 54 | regulation of vasoconstriction |
GO:0022408 | 0.0095 | 2.4217 | 4.8763 | 11 | 110 | negative regulation of cell-cell adhesion |
GO:0001960 | 0.0096 | 4.3398 | 1.3299 | 5 | 30 | negative regulation of cytokine-mediated signaling pathway |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0002252 | 0 | 2.1959 | 25.1877 | 50 | 404 | immune effector process |
GO:0046649 | 0 | 2.1316 | 27.4322 | 53 | 440 | lymphocyte activation |
GO:0002286 | 0 | 4.67 | 3.9901 | 15 | 64 | T cell activation involved in immune response |
GO:0002250 | 0 | 2.5788 | 13.4667 | 31 | 216 | adaptive immune response |
GO:0006342 | 0 | 4.3995 | 4.1772 | 15 | 67 | chromatin silencing |
GO:0098542 | 1e-04 | 2.2453 | 15.6488 | 32 | 251 | defense response to other organism |
GO:0030217 | 1e-04 | 2.5159 | 10.5988 | 24 | 170 | T cell differentiation |
GO:0002366 | 4e-04 | 2.4355 | 9.9753 | 22 | 160 | leukocyte activation involved in immune response |
GO:0033141 | 4e-04 | 8.2556 | 1.0599 | 6 | 17 | positive regulation of peptidyl-serine phosphorylation of STAT protein |
GO:0002323 | 6e-04 | 7.567 | 1.1222 | 6 | 18 | natural killer cell activation involved in immune response |
GO:0044260 | 8e-04 | 1.2551 | 372.7656 | 417 | 5979 | cellular macromolecule metabolic process |
GO:0045087 | 0.0011 | 1.8199 | 21.7587 | 37 | 349 | innate immune response |
GO:0046631 | 0.0013 | 2.8007 | 5.6111 | 14 | 90 | alpha-beta T cell activation |
GO:0002521 | 0.0016 | 2.1147 | 11.7783 | 23 | 191 | leukocyte differentiation |
GO:0043368 | 0.0018 | 5.6735 | 1.3716 | 6 | 22 | positive T cell selection |
GO:0071824 | 0.0022 | 2.0969 | 11.3469 | 22 | 182 | protein-DNA complex subunit organization |
GO:0006996 | 0.0023 | 1.2729 | 177.4985 | 211 | 2847 | organelle organization |
GO:0032943 | 0.0024 | 2.4989 | 6.6216 | 15 | 107 | mononuclear cell proliferation |
GO:0043330 | 0.0024 | 3.9091 | 2.4315 | 8 | 39 | response to exogenous dsRNA |
GO:0009615 | 0.0026 | 2.1457 | 10.1 | 20 | 162 | response to virus |
GO:0040029 | 0.0026 | 2.1457 | 10.1 | 20 | 162 | regulation of gene expression, epigenetic |
GO:0043207 | 0.0026 | 1.6569 | 26.871 | 42 | 431 | response to external biotic stimulus |
GO:0042100 | 0.0027 | 2.9803 | 4.1772 | 11 | 67 | B cell proliferation |
GO:0006281 | 0.003 | 1.6879 | 23.8784 | 38 | 383 | DNA repair |
GO:0050863 | 0.0032 | 2.0644 | 10.9729 | 21 | 176 | regulation of T cell activation |
GO:0050830 | 0.0034 | 3.6716 | 2.5562 | 8 | 41 | defense response to Gram-positive bacterium |
GO:0050688 | 0.0034 | 3.3265 | 3.1173 | 9 | 50 | regulation of defense response to virus |
GO:0001775 | 0.0035 | 1.8145 | 17.0298 | 29 | 277 | cell activation |
GO:0042147 | 0.0037 | 3.0323 | 3.7407 | 10 | 60 | retrograde transport, endosome to Golgi |
GO:0019413 | 0.0039 | Inf | 0.1247 | 2 | 2 | acetate biosynthetic process |
GO:0019427 | 0.0039 | Inf | 0.1247 | 2 | 2 | acetyl-CoA biosynthetic process from acetate |
GO:0019542 | 0.0039 | Inf | 0.1247 | 2 | 2 | propionate biosynthetic process |
GO:0036228 | 0.0039 | Inf | 0.1247 | 2 | 2 | protein localization to nuclear inner membrane |
GO:0061624 | 0.0039 | Inf | 0.1247 | 2 | 2 | fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate |
GO:0061625 | 0.0039 | Inf | 0.1247 | 2 | 2 | glycolytic process through fructose-1-phosphate |
GO:1903708 | 0.004 | 2.2099 | 8.3543 | 17 | 134 | positive regulation of hemopoiesis |
GO:0060179 | 0.0042 | 15.0903 | 0.3741 | 3 | 6 | male mating behavior |
GO:0042102 | 0.0044 | 3.1712 | 3.242 | 9 | 52 | positive regulation of T cell proliferation |
GO:0043367 | 0.0046 | 3.4612 | 2.6809 | 8 | 43 | CD4-positive, alpha-beta T cell differentiation |
GO:0045621 | 0.0047 | 2.9152 | 3.8654 | 10 | 62 | positive regulation of lymphocyte differentiation |
GO:0002682 | 0.0051 | 1.4476 | 47.1958 | 65 | 757 | regulation of immune system process |
GO:1903039 | 0.0051 | 2.2789 | 7.1698 | 15 | 115 | positive regulation of leukocyte cell-cell adhesion |
GO:0042093 | 0.0052 | 3.7833 | 2.1821 | 7 | 35 | T-helper cell differentiation |
GO:0043486 | 0.0052 | 5.3976 | 1.1846 | 5 | 19 | histone exchange |
GO:0006959 | 0.0053 | 2.6906 | 4.5512 | 11 | 73 | humoral immune response |
GO:0033554 | 0.0055 | 1.3344 | 83.5434 | 106 | 1340 | cellular response to stress |
GO:0006367 | 0.0065 | 2.9637 | 3.429 | 9 | 55 | transcription initiation from RNA polymerase II promoter |
GO:0032743 | 0.0066 | 5.0374 | 1.2469 | 5 | 20 | positive regulation of interleukin-2 production |
GO:0006807 | 0.0066 | 1.1975 | 422.8917 | 458 | 6783 | nitrogen compound metabolic process |
GO:0046638 | 0.0067 | 4.1242 | 1.7457 | 6 | 28 | positive regulation of alpha-beta T cell differentiation |
GO:0002520 | 0.0068 | 1.4465 | 43.5174 | 60 | 698 | immune system development |
GO:0007288 | 0.0068 | 6.7116 | 0.8105 | 4 | 13 | sperm axoneme assembly |
GO:0032616 | 0.0068 | 6.7116 | 0.8105 | 4 | 13 | interleukin-13 production |
GO:0050670 | 0.0069 | 2.1325 | 8.105 | 16 | 130 | regulation of lymphocyte proliferation |
GO:0006325 | 0.007 | 1.5168 | 32.5508 | 47 | 529 | chromatin organization |
GO:0018095 | 0.007 | 11.3168 | 0.4364 | 3 | 7 | protein polyglutamylation |
GO:0046459 | 0.007 | 11.3168 | 0.4364 | 3 | 7 | short-chain fatty acid metabolic process |
GO:0002293 | 0.0071 | 3.5305 | 2.3068 | 7 | 37 | alpha-beta T cell differentiation involved in immune response |
GO:1902105 | 0.0072 | 1.9384 | 11.0352 | 20 | 177 | regulation of leukocyte differentiation |
GO:0032259 | 0.0077 | 1.7372 | 16.4593 | 27 | 264 | methylation |
GO:0001773 | 0.0082 | 4.7222 | 1.3093 | 5 | 21 | myeloid dendritic cell activation |
GO:0032946 | 0.0087 | 2.4888 | 4.863 | 11 | 78 | positive regulation of mononuclear cell proliferation |
GO:0050865 | 0.0094 | 1.6283 | 20.6988 | 32 | 332 | regulation of cell activation |
GO:1902532 | 0.0096 | 1.5576 | 25.6241 | 38 | 411 | negative regulation of intracellular signal transduction |
GO:0002696 | 0.0096 | 1.8778 | 11.3469 | 20 | 182 | positive regulation of leukocyte activation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 57.6451 | 1.5225 | 23 | 31 | DNA replication-dependent nucleosome assembly |
GO:0051290 | 0 | 24.2506 | 2.0628 | 23 | 42 | protein heterotetramerization |
GO:0006333 | 0 | 6.9543 | 6.3357 | 33 | 129 | chromatin assembly or disassembly |
GO:0071824 | 0 | 5.5503 | 8.9388 | 39 | 182 | protein-DNA complex subunit organization |
GO:0006323 | 0 | 6.2562 | 7.0724 | 34 | 144 | DNA packaging |
GO:0045653 | 0 | 64.1724 | 0.8349 | 13 | 17 | negative regulation of megakaryocyte differentiation |
GO:0006336 | 0 | 19.7314 | 1.277 | 13 | 26 | DNA replication-independent nucleosome assembly |
GO:0051259 | 0 | 2.2846 | 22.6907 | 47 | 462 | protein oligomerization |
GO:0051276 | 0 | 1.7861 | 43.8098 | 72 | 892 | chromosome organization |
GO:0034622 | 1e-04 | 1.7887 | 38.0635 | 63 | 775 | cellular macromolecular complex assembly |
GO:0060968 | 1e-04 | 4.5914 | 2.8486 | 11 | 58 | regulation of gene silencing |
GO:0050830 | 1e-04 | 5.5069 | 2.0137 | 9 | 41 | defense response to Gram-positive bacterium |
GO:0006334 | 2e-04 | 4.6114 | 2.5666 | 10 | 54 | nucleosome assembly |
GO:0043029 | 4e-04 | 5.3944 | 1.8172 | 8 | 37 | T cell homeostasis |
GO:0006342 | 4e-04 | 3.8507 | 3.2906 | 11 | 67 | chromatin silencing |
GO:0002250 | 4e-04 | 2.3547 | 10.6087 | 23 | 216 | adaptive immune response |
GO:0043368 | 5e-04 | 7.318 | 1.0805 | 6 | 22 | positive T cell selection |
GO:0045637 | 6e-04 | 2.5683 | 7.6618 | 18 | 156 | regulation of myeloid cell differentiation |
GO:1903707 | 7e-04 | 2.9562 | 5.2552 | 14 | 107 | negative regulation of hemopoiesis |
GO:0045321 | 9e-04 | 1.7682 | 25.2938 | 42 | 515 | leukocyte activation |
GO:0002568 | 0.0011 | 29.1697 | 0.2456 | 3 | 5 | somatic diversification of T cell receptor genes |
GO:0033153 | 0.0011 | 29.1697 | 0.2456 | 3 | 5 | T cell receptor V(D)J recombination |
GO:0009988 | 0.0013 | 4.8815 | 1.719 | 7 | 35 | cell-cell recognition |
GO:0043373 | 0.0014 | 11.1249 | 0.5403 | 4 | 11 | CD4-positive, alpha-beta T cell lineage commitment |
GO:0006565 | 0.0024 | Inf | 0.0982 | 2 | 2 | L-serine catabolic process |
GO:1990145 | 0.0024 | Inf | 0.0982 | 2 | 2 | maintenance of translational fidelity |
GO:0043207 | 0.0024 | 1.7512 | 21.1682 | 35 | 431 | response to external biotic stimulus |
GO:0032616 | 0.0029 | 8.6514 | 0.6385 | 4 | 13 | interleukin-13 production |
GO:0098542 | 0.003 | 1.9876 | 12.3277 | 23 | 251 | defense response to other organism |
GO:0002376 | 0.0033 | 1.5051 | 42.1145 | 60 | 882 | immune system process |
GO:0046631 | 0.0045 | 2.7247 | 4.4203 | 11 | 90 | alpha-beta T cell activation |
GO:0007339 | 0.0055 | 5.1263 | 1.1787 | 5 | 24 | binding of sperm to zona pellucida |
GO:0070271 | 0.0057 | 1.4247 | 50.9314 | 69 | 1037 | protein complex biogenesis |
GO:0001776 | 0.0062 | 2.7536 | 3.9782 | 10 | 81 | leukocyte homeostasis |
GO:0048534 | 0.0065 | 1.5218 | 32.4153 | 47 | 660 | hematopoietic or lymphoid organ development |
GO:0042093 | 0.0066 | 4.0334 | 1.719 | 6 | 35 | T-helper cell differentiation |
GO:0042345 | 0.0066 | 4.8696 | 1.2279 | 5 | 25 | regulation of NF-kappaB import into nucleus |
GO:0051092 | 0.0067 | 2.7151 | 4.0274 | 10 | 82 | positive regulation of NF-kappaB transcription factor activity |
GO:0030217 | 0.007 | 2.1155 | 8.0698 | 16 | 165 | T cell differentiation |
GO:0006407 | 0.007 | 38.8366 | 0.1473 | 2 | 3 | rRNA export from nucleus |
GO:0016129 | 0.007 | 38.8366 | 0.1473 | 2 | 3 | phytosteroid biosynthetic process |
GO:1903069 | 0.007 | 38.8366 | 0.1473 | 2 | 3 | regulation of ER-associated ubiquitin-dependent protein catabolic process |
GO:1904170 | 0.007 | 38.8366 | 0.1473 | 2 | 3 | regulation of bleb assembly |
GO:0007249 | 0.0072 | 2.1059 | 8.1038 | 16 | 165 | I-kappaB kinase/NF-kappaB signaling |
GO:0045087 | 0.0074 | 1.7194 | 17.1408 | 28 | 349 | innate immune response |
GO:0051249 | 0.0077 | 1.8487 | 12.5732 | 22 | 256 | regulation of lymphocyte activation |
GO:0006995 | 0.0079 | 9.7202 | 0.442 | 3 | 9 | cellular response to nitrogen starvation |
GO:0032634 | 0.0079 | 9.7202 | 0.442 | 3 | 9 | interleukin-5 production |
GO:0072540 | 0.0079 | 9.7202 | 0.442 | 3 | 9 | T-helper 17 cell lineage commitment |
GO:0002293 | 0.0087 | 3.7726 | 1.8172 | 6 | 37 | alpha-beta T cell differentiation involved in immune response |
GO:1903706 | 0.01 | 2.706 | 3.6288 | 9 | 75 | regulation of hemopoiesis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042401 | 5e-04 | 15.6246 | 0.4119 | 4 | 10 | cellular biogenic amine biosynthetic process |
GO:0008295 | 7e-04 | 35.1022 | 0.206 | 3 | 5 | spermidine biosynthetic process |
GO:0019530 | 7e-04 | 35.1022 | 0.206 | 3 | 5 | taurine metabolic process |
GO:0030317 | 0.0012 | 3.8557 | 2.6362 | 9 | 64 | flagellated sperm motility |
GO:0009445 | 0.0013 | 23.3996 | 0.2471 | 3 | 6 | putrescine metabolic process |
GO:0045471 | 0.0015 | 4.7026 | 1.73 | 7 | 42 | response to ethanol |
GO:0006597 | 0.0017 | Inf | 0.0824 | 2 | 2 | spermine biosynthetic process |
GO:0042700 | 0.0017 | Inf | 0.0824 | 2 | 2 | luteinizing hormone signaling pathway |
GO:0060435 | 0.0017 | Inf | 0.0824 | 2 | 2 | bronchiole development |
GO:1904970 | 0.0017 | Inf | 0.0824 | 2 | 2 | brush border assembly |
GO:0009792 | 0.002 | 1.6943 | 25.6202 | 41 | 622 | embryo development ending in birth or egg hatching |
GO:0044106 | 0.0026 | 4.2189 | 1.8947 | 7 | 46 | cellular amine metabolic process |
GO:0010038 | 0.0027 | 2.3526 | 7.2906 | 16 | 177 | response to metal ion |
GO:0048598 | 0.0036 | 1.6881 | 22.4898 | 36 | 546 | embryonic morphogenesis |
GO:0048706 | 0.0036 | 2.6464 | 4.9016 | 12 | 119 | embryonic skeletal system development |
GO:0006775 | 0.0037 | 5.5839 | 1.0709 | 5 | 26 | fat-soluble vitamin metabolic process |
GO:0007600 | 0.0043 | 1.7973 | 16.4349 | 28 | 399 | sensory perception |
GO:0001964 | 0.0044 | 5.3297 | 1.1121 | 5 | 27 | startle response |
GO:0060429 | 0.0046 | 1.5167 | 36.824 | 53 | 894 | epithelium development |
GO:0061140 | 0.0048 | 11.6971 | 0.3707 | 3 | 9 | lung secretory cell differentiation |
GO:0006957 | 0.0049 | 46.7213 | 0.1236 | 2 | 3 | complement activation, alternative pathway |
GO:0007386 | 0.0049 | 46.7213 | 0.1236 | 2 | 3 | compartment pattern specification |
GO:0046544 | 0.0049 | 46.7213 | 0.1236 | 2 | 3 | development of secondary male sexual characteristics |
GO:0061056 | 0.0049 | 46.7213 | 0.1236 | 2 | 3 | sclerotome development |
GO:1990918 | 0.0049 | 46.7213 | 0.1236 | 2 | 3 | double-strand break repair involved in meiotic recombination |
GO:0003008 | 0.006 | 1.4371 | 47.6569 | 65 | 1157 | system process |
GO:0001756 | 0.0061 | 3.1881 | 2.7597 | 8 | 67 | somitogenesis |
GO:1902930 | 0.0061 | 4.8848 | 1.1945 | 5 | 29 | regulation of alcohol biosynthetic process |
GO:0043691 | 0.0067 | 10.0253 | 0.4119 | 3 | 10 | reverse cholesterol transport |
GO:0050482 | 0.0067 | 6.2455 | 0.7826 | 4 | 19 | arachidonic acid secretion |
GO:0097755 | 0.0071 | 3.4255 | 2.2655 | 7 | 55 | positive regulation of blood vessel diameter |
GO:0007601 | 0.0076 | 2.8231 | 3.46 | 9 | 84 | visual perception |
GO:0007498 | 0.0081 | 2.6157 | 4.119 | 10 | 100 | mesoderm development |
GO:0030903 | 0.0082 | 5.8547 | 0.8238 | 4 | 20 | notochord development |
GO:0006123 | 0.009 | 8.7714 | 0.4531 | 3 | 11 | mitochondrial electron transport, cytochrome c to oxygen |
GO:0022602 | 0.0093 | 2.9378 | 2.9657 | 8 | 72 | ovulation cycle process |
GO:0042632 | 0.0094 | 3.2232 | 2.389 | 7 | 58 | cholesterol homeostasis |
GO:0006344 | 0.0096 | 23.3588 | 0.1648 | 2 | 4 | maintenance of chromatin silencing |
GO:0014028 | 0.0096 | 23.3588 | 0.1648 | 2 | 4 | notochord formation |
GO:0016998 | 0.0096 | 23.3588 | 0.1648 | 2 | 4 | cell wall macromolecule catabolic process |
GO:0034374 | 0.0096 | 23.3588 | 0.1648 | 2 | 4 | low-density lipoprotein particle remodeling |
GO:0045541 | 0.0096 | 23.3588 | 0.1648 | 2 | 4 | negative regulation of cholesterol biosynthetic process |
GO:0060012 | 0.0096 | 23.3588 | 0.1648 | 2 | 4 | synaptic transmission, glycinergic |
GO:0060486 | 0.0096 | 23.3588 | 0.1648 | 2 | 4 | Clara cell differentiation |
GO:0071420 | 0.0096 | 23.3588 | 0.1648 | 2 | 4 | cellular response to histamine |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006333 | 0 | 3.6266 | 6.3454 | 20 | 129 | chromatin assembly or disassembly |
GO:0006323 | 0 | 3.376 | 7.0832 | 21 | 144 | DNA packaging |
GO:0002250 | 1e-04 | 2.5905 | 10.6248 | 25 | 216 | adaptive immune response |
GO:0006342 | 1e-04 | 4.2772 | 3.2957 | 12 | 67 | chromatin silencing |
GO:0051249 | 2e-04 | 2.3338 | 12.5924 | 27 | 256 | regulation of lymphocyte activation |
GO:0030098 | 2e-04 | 2.3265 | 12.1497 | 26 | 247 | lymphocyte differentiation |
GO:0071824 | 2e-04 | 2.5714 | 8.9524 | 21 | 182 | protein-DNA complex subunit organization |
GO:0043207 | 4e-04 | 1.9223 | 21.2004 | 38 | 431 | response to external biotic stimulus |
GO:0001775 | 4e-04 | 2.1826 | 13.3563 | 27 | 277 | cell activation |
GO:0002252 | 4e-04 | 1.9425 | 19.8723 | 36 | 404 | immune effector process |
GO:0006335 | 6e-04 | 5.6877 | 1.5249 | 7 | 31 | DNA replication-dependent nucleosome assembly |
GO:0098542 | 6e-04 | 2.1832 | 12.3464 | 25 | 251 | defense response to other organism |
GO:0006334 | 7e-04 | 3.8677 | 2.9755 | 10 | 61 | nucleosome assembly |
GO:0050870 | 7e-04 | 2.9514 | 5.2632 | 14 | 107 | positive regulation of T cell activation |
GO:0006959 | 8e-04 | 3.4708 | 3.5908 | 11 | 73 | humoral immune response |
GO:0002366 | 9e-04 | 2.491 | 7.8702 | 18 | 160 | leukocyte activation involved in immune response |
GO:0000188 | 0.001 | 12.9592 | 0.4919 | 4 | 10 | inactivation of MAPK activity |
GO:0002286 | 0.0011 | 3.6194 | 3.1481 | 10 | 64 | T cell activation involved in immune response |
GO:0002568 | 0.0011 | 29.1229 | 0.2459 | 3 | 5 | somatic diversification of T cell receptor genes |
GO:0030854 | 0.0011 | 29.1229 | 0.2459 | 3 | 5 | positive regulation of granulocyte differentiation |
GO:0033153 | 0.0011 | 29.1229 | 0.2459 | 3 | 5 | T cell receptor V(D)J recombination |
GO:0060326 | 0.0014 | 2.3889 | 8.1654 | 18 | 166 | cell chemotaxis |
GO:0070661 | 0.0014 | 2.2601 | 9.5426 | 20 | 194 | leukocyte proliferation |
GO:0002696 | 0.0016 | 2.2904 | 8.9524 | 19 | 182 | positive regulation of leukocyte activation |
GO:0022409 | 0.0017 | 2.4908 | 6.9848 | 16 | 142 | positive regulation of cell-cell adhesion |
GO:0046651 | 0.0017 | 2.2763 | 9.0016 | 19 | 183 | lymphocyte proliferation |
GO:0006952 | 0.0019 | 1.7104 | 24.7876 | 40 | 514 | defense response |
GO:0050865 | 0.002 | 1.8892 | 16.3307 | 29 | 332 | regulation of cell activation |
GO:0048251 | 0.0021 | 19.4137 | 0.2951 | 3 | 6 | elastic fiber assembly |
GO:2000388 | 0.0024 | Inf | 0.0984 | 2 | 2 | positive regulation of antral ovarian follicle growth |
GO:1903037 | 0.0025 | 2.1949 | 9.2967 | 19 | 189 | regulation of leukocyte cell-cell adhesion |
GO:0072538 | 0.0029 | 8.6374 | 0.6395 | 4 | 13 | T-helper 17 type immune response |
GO:0002684 | 0.0034 | 1.8346 | 16.1748 | 28 | 334 | positive regulation of immune system process |
GO:0046632 | 0.0034 | 4.7045 | 1.5151 | 6 | 31 | alpha-beta T cell differentiation |
GO:0051276 | 0.0035 | 1.4901 | 43.8765 | 62 | 892 | chromosome organization |
GO:0042113 | 0.0035 | 2.1665 | 8.9032 | 18 | 181 | B cell activation |
GO:0030101 | 0.0036 | 3.5455 | 2.5578 | 8 | 52 | natural killer cell activation |
GO:0043368 | 0.0037 | 5.7211 | 1.0822 | 5 | 22 | positive T cell selection |
GO:0050729 | 0.0039 | 3.1931 | 3.1481 | 9 | 64 | positive regulation of inflammatory response |
GO:0032673 | 0.0039 | 7.7731 | 0.6886 | 4 | 14 | regulation of interleukin-4 production |
GO:0006955 | 0.0043 | 1.6976 | 21.13 | 34 | 444 | immune response |
GO:0032674 | 0.0055 | 11.6464 | 0.3935 | 3 | 8 | regulation of interleukin-5 production |
GO:0019884 | 0.0066 | 6.4766 | 0.787 | 4 | 16 | antigen processing and presentation of exogenous antigen |
GO:0042093 | 0.0066 | 4.0269 | 1.7216 | 6 | 35 | T-helper cell differentiation |
GO:0009957 | 0.007 | 38.7744 | 0.1476 | 2 | 3 | epidermal cell fate specification |
GO:0042414 | 0.007 | 38.7744 | 0.1476 | 2 | 3 | epinephrine metabolic process |
GO:0050705 | 0.007 | 38.7744 | 0.1476 | 2 | 3 | regulation of interleukin-1 alpha secretion |
GO:0050909 | 0.0079 | 4.6299 | 1.2789 | 5 | 26 | sensory perception of taste |
GO:0006283 | 0.008 | 9.7046 | 0.4427 | 3 | 9 | transcription-coupled nucleotide-excision repair |
GO:0009650 | 0.008 | 9.7046 | 0.4427 | 3 | 9 | UV protection |
GO:0032736 | 0.008 | 9.7046 | 0.4427 | 3 | 9 | positive regulation of interleukin-13 production |
GO:0072540 | 0.008 | 9.7046 | 0.4427 | 3 | 9 | T-helper 17 cell lineage commitment |
GO:0002293 | 0.0087 | 3.7665 | 1.82 | 6 | 37 | alpha-beta T cell differentiation involved in immune response |
GO:0002437 | 0.0093 | 4.4191 | 1.3281 | 5 | 27 | inflammatory response to antigenic stimulus |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045653 | 0 | 46.0349 | 1.1361 | 13 | 17 | negative regulation of megakaryocyte differentiation |
GO:0006336 | 0 | 14.1544 | 1.7376 | 13 | 26 | DNA replication-independent nucleosome assembly |
GO:0006335 | 0 | 11.666 | 2.0718 | 14 | 31 | DNA replication-dependent nucleosome assembly |
GO:0051276 | 0 | 1.8826 | 59.6134 | 101 | 892 | chromosome organization |
GO:0071824 | 0 | 3.0523 | 12.1633 | 32 | 182 | protein-DNA complex subunit organization |
GO:0006323 | 0 | 3.2915 | 9.6237 | 27 | 144 | DNA packaging |
GO:0006333 | 0 | 3.4243 | 8.6212 | 25 | 129 | chromatin assembly or disassembly |
GO:0090304 | 0 | 1.4139 | 247.5425 | 309 | 3704 | nucleic acid metabolic process |
GO:0051290 | 0 | 6.3369 | 2.8069 | 13 | 42 | protein heterotetramerization |
GO:0044260 | 0 | 1.3833 | 379.646 | 445 | 5763 | cellular macromolecule metabolic process |
GO:0006725 | 0 | 1.3512 | 283.2972 | 340 | 4239 | cellular aromatic compound metabolic process |
GO:1901360 | 0 | 1.3439 | 290.7154 | 347 | 4350 | organic cyclic compound metabolic process |
GO:0040029 | 0 | 2.7194 | 10.8266 | 26 | 162 | regulation of gene expression, epigenetic |
GO:0006342 | 0 | 4.0795 | 4.4777 | 15 | 67 | chromatin silencing |
GO:0046483 | 0 | 1.3406 | 281.0249 | 336 | 4205 | heterocycle metabolic process |
GO:0002323 | 1e-04 | 8.9478 | 1.203 | 7 | 18 | natural killer cell activation involved in immune response |
GO:0002252 | 1e-04 | 1.8848 | 26.9998 | 47 | 404 | immune effector process |
GO:0033554 | 2e-04 | 1.4616 | 89.5537 | 122 | 1340 | cellular response to stress |
GO:0009987 | 2e-04 | 1.3754 | 701.66 | 743 | 10499 | cellular process |
GO:0051259 | 3e-04 | 1.777 | 30.876 | 51 | 462 | protein oligomerization |
GO:0010564 | 3e-04 | 1.7803 | 30.2077 | 50 | 452 | regulation of cell cycle process |
GO:0034641 | 3e-04 | 1.2782 | 309.2945 | 357 | 4628 | cellular nitrogen compound metabolic process |
GO:0044238 | 3e-04 | 1.2714 | 477.7089 | 527 | 7148 | primary metabolic process |
GO:0006907 | 6e-04 | 7.6609 | 1.1361 | 6 | 17 | pinocytosis |
GO:0033141 | 6e-04 | 7.6609 | 1.1361 | 6 | 17 | positive regulation of peptidyl-serine phosphorylation of STAT protein |
GO:0045637 | 7e-04 | 2.3251 | 10.4257 | 22 | 156 | regulation of myeloid cell differentiation |
GO:1903707 | 7e-04 | 2.6692 | 7.1509 | 17 | 107 | negative regulation of hemopoiesis |
GO:0043330 | 9e-04 | 4.2214 | 2.6064 | 9 | 39 | response to exogenous dsRNA |
GO:0002286 | 0.001 | 3.2525 | 4.2772 | 12 | 64 | T cell activation involved in immune response |
GO:0002366 | 0.001 | 2.2569 | 10.693 | 22 | 160 | leukocyte activation involved in immune response |
GO:0048023 | 0.0011 | 42.0269 | 0.2673 | 3 | 4 | positive regulation of melanin biosynthetic process |
GO:0065003 | 0.0012 | 1.3929 | 88.4176 | 116 | 1323 | macromolecular complex assembly |
GO:0002250 | 0.0012 | 2.0257 | 14.4355 | 27 | 216 | adaptive immune response |
GO:0043414 | 0.0012 | 2.0257 | 14.4355 | 27 | 216 | macromolecule methylation |
GO:0018205 | 0.0013 | 1.9137 | 17.4429 | 31 | 261 | peptidyl-lysine modification |
GO:0032438 | 0.0016 | 7.7953 | 0.9356 | 5 | 14 | melanosome organization |
GO:0071806 | 0.002 | 3.3508 | 3.4752 | 10 | 52 | protein transmembrane transport |
GO:0071157 | 0.0023 | 7.0152 | 1.0025 | 5 | 15 | negative regulation of cell cycle arrest |
GO:0070507 | 0.0024 | 2.2184 | 9.3564 | 19 | 140 | regulation of microtubule cytoskeleton organization |
GO:0071353 | 0.0026 | 5.2648 | 1.4703 | 6 | 22 | cellular response to interleukin-4 |
GO:0000726 | 0.0026 | 3.8776 | 2.4728 | 8 | 37 | non-recombinational repair |
GO:0006297 | 0.0027 | 21.0118 | 0.3342 | 3 | 5 | nucleotide-excision repair, DNA gap filling |
GO:0006616 | 0.0027 | 21.0118 | 0.3342 | 3 | 5 | SRP-dependent cotranslational protein targeting to membrane, translocation |
GO:0051661 | 0.0027 | 21.0118 | 0.3342 | 3 | 5 | maintenance of centrosome location |
GO:1900034 | 0.0027 | 21.0118 | 0.3342 | 3 | 5 | regulation of cellular response to heat |
GO:2001034 | 0.0027 | 21.0118 | 0.3342 | 3 | 5 | positive regulation of double-strand break repair via nonhomologous end joining |
GO:0032480 | 0.0031 | 6.3769 | 1.0693 | 5 | 16 | negative regulation of type I interferon production |
GO:0048194 | 0.0033 | 4.9547 | 1.5371 | 6 | 23 | Golgi vesicle budding |
GO:1902749 | 0.0039 | 2.6822 | 5.0123 | 12 | 75 | regulation of cell cycle G2/M phase transition |
GO:0006427 | 0.0045 | Inf | 0.1337 | 2 | 2 | histidyl-tRNA aminoacylation |
GO:0061763 | 0.0045 | Inf | 0.1337 | 2 | 2 | multivesicular body-lysosome fusion |
GO:0090182 | 0.0045 | Inf | 0.1337 | 2 | 2 | regulation of secretion of lysosomal enzymes |
GO:0071285 | 0.0045 | 8.0103 | 0.7351 | 4 | 11 | cellular response to lithium ion |
GO:0060612 | 0.0045 | 3.9326 | 2.1386 | 7 | 32 | adipose tissue development |
GO:0034470 | 0.0045 | 1.7435 | 18.9132 | 31 | 283 | ncRNA processing |
GO:0042113 | 0.0047 | 1.9555 | 12.0964 | 22 | 181 | B cell activation |
GO:0006281 | 0.0049 | 1.6591 | 22.9802 | 36 | 346 | DNA repair |
GO:0046719 | 0.0051 | 14.0067 | 0.401 | 3 | 6 | regulation by virus of viral protein levels in host cell |
GO:0060179 | 0.0051 | 14.0067 | 0.401 | 3 | 6 | male mating behavior |
GO:0060753 | 0.0051 | 14.0067 | 0.401 | 3 | 6 | regulation of mast cell chemotaxis |
GO:1900376 | 0.0051 | 14.0067 | 0.401 | 3 | 6 | regulation of secondary metabolite biosynthetic process |
GO:0050687 | 0.0054 | 5.395 | 1.203 | 5 | 18 | negative regulation of defense response to virus |
GO:0070734 | 0.0054 | 5.395 | 1.203 | 5 | 18 | histone H3-K27 methylation |
GO:0051054 | 0.0056 | 1.8901 | 13.0321 | 23 | 195 | positive regulation of DNA metabolic process |
GO:0006396 | 0.0058 | 1.5857 | 27.2859 | 41 | 414 | RNA processing |
GO:0060255 | 0.0059 | 1.2043 | 285.3689 | 320 | 4270 | regulation of macromolecule metabolic process |
GO:0002377 | 0.006 | 2.5213 | 5.2797 | 12 | 79 | immunoglobulin production |
GO:0070306 | 0.0063 | 4.2105 | 1.7376 | 6 | 26 | lens fiber cell differentiation |
GO:1903432 | 0.0063 | 4.2105 | 1.7376 | 6 | 26 | regulation of TORC1 signaling |
GO:0006582 | 0.0064 | 7.0084 | 0.802 | 4 | 12 | melanin metabolic process |
GO:0034219 | 0.0064 | 7.0084 | 0.802 | 4 | 12 | carbohydrate transmembrane transport |
GO:0070723 | 0.0064 | 7.0084 | 0.802 | 4 | 12 | response to cholesterol |
GO:0036503 | 0.0066 | 2.484 | 5.3465 | 12 | 80 | ERAD pathway |
GO:0120034 | 0.0066 | 2.484 | 5.3465 | 12 | 80 | positive regulation of plasma membrane bounded cell projection assembly |
GO:0032462 | 0.007 | 5.0092 | 1.2698 | 5 | 19 | regulation of protein homooligomerization |
GO:1990830 | 0.0075 | 2.179 | 7.4851 | 15 | 112 | cellular response to leukemia inhibitory factor |
GO:0090329 | 0.0075 | 3.5104 | 2.3391 | 7 | 35 | regulation of DNA-dependent DNA replication |
GO:0071705 | 0.0077 | 1.2765 | 112.7441 | 137 | 1687 | nitrogen compound transport |
GO:0002831 | 0.008 | 2.3169 | 6.1485 | 13 | 92 | regulation of response to biotic stimulus |
GO:0002700 | 0.008 | 2.4126 | 5.4802 | 12 | 82 | regulation of production of molecular mediator of immune response |
GO:0006334 | 0.0083 | 2.8505 | 3.5625 | 9 | 54 | nucleosome assembly |
GO:0002190 | 0.0085 | 10.5042 | 0.4678 | 3 | 7 | cap-independent translational initiation |
GO:0015780 | 0.0085 | 10.5042 | 0.4678 | 3 | 7 | nucleotide-sugar transport |
GO:0045039 | 0.0085 | 10.5042 | 0.4678 | 3 | 7 | protein import into mitochondrial inner membrane |
GO:0046459 | 0.0085 | 10.5042 | 0.4678 | 3 | 7 | short-chain fatty acid metabolic process |
GO:0090186 | 0.0085 | 10.5042 | 0.4678 | 3 | 7 | regulation of pancreatic juice secretion |
GO:0002520 | 0.0087 | 1.4145 | 46.6481 | 63 | 698 | immune system development |
GO:0040015 | 0.0087 | 6.2292 | 0.8688 | 4 | 13 | negative regulation of multicellular organism growth |
GO:0006379 | 0.0088 | 4.6749 | 1.3366 | 5 | 20 | mRNA cleavage |
GO:0032801 | 0.0088 | 4.6749 | 1.3366 | 5 | 20 | receptor catabolic process |
GO:0045830 | 0.0088 | 4.6749 | 1.3366 | 5 | 20 | positive regulation of isotype switching |
GO:0051602 | 0.0088 | 4.6749 | 1.3366 | 5 | 20 | response to electrical stimulus |
GO:0045184 | 0.0097 | 1.279 | 101.5833 | 124 | 1520 | establishment of protein localization |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045653 | 0 | 46.3729 | 1.1285 | 13 | 17 | negative regulation of megakaryocyte differentiation |
GO:0006336 | 0 | 16.655 | 1.7259 | 14 | 26 | DNA replication-independent nucleosome assembly |
GO:0006335 | 0 | 13.3945 | 2.0579 | 15 | 31 | DNA replication-dependent nucleosome assembly |
GO:0071824 | 0 | 3.5722 | 12.0816 | 36 | 182 | protein-DNA complex subunit organization |
GO:0006333 | 0 | 3.9934 | 8.5634 | 28 | 129 | chromatin assembly or disassembly |
GO:0006323 | 0 | 3.4728 | 9.5591 | 28 | 144 | DNA packaging |
GO:0051276 | 0 | 1.8038 | 59.2133 | 97 | 892 | chromosome organization |
GO:0051290 | 0 | 6.3834 | 2.7881 | 13 | 42 | protein heterotetramerization |
GO:0002323 | 0 | 11.3445 | 1.1949 | 8 | 18 | natural killer cell activation involved in immune response |
GO:1903707 | 0 | 3.2846 | 7.1029 | 20 | 107 | negative regulation of hemopoiesis |
GO:0006342 | 0 | 4.1095 | 4.4476 | 15 | 67 | chromatin silencing |
GO:0002227 | 0 | 16.985 | 0.7302 | 6 | 11 | innate immune response in mucosa |
GO:0045637 | 0 | 2.7328 | 10.3557 | 25 | 156 | regulation of myeloid cell differentiation |
GO:0002366 | 1e-04 | 2.651 | 10.6212 | 25 | 160 | leukocyte activation involved in immune response |
GO:0045780 | 1e-04 | 9.9152 | 1.1285 | 7 | 17 | positive regulation of bone resorption |
GO:0002376 | 2e-04 | 1.4599 | 89.6726 | 122 | 1360 | immune system process |
GO:0046850 | 2e-04 | 4.7301 | 2.6553 | 10 | 40 | regulation of bone remodeling |
GO:0002286 | 2e-04 | 3.6234 | 4.2485 | 13 | 64 | T cell activation involved in immune response |
GO:0019731 | 3e-04 | 9.4331 | 0.9957 | 6 | 15 | antibacterial humoral response |
GO:0002697 | 3e-04 | 2.2016 | 13.9403 | 28 | 210 | regulation of immune effector process |
GO:0002251 | 4e-04 | 8.4891 | 1.0621 | 6 | 16 | organ or tissue specific immune response |
GO:0044260 | 5e-04 | 1.2625 | 396.9015 | 445 | 5979 | cellular macromolecule metabolic process |
GO:0002250 | 5e-04 | 2.1303 | 14.3386 | 28 | 216 | adaptive immune response |
GO:0006907 | 6e-04 | 7.7168 | 1.1285 | 6 | 17 | pinocytosis |
GO:0033141 | 6e-04 | 7.7168 | 1.1285 | 6 | 17 | positive regulation of peptidyl-serine phosphorylation of STAT protein |
GO:0002190 | 6e-04 | 18.8326 | 0.4647 | 4 | 7 | cap-independent translational initiation |
GO:0034105 | 7e-04 | 5.8292 | 1.5932 | 7 | 24 | positive regulation of tissue remodeling |
GO:0090304 | 7e-04 | 1.2749 | 245.8811 | 288 | 3704 | nucleic acid metabolic process |
GO:0051259 | 7e-04 | 1.7077 | 30.6688 | 49 | 462 | protein oligomerization |
GO:0061844 | 8e-04 | 7.0731 | 1.1949 | 6 | 18 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0006959 | 9e-04 | 3.0777 | 4.8459 | 13 | 73 | humoral immune response |
GO:0001510 | 0.001 | 3.7319 | 3.1864 | 10 | 48 | RNA methylation |
GO:0040029 | 0.0011 | 2.2408 | 10.754 | 22 | 162 | regulation of gene expression, epigenetic |
GO:1901360 | 0.0011 | 1.2524 | 288.7643 | 331 | 4350 | organic cyclic compound metabolic process |
GO:1990830 | 0.0011 | 2.5464 | 7.4349 | 17 | 112 | cellular response to leukemia inhibitory factor |
GO:0002192 | 0.0011 | 42.3322 | 0.2655 | 3 | 4 | IRES-dependent translational initiation of linear mRNA |
GO:0048023 | 0.0011 | 42.3322 | 0.2655 | 3 | 4 | positive regulation of melanin biosynthetic process |
GO:0006725 | 0.0012 | 1.2515 | 281.3958 | 323 | 4239 | cellular aromatic compound metabolic process |
GO:0032943 | 0.0012 | 2.127 | 12.2808 | 24 | 185 | mononuclear cell proliferation |
GO:0048534 | 0.0013 | 1.5499 | 43.8125 | 64 | 660 | hematopoietic or lymphoid organ development |
GO:0042100 | 0.0014 | 3.0969 | 4.4476 | 12 | 67 | B cell proliferation |
GO:0046483 | 0.0014 | 1.2477 | 279.1388 | 320 | 4205 | heterocycle metabolic process |
GO:0034622 | 0.0014 | 1.5039 | 51.4465 | 73 | 775 | cellular macromolecular complex assembly |
GO:0075522 | 0.0019 | 11.2977 | 0.5974 | 4 | 9 | IRES-dependent viral translational initiation |
GO:0000724 | 0.0021 | 2.6514 | 5.9081 | 14 | 89 | double-strand break repair via homologous recombination |
GO:0006334 | 0.0024 | 3.2714 | 3.5341 | 10 | 54 | nucleosome assembly |
GO:0006281 | 0.0025 | 1.7238 | 22.8505 | 37 | 346 | DNA repair |
GO:0009987 | 0.0025 | 1.2864 | 696.9509 | 730 | 10499 | cellular process |
GO:0009890 | 0.0026 | 1.3776 | 79.7255 | 104 | 1201 | negative regulation of biosynthetic process |
GO:0006616 | 0.0026 | 21.1644 | 0.3319 | 3 | 5 | SRP-dependent cotranslational protein targeting to membrane, translocation |
GO:1904177 | 0.0026 | 21.1644 | 0.3319 | 3 | 5 | regulation of adipose tissue development |
GO:2001034 | 0.0026 | 21.1644 | 0.3319 | 3 | 5 | positive regulation of double-strand break repair via nonhomologous end joining |
GO:0033554 | 0.0029 | 1.3531 | 88.9527 | 114 | 1340 | cellular response to stress |
GO:2000113 | 0.0031 | 1.3851 | 73.0872 | 96 | 1101 | negative regulation of cellular macromolecule biosynthetic process |
GO:0045184 | 0.0032 | 1.3293 | 100.9015 | 127 | 1520 | establishment of protein localization |
GO:0043330 | 0.0036 | 3.6534 | 2.5889 | 8 | 39 | response to exogenous dsRNA |
GO:0051253 | 0.0037 | 1.3931 | 66.5154 | 88 | 1002 | negative regulation of RNA metabolic process |
GO:0030183 | 0.0043 | 2.4236 | 6.3727 | 14 | 96 | B cell differentiation |
GO:0032688 | 0.0044 | 8.0685 | 0.7302 | 4 | 11 | negative regulation of interferon-beta production |
GO:0006427 | 0.0044 | Inf | 0.1328 | 2 | 2 | histidyl-tRNA aminoacylation |
GO:0051835 | 0.0044 | Inf | 0.1328 | 2 | 2 | positive regulation of synapse structural plasticity |
GO:0033036 | 0.0048 | 1.2633 | 149.0953 | 178 | 2246 | macromolecule localization |
GO:0002576 | 0.005 | 14.1085 | 0.3983 | 3 | 6 | platelet degranulation |
GO:1900376 | 0.005 | 14.1085 | 0.3983 | 3 | 6 | regulation of secondary metabolite biosynthetic process |
GO:0016192 | 0.0055 | 1.38 | 63.9264 | 84 | 963 | vesicle-mediated transport |
GO:0006261 | 0.006 | 2.2416 | 7.3021 | 15 | 110 | DNA-dependent DNA replication |
GO:0034219 | 0.0062 | 7.0594 | 0.7966 | 4 | 12 | carbohydrate transmembrane transport |
GO:0034641 | 0.0064 | 1.1988 | 307.2187 | 342 | 4628 | cellular nitrogen compound metabolic process |
GO:0019882 | 0.0065 | 2.7777 | 4.0493 | 10 | 61 | antigen processing and presentation |
GO:1903507 | 0.0066 | 1.3761 | 61.7358 | 81 | 930 | negative regulation of nucleic acid-templated transcription |
GO:0071806 | 0.0067 | 2.9636 | 3.4519 | 9 | 52 | protein transmembrane transport |
GO:0032844 | 0.0068 | 1.5885 | 25.8892 | 39 | 390 | regulation of homeostatic process |
GO:0032462 | 0.0068 | 5.0457 | 1.2613 | 5 | 19 | regulation of protein homooligomerization |
GO:0006892 | 0.0076 | 2.5554 | 4.7795 | 11 | 72 | post-Golgi vesicle-mediated transport |
GO:0071705 | 0.008 | 1.2754 | 111.9874 | 136 | 1687 | nitrogen compound transport |
GO:0050866 | 0.0083 | 2.1504 | 7.5676 | 15 | 114 | negative regulation of cell activation |
GO:0015780 | 0.0083 | 10.5805 | 0.4647 | 3 | 7 | nucleotide-sugar transport |
GO:0043312 | 0.0083 | 10.5805 | 0.4647 | 3 | 7 | neutrophil degranulation |
GO:0015833 | 0.0085 | 1.2903 | 97.516 | 120 | 1469 | peptide transport |
GO:0072599 | 0.0085 | 4.7089 | 1.3277 | 5 | 20 | establishment of protein localization to endoplasmic reticulum |
GO:0044774 | 0.0086 | 2.8314 | 3.5847 | 9 | 54 | mitotic DNA integrity checkpoint |
GO:0030100 | 0.0088 | 1.8664 | 12.0153 | 21 | 181 | regulation of endocytosis |
GO:0051154 | 0.009 | 3.855 | 1.8587 | 6 | 28 | negative regulation of striated muscle cell differentiation |
GO:0000077 | 0.009 | 2.2759 | 6.24 | 13 | 94 | DNA damage checkpoint |
GO:0002218 | 0.009 | 2.2759 | 6.24 | 13 | 94 | activation of innate immune response |
GO:0045087 | 0.0092 | 1.6064 | 22.3041 | 34 | 338 | innate immune response |
GO:0000726 | 0.0099 | 3.2998 | 2.4562 | 7 | 37 | non-recombinational repair |
GO:1902750 | 0.0099 | 3.2998 | 2.4562 | 7 | 37 | negative regulation of cell cycle G2/M phase transition |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006959 | 0 | 4.4552 | 3.438 | 13 | 73 | humoral immune response |
GO:0033141 | 1e-04 | 11.1329 | 0.8006 | 6 | 17 | positive regulation of peptidyl-serine phosphorylation of STAT protein |
GO:0098914 | 1e-04 | Inf | 0.1413 | 3 | 3 | membrane repolarization during atrial cardiac muscle cell action potential |
GO:0002323 | 1e-04 | 10.2043 | 0.8477 | 6 | 18 | natural killer cell activation involved in immune response |
GO:0099622 | 2e-04 | 9.4186 | 0.8948 | 6 | 19 | cardiac muscle cell membrane repolarization |
GO:1901381 | 2e-04 | 6.809 | 1.3187 | 7 | 28 | positive regulation of potassium ion transmembrane transport |
GO:0006342 | 3e-04 | 4.0273 | 3.1554 | 11 | 67 | chromatin silencing |
GO:0071804 | 4e-04 | 2.9135 | 6.0754 | 16 | 129 | cellular potassium ion transport |
GO:0060372 | 4e-04 | 60.9856 | 0.1884 | 3 | 4 | regulation of atrial cardiac muscle cell membrane repolarization |
GO:0086002 | 7e-04 | 5.4974 | 1.5542 | 7 | 33 | cardiac muscle cell action potential involved in contraction |
GO:0003012 | 8e-04 | 2.1004 | 13.281 | 26 | 282 | muscle system process |
GO:0060681 | 0.001 | 30.4904 | 0.2355 | 3 | 5 | branch elongation involved in ureteric bud branching |
GO:0007626 | 0.001 | 2.3284 | 9.2779 | 20 | 197 | locomotory behavior |
GO:0042100 | 0.0011 | 3.5908 | 3.1554 | 10 | 67 | B cell proliferation |
GO:0086026 | 0.0012 | 11.6294 | 0.5181 | 4 | 11 | atrial cardiac muscle cell to AV node cell signaling |
GO:0086065 | 0.0013 | 5.8269 | 1.2716 | 6 | 27 | cell communication involved in cardiac conduction |
GO:0034767 | 0.0014 | 2.8668 | 4.9922 | 13 | 106 | positive regulation of ion transmembrane transport |
GO:0001508 | 0.0015 | 2.8361 | 5.0392 | 13 | 107 | action potential |
GO:0086091 | 0.0017 | 5.5616 | 1.3187 | 6 | 28 | regulation of heart rate by cardiac conduction |
GO:0044057 | 0.0017 | 1.866 | 17.6609 | 31 | 375 | regulation of system process |
GO:0043330 | 0.002 | 4.4645 | 1.8367 | 7 | 39 | response to exogenous dsRNA |
GO:1903169 | 0.0021 | 2.8587 | 4.6154 | 12 | 98 | regulation of calcium ion transmembrane transport |
GO:0001810 | 0.0022 | Inf | 0.0942 | 2 | 2 | regulation of type I hypersensitivity |
GO:0010848 | 0.0022 | Inf | 0.0942 | 2 | 2 | regulation of chromatin disassembly |
GO:0042700 | 0.0022 | Inf | 0.0942 | 2 | 2 | luteinizing hormone signaling pathway |
GO:1904970 | 0.0022 | Inf | 0.0942 | 2 | 2 | brush border assembly |
GO:0060306 | 0.0025 | 6.3655 | 0.989 | 5 | 21 | regulation of membrane repolarization |
GO:0035637 | 0.0025 | 2.7932 | 4.7096 | 12 | 100 | multicellular organismal signaling |
GO:0006941 | 0.0038 | 2.642 | 4.9451 | 12 | 105 | striated muscle contraction |
GO:0040029 | 0.0041 | 2.2491 | 7.6295 | 16 | 162 | regulation of gene expression, epigenetic |
GO:0030183 | 0.0054 | 2.6472 | 4.5212 | 11 | 96 | B cell differentiation |
GO:0031295 | 0.0056 | 6.7812 | 0.7535 | 4 | 16 | T cell costimulation |
GO:0034762 | 0.0057 | 1.7983 | 15.259 | 26 | 324 | regulation of transmembrane transport |
GO:0043269 | 0.0058 | 1.6336 | 23.1711 | 36 | 492 | regulation of ion transport |
GO:0006937 | 0.006 | 2.4807 | 5.2276 | 12 | 111 | regulation of muscle contraction |
GO:0010756 | 0.0064 | 40.5924 | 0.1413 | 2 | 3 | positive regulation of plasminogen activation |
GO:0015840 | 0.0064 | 40.5924 | 0.1413 | 2 | 3 | urea transport |
GO:0035964 | 0.0064 | 40.5924 | 0.1413 | 2 | 3 | COPI-coated vesicle budding |
GO:0043266 | 0.0071 | 2.8721 | 3.438 | 9 | 73 | regulation of potassium ion transport |
GO:0007628 | 0.0071 | 3.9442 | 1.7425 | 6 | 37 | adult walking behavior |
GO:0006641 | 0.0083 | 3.0232 | 2.9199 | 8 | 62 | triglyceride metabolic process |
GO:0098662 | 0.0084 | 1.6679 | 18.8854 | 30 | 401 | inorganic cation transmembrane transport |
GO:0051590 | 0.0088 | 5.8115 | 0.8477 | 4 | 18 | positive regulation of neurotransmitter transport |
GO:0009954 | 0.0091 | 4.4257 | 1.3187 | 5 | 28 | proximal/distal pattern formation |
GO:0010919 | 0.0097 | 8.7081 | 0.471 | 3 | 10 | regulation of inositol phosphate biosynthetic process |
GO:0060452 | 0.0097 | 8.7081 | 0.471 | 3 | 10 | positive regulation of cardiac muscle contraction |
GO:0006638 | 0.01 | 2.7023 | 3.6264 | 9 | 77 | neutral lipid metabolic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0002323 | 0 | 14.9621 | 0.7428 | 7 | 18 | natural killer cell activation involved in immune response |
GO:0033141 | 0 | 12.8012 | 0.7015 | 6 | 17 | positive regulation of peptidyl-serine phosphorylation of STAT protein |
GO:0007155 | 1e-04 | 1.7715 | 36.5607 | 60 | 886 | cell adhesion |
GO:0045662 | 1e-04 | 10.0557 | 0.8253 | 6 | 20 | negative regulation of myoblast differentiation |
GO:0045087 | 1e-04 | 2.2531 | 14.4014 | 30 | 349 | innate immune response |
GO:0003008 | 2e-04 | 1.6507 | 47.7434 | 73 | 1157 | system process |
GO:0002286 | 3e-04 | 4.3635 | 2.641 | 10 | 64 | T cell activation involved in immune response |
GO:0006959 | 5e-04 | 4.9955 | 1.8813 | 8 | 46 | humoral immune response |
GO:0072179 | 7e-04 | 35.0355 | 0.2063 | 3 | 5 | nephric duct formation |
GO:0050672 | 7e-04 | 4.7004 | 1.9807 | 8 | 48 | negative regulation of lymphocyte proliferation |
GO:0070664 | 9e-04 | 4.4758 | 2.0632 | 8 | 50 | negative regulation of leukocyte proliferation |
GO:0043330 | 0.001 | 5.1348 | 1.6093 | 7 | 39 | response to exogenous dsRNA |
GO:0050868 | 0.0011 | 3.9199 | 2.5997 | 9 | 63 | negative regulation of T cell activation |
GO:0006525 | 0.0011 | 11.6943 | 0.4952 | 4 | 12 | arginine metabolic process |
GO:0032944 | 0.0011 | 2.8022 | 5.447 | 14 | 132 | regulation of mononuclear cell proliferation |
GO:0030240 | 0.0013 | 23.3552 | 0.2476 | 3 | 6 | skeletal muscle thin filament assembly |
GO:0061218 | 0.0013 | 23.3552 | 0.2476 | 3 | 6 | negative regulation of mesonephros development |
GO:0042129 | 0.0014 | 3.199 | 3.7964 | 11 | 92 | regulation of T cell proliferation |
GO:0006342 | 0.0016 | 3.6484 | 2.7647 | 9 | 67 | chromatin silencing |
GO:0042100 | 0.0016 | 3.6484 | 2.7647 | 9 | 67 | B cell proliferation |
GO:0002037 | 0.0017 | Inf | 0.0825 | 2 | 2 | negative regulation of L-glutamate transport |
GO:0002740 | 0.0017 | Inf | 0.0825 | 2 | 2 | negative regulation of cytokine secretion involved in immune response |
GO:0002874 | 0.0017 | Inf | 0.0825 | 2 | 2 | regulation of chronic inflammatory response to antigenic stimulus |
GO:0010963 | 0.0017 | Inf | 0.0825 | 2 | 2 | regulation of L-arginine import |
GO:0019547 | 0.0017 | Inf | 0.0825 | 2 | 2 | arginine catabolic process to ornithine |
GO:0002828 | 0.0017 | 6.8868 | 0.9078 | 5 | 22 | regulation of type 2 immune response |
GO:0055001 | 0.0018 | 2.6439 | 5.7358 | 14 | 139 | muscle cell development |
GO:0048525 | 0.002 | 3.9145 | 2.3108 | 8 | 56 | negative regulation of viral process |
GO:0035265 | 0.0022 | 2.5813 | 5.8596 | 14 | 142 | organ growth |
GO:0002695 | 0.0025 | 2.9429 | 4.0852 | 11 | 99 | negative regulation of leukocyte activation |
GO:0051955 | 0.0028 | 4.8488 | 1.4443 | 6 | 35 | regulation of amino acid transport |
GO:0009615 | 0.0029 | 2.4091 | 6.6849 | 15 | 162 | response to virus |
GO:0000050 | 0.0033 | 14.0109 | 0.3301 | 3 | 8 | urea cycle |
GO:0046007 | 0.0033 | 14.0109 | 0.3301 | 3 | 8 | negative regulation of activated T cell proliferation |
GO:0060677 | 0.0033 | 14.0109 | 0.3301 | 3 | 8 | ureteric bud elongation |
GO:0009952 | 0.0035 | 2.2197 | 8.1704 | 17 | 198 | anterior/posterior pattern specification |
GO:0002250 | 0.0037 | 2.1496 | 8.9132 | 18 | 216 | adaptive immune response |
GO:0042742 | 0.004 | 2.7538 | 4.3328 | 11 | 105 | defense response to bacterium |
GO:0022408 | 0.0045 | 2.7058 | 4.4003 | 11 | 107 | negative regulation of cell-cell adhesion |
GO:0033002 | 0.0046 | 2.2833 | 7.015 | 15 | 170 | muscle cell proliferation |
GO:0001580 | 0.0049 | 11.6749 | 0.3714 | 3 | 9 | detection of chemical stimulus involved in sensory perception of bitter taste |
GO:0002544 | 0.0049 | 11.6749 | 0.3714 | 3 | 9 | chronic inflammatory response |
GO:0033601 | 0.0049 | 11.6749 | 0.3714 | 3 | 9 | positive regulation of mammary gland epithelial cell proliferation |
GO:0036414 | 0.005 | 46.6327 | 0.1238 | 2 | 3 | histone citrullination |
GO:0061209 | 0.005 | 46.6327 | 0.1238 | 2 | 3 | cell proliferation involved in mesonephros development |
GO:0070317 | 0.005 | 46.6327 | 0.1238 | 2 | 3 | negative regulation of G0 to G1 transition |
GO:0071502 | 0.005 | 46.6327 | 0.1238 | 2 | 3 | cellular response to temperature stimulus |
GO:0072199 | 0.005 | 46.6327 | 0.1238 | 2 | 3 | regulation of mesenchymal cell proliferation involved in ureter development |
GO:0090467 | 0.005 | 46.6327 | 0.1238 | 2 | 3 | arginine import |
GO:2000048 | 0.005 | 46.6327 | 0.1238 | 2 | 3 | negative regulation of cell-cell adhesion mediated by cadherin |
GO:0045071 | 0.0053 | 5.0878 | 1.1554 | 5 | 28 | negative regulation of viral genome replication |
GO:0032943 | 0.0053 | 3.6284 | 2.1528 | 7 | 53 | mononuclear cell proliferation |
GO:0006956 | 0.0055 | 6.6794 | 0.7428 | 4 | 18 | complement activation |
GO:0070233 | 0.0055 | 6.6794 | 0.7428 | 4 | 18 | negative regulation of T cell apoptotic process |
GO:0071467 | 0.0055 | 6.6794 | 0.7428 | 4 | 18 | cellular response to pH |
GO:0051147 | 0.0059 | 2.3737 | 5.8596 | 13 | 142 | regulation of muscle cell differentiation |
GO:0048660 | 0.0065 | 2.5615 | 4.6217 | 11 | 112 | regulation of smooth muscle cell proliferation |
GO:0034097 | 0.0065 | 1.6568 | 20.9213 | 33 | 507 | response to cytokine |
GO:0008283 | 0.0067 | 1.4036 | 54.8913 | 73 | 1350 | cell proliferation |
GO:0071941 | 0.0067 | 10.0062 | 0.4126 | 3 | 10 | nitrogen cycle metabolic process |
GO:0072176 | 0.0067 | 10.0062 | 0.4126 | 3 | 10 | nephric duct development |
GO:0048754 | 0.0068 | 2.2443 | 6.6436 | 14 | 161 | branching morphogenesis of an epithelial tube |
GO:0009582 | 0.0071 | 2.856 | 3.425 | 9 | 83 | detection of abiotic stimulus |
GO:0010927 | 0.0071 | 2.856 | 3.425 | 9 | 83 | cellular component assembly involved in morphogenesis |
GO:0002263 | 0.0076 | 2.2138 | 6.7262 | 14 | 163 | cell activation involved in immune response |
GO:0007601 | 0.0076 | 2.8177 | 3.4662 | 9 | 84 | visual perception |
GO:0009581 | 0.0076 | 2.8177 | 3.4662 | 9 | 84 | detection of external stimulus |
GO:0050906 | 0.008 | 3.0273 | 2.8885 | 8 | 70 | detection of stimulus involved in sensory perception |
GO:0045214 | 0.0082 | 4.4997 | 1.2792 | 5 | 31 | sarcomere organization |
GO:0002455 | 0.0082 | 5.8435 | 0.8253 | 4 | 20 | humoral immune response mediated by circulating immunoglobulin |
GO:0061061 | 0.0086 | 1.6213 | 21.3339 | 33 | 517 | muscle structure development |
GO:0002698 | 0.0087 | 2.979 | 2.9298 | 8 | 71 | negative regulation of immune effector process |
GO:0031347 | 0.0087 | 1.7968 | 13.4523 | 23 | 326 | regulation of defense response |
GO:0060041 | 0.0089 | 2.4397 | 4.828 | 11 | 117 | retina development in camera-type eye |
GO:0021930 | 0.009 | 8.7548 | 0.4539 | 3 | 11 | cerebellar granule cell precursor proliferation |
GO:0045019 | 0.009 | 8.7548 | 0.4539 | 3 | 11 | negative regulation of nitric oxide biosynthetic process |
GO:0019221 | 0.0094 | 1.9857 | 9.037 | 17 | 219 | cytokine-mediated signaling pathway |
GO:0051146 | 0.0094 | 1.9857 | 9.037 | 17 | 219 | striated muscle cell differentiation |
GO:0002922 | 0.0096 | 23.3145 | 0.1651 | 2 | 4 | positive regulation of humoral immune response |
GO:0003097 | 0.0096 | 23.3145 | 0.1651 | 2 | 4 | renal water transport |
GO:0010760 | 0.0096 | 23.3145 | 0.1651 | 2 | 4 | negative regulation of macrophage chemotaxis |
GO:0016115 | 0.0096 | 23.3145 | 0.1651 | 2 | 4 | terpenoid catabolic process |
GO:0035549 | 0.0096 | 23.3145 | 0.1651 | 2 | 4 | positive regulation of interferon-beta secretion |
GO:0061668 | 0.0096 | 23.3145 | 0.1651 | 2 | 4 | mitochondrial ribosome assembly |
GO:0072095 | 0.0096 | 23.3145 | 0.1651 | 2 | 4 | regulation of branch elongation involved in ureteric bud branching |
GO:1902023 | 0.0096 | 23.3145 | 0.1651 | 2 | 4 | L-arginine transport |
GO:0046633 | 0.0098 | 5.4994 | 0.8666 | 4 | 21 | alpha-beta T cell proliferation |
GO:0060065 | 0.0098 | 5.4994 | 0.8666 | 4 | 21 | uterus development |
GO:0048747 | 0.01 | 3.6027 | 1.8569 | 6 | 45 | muscle fiber development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0003008 | 0 | 1.9875 | 51.9815 | 92 | 1157 | system process |
GO:0099537 | 0 | 2.4687 | 20.7117 | 46 | 461 | trans-synaptic signaling |
GO:0007268 | 0 | 2.3413 | 17.3071 | 37 | 389 | chemical synaptic transmission |
GO:0030534 | 0 | 3.3861 | 6.3348 | 19 | 141 | adult behavior |
GO:0007218 | 0 | 5.8257 | 2.1116 | 10 | 47 | neuropeptide signaling pathway |
GO:0030916 | 1e-04 | 42.794 | 0.2696 | 4 | 6 | otic vesicle formation |
GO:0072190 | 1e-04 | Inf | 0.1348 | 3 | 3 | ureter urothelium development |
GO:0007186 | 2e-04 | 1.991 | 20.5276 | 38 | 463 | G-protein coupled receptor signaling pathway |
GO:0006323 | 3e-04 | 2.8993 | 6.4696 | 17 | 144 | DNA packaging |
GO:0030001 | 3e-04 | 1.8182 | 27.0915 | 46 | 603 | metal ion transport |
GO:0043269 | 4e-04 | 1.8878 | 22.1045 | 39 | 492 | regulation of ion transport |
GO:0051938 | 4e-04 | 17.1136 | 0.4044 | 4 | 9 | L-glutamate import |
GO:0006936 | 4e-04 | 2.4375 | 9.345 | 21 | 208 | muscle contraction |
GO:0048665 | 4e-04 | 6.0106 | 1.4377 | 7 | 32 | neuron fate specification |
GO:0007267 | 5e-04 | 2.1067 | 14.2759 | 28 | 333 | cell-cell signaling |
GO:0003148 | 5e-04 | 7.1473 | 1.0783 | 6 | 24 | outflow tract septum morphogenesis |
GO:0007626 | 6e-04 | 2.4503 | 8.8508 | 20 | 197 | locomotory behavior |
GO:0019233 | 6e-04 | 3.1877 | 4.5377 | 13 | 101 | sensory perception of pain |
GO:1904062 | 7e-04 | 2.3606 | 9.6146 | 21 | 214 | regulation of cation transmembrane transport |
GO:0098660 | 7e-04 | 1.9034 | 19.6335 | 35 | 437 | inorganic ion transmembrane transport |
GO:0006333 | 7e-04 | 2.8431 | 5.7957 | 15 | 129 | chromatin assembly or disassembly |
GO:0001661 | 8e-04 | 32.0418 | 0.2246 | 3 | 5 | conditioned taste aversion |
GO:0080154 | 9e-04 | 8.2363 | 0.8087 | 5 | 18 | regulation of fertilization |
GO:0031644 | 0.001 | 3.6471 | 3.1 | 10 | 69 | regulation of neurological system process |
GO:0001508 | 0.001 | 2.9828 | 4.8073 | 13 | 107 | action potential |
GO:0060968 | 0.001 | 3.9487 | 2.6058 | 9 | 58 | regulation of gene silencing |
GO:0045165 | 0.0011 | 2.2538 | 10.0189 | 21 | 223 | cell fate commitment |
GO:0009712 | 0.0013 | 4.845 | 1.7073 | 7 | 38 | catechol-containing compound metabolic process |
GO:0071824 | 0.0014 | 2.3743 | 8.1769 | 18 | 182 | protein-DNA complex subunit organization |
GO:0006334 | 0.0014 | 3.7507 | 2.7195 | 9 | 61 | nucleosome assembly |
GO:0034762 | 0.0015 | 1.9764 | 14.5566 | 27 | 324 | regulation of transmembrane transport |
GO:0010524 | 0.0016 | 4.6932 | 1.7522 | 7 | 39 | positive regulation of calcium ion transport into cytosol |
GO:0061439 | 0.0016 | 21.3595 | 0.2696 | 3 | 6 | kidney vasculature morphogenesis |
GO:0072161 | 0.0016 | 21.3595 | 0.2696 | 3 | 6 | mesenchymal cell differentiation involved in kidney development |
GO:0007612 | 0.002 | 2.6258 | 5.7957 | 14 | 129 | learning |
GO:0006565 | 0.002 | Inf | 0.0899 | 2 | 2 | L-serine catabolic process |
GO:0009946 | 0.002 | Inf | 0.0899 | 2 | 2 | proximal/distal axis specification |
GO:0032912 | 0.002 | Inf | 0.0899 | 2 | 2 | negative regulation of transforming growth factor beta2 production |
GO:0046874 | 0.002 | Inf | 0.0899 | 2 | 2 | quinolinate metabolic process |
GO:0048389 | 0.002 | Inf | 0.0899 | 2 | 2 | intermediate mesoderm development |
GO:0061227 | 0.002 | Inf | 0.0899 | 2 | 2 | pattern specification involved in mesonephros development |
GO:0072098 | 0.002 | Inf | 0.0899 | 2 | 2 | anterior/posterior pattern specification involved in kidney development |
GO:0086098 | 0.002 | Inf | 0.0899 | 2 | 2 | angiotensin-activated signaling pathway involved in heart process |
GO:0042415 | 0.0021 | 9.5046 | 0.5841 | 4 | 13 | norepinephrine metabolic process |
GO:0071599 | 0.0021 | 9.5046 | 0.5841 | 4 | 13 | otic vesicle development |
GO:0019226 | 0.0021 | 3.5162 | 2.8754 | 9 | 64 | transmission of nerve impulse |
GO:0007399 | 0.0022 | 1.3915 | 80.5107 | 105 | 1792 | nervous system development |
GO:0006335 | 0.0023 | 5.1433 | 1.3928 | 6 | 31 | DNA replication-dependent nucleosome assembly |
GO:0021884 | 0.0023 | 5.1433 | 1.3928 | 6 | 31 | forebrain neuron development |
GO:0021983 | 0.0023 | 5.1433 | 1.3928 | 6 | 31 | pituitary gland development |
GO:1902893 | 0.0023 | 5.1433 | 1.3928 | 6 | 31 | regulation of pri-miRNA transcription from RNA polymerase II promoter |
GO:0032411 | 0.0023 | 3.2096 | 3.4594 | 10 | 77 | positive regulation of transporter activity |
GO:0051966 | 0.0023 | 3.8167 | 2.3812 | 8 | 53 | regulation of synaptic transmission, glutamatergic |
GO:0007155 | 0.0024 | 1.5413 | 39.8061 | 58 | 886 | cell adhesion |
GO:0048699 | 0.0024 | 1.4547 | 56.8787 | 78 | 1266 | generation of neurons |
GO:0015672 | 0.0024 | 1.9041 | 15.0508 | 27 | 335 | monovalent inorganic cation transport |
GO:1901016 | 0.0024 | 4.2899 | 1.887 | 7 | 42 | regulation of potassium ion transmembrane transporter activity |
GO:0048791 | 0.0025 | 6.2964 | 0.9884 | 5 | 22 | calcium ion-regulated exocytosis of neurotransmitter |
GO:0060235 | 0.0028 | 16.0184 | 0.3145 | 3 | 7 | lens induction in camera-type eye |
GO:0098712 | 0.0028 | 16.0184 | 0.3145 | 3 | 7 | L-glutamate import across plasma membrane |
GO:0010954 | 0.0028 | 8.5534 | 0.629 | 4 | 14 | positive regulation of protein processing |
GO:0034767 | 0.0028 | 2.7487 | 4.7624 | 12 | 106 | positive regulation of ion transmembrane transport |
GO:0060828 | 0.0029 | 2.3337 | 7.3682 | 16 | 164 | regulation of canonical Wnt signaling pathway |
GO:0006342 | 0.0029 | 3.3336 | 3.0102 | 9 | 67 | chromatin silencing |
GO:2000021 | 0.0031 | 2.3969 | 6.7392 | 15 | 150 | regulation of ion homeostasis |
GO:0009953 | 0.0032 | 2.8512 | 4.2232 | 11 | 94 | dorsal/ventral pattern formation |
GO:0023061 | 0.0034 | 1.8316 | 16.174 | 28 | 360 | signal release |
GO:0007269 | 0.0036 | 2.663 | 4.8971 | 12 | 109 | neurotransmitter secretion |
GO:0051956 | 0.0037 | 7.7752 | 0.6739 | 4 | 15 | negative regulation of amino acid transport |
GO:0007340 | 0.0038 | 5.6327 | 1.0783 | 5 | 24 | acrosome reaction |
GO:0008217 | 0.0038 | 2.5226 | 5.5711 | 13 | 124 | regulation of blood pressure |
GO:0030177 | 0.0038 | 2.7837 | 4.3131 | 11 | 96 | positive regulation of Wnt signaling pathway |
GO:0051899 | 0.004 | 3.1689 | 3.145 | 9 | 70 | membrane depolarization |
GO:2001259 | 0.0042 | 4.4525 | 1.5658 | 6 | 35 | positive regulation of cation channel activity |
GO:0000050 | 0.0043 | 12.8137 | 0.3594 | 3 | 8 | urea cycle |
GO:0002495 | 0.0043 | 12.8137 | 0.3594 | 3 | 8 | antigen processing and presentation of peptide antigen via MHC class II |
GO:0019372 | 0.0043 | 12.8137 | 0.3594 | 3 | 8 | lipoxygenase pathway |
GO:2000543 | 0.0043 | 12.8137 | 0.3594 | 3 | 8 | positive regulation of gastrulation |
GO:0099565 | 0.0044 | 3.1175 | 3.1899 | 9 | 71 | chemical synaptic transmission, postsynaptic |
GO:0009612 | 0.0044 | 2.5825 | 5.0319 | 12 | 112 | response to mechanical stimulus |
GO:0001958 | 0.0045 | 5.3507 | 1.1232 | 5 | 25 | endochondral ossification |
GO:0060294 | 0.0048 | 7.1267 | 0.7188 | 4 | 16 | cilium movement involved in cell motility |
GO:0098742 | 0.0048 | 2.5568 | 5.0768 | 12 | 113 | cell-cell adhesion via plasma-membrane adhesion molecules |
GO:0071805 | 0.005 | 2.4341 | 5.7508 | 13 | 128 | potassium ion transmembrane transport |
GO:0044236 | 0.0051 | 2.8275 | 3.8638 | 10 | 86 | multicellular organism metabolic process |
GO:0043266 | 0.0052 | 3.0196 | 3.2797 | 9 | 73 | regulation of potassium ion transport |
GO:0060078 | 0.0052 | 3.0196 | 3.2797 | 9 | 73 | regulation of postsynaptic membrane potential |
GO:0050890 | 0.0054 | 1.983 | 10.6928 | 20 | 238 | cognition |
GO:0007605 | 0.0055 | 2.5067 | 5.1667 | 12 | 115 | sensory perception of sound |
GO:0055065 | 0.0056 | 1.7232 | 18.3306 | 30 | 408 | metal ion homeostasis |
GO:0007628 | 0.0057 | 4.1458 | 1.6623 | 6 | 37 | adult walking behavior |
GO:0051952 | 0.0057 | 2.9729 | 3.3247 | 9 | 74 | regulation of amine transport |
GO:0010046 | 0.0059 | 42.6544 | 0.1348 | 2 | 3 | response to mycotoxin |
GO:0019244 | 0.0059 | 42.6544 | 0.1348 | 2 | 3 | lactate biosynthetic process from pyruvate |
GO:0034124 | 0.0059 | 42.6544 | 0.1348 | 2 | 3 | regulation of MyD88-dependent toll-like receptor signaling pathway |
GO:0035993 | 0.0059 | 42.6544 | 0.1348 | 2 | 3 | deltoid tuberosity development |
GO:0042414 | 0.0059 | 42.6544 | 0.1348 | 2 | 3 | epinephrine metabolic process |
GO:0061056 | 0.0059 | 42.6544 | 0.1348 | 2 | 3 | sclerotome development |
GO:0061792 | 0.0059 | 42.6544 | 0.1348 | 2 | 3 | secretory granule maturation |
GO:0070949 | 0.0059 | 42.6544 | 0.1348 | 2 | 3 | regulation of neutrophil mediated killing of symbiont cell |
GO:1900106 | 0.0059 | 42.6544 | 0.1348 | 2 | 3 | positive regulation of hyaluranon cable assembly |
GO:2000048 | 0.0059 | 42.6544 | 0.1348 | 2 | 3 | negative regulation of cell-cell adhesion mediated by cadherin |
GO:0001704 | 0.006 | 2.7546 | 3.9537 | 10 | 88 | formation of primary germ layer |
GO:0044745 | 0.0062 | 10.6773 | 0.4044 | 3 | 9 | amino acid transmembrane import |
GO:0001964 | 0.0064 | 4.8635 | 1.2131 | 5 | 27 | startle response |
GO:0035116 | 0.0064 | 4.8635 | 1.2131 | 5 | 27 | embryonic hindlimb morphogenesis |
GO:0198738 | 0.0065 | 1.7988 | 14.6465 | 25 | 326 | cell-cell signaling by wnt |
GO:0097756 | 0.0068 | 2.8837 | 3.4145 | 9 | 76 | negative regulation of blood vessel diameter |
GO:0048706 | 0.0072 | 2.4123 | 5.3464 | 12 | 119 | embryonic skeletal system development |
GO:0016048 | 0.0075 | 6.1077 | 0.8087 | 4 | 18 | detection of temperature stimulus |
GO:0060004 | 0.0075 | 6.1077 | 0.8087 | 4 | 18 | reflex |
GO:0061437 | 0.0075 | 6.1077 | 0.8087 | 4 | 18 | renal system vasculature development |
GO:0030317 | 0.0076 | 3.0643 | 2.8754 | 8 | 64 | flagellated sperm motility |
GO:0048762 | 0.0078 | 2.1402 | 7.458 | 15 | 166 | mesenchymal cell differentiation |
GO:0021953 | 0.0081 | 2.1988 | 6.7869 | 14 | 152 | central nervous system neuron differentiation |
GO:1901605 | 0.0082 | 2.2743 | 6.1102 | 13 | 136 | alpha-amino acid metabolic process |
GO:0032964 | 0.0084 | 3.7791 | 1.7971 | 6 | 40 | collagen biosynthetic process |
GO:0035970 | 0.0085 | 9.1512 | 0.4493 | 3 | 10 | peptidyl-threonine dephosphorylation |
GO:0042487 | 0.0085 | 9.1512 | 0.4493 | 3 | 10 | regulation of odontogenesis of dentin-containing tooth |
GO:0043589 | 0.0085 | 9.1512 | 0.4493 | 3 | 10 | skin morphogenesis |
GO:0071941 | 0.0085 | 9.1512 | 0.4493 | 3 | 10 | nitrogen cycle metabolic process |
GO:1903818 | 0.0085 | 9.1512 | 0.4493 | 3 | 10 | positive regulation of voltage-gated potassium channel activity |
GO:0032412 | 0.0087 | 2.3461 | 5.479 | 12 | 123 | regulation of ion transmembrane transporter activity |
GO:0021522 | 0.0087 | 4.4575 | 1.3029 | 5 | 29 | spinal cord motor neuron differentiation |
GO:0042417 | 0.0087 | 4.4575 | 1.3029 | 5 | 29 | dopamine metabolic process |
GO:1902476 | 0.0087 | 4.4575 | 1.3029 | 5 | 29 | chloride transmembrane transport |
GO:0014048 | 0.0091 | 5.7001 | 0.8536 | 4 | 19 | regulation of glutamate secretion |
GO:2000738 | 0.0091 | 5.7001 | 0.8536 | 4 | 19 | positive regulation of stem cell differentiation |
GO:0060425 | 0.0091 | 3.2612 | 2.3812 | 7 | 53 | lung morphogenesis |
GO:1903522 | 0.0092 | 2.098 | 7.5928 | 15 | 169 | regulation of blood circulation |
GO:0098739 | 0.0094 | 3.6709 | 1.842 | 6 | 41 | import across plasma membrane |
GO:1905114 | 0.0095 | 1.7605 | 14.3262 | 24 | 322 | cell surface receptor signaling pathway involved in cell-cell signaling |
GO:0003015 | 0.0095 | 2.1526 | 6.9189 | 14 | 154 | heart process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050431 | 6e-04 | 9.4575 | 0.7228 | 5 | 17 | transforming growth factor beta binding |
GO:0022838 | 6e-04 | 2.1513 | 12.968 | 26 | 305 | substrate-specific channel activity |
GO:0005125 | 7e-04 | 2.9677 | 5.1872 | 14 | 122 | cytokine activity |
GO:0004620 | 0.0012 | 3.8695 | 2.6361 | 9 | 62 | phospholipase activity |
GO:0022803 | 0.0013 | 2.032 | 13.6483 | 26 | 321 | passive transmembrane transporter activity |
GO:0008307 | 0.0016 | 7.0909 | 0.8929 | 5 | 21 | structural constituent of muscle |
GO:0005133 | 0.0018 | Inf | 0.085 | 2 | 2 | interferon-gamma receptor binding |
GO:0005146 | 0.0018 | Inf | 0.085 | 2 | 2 | leukemia inhibitory factor receptor binding |
GO:0032029 | 0.0018 | Inf | 0.085 | 2 | 2 | myosin tail binding |
GO:0005509 | 0.002 | 1.8616 | 17.0923 | 30 | 402 | calcium ion binding |
GO:0004867 | 0.002 | 5.2416 | 1.3606 | 6 | 32 | serine-type endopeptidase inhibitor activity |
GO:0005261 | 0.0024 | 2.1449 | 9.9492 | 20 | 234 | cation channel activity |
GO:0016289 | 0.003 | 8.2398 | 0.6378 | 4 | 15 | CoA hydrolase activity |
GO:0016290 | 0.0036 | 13.5781 | 0.3401 | 3 | 8 | palmitoyl-CoA hydrolase activity |
GO:0072341 | 0.0037 | 3.4997 | 2.5511 | 8 | 60 | modified amino acid binding |
GO:0030545 | 0.0052 | 1.9194 | 12.1177 | 22 | 285 | receptor regulator activity |
GO:0004668 | 0.0053 | 45.1943 | 0.1276 | 2 | 3 | protein-arginine deiminase activity |
GO:0005412 | 0.0053 | 45.1943 | 0.1276 | 2 | 3 | glucose:sodium symporter activity |
GO:0008107 | 0.0053 | 45.1943 | 0.1276 | 2 | 3 | galactoside 2-alpha-L-fucosyltransferase activity |
GO:0004745 | 0.0053 | 11.3142 | 0.3827 | 3 | 9 | retinol dehydrogenase activity |
GO:0004806 | 0.0053 | 11.3142 | 0.3827 | 3 | 9 | triglyceride lipase activity |
GO:0046873 | 0.0055 | 1.8495 | 13.6908 | 24 | 322 | metal ion transmembrane transporter activity |
GO:0015075 | 0.0058 | 1.6012 | 25.5959 | 39 | 602 | ion transmembrane transporter activity |
GO:0022836 | 0.0073 | 1.9994 | 9.5241 | 18 | 224 | gated channel activity |
GO:0042165 | 0.0091 | 5.6627 | 0.8504 | 4 | 20 | neurotransmitter binding |
GO:0004871 | 0.0093 | 1.476 | 34.7798 | 49 | 818 | signal transducer activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005216 | 0 | 2.7131 | 12.6481 | 31 | 298 | ion channel activity |
GO:0022803 | 0 | 2.5877 | 13.6243 | 32 | 321 | passive transmembrane transporter activity |
GO:0005215 | 0 | 1.7787 | 39.5996 | 65 | 933 | transporter activity |
GO:0099600 | 1e-04 | 2.0056 | 23.7258 | 44 | 559 | transmembrane receptor activity |
GO:0048018 | 1e-04 | 2.4754 | 10.9928 | 25 | 259 | receptor ligand activity |
GO:0005230 | 1e-04 | 5.4134 | 1.9948 | 9 | 47 | extracellular ligand-gated ion channel activity |
GO:0022843 | 2e-04 | 3.4569 | 4.5414 | 14 | 107 | voltage-gated cation channel activity |
GO:0046873 | 3e-04 | 2.2083 | 13.6667 | 28 | 322 | metal ion transmembrane transporter activity |
GO:0005267 | 3e-04 | 3.4268 | 4.2443 | 13 | 100 | potassium channel activity |
GO:0005044 | 3e-04 | 8.0371 | 0.9762 | 6 | 23 | scavenger receptor activity |
GO:0008324 | 3e-04 | 1.9632 | 19.6512 | 36 | 463 | cation transmembrane transporter activity |
GO:0022835 | 4e-04 | 6.1375 | 1.4006 | 7 | 33 | transmitter-gated channel activity |
GO:0022832 | 5e-04 | 2.785 | 6.2816 | 16 | 148 | voltage-gated channel activity |
GO:0099094 | 8e-04 | 4.1103 | 2.5042 | 9 | 59 | ligand-gated cation channel activity |
GO:0022836 | 0.0012 | 3.5271 | 3.1698 | 10 | 76 | gated channel activity |
GO:0001596 | 0.0018 | Inf | 0.0849 | 2 | 2 | angiotensin type I receptor activity |
GO:0004014 | 0.0018 | Inf | 0.0849 | 2 | 2 | adenosylmethionine decarboxylase activity |
GO:0005294 | 0.0018 | Inf | 0.0849 | 2 | 2 | neutral L-amino acid secondary active transmembrane transporter activity |
GO:0016499 | 0.0018 | Inf | 0.0849 | 2 | 2 | orexin receptor activity |
GO:0019810 | 0.0018 | Inf | 0.0849 | 2 | 2 | putrescine binding |
GO:0004872 | 0.002 | 3.0477 | 3.961 | 11 | 97 | receptor activity |
GO:0022891 | 0.002 | 1.7298 | 23.2643 | 38 | 554 | substrate-specific transmembrane transporter activity |
GO:0005126 | 0.0024 | 2.3087 | 7.8945 | 17 | 186 | cytokine receptor binding |
GO:0015171 | 0.0033 | 3.5753 | 2.5042 | 8 | 59 | amino acid transmembrane transporter activity |
GO:0005102 | 0.0035 | 1.5827 | 31.3577 | 47 | 760 | receptor binding |
GO:0032036 | 0.0036 | 13.6032 | 0.3395 | 3 | 8 | myosin heavy chain binding |
GO:0017046 | 0.0037 | 4.5497 | 1.528 | 6 | 36 | peptide hormone binding |
GO:0005234 | 0.0039 | 7.5666 | 0.6791 | 4 | 16 | extracellularly glutamate-gated ion channel activity |
GO:0005251 | 0.0039 | 7.5666 | 0.6791 | 4 | 16 | delayed rectifier potassium channel activity |
GO:0038023 | 0.0039 | 1.6921 | 21.8074 | 35 | 519 | signaling receptor activity |
GO:0001158 | 0.0047 | 2.8528 | 3.8199 | 10 | 90 | enhancer sequence-specific DNA binding |
GO:0004970 | 0.0049 | 6.984 | 0.7215 | 4 | 17 | ionotropic glutamate receptor activity |
GO:0008009 | 0.0049 | 6.984 | 0.7215 | 4 | 17 | chemokine activity |
GO:0004945 | 0.0052 | 45.2779 | 0.1273 | 2 | 3 | angiotensin type II receptor activity |
GO:0022850 | 0.0052 | 45.2779 | 0.1273 | 2 | 3 | serotonin-gated cation-selective channel activity |
GO:0050694 | 0.0052 | 45.2779 | 0.1273 | 2 | 3 | galactose 3-O-sulfotransferase activity |
GO:0001848 | 0.0053 | 11.3351 | 0.382 | 3 | 9 | complement binding |
GO:0001653 | 0.0061 | 2.9313 | 3.353 | 9 | 79 | peptide receptor activity |
GO:0004714 | 0.0068 | 3.4636 | 2.2495 | 7 | 53 | transmembrane receptor protein tyrosine kinase activity |
GO:0005342 | 0.0069 | 2.6839 | 4.0321 | 10 | 95 | organic acid transmembrane transporter activity |
GO:0001965 | 0.008 | 4.5434 | 1.2733 | 5 | 30 | G-protein alpha-subunit binding |
GO:0042165 | 0.009 | 5.6732 | 0.8489 | 4 | 20 | neurotransmitter binding |
GO:0046965 | 0.009 | 5.6732 | 0.8489 | 4 | 20 | retinoid X receptor binding |
GO:0005201 | 0.0092 | 4.3683 | 1.3157 | 5 | 31 | extracellular matrix structural constituent |
GO:0004930 | 0.0095 | 1.9021 | 10.5259 | 19 | 248 | G-protein coupled receptor activity |
GO:0016595 | 0.0097 | 8.5 | 0.4669 | 3 | 11 | glutamate binding |
GO:0017127 | 0.0097 | 8.5 | 0.4669 | 3 | 11 | cholesterol transporter activity |
GO:0005262 | 0.0098 | 2.6986 | 3.6077 | 9 | 85 | calcium channel activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004872 | 0 | 2.5962 | 35.1299 | 79 | 722 | receptor activity |
GO:0004871 | 0 | 2.1006 | 39.8009 | 75 | 818 | signal transducer activity |
GO:0004896 | 0 | 6.0599 | 2.2868 | 11 | 47 | cytokine receptor activity |
GO:0004888 | 0 | 2.5457 | 11.6558 | 27 | 247 | transmembrane signaling receptor activity |
GO:0005044 | 6e-04 | 6.9558 | 1.1191 | 6 | 23 | scavenger receptor activity |
GO:0005126 | 7e-04 | 2.3987 | 9.0501 | 20 | 186 | cytokine receptor binding |
GO:0050840 | 0.0013 | 4.2677 | 2.1895 | 8 | 45 | extracellular matrix binding |
GO:0022838 | 0.002 | 1.9379 | 14.8402 | 27 | 305 | substrate-specific channel activity |
GO:0022803 | 0.002 | 1.9076 | 15.6187 | 28 | 321 | passive transmembrane transporter activity |
GO:0042015 | 0.0024 | Inf | 0.0973 | 2 | 2 | interleukin-20 binding |
GO:0048248 | 0.0024 | Inf | 0.0973 | 2 | 2 | CXCR3 chemokine receptor binding |
GO:0051916 | 0.0024 | Inf | 0.0973 | 2 | 2 | granulocyte colony-stimulating factor binding |
GO:0005261 | 0.0024 | 2.0651 | 11.3856 | 22 | 234 | cation channel activity |
GO:0005125 | 0.0024 | 2.5683 | 5.9361 | 14 | 122 | cytokine activity |
GO:0008519 | 0.0029 | 6.1497 | 1.0218 | 5 | 21 | ammonium transmembrane transporter activity |
GO:0005215 | 0.0031 | 1.488 | 45.3964 | 64 | 933 | transporter activity |
GO:0022834 | 0.0042 | 2.7521 | 4.3791 | 11 | 90 | ligand-gated channel activity |
GO:0030246 | 0.0044 | 2.3036 | 7.0065 | 15 | 144 | carbohydrate binding |
GO:0015075 | 0.0045 | 1.5811 | 29.2911 | 44 | 602 | ion transmembrane transporter activity |
GO:0001653 | 0.0048 | 2.8623 | 3.8439 | 10 | 79 | peptide receptor activity |
GO:0004930 | 0.0048 | 1.935 | 12.0668 | 22 | 248 | G-protein coupled receptor activity |
GO:0015370 | 0.0054 | 4.2195 | 1.6543 | 6 | 34 | solute:sodium symporter activity |
GO:0030545 | 0.0064 | 1.8285 | 13.8671 | 24 | 285 | receptor regulator activity |
GO:0016209 | 0.0064 | 3.5367 | 2.2382 | 7 | 46 | antioxidant activity |
GO:0022851 | 0.0069 | 39.2222 | 0.146 | 2 | 3 | GABA-gated chloride ion channel activity |
GO:0005230 | 0.0072 | 3.448 | 2.2868 | 7 | 47 | extracellular ligand-gated ion channel activity |
GO:0005539 | 0.0073 | 2.3162 | 6.0334 | 13 | 124 | glycosaminoglycan binding |
GO:0001848 | 0.0077 | 9.8168 | 0.4379 | 3 | 9 | complement binding |
GO:0046873 | 0.0079 | 1.7473 | 15.6673 | 26 | 322 | metal ion transmembrane transporter activity |
GO:0016709 | 0.0098 | 5.6148 | 0.8758 | 4 | 18 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005132 | 1e-04 | 13.46 | 0.7834 | 6 | 13 | type I interferon receptor binding |
GO:0097677 | 8e-04 | 15.6679 | 0.4821 | 4 | 8 | STAT family protein binding |
GO:0004468 | 0.002 | 23.4763 | 0.3013 | 3 | 5 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor |
GO:0035091 | 0.0024 | 2.0715 | 11.4492 | 22 | 190 | phosphatidylinositol binding |
GO:0043015 | 0.0031 | 4.9542 | 1.5065 | 6 | 25 | gamma-tubulin binding |
GO:0003684 | 0.0031 | 3.3683 | 3.0732 | 9 | 51 | damaged DNA binding |
GO:0004821 | 0.0036 | Inf | 0.1205 | 2 | 2 | histidine-tRNA ligase activity |
GO:0030368 | 0.0038 | 15.6496 | 0.3616 | 3 | 6 | interleukin-17 receptor activity |
GO:0000340 | 0.0064 | 11.7363 | 0.4218 | 3 | 7 | RNA 7-methylguanosine cap binding |
GO:0000979 | 0.0075 | 2.8855 | 3.495 | 9 | 58 | RNA polymerase II core promoter sequence-specific DNA binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0060089 | 0 | 2.2482 | 37.0275 | 74 | 761 | molecular transducer activity |
GO:0099600 | 0 | 2.3873 | 27.1989 | 58 | 559 | transmembrane receptor activity |
GO:0038023 | 0 | 2.2031 | 24.973 | 50 | 519 | signaling receptor activity |
GO:0005261 | 0 | 2.6175 | 11.3856 | 27 | 234 | cation channel activity |
GO:0022838 | 0 | 2.3587 | 14.8402 | 32 | 305 | substrate-specific channel activity |
GO:0022803 | 0 | 2.3067 | 15.6187 | 33 | 321 | passive transmembrane transporter activity |
GO:0017046 | 0 | 6.5949 | 1.7516 | 9 | 36 | peptide hormone binding |
GO:0004930 | 1e-04 | 2.4489 | 12.0668 | 27 | 248 | G-protein coupled receptor activity |
GO:0022836 | 1e-04 | 2.5146 | 10.899 | 25 | 224 | gated channel activity |
GO:0005102 | 2e-04 | 1.6124 | 52.7199 | 79 | 1089 | receptor binding |
GO:0004089 | 2e-04 | 26.225 | 0.3406 | 4 | 7 | carbonate dehydratase activity |
GO:0001102 | 2e-04 | 6.0786 | 1.6543 | 8 | 34 | RNA polymerase II activating transcription factor binding |
GO:0005125 | 3e-04 | 3.0005 | 5.9361 | 16 | 122 | cytokine activity |
GO:0005509 | 3e-04 | 1.9773 | 19.5598 | 36 | 402 | calcium ion binding |
GO:0030545 | 3e-04 | 2.1811 | 13.8671 | 28 | 285 | receptor regulator activity |
GO:0015276 | 4e-04 | 3.348 | 4.3791 | 13 | 90 | ligand-gated ion channel activity |
GO:0030507 | 0.0013 | 5.911 | 1.2651 | 6 | 26 | spectrin binding |
GO:0008083 | 0.0014 | 2.8615 | 5.0116 | 13 | 103 | growth factor activity |
GO:0001653 | 0.0015 | 3.2001 | 3.8439 | 11 | 79 | peptide receptor activity |
GO:0005539 | 0.0015 | 5.6976 | 1.2989 | 6 | 27 | glycosaminoglycan binding |
GO:0004383 | 0.002 | 9.8305 | 0.5839 | 4 | 12 | guanylate cyclase activity |
GO:0031628 | 0.0021 | 19.6383 | 0.2919 | 3 | 6 | opioid receptor binding |
GO:0004031 | 0.0024 | Inf | 0.0973 | 2 | 2 | aldehyde oxidase activity |
GO:0004854 | 0.0024 | Inf | 0.0973 | 2 | 2 | xanthine dehydrogenase activity |
GO:0005160 | 0.0025 | 4.3127 | 1.8976 | 7 | 39 | transforming growth factor beta receptor binding |
GO:0008201 | 0.0026 | 2.7934 | 4.7197 | 12 | 97 | heparin binding |
GO:0045503 | 0.0029 | 6.1497 | 1.0218 | 5 | 21 | dynein light chain binding |
GO:0005149 | 0.0035 | 14.7276 | 0.3406 | 3 | 7 | interleukin-1 receptor binding |
GO:0033218 | 0.0042 | 1.9615 | 11.9208 | 22 | 245 | amide binding |
GO:0022835 | 0.0047 | 4.3761 | 1.6057 | 6 | 33 | transmitter-gated channel activity |
GO:0001190 | 0.0048 | 3.3571 | 2.6761 | 8 | 55 | transcriptional activator activity, RNA polymerase II transcription factor binding |
GO:0033612 | 0.0049 | 7.1478 | 0.7298 | 4 | 15 | receptor serine/threonine kinase binding |
GO:0004016 | 0.0053 | 11.7811 | 0.3893 | 3 | 8 | adenylate cyclase activity |
GO:0042577 | 0.0053 | 11.7811 | 0.3893 | 3 | 8 | lipid phosphatase activity |
GO:0003700 | 0.0056 | 1.4578 | 43.9853 | 61 | 904 | DNA binding transcription factor activity |
GO:0005231 | 0.0063 | 4.0737 | 1.703 | 6 | 35 | excitatory extracellular ligand-gated ion channel activity |
GO:0004886 | 0.0069 | 39.2222 | 0.146 | 2 | 3 | 9-cis retinoic acid receptor activity |
GO:0004977 | 0.0069 | 39.2222 | 0.146 | 2 | 3 | melanocortin receptor activity |
GO:0022851 | 0.0069 | 39.2222 | 0.146 | 2 | 3 | GABA-gated chloride ion channel activity |
GO:0015075 | 0.0074 | 1.5397 | 29.2911 | 43 | 602 | ion transmembrane transporter activity |
GO:0004890 | 0.0077 | 9.8168 | 0.4379 | 3 | 9 | GABA-A receptor activity |
GO:0070700 | 0.0077 | 9.8168 | 0.4379 | 3 | 9 | BMP receptor binding |
GO:0035586 | 0.008 | 6.0472 | 0.8272 | 4 | 17 | purinergic receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005132 | 0 | 23.5861 | 0.4613 | 6 | 13 | type I interferon receptor binding |
GO:0005125 | 1e-04 | 3.6006 | 4.3288 | 14 | 122 | cytokine activity |
GO:0001848 | 2e-04 | 21.9234 | 0.3193 | 4 | 9 | complement binding |
GO:0030545 | 5e-04 | 2.3359 | 10.1123 | 22 | 285 | receptor regulator activity |
GO:0015171 | 0.0011 | 4.3201 | 2.0934 | 8 | 59 | amino acid transmembrane transporter activity |
GO:0004014 | 0.0013 | Inf | 0.071 | 2 | 2 | adenosylmethionine decarboxylase activity |
GO:0019810 | 0.0013 | Inf | 0.071 | 2 | 2 | putrescine binding |
GO:0005542 | 0.0014 | 20.5111 | 0.2484 | 3 | 7 | folic acid binding |
GO:0022804 | 0.0019 | 2.2381 | 9.0478 | 19 | 255 | active transmembrane transporter activity |
GO:0015267 | 0.0025 | 2.0488 | 11.3896 | 22 | 321 | channel activity |
GO:0042887 | 0.0032 | 7.8243 | 0.6387 | 4 | 18 | amide transmembrane transporter activity |
GO:0015293 | 0.0033 | 2.9969 | 3.6191 | 10 | 102 | symporter activity |
GO:0005290 | 0.0037 | 54.5932 | 0.1064 | 2 | 3 | L-histidine transmembrane transporter activity |
GO:0019828 | 0.0037 | 54.5932 | 0.1064 | 2 | 3 | aspartic-type endopeptidase inhibitor activity |
GO:0030943 | 0.0037 | 54.5932 | 0.1064 | 2 | 3 | mitochondrion targeting sequence binding |
GO:0005518 | 0.0039 | 4.4518 | 1.5257 | 6 | 43 | collagen binding |
GO:0005216 | 0.0048 | 1.9977 | 10.5735 | 20 | 298 | ion channel activity |
GO:0046873 | 0.0055 | 1.9381 | 11.4251 | 21 | 322 | metal ion transmembrane transporter activity |
GO:0005342 | 0.0065 | 2.8805 | 3.3708 | 9 | 95 | organic acid transmembrane transporter activity |
GO:0004457 | 0.0072 | 27.2945 | 0.1419 | 2 | 4 | lactate dehydrogenase activity |
GO:0015450 | 0.0072 | 27.2945 | 0.1419 | 2 | 4 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity |
GO:0043546 | 0.0072 | 27.2945 | 0.1419 | 2 | 4 | molybdopterin cofactor binding |
GO:0019955 | 0.0073 | 3.3734 | 2.2708 | 7 | 64 | cytokine binding |
GO:0008146 | 0.0074 | 4.5682 | 1.2419 | 5 | 35 | sulfotransferase activity |
GO:0005044 | 0.0081 | 5.763 | 0.8161 | 4 | 23 | scavenger receptor activity |
GO:0005267 | 0.0091 | 2.7212 | 3.5482 | 9 | 100 | potassium channel activity |
GO:0005215 | 0.0093 | 1.4907 | 33.1044 | 47 | 933 | transporter activity |
GO:0005212 | 0.0097 | 8.2006 | 0.4613 | 3 | 13 | structural constituent of eye lens |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004872 | 1e-04 | 1.8723 | 30.59 | 53 | 722 | receptor activity |
GO:0004871 | 1e-04 | 1.7706 | 34.6574 | 57 | 818 | signal transducer activity |
GO:0004930 | 1e-04 | 2.4846 | 10.5074 | 24 | 248 | G-protein coupled receptor activity |
GO:0005509 | 0.001 | 1.9401 | 17.0321 | 31 | 402 | calcium ion binding |
GO:0003985 | 0.0018 | Inf | 0.0847 | 2 | 2 | acetyl-CoA C-acetyltransferase activity |
GO:0004031 | 0.0018 | Inf | 0.0847 | 2 | 2 | aldehyde oxidase activity |
GO:0004854 | 0.0018 | Inf | 0.0847 | 2 | 2 | xanthine dehydrogenase activity |
GO:0004888 | 0.007 | 1.8934 | 11.699 | 21 | 283 | transmembrane signaling receptor activity |
GO:0003993 | 0.0073 | 9.7331 | 0.4237 | 3 | 10 | acid phosphatase activity |
GO:0048407 | 0.0073 | 9.7331 | 0.4237 | 3 | 10 | platelet-derived growth factor binding |
GO:0042165 | 0.009 | 5.6837 | 0.8474 | 4 | 20 | neurotransmitter binding |
GO:0022890 | 0.009 | 1.7056 | 16.6084 | 27 | 392 | inorganic cation transmembrane transporter activity |
GO:0015081 | 0.0091 | 2.5673 | 4.1945 | 10 | 99 | sodium ion transmembrane transporter activity |
GO:0003700 | 0.0098 | 1.4498 | 38.3011 | 53 | 904 | DNA binding transcription factor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0015075 | 1e-04 | 1.9977 | 23.2526 | 43 | 602 | ion transmembrane transporter activity |
GO:0022838 | 1e-04 | 2.3895 | 11.7808 | 26 | 305 | substrate-specific channel activity |
GO:0022836 | 2e-04 | 2.6416 | 8.6521 | 21 | 224 | gated channel activity |
GO:0031433 | 2e-04 | 75.0994 | 0.1545 | 3 | 4 | telethonin binding |
GO:0022803 | 3e-04 | 2.257 | 12.3988 | 26 | 321 | passive transmembrane transporter activity |
GO:0051393 | 6e-04 | 8.9663 | 0.7339 | 5 | 19 | alpha-actinin binding |
GO:0046873 | 7e-04 | 2.1508 | 12.4375 | 25 | 322 | metal ion transmembrane transporter activity |
GO:1904315 | 0.0012 | 11.1406 | 0.5021 | 4 | 13 | transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential |
GO:0008481 | 0.0015 | Inf | 0.0773 | 2 | 2 | sphinganine kinase activity |
GO:0017050 | 0.0015 | Inf | 0.0773 | 2 | 2 | D-erythro-sphingosine kinase activity |
GO:0047223 | 0.0015 | Inf | 0.0773 | 2 | 2 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity |
GO:0098960 | 0.0016 | 10.0258 | 0.5408 | 4 | 14 | postsynaptic neurotransmitter receptor activity |
GO:0031995 | 0.0018 | 18.7705 | 0.2704 | 3 | 7 | insulin-like growth factor II binding |
GO:0005231 | 0.002 | 5.1984 | 1.3519 | 6 | 35 | excitatory extracellular ligand-gated ion channel activity |
GO:0015077 | 0.0021 | 2.1728 | 9.8109 | 20 | 254 | monovalent inorganic cation transmembrane transporter activity |
GO:0030898 | 0.0028 | 15.0152 | 0.309 | 3 | 8 | actin-dependent ATPase activity |
GO:0005261 | 0.003 | 2.3971 | 6.6974 | 15 | 175 | cation channel activity |
GO:0022892 | 0.0031 | 1.603 | 30.3211 | 46 | 785 | substrate-specific transporter activity |
GO:0005343 | 0.0035 | 7.7103 | 0.6566 | 4 | 17 | organic acid:sodium symporter activity |
GO:0005244 | 0.0048 | 2.4329 | 5.7166 | 13 | 148 | voltage-gated ion channel activity |
GO:0003951 | 0.0056 | 10.7235 | 0.3863 | 3 | 10 | NAD+ kinase activity |
GO:0019838 | 0.0059 | 2.5927 | 4.5578 | 11 | 118 | growth factor binding |
GO:0005184 | 0.0065 | 6.2632 | 0.7725 | 4 | 20 | neuropeptide hormone activity |
GO:0042165 | 0.0065 | 6.2632 | 0.7725 | 4 | 20 | neurotransmitter binding |
GO:0016247 | 0.0073 | 2.652 | 4.0557 | 10 | 105 | channel regulator activity |
GO:0099094 | 0.0074 | 3.3828 | 2.2789 | 7 | 59 | ligand-gated cation channel activity |
GO:0000146 | 0.0075 | 9.3823 | 0.4249 | 3 | 11 | microfilament motor activity |
GO:0005104 | 0.0078 | 5.8943 | 0.8111 | 4 | 21 | fibroblast growth factor receptor binding |
GO:0022835 | 0.0082 | 4.4783 | 1.2746 | 5 | 33 | transmitter-gated channel activity |
GO:0001515 | 0.0085 | 24.9825 | 0.1545 | 2 | 4 | opioid peptide activity |
GO:0004994 | 0.0085 | 24.9825 | 0.1545 | 2 | 4 | somatostatin receptor activity |
GO:0005332 | 0.0085 | 24.9825 | 0.1545 | 2 | 4 | gamma-aminobutyric acid:sodium symporter activity |
GO:0004620 | 0.0097 | 3.1976 | 2.3948 | 7 | 62 | phospholipase activity |
GO:0005416 | 0.0097 | 8.3392 | 0.4635 | 3 | 12 | cation:amino acid symporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0015267 | 3e-04 | 2.2522 | 12.4229 | 26 | 321 | channel activity |
GO:0015459 | 6e-04 | 5.6722 | 1.4706 | 7 | 38 | potassium channel regulator activity |
GO:0005216 | 6e-04 | 2.233 | 11.5327 | 24 | 298 | ion channel activity |
GO:0016641 | 6e-04 | 14.2969 | 0.4257 | 4 | 11 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor |
GO:0005518 | 0.0012 | 4.8825 | 1.6641 | 7 | 43 | collagen binding |
GO:0004667 | 0.0015 | Inf | 0.0774 | 2 | 2 | prostaglandin-D synthase activity |
GO:0005215 | 0.0019 | 1.5873 | 36.1076 | 54 | 933 | transporter activity |
GO:0044325 | 0.0019 | 3.0461 | 3.9475 | 11 | 102 | ion channel binding |
GO:0005249 | 0.0021 | 3.4825 | 2.8638 | 9 | 74 | voltage-gated potassium channel activity |
GO:0016247 | 0.0024 | 2.9482 | 4.0636 | 11 | 105 | channel regulator activity |
GO:0022834 | 0.0025 | 3.1464 | 3.483 | 10 | 90 | ligand-gated channel activity |
GO:0004872 | 0.0032 | 1.625 | 27.9418 | 43 | 722 | receptor activity |
GO:0005283 | 0.0041 | 12.4864 | 0.3483 | 3 | 9 | sodium:amino acid symporter activity |
GO:0017077 | 0.0044 | 49.868 | 0.1161 | 2 | 3 | oxidative phosphorylation uncoupler activity |
GO:0050694 | 0.0044 | 49.868 | 0.1161 | 2 | 3 | galactose 3-O-sulfotransferase activity |
GO:0005031 | 0.0044 | 7.1445 | 0.6966 | 4 | 18 | tumor necrosis factor-activated receptor activity |
GO:0004888 | 0.005 | 1.69 | 20.55 | 33 | 531 | transmembrane signaling receptor activity |
GO:0022891 | 0.0072 | 1.5881 | 25.1166 | 38 | 649 | substrate-specific transmembrane transporter activity |
GO:0050840 | 0.0074 | 3.8546 | 1.7415 | 6 | 45 | extracellular matrix binding |
GO:0008324 | 0.0074 | 1.699 | 17.9183 | 29 | 463 | cation transmembrane transporter activity |
GO:0099094 | 0.0075 | 3.3759 | 2.2833 | 7 | 59 | ligand-gated cation channel activity |
GO:0015079 | 0.0091 | 2.4272 | 4.8376 | 11 | 125 | potassium ion transmembrane transporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004872 | 0 | 2.3152 | 35.0758 | 72 | 722 | receptor activity |
GO:0004871 | 0 | 1.8998 | 39.7397 | 69 | 818 | signal transducer activity |
GO:0004888 | 0 | 2.1001 | 23.3419 | 45 | 484 | transmembrane signaling receptor activity |
GO:0017046 | 0 | 6.6057 | 1.7489 | 9 | 36 | peptide hormone binding |
GO:0005126 | 7e-04 | 2.4027 | 9.0362 | 20 | 186 | cytokine receptor binding |
GO:0046873 | 0.001 | 1.9822 | 15.6432 | 29 | 322 | metal ion transmembrane transporter activity |
GO:0008528 | 0.0011 | 3.3541 | 3.6922 | 11 | 76 | G-protein coupled peptide receptor activity |
GO:0008324 | 0.0011 | 1.7977 | 22.4932 | 38 | 463 | cation transmembrane transporter activity |
GO:0048018 | 0.0018 | 2.2082 | 9.734 | 20 | 202 | receptor ligand activity |
GO:0015267 | 0.002 | 1.9108 | 15.5947 | 28 | 321 | channel activity |
GO:0001664 | 0.0022 | 2.1646 | 9.9106 | 20 | 204 | G-protein coupled receptor binding |
GO:0001596 | 0.0024 | Inf | 0.0972 | 2 | 2 | angiotensin type I receptor activity |
GO:0048248 | 0.0024 | Inf | 0.0972 | 2 | 2 | CXCR3 chemokine receptor binding |
GO:0051916 | 0.0024 | Inf | 0.0972 | 2 | 2 | granulocyte colony-stimulating factor binding |
GO:0001965 | 0.0028 | 4.9323 | 1.4574 | 6 | 30 | G-protein alpha-subunit binding |
GO:0015077 | 0.003 | 1.9848 | 12.3397 | 23 | 254 | monovalent inorganic cation transmembrane transporter activity |
GO:0004089 | 0.0034 | 14.7515 | 0.3401 | 3 | 7 | carbonate dehydratase activity |
GO:0005540 | 0.0037 | 7.876 | 0.6801 | 4 | 14 | hyaluronic acid binding |
GO:0022857 | 0.0041 | 1.5374 | 34.9301 | 51 | 719 | transmembrane transporter activity |
GO:0003700 | 0.0054 | 1.4604 | 43.9177 | 61 | 904 | DNA binding transcription factor activity |
GO:0005216 | 0.0056 | 1.8252 | 14.4773 | 25 | 298 | ion channel activity |
GO:0050840 | 0.0056 | 3.636 | 2.1862 | 7 | 45 | extracellular matrix binding |
GO:0005179 | 0.006 | 3.2248 | 2.7691 | 8 | 57 | hormone activity |
GO:0001653 | 0.0067 | 39.761 | 0.1441 | 2 | 3 | peptide receptor activity |
GO:0004104 | 0.0068 | 39.2859 | 0.1457 | 2 | 3 | cholinesterase activity |
GO:0004945 | 0.0068 | 39.2859 | 0.1457 | 2 | 3 | angiotensin type II receptor activity |
GO:0005412 | 0.0068 | 39.2859 | 0.1457 | 2 | 3 | glucose:sodium symporter activity |
GO:0046870 | 0.0068 | 39.2859 | 0.1457 | 2 | 3 | cadmium ion binding |
GO:0004896 | 0.0071 | 3.4537 | 2.2833 | 7 | 47 | cytokine receptor activity |
GO:0001228 | 0.0074 | 1.7182 | 17.1493 | 28 | 353 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
GO:0001848 | 0.0077 | 9.8328 | 0.4372 | 3 | 9 | complement binding |
GO:0008009 | 0.0079 | 6.057 | 0.8259 | 4 | 17 | chemokine activity |
GO:0005164 | 0.0088 | 4.4777 | 1.3117 | 5 | 27 | tumor necrosis factor receptor binding |
GO:0005267 | 0.0091 | 2.445 | 4.8581 | 11 | 100 | potassium channel activity |
GO:0005031 | 0.0098 | 5.6239 | 0.8745 | 4 | 18 | tumor necrosis factor-activated receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005132 | 0 | 72.9731 | 0.5771 | 10 | 13 | type I interferon receptor binding |
GO:0005125 | 0 | 4.8801 | 5.4155 | 22 | 122 | cytokine activity |
GO:0030545 | 0 | 2.9263 | 12.651 | 33 | 285 | receptor regulator activity |
GO:0004896 | 0 | 5.901 | 2.0863 | 10 | 47 | cytokine receptor activity |
GO:0060089 | 0 | 1.8603 | 33.7804 | 58 | 761 | molecular transducer activity |
GO:0099600 | 6e-04 | 1.806 | 24.8138 | 42 | 559 | transmembrane receptor activity |
GO:0038023 | 7e-04 | 1.7667 | 26.545 | 44 | 598 | signaling receptor activity |
GO:0005164 | 0.001 | 6.2035 | 1.1985 | 6 | 27 | tumor necrosis factor receptor binding |
GO:0042605 | 0.0019 | 6.7761 | 0.9322 | 5 | 21 | peptide antigen binding |
GO:0004014 | 0.002 | Inf | 0.0888 | 2 | 2 | adenosylmethionine decarboxylase activity |
GO:0019810 | 0.002 | Inf | 0.0888 | 2 | 2 | putrescine binding |
GO:0019958 | 0.002 | Inf | 0.0888 | 2 | 2 | C-X-C chemokine binding |
GO:0005044 | 0.0029 | 6.0223 | 1.021 | 5 | 23 | scavenger receptor activity |
GO:0038036 | 0.0041 | 12.9773 | 0.3551 | 3 | 8 | sphingosine-1-phosphate receptor activity |
GO:0016494 | 0.0057 | 43.198 | 0.1332 | 2 | 3 | C-X-C chemokine receptor activity |
GO:0034987 | 0.0057 | 43.198 | 0.1332 | 2 | 3 | immunoglobulin receptor binding |
GO:0019955 | 0.0071 | 3.1038 | 2.8409 | 8 | 64 | cytokine binding |
GO:0005031 | 0.0072 | 6.1858 | 0.799 | 4 | 18 | tumor necrosis factor-activated receptor activity |
GO:0005126 | 0.0089 | 2.1068 | 7.5572 | 15 | 173 | cytokine receptor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0003684 | 1e-04 | 4.692 | 3.1725 | 12 | 51 | damaged DNA binding |
GO:0005132 | 1e-04 | 13.0088 | 0.8087 | 6 | 13 | type I interferon receptor binding |
GO:0003723 | 6e-04 | 1.4307 | 85.0346 | 114 | 1367 | RNA binding |
GO:0008242 | 9e-04 | 15.1439 | 0.4976 | 4 | 8 | omega peptidase activity |
GO:0097677 | 9e-04 | 15.1439 | 0.4976 | 4 | 8 | STAT family protein binding |
GO:0004704 | 9e-04 | 45.3877 | 0.2488 | 3 | 4 | NF-kappaB-inducing kinase activity |
GO:0008757 | 9e-04 | 2.4994 | 7.9623 | 18 | 128 | S-adenosylmethionine-dependent methyltransferase activity |
GO:0140097 | 0.0028 | 2.1807 | 9.4552 | 19 | 152 | catalytic activity, acting on DNA |
GO:0043130 | 0.0032 | 3.102 | 3.6701 | 10 | 59 | ubiquitin binding |
GO:0097159 | 0.0037 | 1.2255 | 270.2196 | 306 | 4344 | organic cyclic compound binding |
GO:0016231 | 0.0039 | Inf | 0.1244 | 2 | 2 | beta-N-acetylglucosaminidase activity |
GO:0008296 | 0.0042 | 15.1268 | 0.3732 | 3 | 6 | 3'-5'-exodeoxyribonuclease activity |
GO:1901363 | 0.0043 | 1.2216 | 266.985 | 302 | 4292 | heterocyclic compound binding |
GO:0004518 | 0.005 | 2.0556 | 9.9528 | 19 | 160 | nuclease activity |
GO:0003735 | 0.0066 | 2.0891 | 8.7709 | 17 | 141 | structural constituent of ribosome |
GO:0016741 | 0.0079 | 1.9184 | 11.1347 | 20 | 179 | transferase activity, transferring one-carbon groups |
GO:0005125 | 0.0087 | 2.1339 | 7.589 | 15 | 122 | cytokine activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 4.8305 | 8.1271 | 32 | 165 | histone binding |
GO:0031492 | 0 | 11.1098 | 1.7732 | 13 | 36 | nucleosomal DNA binding |
GO:0003677 | 0.001 | 1.417 | 83.0442 | 110 | 1686 | DNA binding |
GO:0047276 | 0.0024 | Inf | 0.0985 | 2 | 2 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity |
GO:0003735 | 0.004 | 2.3282 | 6.945 | 15 | 141 | structural constituent of ribosome |
GO:0005164 | 0.0093 | 4.4128 | 1.3299 | 5 | 27 | tumor necrosis factor receptor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0022836 | 1e-04 | 2.6005 | 9.2222 | 22 | 224 | gated channel activity |
GO:0022803 | 8e-04 | 2.1048 | 13.2158 | 26 | 321 | passive transmembrane transporter activity |
GO:0022838 | 8e-04 | 2.1308 | 12.5571 | 25 | 305 | substrate-specific channel activity |
GO:0099604 | 0.0011 | 7.8251 | 0.8234 | 5 | 20 | ligand-gated calcium channel activity |
GO:0005261 | 0.0016 | 2.2209 | 9.634 | 20 | 234 | cation channel activity |
GO:0004014 | 0.0017 | Inf | 0.0823 | 2 | 2 | adenosylmethionine decarboxylase activity |
GO:0019810 | 0.0017 | Inf | 0.0823 | 2 | 2 | putrescine binding |
GO:0022835 | 0.002 | 5.2214 | 1.3586 | 6 | 33 | transmitter-gated channel activity |
GO:0005230 | 0.0029 | 4.1152 | 1.935 | 7 | 47 | extracellular ligand-gated ion channel activity |
GO:0051959 | 0.0031 | 5.8665 | 1.0293 | 5 | 25 | dynein light intermediate chain binding |
GO:0019828 | 0.0049 | 46.7445 | 0.1235 | 2 | 3 | aspartic-type endopeptidase inhibitor activity |
GO:0022851 | 0.0049 | 46.7445 | 0.1235 | 2 | 3 | GABA-gated chloride ion channel activity |
GO:0046848 | 0.0049 | 46.7445 | 0.1235 | 2 | 3 | hydroxyapatite binding |
GO:0003700 | 0.0057 | 1.4985 | 37.2184 | 53 | 904 | DNA binding transcription factor activity |
GO:0001972 | 0.0067 | 10.0303 | 0.4117 | 3 | 10 | retinoic acid binding |
GO:0015085 | 0.007 | 2.677 | 4.0347 | 10 | 98 | calcium ion transmembrane transporter activity |
GO:0017127 | 0.0089 | 8.7758 | 0.4529 | 3 | 11 | cholesterol transporter activity |
GO:0003796 | 0.0096 | 23.3704 | 0.1647 | 2 | 4 | lysozyme activity |
GO:0030151 | 0.0096 | 23.3704 | 0.1647 | 2 | 4 | molybdenum ion binding |
GO:0005217 | 0.0097 | 5.5126 | 0.8646 | 4 | 21 | intracellular ligand-gated ion channel activity |
GO:0016814 | 0.0097 | 5.5126 | 0.8646 | 4 | 21 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031492 | 0 | 6.6275 | 1.7435 | 9 | 36 | nucleosomal DNA binding |
GO:0016641 | 0.0014 | 11.2908 | 0.5327 | 4 | 11 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor |
GO:0035005 | 0.002 | 19.7345 | 0.2906 | 3 | 6 | 1-phosphatidylinositol-4-phosphate 3-kinase activity |
GO:0019958 | 0.0023 | Inf | 0.0969 | 2 | 2 | C-X-C chemokine binding |
GO:0070576 | 0.0023 | Inf | 0.0969 | 2 | 2 | vitamin D 24-hydroxylase activity |
GO:0038036 | 0.0053 | 11.8388 | 0.3875 | 3 | 8 | sphingosine-1-phosphate receptor activity |
GO:0043015 | 0.0062 | 4.9424 | 1.2108 | 5 | 25 | gamma-tubulin binding |
GO:0005119 | 0.0068 | 39.414 | 0.1453 | 2 | 3 | smoothened binding |
GO:0008158 | 0.0068 | 39.414 | 0.1453 | 2 | 3 | hedgehog receptor activity |
GO:0016494 | 0.0068 | 39.414 | 0.1453 | 2 | 3 | C-X-C chemokine receptor activity |
GO:0033829 | 0.0068 | 39.414 | 0.1453 | 2 | 3 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity |
GO:0016303 | 0.0076 | 9.8649 | 0.4359 | 3 | 9 | 1-phosphatidylinositol-3-kinase activity |
GO:0008137 | 0.0078 | 6.0768 | 0.8233 | 4 | 17 | NADH dehydrogenase (ubiquinone) activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0003723 | 0 | 1.7918 | 89.7364 | 143 | 1360 | RNA binding |
GO:0042393 | 0 | 2.9458 | 10.9185 | 28 | 165 | histone binding |
GO:1901363 | 0 | 1.3548 | 284.0129 | 341 | 4292 | heterocyclic compound binding |
GO:0097159 | 0 | 1.3497 | 287.4539 | 344 | 4344 | organic cyclic compound binding |
GO:0097677 | 1e-04 | 23.6481 | 0.5294 | 5 | 8 | STAT family protein binding |
GO:0003684 | 1e-04 | 4.3881 | 3.3748 | 12 | 51 | damaged DNA binding |
GO:0005132 | 1e-04 | 12.1718 | 0.8602 | 6 | 13 | type I interferon receptor binding |
GO:0035005 | 3e-04 | 28.3477 | 0.397 | 4 | 6 | 1-phosphatidylinositol-4-phosphate 3-kinase activity |
GO:0005087 | 0.0011 | 42.4767 | 0.2647 | 3 | 4 | Ran guanyl-nucleotide exchange factor activity |
GO:0046934 | 0.0011 | 42.4767 | 0.2647 | 3 | 4 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity |
GO:0016303 | 0.0018 | 11.3364 | 0.5956 | 4 | 9 | 1-phosphatidylinositol-3-kinase activity |
GO:0008757 | 0.0019 | 2.3364 | 8.4701 | 18 | 128 | S-adenosylmethionine-dependent methyltransferase activity |
GO:0004521 | 0.002 | 3.6558 | 2.9116 | 9 | 44 | endoribonuclease activity |
GO:0016741 | 0.0036 | 2.0024 | 11.8449 | 22 | 179 | transferase activity, transferring one-carbon groups |
GO:0046966 | 0.004 | 4.7293 | 1.5881 | 6 | 24 | thyroid hormone receptor binding |
GO:0004821 | 0.0044 | Inf | 0.1323 | 2 | 2 | histidine-tRNA ligase activity |
GO:0015230 | 0.0044 | Inf | 0.1323 | 2 | 2 | FAD transmembrane transporter activity |
GO:0016231 | 0.0044 | Inf | 0.1323 | 2 | 2 | beta-N-acetylglucosaminidase activity |
GO:0031755 | 0.0044 | Inf | 0.1323 | 2 | 2 | Edg-2 lysophosphatidic acid receptor binding |
GO:0005515 | 0.0048 | 1.206 | 415.1581 | 452 | 6467 | protein binding |
GO:0005114 | 0.005 | 14.1566 | 0.397 | 3 | 6 | type II transforming growth factor beta receptor binding |
GO:0005338 | 0.005 | 14.1566 | 0.397 | 3 | 6 | nucleotide-sugar transmembrane transporter activity |
GO:0043130 | 0.005 | 2.9015 | 3.9042 | 10 | 59 | ubiquitin binding |
GO:0000030 | 0.0067 | 5.063 | 1.2573 | 5 | 19 | mannosyltransferase activity |
GO:0030331 | 0.0071 | 3.5482 | 2.316 | 7 | 35 | estrogen receptor binding |
GO:0051087 | 0.0074 | 2.5642 | 4.7644 | 11 | 72 | chaperone binding |
GO:0008173 | 0.0074 | 2.9059 | 3.5071 | 9 | 53 | RNA methyltransferase activity |
GO:1990247 | 0.0083 | 10.6166 | 0.4632 | 3 | 7 | N6-methyladenosine-containing RNA binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 2.9532 | 10.8938 | 28 | 165 | histone binding |
GO:0003723 | 0 | 1.5398 | 90.2533 | 128 | 1367 | RNA binding |
GO:0005132 | 1e-04 | 12.2016 | 0.8583 | 6 | 13 | type I interferon receptor binding |
GO:0031489 | 8e-04 | 7.1147 | 1.1884 | 6 | 18 | myosin V binding |
GO:0140098 | 0.0011 | 1.8542 | 20.269 | 35 | 307 | catalytic activity, acting on RNA |
GO:1901363 | 0.0012 | 1.2517 | 283.3703 | 325 | 4292 | heterocyclic compound binding |
GO:0097159 | 0.0014 | 1.2474 | 286.8035 | 328 | 4344 | organic cyclic compound binding |
GO:0008175 | 0.0039 | 4.7409 | 1.5845 | 6 | 24 | tRNA methyltransferase activity |
GO:0046966 | 0.0039 | 4.7409 | 1.5845 | 6 | 24 | thyroid hormone receptor binding |
GO:0000033 | 0.0044 | Inf | 0.132 | 2 | 2 | alpha-1,3-mannosyltransferase activity |
GO:0004821 | 0.0044 | Inf | 0.132 | 2 | 2 | histidine-tRNA ligase activity |
GO:0015091 | 0.0044 | Inf | 0.132 | 2 | 2 | ferric iron transmembrane transporter activity |
GO:0008757 | 0.0044 | 2.1895 | 8.4509 | 17 | 128 | S-adenosylmethionine-dependent methyltransferase activity |
GO:0005338 | 0.0049 | 14.1911 | 0.3961 | 3 | 6 | nucleotide-sugar transmembrane transporter activity |
GO:0044877 | 0.0053 | 1.3926 | 60.3449 | 80 | 914 | macromolecular complex binding |
GO:0019904 | 0.0065 | 1.4547 | 42.5848 | 59 | 645 | protein domain specific binding |
GO:0003677 | 0.0065 | 1.2852 | 111.3146 | 136 | 1686 | DNA binding |
GO:0016741 | 0.0073 | 1.9017 | 11.8181 | 21 | 179 | transferase activity, transferring one-carbon groups |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005132 | 0 | 17.3585 | 0.617 | 6 | 13 | type I interferon receptor binding |
GO:0086089 | 1e-04 | Inf | 0.1424 | 3 | 3 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization |
GO:0015459 | 3e-04 | 5.4079 | 1.8034 | 8 | 38 | potassium channel regulator activity |
GO:0030545 | 5e-04 | 2.1494 | 13.5257 | 27 | 285 | receptor regulator activity |
GO:0099600 | 0.0012 | 1.7215 | 26.5294 | 43 | 559 | transmembrane receptor activity |
GO:0004930 | 0.0017 | 2.0913 | 11.7697 | 23 | 248 | G-protein coupled receptor activity |
GO:0005125 | 0.0019 | 2.638 | 5.79 | 14 | 122 | cytokine activity |
GO:0051916 | 0.0022 | Inf | 0.0949 | 2 | 2 | granulocyte colony-stimulating factor binding |
GO:0060089 | 0.0031 | 1.5483 | 36.116 | 53 | 761 | molecular transducer activity |
GO:0016247 | 0.0041 | 2.6205 | 4.9832 | 12 | 105 | channel regulator activity |
GO:0038023 | 0.0043 | 1.5954 | 28.3803 | 43 | 598 | signaling receptor activity |
GO:0004983 | 0.005 | 12.0951 | 0.3797 | 3 | 8 | neuropeptide Y receptor activity |
GO:0038024 | 0.0056 | 4.1827 | 1.6611 | 6 | 35 | cargo receptor activity |
GO:0034987 | 0.0065 | 40.2658 | 0.1424 | 2 | 3 | immunoglobulin receptor binding |
GO:0030507 | 0.0068 | 4.8088 | 1.2339 | 5 | 26 | spectrin binding |
GO:0042975 | 0.0073 | 6.2085 | 0.8068 | 4 | 17 | peroxisome proliferator activated receptor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031800 | 1e-04 | Inf | 0.1527 | 3 | 3 | type 3 metabotropic glutamate receptor binding |
GO:0005164 | 3e-04 | 6.5834 | 1.3744 | 7 | 27 | tumor necrosis factor receptor binding |
GO:0015301 | 4e-04 | 8.0532 | 1.018 | 6 | 20 | anion:anion antiporter activity |
GO:0042393 | 6e-04 | 2.5273 | 8.2237 | 19 | 162 | histone binding |
GO:0008271 | 7e-04 | 14.9988 | 0.4581 | 4 | 9 | secondary active sulfate transmembrane transporter activity |
GO:0019531 | 7e-04 | 14.9988 | 0.4581 | 4 | 9 | oxalate transmembrane transporter activity |
GO:0015106 | 0.0012 | 7.8191 | 0.8653 | 5 | 17 | bicarbonate transmembrane transporter activity |
GO:0030545 | 0.0014 | 1.9906 | 14.5071 | 27 | 285 | receptor regulator activity |
GO:0030507 | 0.0016 | 5.6346 | 1.3235 | 6 | 26 | spectrin binding |
GO:0015297 | 0.0017 | 3.6836 | 2.7996 | 9 | 55 | antiporter activity |
GO:0030235 | 0.0023 | 18.7238 | 0.3054 | 3 | 6 | nitric-oxide synthase regulator activity |
GO:0019958 | 0.0026 | Inf | 0.1018 | 2 | 2 | C-X-C chemokine binding |
GO:0072341 | 0.0031 | 3.3211 | 3.0541 | 9 | 60 | modified amino acid binding |
GO:0008179 | 0.0033 | 8.33 | 0.6617 | 4 | 13 | adenylate cyclase binding |
GO:0044325 | 0.0056 | 2.5128 | 5.192 | 12 | 102 | ion channel binding |
GO:0015278 | 0.0058 | 6.8144 | 0.7635 | 4 | 15 | calcium-release channel activity |
GO:0016634 | 0.0061 | 11.2325 | 0.4072 | 3 | 8 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor |
GO:0005126 | 0.0067 | 2.0249 | 9.4678 | 18 | 186 | cytokine receptor binding |
GO:0005275 | 0.0075 | 37.3982 | 0.1527 | 2 | 3 | amine transmembrane transporter activity |
GO:0016494 | 0.0075 | 37.3982 | 0.1527 | 2 | 3 | C-X-C chemokine receptor activity |
GO:0031493 | 0.0075 | 37.3982 | 0.1527 | 2 | 3 | nucleosomal histone binding |
GO:0097177 | 0.0075 | 37.3982 | 0.1527 | 2 | 3 | mitochondrial ribosome binding |
GO:0001848 | 0.0088 | 9.3597 | 0.4581 | 3 | 9 | complement binding |
GO:0004745 | 0.0088 | 9.3597 | 0.4581 | 3 | 9 | retinol dehydrogenase activity |
GO:0004806 | 0.0088 | 9.3597 | 0.4581 | 3 | 9 | triglyceride lipase activity |
GO:0050998 | 0.0093 | 5.7651 | 0.8653 | 4 | 17 | nitric-oxide synthase binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0030545 | 0 | 3.0475 | 11.7977 | 32 | 285 | receptor regulator activity |
GO:0005125 | 0 | 4.3881 | 5.0502 | 19 | 122 | cytokine activity |
GO:0005132 | 0 | 20.0559 | 0.5381 | 6 | 13 | type I interferon receptor binding |
GO:0005509 | 1e-04 | 2.2142 | 16.6409 | 34 | 402 | calcium ion binding |
GO:0004364 | 0.0011 | 7.7804 | 0.8279 | 5 | 20 | glutathione transferase activity |
GO:0033265 | 0.0013 | 23.2782 | 0.2484 | 3 | 6 | choline binding |
GO:0008307 | 0.0014 | 7.2936 | 0.8693 | 5 | 21 | structural constituent of muscle |
GO:0003990 | 0.0017 | Inf | 0.0828 | 2 | 2 | acetylcholinesterase activity |
GO:0003996 | 0.0017 | Inf | 0.0828 | 2 | 2 | acyl-CoA ligase activity |
GO:0003998 | 0.0017 | Inf | 0.0828 | 2 | 2 | acylphosphatase activity |
GO:0004053 | 0.0017 | Inf | 0.0828 | 2 | 2 | arginase activity |
GO:0019958 | 0.0017 | Inf | 0.0828 | 2 | 2 | C-X-C chemokine binding |
GO:0051371 | 0.0022 | 17.4573 | 0.2898 | 3 | 7 | muscle alpha-actinin binding |
GO:0005102 | 0.0036 | 1.4807 | 45.7004 | 64 | 1104 | receptor binding |
GO:0002060 | 0.005 | 46.4791 | 0.1242 | 2 | 3 | purine nucleobase binding |
GO:0004321 | 0.005 | 46.4791 | 0.1242 | 2 | 3 | fatty-acyl-CoA synthase activity |
GO:0004668 | 0.005 | 46.4791 | 0.1242 | 2 | 3 | protein-arginine deiminase activity |
GO:0016286 | 0.005 | 46.4791 | 0.1242 | 2 | 3 | small conductance calcium-activated potassium channel activity |
GO:0016494 | 0.005 | 46.4791 | 0.1242 | 2 | 3 | C-X-C chemokine receptor activity |
GO:0019828 | 0.005 | 46.4791 | 0.1242 | 2 | 3 | aspartic-type endopeptidase inhibitor activity |
GO:0047760 | 0.005 | 46.4791 | 0.1242 | 2 | 3 | butyrate-CoA ligase activity |
GO:0005501 | 0.0056 | 6.6573 | 0.7451 | 4 | 18 | retinoid binding |
GO:0003993 | 0.0068 | 9.9732 | 0.414 | 3 | 10 | acid phosphatase activity |
GO:0043295 | 0.0091 | 8.7259 | 0.4553 | 3 | 11 | glutathione binding |
GO:0005499 | 0.0097 | 23.2377 | 0.1656 | 2 | 4 | vitamin D binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005509 | 0 | 2.3918 | 17.9349 | 39 | 402 | calcium ion binding |
GO:0004930 | 0 | 2.8105 | 11.0643 | 28 | 248 | G-protein coupled receptor activity |
GO:0022836 | 0 | 2.8946 | 9.9936 | 26 | 224 | gated channel activity |
GO:0099600 | 0 | 2.1001 | 24.9393 | 48 | 559 | transmembrane receptor activity |
GO:0016247 | 0 | 3.9284 | 4.6845 | 16 | 105 | channel regulator activity |
GO:0022838 | 0 | 2.4069 | 13.6073 | 30 | 305 | substrate-specific channel activity |
GO:0022803 | 1e-04 | 2.2717 | 14.3211 | 30 | 321 | passive transmembrane transporter activity |
GO:0060089 | 1e-04 | 1.7737 | 33.9513 | 56 | 761 | molecular transducer activity |
GO:0031492 | 1e-04 | 6.188 | 1.6061 | 8 | 36 | nucleosomal DNA binding |
GO:0001653 | 2e-04 | 3.8937 | 3.5245 | 12 | 79 | peptide receptor activity |
GO:0005244 | 3e-04 | 2.8312 | 6.6029 | 17 | 148 | voltage-gated ion channel activity |
GO:0005261 | 3e-04 | 2.3878 | 10.4397 | 23 | 234 | cation channel activity |
GO:0001786 | 6e-04 | 5.606 | 1.5169 | 7 | 34 | phosphatidylserine binding |
GO:0015280 | 8e-04 | 32.2791 | 0.2231 | 3 | 5 | ligand-gated sodium channel activity |
GO:0042923 | 0.0015 | 10.7728 | 0.5354 | 4 | 12 | neuropeptide binding |
GO:0008188 | 0.0015 | 7.2239 | 0.8883 | 5 | 20 | neuropeptide receptor activity |
GO:0016702 | 0.0015 | 7.1901 | 0.8923 | 5 | 20 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen |
GO:0044325 | 0.0019 | 2.8934 | 4.5506 | 12 | 102 | ion channel binding |
GO:0016934 | 0.002 | Inf | 0.0892 | 2 | 2 | extracellularly glycine-gated chloride channel activity |
GO:0070080 | 0.002 | Inf | 0.0892 | 2 | 2 | titin Z domain binding |
GO:0015276 | 0.0022 | 3.019 | 4.0153 | 11 | 90 | ligand-gated ion channel activity |
GO:0004983 | 0.0042 | 12.9086 | 0.3569 | 3 | 8 | neuropeptide Y receptor activity |
GO:0015075 | 0.0046 | 1.6068 | 26.8577 | 41 | 602 | ion transmembrane transporter activity |
GO:0005246 | 0.0052 | 5.1333 | 1.16 | 5 | 26 | calcium channel regulator activity |
GO:0005249 | 0.0055 | 2.9952 | 3.3014 | 9 | 74 | voltage-gated potassium channel activity |
GO:0004977 | 0.0058 | 42.9697 | 0.1338 | 2 | 3 | melanocortin receptor activity |
GO:0005111 | 0.0058 | 42.9697 | 0.1338 | 2 | 3 | type 2 fibroblast growth factor receptor binding |
GO:0050501 | 0.0058 | 42.9697 | 0.1338 | 2 | 3 | hyaluronan synthase activity |
GO:0070905 | 0.0058 | 42.9697 | 0.1338 | 2 | 3 | serine binding |
GO:0015459 | 0.0063 | 4.0459 | 1.6953 | 6 | 38 | potassium channel regulator activity |
GO:0046873 | 0.0064 | 2.0771 | 8.6934 | 17 | 197 | metal ion transmembrane transporter activity |
GO:0038023 | 0.0079 | 1.6086 | 22.8235 | 35 | 519 | signaling receptor activity |
GO:0015079 | 0.01 | 2.3003 | 5.5768 | 12 | 125 | potassium ion transmembrane transporter activity |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0022404 | 0 | 3.9683 | 5.3446 | 18 | 97 | molting cycle process |
GO:0008544 | 0 | 2.551 | 13.8849 | 32 | 252 | epidermis development |
GO:0042633 | 0 | 3.5979 | 6.116 | 19 | 111 | hair cycle |
GO:0042060 | 0 | 2.2082 | 17.7418 | 36 | 322 | wound healing |
GO:0050866 | 1e-04 | 2.6804 | 9.0913 | 22 | 165 | negative regulation of cell activation |
GO:0043588 | 1e-04 | 2.9107 | 7.2974 | 19 | 134 | skin development |
GO:0007162 | 2e-04 | 2.2986 | 12.7829 | 27 | 232 | negative regulation of cell adhesion |
GO:0097205 | 2e-04 | 9.4116 | 0.9367 | 6 | 17 | renal filtration |
GO:0022407 | 5e-04 | 1.9368 | 19.3397 | 35 | 351 | regulation of cell-cell adhesion |
GO:0032945 | 6e-04 | 3.4065 | 4.0222 | 12 | 73 | negative regulation of mononuclear cell proliferation |
GO:0014028 | 6e-04 | 51.6206 | 0.2204 | 3 | 4 | notochord formation |
GO:0050863 | 6e-04 | 2.1105 | 13.7747 | 27 | 250 | regulation of T cell activation |
GO:0001942 | 7e-04 | 3.3672 | 4.0594 | 12 | 74 | hair follicle development |
GO:0051250 | 7e-04 | 2.6586 | 7.0527 | 17 | 128 | negative regulation of lymphocyte activation |
GO:1903038 | 7e-04 | 2.8585 | 5.8405 | 15 | 106 | negative regulation of leukocyte cell-cell adhesion |
GO:0048732 | 8e-04 | 2.0466 | 14.6814 | 28 | 269 | gland development |
GO:0031589 | 0.001 | 1.9828 | 15.6481 | 29 | 284 | cell-substrate adhesion |
GO:0030855 | 0.0012 | 1.7117 | 27.2284 | 44 | 496 | epithelial cell differentiation |
GO:0050878 | 0.0014 | 1.9961 | 14.4655 | 27 | 264 | regulation of body fluid levels |
GO:0009888 | 0.0014 | 1.4226 | 72.0149 | 97 | 1335 | tissue development |
GO:0009115 | 0.0015 | 25.8086 | 0.2755 | 3 | 5 | xanthine catabolic process |
GO:0021563 | 0.0015 | 25.8086 | 0.2755 | 3 | 5 | glossopharyngeal nerve development |
GO:1903317 | 0.0016 | 3.1712 | 3.912 | 11 | 71 | regulation of protein maturation |
GO:0042130 | 0.0019 | 3.3244 | 3.4161 | 10 | 62 | negative regulation of T cell proliferation |
GO:0006958 | 0.002 | 5.4459 | 1.3775 | 6 | 25 | complement activation, classical pathway |
GO:0050670 | 0.002 | 2.1458 | 10.5239 | 21 | 191 | regulation of lymphocyte proliferation |
GO:0023052 | 0.0022 | 1.2419 | 248.1101 | 286 | 4503 | signaling |
GO:0003093 | 0.0022 | 9.8398 | 0.6061 | 4 | 11 | regulation of glomerular filtration |
GO:0002694 | 0.0027 | 1.7085 | 22.866 | 37 | 415 | regulation of leukocyte activation |
GO:0030216 | 0.0028 | 2.9383 | 4.1716 | 11 | 76 | keratinocyte differentiation |
GO:0002526 | 0.0028 | 2.768 | 4.7936 | 12 | 87 | acute inflammatory response |
GO:0038044 | 0.0029 | 17.2046 | 0.3306 | 3 | 6 | transforming growth factor-beta secretion |
GO:0021568 | 0.003 | Inf | 0.1102 | 2 | 2 | rhombomere 2 development |
GO:0042418 | 0.003 | Inf | 0.1102 | 2 | 2 | epinephrine biosynthetic process |
GO:0097535 | 0.003 | Inf | 0.1102 | 2 | 2 | lymphoid lineage cell migration into thymus |
GO:1903352 | 0.003 | Inf | 0.1102 | 2 | 2 | L-ornithine transmembrane transport |
GO:0048562 | 0.0031 | 2.1455 | 9.5095 | 19 | 174 | embryonic organ morphogenesis |
GO:0003334 | 0.0032 | 8.6093 | 0.6612 | 4 | 12 | keratinocyte development |
GO:0007154 | 0.0034 | 1.228 | 250.9201 | 287 | 4554 | cell communication |
GO:0070663 | 0.0035 | 2.0367 | 11.0198 | 21 | 200 | regulation of leukocyte proliferation |
GO:0043616 | 0.0036 | 4.0256 | 2.0387 | 7 | 37 | keratinocyte proliferation |
GO:0030903 | 0.0039 | 5.7434 | 1.102 | 5 | 20 | notochord development |
GO:0002687 | 0.0039 | 2.5276 | 5.6201 | 13 | 102 | positive regulation of leukocyte migration |
GO:0007166 | 0.004 | 1.3061 | 109.5916 | 136 | 1989 | cell surface receptor signaling pathway |
GO:0001736 | 0.0044 | 3.4522 | 2.6447 | 8 | 48 | establishment of planar polarity |
GO:0120031 | 0.0047 | 1.6459 | 23.6374 | 37 | 429 | plasma membrane bounded cell projection assembly |
GO:0007155 | 0.0047 | 1.5155 | 35.9681 | 52 | 671 | cell adhesion |
GO:0022612 | 0.0048 | 2.2173 | 7.7689 | 16 | 141 | gland morphogenesis |
GO:0010954 | 0.0049 | 5.3841 | 1.1571 | 5 | 21 | positive regulation of protein processing |
GO:0051797 | 0.0049 | 5.3841 | 1.1571 | 5 | 21 | regulation of hair follicle development |
GO:0050891 | 0.0049 | 3.7735 | 2.1489 | 7 | 39 | multicellular organismal water homeostasis |
GO:0030198 | 0.0049 | 2.0055 | 10.6341 | 20 | 193 | extracellular matrix organization |
GO:0071670 | 0.0049 | 12.9026 | 0.3857 | 3 | 7 | smooth muscle cell chemotaxis |
GO:1903708 | 0.0049 | 2.0941 | 9.2015 | 18 | 167 | positive regulation of hemopoiesis |
GO:0072376 | 0.005 | 3.3678 | 2.6998 | 8 | 49 | protein activation cascade |
GO:0035239 | 0.0056 | 1.6635 | 21.4885 | 34 | 390 | tube morphogenesis |
GO:0010454 | 0.0059 | 6.8865 | 0.7714 | 4 | 14 | negative regulation of cell fate commitment |
GO:0060742 | 0.0059 | 6.8865 | 0.7714 | 4 | 14 | epithelial cell differentiation involved in prostate gland development |
GO:0048731 | 0.0061 | 1.2202 | 215.1059 | 247 | 3904 | system development |
GO:0061180 | 0.0065 | 2.7419 | 4.0222 | 10 | 73 | mammary gland epithelium development |
GO:0008285 | 0.0072 | 1.5027 | 33.3899 | 48 | 606 | negative regulation of cell proliferation |
GO:0045066 | 0.0074 | 4.7852 | 1.2673 | 5 | 23 | regulatory T cell differentiation |
GO:0060285 | 0.0074 | 4.7852 | 1.2673 | 5 | 23 | cilium-dependent cell motility |
GO:0007156 | 0.0074 | 2.5344 | 4.7385 | 11 | 86 | homophilic cell adhesion via plasma membrane adhesion molecules |
GO:0090102 | 0.0075 | 3.4494 | 2.3142 | 7 | 42 | cochlea development |
GO:0048705 | 0.0076 | 1.8528 | 12.5625 | 22 | 228 | skeletal system morphogenesis |
GO:1990845 | 0.0077 | 6.26 | 0.8265 | 4 | 15 | adaptive thermogenesis |
GO:0051239 | 0.0078 | 1.2492 | 140.502 | 167 | 2550 | regulation of multicellular organismal process |
GO:0010466 | 0.0081 | 2.0305 | 8.926 | 17 | 162 | negative regulation of peptidase activity |
GO:0048771 | 0.0081 | 2.0305 | 8.926 | 17 | 162 | tissue remodeling |
GO:0002009 | 0.0081 | 1.544 | 27.7698 | 41 | 504 | morphogenesis of an epithelium |
GO:0050896 | 0.0084 | 1.1868 | 342.8849 | 377 | 6261 | response to stimulus |
GO:0050793 | 0.0087 | 1.2605 | 121.3827 | 146 | 2203 | regulation of developmental process |
GO:0010749 | 0.0088 | 34.3744 | 0.1653 | 2 | 3 | regulation of nitric oxide mediated signal transduction |
GO:0016129 | 0.0088 | 34.3744 | 0.1653 | 2 | 3 | phytosteroid biosynthetic process |
GO:0021773 | 0.0088 | 34.3744 | 0.1653 | 2 | 3 | striatal medium spiny neuron differentiation |
GO:0032474 | 0.0088 | 34.3744 | 0.1653 | 2 | 3 | otolith morphogenesis |
GO:0032929 | 0.0088 | 34.3744 | 0.1653 | 2 | 3 | negative regulation of superoxide anion generation |
GO:0046813 | 0.0088 | 34.3744 | 0.1653 | 2 | 3 | receptor-mediated virion attachment to host cell |
GO:0048817 | 0.0088 | 34.3744 | 0.1653 | 2 | 3 | negative regulation of hair follicle maturation |
GO:0051142 | 0.0088 | 34.3744 | 0.1653 | 2 | 3 | positive regulation of NK T cell proliferation |
GO:1903400 | 0.0088 | 34.3744 | 0.1653 | 2 | 3 | L-arginine transmembrane transport |
GO:1903401 | 0.0088 | 34.3744 | 0.1653 | 2 | 3 | L-lysine transmembrane transport |
GO:2000255 | 0.0088 | 34.3744 | 0.1653 | 2 | 3 | negative regulation of male germ cell proliferation |
GO:0002683 | 0.0095 | 1.6226 | 20.6621 | 32 | 375 | negative regulation of immune system process |
GO:0042471 | 0.0095 | 2.1622 | 6.9425 | 14 | 126 | ear morphogenesis |
GO:0016055 | 0.0097 | 1.6333 | 19.8907 | 31 | 361 | Wnt signaling pathway |
GO:0019748 | 0.0097 | 3.2625 | 2.4243 | 7 | 44 | secondary metabolic process |
GO:0016601 | 0.0098 | 3.6932 | 1.8734 | 6 | 34 | Rac protein signal transduction |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006597 | 2e-04 | Inf | 0.0296 | 2 | 2 | spermine biosynthetic process |
GO:0009584 | 5e-04 | 12.8719 | 0.3703 | 4 | 25 | detection of visible light |
GO:0002695 | 0.0015 | 3.9565 | 2.1623 | 8 | 146 | negative regulation of leukocyte activation |
GO:0007190 | 0.0016 | 15.5358 | 0.237 | 3 | 16 | activation of adenylate cyclase activity |
GO:0072520 | 0.0016 | 15.5358 | 0.237 | 3 | 16 | seminiferous tubule development |
GO:0045063 | 0.0019 | 14.4252 | 0.2518 | 3 | 17 | T-helper 1 cell differentiation |
GO:0008295 | 0.0021 | 44.7179 | 0.0741 | 2 | 5 | spermidine biosynthetic process |
GO:0007601 | 0.0022 | 4.1789 | 1.792 | 7 | 121 | visual perception |
GO:0050868 | 0.0035 | 4.3776 | 1.4662 | 6 | 99 | negative regulation of T cell activation |
GO:0015886 | 0.0044 | 26.8274 | 0.1037 | 2 | 7 | heme transport |
GO:0021910 | 0.0044 | 26.8274 | 0.1037 | 2 | 7 | smoothened signaling pathway involved in ventral spinal cord patterning |
GO:0050672 | 0.0045 | 4.9755 | 1.0811 | 5 | 73 | negative regulation of lymphocyte proliferation |
GO:0070664 | 0.0054 | 4.7643 | 1.1256 | 5 | 76 | negative regulation of leukocyte proliferation |
GO:0002839 | 0.0058 | 22.3547 | 0.1185 | 2 | 8 | positive regulation of immune response to tumor cell |
GO:0009566 | 0.0075 | 3.279 | 2.2511 | 7 | 152 | fertilization |
GO:0050482 | 0.0088 | 7.7615 | 0.4295 | 3 | 29 | arachidonic acid secretion |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0072520 | 1e-04 | 24.1198 | 0.2219 | 4 | 16 | seminiferous tubule development |
GO:0006597 | 2e-04 | Inf | 0.0277 | 2 | 2 | spermine biosynthetic process |
GO:0046546 | 6e-04 | 5.3216 | 1.4285 | 7 | 103 | development of primary male sexual characteristics |
GO:0042401 | 7e-04 | 21.611 | 0.1803 | 3 | 13 | cellular biogenic amine biosynthetic process |
GO:0008295 | 0.0019 | 47.8265 | 0.0693 | 2 | 5 | spermidine biosynthetic process |
GO:0030819 | 0.0021 | 6.0394 | 0.9015 | 5 | 65 | positive regulation of cAMP biosynthetic process |
GO:0050832 | 0.0022 | 13.5017 | 0.2635 | 3 | 19 | defense response to fungus |
GO:0052652 | 0.0022 | 4.1462 | 1.8029 | 7 | 130 | cyclic purine nucleotide metabolic process |
GO:0032277 | 0.0028 | 35.8676 | 0.0832 | 2 | 6 | negative regulation of gonadotropin secretion |
GO:0002679 | 0.0051 | 23.9087 | 0.111 | 2 | 8 | respiratory burst involved in defense response |
GO:0009566 | 0.0053 | 3.5122 | 2.1081 | 7 | 152 | fertilization |
GO:0090308 | 0.0065 | 20.4918 | 0.1248 | 2 | 9 | regulation of methylation-dependent chromatin silencing |
GO:0030801 | 0.0069 | 4.4676 | 1.1927 | 5 | 86 | positive regulation of cyclic nucleotide metabolic process |
GO:0030810 | 0.0069 | 4.4676 | 1.1927 | 5 | 86 | positive regulation of nucleotide biosynthetic process |
GO:0050482 | 0.0074 | 8.3035 | 0.4022 | 3 | 29 | arachidonic acid secretion |
GO:0010453 | 0.0081 | 7.9954 | 0.4161 | 3 | 30 | regulation of cell fate commitment |
GO:0050866 | 0.0082 | 3.2205 | 2.2884 | 7 | 165 | negative regulation of cell activation |
GO:0051250 | 0.0089 | 3.5666 | 1.7752 | 6 | 128 | negative regulation of lymphocyte activation |
GO:0006885 | 0.0095 | 4.1104 | 1.2898 | 5 | 93 | regulation of pH |
GO:0071468 | 0.0097 | 15.9361 | 0.1526 | 2 | 11 | cellular response to acidic pH |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007340 | 5e-04 | 73.5648 | 0.0328 | 2 | 29 | acrosome reaction |
GO:0014739 | 0.0011 | Inf | 0.0011 | 1 | 1 | positive regulation of muscle hyperplasia |
GO:0032078 | 0.0011 | Inf | 0.0011 | 1 | 1 | negative regulation of endodeoxyribonuclease activity |
GO:0071626 | 0.0023 | 936.2353 | 0.0023 | 1 | 2 | mastication |
GO:0098583 | 0.0023 | 936.2353 | 0.0023 | 1 | 2 | learned vocalization behavior |
GO:1905747 | 0.0023 | 936.2353 | 0.0023 | 1 | 2 | negative regulation of saliva secretion |
GO:1905748 | 0.0023 | 936.2353 | 0.0023 | 1 | 2 | hard palate morphogenesis |
GO:0007356 | 0.0034 | 468.0882 | 0.0034 | 1 | 3 | thorax and anterior abdomen determination |
GO:0071672 | 0.0034 | 468.0882 | 0.0034 | 1 | 3 | negative regulation of smooth muscle cell chemotaxis |
GO:0071673 | 0.0034 | 468.0882 | 0.0034 | 1 | 3 | positive regulation of smooth muscle cell chemotaxis |
GO:0021650 | 0.0045 | 312.0392 | 0.0045 | 1 | 4 | vestibulocochlear nerve formation |
GO:1900004 | 0.0045 | 312.0392 | 0.0045 | 1 | 4 | negative regulation of serine-type endopeptidase activity |
GO:1902571 | 0.0045 | 312.0392 | 0.0045 | 1 | 4 | regulation of serine-type peptidase activity |
GO:0002250 | 0.0045 | 10.3761 | 0.3434 | 3 | 304 | adaptive immune response |
GO:1901078 | 0.0056 | 234.0147 | 0.0056 | 1 | 5 | negative regulation of relaxation of muscle |
GO:0045321 | 0.0061 | 6.4918 | 0.7625 | 4 | 675 | leukocyte activation |
GO:0051249 | 0.0066 | 9.0541 | 0.392 | 3 | 347 | regulation of lymphocyte activation |
GO:0051534 | 0.0068 | 187.2 | 0.0068 | 1 | 6 | negative regulation of NFAT protein import into nucleus |
GO:0007341 | 0.0079 | 155.9902 | 0.0079 | 1 | 7 | penetration of zona pellucida |
GO:0032074 | 0.0079 | 155.9902 | 0.0079 | 1 | 7 | negative regulation of nuclease activity |
GO:0060017 | 0.0079 | 155.9902 | 0.0079 | 1 | 7 | parathyroid gland development |
GO:0071294 | 0.0079 | 155.9902 | 0.0079 | 1 | 7 | cellular response to zinc ion |
GO:0021562 | 0.009 | 133.6975 | 0.009 | 1 | 8 | vestibulocochlear nerve development |
GO:0032070 | 0.009 | 133.6975 | 0.009 | 1 | 8 | regulation of deoxyribonuclease activity |
GO:0090026 | 0.009 | 133.6975 | 0.009 | 1 | 8 | positive regulation of monocyte chemotaxis |
GO:0048608 | 0.0097 | 7.8186 | 0.4518 | 3 | 400 | reproductive structure development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006597 | 0 | Inf | 0.0108 | 2 | 2 | spermine biosynthetic process |
GO:0008295 | 3e-04 | 125.7619 | 0.027 | 2 | 5 | spermidine biosynthetic process |
GO:0032945 | 6e-04 | 11.1559 | 0.394 | 4 | 73 | negative regulation of mononuclear cell proliferation |
GO:0071468 | 0.0015 | 41.9048 | 0.0594 | 2 | 11 | cellular response to acidic pH |
GO:0006595 | 0.0022 | 34.2814 | 0.0702 | 2 | 13 | polyamine metabolic process |
GO:0042401 | 0.0022 | 34.2814 | 0.0702 | 2 | 13 | cellular biogenic amine biosynthetic process |
GO:0002070 | 0.0033 | 26.9303 | 0.0864 | 2 | 16 | epithelial cell maturation |
GO:0007190 | 0.0033 | 26.9303 | 0.0864 | 2 | 16 | activation of adenylate cyclase activity |
GO:0072520 | 0.0033 | 26.9303 | 0.0864 | 2 | 16 | seminiferous tubule development |
GO:0050670 | 0.0037 | 5.1981 | 1.0308 | 5 | 191 | regulation of lymphocyte proliferation |
GO:0036344 | 0.0042 | 23.561 | 0.0971 | 2 | 18 | platelet morphogenesis |
GO:0070663 | 0.0045 | 4.9554 | 1.0794 | 5 | 200 | regulation of leukocyte proliferation |
GO:0042130 | 0.0046 | 9.6733 | 0.3346 | 3 | 62 | negative regulation of T cell proliferation |
GO:0051250 | 0.0051 | 6.1861 | 0.6908 | 4 | 128 | negative regulation of lymphocyte activation |
GO:0007141 | 0.0051 | 20.9405 | 0.1079 | 2 | 20 | male meiosis I |
GO:0006592 | 0.0054 | Inf | 0.0054 | 1 | 1 | ornithine biosynthetic process |
GO:0035702 | 0.0054 | Inf | 0.0054 | 1 | 1 | monocyte homeostasis |
GO:0070105 | 0.0054 | Inf | 0.0054 | 1 | 1 | positive regulation of interleukin-6-mediated signaling pathway |
GO:0072755 | 0.0054 | Inf | 0.0054 | 1 | 1 | cellular response to benomyl |
GO:1905221 | 0.0054 | Inf | 0.0054 | 1 | 1 | positive regulation of platelet formation |
GO:1990959 | 0.0054 | Inf | 0.0054 | 1 | 1 | eosinophil homeostasis |
GO:1990960 | 0.0054 | Inf | 0.0054 | 1 | 1 | basophil homeostasis |
GO:0002694 | 0.0071 | 3.3534 | 2.2397 | 7 | 415 | regulation of leukocyte activation |
GO:0000470 | 0.0074 | 17.1288 | 0.1295 | 2 | 24 | maturation of LSU-rRNA |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0014739 | 6e-04 | Inf | 6e-04 | 1 | 1 | positive regulation of muscle hyperplasia |
GO:0032078 | 6e-04 | Inf | 6e-04 | 1 | 1 | negative regulation of endodeoxyribonuclease activity |
GO:0071626 | 0.0013 | 1769.3333 | 0.0013 | 1 | 2 | mastication |
GO:0098583 | 0.0013 | 1769.3333 | 0.0013 | 1 | 2 | learned vocalization behavior |
GO:1905747 | 0.0013 | 1769.3333 | 0.0013 | 1 | 2 | negative regulation of saliva secretion |
GO:1905748 | 0.0013 | 1769.3333 | 0.0013 | 1 | 2 | hard palate morphogenesis |
GO:0042110 | 0.0017 | 16.4233 | 0.256 | 3 | 408 | T cell activation |
GO:0007356 | 0.0019 | 884.6111 | 0.0019 | 1 | 3 | thorax and anterior abdomen determination |
GO:0071672 | 0.0019 | 884.6111 | 0.0019 | 1 | 3 | negative regulation of smooth muscle cell chemotaxis |
GO:0071673 | 0.0019 | 884.6111 | 0.0019 | 1 | 3 | positive regulation of smooth muscle cell chemotaxis |
GO:0021650 | 0.0025 | 589.7037 | 0.0025 | 1 | 4 | vestibulocochlear nerve formation |
GO:1900004 | 0.0025 | 589.7037 | 0.0025 | 1 | 4 | negative regulation of serine-type endopeptidase activity |
GO:1902571 | 0.0025 | 589.7037 | 0.0025 | 1 | 4 | regulation of serine-type peptidase activity |
GO:0007286 | 0.0031 | 29.4608 | 0.0853 | 2 | 136 | spermatid development |
GO:1901078 | 0.0031 | 442.25 | 0.0031 | 1 | 5 | negative regulation of relaxation of muscle |
GO:0009566 | 0.0039 | 26.2917 | 0.0954 | 2 | 152 | fertilization |
GO:0007341 | 0.0044 | 294.7963 | 0.0044 | 1 | 7 | penetration of zona pellucida |
GO:0032074 | 0.0044 | 294.7963 | 0.0044 | 1 | 7 | negative regulation of nuclease activity |
GO:0021562 | 0.005 | 252.6667 | 0.005 | 1 | 8 | vestibulocochlear nerve development |
GO:0032070 | 0.005 | 252.6667 | 0.005 | 1 | 8 | regulation of deoxyribonuclease activity |
GO:0090026 | 0.005 | 252.6667 | 0.005 | 1 | 8 | positive regulation of monocyte chemotaxis |
GO:0001787 | 0.0056 | 221.0694 | 0.0056 | 1 | 9 | natural killer cell proliferation |
GO:0002176 | 0.0056 | 221.0694 | 0.0056 | 1 | 9 | male germ cell proliferation |
GO:0035093 | 0.0056 | 221.0694 | 0.0056 | 1 | 9 | spermatogenesis, exchange of chromosomal proteins |
GO:0021559 | 0.0063 | 196.4938 | 0.0063 | 1 | 10 | trigeminal nerve development |
GO:0072540 | 0.0063 | 196.4938 | 0.0063 | 1 | 10 | T-helper 17 cell lineage commitment |
GO:0032740 | 0.0069 | 176.8333 | 0.0069 | 1 | 11 | positive regulation of interleukin-17 production |
GO:0090257 | 0.007 | 19.2659 | 0.1293 | 2 | 206 | regulation of muscle system process |
GO:0045321 | 0.0073 | 9.7277 | 0.4236 | 3 | 675 | leukocyte activation |
GO:0008595 | 0.0075 | 160.7475 | 0.0075 | 1 | 12 | anterior/posterior axis specification, embryo |
GO:0030432 | 0.0075 | 160.7475 | 0.0075 | 1 | 12 | peristalsis |
GO:0031223 | 0.0075 | 160.7475 | 0.0075 | 1 | 12 | auditory behavior |
GO:0043373 | 0.0081 | 147.3426 | 0.0082 | 1 | 13 | CD4-positive, alpha-beta T cell lineage commitment |
GO:0007340 | 0.0084 | 141.9464 | 0.0085 | 1 | 15 | acrosome reaction |
GO:0060046 | 0.0088 | 136 | 0.0088 | 1 | 14 | regulation of acrosome reaction |
GO:0007548 | 0.0089 | 16.9848 | 0.1462 | 2 | 233 | sex differentiation |
GO:0035112 | 0.0094 | 126.2778 | 0.0094 | 1 | 15 | genitalia morphogenesis |
GO:0007350 | 0.01 | 117.8519 | 0.01 | 1 | 16 | blastoderm segmentation |
GO:0072520 | 0.01 | 117.8519 | 0.01 | 1 | 16 | seminiferous tubule development |
GO:0097094 | 0.01 | 117.8519 | 0.01 | 1 | 16 | craniofacial suture morphogenesis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 63.004 | 0.7003 | 18 | 31 | DNA replication-dependent nucleosome assembly |
GO:0045653 | 0 | 145.8379 | 0.3841 | 13 | 17 | negative regulation of megakaryocyte differentiation |
GO:0051290 | 0 | 26.569 | 1.0392 | 17 | 46 | protein heterotetramerization |
GO:0006336 | 0 | 48.4366 | 0.61 | 14 | 27 | DNA replication-independent nucleosome assembly |
GO:0034728 | 0 | 9.3053 | 2.8014 | 21 | 124 | nucleosome organization |
GO:0031497 | 0 | 9.7925 | 2.5529 | 20 | 113 | chromatin assembly |
GO:0065004 | 0 | 7.8057 | 3.5695 | 23 | 158 | protein-DNA complex assembly |
GO:0006342 | 0 | 11.434 | 1.6718 | 15 | 74 | chromatin silencing |
GO:0071103 | 0 | 5.5619 | 4.1343 | 20 | 183 | DNA conformation change |
GO:0045637 | 0 | 5.4938 | 4.1795 | 20 | 185 | regulation of myeloid cell differentiation |
GO:1903707 | 0 | 6.308 | 2.9369 | 16 | 130 | negative regulation of hemopoiesis |
GO:0048534 | 0 | 2.5998 | 17.9605 | 42 | 795 | hematopoietic or lymphoid organ development |
GO:0040029 | 0 | 4.3978 | 4.0439 | 16 | 179 | regulation of gene expression, epigenetic |
GO:0051276 | 0 | 2.4074 | 16.8575 | 37 | 781 | chromosome organization |
GO:0065003 | 1e-04 | 1.8477 | 33.1647 | 56 | 1468 | macromolecular complex assembly |
GO:0046483 | 1e-04 | 1.5316 | 105.5714 | 139 | 4673 | heterocycle metabolic process |
GO:0045596 | 1e-04 | 2.2576 | 14.7976 | 31 | 655 | negative regulation of cell differentiation |
GO:0006725 | 2e-04 | 1.4923 | 106.588 | 138 | 4718 | cellular aromatic compound metabolic process |
GO:0016043 | 2e-04 | 1.4784 | 114.4048 | 146 | 5064 | cellular component organization |
GO:0048519 | 3e-04 | 1.4947 | 97.7546 | 128 | 4327 | negative regulation of biological process |
GO:1901360 | 3e-04 | 1.4735 | 110.1801 | 141 | 4877 | organic cyclic compound metabolic process |
GO:0070271 | 3e-04 | 1.8332 | 26.455 | 45 | 1171 | protein complex biogenesis |
GO:0002705 | 3e-04 | 4.5647 | 2.1688 | 9 | 96 | positive regulation of leukocyte mediated immunity |
GO:0002682 | 3e-04 | 1.9009 | 22.6144 | 40 | 1001 | regulation of immune system process |
GO:0002874 | 5e-04 | Inf | 0.0452 | 2 | 2 | regulation of chronic inflammatory response to antigenic stimulus |
GO:0002821 | 7e-04 | 4.5744 | 1.9203 | 8 | 85 | positive regulation of adaptive immune response |
GO:0006991 | 9e-04 | 21.8053 | 0.2033 | 3 | 9 | response to sterol depletion |
GO:0032933 | 9e-04 | 21.8053 | 0.2033 | 3 | 9 | SREBP signaling pathway |
GO:0034641 | 9e-04 | 1.7543 | 28.1342 | 45 | 1352 | cellular nitrogen compound metabolic process |
GO:0010629 | 0.001 | 1.6737 | 32.7355 | 51 | 1449 | negative regulation of gene expression |
GO:0008152 | 0.001 | 1.4121 | 201.9479 | 231 | 8939 | metabolic process |
GO:0051259 | 0.001 | 2.1272 | 11.9736 | 24 | 530 | protein oligomerization |
GO:0002706 | 0.0011 | 3.7778 | 2.5755 | 9 | 114 | regulation of lymphocyte mediated immunity |
GO:0019985 | 0.0012 | 18.6891 | 0.2259 | 3 | 10 | translesion synthesis |
GO:0042254 | 0.0013 | 2.7115 | 5.4898 | 14 | 243 | ribosome biogenesis |
GO:0002822 | 0.0013 | 3.6721 | 2.6432 | 9 | 117 | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
GO:0052572 | 0.0015 | 87.0056 | 0.0678 | 2 | 3 | response to host immune response |
GO:0009890 | 0.0015 | 1.6656 | 30.16 | 47 | 1335 | negative regulation of biosynthetic process |
GO:0071822 | 0.0017 | 1.6644 | 29.5049 | 46 | 1306 | protein complex subunit organization |
GO:0016070 | 0.0017 | 1.4292 | 81.9178 | 106 | 3626 | RNA metabolic process |
GO:0045672 | 0.0019 | 8.7388 | 0.5422 | 4 | 24 | positive regulation of osteoclast differentiation |
GO:0071281 | 0.0022 | 14.5341 | 0.2711 | 3 | 12 | cellular response to iron ion |
GO:0043457 | 0.0026 | 7.9433 | 0.5874 | 4 | 26 | regulation of cellular respiration |
GO:0007614 | 0.0028 | 13.0798 | 0.2937 | 3 | 13 | short-term memory |
GO:0002740 | 0.003 | 43.5 | 0.0904 | 2 | 4 | negative regulation of cytokine secretion involved in immune response |
GO:0016557 | 0.003 | 43.5 | 0.0904 | 2 | 4 | peroxisome membrane biogenesis |
GO:0071593 | 0.003 | 43.5 | 0.0904 | 2 | 4 | lymphocyte aggregation |
GO:0090191 | 0.003 | 43.5 | 0.0904 | 2 | 4 | negative regulation of branching involved in ureteric bud morphogenesis |
GO:0071840 | 0.0034 | 3.1828 | 3.0316 | 9 | 154 | cellular component organization or biogenesis |
GO:0048193 | 0.0036 | 2.6112 | 4.8572 | 12 | 215 | Golgi vesicle transport |
GO:0009059 | 0.0039 | 1.3775 | 88.5372 | 111 | 3919 | macromolecule biosynthetic process |
GO:0031623 | 0.004 | 3.7467 | 2.0107 | 7 | 89 | receptor internalization |
GO:0051983 | 0.004 | 3.7467 | 2.0107 | 7 | 89 | regulation of chromosome segregation |
GO:1900153 | 0.0043 | 10.8985 | 0.3389 | 3 | 15 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay |
GO:0016072 | 0.0043 | 2.6807 | 4.3376 | 11 | 192 | rRNA metabolic process |
GO:0001562 | 0.0044 | 6.7195 | 0.6778 | 4 | 30 | response to protozoan |
GO:0044271 | 0.0047 | 1.3719 | 85.3291 | 107 | 3777 | cellular nitrogen compound biosynthetic process |
GO:0002904 | 0.0049 | 28.9981 | 0.113 | 2 | 5 | positive regulation of B cell apoptotic process |
GO:0042663 | 0.0049 | 28.9981 | 0.113 | 2 | 5 | regulation of endodermal cell fate specification |
GO:0052173 | 0.0049 | 28.9981 | 0.113 | 2 | 5 | response to defenses of other organism involved in symbiotic interaction |
GO:0075136 | 0.0049 | 28.9981 | 0.113 | 2 | 5 | response to host |
GO:1900157 | 0.0049 | 28.9981 | 0.113 | 2 | 5 | regulation of bone mineralization involved in bone maturation |
GO:0010467 | 0.0049 | 1.4381 | 58.4357 | 77 | 2781 | gene expression |
GO:0006281 | 0.0049 | 2.071 | 9.1271 | 18 | 404 | DNA repair |
GO:0001913 | 0.005 | 6.4702 | 0.7003 | 4 | 31 | T cell mediated cytotoxicity |
GO:0002891 | 0.005 | 6.4702 | 0.7003 | 4 | 31 | positive regulation of immunoglobulin mediated immune response |
GO:0006826 | 0.005 | 6.4702 | 0.7003 | 4 | 31 | iron ion transport |
GO:0001711 | 0.0051 | 10.0595 | 0.3615 | 3 | 16 | endodermal cell fate commitment |
GO:0140053 | 0.0057 | 3.9828 | 1.6266 | 6 | 72 | mitochondrial gene expression |
GO:0002637 | 0.0062 | 4.6533 | 1.1748 | 5 | 52 | regulation of immunoglobulin production |
GO:0016445 | 0.0068 | 4.556 | 1.1974 | 5 | 53 | somatic diversification of immunoglobulins |
GO:0002711 | 0.007 | 5.8221 | 0.7681 | 4 | 34 | positive regulation of T cell mediated immunity |
GO:0090304 | 0.0071 | 2.0476 | 8.77 | 17 | 425 | nucleic acid metabolic process |
GO:0033625 | 0.0072 | 21.7472 | 0.1356 | 2 | 6 | positive regulation of integrin activation |
GO:0045046 | 0.0072 | 21.7472 | 0.1356 | 2 | 6 | protein import into peroxisome membrane |
GO:0021542 | 0.0073 | 8.7171 | 0.4067 | 3 | 18 | dentate gyrus development |
GO:0031645 | 0.0073 | 8.7171 | 0.4067 | 3 | 18 | negative regulation of neurological system process |
GO:0060255 | 0.0074 | 1.3235 | 108.2372 | 130 | 4791 | regulation of macromolecule metabolic process |
GO:1902749 | 0.0074 | 3.7542 | 1.717 | 6 | 76 | regulation of cell cycle G2/M phase transition |
GO:0090068 | 0.0075 | 2.4731 | 4.6765 | 11 | 207 | positive regulation of cell cycle process |
GO:0031324 | 0.008 | 1.4297 | 47.6687 | 64 | 2110 | negative regulation of cellular metabolic process |
GO:0002521 | 0.0088 | 1.9077 | 10.4148 | 19 | 461 | leukocyte differentiation |
GO:0033554 | 0.0094 | 1.4934 | 33.2099 | 47 | 1470 | cellular response to stress |
GO:0008284 | 0.0095 | 1.6641 | 18.2542 | 29 | 808 | positive regulation of cell proliferation |
GO:0010564 | 0.0097 | 2.1982 | 6.1909 | 13 | 279 | regulation of cell cycle process |
GO:1901136 | 0.0097 | 3.1317 | 2.3721 | 7 | 105 | carbohydrate derivative catabolic process |
GO:0002440 | 0.0098 | 2.6546 | 3.5695 | 9 | 158 | production of molecular mediator of immune response |
GO:0048660 | 0.0098 | 2.8551 | 2.9595 | 8 | 131 | regulation of smooth muscle cell proliferation |
GO:2000113 | 0.0099 | 1.5376 | 27.3586 | 40 | 1211 | negative regulation of cellular macromolecule biosynthetic process |
GO:0072321 | 0.0099 | 17.3966 | 0.1581 | 2 | 7 | chaperone-mediated protein transport |
GO:1903012 | 0.0099 | 17.3966 | 0.1581 | 2 | 7 | positive regulation of bone development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:1900107 | 5e-04 | 81.2821 | 0.0351 | 2 | 7 | regulation of nodal signaling pathway |
GO:0032926 | 0.0013 | 45.1453 | 0.0552 | 2 | 11 | negative regulation of activin receptor signaling pathway |
GO:0007368 | 0.0026 | 7.5335 | 0.5723 | 4 | 114 | determination of left/right symmetry |
GO:0042074 | 0.0029 | 29.0128 | 0.0803 | 2 | 16 | cell migration involved in gastrulation |
GO:0009799 | 0.0034 | 6.9598 | 0.6175 | 4 | 123 | specification of symmetry |
GO:0045069 | 0.0037 | 10.431 | 0.3113 | 3 | 62 | regulation of viral genome replication |
GO:0003147 | 0.005 | Inf | 0.005 | 1 | 1 | neural crest cell migration involved in heart formation |
GO:0007065 | 0.005 | Inf | 0.005 | 1 | 1 | male meiosis sister chromatid cohesion |
GO:0007285 | 0.005 | Inf | 0.005 | 1 | 1 | primary spermatocyte growth |
GO:0061713 | 0.005 | Inf | 0.005 | 1 | 1 | anterior neural tube closure |
GO:0071231 | 0.005 | Inf | 0.005 | 1 | 1 | cellular response to folic acid |
GO:1900114 | 0.005 | Inf | 0.005 | 1 | 1 | positive regulation of histone H3-K9 trimethylation |
GO:1900124 | 0.005 | Inf | 0.005 | 1 | 1 | negative regulation of nodal receptor complex assembly |
GO:0048232 | 0.0058 | 3.4983 | 2.1588 | 7 | 430 | male gamete generation |
GO:0006955 | 0.0078 | 2.5238 | 4.7844 | 11 | 953 | immune response |
GO:0051704 | 0.0088 | 2.1764 | 7.7063 | 15 | 1535 | multi-organism process |
GO:0051607 | 0.0095 | 5.1304 | 0.8284 | 4 | 165 | defense response to virus |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006393 | 0 | Inf | 0.0118 | 2 | 2 | termination of mitochondrial transcription |
GO:0009408 | 0.001 | 10.0133 | 0.4365 | 4 | 74 | response to heat |
GO:0001867 | 0.0015 | 43.0245 | 0.059 | 2 | 10 | complement activation, lectin pathway |
GO:0030238 | 0.0022 | 34.4152 | 0.0708 | 2 | 12 | male sex determination |
GO:0010529 | 0.0026 | 31.2846 | 0.0767 | 2 | 13 | negative regulation of transposition |
GO:0006168 | 0.0059 | Inf | 0.0059 | 1 | 1 | adenine salvage |
GO:0008218 | 0.0059 | Inf | 0.0059 | 1 | 1 | bioluminescence |
GO:0014809 | 0.0059 | Inf | 0.0059 | 1 | 1 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion |
GO:0018900 | 0.0059 | Inf | 0.0059 | 1 | 1 | dichloromethane metabolic process |
GO:0046083 | 0.0059 | Inf | 0.0059 | 1 | 1 | adenine metabolic process |
GO:1900124 | 0.0059 | Inf | 0.0059 | 1 | 1 | negative regulation of nodal receptor complex assembly |
GO:0002931 | 0.0087 | 15.6314 | 0.1416 | 2 | 24 | response to ischemia |
GO:0140053 | 0.0088 | 7.5356 | 0.4247 | 3 | 72 | mitochondrial gene expression |
GO:0043901 | 0.0097 | 5.0946 | 0.8318 | 4 | 141 | negative regulation of multi-organism process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0070051 | 0 | 69.3472 | 0.2738 | 4 | 5 | fibrinogen binding |
GO:0005509 | 0 | 1.9228 | 28.5897 | 51 | 522 | calcium ion binding |
GO:0030545 | 2e-04 | 2.0341 | 19.0598 | 36 | 348 | receptor regulator activity |
GO:0050431 | 4e-04 | 8.0137 | 1.0406 | 6 | 19 | transforming growth factor beta binding |
GO:0001968 | 8e-04 | 5.5277 | 1.5883 | 7 | 29 | fibronectin binding |
GO:0017147 | 0.001 | 5.287 | 1.6431 | 7 | 30 | Wnt-protein binding |
GO:0005179 | 0.001 | 3.1677 | 4.272 | 12 | 78 | hormone activity |
GO:0004872 | 0.0011 | 1.5029 | 53.4003 | 76 | 975 | receptor activity |
GO:0004031 | 0.0015 | 25.9735 | 0.2738 | 3 | 5 | aldehyde oxidase activity |
GO:0004854 | 0.0015 | 25.9735 | 0.2738 | 3 | 5 | xanthine dehydrogenase activity |
GO:0005102 | 0.0017 | 1.4264 | 67.2478 | 91 | 1237 | receptor binding |
GO:0005523 | 0.0022 | 9.9028 | 0.6025 | 4 | 11 | tropomyosin binding |
GO:0015269 | 0.0023 | 6.6704 | 0.9859 | 5 | 18 | calcium-activated potassium channel activity |
GO:0030414 | 0.0025 | 2.3856 | 7.2843 | 16 | 133 | peptidase inhibitor activity |
GO:0008047 | 0.0028 | 1.7309 | 21.3601 | 35 | 390 | enzyme activator activity |
GO:0005289 | 0.003 | Inf | 0.1095 | 2 | 2 | high-affinity arginine transmembrane transporter activity |
GO:0005292 | 0.003 | Inf | 0.1095 | 2 | 2 | high-affinity lysine transmembrane transporter activity |
GO:0016262 | 0.003 | Inf | 0.1095 | 2 | 2 | protein N-acetylglucosaminyltransferase activity |
GO:0005542 | 0.0031 | 8.6644 | 0.6572 | 4 | 12 | folic acid binding |
GO:0045294 | 0.0031 | 8.6644 | 0.6572 | 4 | 12 | alpha-catenin binding |
GO:0043236 | 0.0051 | 4.3376 | 1.6431 | 6 | 30 | laminin binding |
GO:0061135 | 0.0058 | 2.2339 | 7.2296 | 15 | 132 | endopeptidase regulator activity |
GO:0004867 | 0.0069 | 2.7163 | 4.0529 | 10 | 74 | serine-type endopeptidase inhibitor activity |
GO:0016209 | 0.0078 | 3.0873 | 2.9028 | 8 | 53 | antioxidant activity |
GO:0003865 | 0.0087 | 34.5938 | 0.1643 | 2 | 3 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity |
GO:0004667 | 0.0087 | 34.5938 | 0.1643 | 2 | 3 | prostaglandin-D synthase activity |
GO:0008158 | 0.0087 | 34.5938 | 0.1643 | 2 | 3 | hedgehog receptor activity |
GO:0017077 | 0.0087 | 34.5938 | 0.1643 | 2 | 3 | oxidative phosphorylation uncoupler activity |
GO:0019828 | 0.0087 | 34.5938 | 0.1643 | 2 | 3 | aspartic-type endopeptidase inhibitor activity |
GO:0035373 | 0.0087 | 34.5938 | 0.1643 | 2 | 3 | chondroitin sulfate proteoglycan binding |
GO:0042015 | 0.0087 | 34.5938 | 0.1643 | 2 | 3 | interleukin-20 binding |
GO:0047751 | 0.0087 | 34.5938 | 0.1643 | 2 | 3 | cholestenone 5-alpha-reductase activity |
GO:0051870 | 0.0087 | 34.5938 | 0.1643 | 2 | 3 | methotrexate binding |
GO:0070548 | 0.0087 | 34.5938 | 0.1643 | 2 | 3 | L-glutamine aminotransferase activity |
GO:0070644 | 0.0087 | 34.5938 | 0.1643 | 2 | 3 | vitamin D response element binding |
GO:0005178 | 0.0098 | 2.3193 | 5.5865 | 12 | 102 | integrin binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004014 | 0 | Inf | 0.0127 | 2 | 2 | adenosylmethionine decarboxylase activity |
GO:0019810 | 0 | Inf | 0.0127 | 2 | 2 | putrescine binding |
GO:0030545 | 0.0017 | 3.912 | 2.2101 | 8 | 348 | receptor regulator activity |
GO:0005165 | 0.004 | 24.5361 | 0.0953 | 2 | 15 | neurotrophin receptor binding |
GO:0016209 | 0.0046 | 9.6441 | 0.3366 | 3 | 53 | antioxidant activity |
GO:0005539 | 0.005 | 4.8179 | 1.1051 | 5 | 174 | glycosaminoglycan binding |
GO:0004603 | 0.0064 | Inf | 0.0064 | 1 | 1 | phenylethanolamine N-methyltransferase activity |
GO:0032500 | 0.0064 | Inf | 0.0064 | 1 | 1 | muramyl dipeptide binding |
GO:0038164 | 0.0064 | Inf | 0.0064 | 1 | 1 | thrombopoietin receptor activity |
GO:0042007 | 0.0064 | Inf | 0.0064 | 1 | 1 | interleukin-18 binding |
GO:0046911 | 0.0064 | Inf | 0.0064 | 1 | 1 | metal chelating activity |
GO:0071791 | 0.0064 | Inf | 0.0064 | 1 | 1 | chemokine (C-C motif) ligand 5 binding |
GO:0008083 | 0.008 | 5.389 | 0.7875 | 4 | 124 | growth factor activity |
GO:0071813 | 0.0085 | 15.9414 | 0.1397 | 2 | 22 | lipoprotein particle binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0032500 | 0.0014 | Inf | 0.0014 | 1 | 1 | muramyl dipeptide binding |
GO:0042007 | 0.0014 | Inf | 0.0014 | 1 | 1 | interleukin-18 binding |
GO:0050436 | 0.0028 | 756.1905 | 0.0028 | 1 | 2 | microfibril binding |
GO:0042834 | 0.0096 | 125.9921 | 0.0097 | 1 | 7 | peptidoglycan binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0015433 | 1e-04 | Inf | 0.0165 | 2 | 2 | peptide antigen-transporting ATPase activity |
GO:0046980 | 1e-04 | Inf | 0.0165 | 2 | 2 | tapasin binding |
GO:0023029 | 2e-04 | 244.5116 | 0.0247 | 2 | 3 | MHC class Ib protein binding |
GO:0046978 | 2e-04 | 244.5116 | 0.0247 | 2 | 3 | TAP1 binding |
GO:0046979 | 2e-04 | 244.5116 | 0.0247 | 2 | 3 | TAP2 binding |
GO:0003823 | 5e-04 | 12.3874 | 0.3624 | 4 | 44 | antigen binding |
GO:0050750 | 9e-04 | 18.4594 | 0.1895 | 3 | 23 | low-density lipoprotein particle receptor binding |
GO:0005102 | 0.0013 | 2.2153 | 11.0299 | 22 | 1339 | receptor binding |
GO:0030545 | 0.0024 | 3.3584 | 2.8666 | 9 | 348 | receptor regulator activity |
GO:0042288 | 0.0042 | 24.4372 | 0.0988 | 2 | 12 | MHC class I protein binding |
GO:1990381 | 0.0066 | 18.7943 | 0.1236 | 2 | 15 | ubiquitin-specific protease binding |
GO:0005125 | 0.0068 | 4.463 | 1.1862 | 5 | 144 | cytokine activity |
GO:0004402 | 0.0076 | 8.0126 | 0.4036 | 3 | 49 | histone acetyltransferase activity |
GO:0001856 | 0.0082 | Inf | 0.0082 | 1 | 1 | complement component C5a binding |
GO:0003912 | 0.0082 | Inf | 0.0082 | 1 | 1 | DNA nucleotidylexotransferase activity |
GO:0005144 | 0.0082 | Inf | 0.0082 | 1 | 1 | interleukin-13 receptor binding |
GO:0009007 | 0.0082 | Inf | 0.0082 | 1 | 1 | site-specific DNA-methyltransferase (adenine-specific) activity |
GO:0030108 | 0.0082 | Inf | 0.0082 | 1 | 1 | HLA-A specific activating MHC class I receptor activity |
GO:0030305 | 0.0082 | Inf | 0.0082 | 1 | 1 | heparanase activity |
GO:0031768 | 0.0082 | Inf | 0.0082 | 1 | 1 | ghrelin receptor binding |
GO:0047988 | 0.0082 | Inf | 0.0082 | 1 | 1 | hydroxyacid-oxoacid transhydrogenase activity |
GO:0050313 | 0.0082 | Inf | 0.0082 | 1 | 1 | sulfur dioxygenase activity |
GO:0061798 | 0.0082 | Inf | 0.0082 | 1 | 1 | GTP 3',8'-cyclase activity |
GO:0061799 | 0.0082 | Inf | 0.0082 | 1 | 1 | cyclic pyranopterin monophosphate synthase activity |
GO:0098770 | 0.0082 | Inf | 0.0082 | 1 | 1 | FBXO family protein binding |
GO:0101006 | 0.0082 | Inf | 0.0082 | 1 | 1 | protein histidine phosphatase activity |
GO:0016746 | 0.0092 | 3.5399 | 1.7875 | 6 | 217 | transferase activity, transferring acyl groups |
GO:0008137 | 0.0095 | 15.2674 | 0.1483 | 2 | 18 | NADH dehydrogenase (ubiquinone) activity |
GO:0048020 | 0.0095 | 15.2674 | 0.1483 | 2 | 18 | CCR chemokine receptor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0001205 | 2e-04 | 110.1389 | 0.0235 | 2 | 34 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding |
GO:0042007 | 7e-04 | Inf | 7e-04 | 1 | 1 | interleukin-18 binding |
GO:0000980 | 0.0012 | 48.1553 | 0.0519 | 2 | 75 | RNA polymerase II distal enhancer sequence-specific DNA binding |
GO:0035326 | 0.0025 | 32.1774 | 0.0768 | 2 | 111 | enhancer binding |
GO:0051525 | 0.0028 | 529.6333 | 0.0028 | 1 | 4 | NFAT protein binding |
GO:0048019 | 0.0055 | 226.9286 | 0.0055 | 1 | 8 | receptor antagonist activity |
GO:0071933 | 0.0069 | 176.4778 | 0.0069 | 1 | 10 | Arp2/3 complex binding |
GO:0005522 | 0.0076 | 158.82 | 0.0076 | 1 | 11 | profilin binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004014 | 2e-04 | Inf | 0.0302 | 2 | 2 | adenosylmethionine decarboxylase activity |
GO:0019810 | 2e-04 | Inf | 0.0302 | 2 | 2 | putrescine binding |
GO:0004857 | 0.0027 | 2.7137 | 4.6784 | 12 | 310 | enzyme inhibitor activity |
GO:0004864 | 0.0093 | 7.613 | 0.4377 | 3 | 29 | protein phosphatase inhibitor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004014 | 2e-04 | Inf | 0.0288 | 2 | 2 | adenosylmethionine decarboxylase activity |
GO:0019810 | 2e-04 | Inf | 0.0288 | 2 | 2 | putrescine binding |
GO:0019955 | 0.002 | 4.9345 | 1.3104 | 6 | 91 | cytokine binding |
GO:0102991 | 0.003 | 34.5154 | 0.0864 | 2 | 6 | myristoyl-CoA hydrolase activity |
GO:0061135 | 0.003 | 3.9223 | 1.9008 | 7 | 132 | endopeptidase regulator activity |
GO:0030414 | 0.0031 | 3.8909 | 1.9152 | 7 | 133 | peptidase inhibitor activity |
GO:0004867 | 0.0043 | 5.0482 | 1.0656 | 5 | 74 | serine-type endopeptidase inhibitor activity |
GO:0030545 | 0.0047 | 2.5244 | 5.0111 | 12 | 348 | receptor regulator activity |
GO:0005179 | 0.0053 | 4.7704 | 1.1232 | 5 | 78 | hormone activity |
GO:0016176 | 0.0055 | 23.0073 | 0.1152 | 2 | 8 | superoxide-generating NADPH oxidase activator activity |
GO:0052689 | 0.0081 | 3.6402 | 1.7424 | 6 | 121 | carboxylic ester hydrolase activity |
GO:0001968 | 0.0082 | 7.9891 | 0.4176 | 3 | 29 | fibronectin binding |
GO:0008083 | 0.0091 | 3.547 | 1.7856 | 6 | 124 | growth factor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0003700 | 0.0031 | 2.7547 | 4.8709 | 12 | 1006 | DNA binding transcription factor activity |
GO:0031771 | 0.0048 | Inf | 0.0048 | 1 | 1 | type 1 hypocretin receptor binding |
GO:0031772 | 0.0048 | Inf | 0.0048 | 1 | 1 | type 2 hypocretin receptor binding |
GO:0047312 | 0.0048 | Inf | 0.0048 | 1 | 1 | L-phenylalanine:pyruvate aminotransferase activity |
GO:0047316 | 0.0048 | Inf | 0.0048 | 1 | 1 | glutamine-phenylpyruvate transaminase activity |
GO:0047945 | 0.0048 | Inf | 0.0048 | 1 | 1 | L-glutamine:pyruvate aminotransferase activity |
GO:0061690 | 0.0048 | Inf | 0.0048 | 1 | 1 | lipoamidase activity |
GO:1990081 | 0.0048 | Inf | 0.0048 | 1 | 1 | trimethylamine receptor activity |
GO:0003955 | 0.0097 | 208.2237 | 0.0097 | 1 | 2 | NAD(P)H dehydrogenase (quinone) activity |
GO:0010465 | 0.0097 | 208.2237 | 0.0097 | 1 | 2 | nerve growth factor receptor activity |
GO:0047708 | 0.0097 | 208.2237 | 0.0097 | 1 | 2 | biotinidase activity |
GO:0047804 | 0.0097 | 208.2237 | 0.0097 | 1 | 2 | cysteine-S-conjugate beta-lyase activity |
GO:0008227 | 0.0098 | 14.526 | 0.1501 | 2 | 31 | G-protein coupled amine receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0008201 | 0.0047 | 6.3195 | 0.6774 | 4 | 133 | heparin binding |
GO:0003885 | 0.0051 | Inf | 0.0051 | 1 | 1 | D-arabinono-1,4-lactone oxidase activity |
GO:0004632 | 0.0051 | Inf | 0.0051 | 1 | 1 | phosphopantothenate--cysteine ligase activity |
GO:0009918 | 0.0051 | Inf | 0.0051 | 1 | 1 | sterol delta7 reductase activity |
GO:0018733 | 0.0051 | Inf | 0.0051 | 1 | 1 | 3,4-dihydrocoumarin hydrolase activity |
GO:0032395 | 0.0051 | Inf | 0.0051 | 1 | 1 | MHC class II receptor activity |
GO:0047598 | 0.0051 | Inf | 0.0051 | 1 | 1 | 7-dehydrocholesterol reductase activity |
GO:0047856 | 0.0051 | Inf | 0.0051 | 1 | 1 | dihydrocoumarin hydrolase activity |
GO:0050105 | 0.0051 | Inf | 0.0051 | 1 | 1 | L-gulonolactone oxidase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046873 | 0.0032 | 3.9328 | 1.9355 | 7 | 405 | metal ion transmembrane transporter activity |
GO:0003837 | 0.0048 | Inf | 0.0048 | 1 | 1 | beta-ureidopropionase activity |
GO:0003885 | 0.0048 | Inf | 0.0048 | 1 | 1 | D-arabinono-1,4-lactone oxidase activity |
GO:0016412 | 0.0048 | Inf | 0.0048 | 1 | 1 | serine O-acyltransferase activity |
GO:0016784 | 0.0048 | Inf | 0.0048 | 1 | 1 | 3-mercaptopyruvate sulfurtransferase activity |
GO:0050105 | 0.0048 | Inf | 0.0048 | 1 | 1 | L-gulonolactone oxidase activity |
GO:1905574 | 0.0048 | Inf | 0.0048 | 1 | 1 | ganglioside GM2 binding |
GO:1905575 | 0.0048 | Inf | 0.0048 | 1 | 1 | ganglioside GM3 binding |
GO:1905577 | 0.0048 | Inf | 0.0048 | 1 | 1 | ganglioside GP1c binding |
GO:0005249 | 0.0081 | 7.7953 | 0.411 | 3 | 86 | voltage-gated potassium channel activity |
GO:0017147 | 0.009 | 15.25 | 0.1434 | 2 | 30 | Wnt-protein binding |
GO:0030116 | 0.0095 | 211.0133 | 0.0096 | 1 | 2 | glial cell-derived neurotrophic factor receptor binding |
GO:1905573 | 0.0095 | 211.0133 | 0.0096 | 1 | 2 | ganglioside GM1 binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0030545 | 0 | 4.3353 | 3.3043 | 13 | 348 | receptor regulator activity |
GO:0004888 | 0 | 3.1373 | 6.7415 | 19 | 710 | transmembrane signaling receptor activity |
GO:0004872 | 1e-04 | 2.6483 | 9.2577 | 22 | 975 | receptor activity |
GO:0004871 | 3e-04 | 2.4658 | 9.8844 | 22 | 1041 | signal transducer activity |
GO:0005125 | 4e-04 | 5.5406 | 1.3673 | 7 | 144 | cytokine activity |
GO:0034711 | 0.0013 | 52.8456 | 0.057 | 2 | 6 | inhibin binding |
GO:0005126 | 0.0039 | 3.7308 | 1.9903 | 7 | 211 | cytokine receptor binding |
GO:0015405 | 0.004 | 5.1034 | 1.0445 | 5 | 110 | P-P-bond-hydrolysis-driven transmembrane transporter activity |
GO:0008083 | 0.0066 | 4.499 | 1.1774 | 5 | 124 | growth factor activity |
GO:0017046 | 0.0069 | 8.3823 | 0.3893 | 3 | 41 | peptide hormone binding |
GO:0004869 | 0.0084 | 7.7675 | 0.4178 | 3 | 44 | cysteine-type endopeptidase inhibitor activity |
GO:0061135 | 0.0085 | 4.2134 | 1.2533 | 5 | 132 | endopeptidase regulator activity |
GO:0030414 | 0.0088 | 4.1802 | 1.2628 | 5 | 133 | peptidase inhibitor activity |
GO:0001792 | 0.0095 | Inf | 0.0095 | 1 | 1 | polymeric immunoglobulin receptor activity |
GO:0001918 | 0.0095 | Inf | 0.0095 | 1 | 1 | farnesylated protein binding |
GO:0004008 | 0.0095 | Inf | 0.0095 | 1 | 1 | copper-exporting ATPase activity |
GO:0004990 | 0.0095 | Inf | 0.0095 | 1 | 1 | oxytocin receptor activity |
GO:0005144 | 0.0095 | Inf | 0.0095 | 1 | 1 | interleukin-13 receptor binding |
GO:0008747 | 0.0095 | Inf | 0.0095 | 1 | 1 | N-acetylneuraminate lyase activity |
GO:0030377 | 0.0095 | Inf | 0.0095 | 1 | 1 | urokinase plasminogen activator receptor activity |
GO:0033038 | 0.0095 | Inf | 0.0095 | 1 | 1 | bitter taste receptor activity |
GO:0042922 | 0.0095 | Inf | 0.0095 | 1 | 1 | neuromedin U receptor binding |
GO:0047408 | 0.0095 | Inf | 0.0095 | 1 | 1 | alkenylglycerophosphocholine hydrolase activity |
GO:0047409 | 0.0095 | Inf | 0.0095 | 1 | 1 | alkenylglycerophosphoethanolamine hydrolase activity |
GO:0047747 | 0.0095 | Inf | 0.0095 | 1 | 1 | cholate-CoA ligase activity |
GO:0071791 | 0.0095 | Inf | 0.0095 | 1 | 1 | chemokine (C-C motif) ligand 5 binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0099600 | 7e-04 | 1.6124 | 40.0739 | 61 | 748 | transmembrane receptor activity |
GO:0004715 | 8e-04 | 4.2179 | 2.518 | 9 | 47 | non-membrane spanning protein tyrosine kinase activity |
GO:0023026 | 8e-04 | 8.879 | 0.8036 | 5 | 15 | MHC class II protein complex binding |
GO:0005126 | 0.001 | 2.1817 | 11.3579 | 23 | 212 | cytokine receptor binding |
GO:0004129 | 0.0012 | 8.0713 | 0.8572 | 5 | 16 | cytochrome-c oxidase activity |
GO:0038023 | 0.0013 | 1.553 | 42.8063 | 63 | 799 | signaling receptor activity |
GO:0016675 | 0.0016 | 7.3982 | 0.9108 | 5 | 17 | oxidoreductase activity, acting on a heme group of donors |
GO:0004930 | 0.0018 | 1.8566 | 17.7333 | 31 | 331 | G-protein coupled receptor activity |
GO:0005125 | 0.0018 | 2.3925 | 7.7148 | 17 | 144 | cytokine activity |
GO:0033549 | 0.002 | 10.1375 | 0.5893 | 4 | 11 | MAP kinase phosphatase activity |
GO:0004014 | 0.0029 | Inf | 0.1071 | 2 | 2 | adenosylmethionine decarboxylase activity |
GO:0004962 | 0.0029 | Inf | 0.1071 | 2 | 2 | endothelin receptor activity |
GO:0019810 | 0.0029 | Inf | 0.1071 | 2 | 2 | putrescine binding |
GO:0032403 | 0.0031 | 1.481 | 46.0743 | 65 | 860 | protein complex binding |
GO:0005031 | 0.0034 | 5.9174 | 1.0715 | 5 | 20 | tumor necrosis factor-activated receptor activity |
GO:0034987 | 0.0046 | 13.2924 | 0.375 | 3 | 7 | immunoglobulin receptor binding |
GO:0046965 | 0.0054 | 5.2205 | 1.1786 | 5 | 22 | retinoid X receptor binding |
GO:0004872 | 0.006 | 2.2182 | 7.2604 | 15 | 139 | receptor activity |
GO:0071837 | 0.0065 | 4.9301 | 1.2322 | 5 | 23 | HMG box domain binding |
GO:0038036 | 0.007 | 10.6332 | 0.4286 | 3 | 8 | sphingosine-1-phosphate receptor activity |
GO:0030545 | 0.0071 | 1.6909 | 18.644 | 30 | 348 | receptor regulator activity |
GO:0016309 | 0.0083 | 35.4118 | 0.1607 | 2 | 3 | 1-phosphatidylinositol-5-phosphate 4-kinase activity |
GO:0004725 | 0.0085 | 2.4788 | 4.8217 | 11 | 90 | protein tyrosine phosphatase activity |
GO:0043027 | 0.0095 | 4.4365 | 1.3394 | 5 | 25 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0015485 | 1e-04 | 20.028 | 0.2358 | 4 | 30 | cholesterol binding |
GO:0004896 | 0.0022 | 7.8698 | 0.5502 | 4 | 70 | cytokine receptor activity |
GO:0005496 | 0.0029 | 7.3132 | 0.5895 | 4 | 75 | steroid binding |
GO:0008301 | 0.0032 | 28.4896 | 0.0865 | 2 | 11 | DNA binding, bending |
GO:0061135 | 0.0039 | 5.1348 | 1.0375 | 5 | 132 | endopeptidase regulator activity |
GO:0003823 | 0.005 | 9.4384 | 0.3458 | 3 | 44 | antigen binding |
GO:0099600 | 0.006 | 2.3756 | 5.8794 | 13 | 748 | transmembrane receptor activity |
GO:0017127 | 0.006 | 19.7186 | 0.1179 | 2 | 15 | cholesterol transporter activity |
GO:0060089 | 0.0066 | 2.144 | 8.0724 | 16 | 1027 | molecular transducer activity |
GO:0000170 | 0.0079 | Inf | 0.0079 | 1 | 1 | sphingosine hydroxylase activity |
GO:0001856 | 0.0079 | Inf | 0.0079 | 1 | 1 | complement component C5a binding |
GO:0003837 | 0.0079 | Inf | 0.0079 | 1 | 1 | beta-ureidopropionase activity |
GO:0003912 | 0.0079 | Inf | 0.0079 | 1 | 1 | DNA nucleotidylexotransferase activity |
GO:0004555 | 0.0079 | Inf | 0.0079 | 1 | 1 | alpha,alpha-trehalase activity |
GO:0008720 | 0.0079 | Inf | 0.0079 | 1 | 1 | D-lactate dehydrogenase activity |
GO:0030171 | 0.0079 | Inf | 0.0079 | 1 | 1 | voltage-gated proton channel activity |
GO:0035757 | 0.0079 | Inf | 0.0079 | 1 | 1 | chemokine (C-C motif) ligand 19 binding |
GO:0035758 | 0.0079 | Inf | 0.0079 | 1 | 1 | chemokine (C-C motif) ligand 21 binding |
GO:0038117 | 0.0079 | Inf | 0.0079 | 1 | 1 | C-C motif chemokine 19 receptor activity |
GO:0038121 | 0.0079 | Inf | 0.0079 | 1 | 1 | C-C motif chemokine 21 receptor activity |
GO:0045509 | 0.0079 | Inf | 0.0079 | 1 | 1 | interleukin-27 receptor activity |
GO:0035586 | 0.0096 | 15.0751 | 0.1493 | 2 | 19 | purinergic receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0008720 | 0.001 | Inf | 0.001 | 1 | 1 | D-lactate dehydrogenase activity |
GO:0030171 | 0.001 | Inf | 0.001 | 1 | 1 | voltage-gated proton channel activity |
GO:0004458 | 0.002 | 1059.0667 | 0.002 | 1 | 2 | D-lactate dehydrogenase (cytochrome) activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004014 | 0 | Inf | 0.0107 | 2 | 2 | adenosylmethionine decarboxylase activity |
GO:0019810 | 0 | Inf | 0.0107 | 2 | 2 | putrescine binding |
GO:0030247 | 0.0041 | 23.7982 | 0.0962 | 2 | 18 | polysaccharide binding |
GO:0004349 | 0.0053 | Inf | 0.0053 | 1 | 1 | glutamate 5-kinase activity |
GO:0004350 | 0.0053 | Inf | 0.0053 | 1 | 1 | glutamate-5-semialdehyde dehydrogenase activity |
GO:0004603 | 0.0053 | Inf | 0.0053 | 1 | 1 | phenylethanolamine N-methyltransferase activity |
GO:0017084 | 0.0053 | Inf | 0.0053 | 1 | 1 | delta1-pyrroline-5-carboxylate synthetase activity |
GO:0031854 | 0.0053 | Inf | 0.0053 | 1 | 1 | orexigenic neuropeptide QRFP receptor binding |
GO:0038164 | 0.0053 | Inf | 0.0053 | 1 | 1 | thrombopoietin receptor activity |
GO:0042007 | 0.0053 | Inf | 0.0053 | 1 | 1 | interleukin-18 binding |
GO:0008201 | 0.0056 | 6.0059 | 0.7109 | 4 | 133 | heparin binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0003912 | 5e-04 | Inf | 5e-04 | 1 | 1 | DNA nucleotidylexotransferase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0015433 | 5e-04 | Inf | 0.0443 | 2 | 2 | peptide antigen-transporting ATPase activity |
GO:0046980 | 5e-04 | Inf | 0.0443 | 2 | 2 | tapasin binding |
GO:1904680 | 7e-04 | 11.905 | 0.4205 | 4 | 19 | peptide transmembrane transporter activity |
GO:0023029 | 0.0014 | 88.8571 | 0.0664 | 2 | 3 | MHC class Ib protein binding |
GO:0046978 | 0.0014 | 88.8571 | 0.0664 | 2 | 3 | TAP1 binding |
GO:0046979 | 0.0014 | 88.8571 | 0.0664 | 2 | 3 | TAP2 binding |
GO:0050750 | 0.0015 | 9.3962 | 0.5091 | 4 | 23 | low-density lipoprotein particle receptor binding |
GO:0016787 | 0.002 | 1.5194 | 48.3632 | 68 | 2185 | hydrolase activity |
GO:0140098 | 0.0023 | 2.3724 | 7.1272 | 16 | 322 | catalytic activity, acting on RNA |
GO:0004950 | 0.004 | 11.1311 | 0.332 | 3 | 15 | chemokine receptor activity |
GO:1990381 | 0.004 | 11.1311 | 0.332 | 3 | 15 | ubiquitin-specific protease binding |
GO:0032813 | 0.008 | 5.5744 | 0.7968 | 4 | 36 | tumor necrosis factor receptor superfamily binding |
GO:0032182 | 0.0081 | 3.6768 | 1.7486 | 6 | 79 | ubiquitin-like protein binding |
GO:0000774 | 0.0095 | 17.7669 | 0.1549 | 2 | 7 | adenyl-nucleotide exchange factor activity |
GO:0016428 | 0.0095 | 17.7669 | 0.1549 | 2 | 7 | tRNA (cytosine-5-)-methyltransferase activity |
GO:0097200 | 0.0095 | 17.7669 | 0.1549 | 2 | 7 | cysteine-type endopeptidase activity involved in execution phase of apoptosis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 7.0037 | 3.9162 | 23 | 173 | histone binding |
GO:0003677 | 2e-04 | 1.7156 | 41.5167 | 65 | 1834 | DNA binding |
GO:0003723 | 2e-04 | 1.8 | 32.0166 | 53 | 1432 | RNA binding |
GO:0097159 | 9e-04 | 1.425 | 109.9943 | 138 | 4859 | organic cyclic compound binding |
GO:1901363 | 0.001 | 1.4188 | 108.5229 | 136 | 4794 | heterocyclic compound binding |
GO:1990381 | 0.0043 | 10.8761 | 0.3396 | 3 | 15 | ubiquitin-specific protease binding |
GO:0019904 | 0.0044 | 1.791 | 16.4573 | 28 | 727 | protein domain specific binding |
GO:0034511 | 0.0072 | 21.7025 | 0.1358 | 2 | 6 | U3 snoRNA binding |
GO:0043022 | 0.008 | 4.3642 | 1.245 | 5 | 55 | ribosome binding |
GO:0030515 | 0.0084 | 8.1988 | 0.4279 | 3 | 19 | snoRNA binding |
GO:0004722 | 0.0092 | 4.1958 | 1.2903 | 5 | 57 | protein serine/threonine phosphatase activity |
GO:0140036 | 0.01 | 17.3609 | 0.1585 | 2 | 7 | ubiquitin-dependent protein binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004601 | 4e-04 | 24.3031 | 0.1426 | 3 | 28 | peroxidase activity |
GO:0030246 | 0.0045 | 4.9628 | 1.0798 | 5 | 212 | carbohydrate binding |
GO:0004912 | 0.0051 | Inf | 0.0051 | 1 | 1 | interleukin-3 receptor activity |
GO:0004982 | 0.0051 | Inf | 0.0051 | 1 | 1 | N-formyl peptide receptor activity |
GO:0019978 | 0.0051 | Inf | 0.0051 | 1 | 1 | interleukin-3 binding |
GO:0031841 | 0.0051 | Inf | 0.0051 | 1 | 1 | neuropeptide Y receptor binding |
GO:0033971 | 0.0051 | Inf | 0.0051 | 1 | 1 | hydroxyisourate hydrolase activity |
GO:0047844 | 0.0051 | Inf | 0.0051 | 1 | 1 | deoxycytidine deaminase activity |
GO:0050571 | 0.0051 | Inf | 0.0051 | 1 | 1 | 1,5-anhydro-D-fructose reductase activity |
GO:0005125 | 0.0063 | 5.8189 | 0.7334 | 4 | 144 | cytokine activity |
GO:0004984 | 0.0069 | 8.2977 | 0.3871 | 3 | 76 | olfactory receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0008242 | 0.001 | 55.4386 | 0.0488 | 2 | 8 | omega peptidase activity |
GO:0004955 | 0.002 | 36.952 | 0.0671 | 2 | 11 | prostaglandin receptor activity |
GO:0004953 | 0.0037 | 25.5757 | 0.0915 | 2 | 15 | icosanoid receptor activity |
GO:0000215 | 0.0061 | Inf | 0.0061 | 1 | 1 | tRNA 2'-phosphotransferase activity |
GO:0002055 | 0.0061 | Inf | 0.0061 | 1 | 1 | adenine binding |
GO:0003881 | 0.0061 | Inf | 0.0061 | 1 | 1 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity |
GO:0003999 | 0.0061 | Inf | 0.0061 | 1 | 1 | adenine phosphoribosyltransferase activity |
GO:0005183 | 0.0061 | Inf | 0.0061 | 1 | 1 | gonadotropin hormone-releasing hormone activity |
GO:0008397 | 0.0061 | Inf | 0.0061 | 1 | 1 | sterol 12-alpha-hydroxylase activity |
GO:0008579 | 0.0061 | Inf | 0.0061 | 1 | 1 | JUN kinase phosphatase activity |
GO:0016824 | 0.0061 | Inf | 0.0061 | 1 | 1 | hydrolase activity, acting on acid halide bonds |
GO:0047651 | 0.0061 | Inf | 0.0061 | 1 | 1 | alkylhalidase activity |
GO:0047844 | 0.0061 | Inf | 0.0061 | 1 | 1 | deoxycytidine deaminase activity |
GO:0050571 | 0.0061 | Inf | 0.0061 | 1 | 1 | 1,5-anhydro-D-fructose reductase activity |
GO:0043178 | 0.0064 | 8.518 | 0.3782 | 3 | 62 | alcohol binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0008106 | 0.0011 | 50.2286 | 0.0498 | 2 | 11 | alcohol dehydrogenase (NADP+) activity |
GO:0004954 | 0.0013 | 45.2029 | 0.0543 | 2 | 12 | prostanoid receptor activity |
GO:0004602 | 0.0015 | 41.0909 | 0.0589 | 2 | 13 | glutathione peroxidase activity |
GO:0016614 | 0.0027 | 7.4511 | 0.5795 | 4 | 128 | oxidoreductase activity, acting on CH-OH group of donors |
GO:0004371 | 0.0045 | Inf | 0.0045 | 1 | 1 | glycerone kinase activity |
GO:0004655 | 0.0045 | Inf | 0.0045 | 1 | 1 | porphobilinogen synthase activity |
GO:0008397 | 0.0045 | Inf | 0.0045 | 1 | 1 | sterol 12-alpha-hydroxylase activity |
GO:0016824 | 0.0045 | Inf | 0.0045 | 1 | 1 | hydrolase activity, acting on acid halide bonds |
GO:0034012 | 0.0045 | Inf | 0.0045 | 1 | 1 | FAD-AMP lyase (cyclizing) activity |
GO:0045550 | 0.0045 | Inf | 0.0045 | 1 | 1 | geranylgeranyl reductase activity |
GO:0047651 | 0.0045 | Inf | 0.0045 | 1 | 1 | alkylhalidase activity |
GO:0047718 | 0.0045 | Inf | 0.0045 | 1 | 1 | indanol dehydrogenase activity |
GO:0050354 | 0.0045 | Inf | 0.0045 | 1 | 1 | triokinase activity |
GO:0005164 | 0.0057 | 19.6373 | 0.1132 | 2 | 25 | tumor necrosis factor receptor binding |
GO:0004364 | 0.0061 | 18.8179 | 0.1177 | 2 | 26 | glutathione transferase activity |
GO:0005501 | 0.0076 | 16.7238 | 0.1313 | 2 | 29 | retinoid binding |
GO:0016684 | 0.0086 | 15.5685 | 0.1404 | 2 | 31 | oxidoreductase activity, acting on peroxide as acceptor |
GO:0001785 | 0.009 | 222.9577 | 0.0091 | 1 | 2 | prostaglandin J receptor activity |
GO:0004874 | 0.009 | 222.9577 | 0.0091 | 1 | 2 | aryl hydrocarbon receptor activity |
GO:0004956 | 0.009 | 222.9577 | 0.0091 | 1 | 2 | prostaglandin D receptor activity |
GO:0016501 | 0.009 | 222.9577 | 0.0091 | 1 | 2 | prostacyclin receptor activity |
GO:0018479 | 0.009 | 222.9577 | 0.0091 | 1 | 2 | benzaldehyde dehydrogenase (NAD+) activity |
GO:1904854 | 0.009 | 222.9577 | 0.0091 | 1 | 2 | proteasome core complex binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0003755 | 0.0035 | 10.8726 | 0.3057 | 3 | 34 | peptidyl-prolyl cis-trans isomerase activity |
GO:0016290 | 0.0042 | 24.8243 | 0.0989 | 2 | 11 | palmitoyl-CoA hydrolase activity |
GO:0016853 | 0.006 | 4.6062 | 1.151 | 5 | 128 | isomerase activity |
GO:0005528 | 0.0068 | 18.6147 | 0.1259 | 2 | 14 | FK506 binding |
GO:0004950 | 0.0078 | 17.1817 | 0.1349 | 2 | 15 | chemokine receptor activity |
GO:0001621 | 0.009 | Inf | 0.009 | 1 | 1 | ADP receptor activity |
GO:0004476 | 0.009 | Inf | 0.009 | 1 | 1 | mannose-6-phosphate isomerase activity |
GO:0004511 | 0.009 | Inf | 0.009 | 1 | 1 | tyrosine 3-monooxygenase activity |
GO:0008115 | 0.009 | Inf | 0.009 | 1 | 1 | sarcosine oxidase activity |
GO:0008720 | 0.009 | Inf | 0.009 | 1 | 1 | D-lactate dehydrogenase activity |
GO:0031835 | 0.009 | Inf | 0.009 | 1 | 1 | substance P receptor binding |
GO:0035757 | 0.009 | Inf | 0.009 | 1 | 1 | chemokine (C-C motif) ligand 19 binding |
GO:0035758 | 0.009 | Inf | 0.009 | 1 | 1 | chemokine (C-C motif) ligand 21 binding |
GO:0038117 | 0.009 | Inf | 0.009 | 1 | 1 | C-C motif chemokine 19 receptor activity |
GO:0038121 | 0.009 | Inf | 0.009 | 1 | 1 | C-C motif chemokine 21 receptor activity |
GO:0050031 | 0.009 | Inf | 0.009 | 1 | 1 | L-pipecolate oxidase activity |
GO:0050459 | 0.009 | Inf | 0.009 | 1 | 1 | ethanolamine-phosphate phospho-lyase activity |
GO:0061811 | 0.009 | Inf | 0.009 | 1 | 1 | ADP-ribosyl cyclase activity |
GO:0061812 | 0.009 | Inf | 0.009 | 1 | 1 | cyclic ADP-ribose hydrolase |
GO:0070009 | 0.009 | Inf | 0.009 | 1 | 1 | serine-type aminopeptidase activity |
GO:0005086 | 0.01 | 14.8889 | 0.1529 | 2 | 17 | ARF guanyl-nucleotide exchange factor activity |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006811 | 0 | 1.6341 | 73.3029 | 110 | 1067 | ion transport |
GO:0010959 | 0 | 2.173 | 19.7856 | 39 | 288 | regulation of metal ion transport |
GO:0055085 | 2e-04 | 1.6041 | 53.5173 | 80 | 779 | transmembrane transport |
GO:0034765 | 2e-04 | 1.9855 | 21.3657 | 39 | 311 | regulation of ion transmembrane transport |
GO:0050891 | 2e-04 | 6.069 | 1.7862 | 8 | 26 | multicellular organismal water homeostasis |
GO:0042074 | 3e-04 | 9.0902 | 1.0305 | 6 | 15 | cell migration involved in gastrulation |
GO:0046952 | 3e-04 | Inf | 0.2061 | 3 | 3 | ketone body catabolic process |
GO:0098660 | 5e-04 | 1.7521 | 30.0219 | 49 | 437 | inorganic ion transmembrane transport |
GO:0007601 | 5e-04 | 2.9793 | 5.7708 | 15 | 84 | visual perception |
GO:0019748 | 6e-04 | 5.2008 | 1.9923 | 8 | 29 | secondary metabolic process |
GO:0061436 | 8e-04 | 9.7304 | 0.8244 | 5 | 12 | establishment of skin barrier |
GO:0051155 | 8e-04 | 3.5813 | 3.6411 | 11 | 53 | positive regulation of striated muscle cell differentiation |
GO:0016101 | 9e-04 | 5.6171 | 1.6488 | 7 | 24 | diterpenoid metabolic process |
GO:0007218 | 0.0011 | 3.6931 | 3.2289 | 10 | 47 | neuropeptide signaling pathway |
GO:0030239 | 0.0011 | 3.6931 | 3.2289 | 10 | 47 | myofibril assembly |
GO:0009888 | 0.0011 | 1.3796 | 96.2487 | 125 | 1401 | tissue development |
GO:0016115 | 0.0012 | 40.798 | 0.2748 | 3 | 4 | terpenoid catabolic process |
GO:0021557 | 0.0012 | 40.798 | 0.2748 | 3 | 4 | oculomotor nerve development |
GO:0043415 | 0.0012 | 40.798 | 0.2748 | 3 | 4 | positive regulation of skeletal muscle tissue regeneration |
GO:0071804 | 0.0013 | 2.3698 | 8.8623 | 19 | 129 | cellular potassium ion transport |
GO:0098655 | 0.0014 | 1.6613 | 30.7776 | 48 | 448 | cation transmembrane transport |
GO:0044057 | 0.0021 | 1.6951 | 25.7625 | 41 | 375 | regulation of system process |
GO:0042573 | 0.0021 | 10.8879 | 0.6183 | 4 | 9 | retinoic acid metabolic process |
GO:0051216 | 0.0021 | 2.1507 | 10.6485 | 21 | 155 | cartilage development |
GO:0006836 | 0.0022 | 2.195 | 9.9615 | 20 | 145 | neurotransmitter transport |
GO:0007188 | 0.0023 | 2.4349 | 7.2822 | 16 | 106 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
GO:0006874 | 0.0028 | 1.7909 | 19.0986 | 32 | 278 | cellular calcium ion homeostasis |
GO:0015672 | 0.0028 | 1.7118 | 23.0145 | 37 | 335 | monovalent inorganic cation transport |
GO:0061526 | 0.0029 | 20.3974 | 0.3435 | 3 | 5 | acetylcholine secretion |
GO:1902093 | 0.0029 | 20.3974 | 0.3435 | 3 | 5 | positive regulation of flagellated sperm motility |
GO:2001286 | 0.0029 | 20.3974 | 0.3435 | 3 | 5 | regulation of caveolin-mediated endocytosis |
GO:0055001 | 0.0031 | 2.1706 | 9.5493 | 19 | 139 | muscle cell development |
GO:0045933 | 0.0031 | 3.4126 | 3.0915 | 9 | 45 | positive regulation of muscle contraction |
GO:0003012 | 0.0035 | 1.7617 | 19.3734 | 32 | 282 | muscle system process |
GO:0007204 | 0.0038 | 1.9606 | 12.6408 | 23 | 184 | positive regulation of cytosolic calcium ion concentration |
GO:0007186 | 0.0039 | 1.5735 | 31.5729 | 47 | 463 | G-protein coupled receptor signaling pathway |
GO:0007167 | 0.0041 | 1.4632 | 46.7847 | 65 | 681 | enzyme linked receptor protein signaling pathway |
GO:1901568 | 0.0044 | 2.7828 | 4.4655 | 11 | 65 | fatty acid derivative metabolic process |
GO:0060349 | 0.0046 | 2.5034 | 5.7708 | 13 | 84 | bone morphogenesis |
GO:0003009 | 0.0047 | 5.6738 | 1.1679 | 5 | 17 | skeletal muscle contraction |
GO:0006649 | 0.0047 | Inf | 0.1374 | 2 | 2 | phospholipid transfer to membrane |
GO:0010749 | 0.0047 | Inf | 0.1374 | 2 | 2 | regulation of nitric oxide mediated signal transduction |
GO:0014724 | 0.0047 | Inf | 0.1374 | 2 | 2 | regulation of twitch skeletal muscle contraction |
GO:0021623 | 0.0047 | Inf | 0.1374 | 2 | 2 | oculomotor nerve formation |
GO:0030103 | 0.0047 | Inf | 0.1374 | 2 | 2 | vasopressin secretion |
GO:0031448 | 0.0047 | Inf | 0.1374 | 2 | 2 | positive regulation of fast-twitch skeletal muscle fiber contraction |
GO:0042418 | 0.0047 | Inf | 0.1374 | 2 | 2 | epinephrine biosynthetic process |
GO:0048014 | 0.0047 | Inf | 0.1374 | 2 | 2 | Tie signaling pathway |
GO:0048022 | 0.0047 | Inf | 0.1374 | 2 | 2 | negative regulation of melanin biosynthetic process |
GO:0060316 | 0.0047 | Inf | 0.1374 | 2 | 2 | positive regulation of ryanodine-sensitive calcium-release channel activity |
GO:0070165 | 0.0047 | Inf | 0.1374 | 2 | 2 | positive regulation of adiponectin secretion |
GO:1902283 | 0.0047 | Inf | 0.1374 | 2 | 2 | negative regulation of primary amine oxidase activity |
GO:1902340 | 0.0047 | Inf | 0.1374 | 2 | 2 | negative regulation of chromosome condensation |
GO:0007271 | 0.0048 | 4.5418 | 1.6488 | 6 | 24 | synaptic transmission, cholinergic |
GO:1901385 | 0.0048 | 4.5418 | 1.6488 | 6 | 24 | regulation of voltage-gated calcium channel activity |
GO:0051049 | 0.0048 | 1.315 | 98.4471 | 123 | 1433 | regulation of transport |
GO:0021930 | 0.0049 | 7.7758 | 0.7557 | 4 | 11 | cerebellar granule cell precursor proliferation |
GO:2000252 | 0.0049 | 7.7758 | 0.7557 | 4 | 11 | negative regulation of feeding behavior |
GO:1901379 | 0.005 | 2.905 | 3.9159 | 10 | 57 | regulation of potassium ion transmembrane transport |
GO:0010634 | 0.0052 | 2.3638 | 6.5265 | 14 | 95 | positive regulation of epithelial cell migration |
GO:0051272 | 0.0054 | 1.6137 | 25.5564 | 39 | 372 | positive regulation of cellular component movement |
GO:0006104 | 0.0055 | 13.5972 | 0.4122 | 3 | 6 | succinyl-CoA metabolic process |
GO:0015871 | 0.0055 | 13.5972 | 0.4122 | 3 | 6 | choline transport |
GO:0060762 | 0.0055 | 13.5972 | 0.4122 | 3 | 6 | regulation of branching involved in mammary gland duct morphogenesis |
GO:1901374 | 0.0055 | 13.5972 | 0.4122 | 3 | 6 | acetate ester transport |
GO:0070588 | 0.0057 | 1.8893 | 13.053 | 23 | 190 | calcium ion transmembrane transport |
GO:0090279 | 0.0059 | 4.3024 | 1.7175 | 6 | 25 | regulation of calcium ion import |
GO:0090132 | 0.006 | 1.8779 | 13.1217 | 23 | 191 | epithelium migration |
GO:0006956 | 0.0061 | 5.2369 | 1.2366 | 5 | 18 | complement activation |
GO:0071467 | 0.0061 | 5.2369 | 1.2366 | 5 | 18 | cellular response to pH |
GO:0040017 | 0.0062 | 1.5883 | 26.5869 | 40 | 387 | positive regulation of locomotion |
GO:0007600 | 0.0062 | 1.5783 | 27.4113 | 41 | 399 | sensory perception |
GO:0061180 | 0.0063 | 2.6357 | 4.6716 | 11 | 68 | mammary gland epithelium development |
GO:0001505 | 0.0066 | 2.002 | 10.2363 | 19 | 149 | regulation of neurotransmitter levels |
GO:0010759 | 0.007 | 6.8033 | 0.8244 | 4 | 12 | positive regulation of macrophage chemotaxis |
GO:0021534 | 0.007 | 6.8033 | 0.8244 | 4 | 12 | cell proliferation in hindbrain |
GO:0055082 | 0.0076 | 1.4906 | 35.2431 | 50 | 513 | cellular chemical homeostasis |
GO:0033599 | 0.0078 | 4.8625 | 1.3053 | 5 | 19 | regulation of mammary gland epithelial cell proliferation |
GO:0048266 | 0.0078 | 4.8625 | 1.3053 | 5 | 19 | behavioral response to pain |
GO:0051897 | 0.0078 | 2.5459 | 4.809 | 11 | 70 | positive regulation of protein kinase B signaling |
GO:0048870 | 0.0086 | 1.3301 | 73.9899 | 94 | 1077 | cell motility |
GO:0005513 | 0.0092 | 10.1971 | 0.4809 | 3 | 7 | detection of calcium ion |
GO:0007262 | 0.0092 | 10.1971 | 0.4809 | 3 | 7 | STAT protein import into nucleus |
GO:0030388 | 0.0092 | 10.1971 | 0.4809 | 3 | 7 | fructose 1,6-bisphosphate metabolic process |
GO:0048743 | 0.0092 | 10.1971 | 0.4809 | 3 | 7 | positive regulation of skeletal muscle fiber development |
GO:0003015 | 0.0093 | 1.9271 | 10.5798 | 19 | 154 | heart process |
GO:0006720 | 0.0093 | 3.0301 | 3.0228 | 8 | 44 | isoprenoid metabolic process |
GO:0061371 | 0.0094 | 2.7904 | 3.6411 | 9 | 53 | determination of heart left/right asymmetry |
GO:0031424 | 0.0096 | 6.0469 | 0.8931 | 4 | 13 | keratinization |
GO:0001578 | 0.0097 | 2.462 | 4.9464 | 11 | 72 | microtubule bundle formation |
GO:0030878 | 0.0099 | 4.5379 | 1.374 | 5 | 20 | thyroid gland development |
GO:0098868 | 0.0099 | 4.5379 | 1.374 | 5 | 20 | bone growth |
GO:1905521 | 0.0099 | 4.5379 | 1.374 | 5 | 20 | regulation of macrophage migration |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045321 | 5e-04 | 2.4823 | 8.7008 | 20 | 515 | leukocyte activation |
GO:0000965 | 8e-04 | 117.4107 | 0.0507 | 2 | 3 | mitochondrial RNA 3'-end processing |
GO:0045658 | 8e-04 | 117.4107 | 0.0507 | 2 | 3 | regulation of neutrophil differentiation |
GO:0032418 | 0.0015 | 6.5892 | 0.8447 | 5 | 50 | lysosome localization |
GO:0071415 | 0.0017 | 58.7009 | 0.0676 | 2 | 4 | cellular response to purine-containing compound |
GO:0042116 | 0.0025 | 7.8805 | 0.5744 | 4 | 34 | macrophage activation |
GO:0050820 | 0.0032 | 11.7812 | 0.3041 | 3 | 18 | positive regulation of coagulation |
GO:0003376 | 0.0041 | 29.346 | 0.1014 | 2 | 6 | sphingosine-1-phosphate signaling pathway |
GO:0051138 | 0.0041 | 29.346 | 0.1014 | 2 | 6 | positive regulation of NK T cell differentiation |
GO:0050709 | 0.0049 | 4.0953 | 1.5712 | 6 | 93 | negative regulation of protein secretion |
GO:0042110 | 0.0055 | 2.4781 | 5.1191 | 12 | 303 | T cell activation |
GO:0002756 | 0.0056 | 23.475 | 0.1183 | 2 | 7 | MyD88-independent toll-like receptor signaling pathway |
GO:0030259 | 0.0056 | 23.475 | 0.1183 | 2 | 7 | lipid glycosylation |
GO:0045576 | 0.0058 | 6.0578 | 0.7265 | 4 | 43 | mast cell activation |
GO:0002682 | 0.0061 | 2.702 | 3.9164 | 10 | 241 | regulation of immune system process |
GO:0019722 | 0.0063 | 3.8712 | 1.6557 | 6 | 98 | calcium-mediated signaling |
GO:0044283 | 0.0065 | 2.3278 | 5.8962 | 13 | 349 | small molecule biosynthetic process |
GO:0002263 | 0.0065 | 3.0769 | 2.7538 | 8 | 163 | cell activation involved in immune response |
GO:0033688 | 0.0066 | 8.8325 | 0.3886 | 3 | 23 | regulation of osteoblast proliferation |
GO:0002684 | 0.0067 | 2.0623 | 8.7176 | 17 | 516 | positive regulation of immune system process |
GO:0060326 | 0.0072 | 3.0178 | 2.8045 | 8 | 166 | cell chemotaxis |
GO:0007340 | 0.0074 | 8.4113 | 0.4055 | 3 | 24 | acrosome reaction |
GO:0033683 | 0.0074 | 19.561 | 0.1352 | 2 | 8 | nucleotide-excision repair, DNA incision |
GO:0045073 | 0.0074 | 19.561 | 0.1352 | 2 | 8 | regulation of chemokine biosynthetic process |
GO:0050755 | 0.0074 | 19.561 | 0.1352 | 2 | 8 | chemokine metabolic process |
GO:0051048 | 0.0083 | 2.9423 | 2.8721 | 8 | 170 | negative regulation of secretion |
GO:0048246 | 0.0083 | 8.0283 | 0.4224 | 3 | 25 | macrophage chemotaxis |
GO:0002275 | 0.0093 | 5.2476 | 0.8278 | 4 | 49 | myeloid cell activation involved in immune response |
GO:0048538 | 0.0093 | 5.2476 | 0.8278 | 4 | 49 | thymus development |
GO:0030851 | 0.0093 | 7.6787 | 0.4393 | 3 | 26 | granulocyte differentiation |
GO:0001781 | 0.0095 | 16.7653 | 0.1521 | 2 | 9 | neutrophil apoptotic process |
GO:0002689 | 0.0095 | 16.7653 | 0.1521 | 2 | 9 | negative regulation of leukocyte chemotaxis |
GO:0006283 | 0.0095 | 16.7653 | 0.1521 | 2 | 9 | transcription-coupled nucleotide-excision repair |
GO:0006691 | 0.0095 | 16.7653 | 0.1521 | 2 | 9 | leukotriene metabolic process |
GO:0009650 | 0.0095 | 16.7653 | 0.1521 | 2 | 9 | UV protection |
GO:0045351 | 0.0095 | 16.7653 | 0.1521 | 2 | 9 | type I interferon biosynthetic process |
GO:0045779 | 0.0095 | 16.7653 | 0.1521 | 2 | 9 | negative regulation of bone resorption |
GO:0051004 | 0.0095 | 16.7653 | 0.1521 | 2 | 9 | regulation of lipoprotein lipase activity |
GO:1900038 | 0.0095 | 16.7653 | 0.1521 | 2 | 9 | negative regulation of cellular response to hypoxia |
GO:1903140 | 0.0095 | 16.7653 | 0.1521 | 2 | 9 | regulation of establishment of endothelial barrier |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0000821 | 0.0011 | Inf | 0.0011 | 1 | 1 | regulation of arginine metabolic process |
GO:0060376 | 0.0011 | Inf | 0.0011 | 1 | 1 | positive regulation of mast cell differentiation |
GO:0033026 | 0.0034 | 477.1429 | 0.0034 | 1 | 3 | negative regulation of mast cell apoptotic process |
GO:0035993 | 0.0034 | 477.1429 | 0.0034 | 1 | 3 | deltoid tuberosity development |
GO:0046544 | 0.0034 | 477.1429 | 0.0034 | 1 | 3 | development of secondary male sexual characteristics |
GO:0061056 | 0.0034 | 477.1429 | 0.0034 | 1 | 3 | sclerotome development |
GO:0000255 | 0.0045 | 318.0714 | 0.0045 | 1 | 4 | allantoin metabolic process |
GO:0006549 | 0.0045 | 318.0714 | 0.0045 | 1 | 4 | isoleucine metabolic process |
GO:0033023 | 0.0045 | 318.0714 | 0.0045 | 1 | 4 | mast cell homeostasis |
GO:0035990 | 0.0045 | 318.0714 | 0.0045 | 1 | 4 | tendon cell differentiation |
GO:0046449 | 0.0045 | 318.0714 | 0.0045 | 1 | 4 | creatinine metabolic process |
GO:0060397 | 0.0045 | 318.0714 | 0.0045 | 1 | 4 | JAK-STAT cascade involved in growth hormone signaling pathway |
GO:0070668 | 0.0045 | 318.0714 | 0.0045 | 1 | 4 | positive regulation of mast cell proliferation |
GO:0007498 | 0.0055 | 20.8226 | 0.1121 | 2 | 100 | mesoderm development |
GO:0001778 | 0.0056 | 238.5357 | 0.0056 | 1 | 5 | plasma membrane repair |
GO:0006521 | 0.0056 | 238.5357 | 0.0056 | 1 | 5 | regulation of cellular amino acid metabolic process |
GO:0006600 | 0.0056 | 238.5357 | 0.0056 | 1 | 5 | creatine metabolic process |
GO:0019530 | 0.0056 | 238.5357 | 0.0056 | 1 | 5 | taurine metabolic process |
GO:0045588 | 0.0056 | 238.5357 | 0.0056 | 1 | 5 | positive regulation of gamma-delta T cell differentiation |
GO:0007167 | 0.0058 | 6.8135 | 0.7636 | 4 | 681 | enzyme linked receptor protein signaling pathway |
GO:0035989 | 0.0067 | 190.8143 | 0.0067 | 1 | 6 | tendon development |
GO:0043569 | 0.0067 | 190.8143 | 0.0067 | 1 | 6 | negative regulation of insulin-like growth factor receptor signaling pathway |
GO:0045086 | 0.0067 | 190.8143 | 0.0067 | 1 | 6 | positive regulation of interleukin-2 biosynthetic process |
GO:1903715 | 0.0067 | 190.8143 | 0.0067 | 1 | 6 | regulation of aerobic respiration |
GO:0006573 | 0.0078 | 159 | 0.0078 | 1 | 7 | valine metabolic process |
GO:0046643 | 0.0078 | 159 | 0.0078 | 1 | 7 | regulation of gamma-delta T cell activation |
GO:0048680 | 0.0089 | 136.2755 | 0.009 | 1 | 8 | positive regulation of axon regeneration |
GO:2000543 | 0.0089 | 136.2755 | 0.009 | 1 | 8 | positive regulation of gastrulation |
GO:2001223 | 0.0089 | 136.2755 | 0.009 | 1 | 8 | negative regulation of neuron migration |
GO:0030509 | 0.0091 | 15.9062 | 0.1458 | 2 | 130 | BMP signaling pathway |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0008295 | 1e-04 | 62.5831 | 0.1181 | 3 | 5 | spermidine biosynthetic process |
GO:0009886 | 2e-04 | 18.5926 | 0.3071 | 4 | 13 | post-embryonic animal morphogenesis |
GO:0007276 | 3e-04 | 2.3411 | 11.0318 | 24 | 467 | gamete generation |
GO:0072521 | 5e-04 | 2.4082 | 9.3546 | 21 | 396 | purine-containing compound metabolic process |
GO:0006597 | 6e-04 | Inf | 0.0472 | 2 | 2 | spermine biosynthetic process |
GO:0042700 | 6e-04 | Inf | 0.0472 | 2 | 2 | luteinizing hormone signaling pathway |
GO:0060435 | 6e-04 | Inf | 0.0472 | 2 | 2 | bronchiole development |
GO:1904970 | 6e-04 | Inf | 0.0472 | 2 | 2 | brush border assembly |
GO:0003006 | 0.001 | 2.1056 | 12.6854 | 25 | 537 | developmental process involved in reproduction |
GO:0022412 | 0.0012 | 2.5556 | 6.6852 | 16 | 283 | cellular process involved in reproduction in multicellular organism |
GO:0030823 | 0.0013 | 9.8371 | 0.4961 | 4 | 21 | regulation of cGMP metabolic process |
GO:0042401 | 0.0014 | 17.874 | 0.2362 | 3 | 10 | cellular biogenic amine biosynthetic process |
GO:0007283 | 0.0015 | 2.3448 | 8.1734 | 18 | 346 | spermatogenesis |
GO:0001539 | 0.0016 | 9.2899 | 0.5197 | 4 | 22 | cilium or flagellum-dependent cell motility |
GO:0048469 | 0.0017 | 3.2761 | 3.2835 | 10 | 139 | cell maturation |
GO:0009150 | 0.0022 | 2.2599 | 8.4569 | 18 | 358 | purine ribonucleotide metabolic process |
GO:0001707 | 0.0022 | 4.9374 | 1.3465 | 6 | 57 | mesoderm formation |
GO:0006595 | 0.0025 | 13.8999 | 0.2835 | 3 | 12 | polyamine metabolic process |
GO:0006958 | 0.0025 | 13.8999 | 0.2835 | 3 | 12 | complement activation, classical pathway |
GO:0007498 | 0.0025 | 3.6615 | 2.3623 | 8 | 100 | mesoderm development |
GO:0046660 | 0.0027 | 3.6218 | 2.3859 | 8 | 101 | female sex differentiation |
GO:0007369 | 0.0028 | 3.038 | 3.5198 | 10 | 149 | gastrulation |
GO:0006182 | 0.003 | 7.5985 | 0.6142 | 4 | 26 | cGMP biosynthetic process |
GO:0001545 | 0.0032 | 41.5892 | 0.0945 | 2 | 4 | primary ovarian follicle growth |
GO:0090315 | 0.0032 | 41.5892 | 0.0945 | 2 | 4 | negative regulation of protein targeting to membrane |
GO:0006753 | 0.0032 | 2.0371 | 10.9137 | 21 | 462 | nucleoside phosphate metabolic process |
GO:0019693 | 0.0033 | 2.1682 | 8.7876 | 18 | 372 | ribose phosphate metabolic process |
GO:0010954 | 0.0039 | 11.3709 | 0.3307 | 3 | 14 | positive regulation of protein processing |
GO:0030317 | 0.0039 | 4.3392 | 1.5118 | 6 | 64 | flagellated sperm motility |
GO:2001257 | 0.004 | 3.3665 | 2.5512 | 8 | 108 | regulation of cation channel activity |
GO:0035082 | 0.0044 | 5.1055 | 1.0866 | 5 | 46 | axoneme assembly |
GO:0008585 | 0.0045 | 3.6758 | 2.0552 | 7 | 87 | female gonad development |
GO:0051186 | 0.0045 | 2.3468 | 6.3072 | 14 | 267 | cofactor metabolic process |
GO:0000003 | 0.0047 | 1.6674 | 22.9376 | 36 | 971 | reproduction |
GO:0032532 | 0.0053 | 27.724 | 0.1181 | 2 | 5 | regulation of microvillus length |
GO:2000821 | 0.0053 | 27.724 | 0.1181 | 2 | 5 | regulation of grooming behavior |
GO:2001286 | 0.0053 | 27.724 | 0.1181 | 2 | 5 | regulation of caveolin-mediated endocytosis |
GO:0044703 | 0.0056 | 1.8021 | 15.2366 | 26 | 645 | multi-organism reproductive process |
GO:0071622 | 0.0058 | 6.189 | 0.7323 | 4 | 31 | regulation of granulocyte chemotaxis |
GO:0060294 | 0.0058 | 9.6201 | 0.378 | 3 | 16 | cilium movement involved in cell motility |
GO:0006140 | 0.0063 | 2.686 | 3.945 | 10 | 167 | regulation of nucleotide metabolic process |
GO:0007286 | 0.0072 | 3.0303 | 2.8111 | 8 | 119 | spermatid development |
GO:0008635 | 0.0078 | 20.7914 | 0.1417 | 2 | 6 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c |
GO:0014816 | 0.0078 | 20.7914 | 0.1417 | 2 | 6 | skeletal muscle satellite cell differentiation |
GO:0031282 | 0.0078 | 20.7914 | 0.1417 | 2 | 6 | regulation of guanylate cyclase activity |
GO:0042535 | 0.0078 | 20.7914 | 0.1417 | 2 | 6 | positive regulation of tumor necrosis factor biosynthetic process |
GO:0070314 | 0.0078 | 20.7914 | 0.1417 | 2 | 6 | G1 to G0 transition |
GO:0006090 | 0.008 | 3.6982 | 1.7481 | 6 | 74 | pyruvate metabolic process |
GO:0030728 | 0.0082 | 8.3361 | 0.4252 | 3 | 18 | ovulation |
GO:0043949 | 0.0082 | 8.3361 | 0.4252 | 3 | 18 | regulation of cAMP-mediated signaling |
GO:0071467 | 0.0082 | 8.3361 | 0.4252 | 3 | 18 | cellular response to pH |
GO:0009144 | 0.0089 | 2.4173 | 4.7954 | 11 | 203 | purine nucleoside triphosphate metabolic process |
GO:0009790 | 0.0092 | 1.608 | 22.3234 | 34 | 945 | embryo development |
GO:0048266 | 0.0096 | 7.8145 | 0.4488 | 3 | 19 | behavioral response to pain |
GO:0042698 | 0.0096 | 3.5411 | 1.8189 | 6 | 77 | ovulation cycle |
GO:0051346 | 0.0098 | 2.2829 | 5.5277 | 12 | 234 | negative regulation of hydrolase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0008295 | 1e-04 | 73.0651 | 0.1017 | 3 | 5 | spermidine biosynthetic process |
GO:0030317 | 3e-04 | 6.0467 | 1.3013 | 7 | 64 | flagellated sperm motility |
GO:0006597 | 4e-04 | Inf | 0.0407 | 2 | 2 | spermine biosynthetic process |
GO:0042700 | 4e-04 | Inf | 0.0407 | 2 | 2 | luteinizing hormone signaling pathway |
GO:1904970 | 4e-04 | Inf | 0.0407 | 2 | 2 | brush border assembly |
GO:0009259 | 5e-04 | 2.6132 | 7.4014 | 18 | 364 | ribonucleotide metabolic process |
GO:0042401 | 9e-04 | 20.8678 | 0.2033 | 3 | 10 | cellular biogenic amine biosynthetic process |
GO:0001539 | 9e-04 | 10.8516 | 0.4473 | 4 | 22 | cilium or flagellum-dependent cell motility |
GO:0042698 | 0.001 | 4.9189 | 1.5657 | 7 | 77 | ovulation cycle |
GO:0002578 | 0.0012 | 97.0667 | 0.061 | 2 | 3 | negative regulation of antigen processing and presentation |
GO:0033026 | 0.0012 | 97.0667 | 0.061 | 2 | 3 | negative regulation of mast cell apoptotic process |
GO:0046544 | 0.0012 | 97.0667 | 0.061 | 2 | 3 | development of secondary male sexual characteristics |
GO:1990918 | 0.0012 | 97.0667 | 0.061 | 2 | 3 | double-strand break repair involved in meiotic recombination |
GO:0046031 | 0.0012 | 5.5548 | 1.1997 | 6 | 59 | ADP metabolic process |
GO:0072376 | 0.0013 | 9.7649 | 0.488 | 4 | 24 | protein activation cascade |
GO:0016052 | 0.0015 | 4.5285 | 1.6877 | 7 | 83 | carbohydrate catabolic process |
GO:0002763 | 0.0015 | 6.614 | 0.854 | 5 | 42 | positive regulation of myeloid leukocyte differentiation |
GO:0006595 | 0.0016 | 16.228 | 0.244 | 3 | 12 | polyamine metabolic process |
GO:0006958 | 0.0016 | 16.228 | 0.244 | 3 | 12 | complement activation, classical pathway |
GO:0009135 | 0.0019 | 5.074 | 1.3013 | 6 | 64 | purine nucleoside diphosphate metabolic process |
GO:0008585 | 0.0019 | 4.3007 | 1.769 | 7 | 87 | female gonad development |
GO:0045137 | 0.0021 | 3.1682 | 3.3753 | 10 | 166 | development of primary sexual characteristics |
GO:0006140 | 0.0022 | 3.1478 | 3.3957 | 10 | 167 | regulation of nucleotide metabolic process |
GO:0001545 | 0.0024 | 48.5296 | 0.0813 | 2 | 4 | primary ovarian follicle growth |
GO:0033023 | 0.0024 | 48.5296 | 0.0813 | 2 | 4 | mast cell homeostasis |
GO:0070668 | 0.0024 | 48.5296 | 0.0813 | 2 | 4 | positive regulation of mast cell proliferation |
GO:0090315 | 0.0024 | 48.5296 | 0.0813 | 2 | 4 | negative regulation of protein targeting to membrane |
GO:0009185 | 0.0025 | 4.7452 | 1.3827 | 6 | 68 | ribonucleoside diphosphate metabolic process |
GO:0055086 | 0.0026 | 2.1242 | 10.004 | 20 | 492 | nucleobase-containing small molecule metabolic process |
GO:0030810 | 0.0027 | 4.6695 | 1.403 | 6 | 69 | positive regulation of nucleotide biosynthetic process |
GO:0009152 | 0.0029 | 3.0305 | 3.5177 | 10 | 173 | purine ribonucleotide biosynthetic process |
GO:0030801 | 0.0032 | 4.5252 | 1.4437 | 6 | 71 | positive regulation of cyclic nucleotide metabolic process |
GO:0046390 | 0.0035 | 2.9392 | 3.6193 | 10 | 178 | ribose phosphate biosynthetic process |
GO:1900544 | 0.0036 | 3.8199 | 1.9723 | 7 | 97 | positive regulation of purine nucleotide metabolic process |
GO:0060294 | 0.0038 | 11.2313 | 0.3253 | 3 | 16 | cilium movement involved in cell motility |
GO:0032504 | 0.0039 | 1.9714 | 11.834 | 22 | 582 | multicellular organism reproduction |
GO:0032532 | 0.004 | 32.3506 | 0.1017 | 2 | 5 | regulation of microvillus length |
GO:2001286 | 0.004 | 32.3506 | 0.1017 | 2 | 5 | regulation of caveolin-mediated endocytosis |
GO:0052652 | 0.0043 | 3.6958 | 2.0333 | 7 | 100 | cyclic purine nucleotide metabolic process |
GO:0048771 | 0.0044 | 3.3069 | 2.5823 | 8 | 127 | tissue remodeling |
GO:0046660 | 0.0045 | 3.6562 | 2.0537 | 7 | 101 | female sex differentiation |
GO:0072522 | 0.0046 | 2.8201 | 3.7617 | 10 | 185 | purine-containing compound biosynthetic process |
GO:0030819 | 0.0047 | 4.9897 | 1.098 | 5 | 54 | positive regulation of cAMP biosynthetic process |
GO:1901293 | 0.0049 | 2.639 | 4.4123 | 11 | 217 | nucleoside phosphate biosynthetic process |
GO:0046942 | 0.0055 | 2.7407 | 3.8633 | 10 | 190 | carboxylic acid transport |
GO:0014816 | 0.0059 | 24.2611 | 0.122 | 2 | 6 | skeletal muscle satellite cell differentiation |
GO:0006801 | 0.0059 | 6.0975 | 0.732 | 4 | 36 | superoxide metabolic process |
GO:0044703 | 0.0064 | 1.8538 | 13.115 | 23 | 645 | multi-organism reproductive process |
GO:0007276 | 0.0072 | 1.9975 | 9.4957 | 18 | 467 | gamete generation |
GO:0048469 | 0.0075 | 3.0012 | 2.8263 | 8 | 139 | cell maturation |
GO:0006857 | 0.0081 | 19.4074 | 0.1423 | 2 | 7 | oligopeptide transport |
GO:0016584 | 0.0081 | 19.4074 | 0.1423 | 2 | 7 | nucleosome positioning |
GO:0043950 | 0.0081 | 19.4074 | 0.1423 | 2 | 7 | positive regulation of cAMP-mediated signaling |
GO:2001046 | 0.0081 | 19.4074 | 0.1423 | 2 | 7 | positive regulation of integrin-mediated signaling pathway |
GO:0071695 | 0.0082 | 2.9556 | 2.867 | 8 | 141 | anatomical structure maturation |
GO:0006163 | 0.0083 | 2.336 | 5.4078 | 12 | 271 | purine nucleotide metabolic process |
GO:0060065 | 0.0084 | 8.1084 | 0.427 | 3 | 21 | uterus development |
GO:0051186 | 0.0086 | 2.3258 | 5.429 | 12 | 267 | cofactor metabolic process |
GO:0046068 | 0.0086 | 5.4183 | 0.8133 | 4 | 40 | cGMP metabolic process |
GO:0030947 | 0.0096 | 7.6811 | 0.4473 | 3 | 22 | regulation of vascular endothelial growth factor receptor signaling pathway |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006954 | 5e-04 | 2.7075 | 6.7549 | 17 | 360 | inflammatory response |
GO:0007606 | 9e-04 | 4.3766 | 1.9889 | 8 | 106 | sensory perception of chemical stimulus |
GO:0070098 | 0.001 | 10.6121 | 0.4503 | 4 | 24 | chemokine-mediated signaling pathway |
GO:0007155 | 0.0012 | 1.9458 | 16.6245 | 30 | 886 | cell adhesion |
GO:0010719 | 0.0015 | 9.2258 | 0.5066 | 4 | 27 | negative regulation of epithelial to mesenchymal transition |
GO:2000026 | 0.0015 | 1.7143 | 27.9952 | 44 | 1492 | regulation of multicellular organismal development |
GO:0006955 | 0.0018 | 2.0122 | 13.3034 | 25 | 709 | immune response |
GO:0050808 | 0.0024 | 2.9178 | 4.0154 | 11 | 214 | synapse organization |
GO:0001775 | 0.0025 | 2.0522 | 11.427 | 22 | 609 | cell activation |
GO:0034242 | 0.0034 | 35.1352 | 0.0938 | 2 | 5 | negative regulation of syncytium formation by plasma membrane fusion |
GO:0032501 | 0.0036 | 1.4274 | 90.9657 | 112 | 4848 | multicellular organismal process |
GO:0002042 | 0.0036 | 7.0694 | 0.638 | 4 | 34 | cell migration involved in sprouting angiogenesis |
GO:0032496 | 0.0037 | 3.1327 | 3.0585 | 9 | 163 | response to lipopolysaccharide |
GO:0002687 | 0.0041 | 4.2616 | 1.5198 | 6 | 81 | positive regulation of leukocyte migration |
GO:0071467 | 0.0043 | 10.5734 | 0.3377 | 3 | 18 | cellular response to pH |
GO:0016525 | 0.0053 | 4.8304 | 1.1258 | 5 | 60 | negative regulation of angiogenesis |
GO:0098742 | 0.0054 | 3.5238 | 2.1203 | 7 | 113 | cell-cell adhesion via plasma-membrane adhesion molecules |
GO:0030279 | 0.0057 | 4.7438 | 1.1446 | 5 | 61 | negative regulation of ossification |
GO:0090101 | 0.0069 | 3.8023 | 1.6887 | 6 | 90 | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:0042268 | 0.0069 | 21.0779 | 0.1313 | 2 | 7 | regulation of cytolysis |
GO:0043950 | 0.0069 | 21.0779 | 0.1313 | 2 | 7 | positive regulation of cAMP-mediated signaling |
GO:0045346 | 0.0069 | 21.0779 | 0.1313 | 2 | 7 | regulation of MHC class II biosynthetic process |
GO:0032103 | 0.0074 | 2.7845 | 3.415 | 9 | 182 | positive regulation of response to external stimulus |
GO:0048731 | 0.0075 | 1.4153 | 63.5521 | 81 | 3387 | system development |
GO:0002682 | 0.0083 | 1.7875 | 14.204 | 24 | 757 | regulation of immune system process |
GO:0045577 | 0.0088 | 7.927 | 0.4316 | 3 | 23 | regulation of B cell differentiation |
GO:1901343 | 0.0089 | 4.2144 | 1.2759 | 5 | 68 | negative regulation of vasculature development |
GO:0042221 | 0.009 | 1.449 | 46.6274 | 62 | 2485 | response to chemical |
GO:0010744 | 0.0091 | 17.5636 | 0.1501 | 2 | 8 | positive regulation of macrophage derived foam cell differentiation |
GO:0030948 | 0.0091 | 17.5636 | 0.1501 | 2 | 8 | negative regulation of vascular endothelial growth factor receptor signaling pathway |
GO:0043542 | 0.0092 | 3.1625 | 2.3454 | 7 | 125 | endothelial cell migration |
GO:0050982 | 0.0099 | 5.1684 | 0.8444 | 4 | 45 | detection of mechanical stimulus |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045653 | 0 | 91.8062 | 1.3013 | 15 | 17 | negative regulation of megakaryocyte differentiation |
GO:0002323 | 0 | 24.4012 | 1.3779 | 12 | 18 | natural killer cell activation involved in immune response |
GO:0006955 | 0 | 4.9122 | 7.4603 | 28 | 102 | immune response |
GO:0006959 | 0 | 5.6537 | 5.5881 | 23 | 73 | humoral immune response |
GO:0002682 | 0 | 4.3069 | 8.5061 | 29 | 117 | regulation of immune system process |
GO:0032943 | 0 | 4.4264 | 8.094 | 28 | 107 | mononuclear cell proliferation |
GO:0033141 | 0 | 22.3457 | 1.3013 | 11 | 17 | positive regulation of peptidyl-serine phosphorylation of STAT protein |
GO:0046649 | 0 | 2.7587 | 21.0789 | 50 | 280 | lymphocyte activation |
GO:0002366 | 0 | 3.4619 | 12.2479 | 35 | 160 | leukocyte activation involved in immune response |
GO:0006336 | 0 | 12.2057 | 1.9903 | 13 | 26 | DNA replication-independent nucleosome assembly |
GO:0001775 | 0 | 2.4927 | 26.6468 | 58 | 358 | cell activation |
GO:0042100 | 0 | 5.6016 | 5.1288 | 21 | 67 | B cell proliferation |
GO:0009607 | 0 | 2.2567 | 35.1361 | 70 | 459 | response to biotic stimulus |
GO:0045637 | 0 | 3.4431 | 11.9417 | 34 | 156 | regulation of myeloid cell differentiation |
GO:0048534 | 0 | 2.0279 | 48.6323 | 88 | 638 | hematopoietic or lymphoid organ development |
GO:1903707 | 0 | 3.9471 | 8.1908 | 26 | 107 | negative regulation of hemopoiesis |
GO:0070663 | 0 | 3.4542 | 10.4873 | 30 | 137 | regulation of leukocyte proliferation |
GO:0002250 | 0 | 2.8125 | 16.5346 | 40 | 216 | adaptive immune response |
GO:0050863 | 0 | 3.0651 | 13.4727 | 35 | 176 | regulation of T cell activation |
GO:0006335 | 0 | 8.8117 | 2.373 | 13 | 31 | DNA replication-dependent nucleosome assembly |
GO:0051290 | 0 | 6.7867 | 3.2151 | 15 | 42 | protein heterotetramerization |
GO:0022407 | 0 | 2.4876 | 20.1325 | 44 | 263 | regulation of cell-cell adhesion |
GO:0002286 | 0 | 4.7871 | 4.8992 | 18 | 64 | T cell activation involved in immune response |
GO:1903039 | 0 | 3.4098 | 8.8032 | 25 | 115 | positive regulation of leukocyte cell-cell adhesion |
GO:0002252 | 0 | 3.0481 | 11.1506 | 29 | 149 | immune effector process |
GO:0002694 | 0 | 2.7701 | 13.7423 | 33 | 182 | regulation of leukocyte activation |
GO:0050670 | 0 | 3.9721 | 6.2443 | 20 | 82 | regulation of lymphocyte proliferation |
GO:0043330 | 0 | 6.0964 | 2.9854 | 13 | 39 | response to exogenous dsRNA |
GO:0050867 | 0 | 2.6339 | 14.774 | 34 | 193 | positive regulation of cell activation |
GO:0019221 | 0 | 2.5069 | 16.7643 | 37 | 219 | cytokine-mediated signaling pathway |
GO:0045087 | 0 | 2.5425 | 16.1025 | 36 | 213 | innate immune response |
GO:0042832 | 0 | 10.9445 | 1.4544 | 9 | 19 | defense response to protozoan |
GO:0032729 | 0 | 5.8702 | 3.062 | 13 | 40 | positive regulation of interferon-gamma production |
GO:0030183 | 0 | 4.0192 | 5.5649 | 18 | 73 | B cell differentiation |
GO:0051251 | 0 | 2.7192 | 12.2479 | 29 | 160 | positive regulation of lymphocyte activation |
GO:0006952 | 0 | 3.1215 | 8.6182 | 23 | 119 | defense response |
GO:0032946 | 0 | 3.6659 | 5.9708 | 18 | 78 | positive regulation of mononuclear cell proliferation |
GO:0042102 | 0 | 4.4922 | 3.9806 | 14 | 52 | positive regulation of T cell proliferation |
GO:0002274 | 0 | 3.0601 | 8.4204 | 22 | 110 | myeloid leukocyte activation |
GO:0042742 | 0 | 3.0581 | 8.0377 | 21 | 105 | defense response to bacterium |
GO:0045785 | 1e-04 | 2.1342 | 20.209 | 39 | 264 | positive regulation of cell adhesion |
GO:0002521 | 1e-04 | 2.4456 | 13.3428 | 29 | 177 | leukocyte differentiation |
GO:0034728 | 1e-04 | 2.8033 | 9.0328 | 22 | 118 | nucleosome organization |
GO:0050853 | 1e-04 | 6.4343 | 1.9903 | 9 | 26 | B cell receptor signaling pathway |
GO:0046425 | 1e-04 | 2.8528 | 8.497 | 21 | 111 | regulation of JAK-STAT cascade |
GO:0031295 | 1e-04 | 9.4404 | 1.2248 | 7 | 16 | T cell costimulation |
GO:0016052 | 2e-04 | 3.1428 | 6.3536 | 17 | 83 | carbohydrate catabolic process |
GO:0031497 | 2e-04 | 2.7764 | 8.2673 | 20 | 108 | chromatin assembly |
GO:0033135 | 2e-04 | 2.6732 | 8.9563 | 21 | 117 | regulation of peptidyl-serine phosphorylation |
GO:0030168 | 2e-04 | 3.3241 | 5.3585 | 15 | 70 | platelet activation |
GO:0061844 | 2e-04 | 7.7227 | 1.3779 | 7 | 18 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0097696 | 3e-04 | 2.5916 | 9.1859 | 21 | 120 | STAT cascade |
GO:0031347 | 3e-04 | 1.8695 | 24.9551 | 43 | 326 | regulation of defense response |
GO:0051607 | 4e-04 | 2.4663 | 10.028 | 22 | 131 | defense response to virus |
GO:0072678 | 4e-04 | 5.7138 | 1.9137 | 8 | 25 | T cell migration |
GO:0002699 | 4e-04 | 2.5147 | 9.4156 | 21 | 123 | positive regulation of immune effector process |
GO:0051707 | 4e-04 | 2.2772 | 12.1731 | 25 | 163 | response to other organism |
GO:0030886 | 4e-04 | Inf | 0.2296 | 3 | 3 | negative regulation of myeloid dendritic cell activation |
GO:0034154 | 4e-04 | Inf | 0.2296 | 3 | 3 | toll-like receptor 7 signaling pathway |
GO:0034097 | 5e-04 | 1.6578 | 38.8105 | 60 | 507 | response to cytokine |
GO:0006757 | 5e-04 | 3.5608 | 4.0571 | 12 | 53 | ATP generation from ADP |
GO:0007155 | 6e-04 | 1.5767 | 46.7223 | 69 | 622 | cell adhesion |
GO:0002532 | 7e-04 | 4.051 | 3.062 | 10 | 40 | production of molecular mediator involved in inflammatory response |
GO:0002526 | 8e-04 | 3.3946 | 4.2102 | 12 | 55 | acute inflammatory response |
GO:0043270 | 8e-04 | 2.0183 | 16.2285 | 30 | 212 | positive regulation of ion transport |
GO:0006110 | 9e-04 | 4.8555 | 2.1434 | 8 | 28 | regulation of glycolytic process |
GO:1902105 | 0.001 | 2.1052 | 13.5492 | 26 | 177 | regulation of leukocyte differentiation |
GO:0034764 | 0.001 | 2.4394 | 8.7266 | 19 | 114 | positive regulation of transmembrane transport |
GO:0002684 | 0.0011 | 3.4597 | 3.7839 | 11 | 51 | positive regulation of immune system process |
GO:0032418 | 0.0012 | 3.4286 | 3.8275 | 11 | 50 | lysosome localization |
GO:0009617 | 0.0012 | 2.1393 | 12.3183 | 24 | 163 | response to bacterium |
GO:0043304 | 0.0012 | 5.3072 | 1.7606 | 7 | 23 | regulation of mast cell degranulation |
GO:0097028 | 0.0012 | 5.3072 | 1.7606 | 7 | 23 | dendritic cell differentiation |
GO:0032675 | 0.0013 | 2.7261 | 6.277 | 15 | 82 | regulation of interleukin-6 production |
GO:0007599 | 0.0014 | 2.3015 | 9.6452 | 20 | 126 | hemostasis |
GO:0032496 | 0.0014 | 2.1089 | 12.4775 | 24 | 163 | response to lipopolysaccharide |
GO:0033003 | 0.0015 | 4.4134 | 2.2965 | 8 | 30 | regulation of mast cell activation |
GO:0065004 | 0.0015 | 2.1437 | 11.7886 | 23 | 154 | protein-DNA complex assembly |
GO:0006342 | 0.0015 | 2.9287 | 5.1288 | 13 | 67 | chromatin silencing |
GO:0002679 | 0.0017 | 36.2938 | 0.3062 | 3 | 4 | respiratory burst involved in defense response |
GO:0010760 | 0.0017 | 36.2938 | 0.3062 | 3 | 4 | negative regulation of macrophage chemotaxis |
GO:0071415 | 0.0017 | 36.2938 | 0.3062 | 3 | 4 | cellular response to purine-containing compound |
GO:0050817 | 0.0017 | 2.2586 | 9.7983 | 20 | 128 | coagulation |
GO:0043299 | 0.0018 | 3.4708 | 3.4447 | 10 | 45 | leukocyte degranulation |
GO:0070228 | 0.0018 | 3.4708 | 3.4447 | 10 | 45 | regulation of lymphocyte apoptotic process |
GO:0006954 | 0.0019 | 1.8123 | 20.1798 | 34 | 267 | inflammatory response |
GO:0046939 | 0.002 | 2.8236 | 5.2819 | 13 | 69 | nucleotide phosphorylation |
GO:0002279 | 0.0023 | 4.0449 | 2.4496 | 8 | 32 | mast cell activation involved in immune response |
GO:0002448 | 0.0023 | 4.0449 | 2.4496 | 8 | 32 | mast cell mediated immunity |
GO:0032101 | 0.0025 | 1.5783 | 34.983 | 52 | 457 | regulation of response to external stimulus |
GO:1903580 | 0.0027 | 4.4681 | 1.9903 | 7 | 26 | positive regulation of ATP metabolic process |
GO:2000401 | 0.0027 | 4.4681 | 1.9903 | 7 | 26 | regulation of lymphocyte migration |
GO:0031663 | 0.0028 | 3.8828 | 2.5261 | 8 | 33 | lipopolysaccharide-mediated signaling pathway |
GO:0048002 | 0.0028 | 3.8828 | 2.5261 | 8 | 33 | antigen processing and presentation of peptide antigen |
GO:0002429 | 0.0029 | 2.4668 | 6.8129 | 15 | 89 | immune response-activating cell surface receptor signaling pathway |
GO:1903708 | 0.0029 | 2.1386 | 10.2576 | 20 | 134 | positive regulation of hemopoiesis |
GO:0009179 | 0.003 | 2.805 | 4.8992 | 12 | 64 | purine ribonucleoside diphosphate metabolic process |
GO:0002687 | 0.0031 | 2.5418 | 6.2005 | 14 | 81 | positive regulation of leukocyte migration |
GO:0001580 | 0.0031 | 9.6847 | 0.6889 | 4 | 9 | detection of chemical stimulus involved in sensory perception of bitter taste |
GO:0050776 | 0.0032 | 2.6485 | 5.5534 | 13 | 74 | regulation of immune response |
GO:0050778 | 0.0033 | 1.9595 | 13.2736 | 24 | 175 | positive regulation of immune response |
GO:0042092 | 0.0034 | 4.2444 | 2.0668 | 7 | 27 | type 2 immune response |
GO:0002260 | 0.0035 | 2.9052 | 4.3633 | 11 | 57 | lymphocyte homeostasis |
GO:0045089 | 0.0036 | 2.1435 | 9.7218 | 19 | 127 | positive regulation of innate immune response |
GO:0097530 | 0.0038 | 2.5911 | 5.6646 | 13 | 74 | granulocyte migration |
GO:0045117 | 0.004 | 4.8479 | 1.6075 | 6 | 21 | azole transport |
GO:0051354 | 0.004 | 4.8479 | 1.6075 | 6 | 21 | negative regulation of oxidoreductase activity |
GO:0034162 | 0.004 | 18.1454 | 0.3827 | 3 | 5 | toll-like receptor 9 signaling pathway |
GO:0071651 | 0.004 | 18.1454 | 0.3827 | 3 | 5 | positive regulation of chemokine (C-C motif) ligand 5 production |
GO:0002313 | 0.0041 | 6.0564 | 1.1482 | 5 | 15 | mature B cell differentiation involved in immune response |
GO:0042330 | 0.0041 | 1.596 | 29.2418 | 44 | 382 | taxis |
GO:0009988 | 0.0042 | 3.5946 | 2.6792 | 8 | 35 | cell-cell recognition |
GO:0009954 | 0.0043 | 4.042 | 2.1434 | 7 | 28 | proximal/distal pattern formation |
GO:0009132 | 0.0044 | 2.4323 | 6.4301 | 14 | 84 | nucleoside diphosphate metabolic process |
GO:0071887 | 0.0044 | 2.4323 | 6.4301 | 14 | 84 | leukocyte apoptotic process |
GO:0008283 | 0.0044 | 1.2938 | 116.3549 | 143 | 1520 | cell proliferation |
GO:0002688 | 0.0045 | 2.6514 | 5.1288 | 12 | 67 | regulation of leukocyte chemotaxis |
GO:0002764 | 0.0049 | 1.9211 | 12.9368 | 23 | 169 | immune response-regulating signaling pathway |
GO:0051193 | 0.005 | 3.466 | 2.7558 | 8 | 36 | regulation of cofactor metabolic process |
GO:0001819 | 0.0051 | 1.8107 | 15.9947 | 27 | 211 | positive regulation of cytokine production |
GO:0048535 | 0.0051 | 4.5446 | 1.6841 | 6 | 22 | lymph node development |
GO:0030595 | 0.0052 | 2.9123 | 3.9537 | 10 | 52 | leukocyte chemotaxis |
GO:0045582 | 0.0054 | 2.8907 | 3.9806 | 10 | 52 | positive regulation of T cell differentiation |
GO:0050707 | 0.0055 | 2.2123 | 7.9611 | 16 | 104 | regulation of cytokine secretion |
GO:0002251 | 0.0056 | 5.5054 | 1.2248 | 5 | 16 | organ or tissue specific immune response |
GO:0031640 | 0.0056 | 5.5054 | 1.2248 | 5 | 16 | killing of cells of other organism |
GO:0048872 | 0.0056 | 1.7368 | 18.4484 | 30 | 241 | homeostasis of number of cells |
GO:0050900 | 0.0056 | 3.0928 | 3.3846 | 9 | 45 | leukocyte migration |
GO:0032414 | 0.0057 | 2.5579 | 5.2819 | 12 | 69 | positive regulation of ion transmembrane transporter activity |
GO:0002767 | 0.0059 | Inf | 0.1531 | 2 | 2 | immune response-inhibiting cell surface receptor signaling pathway |
GO:0003366 | 0.0059 | Inf | 0.1531 | 2 | 2 | cell-matrix adhesion involved in ameboidal cell migration |
GO:0006597 | 0.0059 | Inf | 0.1531 | 2 | 2 | spermine biosynthetic process |
GO:0042700 | 0.0059 | Inf | 0.1531 | 2 | 2 | luteinizing hormone signaling pathway |
GO:0060266 | 0.0059 | Inf | 0.1531 | 2 | 2 | negative regulation of respiratory burst involved in inflammatory response |
GO:0060309 | 0.0059 | Inf | 0.1531 | 2 | 2 | elastin catabolic process |
GO:0071593 | 0.0059 | Inf | 0.1531 | 2 | 2 | lymphocyte aggregation |
GO:1901731 | 0.0059 | Inf | 0.1531 | 2 | 2 | positive regulation of platelet aggregation |
GO:2000360 | 0.0059 | Inf | 0.1531 | 2 | 2 | negative regulation of binding of sperm to zona pellucida |
GO:2000864 | 0.0059 | Inf | 0.1531 | 2 | 2 | regulation of estradiol secretion |
GO:0007159 | 0.0059 | 2.3411 | 6.6289 | 14 | 88 | leukocyte cell-cell adhesion |
GO:0002695 | 0.0059 | 2.259 | 7.3288 | 15 | 96 | negative regulation of leukocyte activation |
GO:0045577 | 0.0065 | 4.2769 | 1.7606 | 6 | 23 | regulation of B cell differentiation |
GO:0050922 | 0.0065 | 4.2769 | 1.7606 | 6 | 23 | negative regulation of chemotaxis |
GO:0046635 | 0.0071 | 3.2344 | 2.9089 | 8 | 38 | positive regulation of alpha-beta T cell activation |
GO:0001821 | 0.0073 | 6.9165 | 0.842 | 4 | 11 | histamine secretion |
GO:0002227 | 0.0073 | 6.9165 | 0.842 | 4 | 11 | innate immune response in mucosa |
GO:0045837 | 0.0073 | 6.9165 | 0.842 | 4 | 11 | negative regulation of membrane potential |
GO:0046184 | 0.0073 | 6.9165 | 0.842 | 4 | 11 | aldehyde biosynthetic process |
GO:0048305 | 0.0074 | 5.0462 | 1.3013 | 5 | 17 | immunoglobulin secretion |
GO:0001955 | 0.0075 | 12.096 | 0.4593 | 3 | 6 | blood vessel maturation |
GO:0002576 | 0.0075 | 12.096 | 0.4593 | 3 | 6 | platelet degranulation |
GO:0019886 | 0.0075 | 12.096 | 0.4593 | 3 | 6 | antigen processing and presentation of exogenous peptide antigen via MHC class II |
GO:0032790 | 0.0075 | 12.096 | 0.4593 | 3 | 6 | ribosome disassembly |
GO:0033860 | 0.0075 | 12.096 | 0.4593 | 3 | 6 | regulation of NAD(P)H oxidase activity |
GO:0002703 | 0.0077 | 2.0685 | 8.9563 | 17 | 117 | regulation of leukocyte mediated immunity |
GO:0045124 | 0.0078 | 3.5358 | 2.373 | 7 | 31 | regulation of bone resorption |
GO:0034121 | 0.0084 | 3.1298 | 2.9854 | 8 | 39 | regulation of toll-like receptor signaling pathway |
GO:0006140 | 0.0086 | 1.8486 | 12.7837 | 22 | 167 | regulation of nucleotide metabolic process |
GO:0034109 | 0.0087 | 2.5201 | 4.8992 | 11 | 64 | homotypic cell-cell adhesion |
GO:0050854 | 0.0093 | 3.3941 | 2.4496 | 7 | 32 | regulation of antigen receptor-mediated signaling pathway |
GO:0050672 | 0.0097 | 2.7997 | 3.6744 | 9 | 48 | negative regulation of lymphocyte proliferation |
GO:0038083 | 0.0098 | 3.0317 | 3.062 | 8 | 40 | peptidyl-tyrosine autophosphorylation |
GO:0050869 | 0.0099 | 3.8261 | 1.9137 | 6 | 25 | negative regulation of B cell activation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0043368 | 0 | 20.5992 | 0.3174 | 5 | 22 | positive T cell selection |
GO:0002250 | 1e-04 | 4.2184 | 3.1164 | 12 | 216 | adaptive immune response |
GO:0002366 | 1e-04 | 4.7483 | 2.3084 | 10 | 160 | leukocyte activation involved in immune response |
GO:0051251 | 1e-04 | 4.7483 | 2.3084 | 10 | 160 | positive regulation of lymphocyte activation |
GO:0002694 | 1e-04 | 3.5022 | 4.3572 | 14 | 302 | regulation of leukocyte activation |
GO:0001775 | 2e-04 | 3.0182 | 5.7743 | 16 | 416 | cell activation |
GO:0072540 | 2e-04 | 34.6789 | 0.1298 | 3 | 9 | T-helper 17 cell lineage commitment |
GO:0002252 | 3e-04 | 2.9812 | 5.8288 | 16 | 404 | immune effector process |
GO:0046632 | 4e-04 | 6.7908 | 0.9811 | 6 | 68 | alpha-beta T cell differentiation |
GO:0043373 | 4e-04 | 26.0053 | 0.1587 | 3 | 11 | CD4-positive, alpha-beta T cell lineage commitment |
GO:0050867 | 5e-04 | 3.8822 | 2.7846 | 10 | 193 | positive regulation of cell activation |
GO:0006955 | 7e-04 | 3.2302 | 4.0089 | 12 | 297 | immune response |
GO:0072538 | 8e-04 | 20.8011 | 0.1876 | 3 | 13 | T-helper 17 type immune response |
GO:0002684 | 8e-04 | 3.6378 | 2.9624 | 10 | 214 | positive regulation of immune system process |
GO:0007165 | 9e-04 | 1.6416 | 49.9777 | 70 | 3464 | signal transduction |
GO:0002562 | 9e-04 | 7.4338 | 0.7502 | 5 | 52 | somatic diversification of immune receptors via germline recombination within a single locus |
GO:0030098 | 9e-04 | 3.316 | 3.5637 | 11 | 247 | lymphocyte differentiation |
GO:0050863 | 0.001 | 3.8126 | 2.5393 | 9 | 176 | regulation of T cell activation |
GO:0002274 | 0.0011 | 4.7796 | 1.5871 | 7 | 110 | myeloid leukocyte activation |
GO:1903039 | 0.0014 | 4.5566 | 1.6592 | 7 | 115 | positive regulation of leukocyte cell-cell adhesion |
GO:0050778 | 0.0015 | 2.9478 | 4.3572 | 12 | 302 | positive regulation of immune response |
GO:0031349 | 0.0015 | 3.5944 | 2.6836 | 9 | 186 | positive regulation of defense response |
GO:0009988 | 0.0015 | 8.9797 | 0.505 | 4 | 35 | cell-cell recognition |
GO:0002360 | 0.0021 | 13.8621 | 0.2597 | 3 | 18 | T cell lineage commitment |
GO:0002286 | 0.0023 | 5.9164 | 0.9234 | 5 | 64 | T cell activation involved in immune response |
GO:0050670 | 0.0028 | 3.9963 | 1.8756 | 7 | 130 | regulation of lymphocyte proliferation |
GO:0016064 | 0.003 | 5.5391 | 0.9811 | 5 | 68 | immunoglobulin mediated immune response |
GO:1902107 | 0.0034 | 4.4207 | 1.4572 | 6 | 101 | positive regulation of leukocyte differentiation |
GO:0002449 | 0.0036 | 3.8087 | 1.9622 | 7 | 136 | lymphocyte mediated immunity |
GO:0042107 | 0.0036 | 5.2861 | 1.0244 | 5 | 71 | cytokine metabolic process |
GO:0070663 | 0.0037 | 3.7791 | 1.9766 | 7 | 137 | regulation of leukocyte proliferation |
GO:0002756 | 0.0041 | 27.6 | 0.101 | 2 | 7 | MyD88-independent toll-like receptor signaling pathway |
GO:0032071 | 0.0041 | 27.6 | 0.101 | 2 | 7 | regulation of endodeoxyribonuclease activity |
GO:0032074 | 0.0041 | 27.6 | 0.101 | 2 | 7 | negative regulation of nuclease activity |
GO:0007339 | 0.0048 | 9.897 | 0.3463 | 3 | 24 | binding of sperm to zona pellucida |
GO:0032946 | 0.0054 | 4.7767 | 1.1254 | 5 | 78 | positive regulation of mononuclear cell proliferation |
GO:0034340 | 0.0054 | 9.4464 | 0.3607 | 3 | 25 | response to type I interferon |
GO:0032418 | 0.0058 | 6.0446 | 0.7214 | 4 | 50 | lysosome localization |
GO:0030851 | 0.006 | 9.035 | 0.3751 | 3 | 26 | granulocyte differentiation |
GO:0045088 | 0.0063 | 3.408 | 2.1786 | 7 | 151 | regulation of innate immune response |
GO:0042102 | 0.0066 | 5.7919 | 0.7502 | 4 | 52 | positive regulation of T cell proliferation |
GO:0042110 | 0.0068 | 4.4944 | 1.1899 | 5 | 87 | T cell activation |
GO:0002689 | 0.007 | 19.7113 | 0.1298 | 2 | 9 | negative regulation of leukocyte chemotaxis |
GO:0006691 | 0.007 | 19.7113 | 0.1298 | 2 | 9 | leukotriene metabolic process |
GO:0045351 | 0.007 | 19.7113 | 0.1298 | 2 | 9 | type I interferon biosynthetic process |
GO:0060340 | 0.007 | 19.7113 | 0.1298 | 2 | 9 | positive regulation of type I interferon-mediated signaling pathway |
GO:0060259 | 0.0082 | 7.9907 | 0.4184 | 3 | 29 | regulation of feeding behavior |
GO:0051707 | 0.0098 | 2.2057 | 6.2184 | 13 | 431 | response to other organism |
GO:0006335 | 0.0099 | 7.4188 | 0.4473 | 3 | 31 | DNA replication-dependent nucleosome assembly |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:1903037 | 0 | 23.8641 | 0.2826 | 5 | 189 | regulation of leukocyte cell-cell adhesion |
GO:0051249 | 0 | 17.405 | 0.3827 | 5 | 256 | regulation of lymphocyte activation |
GO:0022409 | 1e-04 | 23.9475 | 0.2123 | 4 | 142 | positive regulation of cell-cell adhesion |
GO:0002682 | 1e-04 | 9.0512 | 1.1318 | 7 | 757 | regulation of immune system process |
GO:0050865 | 1e-04 | 13.2824 | 0.4964 | 5 | 332 | regulation of cell activation |
GO:0002696 | 1e-04 | 18.5098 | 0.2721 | 4 | 182 | positive regulation of leukocyte activation |
GO:0002250 | 3e-04 | 15.5012 | 0.3229 | 4 | 216 | adaptive immune response |
GO:0043368 | 5e-04 | 74.0944 | 0.0329 | 2 | 22 | positive T cell selection |
GO:0030155 | 5e-04 | 9.4092 | 0.6907 | 5 | 462 | regulation of cell adhesion |
GO:1903708 | 0.001 | 17.8168 | 0.2003 | 3 | 134 | positive regulation of hemopoiesis |
GO:0009988 | 0.0012 | 44.862 | 0.0523 | 2 | 35 | cell-cell recognition |
GO:0032078 | 0.0015 | Inf | 0.0015 | 1 | 1 | negative regulation of endodeoxyribonuclease activity |
GO:0045087 | 0.0016 | 9.429 | 0.5218 | 4 | 349 | innate immune response |
GO:0038083 | 0.0016 | 38.9444 | 0.0598 | 2 | 40 | peptidyl-tyrosine autophosphorylation |
GO:1902105 | 0.0022 | 13.3702 | 0.2646 | 3 | 177 | regulation of leukocyte differentiation |
GO:0050870 | 0.0025 | 31.2594 | 0.0743 | 2 | 55 | positive regulation of T cell activation |
GO:0042102 | 0.0027 | 29.5711 | 0.0777 | 2 | 52 | positive regulation of T cell proliferation |
GO:0070661 | 0.0029 | 12.1645 | 0.2901 | 3 | 194 | leukocyte proliferation |
GO:0050852 | 0.003 | 27.891 | 0.0822 | 2 | 55 | T cell receptor signaling pathway |
GO:0045621 | 0.0038 | 24.6241 | 0.0927 | 2 | 62 | positive regulation of lymphocyte differentiation |
GO:0043366 | 0.0045 | 351.4474 | 0.0045 | 1 | 3 | beta selection |
GO:1990918 | 0.0045 | 351.4474 | 0.0045 | 1 | 3 | double-strand break repair involved in meiotic recombination |
GO:0048513 | 0.0054 | 3.6662 | 3.657 | 9 | 2446 | animal organ development |
GO:0032946 | 0.006 | 19.4167 | 0.1166 | 2 | 78 | positive regulation of mononuclear cell proliferation |
GO:0000706 | 0.006 | 234.2807 | 0.006 | 1 | 4 | meiotic DNA double-strand break processing |
GO:0042138 | 0.006 | 234.2807 | 0.006 | 1 | 4 | meiotic DNA double-strand break formation |
GO:0045580 | 0.0074 | 17.349 | 0.1301 | 2 | 87 | regulation of T cell differentiation |
GO:0007341 | 0.0075 | 175.6974 | 0.0075 | 1 | 5 | penetration of zona pellucida |
GO:0045588 | 0.0075 | 175.6974 | 0.0075 | 1 | 5 | positive regulation of gamma-delta T cell differentiation |
GO:0045657 | 0.0075 | 175.6974 | 0.0075 | 1 | 5 | positive regulation of monocyte differentiation |
GO:0002429 | 0.0077 | 16.9476 | 0.1331 | 2 | 89 | immune response-activating cell surface receptor signaling pathway |
GO:0046631 | 0.0079 | 16.7538 | 0.1346 | 2 | 90 | alpha-beta T cell activation |
GO:0022610 | 0.0087 | 4.6919 | 1.3321 | 5 | 891 | biological adhesion |
GO:0000237 | 0.0089 | 140.5474 | 0.009 | 1 | 6 | leptotene |
GO:0001787 | 0.0089 | 140.5474 | 0.009 | 1 | 6 | natural killer cell proliferation |
GO:0050778 | 0.0098 | 7.7069 | 0.4515 | 3 | 302 | positive regulation of immune response |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050863 | 1e-04 | 21.9053 | 0.2368 | 4 | 176 | regulation of T cell activation |
GO:0002250 | 2e-04 | 17.7183 | 0.2906 | 4 | 216 | adaptive immune response |
GO:0008037 | 2e-04 | 30.8674 | 0.1198 | 3 | 89 | cell recognition |
GO:0022407 | 4e-04 | 14.4512 | 0.3539 | 4 | 263 | regulation of cell-cell adhesion |
GO:1903039 | 5e-04 | 23.6554 | 0.1547 | 3 | 115 | positive regulation of leukocyte cell-cell adhesion |
GO:0002684 | 5e-04 | 9.6703 | 0.6943 | 5 | 516 | positive regulation of immune system process |
GO:0035036 | 5e-04 | 69.4531 | 0.035 | 2 | 26 | sperm-egg recognition |
GO:0002694 | 6e-04 | 12.5225 | 0.4064 | 4 | 302 | regulation of leukocyte activation |
GO:0051251 | 0.0012 | 16.8178 | 0.2153 | 3 | 160 | positive regulation of lymphocyte activation |
GO:0032078 | 0.0013 | Inf | 0.0013 | 1 | 1 | negative regulation of endodeoxyribonuclease activity |
GO:0050867 | 0.0021 | 13.8621 | 0.2597 | 3 | 193 | positive regulation of cell activation |
GO:0070661 | 0.0021 | 13.7885 | 0.261 | 3 | 194 | leukocyte proliferation |
GO:0042102 | 0.0022 | 33.2725 | 0.07 | 2 | 52 | positive regulation of T cell proliferation |
GO:0071626 | 0.0027 | 785.7647 | 0.0027 | 1 | 2 | mastication |
GO:0098583 | 0.0027 | 785.7647 | 0.0027 | 1 | 2 | learned vocalization behavior |
GO:1905747 | 0.0027 | 785.7647 | 0.0027 | 1 | 2 | negative regulation of saliva secretion |
GO:1905748 | 0.0027 | 785.7647 | 0.0027 | 1 | 2 | hard palate morphogenesis |
GO:0046649 | 0.0035 | 11.6652 | 0.3178 | 3 | 280 | lymphocyte activation |
GO:0007356 | 0.004 | 392.8529 | 0.004 | 1 | 3 | thorax and anterior abdomen determination |
GO:0043366 | 0.004 | 392.8529 | 0.004 | 1 | 3 | beta selection |
GO:0032946 | 0.0048 | 21.847 | 0.105 | 2 | 78 | positive regulation of mononuclear cell proliferation |
GO:0045785 | 0.005 | 10.0368 | 0.3552 | 3 | 264 | positive regulation of cell adhesion |
GO:0022610 | 0.0054 | 5.4146 | 1.1989 | 5 | 891 | biological adhesion |
GO:0021650 | 0.0054 | 261.8824 | 0.0054 | 1 | 4 | vestibulocochlear nerve formation |
GO:1901078 | 0.0054 | 261.8824 | 0.0054 | 1 | 4 | negative regulation of relaxation of muscle |
GO:0046631 | 0.0064 | 18.8509 | 0.1211 | 2 | 90 | alpha-beta T cell activation |
GO:0007341 | 0.0067 | 196.3971 | 0.0067 | 1 | 5 | penetration of zona pellucida |
GO:0045657 | 0.0067 | 196.3971 | 0.0067 | 1 | 5 | positive regulation of monocyte differentiation |
GO:1902107 | 0.008 | 16.7424 | 0.1359 | 2 | 101 | positive regulation of leukocyte differentiation |
GO:0001787 | 0.008 | 157.1059 | 0.0081 | 1 | 6 | natural killer cell proliferation |
GO:0048251 | 0.008 | 157.1059 | 0.0081 | 1 | 6 | elastic fiber assembly |
GO:0032074 | 0.0094 | 130.9118 | 0.0094 | 1 | 7 | negative regulation of nuclease activity |
GO:0045059 | 0.0094 | 130.9118 | 0.0094 | 1 | 7 | positive thymic T cell selection |
GO:0045060 | 0.0094 | 130.9118 | 0.0094 | 1 | 7 | negative thymic T cell selection |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045653 | 0 | 71.6121 | 0.7536 | 13 | 17 | negative regulation of megakaryocyte differentiation |
GO:0006335 | 0 | 18.1589 | 1.3742 | 14 | 31 | DNA replication-dependent nucleosome assembly |
GO:0006336 | 0 | 22.019 | 1.1526 | 13 | 26 | DNA replication-independent nucleosome assembly |
GO:0051290 | 0 | 9.8582 | 1.8619 | 13 | 42 | protein heterotetramerization |
GO:0034728 | 0 | 4.5183 | 5.2309 | 20 | 118 | nucleosome organization |
GO:0071103 | 0 | 3.7072 | 7.7577 | 25 | 175 | DNA conformation change |
GO:0065004 | 0 | 3.8974 | 6.8268 | 23 | 154 | protein-DNA complex assembly |
GO:0006342 | 0 | 5.8081 | 2.9701 | 14 | 67 | chromatin silencing |
GO:0031497 | 0 | 4.4153 | 4.7876 | 18 | 108 | chromatin assembly |
GO:0002323 | 0 | 13.8708 | 0.7979 | 7 | 18 | natural killer cell activation involved in immune response |
GO:0040029 | 0 | 3.292 | 7.1814 | 21 | 162 | regulation of gene expression, epigenetic |
GO:1903707 | 0 | 3.8678 | 4.7433 | 16 | 107 | negative regulation of hemopoiesis |
GO:0045637 | 0 | 3.2461 | 6.9155 | 20 | 156 | regulation of myeloid cell differentiation |
GO:0002366 | 0 | 3.1523 | 7.0928 | 20 | 160 | leukocyte activation involved in immune response |
GO:0033141 | 1e-04 | 11.869 | 0.7536 | 6 | 17 | positive regulation of peptidyl-serine phosphorylation of STAT protein |
GO:0090304 | 2e-04 | 1.3945 | 158.014 | 197 | 3605 | nucleic acid metabolic process |
GO:0051259 | 2e-04 | 1.9959 | 20.4804 | 38 | 462 | protein oligomerization |
GO:0002250 | 2e-04 | 2.5004 | 9.5752 | 22 | 216 | adaptive immune response |
GO:0051276 | 3e-04 | 1.7727 | 30.8481 | 51 | 717 | chromosome organization |
GO:0006725 | 3e-04 | 1.3561 | 187.9141 | 227 | 4239 | cellular aromatic compound metabolic process |
GO:0002682 | 4e-04 | 1.7217 | 33.5577 | 54 | 757 | regulation of immune system process |
GO:1901360 | 4e-04 | 1.3424 | 192.8347 | 231 | 4350 | organic cyclic compound metabolic process |
GO:0046483 | 5e-04 | 1.3423 | 186.4069 | 224 | 4205 | heterocycle metabolic process |
GO:0002286 | 5e-04 | 4.0436 | 2.8371 | 10 | 64 | T cell activation involved in immune response |
GO:0044260 | 5e-04 | 1.3322 | 250.0321 | 289 | 5763 | cellular macromolecule metabolic process |
GO:0010564 | 5e-04 | 1.9216 | 20.0371 | 36 | 452 | regulation of cell cycle process |
GO:0002252 | 5e-04 | 1.9716 | 17.9092 | 33 | 404 | immune effector process |
GO:0006907 | 7e-04 | 9.0505 | 0.7536 | 5 | 17 | pinocytosis |
GO:0090329 | 7e-04 | 5.442 | 1.5515 | 7 | 35 | regulation of DNA-dependent DNA replication |
GO:2001034 | 8e-04 | 32.4966 | 0.2216 | 3 | 5 | positive regulation of double-strand break repair via nonhomologous end joining |
GO:0071285 | 0.001 | 12.3958 | 0.4876 | 4 | 11 | cellular response to lithium ion |
GO:0000726 | 0.001 | 5.0784 | 1.6402 | 7 | 37 | non-recombinational repair |
GO:0051054 | 0.0011 | 2.3712 | 8.6443 | 19 | 195 | positive regulation of DNA metabolic process |
GO:0043330 | 0.0014 | 4.7602 | 1.7289 | 7 | 39 | response to exogenous dsRNA |
GO:0044786 | 0.0015 | 5.6711 | 1.2856 | 6 | 29 | cell cycle DNA replication |
GO:0032801 | 0.0015 | 7.2387 | 0.8866 | 5 | 20 | receptor catabolic process |
GO:0045830 | 0.0015 | 7.2387 | 0.8866 | 5 | 20 | positive regulation of isotype switching |
GO:0051602 | 0.0015 | 7.2387 | 0.8866 | 5 | 20 | response to electrical stimulus |
GO:0060179 | 0.0016 | 21.6627 | 0.266 | 3 | 6 | male mating behavior |
GO:0006396 | 0.0016 | 1.6468 | 30.8979 | 48 | 697 | RNA processing |
GO:0006427 | 0.002 | Inf | 0.0887 | 2 | 2 | histidyl-tRNA aminoacylation |
GO:0006260 | 0.002 | 2.1851 | 9.7969 | 20 | 221 | DNA replication |
GO:0040015 | 0.002 | 9.6397 | 0.5763 | 4 | 13 | negative regulation of multicellular organism growth |
GO:0090502 | 0.0024 | 6.3861 | 0.9753 | 5 | 22 | RNA phosphodiester bond hydrolysis, endonucleolytic |
GO:0048534 | 0.0026 | 1.6248 | 29.2577 | 45 | 660 | hematopoietic or lymphoid organ development |
GO:0015780 | 0.0027 | 16.2458 | 0.3103 | 3 | 7 | nucleotide-sugar transport |
GO:0042100 | 0.0027 | 3.3814 | 2.9701 | 9 | 67 | B cell proliferation |
GO:0032438 | 0.0027 | 8.675 | 0.6206 | 4 | 14 | melanosome organization |
GO:0002440 | 0.0029 | 2.6064 | 5.4082 | 13 | 122 | production of molecular mediator of immune response |
GO:0002312 | 0.0031 | 3.6285 | 2.4825 | 8 | 56 | B cell activation involved in immune response |
GO:0030433 | 0.0031 | 3.6285 | 2.4825 | 8 | 56 | ubiquitin-dependent ERAD pathway |
GO:0030183 | 0.0034 | 2.8237 | 4.2557 | 11 | 96 | B cell differentiation |
GO:0002714 | 0.0035 | 5.7129 | 1.0639 | 5 | 24 | positive regulation of B cell mediated immunity |
GO:0032943 | 0.0036 | 2.2164 | 8.201 | 17 | 185 | mononuclear cell proliferation |
GO:0006974 | 0.0038 | 1.6274 | 26.5536 | 41 | 599 | cellular response to DNA damage stimulus |
GO:0002637 | 0.0039 | 3.9037 | 2.0392 | 7 | 46 | regulation of immunoglobulin production |
GO:0034498 | 0.0041 | 12.9956 | 0.3546 | 3 | 8 | early endosome to Golgi transport |
GO:0098787 | 0.0041 | 12.9956 | 0.3546 | 3 | 8 | mRNA cleavage involved in mRNA processing |
GO:0046649 | 0.0041 | 1.7302 | 19.5051 | 32 | 440 | lymphocyte activation |
GO:0090305 | 0.0043 | 2.7268 | 4.3887 | 11 | 99 | nucleic acid phosphodiester bond hydrolysis |
GO:0016445 | 0.0049 | 3.7127 | 2.1278 | 7 | 48 | somatic diversification of immunoglobulins |
GO:0051302 | 0.0049 | 2.5429 | 5.0979 | 12 | 115 | regulation of cell division |
GO:0034641 | 0.0051 | 1.2538 | 205.1584 | 235 | 4628 | cellular nitrogen compound metabolic process |
GO:0065003 | 0.0052 | 1.4037 | 58.6484 | 78 | 1323 | macromolecular complex assembly |
GO:1901990 | 0.0052 | 2.075 | 9.2206 | 18 | 208 | regulation of mitotic cell cycle phase transition |
GO:1902750 | 0.0053 | 4.205 | 1.6402 | 6 | 37 | negative regulation of cell cycle G2/M phase transition |
GO:0043414 | 0.0053 | 3.0067 | 3.2865 | 9 | 75 | macromolecule methylation |
GO:0006289 | 0.0055 | 3.624 | 2.1722 | 7 | 49 | nucleotide-excision repair |
GO:0090481 | 0.0057 | 43.2589 | 0.133 | 2 | 3 | pyrimidine nucleotide-sugar transmembrane transport |
GO:1901666 | 0.0057 | 43.2589 | 0.133 | 2 | 3 | positive regulation of NAD+ ADP-ribosyltransferase activity |
GO:1903679 | 0.0057 | 43.2589 | 0.133 | 2 | 3 | positive regulation of cap-independent translational initiation |
GO:1905075 | 0.0057 | 43.2589 | 0.133 | 2 | 3 | positive regulation of occluding junction disassembly |
GO:0007095 | 0.0057 | 6.6715 | 0.7536 | 4 | 17 | mitotic G2 DNA damage checkpoint |
GO:0032463 | 0.006 | 10.8288 | 0.399 | 3 | 9 | negative regulation of protein homooligomerization |
GO:0032570 | 0.006 | 10.8288 | 0.399 | 3 | 9 | response to progesterone |
GO:0002204 | 0.0061 | 4.0733 | 1.6845 | 6 | 38 | somatic recombination of immunoglobulin genes involved in immune response |
GO:0006302 | 0.0063 | 2.2007 | 7.2701 | 15 | 164 | double-strand break repair |
GO:0050864 | 0.0069 | 2.69 | 4.034 | 10 | 91 | regulation of B cell activation |
GO:0009987 | 0.007 | 1.3168 | 428.3498 | 452 | 9890 | cellular process |
GO:0070734 | 0.0071 | 6.1945 | 0.7979 | 4 | 18 | histone H3-K27 methylation |
GO:0002562 | 0.0077 | 3.3816 | 2.3052 | 7 | 52 | somatic diversification of immune receptors via germline recombination within a single locus |
GO:0042438 | 0.0082 | 9.2811 | 0.4433 | 3 | 10 | melanin biosynthetic process |
GO:0019748 | 0.0083 | 4.521 | 1.2856 | 5 | 29 | secondary metabolic process |
GO:0001775 | 0.0083 | 1.5528 | 26.9969 | 40 | 609 | cell activation |
GO:0045948 | 0.0087 | 5.7811 | 0.8423 | 4 | 19 | positive regulation of translational initiation |
GO:0120034 | 0.0087 | 2.7594 | 3.5464 | 9 | 80 | positive regulation of plasma membrane bounded cell projection assembly |
GO:0070271 | 0.0093 | 1.4142 | 45.97 | 62 | 1037 | protein complex biogenesis |
GO:0006479 | 0.0099 | 2.2162 | 6.2505 | 13 | 141 | protein methylation |
GO:0071822 | 0.0099 | 1.3882 | 51.3783 | 68 | 1159 | protein complex subunit organization |
GO:0002381 | 0.01 | 3.6195 | 1.8619 | 6 | 42 | immunoglobulin production involved in immunoglobulin mediated immune response |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006342 | 0 | 6.3446 | 2.7347 | 14 | 67 | chromatin silencing |
GO:0002323 | 0 | 15.1358 | 0.7347 | 7 | 18 | natural killer cell activation involved in immune response |
GO:0002286 | 0 | 5.5225 | 2.6122 | 12 | 64 | T cell activation involved in immune response |
GO:1901360 | 0 | 1.4561 | 177.551 | 223 | 4350 | organic cyclic compound metabolic process |
GO:0006725 | 0 | 1.4562 | 173.0204 | 218 | 4239 | cellular aromatic compound metabolic process |
GO:0046483 | 0 | 1.4509 | 171.6327 | 216 | 4205 | heterocycle metabolic process |
GO:0002366 | 0 | 3.2448 | 6.5306 | 19 | 160 | leukocyte activation involved in immune response |
GO:0033141 | 0 | 12.9495 | 0.6939 | 6 | 17 | positive regulation of peptidyl-serine phosphorylation of STAT protein |
GO:0051276 | 2e-04 | 1.745 | 36.4082 | 59 | 892 | chromosome organization |
GO:0034641 | 2e-04 | 1.3738 | 188.898 | 228 | 4628 | cellular nitrogen compound metabolic process |
GO:0090304 | 2e-04 | 1.4322 | 118.1993 | 152 | 2979 | nucleic acid metabolic process |
GO:0048023 | 3e-04 | 70.884 | 0.1633 | 3 | 4 | positive regulation of melanin biosynthetic process |
GO:0040029 | 3e-04 | 2.8116 | 6.6122 | 17 | 162 | regulation of gene expression, epigenetic |
GO:0030183 | 5e-04 | 3.4101 | 3.9184 | 12 | 96 | B cell differentiation |
GO:0043330 | 9e-04 | 5.1944 | 1.5918 | 7 | 39 | response to exogenous dsRNA |
GO:0002252 | 0.0012 | 1.9365 | 16.4898 | 30 | 404 | immune effector process |
GO:1900376 | 0.0012 | 23.6243 | 0.2449 | 3 | 6 | regulation of secondary metabolite biosynthetic process |
GO:0032943 | 0.0015 | 2.4223 | 7.551 | 17 | 185 | mononuclear cell proliferation |
GO:0042100 | 0.0015 | 3.6909 | 2.7347 | 9 | 67 | B cell proliferation |
GO:0065004 | 0.0016 | 2.5794 | 6.2857 | 15 | 154 | protein-DNA complex assembly |
GO:0006427 | 0.0017 | Inf | 0.0816 | 2 | 2 | histidyl-tRNA aminoacylation |
GO:0032438 | 0.002 | 9.462 | 0.5714 | 4 | 14 | melanosome organization |
GO:0015031 | 0.0025 | 1.448 | 58.7755 | 80 | 1440 | protein transport |
GO:0042886 | 0.0025 | 1.4418 | 60.5306 | 82 | 1483 | amide transport |
GO:0006396 | 0.0026 | 1.6346 | 28.449 | 44 | 697 | RNA processing |
GO:0051253 | 0.0027 | 1.5273 | 40.898 | 59 | 1002 | negative regulation of RNA metabolic process |
GO:0006959 | 0.0028 | 3.3433 | 2.9796 | 9 | 73 | humoral immune response |
GO:0008104 | 0.0028 | 1.3783 | 83.0612 | 107 | 2035 | protein localization |
GO:0006302 | 0.0029 | 2.4044 | 6.6939 | 15 | 164 | double-strand break repair |
GO:0048278 | 0.0031 | 4.0513 | 1.9592 | 7 | 48 | vesicle docking |
GO:0034498 | 0.0032 | 14.1724 | 0.3265 | 3 | 8 | early endosome to Golgi transport |
GO:0002250 | 0.0033 | 2.1751 | 8.8163 | 18 | 216 | adaptive immune response |
GO:0042790 | 0.0034 | 7.8838 | 0.6531 | 4 | 16 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter |
GO:1903507 | 0.0034 | 1.5306 | 37.9592 | 55 | 930 | negative regulation of nucleic acid-templated transcription |
GO:0044260 | 0.004 | 1.2845 | 199.159 | 228 | 5101 | cellular macromolecule metabolic process |
GO:0045780 | 0.0043 | 7.2768 | 0.6939 | 4 | 17 | positive regulation of bone resorption |
GO:0051684 | 0.0049 | 47.1691 | 0.1224 | 2 | 3 | maintenance of Golgi location |
GO:0090481 | 0.0049 | 47.1691 | 0.1224 | 2 | 3 | pyrimidine nucleotide-sugar transmembrane transport |
GO:0006261 | 0.0052 | 2.6442 | 4.4898 | 11 | 110 | DNA-dependent DNA replication |
GO:2001234 | 0.0054 | 2.2371 | 7.1429 | 15 | 175 | negative regulation of apoptotic signaling pathway |
GO:0006259 | 0.0054 | 1.5638 | 29.5918 | 44 | 725 | DNA metabolic process |
GO:1990830 | 0.006 | 2.5915 | 4.5714 | 11 | 112 | cellular response to leukemia inhibitory factor |
GO:0016050 | 0.0064 | 1.984 | 10.1224 | 19 | 248 | vesicle organization |
GO:0006367 | 0.0067 | 3.4586 | 2.2449 | 7 | 55 | transcription initiation from RNA polymerase II promoter |
GO:0043414 | 0.0074 | 2.0399 | 8.8163 | 17 | 216 | macromolecule methylation |
GO:0022406 | 0.0074 | 3.3878 | 2.2857 | 7 | 56 | membrane docking |
GO:0090501 | 0.0074 | 3.3878 | 2.2857 | 7 | 56 | RNA phosphodiester bond hydrolysis |
GO:0060255 | 0.0075 | 1.2546 | 174.2857 | 201 | 4270 | regulation of macromolecule metabolic process |
GO:0009890 | 0.0075 | 1.4169 | 49.0204 | 66 | 1201 | negative regulation of biosynthetic process |
GO:0071702 | 0.0077 | 1.3357 | 78.5306 | 99 | 1924 | organic substance transport |
GO:0009987 | 0.0084 | 1.3182 | 422.5491 | 445 | 10443 | cellular process |
GO:2000113 | 0.0086 | 1.426 | 44.9388 | 61 | 1101 | negative regulation of cellular macromolecule biosynthetic process |
GO:0055089 | 0.0087 | 8.8557 | 0.449 | 3 | 11 | fatty acid homeostasis |
GO:0034728 | 0.0088 | 2.445 | 4.8163 | 11 | 118 | nucleosome organization |
GO:0033554 | 0.0089 | 1.3852 | 54.6939 | 72 | 1340 | cellular response to stress |
GO:0060612 | 0.009 | 4.3828 | 1.3061 | 5 | 32 | adipose tissue development |
GO:0010887 | 0.0094 | 23.5827 | 0.1633 | 2 | 4 | negative regulation of cholesterol storage |
GO:1902746 | 0.0094 | 23.5827 | 0.1633 | 2 | 4 | regulation of lens fiber cell differentiation |
GO:0034660 | 0.0095 | 1.7174 | 15.8776 | 26 | 389 | ncRNA metabolic process |
GO:0010629 | 0.0096 | 1.3858 | 53.102 | 70 | 1301 | negative regulation of gene expression |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007603 | 0.0011 | 63.0095 | 0.0531 | 2 | 5 | phototransduction, visible light |
GO:0045542 | 0.0011 | 63.0095 | 0.0531 | 2 | 5 | positive regulation of cholesterol biosynthetic process |
GO:0009583 | 0.0028 | 11.8804 | 0.2866 | 3 | 27 | detection of light stimulus |
GO:0042742 | 0.0052 | 4.7938 | 1.1146 | 5 | 105 | defense response to bacterium |
GO:0014831 | 0.0058 | 20.9937 | 0.1168 | 2 | 11 | gastro-intestinal system smooth muscle contraction |
GO:0045019 | 0.0058 | 20.9937 | 0.1168 | 2 | 11 | negative regulation of nitric oxide biosynthetic process |
GO:0060346 | 0.0058 | 20.9937 | 0.1168 | 2 | 11 | bone trabecula formation |
GO:0032695 | 0.0081 | 17.174 | 0.138 | 2 | 13 | negative regulation of interleukin-12 production |
GO:0095500 | 0.0094 | 15.7417 | 0.1486 | 2 | 14 | acetylcholine receptor signaling pathway |
GO:1905144 | 0.0094 | 15.7417 | 0.1486 | 2 | 14 | response to acetylcholine |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006342 | 0 | 9.7269 | 1.0919 | 9 | 67 | chromatin silencing |
GO:0040029 | 0 | 5.052 | 2.6401 | 12 | 162 | regulation of gene expression, epigenetic |
GO:0001958 | 0 | 15.4214 | 0.4074 | 5 | 25 | endochondral ossification |
GO:2001012 | 1e-04 | 61.1907 | 0.0978 | 3 | 6 | mesenchymal cell differentiation involved in renal system development |
GO:0007267 | 2e-04 | 2.1434 | 17.0137 | 33 | 1044 | cell-cell signaling |
GO:0009946 | 3e-04 | Inf | 0.0326 | 2 | 2 | proximal/distal axis specification |
GO:0048389 | 3e-04 | Inf | 0.0326 | 2 | 2 | intermediate mesoderm development |
GO:0061227 | 3e-04 | Inf | 0.0326 | 2 | 2 | pattern specification involved in mesonephros development |
GO:0072098 | 3e-04 | Inf | 0.0326 | 2 | 2 | anterior/posterior pattern specification involved in kidney development |
GO:0086098 | 3e-04 | Inf | 0.0326 | 2 | 2 | angiotensin-activated signaling pathway involved in heart process |
GO:0048706 | 7e-04 | 4.4781 | 1.9393 | 8 | 119 | embryonic skeletal system development |
GO:0035993 | 8e-04 | 121.8333 | 0.0489 | 2 | 3 | deltoid tuberosity development |
GO:0061792 | 8e-04 | 121.8333 | 0.0489 | 2 | 3 | secretory granule maturation |
GO:0072190 | 8e-04 | 121.8333 | 0.0489 | 2 | 3 | ureter urothelium development |
GO:0030001 | 9e-04 | 2.3036 | 9.8269 | 21 | 603 | metal ion transport |
GO:0051899 | 0.001 | 5.7908 | 1.1408 | 6 | 70 | membrane depolarization |
GO:0072074 | 0.0011 | 18.3474 | 0.2119 | 3 | 13 | kidney mesenchyme development |
GO:0007155 | 0.0012 | 2.0241 | 14.4388 | 27 | 886 | cell adhesion |
GO:0010954 | 0.0014 | 16.6782 | 0.2282 | 3 | 14 | positive regulation of protein processing |
GO:0097094 | 0.0014 | 16.6782 | 0.2282 | 3 | 14 | craniofacial suture morphogenesis |
GO:0002028 | 0.0014 | 5.3692 | 1.2222 | 6 | 75 | regulation of sodium ion transport |
GO:0086103 | 0.0015 | 61.4813 | 0.0646 | 2 | 4 | G-protein coupled receptor signaling pathway involved in heart process |
GO:0035990 | 0.0016 | 60.912 | 0.0652 | 2 | 4 | tendon cell differentiation |
GO:0060279 | 0.0016 | 60.912 | 0.0652 | 2 | 4 | positive regulation of ovulation |
GO:0060686 | 0.0016 | 60.912 | 0.0652 | 2 | 4 | negative regulation of prostatic bud formation |
GO:0072162 | 0.0016 | 60.912 | 0.0652 | 2 | 4 | metanephric mesenchymal cell differentiation |
GO:0031639 | 0.0017 | 15.2872 | 0.2444 | 3 | 15 | plasminogen activation |
GO:0051956 | 0.0017 | 15.2872 | 0.2444 | 3 | 15 | negative regulation of amino acid transport |
GO:0022898 | 0.0019 | 3.4765 | 2.7704 | 9 | 170 | regulation of transmembrane transporter activity |
GO:0030799 | 0.002 | 4.2468 | 1.7763 | 7 | 109 | regulation of cyclic nucleotide metabolic process |
GO:0072111 | 0.002 | 14.1102 | 0.2607 | 3 | 16 | cell proliferation involved in kidney development |
GO:0098660 | 0.0022 | 2.3966 | 7.1216 | 16 | 437 | inorganic ion transmembrane transport |
GO:0098771 | 0.0024 | 2.3037 | 7.8713 | 17 | 483 | inorganic ion homeostasis |
GO:0044036 | 0.0026 | 40.6049 | 0.0815 | 2 | 5 | cell wall macromolecule metabolic process |
GO:0072104 | 0.0026 | 40.6049 | 0.0815 | 2 | 5 | glomerular capillary formation |
GO:0072239 | 0.0026 | 40.6049 | 0.0815 | 2 | 5 | metanephric glomerulus vasculature development |
GO:0044236 | 0.0028 | 4.627 | 1.4015 | 6 | 86 | multicellular organism metabolic process |
GO:0030816 | 0.0029 | 5.5928 | 0.9778 | 5 | 60 | positive regulation of cAMP metabolic process |
GO:0061437 | 0.0029 | 12.227 | 0.2933 | 3 | 18 | renal system vasculature development |
GO:0003013 | 0.0034 | 2.5281 | 5.4594 | 13 | 335 | circulatory system process |
GO:0015672 | 0.0034 | 2.5281 | 5.4594 | 13 | 335 | monovalent inorganic cation transport |
GO:0072503 | 0.0035 | 2.6314 | 4.8401 | 12 | 297 | cellular divalent inorganic cation homeostasis |
GO:2000649 | 0.0036 | 7.0088 | 0.6356 | 4 | 39 | regulation of sodium ion transmembrane transporter activity |
GO:0003057 | 0.0038 | 30.4514 | 0.0978 | 2 | 6 | regulation of the force of heart contraction by chemical signal |
GO:0003180 | 0.0038 | 30.4514 | 0.0978 | 2 | 6 | aortic valve morphogenesis |
GO:0010459 | 0.0038 | 30.4514 | 0.0978 | 2 | 6 | negative regulation of heart rate |
GO:0035989 | 0.0038 | 30.4514 | 0.0978 | 2 | 6 | tendon development |
GO:0061439 | 0.0038 | 30.4514 | 0.0978 | 2 | 6 | kidney vasculature morphogenesis |
GO:1903524 | 0.0038 | 5.2121 | 1.043 | 5 | 64 | positive regulation of blood circulation |
GO:0065007 | 0.0043 | 1.4738 | 128.776 | 148 | 7902 | biological regulation |
GO:0050830 | 0.0043 | 6.6289 | 0.6682 | 4 | 41 | defense response to Gram-positive bacterium |
GO:0055080 | 0.0044 | 2.2166 | 7.6594 | 16 | 470 | cation homeostasis |
GO:0008016 | 0.0046 | 3.6353 | 2.0534 | 7 | 126 | regulation of heart contraction |
GO:0032963 | 0.0047 | 4.9587 | 1.0919 | 5 | 67 | collagen metabolic process |
GO:1903507 | 0.0049 | 1.8358 | 15.1559 | 26 | 930 | negative regulation of nucleic acid-templated transcription |
GO:0031327 | 0.005 | 1.7427 | 19.1322 | 31 | 1174 | negative regulation of cellular biosynthetic process |
GO:0010812 | 0.0051 | 6.288 | 0.7008 | 4 | 43 | negative regulation of cell-substrate adhesion |
GO:0048791 | 0.0052 | 9.6499 | 0.3585 | 3 | 22 | calcium ion-regulated exocytosis of neurotransmitter |
GO:0060235 | 0.0053 | 24.3593 | 0.1141 | 2 | 7 | lens induction in camera-type eye |
GO:0072201 | 0.0053 | 24.3593 | 0.1141 | 2 | 7 | negative regulation of mesenchymal cell proliferation |
GO:0051897 | 0.0056 | 4.7288 | 1.1408 | 5 | 70 | positive regulation of protein kinase B signaling |
GO:0052652 | 0.0058 | 3.9337 | 1.6297 | 6 | 100 | cyclic purine nucleotide metabolic process |
GO:0035725 | 0.006 | 4.6568 | 1.1571 | 5 | 71 | sodium ion transmembrane transport |
GO:0003148 | 0.0067 | 8.7296 | 0.3911 | 3 | 24 | outflow tract septum morphogenesis |
GO:0071260 | 0.0067 | 8.7296 | 0.3911 | 3 | 24 | cellular response to mechanical stimulus |
GO:0002495 | 0.0069 | 20.2978 | 0.1304 | 2 | 8 | antigen processing and presentation of peptide antigen via MHC class II |
GO:0048739 | 0.0069 | 20.2978 | 0.1304 | 2 | 8 | cardiac muscle fiber development |
GO:0060601 | 0.0069 | 20.2978 | 0.1304 | 2 | 8 | lateral sprouting from an epithelium |
GO:0072048 | 0.0069 | 20.2978 | 0.1304 | 2 | 8 | renal system pattern specification |
GO:0072102 | 0.0069 | 20.2978 | 0.1304 | 2 | 8 | glomerulus morphogenesis |
GO:1903800 | 0.0069 | 20.2978 | 0.1304 | 2 | 8 | positive regulation of production of miRNAs involved in gene silencing by miRNA |
GO:2000543 | 0.0069 | 20.2978 | 0.1304 | 2 | 8 | positive regulation of gastrulation |
GO:0002066 | 0.0071 | 5.7014 | 0.7659 | 4 | 47 | columnar/cuboidal epithelial cell development |
GO:0051480 | 0.0071 | 2.8045 | 3.3897 | 9 | 208 | regulation of cytosolic calcium ion concentration |
GO:0051952 | 0.0071 | 4.4533 | 1.206 | 5 | 74 | regulation of amine transport |
GO:0006941 | 0.0074 | 3.7336 | 1.7111 | 6 | 105 | striated muscle contraction |
GO:0055074 | 0.0077 | 2.4713 | 4.6934 | 11 | 288 | calcium ion homeostasis |
GO:0070374 | 0.0077 | 3.2741 | 2.2652 | 7 | 139 | positive regulation of ERK1 and ERK2 cascade |
GO:0007188 | 0.0077 | 3.6959 | 1.7274 | 6 | 106 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
GO:0043270 | 0.008 | 2.7483 | 3.4549 | 9 | 212 | positive regulation of ion transport |
GO:0050794 | 0.008 | 1.4109 | 115.9831 | 134 | 7117 | regulation of cellular process |
GO:1904062 | 0.0085 | 2.7211 | 3.4875 | 9 | 214 | regulation of cation transmembrane transport |
GO:0032570 | 0.0088 | 17.3968 | 0.1467 | 2 | 9 | response to progesterone |
GO:0036065 | 0.0088 | 17.3968 | 0.1467 | 2 | 9 | fucosylation |
GO:0061615 | 0.0088 | 17.3968 | 0.1467 | 2 | 9 | glycolytic process through fructose-6-phosphate |
GO:0072584 | 0.0088 | 17.3968 | 0.1467 | 2 | 9 | caveolin-mediated endocytosis |
GO:0045934 | 0.0091 | 1.6888 | 18.3337 | 29 | 1125 | negative regulation of nucleobase-containing compound metabolic process |
GO:0006323 | 0.0093 | 3.1534 | 2.3467 | 7 | 144 | DNA packaging |
GO:0030817 | 0.0093 | 4.1508 | 1.2874 | 5 | 79 | regulation of cAMP biosynthetic process |
GO:0055082 | 0.0099 | 2.018 | 8.3602 | 16 | 513 | cellular chemical homeostasis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005509 | 0 | 2.3687 | 27.6546 | 58 | 402 | calcium ion binding |
GO:0030545 | 0 | 2.4038 | 19.6059 | 42 | 285 | receptor regulator activity |
GO:0001653 | 0 | 4.0542 | 5.4346 | 18 | 79 | peptide receptor activity |
GO:0022838 | 0 | 2.2174 | 20.9817 | 42 | 305 | substrate-specific channel activity |
GO:0022803 | 0 | 2.1475 | 22.0824 | 43 | 321 | passive transmembrane transporter activity |
GO:0015459 | 0 | 5.5695 | 2.6141 | 11 | 38 | potassium channel regulator activity |
GO:0099600 | 1e-04 | 1.7723 | 38.455 | 63 | 559 | transmembrane receptor activity |
GO:0008188 | 1e-04 | 6.4655 | 1.9262 | 9 | 28 | neuropeptide receptor activity |
GO:0046873 | 1e-04 | 2.0206 | 22.1512 | 41 | 322 | metal ion transmembrane transporter activity |
GO:0022836 | 1e-04 | 2.2152 | 15.4095 | 31 | 224 | gated channel activity |
GO:0004871 | 2e-04 | 1.5811 | 56.2723 | 83 | 818 | signal transducer activity |
GO:0015075 | 3e-04 | 1.656 | 41.4131 | 64 | 602 | ion transmembrane transporter activity |
GO:0005412 | 3e-04 | Inf | 0.2064 | 3 | 3 | glucose:sodium symporter activity |
GO:0008260 | 3e-04 | Inf | 0.2064 | 3 | 3 | 3-oxoacid CoA-transferase activity |
GO:0005215 | 3e-04 | 2.4648 | 9.9341 | 22 | 148 | transporter activity |
GO:0060089 | 4e-04 | 1.5717 | 52.3511 | 77 | 761 | molecular transducer activity |
GO:0004930 | 9e-04 | 1.9664 | 17.0606 | 31 | 248 | G-protein coupled receptor activity |
GO:0004867 | 0.0012 | 4.543 | 2.2014 | 8 | 32 | serine-type endopeptidase inhibitor activity |
GO:0047617 | 0.0012 | 8.5011 | 0.8943 | 5 | 13 | acyl-CoA hydrolase activity |
GO:0031433 | 0.0012 | 40.7391 | 0.2752 | 3 | 4 | telethonin binding |
GO:0016813 | 0.0012 | 13.5913 | 0.5503 | 4 | 8 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines |
GO:0022804 | 0.0014 | 1.9038 | 17.5421 | 31 | 255 | active transmembrane transporter activity |
GO:0005520 | 0.0015 | 5.0177 | 1.7886 | 7 | 26 | insulin-like growth factor binding |
GO:0005179 | 0.0015 | 3.2641 | 3.9212 | 11 | 57 | hormone activity |
GO:0005125 | 0.0017 | 2.3697 | 8.3927 | 18 | 122 | cytokine activity |
GO:0042165 | 0.0017 | 5.8329 | 1.3759 | 6 | 20 | neurotransmitter binding |
GO:0022892 | 0.0022 | 1.4681 | 54.0022 | 75 | 785 | substrate-specific transporter activity |
GO:0008307 | 0.0023 | 5.4436 | 1.4446 | 6 | 21 | structural constituent of muscle |
GO:0017080 | 0.0023 | 4.5391 | 1.9262 | 7 | 28 | sodium channel regulator activity |
GO:0005244 | 0.0028 | 2.1399 | 10.1813 | 20 | 148 | voltage-gated ion channel activity |
GO:0016782 | 0.0039 | 3.0302 | 3.7836 | 10 | 55 | transferase activity, transferring sulfur-containing groups |
GO:0015293 | 0.0041 | 2.356 | 7.0168 | 15 | 102 | symporter activity |
GO:0050431 | 0.0047 | 5.6656 | 1.1695 | 5 | 17 | transforming growth factor beta binding |
GO:0005133 | 0.0047 | Inf | 0.1376 | 2 | 2 | interferon-gamma receptor binding |
GO:0005146 | 0.0047 | Inf | 0.1376 | 2 | 2 | leukemia inhibitory factor receptor binding |
GO:0032029 | 0.0047 | Inf | 0.1376 | 2 | 2 | myosin tail binding |
GO:0015077 | 0.0049 | 1.769 | 17.4733 | 29 | 254 | monovalent inorganic cation transmembrane transporter activity |
GO:0005261 | 0.0053 | 2.3613 | 6.5278 | 14 | 96 | cation channel activity |
GO:0030414 | 0.0055 | 2.5584 | 5.2282 | 12 | 76 | peptidase inhibitor activity |
GO:0016597 | 0.0064 | 2.9909 | 3.4396 | 9 | 50 | amino acid binding |
GO:0099094 | 0.0065 | 2.7819 | 4.0588 | 10 | 59 | ligand-gated cation channel activity |
GO:0061135 | 0.0067 | 2.4805 | 5.3658 | 12 | 78 | endopeptidase regulator activity |
GO:0005267 | 0.0084 | 2.2222 | 6.8793 | 14 | 100 | potassium channel activity |
GO:0005544 | 0.0088 | 3.4024 | 2.4077 | 7 | 35 | calcium-dependent phospholipid binding |
GO:0016790 | 0.0088 | 3.8864 | 1.8574 | 6 | 27 | thiolester hydrolase activity |
GO:0048306 | 0.0095 | 2.7863 | 3.646 | 9 | 53 | calcium-dependent protein binding |
GO:0005212 | 0.0096 | 6.0381 | 0.8943 | 4 | 13 | structural constituent of eye lens |
GO:0015464 | 0.0096 | 6.0381 | 0.8943 | 4 | 13 | acetylcholine receptor activity |
GO:1904315 | 0.0096 | 6.0381 | 0.8943 | 4 | 13 | transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004014 | 1e-04 | Inf | 0.0223 | 2 | 2 | adenosylmethionine decarboxylase activity |
GO:0019810 | 1e-04 | Inf | 0.0223 | 2 | 2 | putrescine binding |
GO:0043546 | 7e-04 | 89.8503 | 0.0446 | 2 | 4 | molybdopterin cofactor binding |
GO:0031683 | 0.0016 | 15.0594 | 0.2342 | 3 | 21 | G-protein beta/gamma-subunit complex binding |
GO:0001848 | 0.0042 | 25.6618 | 0.1004 | 2 | 9 | complement binding |
GO:0005126 | 0.0048 | 3.5887 | 2.0746 | 7 | 186 | cytokine receptor binding |
GO:0031681 | 0.0064 | 19.9562 | 0.1227 | 2 | 11 | G-protein beta-subunit binding |
GO:0016830 | 0.0074 | 8.2049 | 0.4015 | 3 | 36 | carbon-carbon lyase activity |
GO:0047617 | 0.0089 | 16.3253 | 0.145 | 2 | 13 | acyl-CoA hydrolase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0001965 | 0.0014 | 41.323 | 0.0561 | 2 | 30 | G-protein alpha-subunit binding |
GO:0004362 | 0.0019 | Inf | 0.0019 | 1 | 1 | glutathione-disulfide reductase activity |
GO:1901681 | 0.0033 | 11.3717 | 0.3013 | 3 | 161 | sulfur compound binding |
GO:0005133 | 0.0037 | 555.5417 | 0.0037 | 1 | 2 | interferon-gamma receptor binding |
GO:0030695 | 0.0069 | 8.6053 | 0.3949 | 3 | 211 | GTPase regulator activity |
GO:0005261 | 0.0092 | 7.7349 | 0.4379 | 3 | 234 | cation channel activity |
GO:0005384 | 0.0093 | 138.8542 | 0.0094 | 1 | 5 | manganese ion transmembrane transporter activity |
GO:0047631 | 0.0093 | 138.8542 | 0.0094 | 1 | 5 | ADP-ribose diphosphatase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0008266 | 0.0023 | 13.5771 | 0.2707 | 3 | 16 | poly(U) RNA binding |
GO:0034046 | 0.0041 | 29.3058 | 0.1015 | 2 | 6 | poly(G) binding |
GO:0038036 | 0.0075 | 19.5342 | 0.1353 | 2 | 8 | sphingosine-1-phosphate receptor activity |
GO:0008378 | 0.0093 | 7.6682 | 0.4399 | 3 | 26 | galactosyltransferase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004977 | 0.0034 | 476.5 | 0.0034 | 1 | 3 | melanocortin receptor activity |
GO:0015174 | 0.0089 | 136.0918 | 0.009 | 1 | 8 | basic amino acid transmembrane transporter activity |
GO:0030169 | 0.0089 | 136.0918 | 0.009 | 1 | 8 | low-density lipoprotein particle binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004014 | 6e-04 | Inf | 0.0476 | 2 | 2 | adenosylmethionine decarboxylase activity |
GO:0019810 | 6e-04 | Inf | 0.0476 | 2 | 2 | putrescine binding |
GO:0022803 | 7e-04 | 2.5224 | 7.6411 | 18 | 321 | passive transmembrane transporter activity |
GO:0022838 | 0.001 | 2.5009 | 7.2603 | 17 | 305 | substrate-specific channel activity |
GO:0005261 | 0.0015 | 2.6838 | 5.5702 | 14 | 234 | cation channel activity |
GO:0019828 | 0.0017 | 82.5316 | 0.0714 | 2 | 3 | aspartic-type endopeptidase inhibitor activity |
GO:0004457 | 0.0033 | 41.2627 | 0.0952 | 2 | 4 | lactate dehydrogenase activity |
GO:0015269 | 0.004 | 11.2814 | 0.3333 | 3 | 14 | calcium-activated potassium channel activity |
GO:0016616 | 0.0044 | 3.693 | 2.0472 | 7 | 86 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor |
GO:0005105 | 0.0054 | 27.5063 | 0.119 | 2 | 5 | type 1 fibroblast growth factor receptor binding |
GO:0031432 | 0.0054 | 27.5063 | 0.119 | 2 | 5 | titin binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004014 | 4e-04 | Inf | 0.041 | 2 | 2 | adenosylmethionine decarboxylase activity |
GO:0019810 | 4e-04 | Inf | 0.041 | 2 | 2 | putrescine binding |
GO:0019828 | 0.0012 | 96.2059 | 0.0615 | 2 | 3 | aspartic-type endopeptidase inhibitor activity |
GO:0015179 | 0.0022 | 6.0618 | 0.923 | 5 | 45 | L-amino acid transmembrane transporter activity |
GO:0051575 | 0.004 | 32.0637 | 0.1026 | 2 | 5 | 5'-deoxyribose-5-phosphate lyase activity |
GO:0048018 | 0.0073 | 2.3806 | 5.3122 | 12 | 259 | receptor ligand activity |
GO:0046965 | 0.0075 | 8.5097 | 0.4102 | 3 | 20 | retinoid X receptor binding |
GO:0003680 | 0.0082 | 19.2353 | 0.1436 | 2 | 7 | AT DNA binding |
GO:0098772 | 0.0091 | 1.5941 | 23.9973 | 36 | 1170 | molecular function regulator |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0003700 | 5e-04 | 2.6001 | 8.188 | 19 | 904 | DNA binding transcription factor activity |
GO:0031433 | 5e-04 | 111.2269 | 0.0362 | 2 | 4 | telethonin binding |
GO:0019840 | 0.001 | 17.6882 | 0.1993 | 3 | 22 | isoprenoid binding |
GO:0008081 | 0.0027 | 7.5088 | 0.5797 | 4 | 64 | phosphoric diester hydrolase activity |
GO:0001972 | 0.0035 | 27.7941 | 0.0906 | 2 | 10 | retinoic acid binding |
GO:0004621 | 0.0091 | Inf | 0.0091 | 1 | 1 | glycosylphosphatidylinositol phospholipase D activity |
GO:0004900 | 0.0091 | Inf | 0.0091 | 1 | 1 | erythropoietin receptor activity |
GO:0004991 | 0.0091 | Inf | 0.0091 | 1 | 1 | parathyroid hormone receptor activity |
GO:0008700 | 0.0091 | Inf | 0.0091 | 1 | 1 | 4-hydroxy-2-oxoglutarate aldolase activity |
GO:0008775 | 0.0091 | Inf | 0.0091 | 1 | 1 | acetate CoA-transferase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005031 | 3e-04 | 15.4004 | 0.3328 | 4 | 18 | tumor necrosis factor-activated receptor activity |
GO:0048248 | 3e-04 | Inf | 0.037 | 2 | 2 | CXCR3 chemokine receptor binding |
GO:0005126 | 7e-04 | 3.4457 | 3.439 | 11 | 186 | cytokine receptor binding |
GO:0008324 | 0.001 | 2.3776 | 8.5606 | 19 | 463 | cation transmembrane transporter activity |
GO:0048018 | 0.0011 | 2.9056 | 4.7888 | 13 | 259 | receptor ligand activity |
GO:0004872 | 0.0019 | 2.0059 | 13.3494 | 25 | 722 | receptor activity |
GO:0005215 | 0.0021 | 1.8692 | 17.2506 | 30 | 933 | transporter activity |
GO:0048495 | 0.0033 | 35.6707 | 0.0924 | 2 | 5 | Roundabout binding |
GO:0008009 | 0.0035 | 11.5029 | 0.3143 | 3 | 17 | chemokine activity |
GO:0004888 | 0.0046 | 2.0508 | 9.8179 | 19 | 531 | transmembrane signaling receptor activity |
GO:0042165 | 0.0056 | 9.4708 | 0.3698 | 3 | 20 | neurotransmitter binding |
GO:0005451 | 0.0067 | 21.3992 | 0.1294 | 2 | 7 | monovalent cation:proton antiporter activity |
GO:0005044 | 0.0084 | 8.0484 | 0.4253 | 3 | 23 | scavenger receptor activity |
GO:0022891 | 0.0091 | 1.8472 | 11.9996 | 21 | 649 | substrate-specific transmembrane transporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005132 | 0 | 67.2483 | 0.9926 | 11 | 13 | type I interferon receptor binding |
GO:0005125 | 0 | 3.8533 | 9.3151 | 29 | 122 | cytokine activity |
GO:0030545 | 0 | 2.3267 | 21.7606 | 45 | 285 | receptor regulator activity |
GO:0060089 | 0 | 1.6597 | 58.1046 | 89 | 761 | molecular transducer activity |
GO:0004896 | 0 | 4.6721 | 3.5886 | 13 | 47 | cytokine receptor activity |
GO:0038023 | 6e-04 | 1.5915 | 45.6591 | 68 | 598 | signaling receptor activity |
GO:0099600 | 7e-04 | 1.6018 | 42.6813 | 64 | 559 | transmembrane receptor activity |
GO:1990405 | 0.001 | 16.189 | 0.5345 | 4 | 7 | protein antigen binding |
GO:0005031 | 0.0016 | 6.0784 | 1.3744 | 6 | 18 | tumor necrosis factor-activated receptor activity |
GO:0005534 | 0.0017 | 36.3953 | 0.3054 | 3 | 4 | galactose binding |
GO:0038036 | 0.0018 | 12.1407 | 0.6108 | 4 | 8 | sphingosine-1-phosphate receptor activity |
GO:0005102 | 0.002 | 1.3797 | 84.2937 | 110 | 1104 | receptor binding |
GO:0004014 | 0.0058 | Inf | 0.1527 | 2 | 2 | adenosylmethionine decarboxylase activity |
GO:0019810 | 0.0058 | Inf | 0.1527 | 2 | 2 | putrescine binding |
GO:0019958 | 0.0058 | Inf | 0.1527 | 2 | 2 | C-X-C chemokine binding |
GO:0008239 | 0.0074 | 12.1298 | 0.4581 | 3 | 6 | dipeptidyl-peptidase activity |
GO:0042887 | 0.0095 | 4.6707 | 1.3744 | 5 | 18 | amide transmembrane transporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0001784 | 0.0012 | 9.639 | 0.4743 | 4 | 33 | phosphotyrosine residue binding |
GO:0005089 | 0.0014 | 6.6159 | 0.8336 | 5 | 58 | Rho guanyl-nucleotide exchange factor activity |
GO:0005044 | 0.0042 | 10.4341 | 0.3306 | 3 | 23 | scavenger receptor activity |
GO:0032357 | 0.0054 | 23.0895 | 0.115 | 2 | 8 | oxidized purine DNA binding |
GO:0051219 | 0.0062 | 4.6056 | 1.1642 | 5 | 81 | phosphoprotein binding |
GO:0005096 | 0.0072 | 3.0179 | 2.8026 | 8 | 195 | GTPase activator activity |
GO:0051879 | 0.0074 | 8.3441 | 0.4024 | 3 | 28 | Hsp90 protein binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005044 | 5e-04 | 70.4656 | 0.0344 | 2 | 23 | scavenger receptor activity |
GO:0042169 | 8e-04 | 54.7819 | 0.0434 | 2 | 29 | SH2 domain binding |
GO:0001784 | 0.0011 | 47.6989 | 0.0494 | 2 | 33 | phosphotyrosine residue binding |
GO:0004715 | 0.0014 | 42.2349 | 0.0554 | 2 | 37 | non-membrane spanning protein tyrosine kinase activity |
GO:0004991 | 0.0015 | Inf | 0.0015 | 1 | 1 | parathyroid hormone receptor activity |
GO:0031854 | 0.0015 | Inf | 0.0015 | 1 | 1 | orexigenic neuropeptide QRFP receptor binding |
GO:0042610 | 0.0015 | Inf | 0.0015 | 1 | 1 | CD8 receptor binding |
GO:0005157 | 0.003 | 702 | 0.003 | 1 | 2 | macrophage colony-stimulating factor receptor binding |
GO:0070891 | 0.003 | 702 | 0.003 | 1 | 2 | lipoteichoic acid binding |
GO:0003918 | 0.006 | 233.9649 | 0.006 | 1 | 4 | DNA topoisomerase type II (ATP-hydrolyzing) activity |
GO:0051219 | 0.0064 | 18.6498 | 0.1213 | 2 | 81 | phosphoprotein binding |
GO:0042609 | 0.0075 | 175.4605 | 0.0075 | 1 | 5 | CD4 receptor binding |
GO:0015385 | 0.009 | 140.3579 | 0.009 | 1 | 6 | sodium:proton antiporter activity |
GO:0015386 | 0.009 | 140.3579 | 0.009 | 1 | 6 | potassium:proton antiporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004014 | 1e-04 | Inf | 0.0189 | 2 | 2 | adenosylmethionine decarboxylase activity |
GO:0019810 | 1e-04 | Inf | 0.0189 | 2 | 2 | putrescine binding |
GO:0070008 | 0.0046 | 23.6989 | 0.1038 | 2 | 11 | serine-type exopeptidase activity |
GO:0019956 | 0.0055 | 21.3274 | 0.1132 | 2 | 12 | chemokine binding |
GO:0004132 | 0.0094 | Inf | 0.0094 | 1 | 1 | dCMP deaminase activity |
GO:0004148 | 0.0094 | Inf | 0.0094 | 1 | 1 | dihydrolipoyl dehydrogenase activity |
GO:0004778 | 0.0094 | Inf | 0.0094 | 1 | 1 | succinyl-CoA hydrolase activity |
GO:0004918 | 0.0094 | Inf | 0.0094 | 1 | 1 | interleukin-8 receptor activity |
GO:0004964 | 0.0094 | Inf | 0.0094 | 1 | 1 | luteinizing hormone receptor activity |
GO:0019959 | 0.0094 | Inf | 0.0094 | 1 | 1 | interleukin-8 binding |
GO:0035472 | 0.0094 | Inf | 0.0094 | 1 | 1 | choriogonadotropin hormone receptor activity |
GO:0038106 | 0.0094 | Inf | 0.0094 | 1 | 1 | choriogonadotropin hormone binding |
GO:0038164 | 0.0094 | Inf | 0.0094 | 1 | 1 | thrombopoietin receptor activity |
GO:0043544 | 0.0094 | Inf | 0.0094 | 1 | 1 | lipoamide binding |
GO:0005251 | 0.0097 | 15.2293 | 0.1509 | 2 | 16 | delayed rectifier potassium channel activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005044 | 4e-04 | 79.2857 | 0.031 | 2 | 23 | scavenger receptor activity |
GO:0102009 | 0.0013 | Inf | 0.0013 | 1 | 1 | proline dipeptidase activity |
GO:0004872 | 0.0022 | 6.7718 | 0.9728 | 5 | 722 | receptor activity |
GO:0005157 | 0.0027 | 784.7059 | 0.0027 | 1 | 2 | macrophage colony-stimulating factor receptor binding |
GO:0070891 | 0.0027 | 784.7059 | 0.0027 | 1 | 2 | lipoteichoic acid binding |
GO:0004720 | 0.0054 | 261.5294 | 0.0054 | 1 | 4 | protein-lysine 6-oxidase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 4.2597 | 7.1761 | 26 | 165 | histone binding |
GO:0003723 | 0 | 1.7682 | 59.4526 | 95 | 1367 | RNA binding |
GO:0005132 | 0 | 19.0375 | 0.5654 | 6 | 13 | type I interferon receptor binding |
GO:0097159 | 0 | 1.4222 | 188.9261 | 234 | 4344 | organic cyclic compound binding |
GO:1901363 | 0 | 1.4167 | 186.6646 | 231 | 4292 | heterocyclic compound binding |
GO:0035005 | 0 | 44.2842 | 0.2609 | 4 | 6 | 1-phosphatidylinositol-4-phosphate 3-kinase activity |
GO:0003684 | 1e-04 | 5.4406 | 2.2181 | 10 | 51 | damaged DNA binding |
GO:0046934 | 3e-04 | 66.3166 | 0.174 | 3 | 4 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity |
GO:0016303 | 4e-04 | 17.7095 | 0.3914 | 4 | 9 | 1-phosphatidylinositol-3-kinase activity |
GO:0008757 | 0.0013 | 2.7429 | 5.5669 | 14 | 128 | S-adenosylmethionine-dependent methyltransferase activity |
GO:0005114 | 0.0015 | 22.1021 | 0.2609 | 3 | 6 | type II transforming growth factor beta receptor binding |
GO:0005338 | 0.0015 | 22.1021 | 0.2609 | 3 | 6 | nucleotide-sugar transmembrane transporter activity |
GO:0004821 | 0.0019 | Inf | 0.087 | 2 | 2 | histidine-tRNA ligase activity |
GO:0016231 | 0.0019 | Inf | 0.087 | 2 | 2 | beta-N-acetylglucosaminidase activity |
GO:0016741 | 0.0021 | 2.3473 | 7.7849 | 17 | 179 | transferase activity, transferring one-carbon groups |
GO:0097677 | 0.0039 | 13.2592 | 0.3479 | 3 | 8 | STAT family protein binding |
GO:0003677 | 0.0051 | 1.3744 | 70.1522 | 91 | 1635 | DNA binding |
GO:0008170 | 0.0051 | 3.0305 | 3.2618 | 9 | 75 | N-methyltransferase activity |
GO:0010385 | 0.0055 | 44.1347 | 0.1305 | 2 | 3 | double-stranded methylated DNA binding |
GO:0016422 | 0.0055 | 44.1347 | 0.1305 | 2 | 3 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity |
GO:0008173 | 0.0077 | 3.3754 | 2.305 | 7 | 53 | RNA methyltransferase activity |
GO:1904264 | 0.0078 | 9.4694 | 0.4349 | 3 | 10 | ubiquitin protein ligase activity involved in ERAD pathway |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005132 | 0 | 20.4851 | 0.5274 | 6 | 13 | type I interferon receptor binding |
GO:0044877 | 4e-04 | 1.6745 | 37.0827 | 58 | 914 | macromolecular complex binding |
GO:0003723 | 0.0011 | 1.5034 | 55.4618 | 78 | 1367 | RNA binding |
GO:0004821 | 0.0016 | Inf | 0.0811 | 2 | 2 | histidine-tRNA ligase activity |
GO:0015091 | 0.0016 | Inf | 0.0811 | 2 | 2 | ferric iron transmembrane transporter activity |
GO:0046966 | 0.0024 | 6.2717 | 0.9737 | 5 | 24 | thyroid hormone receptor binding |
GO:0097677 | 0.0032 | 14.262 | 0.3246 | 3 | 8 | STAT family protein binding |
GO:0003676 | 0.0038 | 1.4266 | 59.9346 | 80 | 1549 | nucleic acid binding |
GO:0031489 | 0.0052 | 6.7993 | 0.7303 | 4 | 18 | myosin V binding |
GO:0008173 | 0.0053 | 3.6325 | 2.1503 | 7 | 53 | RNA methyltransferase activity |
GO:0043325 | 0.0077 | 5.9484 | 0.8114 | 4 | 20 | phosphatidylinositol-3,4-bisphosphate binding |
GO:0001076 | 0.0083 | 2.356 | 5.4366 | 12 | 134 | transcription factor activity, RNA polymerase II transcription factor binding |
GO:0016423 | 0.0086 | 8.9116 | 0.4463 | 3 | 11 | tRNA (guanine) methyltransferase activity |
GO:0005515 | 0.0089 | 1.2373 | 270.5698 | 298 | 6702 | protein binding |
GO:0004768 | 0.0093 | 23.7315 | 0.1623 | 2 | 4 | stearoyl-CoA 9-desaturase activity |
GO:0035243 | 0.0093 | 23.7315 | 0.1623 | 2 | 4 | protein-arginine omega-N symmetric methyltransferase activity |
GO:0035650 | 0.0093 | 23.7315 | 0.1623 | 2 | 4 | AP-1 adaptor complex binding |
GO:0051425 | 0.0093 | 23.7315 | 0.1623 | 2 | 4 | PTB domain binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0030545 | 2e-04 | 4.1812 | 2.8841 | 11 | 275 | receptor regulator activity |
GO:0005164 | 2e-04 | 16.6276 | 0.287 | 4 | 27 | tumor necrosis factor receptor binding |
GO:0005125 | 3e-04 | 5.9075 | 1.2968 | 7 | 122 | cytokine activity |
GO:0005126 | 8e-04 | 4.3733 | 1.9771 | 8 | 186 | cytokine receptor binding |
GO:0030550 | 0.0016 | 47.1893 | 0.0638 | 2 | 6 | acetylcholine receptor inhibitor activity |
GO:0051378 | 0.0038 | 26.9592 | 0.0957 | 2 | 9 | serotonin binding |
GO:0004993 | 0.0048 | 23.5875 | 0.1063 | 2 | 10 | G-protein coupled serotonin receptor activity |
GO:0099602 | 0.0048 | 23.5875 | 0.1063 | 2 | 10 | neurotransmitter receptor regulator activity |
GO:0005540 | 0.0094 | 15.7202 | 0.1488 | 2 | 14 | hyaluronic acid binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004668 | 1e-04 | 285.2258 | 0.0213 | 2 | 3 | protein-arginine deiminase activity |
GO:0030545 | 9e-04 | 4.3112 | 2.0267 | 8 | 285 | receptor regulator activity |
GO:0005125 | 0.0018 | 6.2426 | 0.8676 | 5 | 122 | cytokine activity |
GO:0005102 | 0.0046 | 2.2666 | 7.8509 | 16 | 1104 | receptor binding |
GO:0008083 | 0.0062 | 5.8453 | 0.7325 | 4 | 103 | growth factor activity |
GO:0002055 | 0.0071 | Inf | 0.0071 | 1 | 1 | adenine binding |
GO:0003999 | 0.0071 | Inf | 0.0071 | 1 | 1 | adenine phosphoribosyltransferase activity |
GO:0004676 | 0.0071 | Inf | 0.0071 | 1 | 1 | 3-phosphoinositide-dependent protein kinase activity |
GO:0004900 | 0.0071 | Inf | 0.0071 | 1 | 1 | erythropoietin receptor activity |
GO:0005139 | 0.0071 | Inf | 0.0071 | 1 | 1 | interleukin-7 receptor binding |
GO:0005141 | 0.0071 | Inf | 0.0071 | 1 | 1 | interleukin-10 receptor binding |
GO:0022894 | 0.0071 | Inf | 0.0071 | 1 | 1 | Intermediate conductance calcium-activated potassium channel activity |
GO:0045550 | 0.0071 | Inf | 0.0071 | 1 | 1 | geranylgeranyl reductase activity |
GO:0047718 | 0.0071 | Inf | 0.0071 | 1 | 1 | indanol dehydrogenase activity |
GO:0005509 | 0.0078 | 3.0037 | 2.8587 | 8 | 402 | calcium ion binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005509 | 3e-04 | 2.8165 | 6.53 | 17 | 402 | calcium ion binding |
GO:0004977 | 8e-04 | 122.2419 | 0.0487 | 2 | 3 | melanocortin receptor activity |
GO:0042923 | 8e-04 | 20.4564 | 0.1949 | 3 | 12 | neuropeptide binding |
GO:0044325 | 0.0014 | 4.5779 | 1.6569 | 7 | 102 | ion channel binding |
GO:0099104 | 0.0015 | 61.1163 | 0.065 | 2 | 4 | potassium channel activator activity |
GO:0016247 | 0.0016 | 8.9602 | 0.5106 | 4 | 32 | channel regulator activity |
GO:0070006 | 0.0017 | 15.3388 | 0.2437 | 3 | 15 | metalloaminopeptidase activity |
GO:0001786 | 0.0021 | 8.2078 | 0.5523 | 4 | 34 | phosphatidylserine binding |
GO:0016702 | 0.0039 | 10.8233 | 0.3249 | 3 | 20 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen |
GO:0022838 | 0.0042 | 2.567 | 4.9543 | 12 | 305 | substrate-specific channel activity |
GO:0005261 | 0.005 | 2.786 | 3.801 | 10 | 234 | cation channel activity |
GO:0051371 | 0.0052 | 24.4409 | 0.1137 | 2 | 7 | muscle alpha-actinin binding |
GO:0043169 | 0.0056 | 1.5088 | 44.118 | 60 | 2716 | cation binding |
GO:0030276 | 0.006 | 6.0007 | 0.731 | 4 | 45 | clathrin binding |
GO:0004888 | 0.006 | 2.0883 | 8.6254 | 17 | 531 | transmembrane signaling receptor activity |
GO:0022803 | 0.0063 | 2.4311 | 5.2142 | 12 | 321 | passive transmembrane transporter activity |
GO:0008528 | 0.0064 | 4.5774 | 1.1751 | 5 | 73 | G-protein coupled peptide receptor activity |
GO:0099106 | 0.0066 | 4.5345 | 1.1858 | 5 | 73 | ion channel regulator activity |
GO:0004872 | 0.007 | 1.9015 | 11.728 | 21 | 722 | receptor activity |
GO:0005080 | 0.0081 | 5.4656 | 0.7959 | 4 | 49 | protein kinase C binding |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
No LOLA Enrichment Analysis was conducted